<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2025//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_250101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">28398525</PMID><DateCompleted><Year>2018</Year><Month>02</Month><Day>23</Day></DateCompleted><DateRevised><Year>2022</Year><Month>04</Month><Day>10</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1527-974X</ISSN><JournalIssue CitedMedium="Internet"><Volume>24</Volume><Issue>6</Issue><PubDate><Year>2017</Year><Month>Nov</Month><Day>01</Day></PubDate></JournalIssue><Title>Journal of the American Medical Informatics Association : JAMIA</Title><ISOAbbreviation>J Am Med Inform Assoc</ISOAbbreviation></Journal><ArticleTitle>A longitudinal analysis of data quality in a large pediatric data research network.</ArticleTitle><Pagination><StartPage>1072</StartPage><EndPage>1079</EndPage><MedlinePgn>1072-1079</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1093/jamia/ocx033</ELocationID><Abstract><AbstractText Label="OBJECTIVE" NlmCategory="OBJECTIVE">PEDSnet is a clinical data research network (CDRN) that aggregates electronic health record data from multiple children's hospitals to enable large-scale research. Assessing data quality to ensure suitability for conducting research is a key requirement in PEDSnet. This study presents a range of data quality issues identified over a period of 18 months and interprets them to evaluate the research capacity of PEDSnet.</AbstractText><AbstractText Label="MATERIALS AND METHODS" NlmCategory="METHODS">Results were generated by a semiautomated data quality assessment workflow. Two investigators reviewed programmatic data quality issues and conducted discussions with the data partners' extract-transform-load analysts to determine the cause for each issue.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">The results include a longitudinal summary of 2182 data quality issues identified across 9 data submission cycles. The metadata from the most recent cycle includes annotations for 850 issues: most frequent types, including missing data (&gt;300) and outliers (&gt;100); most complex domains, including medications (&gt;160) and lab measurements (&gt;140); and primary causes, including source data characteristics (83%) and extract-transform-load errors (9%).</AbstractText><AbstractText Label="DISCUSSION" NlmCategory="CONCLUSIONS">The longitudinal findings demonstrate the network's evolution from identifying difficulties with aligning the data to a common data model to learning norms in clinical pediatrics and determining research capability.</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">While data quality is recognized as a critical aspect in establishing and utilizing a CDRN, the findings from data quality assessments are largely unpublished. This paper presents a real-world account of studying and interpreting data quality findings in a pediatric CDRN, and the lessons learned could be used by other CDRNs.</AbstractText><CopyrightInformation>&#xa9; The Author, 2017. Published by Oxford University Press on behalf of the American Medical Informatics Association. All rights reserved. For Permissions, please email: journals.permissions@oup.com</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Khare</LastName><ForeName>Ritu</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Department of Biomedical and Health Informatics, Children's Hospital of Philadelphia, Philadelphia, PA, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Pediatrics, Children's Hospital of Philadelphia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Utidjian</LastName><ForeName>Levon</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Department of Biomedical and Health Informatics, Children's Hospital of Philadelphia, Philadelphia, PA, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Pediatrics, Children's Hospital of Philadelphia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ruth</LastName><ForeName>Byron J</ForeName><Initials>BJ</Initials><AffiliationInfo><Affiliation>Department of Biomedical and Health Informatics, Children's Hospital of Philadelphia, Philadelphia, PA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kahn</LastName><ForeName>Michael G</ForeName><Initials>MG</Initials><AffiliationInfo><Affiliation>Department of Pediatrics, University of Colorado Denver Anschutz Medical Campus, Aurora, CO, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Burrows</LastName><ForeName>Evanette</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Department of Biomedical and Health Informatics, Children's Hospital of Philadelphia, Philadelphia, PA, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Pediatrics, Children's Hospital of Philadelphia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Marsolo</LastName><ForeName>Keith</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>University of Cincinnati Department of Pediatrics, Cincinnati Children's Hospital Medical Center, Cincinnati, OH, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Patibandla</LastName><ForeName>Nandan</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Information Services Department, Children's Hospital Boston, Boston, MA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Razzaghi</LastName><ForeName>Hanieh</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Department of Pediatrics, Children's Hospital of Philadelphia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Colvin</LastName><ForeName>Ryan</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Department of Pediatrics, Washington University in St. Louis, St. Louis, MO, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ranade</LastName><ForeName>Daksha</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Research Informatics, Seattle Children's Research Institute, Seattle, WA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kitzmiller</LastName><ForeName>Melody</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Research Information Solutions and Innovation, Nationwide Children's Hospital, Columbus, OH, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Eckrich</LastName><ForeName>Daniel</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Center for Pediatric Auditory and Speech Sciences, Nemours Biomedical Research, Wilmington, DE, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bailey</LastName><ForeName>L Charles</ForeName><Initials>LC</Initials><AffiliationInfo><Affiliation>Department of Biomedical and Health Informatics, Children's Hospital of Philadelphia, Philadelphia, PA, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Pediatrics, Children's Hospital of Philadelphia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Pediatrics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>U01 HG008666</GrantID><Acronym>HG</Acronym><Agency>NHGRI NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>J Am Med Inform Assoc</MedlineTA><NlmUniqueID>9430800</NlmUniqueID><ISSNLinking>1067-5027</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D035843" MajorTopicYN="Y">Biomedical Research</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000068598" MajorTopicYN="Y">Data Accuracy</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D066264" MajorTopicYN="N">Datasets as Topic</DescriptorName><QualifierName UI="Q000592" MajorTopicYN="Y">standards</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D057286" MajorTopicYN="N">Electronic Health Records</DescriptorName><QualifierName UI="Q000592" MajorTopicYN="Y">standards</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006776" MajorTopicYN="Y">Hospitals, Pediatric</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008137" MajorTopicYN="N">Longitudinal Studies</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">CDRN</Keyword><Keyword MajorTopicYN="N">data quality</Keyword><Keyword MajorTopicYN="N">electronic health record</Keyword><Keyword MajorTopicYN="N">extract-transform-load</Keyword><Keyword MajorTopicYN="N">secondary use</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2016</Year><Month>10</Month><Day>25</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2017</Year><Month>3</Month><Day>16</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2017</Year><Month>4</Month><Day>12</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2018</Year><Month>2</Month><Day>24</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2017</Year><Month>4</Month><Day>12</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2018</Year><Month>4</Month><Day>8</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">28398525</ArticleId><ArticleId IdType="pmc">PMC6259665</ArticleId><ArticleId IdType="doi">10.1093/jamia/ocx033</ArticleId><ArticleId IdType="pii">3238563</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Collins FS, Hudson KL, Briggs JP, Lauer MS. PCORnet: turning a dream into reality. J Am Med Inform Assoc. 2014;214:576&#x2013;77.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4078299</ArticleId><ArticleId IdType="pubmed">24821744</ArticleId></ArticleIdList></Reference><Reference><Citation>Bailey LC, Milov DE, Kelleher K. et al. Multi-institutional sharing of electronic health record data to assess childhood obesity. PLoS One. 2013;86:e66192.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3688837</ArticleId><ArticleId IdType="pubmed">23823186</ArticleId></ArticleIdList></Reference><Reference><Citation>Brown JS, Kahn M, Toh S. Data quality assessment for comparative effectiveness research in distributed data networks. Med Care. 2013;51(8 Suppl 3):S22&#x2013;29.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4306391</ArticleId><ArticleId IdType="pubmed">23793049</ArticleId></ArticleIdList></Reference><Reference><Citation>Kahn MG, Raebel MA, Glanz JM, Riedlinger K, Steiner JF. A pragmatic framework for single-site and multisite data quality assessment in electronic health record&#x2013;based clinical research. Med Care. 2012;50 (Suppl):S21&#x2013;29.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3833692</ArticleId><ArticleId IdType="pubmed">22692254</ArticleId></ArticleIdList></Reference><Reference><Citation>Weiskopf NG, Weng C. Methods and dimensions of electronic health record data quality assessment: enabling reuse for clinical research. J Am Med Inform Assoc. 2013;201:144&#x2013;51.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3555312</ArticleId><ArticleId IdType="pubmed">22733976</ArticleId></ArticleIdList></Reference><Reference><Citation>Hersh WR, Weiner MG, Embi PJ. et al. Caveats for the use of operational electronic health record data in comparative effectiveness research. Med Care. 2013;51(8 Suppl 3):S30&#x2013;37.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3748381</ArticleId><ArticleId IdType="pubmed">23774517</ArticleId></ArticleIdList></Reference><Reference><Citation>Terry AL, Chevendra V, Thind A, Stewart M, Marshall JN, Cejic S. Using your electronic medical record for research: a primer for avoiding pitfalls. Fam Pract. 2010;271:121&#x2013;26.</Citation><ArticleIdList><ArticleId IdType="pubmed">19828572</ArticleId></ArticleIdList></Reference><Reference><Citation>Arts DG, De Keizer NF, Scheffer GJ. Defining and improving data quality in medical registries: a literature review, case study, and generic framework. J Am Med Inform Assoc. 2002;96:600&#x2013;11.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC349377</ArticleId><ArticleId IdType="pubmed">12386111</ArticleId></ArticleIdList></Reference><Reference><Citation>Holve E, Kahn MJ, Nahm M, Ryan P, Weiskopf. A comprehensive framework for data quality assessment in CER. AMIA Jt Summits Transl Sci Proc. 2013;2013:86&#x2013;88.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3845781</ArticleId><ArticleId IdType="pubmed">24303241</ArticleId></ArticleIdList></Reference><Reference><Citation>Forrest CB, Margolis P, Seid M, Colletti RB. PEDSnet: how a prototype pediatric learning health system is being expanded into a national network. Health Aff (Millwood). 2014;337:1171&#x2013;77.</Citation><ArticleIdList><ArticleId IdType="pubmed">25006143</ArticleId></ArticleIdList></Reference><Reference><Citation>Forrest CB, Margolis PA, Bailey LC. et al. PEDSnet: a National Pediatric Learning Health System. J Am Med Inform Assoc. 2014;214:602&#x2013;06.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4078288</ArticleId><ArticleId IdType="pubmed">24821737</ArticleId></ArticleIdList></Reference><Reference><Citation>Bayley KB, Belnap T, Savitz L. Challenges in using electronic health record data for CER: experience of 4 learning organizations and solutions applied. Med Care. 2013;51(8 Suppl 3):S80&#x2013;86.</Citation><ArticleIdList><ArticleId IdType="pubmed">23774512</ArticleId></ArticleIdList></Reference><Reference><Citation>Kahn MG, Brown JS, Chun AT. et al. Transparent reporting of data quality in distributed data networks. eGEMs. 2015;31:1052.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4434997</ArticleId><ArticleId IdType="pubmed">25992385</ArticleId></ArticleIdList></Reference><Reference><Citation>Khare R, Utidjian L, Schulte G, Marsolo K, Bailey LC. Identifying and understanding data quality issues in a pediatric distributed research network. In: Americal Medical Informatics Association Anuual Symposium 2015; 2015 Nov 14&#x2013;18; San Francisco, CA. Bethesda (MD): AMIA; 2015.</Citation></Reference><Reference><Citation>
Center PDC. ETL Conventions for use with PEDSnet CDM v2.2 OMOP V5. 2015. 
https://pedsnet.org/documents/18/ETL_Conventions_for_use_with_PEDSnet_CDM_v2_2_OMOP_V5.pdf. Accessed October 15, 2016.</Citation></Reference><Reference><Citation>
Observational Medical Outcomes Partnership. OMOP Common Data Model. http://omop.org/CDM. Accessed October 15, 2016.</Citation></Reference><Reference><Citation>Belenkaya R, Mirhaji P, Khayter M, Torok D, Khare R, Ong T. et al. Establishing Interoperability Standards between OMOP CDM v4, v5, and PCORnet CDM. Poster session presented at: OHDSI Symposium 2015; 2015 Oct 20; Washington DC.</Citation></Reference><Reference><Citation>Chen PP. The entity-relationship model: toward a unified view of data. ACM Transactions on Database Systems (TODS) Special Issue: Papers from the International Conference on Very Large Data Bases: ACM. 1976;11:9&#x2013;36.</Citation></Reference><Reference><Citation>Browne A, Pennington J, Bailey LC. Promoting data quality in a clinical data research network using GitHub. In: AMIA Joint Summit on Clinical Research Informatics; 2015 Mar 23&#x2013;27; San Francisco, CA. Bethesda (MD): AMIA; 2015.</Citation></Reference><Reference><Citation>
Bedside IfIBat. The i2b2 Data Model. https://www.i2b2.org/about/intro.html. Accessed October 15, 2016.</Citation></Reference><Reference><Citation>Kahn MG, Callahan T, Barnard J. et al. A harmonized data quality assessment terminology and framework for the secondary use of electronic health record data. eGEMs (Generating Evidence and Methods to improve patient outcomes 2016;41.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5051581</ArticleId><ArticleId IdType="pubmed">27713905</ArticleId></ArticleIdList></Reference><Reference><Citation>Brown A, Patterson DA. To err is human. In: Proceedings of the First Workshop on Evaluating and Architecting System Dependability (EASY&#x2019;01), Goteborg, Sweden. New York (NY): ACM; 2001.</Citation></Reference><Reference><Citation>Khare R, An Y, Wolf S, Nyirjesy P, Liu L, Chou E. Understanding the EMR error control practices among gynecologic physicians. In: iConference 2013; 2013 Feb 12&#x2013;15; Fort Worth, TX; iSchools Consortium; 2013.</Citation></Reference><Reference><Citation>Knatterud GL, Rockhold FW, George SL. et al. Guidelines for quality assurance in multicenter trials: a position paper. Control Clin Trials. 1998;195:477&#x2013;93.</Citation><ArticleIdList><ArticleId IdType="pubmed">9741868</ArticleId></ArticleIdList></Reference><Reference><Citation>Botsis T, Hartvigsen G, Chen F, Weng C. Secondary use of EHR: data quality issues and informatics opportunities. AMIA Jt Summits Transl Sci Proc. 2010;2010:1&#x2013;5.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3041534</ArticleId><ArticleId IdType="pubmed">21347133</ArticleId></ArticleIdList></Reference><Reference><Citation>McPheeters ML, Sathe NA, Jerome RN, Carnahan RM. Methods for systematic reviews of administrative database studies capturing health outcomes of interest. Vaccine. 2013;31 (Suppl 10):K2&#x2013;6.</Citation><ArticleIdList><ArticleId IdType="pubmed">24331070</ArticleId></ArticleIdList></Reference><Reference><Citation>Huser V, DeFalco FJ, Schuemie M. et al. Multi-site evaluation of a data quality tool for patient-level clinical datasets. eGEMs. 2016.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5226382</ArticleId><ArticleId IdType="pubmed">28154833</ArticleId></ArticleIdList></Reference><Reference><Citation>Khare R, Razzaghi H, Utidjian L, Miller M, Bailey LC. Understanding the gaps between data quality checks and research capabilities in a pediatric data research network. In: AMIA Jt Summits Trans Sci 2017; 2017 Mar 27&#x2013;20; San Francisco, CA; Bethesda MD: AMIA; 2017.</Citation></Reference><Reference><Citation>Bailey LC, Kahn MG, Deakyne S, Khare R, Deans K. PEDSnet: from building a high-quality CDRN to conducting science. In: AMIA Ann Symp 2016; 2016 Nov 12&#x2013;18; Chicago, IL; Bethesda (MD): AMIA; 2016.</Citation></Reference><Reference><Citation>Khare R, Li J, Lu Z. LabeledIn: cataloging labeled indications for human drugs. J Biomed Inform. 2014;52:448&#x2013;56.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4260997</ArticleId><ArticleId IdType="pubmed">25220766</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang R, Strong DM. Beyond accuracy: what data quality means to data consumers. J Manag Inform Syst. 1996;12:5&#x2013;34.</Citation></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">28448895</PMID><DateCompleted><Year>2017</Year><Month>12</Month><Day>12</Day></DateCompleted><DateRevised><Year>2018</Year><Month>12</Month><Day>02</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1872-8227</ISSN><JournalIssue CitedMedium="Internet"><Volume>128</Volume><PubDate><Year>2017</Year><Month>Jun</Month></PubDate></JournalIssue><Title>Diabetes research and clinical practice</Title><ISOAbbreviation>Diabetes Res Clin Pract</ISOAbbreviation></Journal><ArticleTitle>Incidence of diabetic ketoacidosis among patients with type 2 diabetes mellitus treated with SGLT2 inhibitors and other antihyperglycemic agents.</ArticleTitle><Pagination><StartPage>83</StartPage><EndPage>90</EndPage><MedlinePgn>83-90</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.diabres.2017.04.004</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S0168-8227(16)31862-9</ELocationID><Abstract><AbstractText Label="AIMS" NlmCategory="OBJECTIVE">To estimate and compare incidence of diabetes ketoacidosis (DKA) among patients with type 2 diabetes who are newly treated with SGLT2 inhibitors (SGLT2i) versus non-SGLT2i antihyperglycemic agents (AHAs) in actual clinical practice.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">A new-user cohort study design using a large insurance claims database in the US. DKA incidence was compared between new users of SGLT2i and new users of non-SGLT2i AHAs pair-matched on exposure propensity scores (EPS) using Cox regression models.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">Overall, crude incidence rates (95% CI) per 1000 patient-years for DKA were 1.69 (1.22-2.30) and 1.83 (1.58-2.10) among new users of SGLT2i (n=34,442) and non-SGLT2i AHAs (n=126,703). These rates more than doubled among patients with prior insulin prescriptions but decreased by more than half in analyses that excluded potential autoimmune diabetes (PAD). The hazard ratio (95% CI) for DKA comparing new users of SGLT2i to new users of non-SGLT2i AHAs was 1.91 (0.94-4.11) (p=0.09) among the 30,196 EPS-matched pairs overall, and 1.13 (0.43-3.00) (p=0.81) among the 27,515 EPS-matched pairs that excluded PAD.</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">This was the first observational study that compared DKA risk between new users of SGLT2i and non-SGLT2i AHAs among patients with type 2 diabetes, and overall no statistically significant difference was detected.</AbstractText><CopyrightInformation>Copyright &#xa9; 2017 The Authors. Published by Elsevier B.V. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Wang</LastName><ForeName>Yiting</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Janssen Research &amp; Development, LLC, Titusville, NJ 08560, USA. Electronic address: ywang28@its.jnj.com.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Desai</LastName><ForeName>Mehul</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Janssen Research &amp; Development, LLC, Raritan, NJ 08869, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ryan</LastName><ForeName>Patrick B</ForeName><Initials>PB</Initials><AffiliationInfo><Affiliation>Janssen Research &amp; Development, LLC, Titusville, NJ 08560, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>DeFalco</LastName><ForeName>Frank J</ForeName><Initials>FJ</Initials><AffiliationInfo><Affiliation>Janssen Research &amp; Development, LLC, Raritan, NJ 08869, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Schuemie</LastName><ForeName>Martijn J</ForeName><Initials>MJ</Initials><AffiliationInfo><Affiliation>Janssen Research &amp; Development, LLC, Titusville, NJ 08560, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Stang</LastName><ForeName>Paul E</ForeName><Initials>PE</Initials><AffiliationInfo><Affiliation>Janssen Research &amp; Development, LLC, Titusville, NJ 08560, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Berlin</LastName><ForeName>Jesse A</ForeName><Initials>JA</Initials><AffiliationInfo><Affiliation>Johnson &amp; Johnson, Titusville, NJ 08560, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yuan</LastName><ForeName>Zhong</ForeName><Initials>Z</Initials><AffiliationInfo><Affiliation>Janssen Research &amp; Development, LLC, Titusville, NJ 08560, USA.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2017</Year><Month>04</Month><Day>13</Day></ArticleDate></Article><MedlineJournalInfo><Country>Ireland</Country><MedlineTA>Diabetes Res Clin Pract</MedlineTA><NlmUniqueID>8508335</NlmUniqueID><ISSNLinking>0168-8227</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D007004">Hypoglycemic Agents</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000077203">Sodium-Glucose Transporter 2 Inhibitors</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D015331" MajorTopicYN="N">Cohort Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003924" MajorTopicYN="N">Diabetes Mellitus, Type 2</DescriptorName><QualifierName UI="Q000188" MajorTopicYN="Y">drug therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016883" MajorTopicYN="N">Diabetic Ketoacidosis</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="Y">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007004" MajorTopicYN="N">Hypoglycemic Agents</DescriptorName><QualifierName UI="Q000494" MajorTopicYN="N">pharmacology</QualifierName><QualifierName UI="Q000627" MajorTopicYN="Y">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015994" MajorTopicYN="N">Incidence</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012189" MajorTopicYN="N">Retrospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000077203" MajorTopicYN="Y">Sodium-Glucose Transporter 2 Inhibitors</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Ketoacidosis</Keyword><Keyword MajorTopicYN="N">Sodium glucose co-transporter 2 (SGLT2) inhibitors</Keyword><Keyword MajorTopicYN="N">Type 2 diabetes mellitus</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2017</Year><Month>1</Month><Day>3</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2017</Year><Month>4</Month><Day>7</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2017</Year><Month>4</Month><Day>28</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2017</Year><Month>12</Month><Day>13</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2017</Year><Month>4</Month><Day>28</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">28448895</ArticleId><ArticleId IdType="doi">10.1016/j.diabres.2017.04.004</ArticleId><ArticleId IdType="pii">S0168-8227(16)31862-9</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">28456512</PMID><DateCompleted><Year>2018</Year><Month>09</Month><Day>17</Day></DateCompleted><DateRevised><Year>2024</Year><Month>06</Month><Day>10</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1873-2860</ISSN><JournalIssue CitedMedium="Internet"><Volume>81</Volume><PubDate><Year>2017</Year><Month>Sep</Month></PubDate></JournalIssue><Title>Artificial intelligence in medicine</Title><ISOAbbreviation>Artif Intell Med</ISOAbbreviation></Journal><ArticleTitle>Inter-labeler and intra-labeler variability of condition severity classification models using active and passive learning methods.</ArticleTitle><Pagination><StartPage>12</StartPage><EndPage>32</EndPage><MedlinePgn>12-32</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.artmed.2017.03.003</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S0933-3657(17)30115-X</ELocationID><Abstract><AbstractText Label="BACKGROUND AND OBJECTIVES" NlmCategory="OBJECTIVE">Labeling instances by domain experts for classification is often time consuming and expensive. To reduce such labeling efforts, we had proposed the application of active learning (AL) methods, introduced our CAESAR-ALE framework for classifying the severity of clinical conditions, and shown its significant reduction of labeling efforts. The use of any of three AL methods (one well known [SVM-Margin], and two that we introduced [Exploitation and Combination_XA]) significantly reduced (by 48% to 64%) condition labeling efforts, compared to standard passive (random instance-selection) SVM learning. Furthermore, our new AL methods achieved maximal accuracy using 12% fewer labeled cases than the SVM-Margin AL method. However, because labelers have varying levels of expertise, a major issue associated with learning methods, and AL methods in particular, is how to best to use the labeling provided by a committee of labelers. First, we wanted to know, based on the labelers' learning curves, whether using AL methods (versus standard passive learning methods) has an effect on the Intra-labeler variability (within the learning curve of each labeler) and inter-labeler variability (among the learning curves of different labelers). Then, we wanted to examine the effect of learning (either passively or actively) from the labels created by the majority consensus of a group of labelers.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">We used our CAESAR-ALE framework for classifying the severity of clinical conditions, the three AL methods and the passive learning method, as mentioned above, to induce the classifications models. We used a dataset of 516 clinical conditions and their severity labeling, represented by features aggregated from the medical records of 1.9 million patients treated at Columbia University Medical Center. We analyzed the variance of the classification performance within (intra-labeler), and especially among (inter-labeler) the classification models that were induced by using the labels provided by seven labelers. We also compared the performance of the passive and active learning models when using the consensus label.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">The AL methods: produced, for the models induced from each labeler, smoother Intra-labeler learning curves during the training phase, compared to the models produced when using the passive learning method. The mean standard deviation of the learning curves of the three AL methods over all labelers (mean: 0.0379; range: [0.0182 to 0.0496]), was significantly lower (p=0.049) than the Intra-labeler standard deviation when using the passive learning method (mean: 0.0484; range: [0.0275-0.0724). Using the AL methods resulted in a lower mean Inter-labeler AUC standard deviation among the AUC values of the labelers' different models during the training phase, compared to the variance of the induced models' AUC values when using passive learning. The Inter-labeler AUC standard deviation, using the passive learning method (0.039), was almost twice as high as the Inter-labeler standard deviation using our two new AL methods (0.02 and 0.019, respectively). The SVM-Margin AL method resulted in an Inter-labeler standard deviation (0.029) that was higher by almost 50% than that of our two AL methods The difference in the inter-labeler standard deviation between the passive learning method and the SVM-Margin learning method was significant (p=0.042). The difference between the SVM-Margin and Exploitation method was insignificant (p=0.29), as was the difference between the Combination_XA and Exploitation methods (p=0.67). Finally, using the consensus label led to a learning curve that had a higher mean intra-labeler variance, but resulted eventually in an AUC that was at least as high as the AUC achieved using the gold standard label and that was always higher than the expected mean AUC of a randomly selected labeler, regardless of the choice of learning method (including a passive learning method). Using a paired t-test, the difference between the intra-labeler AUC standard deviation when using the consensus label, versus that value when using the other two labeling strategies, was significant only when using the passive learning method (p=0.014), but not when using any of the three AL methods.</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">The use of AL methods, (a) reduces intra-labeler variability in the performance of the induced models during the training phase, and thus reduces the risk of halting the process at a local minimum that is significantly different in performance from the rest of the learned models; and (b) reduces Inter-labeler performance variance, and thus reduces the dependence on the use of a particular labeler. In addition, the use of a consensus label, agreed upon by a rather uneven group of labelers, might be at least as good as using the gold standard labeler, who might not be available, and certainly better than randomly selecting one of the group's individual labelers. Finally, using the AL methods: when provided by the consensus label reduced the intra-labeler AUC variance during the learning phase, compared to using passive learning.</AbstractText><CopyrightInformation>Copyright &#xa9; 2017 Elsevier B.V. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Nissim</LastName><ForeName>Nir</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Department of Software and Information Systems Engineering, Ben-Gurion University of the Negev, Beer-Sheva, Israel; Malware Lab, Cyber Security Research Center, Ben-Gurion University of the Negev, Beer-Sheva, Israel. Electronic address: nirni@post.bgu.ac.il.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Shahar</LastName><ForeName>Yuval</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Department of Software and Information Systems Engineering, Ben-Gurion University of the Negev, Beer-Sheva, Israel.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Elovici</LastName><ForeName>Yuval</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Department of Software and Information Systems Engineering, Ben-Gurion University of the Negev, Beer-Sheva, Israel; Malware Lab, Cyber Security Research Center, Ben-Gurion University of the Negev, Beer-Sheva, Israel.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hripcsak</LastName><ForeName>George</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Department of Biomedical Informatics, Columbia University, New York, NY, USA; Observational Health Data Sciences and Informatics, Columbia University, New York, NY, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Moskovitch</LastName><ForeName>Robert</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Department of Software and Information Systems Engineering, Ben-Gurion University of the Negev, Beer-Sheva, Israel; Department of Biomedical Informatics, Columbia University, New York, NY, USA.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>R01 GM107145</GrantID><Acronym>GM</Acronym><Agency>NIGMS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R01 LM006910</GrantID><Acronym>LM</Acronym><Agency>NLM NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2017</Year><Month>04</Month><Day>27</Day></ArticleDate></Article><MedlineJournalInfo><Country>Netherlands</Country><MedlineTA>Artif Intell Med</MedlineTA><NlmUniqueID>8915031</NlmUniqueID><ISSNLinking>0933-3657</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D019540" MajorTopicYN="N">Area Under Curve</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D057225" MajorTopicYN="N">Data Mining</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="Y">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D057286" MajorTopicYN="N">Electronic Health Records</DescriptorName><QualifierName UI="Q000145" MajorTopicYN="Y">classification</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D059032" MajorTopicYN="N">Learning Curve</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015588" MajorTopicYN="N">Observer Variation</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D010641" MajorTopicYN="N">Phenotype</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015203" MajorTopicYN="N">Reproducibility of Results</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012720" MajorTopicYN="N">Severity of Illness Index</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000069553" MajorTopicYN="Y">Supervised Machine Learning</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D013997" MajorTopicYN="N">Time Factors</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Active learning</Keyword><Keyword MajorTopicYN="N">Condition</Keyword><Keyword MajorTopicYN="N">Electronic health records</Keyword><Keyword MajorTopicYN="N">Labeling</Keyword><Keyword MajorTopicYN="N">Phenotyping</Keyword><Keyword MajorTopicYN="N">Severity</Keyword><Keyword MajorTopicYN="N">Variance</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2017</Year><Month>3</Month><Day>1</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2017</Year><Month>3</Month><Day>3</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2017</Year><Month>5</Month><Day>1</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2018</Year><Month>9</Month><Day>18</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2017</Year><Month>5</Month><Day>1</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2018</Year><Month>5</Month><Day>7</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">28456512</ArticleId><ArticleId IdType="mid">NIHMS962423</ArticleId><ArticleId IdType="pmc">PMC5937023</ArticleId><ArticleId IdType="doi">10.1016/j.artmed.2017.03.003</ArticleId><ArticleId IdType="pii">S0933-3657(17)30115-X</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Stang PE, Ryan PB, Racoosin JA, et al. Advancing the science for active surveillance: rationale and design for the Observational Medical Outcomes Partnership. Ann Intern Med. 2010 Nov 2;153(9):600&#x2013;6.</Citation><ArticleIdList><ArticleId IdType="pubmed">21041580</ArticleId></ArticleIdList></Reference><Reference><Citation>Kho AN, Pacheco JA, Peissig PL, et al. Electronic medical records for genetic research: results of the eMERGE consortium. Science translational medicine. 2011 Apr 20;3(79):79re1.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3690272</ArticleId><ArticleId IdType="pubmed">21508311</ArticleId></ArticleIdList></Reference><Reference><Citation>Denny JC, Ritchie MD, Basford MA, et al. PheWAS: demonstrating the feasibility of a phenome-wide scan to discover gene&#x2013;disease associations. Bioinformatics. 2010 May 1;26(9):1205&#x2013;10.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2859132</ArticleId><ArticleId IdType="pubmed">20335276</ArticleId></ArticleIdList></Reference><Reference><Citation>Boland MR, Hripcsak G, Shen Y, Chung WK, Weng C. Defining a comprehensive verotype using electronic health records for personalized medicine. J Am Med Inform Assoc. 2013 Dec 1;20(e2):e232&#x2013;e8.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3861934</ArticleId><ArticleId IdType="pubmed">24001516</ArticleId></ArticleIdList></Reference><Reference><Citation>Weiskopf NG, Weng C. Methods and dimensions of electronic health record data quality assessment: enabling reuse for clinical research. J Am Med Inform Assoc. 2013;20(1):144&#x2013;51.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3555312</ArticleId><ArticleId IdType="pubmed">22733976</ArticleId></ArticleIdList></Reference><Reference><Citation>Hripcsak G, Knirsch C, Zhou L, Wilcox A, Melton GB. Bias associated with mining electronic health records. Journal of biomedical discovery and collaboration. 2011:6&#x2013;48.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3149555</ArticleId><ArticleId IdType="pubmed">21647858</ArticleId></ArticleIdList></Reference><Reference><Citation>Hripcsak G, Albers DJ. Correlating electronic health record concepts with healthcare process events. J Am Med Inform Assoc. 2013 Dec 1;20(e2):e311&#x2013;e8.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3861922</ArticleId><ArticleId IdType="pubmed">23975625</ArticleId></ArticleIdList></Reference><Reference><Citation>Rich P, Scher RK. Nail psoriasis severity index: a useful tool for evaluation of nail psoriasis. Journal of the American Academy of Dermatology. 2003;49(2):206&#x2013;12.</Citation><ArticleIdList><ArticleId IdType="pubmed">12894066</ArticleId></ArticleIdList></Reference><Reference><Citation>Bastien CH, Valli&#xe8;res A, Morin CM. Validation of the Insomnia Severity Index as an outcome measure for insomnia research. Sleep Medicine. 2001;2(4):297&#x2013;307.</Citation><ArticleIdList><ArticleId IdType="pubmed">11438246</ArticleId></ArticleIdList></Reference><Reference><Citation>McLellan AT, Kushner H, Metzger D, et al. The fifth edition of the Addiction Severity Index. Journal of substance abuse treatment. 1992;9(3):199&#x2013;213.</Citation><ArticleIdList><ArticleId IdType="pubmed">1334156</ArticleId></ArticleIdList></Reference><Reference><Citation>Rockwood TH, Church JM, Fleshman JW, et al. Patient and surgeon ranking of the severity of symptoms associated with fecal incontinence. Diseases of the colon &amp; rectum. 1999;42(12):1525&#x2013;31.</Citation><ArticleIdList><ArticleId IdType="pubmed">10613469</ArticleId></ArticleIdList></Reference><Reference><Citation>Horn SD, Horn RA. Reliability and validity of the severity of illness index. Medical care. 1986;24(2):159&#x2013;78.</Citation><ArticleIdList><ArticleId IdType="pubmed">3080648</ArticleId></ArticleIdList></Reference><Reference><Citation>Boland MR, Tatonetti N, Hripcsak G. Intelligent Systems for Molecular Biology Phenotype Day. Boston, MA: 2014. CAESAR: a Classification Approach for Extracting Severity Automatically from Electronic Health Records; pp. 1&#x2013;8. In Press.</Citation><ArticleIdList><ArticleId IdType="pubmed">0</ArticleId></ArticleIdList></Reference><Reference><Citation>Elkin PL, Brown SH, Husser CS, et al. Mayo Clinic Proceedings. Elsevier; 2006. Evaluation of the content coverage of SNOMED CT: ability of SNOMED clinical terms to represent clinical problem lists; pp. 741&#x2013;8. 2006.</Citation><ArticleIdList><ArticleId IdType="pubmed">16770974</ArticleId></ArticleIdList></Reference><Reference><Citation>Stearns MQ, Price C, Spackman KA, Wang AY. SNOMED clinical terms: overview of the development process and project status; Proceedings of the AMIA Symposium; 2001: American Medical Informatics Association; 2001. p. 662.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2243297</ArticleId><ArticleId IdType="pubmed">11825268</ArticleId></ArticleIdList></Reference><Reference><Citation>Elhanan G, Perl Y, Geller J. A survey of SNOMED CT direct users, 2010: impressions and preferences regarding content and quality. Journal of the American Medical Informatics Association. 2011 Dec 1;18(Suppl 1):i36&#x2013;i44. 2011.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3241171</ArticleId><ArticleId IdType="pubmed">21836159</ArticleId></ArticleIdList></Reference><Reference><Citation>Zmiri Dror, Yuval Shahar, Meirav Taieb&#x2010;Maimon. Classification of patients by severity grades during triage in the emergency department using data mining methods. Journal of evaluation in clinical practice 18.2. 2012:378&#x2013;388.</Citation><ArticleIdList><ArticleId IdType="pubmed">21166962</ArticleId></ArticleIdList></Reference><Reference><Citation>HCUP Chronic Condition Indicator for ICD-9-CM. Healthcare Cost and Utilization Project (HCUP) 2011  http://www.hcup-us.ahrq.gov/toolssoftware/chronic/chronic.jsp Accessed on February 25 2014.</Citation></Reference><Reference><Citation>Hwang W, Weller W, Ireys H, Anderson G. Out-Of-Pocket Medical Spending For Care Of Chronic Conditions. Health Affairs. 2001 Nov 1;20(6):267&#x2013;78. 2001.</Citation><ArticleIdList><ArticleId IdType="pubmed">11816667</ArticleId></ArticleIdList></Reference><Reference><Citation>Chi M-j, Lee C-y, Wu S-C. The prevalence of chronic conditions and medical expenditures of the elderly by chronic condition indicator (CCI) Archives of Gerontology and Geriatrics. 2011;52(3):284&#x2013;9.</Citation><ArticleIdList><ArticleId IdType="pubmed">20452688</ArticleId></ArticleIdList></Reference><Reference><Citation>Perotte A, Pivovarov R, Natarajan K, Weiskopf N, Wood F, Elhadad N. Diagnosis code assignment: models and evaluation metrics. Journal of the American Medical Informatics Association. 2014 Mar 1;21(2):231&#x2013;7. 2014.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3932472</ArticleId><ArticleId IdType="pubmed">24296907</ArticleId></ArticleIdList></Reference><Reference><Citation>Perotte A, Hripcsak G. Temporal properties of diagnosis code time series in aggregate. IEEE journal of biomedical and health informatics. 2013 Mar;17(2):477&#x2013;83.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4030411</ArticleId><ArticleId IdType="pubmed">24235118</ArticleId></ArticleIdList></Reference><Reference><Citation>Torii M, Wagholikar K, Liu H. Using machine learning for concept extraction on clinical documents from multiple data sources. Journal of the American Medical Informatics Association. 2011 Jun 27; 2011.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3168314</ArticleId><ArticleId IdType="pubmed">21709161</ArticleId></ArticleIdList></Reference><Reference><Citation>Nguyen AN, Lawley MJ, Hansen DP, et al. Symbolic rule-based classification of lung cancer stages from free-text pathology reports. Journal of the American Medical Informatics Association. 2010 Jul 1;17(4):440&#x2013;5. 2010.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2995652</ArticleId><ArticleId IdType="pubmed">20595312</ArticleId></ArticleIdList></Reference><Reference><Citation>Nissim N, Moskovitch R, Rokach L, Elovici Y. Novel active learning methods for enhanced PC malware detection in windows OS. Expert Systems with Applications. 2014 Oct 1;41(13):5843&#x2013;57.</Citation></Reference><Reference><Citation>Nissim N, Moskovitch R, Rokach L, Elovici Y. Detecting Unknown Computer Worm Activity via Support Vector Machines and Active Learning. Pattern Analysis and Applications. 2012;15:459&#x2013;75.</Citation></Reference><Reference><Citation>Nissim N, Cohen A, Glezer C, Elovici Y. Detection of malicious PDF files and directions for enhancements: A state-of-the art survey. Computers &amp; Security. 2015;48:246&#x2013;66.</Citation></Reference><Reference><Citation>Angluin D. Queries and concept learning. Machine Learning. 1988;2:319&#x2013;42.</Citation></Reference><Reference><Citation>Lewis D, Gale W. A sequential algorithm for training text classifiers; Proceedings of the Seventeenth Annual International ACM-SIGIR Conference on Research and Development in Information Retrieval; Springer-Verlag. 1994. pp. 3&#x2013;12.</Citation></Reference><Reference><Citation>Liu Y. Active learning with support vector machine applied to gene expression data for cancer classification. Journal of chemical information and computer sciences. 2004;44(6):1936&#x2013;41.</Citation><ArticleIdList><ArticleId IdType="pubmed">15554662</ArticleId></ArticleIdList></Reference><Reference><Citation>Warmuth MK, Liao J, R&#xe4;tsch G, Mathieson M, Putta S, Lemmen C. Active learning with support vector machines in the drug discovery process. Journal of chemical information and computer sciences. 2003;43(2):667&#x2013;73.</Citation><ArticleIdList><ArticleId IdType="pubmed">12653536</ArticleId></ArticleIdList></Reference><Reference><Citation>Figueroa RL, Zeng-Treitler Q, Ngo LH, Goryachev S, Wiechmann EP. Active learning for clinical text classification: is it better than random sampling? Journal of the American Medical Informatics Association. 2012 amiajnl-2011&#x2013;000648.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3422824</ArticleId><ArticleId IdType="pubmed">22707743</ArticleId></ArticleIdList></Reference><Reference><Citation>Nguyen DH, Patrick JD. Supervised machine learning and active learning in classification of radiology reports. Journal of the American Medical Informatics Association. 2014 amiajnl-2013&#x2013;002516.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4147614</ArticleId><ArticleId IdType="pubmed">24853067</ArticleId></ArticleIdList></Reference><Reference><Citation>Chang CC, Lin CJ. LIBSVM: a library for support vector machines. ACM Transactions on Intelligent Systems and Technology (TIST) 2011;2(3):27.</Citation></Reference><Reference><Citation>Tong S, Koller D. Support vector machine active learning with applications to text classification. Journal of Machine Learning Research. 2000&#x2013;2001;2:45&#x2013;66.</Citation></Reference><Reference><Citation>Ralf H, Graepel T, Campbell C. Bayes point machines. The Journal of Machine Learning Research. 2001;1:245&#x2013;79.</Citation></Reference><Reference><Citation>Nissim N, Moskovitch R, Rokach L, Elovici Y. Novel Active Learning Methods for Enhanced PC Malware Detection in Windows OS. Expert Systems With Applications. 2014;41(13)</Citation></Reference><Reference><Citation>Nissim N, Moskovitch R, Rokach LYE. Detecting unknown computer worm activity via support vector machines and active learning. Pattern Analysis and Applications. 2012;15(4):459&#x2013;75.</Citation></Reference><Reference><Citation>Moskovitch R, Nissim N, Elovici Y. Malicious code detection using active learning; ACM SIGKDD Workshop in Privacy, Security and Trust in KDD; Las Vegas. 2008.</Citation></Reference><Reference><Citation>Moskovitch R, Stopel D, Feher C, Nissim N, Japkowicz N, Elovici Y. Unknown Malcode Detection and The Imbalance Problem. Journal in Computer Virology. 2009;5(4)</Citation></Reference><Reference><Citation>Nissim N, Cohen A, Moskovitch R, et al. ALPD: Active Learning Framework for Enhancing the Detection of Malicious PDF Files Aimed at Organizations. Proceedings of JISIC. 2014</Citation></Reference><Reference><Citation>Baram Y, El-Yaniv R, Luz K. Online choice of active learning algorithms. Journal of Machine Learning Research. 2004;5:255&#x2013;91.</Citation></Reference><Reference><Citation>Herman R. 72 Statistics on Hourly Physician Compensation.   http://www.beckershospitalreview.com/compensation-issues/72-statistics-on-hourly-physician-compensation.html 2013; Accessed in January 2015.</Citation></Reference><Reference><Citation>Boland MR, Tatonetti NP. Are All Vaccines Created Equal? Using Electronic Health Records to Discover Vaccines Associated With Clinician-Coded Adverse Events; AMIA Summits on Translational Science Proceedings 2015; San Francisco, CA, USA. 2015. pp. 196&#x2013;200.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4525221</ArticleId><ArticleId IdType="pubmed">26306268</ArticleId></ArticleIdList></Reference><Reference><Citation>Boland MR, Tatonetti NP, Hripcsak G. Intelligent Systems for Molecular Biology Phenotype Day. Boston, MA: 2014. CAESAR: a Classification Approach for Extracting Severity Automatically from Electronic Health Records.</Citation><ArticleIdList><ArticleId IdType="pubmed">0</ArticleId></ArticleIdList></Reference><Reference><Citation>Vapnik V. Statistical learning theory. New York: Springer; 1998.</Citation></Reference><Reference><Citation>Boland MR, Tatonetti NP, Hripcsak G. Development and Validation of a Classification Approach for Extracting Severity Automatically from Electronic Health Records. Journal of Biomedical Semantics. 2015;6(14)</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4386082</ArticleId><ArticleId IdType="pubmed">25848530</ArticleId></ArticleIdList></Reference><Reference><Citation>Moskovitch R, Cohen-Kashi S, Dror U, Levy I, Maimon A, Shahar Y. Multiple hierarchical classification of free-text clinical guidelines. Artificial Intelligence in Medicine. 2006;37:177&#x2013;190.</Citation><ArticleIdList><ArticleId IdType="pubmed">16730962</ArticleId></ArticleIdList></Reference><Reference><Citation>Nissim N, Boland MR, Moskovitch R, Tatonetti NP, Elovici Y, Shahar Y, Hripcsak G. Artificial Intelligence in Medicine. Springer International Publishing; 2015. An Active Learning Framework for Efficient Condition Severity Classification; pp. 13&#x2013;24. (AIME-15)</Citation></Reference><Reference><Citation>Vapnik VN. Estimation of dependences based on empirical data. Vol. 41. New York: Springer-Verlag; 1982.</Citation></Reference><Reference><Citation>Joachims T. Making large scale SVM learning practical 1999</Citation></Reference><Reference><Citation>Burges CJ. A tutorial on support vector machines for pattern recognition. Data mining and knowledge discovery. 1998;2(2):121&#x2013;167.</Citation></Reference><Reference><Citation>Berthold Michael. The Fog of Data: Data Exploration in the Life Sciences; Invited talk at 11th AIME conference 2007 In Artificial Intelligence in Medicine.</Citation></Reference><Reference><Citation>Nicolas Cebron, Berthold Michael R. Active learning for object classification: from exploration to exploitation. Data Mining and Knowledge Discovery April 2009. 2008 Jul 27;18(2):283&#x2013;299.</Citation></Reference><Reference><Citation>Moskovitch Robert, Hessing Alon, Shahar Yuval. Vaidurya - A Concept-Based; Context-Sensitive Search Engine For Clinical Guidelines, MedInfo 2004; San Francisco, USA. 2004.</Citation><ArticleIdList><ArticleId IdType="pubmed">15360791</ArticleId></ArticleIdList></Reference><Reference><Citation>Moskovitch Robert, Martins Suzana, Behiri Eytan, Weiss Aviram, Shahar Yuval. A Comparative Evaluation of a Full-text, Concept Based, and Context Sensitive Search Engine. Journal Of American Medical Informatics Association. 2007;14:164&#x2013;174.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2213470</ArticleId><ArticleId IdType="pubmed">17213502</ArticleId></ArticleIdList></Reference><Reference><Citation>Jensen PB, Jensen LJ, Brunak S. Mining electronic health records: towards better research applications and clinical care. Nature Reviews Genetics. 2012;13(6)</Citation><ArticleIdList><ArticleId IdType="pubmed">22549152</ArticleId></ArticleIdList></Reference><Reference><Citation>Bellazzi R, Zupan B. Predictive data mining in clinical medicine: current issues and guidelines. International Journal of Medical Informatics. 2008;77(2)</Citation><ArticleIdList><ArticleId IdType="pubmed">17188928</ArticleId></ArticleIdList></Reference><Reference><Citation>Batal I, Fradkin D, Harrison J, Moerchen F, Hauskrecht M. Mining Recent Temporal Patterns for Event Detection in Multivariate Time Series Data; Proceedings of Knowledge Discovery and Data Mining (KDD); Beijing, China. 2012.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4414327</ArticleId><ArticleId IdType="pubmed">25937993</ArticleId></ArticleIdList></Reference><Reference><Citation>Moskovitch R, Shahar Y. Fast Time Intervals Mining Using Transitivity of Temporal Relations. Knowledge and Information Systems. 2015a;42(1)</Citation></Reference><Reference><Citation>Ng K, Ghoting A, Steinhubl SR, Stewart WF, Malin B, Sun J. PARAMO: A PARAllel predictive MOdeling Platform for Healthcare Analytic Research Using Electronic Health Records. Journal of Biomedical Informatics. 2014;48:160&#x2013;170.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4075460</ArticleId><ArticleId IdType="pubmed">24370496</ArticleId></ArticleIdList></Reference><Reference><Citation>Sun J, McNaughton CD, Zhang P, Perer A, Gkoulalas-Divanis A, Denny JC, Kirby J, Lasko T, Saip A, Malin BA. Predicting Changes in Hypertension Control Using Electronic Health Records from a Chronic Disease Management Program. Journal of the American Medical Informatics Association. 2014;21:337&#x2013;344.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3932462</ArticleId><ArticleId IdType="pubmed">24045907</ArticleId></ArticleIdList></Reference><Reference><Citation>Hripcsak G. Physics of the Medical Record: Handling Time in Health Record Studies; Artificial Intelligence in Medicine; Pavia, Italy. 2015.</Citation></Reference><Reference><Citation>Rana S, Gupta S, Phung D, Venkatesh S. A predictive framework for modeling healthcare data with evolving clinical interventions. Statistical Analysis and Data Mining. In Press.</Citation></Reference><Reference><Citation>Moskovitch R, Shahar Y. Classification of Multivariate Time Series via Temporal Abstraction and Time Intervals Mining. Knowledge and Information Systems. 2015b;45(1):35&#x2013;74.</Citation></Reference><Reference><Citation>Moskovitch R, Shahar Y. Classification Driven Temporal Discretization of Multivariate Time Series. Data Mining and Knowledge Discovery. 2015c;29(4):871&#x2013;913.</Citation></Reference><Reference><Citation>Huang Z, Dong W, Bath P, Ji L, Duan H. On Mining Latent Treatment Patterns from Electronic Medical Records. Data Mining and Knowledge Discovery. 2015;29:914&#x2013;949.</Citation></Reference><Reference><Citation>Nissim Nir, Moskovitch Robert, BarAd Oren, Rokach Lior, Elovici Yuval. ALDROID: Efficient Update of Android Anti-Virus Software Using Designated Active Learning Methods. Knowledge and Information System. In Press.</Citation></Reference><Reference><Citation>Moskovitch R, Nissim N, Elovici Y. Malicious Code Detection and Acquisition Using Active Learning; IEEE International Conference on Intelligence and Security Informatics (IEEE ISI-2007); Rutgers University, New Jersey, USA. 2007.</Citation></Reference><Reference><Citation>Nissim Nir, Cohen Aviad, Moskovitch Robert, Barad Oren, Edry Mattan, Shabatai Assaf, Elovici Yuval. ALPD: Active Learning Framework for Enhancing the Detection of Malicious PDF Files; Intelligence and Security Informatics Conference (JISIC), 2014 IEEE Joint; 2014. pp. 91&#x2013;98.</Citation></Reference><Reference><Citation>Moskovitch R, Nissim N, Englert R, Elovici Y. Detection of Unknown Computer Worms Activity using Active Learning; The 11th International Conference on Information Fusion; Cologne, Germany. 2008.</Citation></Reference><Reference><Citation>Moskovitch Robert, Choi Hyunmi, Hripsack George, Tatonetti Nicholas. Prognosis of Clinical Procedures with Temporal Patterns and One Class Feature Selection; ACM/IEEE Transactions on Computational Biology and Bioinformatics; In Press.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5486920</ArticleId><ArticleId IdType="pubmed">27429447</ArticleId></ArticleIdList></Reference><Reference><Citation>Zheng Yaling, Scott Stephen, Deng Kun. Active learning from multiple noisy labelers with varied costs; Data Mining (ICDM), 2010 IEEE 10th International Conference on. IEEE; 2010.</Citation></Reference><Reference><Citation>Moskovitch R, Shahar Y. Vaidurya: a multiple-ontology, concept-based, context-sensitive clinical-guideline search engine. Journal of biomedical informatics. 2009 Feb;42(1):11&#x2013;21.</Citation><ArticleIdList><ArticleId IdType="pubmed">18721900</ArticleId></ArticleIdList></Reference><Reference><Citation>Roy Nicholas, McCallum Andrew. Toward optimal active learning through Monte Carlo estimation of error reduction; Proceedings of the 18th International Conference on Machine Learning, (ICML 2001); Williamstown. 2001. pp. 441&#x2013;448.</Citation></Reference><Reference><Citation>Nissim Nir, Boland Mary Regina, Tatonetti Nicholas P, Elovici Yuval, Hripcsak George, Shahar Yuval, Moskovitch Robert. Improving condition severity classification with an efficient active learning based framework. Journal of Biomedical Informatics. 2016 Jun;61:44&#x2013;54. ISSN 1532&#x2013;0464.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5486916</ArticleId><ArticleId IdType="pubmed">27016383</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang C, Chaudhuri K. Active Learning from Weak and Strong Labelers; Proceedings of Advances in Neural Information Processing Systems 28 (NIPS 2015); 2015. pp. 703&#x2013;711.</Citation></Reference><Reference><Citation>Yan Y, Fung GM, Rosales R, Dy JG. Active learning from crowds; Proceedings of the 28th international conference on machine learning, (ICML-2011); pp. 1161&#x2013;1168.</Citation></Reference><Reference><Citation>Moskovitch Robert, Wang Fei, Walsh Colin, Hripcsak George, Tatonetti Nicholas. Prediction of Outcome Events via Time Intervals Mining; IEEE International Conference on Data Mining (ICDM); Atlantic City, USA. 2015.</Citation></Reference><Reference><Citation>Boland Mary Regina, Jacunski Alexandra, Lorberbaum Tal, Romano Joseph, Moskovitch Robert, Tatonetti Nicholas P. Systems Biology Approaches for Identifying Adverse Drug Reactions and Elucidating Their Underlying Biological Mechanisms. Wiley Interdisciplinary Reviews: Systems Biology and Medicine. In Press.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4760887</ArticleId><ArticleId IdType="pubmed">26559926</ArticleId></ArticleIdList></Reference><Reference><Citation>Moskovitch Robert, Nissim Nir, Elovici Yuval. Acquisition of malicious code using active learning. Proc. 2nd Int&#x2019;l Workshop on Privacy, Security, &amp; Trust in KDD; 2008.</Citation></Reference><Reference><Citation>Nissim N, Cohen A, Moskovitch R, Shabtai A, Edri M, BarAd O, Elovici Y. Keeping pace with the creation of new malicious PDF files using an active-learning based detection framework. Security Informatics. 2016;5(1):1.</Citation></Reference><Reference><Citation>Nissim Nir, Cohen Aviad, Elovici Yuval. ALDOCX: Detection of Unknown Malicious Microsoft Office Documents Using Designated Active Learning Methods Based on New Structural Feature Extraction Methodology. IEEE Transactions on Information Forensics and Security. 2017 Mar;12(3):631&#x2013;646. doi: 10.1109/TIFS.2016.2631905.</Citation><ArticleIdList><ArticleId IdType="doi">10.1109/TIFS.2016.2631905</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">28479543</PMID><DateCompleted><Year>2018</Year><Month>04</Month><Day>23</Day></DateCompleted><DateRevised><Year>2018</Year><Month>12</Month><Day>02</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1879-8365</ISSN><JournalIssue CitedMedium="Internet"><Volume>237</Volume><PubDate><Year>2017</Year></PubDate></JournalIssue><Title>Studies in health technology and informatics</Title><ISOAbbreviation>Stud Health Technol Inform</ISOAbbreviation></Journal><ArticleTitle>A Realism-Based View on Counts in OMOP's Common Data Model.</ArticleTitle><Pagination><StartPage>55</StartPage><EndPage>62</EndPage><MedlinePgn>55-62</MedlinePgn></Pagination><Abstract><AbstractText>Correctly counting entities is a requirement for analytics tools to function appropriately. The Observational Medical Outcomes Partnership's (OMOP) Common Data Model (CDM) specifications were examined to assess the extent to which counting in OMOP CDM compatible data repositories would work as expected. To that end, constructs (tables, fields and attributes) defined in the OMOP CDM as well as cardinality constraints and other business rules found in its documentation and related literature were compared to the types of entities and axioms proposed in realism-based ontologies. It was found that not only the model itself, but also a proposed standard algorithm for computing condition eras may lead to erroneous counting of several sorts of entities.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Ceusters</LastName><ForeName>Werner</ForeName><Initials>W</Initials><AffiliationInfo><Affiliation>Department of Biomedical Informatics, University at Buffalo, Buffalo NY, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Blaisure</LastName><ForeName>Jonathan</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Biomedical Informatics, University at Buffalo, Buffalo NY, USA.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>Netherlands</Country><MedlineTA>Stud Health Technol Inform</MedlineTA><NlmUniqueID>9214582</NlmUniqueID><ISSNLinking>0926-9630</ISSNLinking></MedlineJournalInfo><MeshHeadingList><MeshHeading><DescriptorName UI="D000465" MajorTopicYN="Y">Algorithms</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016208" MajorTopicYN="Y">Databases, Factual</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D013223" MajorTopicYN="Y">Statistics as Topic</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Common data models</Keyword><Keyword MajorTopicYN="N">OMOP</Keyword><Keyword MajorTopicYN="N">realism-based ontologies</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2017</Year><Month>5</Month><Day>9</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2017</Year><Month>5</Month><Day>10</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2018</Year><Month>4</Month><Day>24</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">28479543</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">28681416</PMID><DateCompleted><Year>2017</Year><Month>08</Month><Day>17</Day></DateCompleted><DateRevised><Year>2022</Year><Month>03</Month><Day>30</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1528-1167</ISSN><JournalIssue CitedMedium="Internet"><Volume>58</Volume><Issue>8</Issue><PubDate><Year>2017</Year><Month>Aug</Month></PubDate></JournalIssue><Title>Epilepsia</Title><ISOAbbreviation>Epilepsia</ISOAbbreviation></Journal><ArticleTitle>Risk of angioedema associated with levetiracetam compared with phenytoin: Findings of the observational health data sciences and informatics research network.</ArticleTitle><Pagination><StartPage>e101</StartPage><EndPage>e106</EndPage><MedlinePgn>e101-e106</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1111/epi.13828</ELocationID><Abstract><AbstractText>Recent adverse event reports have raised the question of increased angioedema risk associated with exposure to levetiracetam. To help address this question, the Observational Health Data Sciences and Informatics research network conducted a retrospective observational new-user cohort study of seizure patients exposed to levetiracetam (n = 276,665) across 10 databases. With phenytoin users (n = 74,682) as a comparator group, propensity score-matching was conducted and hazard ratios computed for angioedema events by per-protocol and intent-to-treat analyses. Angioedema events were rare in both the levetiracetam and phenytoin groups (54 vs. 71 in per-protocol and 248 vs. 435 in intent-to-treat). No significant increase in angioedema risk with levetiracetam was seen in any individual database (hazard ratios ranging from 0.43 to 1.31). Meta-analysis showed a summary hazard ratio of 0.72 (95% confidence interval [CI] 0.39-1.31) and 0.64 (95% CI 0.52-0.79) for the per-protocol and intent-to-treat analyses, respectively. The results suggest that levetiracetam has the same or lower risk for angioedema than phenytoin, which does not currently carry a labeled warning for angioedema. Further studies are warranted to evaluate angioedema risk across all antiepileptic drugs.</AbstractText><CopyrightInformation>Wiley Periodicals, Inc. &#xa9; 2017 International League Against Epilepsy.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Duke</LastName><ForeName>Jon D</ForeName><Initials>JD</Initials><AffiliationInfo><Affiliation>Observational Health Data Sciences and Informatics (OHDSI) Collaborative.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Georgia Tech Research Institute, Atlanta, Georgia, U.S.A.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ryan</LastName><ForeName>Patrick B</ForeName><Initials>PB</Initials><AffiliationInfo><Affiliation>Observational Health Data Sciences and Informatics (OHDSI) Collaborative.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Janssen Research and Development, Raritan, New Jersey, U.S.A.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Columbia University, New York, New York, U.S.A.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Suchard</LastName><ForeName>Marc A</ForeName><Initials>MA</Initials><AffiliationInfo><Affiliation>Observational Health Data Sciences and Informatics (OHDSI) Collaborative.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>University of California Los Angeles, Los Angeles, California, U.S.A.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hripcsak</LastName><ForeName>George</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Observational Health Data Sciences and Informatics (OHDSI) Collaborative.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Columbia University, New York, New York, U.S.A.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jin</LastName><ForeName>Peng</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Observational Health Data Sciences and Informatics (OHDSI) Collaborative.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Columbia University, New York, New York, U.S.A.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Reich</LastName><ForeName>Christian</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Observational Health Data Sciences and Informatics (OHDSI) Collaborative.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Quintiles-IMS, Cambridge, Massachusetts, U.S.A.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Schwalm</LastName><ForeName>Marie-Sophie</ForeName><Initials>MS</Initials><AffiliationInfo><Affiliation>Observational Health Data Sciences and Informatics (OHDSI) Collaborative.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Quintiles-IMS, Cambridge, Massachusetts, U.S.A.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Khoma</LastName><ForeName>Yuriy</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Observational Health Data Sciences and Informatics (OHDSI) Collaborative.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Odysseus Data Services Inc, Cambridge, Massachusetts U.S.A.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Lviv Polytechnic National University, Lviv, Ukraine.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wu</LastName><ForeName>Yonghui</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Observational Health Data Sciences and Informatics (OHDSI) Collaborative.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>The University of Texas Health Science Center at Houston, Houston, Texas, U.S.A.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Xu</LastName><ForeName>Hua</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Observational Health Data Sciences and Informatics (OHDSI) Collaborative.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>The University of Texas Health Science Center at Houston, Houston, Texas, U.S.A.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Shah</LastName><ForeName>Nigam H</ForeName><Initials>NH</Initials><AffiliationInfo><Affiliation>Observational Health Data Sciences and Informatics (OHDSI) Collaborative.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Center for Biomedical Informatics Research, Stanford University, Stanford, California, U.S.A.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Banda</LastName><ForeName>Juan M</ForeName><Initials>JM</Initials><AffiliationInfo><Affiliation>Observational Health Data Sciences and Informatics (OHDSI) Collaborative.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Center for Biomedical Informatics Research, Stanford University, Stanford, California, U.S.A.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Schuemie</LastName><ForeName>Martijn J</ForeName><Initials>MJ</Initials><AffiliationInfo><Affiliation>Observational Health Data Sciences and Informatics (OHDSI) Collaborative.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Janssen Research and Development, Raritan, New Jersey, U.S.A.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>R01 GM101430</GrantID><Acronym>GM</Acronym><Agency>NIGMS NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D064888">Observational Study</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2017</Year><Month>07</Month><Day>06</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Epilepsia</MedlineTA><NlmUniqueID>2983306R</NlmUniqueID><ISSNLinking>0013-9580</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>44YRR34555</RegistryNumber><NameOfSubstance UI="D000077287">Levetiracetam</NameOfSubstance></Chemical><Chemical><RegistryNumber>6158TKW0C5</RegistryNumber><NameOfSubstance UI="D010672">Phenytoin</NameOfSubstance></Chemical><Chemical><RegistryNumber>ZH516LNZ10</RegistryNumber><NameOfSubstance UI="D010889">Piracetam</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000799" MajorTopicYN="N">Angioedema</DescriptorName><QualifierName UI="Q000139" MajorTopicYN="Y">chemically induced</QualifierName><QualifierName UI="Q000453" MajorTopicYN="Y">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D019058" MajorTopicYN="N">Community Networks</DescriptorName><QualifierName UI="Q000706" MajorTopicYN="N">statistics &amp; numerical data</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016208" MajorTopicYN="N">Databases, Factual</DescriptorName><QualifierName UI="Q000706" MajorTopicYN="N">statistics &amp; numerical data</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004827" MajorTopicYN="N">Epilepsy</DescriptorName><QualifierName UI="Q000188" MajorTopicYN="Y">drug therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000077287" MajorTopicYN="N">Levetiracetam</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D010672" MajorTopicYN="N">Phenytoin</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="Y">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D010889" MajorTopicYN="N">Piracetam</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName><QualifierName UI="Q000031" MajorTopicYN="Y">analogs &amp; derivatives</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Adverse drug reactions</Keyword><Keyword MajorTopicYN="N">Angioedema</Keyword><Keyword MajorTopicYN="N">Anticonvulsant hypersensitivity syndrome</Keyword><Keyword MajorTopicYN="N">Levetiracetam</Keyword><Keyword MajorTopicYN="N">Observational research</Keyword><Keyword MajorTopicYN="N">Pharmacovigilance</Keyword></KeywordList><CoiStatement>DISCLOSURE OF CONFLICT OF INTEREST. One of the authors (JD) changed institutions after the protocol had been completed and at his new institution joined an ongoing unrelated informatics project funded by Union Chimique Belge (UCB), a brand manufacturer of levetiracetam. The remaining authors have no conflicts of interest to disclose. We confirm that we have read the Journal&#x2019;s position on issues involved in ethical publication and affirm that this report is consistent with those guidelines.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="accepted"><Year>2017</Year><Month>5</Month><Day>26</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2017</Year><Month>7</Month><Day>7</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2017</Year><Month>8</Month><Day>18</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2017</Year><Month>7</Month><Day>7</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2019</Year><Month>7</Month><Day>16</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">28681416</ArticleId><ArticleId IdType="mid">NIHMS1034326</ArticleId><ArticleId IdType="pmc">PMC6632067</ArticleId><ArticleId IdType="doi">10.1111/epi.13828</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>FDA Adverse Event Reporting System (FAERS) (formerly AERS). Available at: http://www.fda.gov/Drugs/GuidanceComplianceRegulatoryInformation/Surveillance/AdverseDrugEffects/default.htm.
Accessed October 25,2013.</Citation></Reference><Reference><Citation>Research C for DE. FDA Adverse Events Reporting System (FAERS) - Potential Signals of Serious Risks/New Safety Information Identified by the FDA Adverse Event Reporting System (FAERS) between October&#x2013;December
2015.  Available at: http://www.fda.gov/Drugs/GuidanceComplianceRegulatoryInformation/Surveillance/AdverseDrugEffects/ucm491645.htm.
Accessed February 12, 2017.</Citation></Reference><Reference><Citation>Vittorio CC, Muglia JJ. Anticonvulsant hypersensitivity syndrome. ArchInternMed 1995;155:2285.</Citation><ArticleIdList><ArticleId IdType="pubmed">7487252</ArticleId></ArticleIdList></Reference><Reference><Citation>Leyva L, Torres MJ, Posadas S, et al. Anticonvulsant-induced toxic epidermal necrolysis: monitoring the immunologic response. J Allergy Clin Immunol 2000;105:157&#x2013;165.</Citation><ArticleIdList><ArticleId IdType="pubmed">10629466</ArticleId></ArticleIdList></Reference><Reference><Citation>Lerch M Drug-induced angioedema. Chem Immunol Allergy 2012;97:98&#x2013;105.</Citation><ArticleIdList><ArticleId IdType="pubmed">22613856</ArticleId></ArticleIdList></Reference><Reference><Citation>B&#xf6;hm R, von Hehn L, Herdegen T, et al. OpenVigil FDA &#x2013; inspection of U.S. American adverse drug events pharmacovigilance data and novel clinical applications. PLoS ONE 2016;11:e0157753.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4915658</ArticleId><ArticleId IdType="pubmed">27326858</ArticleId></ArticleIdList></Reference><Reference><Citation>DailyMed: About DailyMed. http://dailymed.nlm.nih.gov/dailymed/about.cfm.
Accessed February 10, 2017.</Citation></Reference><Reference><Citation>Hripcsak G, Duke JD, Shah NH, et al.
Observational Health Data Sciences and Informatics (OHDSI): opportunities for observational researchers. Stud Health Technol Inform
2015;216:574&#x2013;578. Available at: http://www.ncbi.nlm.nih.gov/pubmed/26262116.
Accessed February 12, 2017.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4815923</ArticleId><ArticleId IdType="pubmed">26262116</ArticleId></ArticleIdList></Reference><Reference><Citation>OHDSI Research Network Databases. Available at: http://www.ohdsi.org/web/wiki/doku.php?id=resources:data_network.
Accessed April 27, 2017.</Citation></Reference><Reference><Citation>World Health Organization. The importance of pharmacovigilance. 2002.  Available at: http://apps.who.int/iris/bitstream/10665/42493/1/a75646.pdf.
Accessed April 27,2017.</Citation></Reference><Reference><Citation>Schuemie MJ, Suchard M, Ryan P. CohortMethod: New-user cohort method with large scale propensity and outcome models. 2015.  Available at: http://www.github.com/ohdsi/CohortMethod.
Accessed November 15, 2017.</Citation></Reference><Reference><Citation>Suchard MA, Simpson SE, Zorych I, et al. Massive parallelization of serial inference algorithms for complex generalized linear models. ACM Trans Model Comput Simul 2013;23:10.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4201181</ArticleId><ArticleId IdType="pubmed">25328363</ArticleId></ArticleIdList></Reference><Reference><Citation>DailyMed - DILANTIN- phenytoin sodium capsule, extended release. Available at: https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=8848de76-8d74-4620-bcc7-a86a596e5dd9.
Accessed February 12, 2017.</Citation></Reference><Reference><Citation>KnowledgeBaseWeb. Available at: http://www.ohdsi.org/web/knowledgebaseweb/.
Accessed February 12, 2017.</Citation></Reference><Reference><Citation>Rassen JA, Shelat AA, Myers J, et al. One-to-many propensity score matching in cohort studies. Pharmacoepidemiol Drug Saf 2012;21:69&#x2013;80.</Citation><ArticleIdList><ArticleId IdType="pubmed">22552982</ArticleId></ArticleIdList></Reference><Reference><Citation>Arnold BF, Ercumen A, Benjamin-Chung JCJJ. Negative controls to detect selection bias and measurement bias in epidemiologic studies. Epidemiology 2016;275:637&#x2013;641.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4969055</ArticleId><ArticleId IdType="pubmed">27182642</ArticleId></ArticleIdList></Reference><Reference><Citation>Schuemie MJ, Ryan PB, DuMouchel W, et al. Interpreting observational studies: why empirical calibration is needed to correct p-values. Stat Med 2014;33:209&#x2013;218.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4285234</ArticleId><ArticleId IdType="pubmed">23900808</ArticleId></ArticleIdList></Reference><Reference><Citation>King G, Nielsen R. Why propensity scores should not be used for matching. 2016.  Available at: http://j.mp/1sexgVw.
Accessed April 27,2017.</Citation></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">28776047</PMID><DateRevised><Year>2020</Year><Month>10</Month><Day>01</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Print">2509-4971</ISSN><JournalIssue CitedMedium="Print"><Volume>1</Volume><Issue>1</Issue><PubDate><Year>2017</Year><Month>Jun</Month></PubDate></JournalIssue><Title>Journal of healthcare informatics research</Title><ISOAbbreviation>J Healthc Inform Res</ISOAbbreviation></Journal><ArticleTitle>An Interoperable Similarity-based Cohort Identification Method Using the OMOP Common Data Model version 5.0.</ArticleTitle><Pagination><StartPage>1</StartPage><EndPage>18</EndPage><MedlinePgn>1-18</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1007/s41666-017-0005-6</ELocationID><Abstract><AbstractText>Cohort identification for clinical studies tends to be laborious, time-consuming, and expensive. Developing automated or semi-automated methods for cohort identification is one of the "holy grails" in the field of biomedical informatics. We propose a high-throughput similarity-based cohort identification algorithm by applying numerical abstractions on Electronic Health Records (EHR) data. We implement this algorithm using the Observational Medical Outcomes Partnership (OMOP) Common Data Model (CDM), which enables sites using this standardized EHR data representation to avail this algorithm with minimum effort for local implementation. We validate its performance for a retrospective cohort identification task on six clinical trials conducted at the Columbia University Medical Center. Our algorithm achieves an average Area Under the Curve (AUC) of 0.966 and an average Precision at 5 of 0.983. This interoperable method promises to achieve efficient cohort identification in EHR databases. We discuss suitable applications of our method and its limitations and propose warranted future work.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Chakrabarti</LastName><ForeName>Shreya</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Biomedical Informatics, Columbia University, New York NY 10032.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sen</LastName><ForeName>Anando</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Biomedical Informatics, Columbia University, New York NY 10032.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Huser</LastName><ForeName>Vojtech</ForeName><Initials>V</Initials><AffiliationInfo><Affiliation>National Institute of Health, National Library of Medicine, Bethesda, MD 20892.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hruby</LastName><ForeName>Gregory W</ForeName><Initials>GW</Initials><AffiliationInfo><Affiliation>Department of Biomedical Informatics, Columbia University, New York NY 10032.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rusanov</LastName><ForeName>Alexander</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology, Columbia University, New York NY 10032.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Albers</LastName><ForeName>David J</ForeName><Initials>DJ</Initials><AffiliationInfo><Affiliation>Department of Biomedical Informatics, Columbia University, New York NY 10032.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Weng</LastName><ForeName>Chunhua</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Department of Biomedical Informatics, Columbia University, New York NY 10032.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>R01 LM009886</GrantID><Acronym>LM</Acronym><Agency>NLM NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>U01 HG008680</GrantID><Acronym>HG</Acronym><Agency>NHGRI NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>UL1 TR001873</GrantID><Acronym>TR</Acronym><Agency>NCATS NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2017</Year><Month>06</Month><Day>08</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>J Healthc Inform Res</MedlineTA><NlmUniqueID>101707451</NlmUniqueID><ISSNLinking>2509-498X</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Case-based Reasoning (CBR)</Keyword><Keyword MajorTopicYN="N">Cohort Identification</Keyword><Keyword MajorTopicYN="N">Electronic Health Records (EHR)</Keyword><Keyword MajorTopicYN="N">Observational Medical Outcomes Partnership (OMOP)</Keyword><Keyword MajorTopicYN="N">Phenotype</Keyword><Keyword MajorTopicYN="N">Similarity-based</Keyword></KeywordList><CoiStatement>Conflict of Interest None.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2017</Year><Month>8</Month><Day>5</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2017</Year><Month>8</Month><Day>5</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2017</Year><Month>8</Month><Day>5</Day><Hour>6</Hour><Minute>1</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2018</Year><Month>6</Month><Day>1</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">28776047</ArticleId><ArticleId IdType="mid">NIHMS883375</ArticleId><ArticleId IdType="pmc">PMC5536903</ArticleId><ArticleId IdType="doi">10.1007/s41666-017-0005-6</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Hersh WR. Adding value to the electronic health record through secondary use of data for quality assurance, research, and surveillance. Am J Manag Care. 2007;13:277&#x2013;278.</Citation><ArticleIdList><ArticleId IdType="pubmed">17567224</ArticleId></ArticleIdList></Reference><Reference><Citation>Safran C, Bloomrosen M, Hammond WE, Labkoff S, Markel-Fox S, Tang PC, Detmer DE, Expert Panel W (2007) Input from the expert panel (see A.A.: Toward a national framework for the secondary use of health data: an American Medical Informatics Association White Paper. J Am Med Inform Assoc 14: 1&#x2013;9. doi:10.1197/jamia.M2273</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2329823</ArticleId><ArticleId IdType="pubmed">17077452</ArticleId></ArticleIdList></Reference><Reference><Citation>Shivade C, Raghavan P, Fosler-Lussier E, Embi PJ, Elhadad N, Johnson SB, Lai AM. A review of approaches to identifying patient phenotype cohorts using electronic health records. J Am Med Inform Assoc. 2014;21:221&#x2013;230. doi: 10.1136/amiajnl-2013-001935.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/amiajnl-2013-001935</ArticleId><ArticleId IdType="pmc">PMC3932460</ArticleId><ArticleId IdType="pubmed">24201027</ArticleId></ArticleIdList></Reference><Reference><Citation>Conway M, Berg RL, Carrell D, Denny JC, Kho AN, Kullo IJ, Linneman JG, Pacheco JA, Peissig P, Rasmussen L, Weston N, Chute CG, Pathak J (2011) Analyzing the heterogeneity and complexity of Electronic Health Record oriented phenotyping algorithms. AMIA ... Annu. Symp. proceedings. AMIA Symp 274&#x2013;83</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3243189</ArticleId><ArticleId IdType="pubmed">22195079</ArticleId></ArticleIdList></Reference><Reference><Citation>Collins JF, Williford WO, Weiss DG, Bingham SF, Klett CJ. Planning patient recruitment: fantasy and reality. Stat Med. 1984;3:435&#x2013;443. doi: 10.1002/sim.4780030425.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/sim.4780030425</ArticleId><ArticleId IdType="pubmed">6396795</ArticleId></ArticleIdList></Reference><Reference><Citation>Hripcsak G, Albers D. Next-generation phenotyping of electronic health records. J Am Med Inform Assoc. 2013;20:117&#x2013;121. doi: 10.1136/amiajnl-2012-001145.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/amiajnl-2012-001145</ArticleId><ArticleId IdType="pmc">PMC3555337</ArticleId><ArticleId IdType="pubmed">22955496</ArticleId></ArticleIdList></Reference><Reference><Citation>Friedman J, Hastie T, Tibshirani R. The elements of statistical learning. Berlin: Springer; 2001.</Citation></Reference><Reference><Citation>Carroll RJ, Eyler AE, Denny JC (2011) Na&#xef;ve Electronic Health Record phenotype identification for Rheumatoid arthritis. AMIA ... Annu. Symp. proceedings. AMIA Symp. 2011, 189&#x2013;96</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3243261</ArticleId><ArticleId IdType="pubmed">22195070</ArticleId></ArticleIdList></Reference><Reference><Citation>K&#xf6;pcke F, Lubgan D, Fietkau R. Evaluating predictive modeling algorithms to assess patient eligibility for clinical trials from routine data. BMC Med Inform Decis Mak. 2013;13:134. doi: 10.1186/1472-6947-13-134.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1472-6947-13-134</ArticleId><ArticleId IdType="pmc">PMC4029400</ArticleId><ArticleId IdType="pubmed">24321610</ArticleId></ArticleIdList></Reference><Reference><Citation>Xu L. Case based reasoning. IEEE Potentials. 1994;13:10&#x2013;13. doi: 10.1109/45.464654.</Citation><ArticleIdList><ArticleId IdType="doi">10.1109/45.464654</ArticleId></ArticleIdList></Reference><Reference><Citation>Pantazi SV, Arocha JF, Moehr JR, Moehr J, Leven F, Rothemund M, Solomonoff R, et al. Case-based medical informatics. BMC Med Inform Decis Mak. 2004;4:19. doi: 10.1186/1472-6947-4-19.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1472-6947-4-19</ArticleId><ArticleId IdType="pmc">PMC544898</ArticleId><ArticleId IdType="pubmed">15533257</ArticleId></ArticleIdList></Reference><Reference><Citation>Miotto R, Weng C. Case-based reasoning using electronic health records efficiently identifies eligible patients for clinical trials. J Am Med Inform Assoc. 2015;22:141&#x2013;150. doi: 10.1093/jamia/ocu050.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/jamia/ocu050</ArticleId><ArticleId IdType="pmc">PMC4428438</ArticleId><ArticleId IdType="pubmed">25769682</ArticleId></ArticleIdList></Reference><Reference><Citation>Marling C, Whitehouse P (2001) Case-based reasoning in the care of Alzheimer&#x2019;s Disease patients. In: Case-based Reasoning Research and Development. pp. 702&#x2013;715. Springer Berlin Heidelberg</Citation></Reference><Reference><Citation>Bradburn C, Zeleznikow J (1994) The application of case-based reasoning to the tasks of health care planning. Presented at the</Citation></Reference><Reference><Citation>Letham B, Rudin C, Madigan D. Sequential event prediction. Mach Learn. 2013;93:357&#x2013;380. doi: 10.1007/s10994-013-5356-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10994-013-5356-5</ArticleId></ArticleIdList></Reference><Reference><Citation>Vilar S, Ryan PB, Madigan D, Stang PE, Schuemie MJ, Friedman C, Tatonetti NP, Hripcsak G. Similarity-based modeling applied to signal detection in pharmacovigilance. CPT Pharmacometrics Syst Pharmacol. 2014;3:e137. doi: 10.1038/psp.2014.35.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/psp.2014.35</ArticleId><ArticleId IdType="pmc">PMC4211266</ArticleId><ArticleId IdType="pubmed">25250527</ArticleId></ArticleIdList></Reference><Reference><Citation>Longhurst CA, Harrington RA, Shah NH (2014) A &#x201c;green button&#x201d; for using aggregate patient data at the point of care. Health Aff (Millwood) 33(1229&#x2013;35). doi:10.1377/hlthaff.2014.0099</Citation><ArticleIdList><ArticleId IdType="pubmed">25006150</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang Z, Dong W, Duan H, Li H (2014) Similarity measure between patient traces for clinical pathway analysis: problem, method, and applications. IEEE J Biomed Heal Inform 18(4&#x2013;14). doi:10.1109/JBHI.2013.2274281</Citation><ArticleIdList><ArticleId IdType="pubmed">24403398</ArticleId></ArticleIdList></Reference><Reference><Citation>Cuggia M, Besana P, Glasspool D. Comparing semi-automatic systems for recruitment of patients to clinical trials. Int J Med Inform. 2011;80:371&#x2013;388. doi: 10.1016/j.ijmedinf.2011.02.003.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ijmedinf.2011.02.003</ArticleId><ArticleId IdType="pubmed">21459664</ArticleId></ArticleIdList></Reference><Reference><Citation>Hripcsak G, Albers D, Perotte A. Exploiting time in electronic health record correlations. J Am Med Inform Assoc. 2011;18:109&#x2013;115. doi: 10.1136/amiajnl-2011-000463.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/amiajnl-2011-000463</ArticleId><ArticleId IdType="pmc">PMC3241180</ArticleId><ArticleId IdType="pubmed">22116643</ArticleId></ArticleIdList></Reference><Reference><Citation>Rusanov A, Weiskopf N. Hidden in plain sight: bias towards sick patients when sampling patients with sufficient electronic health record data for research. BMC Med Inform Decis Mak. 2014;14:1. doi: 10.1186/1472-6947-14-51.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1472-6947-14-51</ArticleId><ArticleId IdType="pmc">PMC4062889</ArticleId><ArticleId IdType="pubmed">24916006</ArticleId></ArticleIdList></Reference><Reference><Citation>Pivovarov R, Elhadad N. Automated methods for the summarization of electronic health records. J Am Med Inform Assoc. 2015;22:938&#x2013;947. doi: 10.1093/jamia/ocv032.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/jamia/ocv032</ArticleId><ArticleId IdType="pmc">PMC4986665</ArticleId><ArticleId IdType="pubmed">25882031</ArticleId></ArticleIdList></Reference><Reference><Citation>Cohen R, Elhadad M, Elhadad N. Redundancy in electronic health record corpora: analysis, impact on text mining performance and mitigation strategies. BMC Bioinformatics. 2013;14:1. doi: 10.1186/1471-2105-14-S18-S1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1471-2105-14-S18-S1</ArticleId><ArticleId IdType="pmc">PMC3599108</ArticleId><ArticleId IdType="pubmed">23323800</ArticleId></ArticleIdList></Reference><Reference><Citation>Sun J, Wang F, Hu J, Edabollahi S. Supervised patient similarity measure of heterogeneous patient records. ACM SIGKDD Explor. 2012;14:16&#x2013;24. doi: 10.1145/2408736.2408740.</Citation><ArticleIdList><ArticleId IdType="doi">10.1145/2408736.2408740</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang P, Wang F, Hu J, Sorrentino R. Towards personalized medicine: leveraging patient similarity and drug similarity analytics. AMIA Jt Summits Transl Sci proceedings AMIA Jt Summits Transl Sci. 2014;2014:132&#x2013;136.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4333693</ArticleId><ArticleId IdType="pubmed">25717413</ArticleId></ArticleIdList></Reference><Reference><Citation>Overhage J, Ryan P, Reich C. Validation of a common data model for active safety surveillance research. J Am Med Inform Assoc. 2012;19:54&#x2013;60. doi: 10.1136/amiajnl-2011-000376.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/amiajnl-2011-000376</ArticleId><ArticleId IdType="pmc">PMC3240764</ArticleId><ArticleId IdType="pubmed">22037893</ArticleId></ArticleIdList></Reference><Reference><Citation>Hripcsak G, Duke J, Shah N, Reich C. Observational Health Data Sciences and Informatics (OHDSI): opportunities for observational researchers. Stud Health Technol Inform. 2015;216:574.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4815923</ArticleId><ArticleId IdType="pubmed">26262116</ArticleId></ArticleIdList></Reference><Reference><Citation>Observational Medical Outcomes Partnership, http://omop.org/</Citation></Reference><Reference><Citation>Dolin R, Alschuler L, Beebe C. The HL7 clinical document architecture. J Am Med Inform Assoc. 2001;8(6):552&#x2013;569. doi: 10.1136/jamia.2001.0080552.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/jamia.2001.0080552</ArticleId><ArticleId IdType="pmc">PMC130066</ArticleId><ArticleId IdType="pubmed">11687563</ArticleId></ArticleIdList></Reference><Reference><Citation>Friedman D, Cohen B, Averbach A. Race/ethnicity and OMB directive 15: implications for state public health practice. Am J Public Health. 2000;90:1714. doi: 10.2105/AJPH.90.11.1714.</Citation><ArticleIdList><ArticleId IdType="doi">10.2105/AJPH.90.11.1714</ArticleId><ArticleId IdType="pmc">PMC1446393</ArticleId><ArticleId IdType="pubmed">11076237</ArticleId></ArticleIdList></Reference><Reference><Citation>Centers for Disease Control and Prevention, https://www.cdc.gov/</Citation></Reference><Reference><Citation>World Health Organization (1993) ICD-10 Classification of Mental and Behavioural Disorders. Diagnostic Criteria Res. WHO, Geneva</Citation></Reference><Reference><Citation>Donnelly K. SNOMED-CT: the advanced terminology and coding system for eHealth. Stud Health Technol Inform. 2006;121:279.</Citation><ArticleIdList><ArticleId IdType="pubmed">17095826</ArticleId></ArticleIdList></Reference><Reference><Citation>McDonald C, Huff S, Suico J, Hill G. LOINC, a universal standard for identifying laboratory observations: a 5-year update. Clin Chem. 2003;49:624&#x2013;633. doi: 10.1373/49.4.624.</Citation><ArticleIdList><ArticleId IdType="doi">10.1373/49.4.624</ArticleId><ArticleId IdType="pubmed">12651816</ArticleId></ArticleIdList></Reference><Reference><Citation>Schadow G, McDonald C The unified code for units of measure (UCUM). Regenstrief Inst. Indiana</Citation></Reference><Reference><Citation>Cerner Multum. Lexicon, https://www.cerner.com/cerner_multum/</Citation></Reference><Reference><Citation>Pahor M, Chrischilles E, Guralnik J. Drug data coding and analysis in epidemiologic studies. Eur J Epidemiol. 1994;10:405&#x2013;411. doi: 10.1007/BF01719664.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/BF01719664</ArticleId><ArticleId IdType="pubmed">7843344</ArticleId></ArticleIdList></Reference><Reference><Citation>Cimino J, Hripcsak G (1989) Designing an introspective, multipurpose, controlled medical vocabulary. In: Proc 13th Annu Symp Comput Appl Med Care. pp. 513&#x2013;518</Citation></Reference><Reference><Citation>Bodenreider O. The unified medical language system (UMLS): integrating biomedical terminology. Nucleic Acids Res. 2004;32:D267&#x2013;D270. doi: 10.1093/nar/gkh061.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/nar/gkh061</ArticleId><ArticleId IdType="pmc">PMC308795</ArticleId><ArticleId IdType="pubmed">14681409</ArticleId></ArticleIdList></Reference><Reference><Citation>Milstein B, Maguire N, Meier J. Method for computing current procedural terminology codes from physician generated documentation. US Pat. 1996;5:483,443.</Citation></Reference><Reference><Citation>Thadani S, Weng C, Bigger J. Electronic screening improves efficiency in clinical trial recruitment. J Am Med Inform Assoc. 2009;16:869&#x2013;873. doi: 10.1197/jamia.M3119.</Citation><ArticleIdList><ArticleId IdType="doi">10.1197/jamia.M3119</ArticleId><ArticleId IdType="pmc">PMC3002129</ArticleId><ArticleId IdType="pubmed">19717797</ArticleId></ArticleIdList></Reference><Reference><Citation>Albers DJ, Pivovarov R, Elhadad N, Hripcsak G (2015) Model selection for EHR Laboratory tests preserving healthcare context and underlying physiology. In: American Medical Informatics Association</Citation></Reference><Reference><Citation>Pollard H. On the relative stability of the median and arithmetic mean, with particular reference to certain frequency distributions which can be dissected into normal. Ann Math Stat. 1934;5:227&#x2013;262. doi: 10.1214/aoms/1177732678.</Citation><ArticleIdList><ArticleId IdType="doi">10.1214/aoms/1177732678</ArticleId></ArticleIdList></Reference><Reference><Citation>Huber P, Ronchetti E (1975) Robustness of design. Robust Stat. Second Ed. 239&#x2013;248</Citation></Reference><Reference><Citation>Verleysen M, Fran&#xe7;ois D (2005) The curse of dimensionality in data mining and time series prediction. In: computational intelligence and bioinspired systems. pp. 758&#x2013;770. Springer Berlin Heidelberg</Citation></Reference><Reference><Citation>Deza M, Deza E. Encyclopedia of distances. Berlin Heidelberg: Springer; 2009.</Citation></Reference><Reference><Citation>Brown MB, Forsythe AB. 372: the Anova and multiple comparisons for data with heterogeneous variances. Biometrics. 1974;30:719&#x2013;724. doi: 10.2307/2529238.</Citation><ArticleIdList><ArticleId IdType="doi">10.2307/2529238</ArticleId></ArticleIdList></Reference><Reference><Citation>Eisenberg DL, Schreiber CA, Turok DK, Teal SB, Westhoff CL, Creinin MD. Three-year efficacy and safety of a new 52-mg levonorgestrel-releasing intrauterine system. Contraception. 2015;92:10&#x2013;16. doi: 10.1016/j.contraception.2015.04.006.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.contraception.2015.04.006</ArticleId><ArticleId IdType="pubmed">25934164</ArticleId></ArticleIdList></Reference><Reference><Citation>Kent DM, Rothwell PM, Ioannidis JP, Altman DG, Hayward RA, Black D, Feinstein A, et al. Assessing and reporting heterogeneity in treatment effects in clinical trials: a proposal. Trials. 2010;11:1. doi: 10.1186/1745-6215-11-85.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1745-6215-11-85</ArticleId><ArticleId IdType="pmc">PMC2928211</ArticleId><ArticleId IdType="pubmed">20704705</ArticleId></ArticleIdList></Reference><Reference><Citation>Karian Z, Dudewicz E (2000) Fitting statistical distributions: the generalized lambda distribution and generalized bootstrap methods</Citation></Reference><Reference><Citation>Sen A, Chakrabarti S, Goldstein A, Wang S, Ryan P, Weng C. GIST 2.0: A Scalable Multi-trait Metric for Quantifying Population Representativeness of Individual Clinical Studies. J Biomed Inform. 2016;63:325&#x2013;336. doi: 10.1016/j.jbi.2016.09.003.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jbi.2016.09.003</ArticleId><ArticleId IdType="pmc">PMC5077682</ArticleId><ArticleId IdType="pubmed">27600407</ArticleId></ArticleIdList></Reference><Reference><Citation>Hersh W, Weiner M, Embi P, Logan J. Caveats for the use of operational electronic health record data in comparative effectiveness research. Med Care. 2013;51:S30. doi: 10.1097/MLR.0b013e31829b1dbd.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/MLR.0b013e31829b1dbd</ArticleId><ArticleId IdType="pmc">PMC3748381</ArticleId><ArticleId IdType="pubmed">23774517</ArticleId></ArticleIdList></Reference><Reference><Citation>Weiskopf N, Weng C. Methods and dimensions of electronic health record data quality assessment: enabling reuse for clinical research. J Am Med Informatics Assoc. 2013;20:144&#x2013;151. doi: 10.1136/amiajnl-2011-000681.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/amiajnl-2011-000681</ArticleId><ArticleId IdType="pmc">PMC3555312</ArticleId><ArticleId IdType="pubmed">22733976</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">28780741</PMID><DateCompleted><Year>2018</Year><Month>06</Month><Day>27</Day></DateCompleted><DateRevised><Year>2021</Year><Month>01</Month><Day>09</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1179-1942</ISSN><JournalIssue CitedMedium="Internet"><Volume>40</Volume><Issue>12</Issue><PubDate><Year>2017</Year><Month>Dec</Month></PubDate></JournalIssue><Title>Drug safety</Title><ISOAbbreviation>Drug Saf</ISOAbbreviation></Journal><ArticleTitle>Channeling in the Use of Nonprescription Paracetamol and Ibuprofen in an Electronic Medical Records Database: Evidence and Implications.</ArticleTitle><Pagination><StartPage>1279</StartPage><EndPage>1292</EndPage><MedlinePgn>1279-1292</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1007/s40264-017-0581-7</ELocationID><Abstract><AbstractText Label="INTRODUCTION">Over-the-counter analgesics such as paracetamol and ibuprofen are among the most widely used, and having a good understanding of their safety profile is important to public health. Prior observational studies estimating the risks associated with paracetamol use acknowledge the inherent limitations of these studies. One threat to the validity of observational studies is channeling bias, i.e. the notion that patients are systematically exposed to one drug or the other, based on current and past comorbidities, in a manner that affects estimated relative risk.</AbstractText><AbstractText Label="OBJECTIVES">The aim of this study was to examine whether evidence of channeling bias exists in observational studies that compare paracetamol with ibuprofen, and, if so, the extent to which confounding adjustment can mitigate this bias.</AbstractText><AbstractText Label="STUDY DESIGN AND SETTING">In a cohort of 140,770 patients, we examined whether those who received any paracetamol (including concomitant users) were more likely to have prior diagnoses of gastrointestinal (GI) bleeding, myocardial infarction (MI), stroke, or renal disease than those who received ibuprofen alone. We compared propensity score distributions between drugs, and examined the degree to which channeling bias could be controlled using a combination of negative control disease outcome models and large-scale propensity score matching. Analyses were conducted using the Clinical Practice Research Datalink.</AbstractText><AbstractText Label="RESULTS">The proportions of prior MI, GI bleeding, renal disease, and stroke were significantly higher in those prescribed any paracetamol versus ibuprofen alone, after adjusting for sex and age. We were not able to adequately remove selection bias using a selected set of covariates for propensity score adjustment; however, when we fit the propensity score model using a substantially larger number of covariates, evidence of residual bias was attenuated.</AbstractText><AbstractText Label="CONCLUSIONS">Although using selected covariates for propensity score adjustment may not sufficiently reduce bias, large-scale propensity score matching offers a novel approach to consider to mitigate the effects of channeling bias.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Weinstein</LastName><ForeName>Rachel B</ForeName><Initials>RB</Initials><Identifier Source="ORCID">0000-0002-0023-9578</Identifier><AffiliationInfo><Affiliation>Janssen Research and Development, LLC, 1125 Harbourton-Trenton Rd, Titusville, NJ, 08560, USA. Rweinst1@its.jnj.com.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ryan</LastName><ForeName>Patrick</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Janssen Research and Development, LLC, 1125 Harbourton-Trenton Rd, Titusville, NJ, 08560, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Berlin</LastName><ForeName>Jesse A</ForeName><Initials>JA</Initials><AffiliationInfo><Affiliation>Johnson and Johnson, 1125 Harbourton-Trenton Rd, Titusville, NJ, 08560, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Matcho</LastName><ForeName>Amy</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Janssen Research and Development, LLC, 920 US Route 202, Raritan, NJ, 08869, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Schuemie</LastName><ForeName>Martijn</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Janssen Research and Development, LLC, 1125 Harbourton-Trenton Rd, Titusville, NJ, 08560, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Swerdel</LastName><ForeName>Joel</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Janssen Research and Development, LLC, 1125 Harbourton-Trenton Rd, Titusville, NJ, 08560, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Patel</LastName><ForeName>Kayur</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Jan-Cil UK, High Wycombe, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Fife</LastName><ForeName>Daniel</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Janssen Research and Development, LLC, 1125 Harbourton-Trenton Rd, Titusville, NJ, 08560, USA.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><DataBankList CompleteYN="Y"><DataBank><DataBankName>ClinicalTrials.gov</DataBankName><AccessionNumberList><AccessionNumber>NCT02830178</AccessionNumber></AccessionNumberList></DataBank></DataBankList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>New Zealand</Country><MedlineTA>Drug Saf</MedlineTA><NlmUniqueID>9002928</NlmUniqueID><ISSNLinking>0114-5916</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000700">Analgesics</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D004366">Nonprescription Drugs</NameOfSubstance></Chemical><Chemical><RegistryNumber>362O9ITL9D</RegistryNumber><NameOfSubstance UI="D000082">Acetaminophen</NameOfSubstance></Chemical><Chemical><RegistryNumber>WK2XYI10QM</RegistryNumber><NameOfSubstance UI="D007052">Ibuprofen</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000082" MajorTopicYN="N">Acetaminophen</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="Y">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000293" MajorTopicYN="N">Adolescent</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016907" MajorTopicYN="N">Adverse Drug Reaction Reporting Systems</DescriptorName><QualifierName UI="Q000706" MajorTopicYN="N">statistics &amp; numerical data</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000369" MajorTopicYN="N">Aged, 80 and over</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000700" MajorTopicYN="N">Analgesics</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="Y">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015982" MajorTopicYN="N">Bias</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015331" MajorTopicYN="N">Cohort Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016208" MajorTopicYN="N">Databases, Factual</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D057286" MajorTopicYN="N">Electronic Health Records</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006471" MajorTopicYN="N">Gastrointestinal Hemorrhage</DescriptorName><QualifierName UI="Q000139" MajorTopicYN="N">chemically induced</QualifierName><QualifierName UI="Q000453" MajorTopicYN="Y">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007052" MajorTopicYN="N">Ibuprofen</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="Y">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004366" MajorTopicYN="N">Nonprescription Drugs</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="Y">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D057216" MajorTopicYN="N">Propensity Score</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006113" MajorTopicYN="N">United Kingdom</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D055815" MajorTopicYN="N">Young Adult</DescriptorName></MeshHeading></MeshHeadingList><CoiStatement>Jesse A. Berlin, Daniel Fife, Amy Matcho, Kayur Patel, Martijn Schuemie, Joel Swerdel, Patrick Ryan, and Rachel Weinstein were full-time employees of Johnson &amp; Johnson, or a subsidiary, at the time the study was conducted. Johnson &amp; Johnson manufactures several medications that contain paracetamol or ibuprofen. Jesse A. Berlin, Daniel Fife, Amy Matcho, Kayur Patel, Martijn Schuemie, Joel Swerdel, Patrick Ryan, and Rachel Weinstein own stock, stock options and pension rights from the company.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>2017</Year><Month>8</Month><Day>7</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2018</Year><Month>6</Month><Day>28</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2017</Year><Month>8</Month><Day>7</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2017</Year><Month>8</Month><Day>5</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">28780741</ArticleId><ArticleId IdType="pmc">PMC5688206</ArticleId><ArticleId IdType="doi">10.1007/s40264-017-0581-7</ArticleId><ArticleId IdType="pii">10.1007/s40264-017-0581-7</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Kurth T, Glynn RJ, Walker AM, et al. Analgesic use and change in kidney function in apparently healthy men. Am J Kidney Dis. 2003;42:234&#x2013;244. doi: 10.1016/S0272-6386(03)00647-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0272-6386(03)00647-4</ArticleId><ArticleId IdType="pubmed">12900803</ArticleId></ArticleIdList></Reference><Reference><Citation>Curhan GC, Willett WC, Rosner B, et al. Frequency of analgesic use and risk of hypertension in younger women. Arch Intern Med. 2002;162:2204&#x2013;2208. doi: 10.1001/archinte.162.19.2204.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/archinte.162.19.2204</ArticleId><ArticleId IdType="pubmed">12390063</ArticleId></ArticleIdList></Reference><Reference><Citation>Dedier J, Stampfer M, Hankinson S, et al. Nonnarcotic analgesic use and the risk of hypertension in US women. Hypertension. 2002;40:604&#x2013;608. doi: 10.1161/01.HYP.0000035856.77718.DA.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/01.HYP.0000035856.77718.DA</ArticleId><ArticleId IdType="pubmed">12411450</ArticleId></ArticleIdList></Reference><Reference><Citation>Chan AT, Manson JE, Albert CM, et al. Nonsteroidal anti-inflammatory drugs, paracetamol, and the risk of cardiovascular events. Circulation. 2006;113:1578&#x2013;1587. doi: 10.1161/CIRCULATIONAHA.105.595793.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/CIRCULATIONAHA.105.595793</ArticleId><ArticleId IdType="pubmed">16534006</ArticleId></ArticleIdList></Reference><Reference><Citation>Evans M, Fored CM, Bellocco R, et al. Acetaminophen, aspirin and progression of advanced chronic kidney disease. Nephrol Dial Transplant. 2009;24:1908&#x2013;1918. doi: 10.1093/ndt/gfn745.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/ndt/gfn745</ArticleId><ArticleId IdType="pubmed">19155536</ArticleId></ArticleIdList></Reference><Reference><Citation>Lipworth L, Friis S, Mellemkjaer L, et al. A population-based cohort study of mortality among adults prescribed paracetamol in Denmark. J Clin Epidemiol. 2003;56:796&#x2013;801. doi: 10.1016/S0895-4356(03)00152-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0895-4356(03)00152-5</ArticleId><ArticleId IdType="pubmed">12954473</ArticleId></ArticleIdList></Reference><Reference><Citation>de Vries F, Setakis E, van Staa TP, et al. Concomitant use of ibuprofen and paracetamol and the risk of major clinical safety outcomes. Br J Clin Pharmacol. 2010;70:429&#x2013;438. doi: 10.1111/j.1365-2125.2010.03705.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1365-2125.2010.03705.x</ArticleId><ArticleId IdType="pmc">PMC2949916</ArticleId><ArticleId IdType="pubmed">20716244</ArticleId></ArticleIdList></Reference><Reference><Citation>Roberts E, Delgado Nunes V, Buckner S, Latchem S, Constanti M, Miller P, Doherty M, Zhang W, Birrell F, Porcheret M, Dziedzic K, Bernstein I, Wise E, Conaghan PG. Paracetamol: not as safe as we thought? A systematic literature review of observational studies. Ann Rheum Dis. 2016;75(3):552&#x2013;559. doi: 10.1136/annrheumdis-2014-206914.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/annrheumdis-2014-206914</ArticleId><ArticleId IdType="pmc">PMC4789700</ArticleId><ArticleId IdType="pubmed">25732175</ArticleId></ArticleIdList></Reference><Reference><Citation>Herret E, Gallagher AM, Bhaskaran K, Forbes H, Mathur R, van Staa T, Smeeth L. Data resource profile: Clinical Practice Research Datalink (CPRD) Int J Epidemiol. 2015;44(3):827&#x2013;836. doi: 10.1093/ije/dyv098.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/ije/dyv098</ArticleId><ArticleId IdType="pmc">PMC4521131</ArticleId><ArticleId IdType="pubmed">26050254</ArticleId></ArticleIdList></Reference><Reference><Citation>Matcho A, Ryan P, Fife D, Reich C. Fidelity assessment of a Clinical Practice Research Datalink conversion to the OMOP common data model. Drug Saf. 2014;37:945&#x2013;959. doi: 10.1007/s40264-014-0214-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s40264-014-0214-3</ArticleId><ArticleId IdType="pmc">PMC4206771</ArticleId><ArticleId IdType="pubmed">25187016</ArticleId></ArticleIdList></Reference><Reference><Citation>Tibshirani R. Regression shrinkage and selection via the Lasso. J R Stat Soc B. 1996;58(1):267&#x2013;288.</Citation></Reference><Reference><Citation>Walker AM, Patrick AR, Lauer MS, Hornbrook MC, Marin MG, Platt R, Roger VL, Stang P, Schneeweiss S. A tool for assessing the feasibility of comparative effectiveness research. Comp Eff Res. 2013;2013(3):11&#x2013;20.</Citation></Reference><Reference><Citation>Austin PC, Steyerberg EW. The number of subjects per variable required in linear regression analyses. J Clin Epidemiol. 2015;68:627&#x2013;636. doi: 10.1016/j.jclinepi.2014.12.014.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jclinepi.2014.12.014</ArticleId><ArticleId IdType="pubmed">25704724</ArticleId></ArticleIdList></Reference><Reference><Citation>Ryan PB, Schuemie MJ, Welebob E, Duke J, Valentine S, Hartzema AG. Defining a reference set to support methodological research in drug safety. Drug Saf. 2013;36(Suppl 1):S33&#x2013;S47. doi: 10.1007/s40264-013-0097-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s40264-013-0097-8</ArticleId><ArticleId IdType="pubmed">24166222</ArticleId></ArticleIdList></Reference><Reference><Citation>Tisdale JE, Miller DA. Drug-induced diseases: prevention, detection, and management. Bethesda: American Society of Health-System Pharmacists; 2010.</Citation></Reference><Reference><Citation>Schuemie MJ, Ryan PB, DuMouchel W, Suchard MA, Madigan D. Interpreting observational studies: why empirical calibration is needed to correct p-values. Stat Med. 2014;33(2):209&#x2013;218. doi: 10.1002/sim.5925.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/sim.5925</ArticleId><ArticleId IdType="pmc">PMC4285234</ArticleId><ArticleId IdType="pubmed">23900808</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">28815104</PMID><DateRevised><Year>2024</Year><Month>03</Month><Day>26</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Print">2153-4063</ISSN><JournalIssue CitedMedium="Print"><Volume>2017</Volume><PubDate><Year>2017</Year></PubDate></JournalIssue><Title>AMIA Joint Summits on Translational Science proceedings. AMIA Joint Summits on Translational Science</Title><ISOAbbreviation>AMIA Jt Summits Transl Sci Proc</ISOAbbreviation></Journal><ArticleTitle>Electronic phenotyping with APHRODITE and the Observational Health Sciences and Informatics (OHDSI) data network.</ArticleTitle><Pagination><StartPage>48</StartPage><EndPage>57</EndPage><MedlinePgn>48-57</MedlinePgn></Pagination><Abstract><AbstractText>The widespread usage of electronic health records (EHRs) for clinical research has produced multiple electronic phenotyping approaches. Methods for electronic phenotyping range from those needing extensive specialized medical expert supervision to those based on semi-supervised learning techniques. We present Automated PHenotype Routine for Observational Definition, Identification, Training and Evaluation (APHRODITE), an R- package phenotyping framework that combines noisy labeling and anchor learning. APHRODITE makes these cutting-edge phenotyping approaches available for use with the Observational Health Data Sciences and Informatics (OHDSI) data model for standardized and scalable deployment. APHRODITE uses EHR data available in the OHDSI Common Data Model to build classification models for electronic phenotyping. We demonstrate the utility of APHRODITE by comparing its performance versus traditional rule-based phenotyping approaches. Finally, the resulting phenotype models and model construction workflows built with APHRODITE can be shared between multiple OHDSI sites. Such sharing allows their application on large and diverse patient populations.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Banda</LastName><ForeName>Juan M</ForeName><Initials>JM</Initials><AffiliationInfo><Affiliation>Stanford Univ., Stanford, CA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Halpern</LastName><ForeName>Yoni</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>New York Univ., New York, NY.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sontag</LastName><ForeName>David</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>MIT, Cambridge, MA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Shah</LastName><ForeName>Nigam H</ForeName><Initials>NH</Initials><AffiliationInfo><Affiliation>Stanford Univ., Stanford, CA.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2017</Year><Month>07</Month><Day>26</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>AMIA Jt Summits Transl Sci Proc</MedlineTA><NlmUniqueID>101539486</NlmUniqueID></MedlineJournalInfo></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2017</Year><Month>8</Month><Day>18</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2017</Year><Month>8</Month><Day>18</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2017</Year><Month>8</Month><Day>18</Day><Hour>6</Hour><Minute>1</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2017</Year><Month>7</Month><Day>26</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">28815104</ArticleId><ArticleId IdType="pmc">PMC5543379</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>NIH Health Care Systems Research Collaboratory. Informed consent. In Rethinking Clinical Trials: A Living Textbook of Pragmatic Clinical Trials.  [Septmeber 5th, 2016]. Available from:  http://sites.duke.edu/rethinkingclinicaltrials/informed-consent-in-pragmatic-clinical-trials/</Citation></Reference><Reference><Citation>Agarwal V, Podchiyska T, Banda JM, Goel V, Leung TI, Minty EP, et al. Learning statistical models of phenotypes using noisy labeled training data. Journal of the American Medical Informatics Association. 2016</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5070523</ArticleId><ArticleId IdType="pubmed">27174893</ArticleId></ArticleIdList></Reference><Reference><Citation>Halpern Y, Horng S, Choi Y, Sontag D. Electronic medical record phenotyping using the anchor and learn framework. Journal of the American Medical Informatics Association. 2016</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4926745</ArticleId><ArticleId IdType="pubmed">27107443</ArticleId></ArticleIdList></Reference><Reference><Citation>Longhurst CA, Harrington RA, Shah NH. A &#x2018;green button&#x2019; for using aggregate patient data at the point of care. Health affairs. 2014;33(7):1229&#x2013;35.</Citation><ArticleIdList><ArticleId IdType="pubmed">25006150</ArticleId></ArticleIdList></Reference><Reference><Citation>LePendu P, Iyer SV, Bauer-Mehren A, Harpaz R, Mortensen JM, Podchiyska T, et al. Pharmacovigilance Using Clinical Notes. Clin Pharmacol Ther. 2013;93(6):547&#x2013;55.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3846296</ArticleId><ArticleId IdType="pubmed">23571773</ArticleId></ArticleIdList></Reference><Reference><Citation>Hripcsak G, Ryan P, Duke J, Shah N.H, Park R.W, Huser V, et al. Addressing Clinical Questions at Scale: OHDSI Assessment of Treatment Pathways. Proceedings of the National Academy of Sciences. 2016</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4941483</ArticleId><ArticleId IdType="pubmed">27274072</ArticleId></ArticleIdList></Reference><Reference><Citation>McCarty CA, Chisholm RL, Chute CG, Kullo IJ, Jarvik GP, Larson EB, et al. The eMERGE Network: a consortium of biorepositories linked to electronic medical records data for conducting genomic studies. BMC medical genomics. 2011;4:13.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3038887</ArticleId><ArticleId IdType="pubmed">21269473</ArticleId></ArticleIdList></Reference><Reference><Citation>Newton KM, Peissig PL, Kho AN, Bielinski SJ, Berg RL, Choudhary V, et al. Validation of electronic medical record-based phenotyping algorithms: results and lessons learned from the eMERGE network. Journal of the American Medical Informatics Association : JAMIA. 2013;20(e1):e147&#x2013;e54.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3715338</ArticleId><ArticleId IdType="pubmed">23531748</ArticleId></ArticleIdList></Reference><Reference><Citation>PheKB - Phenotype KnowledgeBase.  [Septmeber 2016]. Available from:  http://www.phekb.org.</Citation></Reference><Reference><Citation>Jiang M, Chen Y, Liu M, Rosenbloom ST, Mani S, Denny JC, et al. A study of machine-learning-based approaches to extract clinical entities and their assertions from discharge summaries. J Am Med Inform Assoc. 2011;18(5):601&#x2013;6.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3168315</ArticleId><ArticleId IdType="pubmed">21508414</ArticleId></ArticleIdList></Reference><Reference><Citation>Overby CL, Pathak J, Gottesman O, Haerian K, Perotte A, Murphy S, et al. A collaborative approach to developing an electronic health record phenotyping algorithm for drug-induced liver injury. J Am Med Inform Assoc. 2013;20(e2):e243&#x2013;52.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3861914</ArticleId><ArticleId IdType="pubmed">23837993</ArticleId></ArticleIdList></Reference><Reference><Citation>Barlas S. Hospitals scramble to meet deadlines for adopting electronic health records: pharmacy systems will be updated slowly but surely. P &amp; T : a peer-reviewed journal for formulary management. 2011;36(1):37&#x2013;40.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3046613</ArticleId><ArticleId IdType="pubmed">21386936</ArticleId></ArticleIdList></Reference><Reference><Citation>Bayley KB, Belnap T, Savitz L, Masica AL, Shah N, Fleming NS. Challenges in using electronic health record data for CER: experience of 4 learning organizations and solutions applied. Medical care. 2013;51(8 Suppl 3):S80&#x2013;6.</Citation><ArticleIdList><ArticleId IdType="pubmed">23774512</ArticleId></ArticleIdList></Reference><Reference><Citation>Yu S, Liao KP, Shaw SY, Gainer VS, Churchill SE, Szolovits P, et al. Toward high-throughput phenotyping: unbiased automated feature extraction and selection from knowledge sources. J Am Med Inform Assoc. 2015;22(5):993&#x2013;1000.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4986664</ArticleId><ArticleId IdType="pubmed">25929596</ArticleId></ArticleIdList></Reference><Reference><Citation>Carroll RJ, Thompson WK, Eyler AE, Mandelin AM, Cai T, Zink RM, et al. Portability of an algorithm to identify rheumatoid arthritis in electronic health records. J Am Med Inform Assoc. 2012;19(e1):e162&#x2013;9.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3392871</ArticleId><ArticleId IdType="pubmed">22374935</ArticleId></ArticleIdList></Reference><Reference><Citation>Liao KP, Cai T, Gainer V, Goryachev S, Zeng-treitler Q, Raychaudhuri S, et al. Electronic medical records for discovery research in rheumatoid arthritis. Arthritis care &amp; research. 2010;62(8):1120&#x2013;7.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3121049</ArticleId><ArticleId IdType="pubmed">20235204</ArticleId></ArticleIdList></Reference><Reference><Citation>Blei DM, Ng AY, Jordan MI. Latent Dirichlet allocation. Journal of Machine Learning Research. 2003;3(4-5):993&#x2013;1022.</Citation></Reference><Reference><Citation>Ghassemi M, Naumann T, Doshi-Velez F, Brimmer N, Joshi R, Rumshisky A, et al. Unfolding Physiological State: Mortality Modelling in Intensive Care Units. KDD : proceedings / International Conference on Knowledge Discovery &amp; Data Mining International Conference on Knowledge Discovery &amp; Data Mining. 2014;2014:75&#x2013;84.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4185189</ArticleId><ArticleId IdType="pubmed">25289175</ArticleId></ArticleIdList></Reference><Reference><Citation>Arnold CW, El-Saden SM, Bui AAT, Taira R. Clinical Case-based Retrieval Using Latent Topic Analysis. AMIA Annual Symposium Proceedings. 2010;2010:26&#x2013;30.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3041464</ArticleId><ArticleId IdType="pubmed">21346934</ArticleId></ArticleIdList></Reference><Reference><Citation>Peissig PL, Santos Costa V, Caldwell MD, Rottscheit C, Berg RL, Mendonca EA, et al. Relational machine learning for electronic health record-driven phenotyping. Journal of Biomedical Informatics. 2014;52:260&#x2013;70.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4261015</ArticleId><ArticleId IdType="pubmed">25048351</ArticleId></ArticleIdList></Reference><Reference><Citation>Ho JC, Ghosh J, Steinhubl SR, Stewart WF, Denny JC, Malin BA, et al. Limestone: High-throughput candidate phenotype generation via tensor factorization. Journal of Biomedical Informatics. 2014;52:199&#x2013;211.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6563906</ArticleId><ArticleId IdType="pubmed">25038555</ArticleId></ArticleIdList></Reference><Reference><Citation>Ho JC, Ghosh J, Sun J. Proceedings of the 20th ACM SIGKDD international conference on Knowledge discovery and data mining. New York, New York, USA. 2623658: ACM; 2014. Marble: high-throughput phenotyping from electronic health records via sparse nonnegative tensor factorization; pp. 115&#x2013;24.</Citation></Reference><Reference><Citation>Peissig PL, Rasmussen LV, Berg RL, Linneman JG, McCarty CA, Waudby C, et al. Importance of multi-modal approaches to effectively identify cataract cases from electronic health records. Journal of the American Medical Informatics Association : JAMIA. 2012;19(2):225&#x2013;34.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3277618</ArticleId><ArticleId IdType="pubmed">22319176</ArticleId></ArticleIdList></Reference><Reference><Citation>Penz JFE, Wilcox AB, Hurdle JF. Automated identification of adverse events related to central venous catheters. Journal of Biomedical Informatics. 2007;40(2):174&#x2013;82.</Citation><ArticleIdList><ArticleId IdType="pubmed">16901760</ArticleId></ArticleIdList></Reference><Reference><Citation>Xu H, Fu Z, Shah A, Chen Y, Peterson NB, Chen Q, et al. Extracting and Integrating Data from Entire Electronic Health Records for Detecting Colorectal Cancer Cases. AMIA Annual Symposium Proceedings. 2011;2011:1564&#x2013;72.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3243156</ArticleId><ArticleId IdType="pubmed">22195222</ArticleId></ArticleIdList></Reference><Reference><Citation>OHDSI 2015: Year in Review 2016.  [Septmeber 2016]. Available from:  http://www.ohdsi.org/wp-content/uploads/2016/02/2015-Year-in-Review1.pdf.</Citation></Reference><Reference><Citation>OHDSI: Github 2016.   [Septmeber 2016]. Available from:  http:/www.github.com/OHDSI.</Citation></Reference><Reference><Citation>Long PM, Servedio RA. Random classification noise defeats all convex potential boosters. Mach Learn. 2010;78(3):287&#x2013;304.</Citation></Reference><Reference><Citation>Aslam JA, Decatur SE. On the sample complexity of noise-tolerant learning. Information Processing Letters. 1996;57(4):189&#x2013;95.</Citation></Reference><Reference><Citation>Simon HU. General bounds on the number of examples needed for learning probabilistic concepts. Journal of Computer and System Sciences. 1996;52(2):239&#x2013;54.</Citation></Reference><Reference><Citation>Elkan C, Noto K. Proceedings of the 14th ACM SIGKDD international conference on Knowledge discovery and data mining. Las Vegas, Nevada, USA. 1401920: ACM; 2008. Learning classifiers from only positive and unlabeled data; pp. 213&#x2013;20.</Citation></Reference><Reference><Citation>Chapman WW, Bridewell W, Hanbury P, Cooper GF, Buchanan BG. A Simple Algorithm for Identifying Negated Findings and Diseases in Discharge Summaries. Journal of Biomedical Informatics. 2001;34(5):301&#x2013;10.</Citation><ArticleIdList><ArticleId IdType="pubmed">12123149</ArticleId></ArticleIdList></Reference><Reference><Citation>Jung K, Shah NH. Implications of non-stationarity on predictive modeling using EHRs. Journal of Biomedical Informatics. 2015;58:168&#x2013;74.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4684770</ArticleId><ArticleId IdType="pubmed">26483171</ArticleId></ArticleIdList></Reference><Reference><Citation>OMOP - Health Outcomes of Interest.  [Septmeber 2016]. Available from:  http://omop.org/HOI.</Citation></Reference><Reference><Citation>Martijn S. Usagi 2015.  [Septmeber 2016]. Available from:  https://github.com/OHDSI/Usagi.</Citation></Reference><Reference><Citation>Kuhn M. Building Predictive Models in R Using the caret Package. Journal of statistical software. 2008;28(5):26.</Citation></Reference><Reference><Citation>Friedman J, Hastie T, Tibshirani R. Regularization Paths for Generalized Linear Models via Coordinate Descent. Journal of statistical software. 2010;33(1):1&#x2013;22.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2929880</ArticleId><ArticleId IdType="pubmed">20808728</ArticleId></ArticleIdList></Reference><Reference><Citation>Liaw A, Wiener W. randomForest: Breiman and Cutler&#x2019;s Random Forests for Classification and Regression.  Available from:  https://cran.r-project.org/web/packages/randomForest/index.html.</Citation></Reference><Reference><Citation>Banda JM. APHRODITE 2015.  [Septmeber 2016]. Available from:  https://github.com/OHDSI/Aphrodite.</Citation></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">28823923</PMID><DateCompleted><Year>2018</Year><Month>07</Month><Day>10</Day></DateCompleted><DateRevised><Year>2018</Year><Month>07</Month><Day>10</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1532-0480</ISSN><JournalIssue CitedMedium="Internet"><Volume>75</Volume><PubDate><Year>2017</Year><Month>Nov</Month></PubDate></JournalIssue><Title>Journal of biomedical informatics</Title><ISOAbbreviation>J Biomed Inform</ISOAbbreviation></Journal><ArticleTitle>Procedure prediction from symbolic Electronic Health Records via time intervals analytics.</ArticleTitle><Pagination><StartPage>70</StartPage><EndPage>82</EndPage><MedlinePgn>70-82</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.jbi.2017.07.018</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S1532-0464(17)30178-8</ELocationID><Abstract><AbstractText>Prediction of medical events, such as clinical procedures, is essential for preventing disease, understanding disease mechanism, and increasing patient quality of care. Although longitudinal clinical data from Electronic Health Records provides opportunities to develop predictive models, the use of these data faces significant challenges. Primarily, while the data are longitudinal and represent thousands of conceptual events having duration, they are also sparse, complicating the application of traditional analysis approaches. Furthermore, the framework presented here takes advantage of the events duration and gaps. International standards for electronic healthcare data represent data elements, such as procedures, conditions, and drug exposures, using eras, or time intervals. Such eras contain both an event and a duration and enable the application of time intervals mining - a relatively new subfield of data mining. In this study, we present Maitreya, a framework for time intervals analytics in longitudinal clinical data. Maitreya discovers frequent time intervals related patterns (TIRPs), which we use as prognostic markers for modelling clinical events. We introduce three novel TIRP metrics that are normalized versions of the horizontal-support, that represents the number of TIRP instances per patient. We evaluate Maitreya on 28 frequent and clinically important procedures, using the three novel TIRP representation metrics in comparison to no temporal representation and previous TIRPs metrics. We also evaluate the epsilon value that makes Allen's relations more flexible with several settings of 30, 60, 90 and 180days in comparison to the default zero. For twenty-two of these procedures, the use of temporal patterns as predictors was superior to non-temporal features, and the use of the vertically normalized horizontal support metric to represent TIRPs as features was most effective. The use of the epsilon value with thirty days was slightly better than the zero.</AbstractText><CopyrightInformation>Copyright &#xa9; 2017. Published by Elsevier Inc.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Moskovitch</LastName><ForeName>Robert</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Department of Biomedical Informatics, Columbia University, NY, USA; Department of Systems Biology, Columbia University, NY, USA; Department of Medicine, Columbia University, NY, USA; Observational Health Data Sciences and Informations (OHDSI), NY, USA; Department of Software and Information Systems Engineering, Ben Gurion Univeristy, Beer Sheva, Israel. Electronic address: robert.moskovitch@columbia.edu.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Polubriaginof</LastName><ForeName>Fernanda</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Department of Biomedical Informatics, Columbia University, NY, USA; Department of Systems Biology, Columbia University, NY, USA; Department of Medicine, Columbia University, NY, USA; Observational Health Data Sciences and Informations (OHDSI), NY, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Weiss</LastName><ForeName>Aviram</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Software and Information Systems Engineering, Ben Gurion Univeristy, Beer Sheva, Israel.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ryan</LastName><ForeName>Patrick</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Department of Biomedical Informatics, Columbia University, NY, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tatonetti</LastName><ForeName>Nicholas</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Department of Biomedical Informatics, Columbia University, NY, USA; Department of Systems Biology, Columbia University, NY, USA; Department of Medicine, Columbia University, NY, USA; Observational Health Data Sciences and Informations (OHDSI), NY, USA. Electronic address: nick.tatonetti@columbia.edu.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2017</Year><Month>08</Month><Day>17</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>J Biomed Inform</MedlineTA><NlmUniqueID>100970413</NlmUniqueID><ISSNLinking>1532-0464</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000465" MajorTopicYN="N">Algorithms</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D057286" MajorTopicYN="Y">Electronic Health Records</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D013996" MajorTopicYN="Y">Time and Motion Studies</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Electronic Health Records</Keyword><Keyword MajorTopicYN="N">Prediction</Keyword><Keyword MajorTopicYN="N">Temporal data mining</Keyword><Keyword MajorTopicYN="N">Time intervals mining</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2016</Year><Month>5</Month><Day>15</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2017</Year><Month>6</Month><Day>19</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2017</Year><Month>7</Month><Day>25</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2017</Year><Month>8</Month><Day>22</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2018</Year><Month>7</Month><Day>11</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2017</Year><Month>8</Month><Day>22</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">28823923</ArticleId><ArticleId IdType="doi">10.1016/j.jbi.2017.07.018</ArticleId><ArticleId IdType="pii">S1532-0464(17)30178-8</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">28903729</PMID><DateCompleted><Year>2018</Year><Month>04</Month><Day>09</Day></DateCompleted><DateRevised><Year>2018</Year><Month>11</Month><Day>13</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1472-6947</ISSN><JournalIssue CitedMedium="Internet"><Volume>17</Volume><Issue>1</Issue><PubDate><Year>2017</Year><Month>Sep</Month><Day>13</Day></PubDate></JournalIssue><Title>BMC medical informatics and decision making</Title><ISOAbbreviation>BMC Med Inform Decis Mak</ISOAbbreviation></Journal><ArticleTitle>Dynamic-ETL: a hybrid approach for health data extraction, transformation and loading.</ArticleTitle><Pagination><StartPage>134</StartPage><MedlinePgn>134</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">134</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1186/s12911-017-0532-3</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Electronic health records (EHRs) contain detailed clinical data stored in proprietary formats with non-standard codes and structures. Participating in multi-site clinical research networks requires EHR data to be restructured and transformed into a common format and standard terminologies, and optimally linked to other data sources. The expertise and scalable solutions needed to transform data to conform to network requirements are beyond the scope of many health care organizations and there is a need for practical tools that lower the barriers of data contribution to clinical research networks.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">We designed and implemented a health data transformation and loading approach, which we refer to as Dynamic ETL (Extraction, Transformation and Loading) (D-ETL), that automates part of the process through use of scalable, reusable and customizable code, while retaining manual aspects of the process that requires knowledge of complex coding syntax. This approach provides the flexibility required for the ETL of heterogeneous data, variations in semantic expertise, and transparency of transformation logic that are essential to implement ETL conventions across clinical research sharing networks. Processing workflows are directed by the ETL specifications guideline, developed by ETL designers with extensive knowledge of the structure and semantics of health data (i.e., "health data domain experts") and target common data model.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">D-ETL was implemented to perform ETL operations that load data from various sources with different database schema structures into the Observational Medical Outcome Partnership (OMOP) common data model. The results showed that ETL rule composition methods and the D-ETL engine offer a scalable solution for health data transformation via automatic query generation to harmonize source datasets.</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">D-ETL supports a flexible and transparent process to transform and load health data into a target data model. This approach offers a solution that lowers technical barriers that prevent data partners from participating in research data networks, and therefore, promotes the advancement of comparative effectiveness research using secondary electronic health data.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Ong</LastName><ForeName>Toan C</ForeName><Initials>TC</Initials><AffiliationInfo><Affiliation>Departments of Pediatrics, University of Colorado Anschutz Medical Campus, School of Medicine, Building AO1 Room L15-1414, 12631 East 17th Avenue, Mail Stop F563, Aurora, CO, 80045, USA. Toan.Ong@ucdenver.edu.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kahn</LastName><ForeName>Michael G</ForeName><Initials>MG</Initials><AffiliationInfo><Affiliation>Departments of Pediatrics, University of Colorado Anschutz Medical Campus, School of Medicine, Building AO1 Room L15-1414, 12631 East 17th Avenue, Mail Stop F563, Aurora, CO, 80045, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Colorado Clinical and Translational Sciences Institute, University of Colorado Anschutz Medical Campus, School of Medicine, Aurora, CO, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kwan</LastName><ForeName>Bethany M</ForeName><Initials>BM</Initials><AffiliationInfo><Affiliation>Departments of Family Medicine, University of Colorado Anschutz Medical Campus, School of Medicine, Aurora, CO, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yamashita</LastName><ForeName>Traci</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Departments of Medicine, University of Colorado Anschutz Medical Campus, School of Medicine, Aurora, CO, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Brandt</LastName><ForeName>Elias</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>DARTNet Institute, Aurora, CO, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hosokawa</LastName><ForeName>Patrick</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Departments of Family Medicine, University of Colorado Anschutz Medical Campus, School of Medicine, Aurora, CO, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Uhrich</LastName><ForeName>Chris</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>OSR Data Corporation, Lincoln, MA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Schilling</LastName><ForeName>Lisa M</ForeName><Initials>LM</Initials><AffiliationInfo><Affiliation>Departments of Medicine, University of Colorado Anschutz Medical Campus, School of Medicine, Aurora, CO, USA.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>R01 HS019908</GrantID><Acronym>HS</Acronym><Agency>AHRQ HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R01 HS022956</GrantID><Acronym>HS</Acronym><Agency>AHRQ HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2017</Year><Month>09</Month><Day>13</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>BMC Med Inform Decis Mak</MedlineTA><NlmUniqueID>101088682</NlmUniqueID><ISSNLinking>1472-6947</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D035843" MajorTopicYN="N">Biomedical Research</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D057186" MajorTopicYN="N">Comparative Effectiveness Research</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D057225" MajorTopicYN="N">Data Mining</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName><QualifierName UI="Q000592" MajorTopicYN="Y">standards</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016208" MajorTopicYN="N">Databases, Factual</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D057286" MajorTopicYN="N">Electronic Health Records</DescriptorName><QualifierName UI="Q000592" MajorTopicYN="Y">standards</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008962" MajorTopicYN="N">Models, Theoretical</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Data harmonization</Keyword><Keyword MajorTopicYN="N">Distributed research networks</Keyword><Keyword MajorTopicYN="N">Electronic health records</Keyword><Keyword MajorTopicYN="N">Extraction</Keyword><Keyword MajorTopicYN="N">Rule-based ETL</Keyword><Keyword MajorTopicYN="N">Transformation and loading</Keyword></KeywordList><CoiStatement>ETHICS APPROVAL AND CONSENT TO PARTICIPATE: The work described in this paper describes ETL infrastructure development, testing, and implementation, but does not describe any research using this infrastructure. The ETL tool is implemented behind data owners&#x2019; firewalls, or behind firewalls of those with whom data owners have HIPAA Business Associate Agreements (BAAs). Ethical and legal approvals for this work are as follows: 1. The IRB approved an &#x201c;infrastructure protocol&#x201d;, indicating that the infrastructure was an approved mechanism for producing and transmitting HIPAA limited data sets for future research. 2. Any data released for research would require separate IRB approval and HIPAA data use agreements with data owners. 3. Data owners signed a legal document (&#x201c;Master Consortium Agreement&#x201d;) developed in collaboration with university legal counsel and each organization&#x2019; own legal counsel, specifying conditions under which the ETL tool is implemented, maintained, and used to produce research data sets within the research network. 4. For development and testing, several data owners provided fully identified patient data to the software developers, under HIPAA BAAs between the data owners and the university (also covering contractors). These data were not used for research. These data governance processes were discussed in great detail and established as described with legal and regulatory officials from the university and data owners. CONSENT FOR PUBLICATION: Not applicable. COMPETING INTERESTS: The authors declare that they have no competing interests. PUBLISHER&#x2019;S NOTE: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2016</Year><Month>5</Month><Day>26</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2017</Year><Month>8</Month><Day>31</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2017</Year><Month>9</Month><Day>15</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2017</Year><Month>9</Month><Day>15</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2018</Year><Month>4</Month><Day>10</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2017</Year><Month>9</Month><Day>13</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">28903729</ArticleId><ArticleId IdType="pmc">PMC5598056</ArticleId><ArticleId IdType="doi">10.1186/s12911-017-0532-3</ArticleId><ArticleId IdType="pii">10.1186/s12911-017-0532-3</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Sox HC, Greenfield S. Comparative effectiveness research: a report from the institute of medicine. Ann Intern Med. 2009;151:203&#x2013;205. doi: 10.7326/0003-4819-151-3-200908040-00125.</Citation><ArticleIdList><ArticleId IdType="doi">10.7326/0003-4819-151-3-200908040-00125</ArticleId><ArticleId IdType="pubmed">19567618</ArticleId></ArticleIdList></Reference><Reference><Citation>Danaei G, Rodr&#xed;guez LAG, Cantero OF et al. Observational data for comparative effectiveness research: an emulation of randomised trials of statins and primary prevention of coronary heart disease. Stat Methods Med Res. 2013;22:70&#x2013;96. doi: 10.1177/0962280211403603.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/0962280211403603</ArticleId><ArticleId IdType="pmc">PMC3613145</ArticleId><ArticleId IdType="pubmed">22016461</ArticleId></ArticleIdList></Reference><Reference><Citation>Institute of Medicine (U.S.) Committee on Improving the Patient Record. In: Dick RS, Steen EB, editors. The computer-based patient record: an essential technology for health care, revised edition. Washington, D.C.: National Academy Press; 1997.</Citation><ArticleIdList><ArticleId IdType="pubmed">25121222</ArticleId></ArticleIdList></Reference><Reference><Citation>Grossmann C, Institute of Medicine (U.S.) Roundtable on Value &amp; Science-Driven Health Care. Clinical data as the basic staple of health learning&#xa0;: creating and protecting a public good&#xa0;: workshop summary. Washington, D.C.: National Academies Press; 2010.</Citation><ArticleIdList><ArticleId IdType="pubmed">21595112</ArticleId></ArticleIdList></Reference><Reference><Citation>Selby JV, Lipstein SH. PCORI at 3 years--progress, lessons, and plans. N Engl J Med. 2014;370:592&#x2013;595. doi: 10.1056/NEJMp1313061.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMp1313061</ArticleId><ArticleId IdType="pubmed">24521104</ArticleId></ArticleIdList></Reference><Reference><Citation>Fleurence RL, Curtis LH, Califf RM, et al. Launching PCORnet, a national patient-centered clinical research network. J Am Med Inform Assoc JAMIA. 2014;21:578&#x2013;582. doi: 10.1136/amiajnl-2014-002747.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/amiajnl-2014-002747</ArticleId><ArticleId IdType="pmc">PMC4078292</ArticleId><ArticleId IdType="pubmed">24821743</ArticleId></ArticleIdList></Reference><Reference><Citation>Holve E, Segal C, Lopez MH, et al. The Electronic Data Methods (EDM) Forum for Comparative Effectiveness Research (CER) Med Care. 2012;50(Suppl):S7&#x2013;10. doi: 10.1097/MLR.0b013e318257a66b.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/MLR.0b013e318257a66b</ArticleId><ArticleId IdType="pubmed">22692262</ArticleId></ArticleIdList></Reference><Reference><Citation>Rassen JA, Schneeweiss S. Using high-dimensional propensity scores to automate confounding control in a distributed medical product safety surveillance system. Pharmacoepidemiol Drug Saf. 2012;21(Suppl 1):41&#x2013;49. doi: 10.1002/pds.2328.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/pds.2328</ArticleId><ArticleId IdType="pubmed">22262592</ArticleId></ArticleIdList></Reference><Reference><Citation>Garbe E, Kloss S, Suling M, et al. High-dimensional versus conventional propensity scores in a comparative effectiveness study of coxibs and reduced upper gastrointestinal complications. Eur J Clin Pharmacol Published Online First: 5 July 2012. doi:10.1007/s00228-012-1334-2.</Citation><ArticleIdList><ArticleId IdType="pubmed">22763756</ArticleId></ArticleIdList></Reference><Reference><Citation>Fleischer NL, Fernald LC, Hubbard AE. Estimating the potential impacts of intervention from observational data: methods for estimating causal attributable risk in a cross-sectional analysis of depressive symptoms in Latin America. J Epidemiol Community Health. 2010;64:16&#x2013;21. doi: 10.1136/jech.2008.085985.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/jech.2008.085985</ArticleId><ArticleId IdType="pubmed">19643766</ArticleId></ArticleIdList></Reference><Reference><Citation>Polsky D, Eremina D, Hess G, et al. The importance of clinical variables in comparative analyses using propensity-score matching: the case of ESA costs for the treatment of chemotherapy-induced anaemia. PharmacoEconomics. 2009;27:755&#x2013;765. doi: 10.2165/11313860-000000000-00000.</Citation><ArticleIdList><ArticleId IdType="doi">10.2165/11313860-000000000-00000</ArticleId><ArticleId IdType="pubmed">19757869</ArticleId></ArticleIdList></Reference><Reference><Citation>McCandless LC, Gustafson P, Austin PC. Bayesian propensity score analysis for observational data. Stat Med. 2009;28:94&#x2013;112. doi: 10.1002/sim.3460.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/sim.3460</ArticleId><ArticleId IdType="pubmed">19012268</ArticleId></ArticleIdList></Reference><Reference><Citation>Jansen RG, Wiertz LF, Meyer ES, et al. Reliability analysis of observational data: problems, solutions, and software implementation. Behav Res Methods Instrum Comput. 2003;35:391&#x2013;399. doi: 10.3758/BF03195516.</Citation><ArticleIdList><ArticleId IdType="doi">10.3758/BF03195516</ArticleId><ArticleId IdType="pubmed">14587547</ArticleId></ArticleIdList></Reference><Reference><Citation>PCORI Methodology Committee. PCORI Methodology Standards. 2012. http://www.pcori.org/assets/PCORI-Methodology-Standards.pdf</Citation></Reference><Reference><Citation>Collins FS, Hudson KL, Briggs JP, et al. PCORnet: turning a dream into reality. J Am Med Inform Assoc JAMIA. 2014;21:576&#x2013;577. doi: 10.1136/amiajnl-2014-002864.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/amiajnl-2014-002864</ArticleId><ArticleId IdType="pmc">PMC4078299</ArticleId><ArticleId IdType="pubmed">24821744</ArticleId></ArticleIdList></Reference><Reference><Citation>Forrest CB, Margolis PA, Bailey LC, et al. PEDSnet: a National Pediatric Learning Health System. J Am Med Inform Assoc JAMIA Published Online First: 12 May 2014. doi: 10.1136/amiajnl-2014-002743.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4078288</ArticleId><ArticleId IdType="pubmed">24821737</ArticleId></ArticleIdList></Reference><Reference><Citation>Behrman RE, Benner JS, Brown JS, et al. Developing the sentinel system &#x2014; A national resource for evidence development. N Engl J Med. 2011;364:498&#x2013;499. doi: 10.1056/NEJMp1014427.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMp1014427</ArticleId><ArticleId IdType="pubmed">21226658</ArticleId></ArticleIdList></Reference><Reference><Citation>Joe V Selby, Richard Platt, Rachael Fleurence, et al. PCORnet: achievements and plans on the road to transforming health research | PCORI. http://www.pcori.org/blog/pcornet-achievements-and-plans-road-transforming-health-research. Accessed 16 May 2016.</Citation></Reference><Reference><Citation>Gini R, Schuemie M, Brown J, et al. Data extraction and management in networks of observational health care databases for scientific research: a comparison among EU-ADR, OMOP, mini-sentinel and MATRICE strategies. EGEMS. 2016;4:1189. doi: 10.13063/2327-9214.1189.</Citation><ArticleIdList><ArticleId IdType="doi">10.13063/2327-9214.1189</ArticleId><ArticleId IdType="pmc">PMC4780748</ArticleId><ArticleId IdType="pubmed">27014709</ArticleId></ArticleIdList></Reference><Reference><Citation>Kahn MG, Batson D, Schilling LM. Data model considerations for clinical effectiveness researchers. Med Care. 2012;50(Suppl):S60&#x2013;S67. doi: 10.1097/MLR.0b013e318259bff4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/MLR.0b013e318259bff4</ArticleId><ArticleId IdType="pmc">PMC3824370</ArticleId><ArticleId IdType="pubmed">22692260</ArticleId></ArticleIdList></Reference><Reference><Citation>Schilling LM, Kwan B, Drolshagen C, et al. Scalable Architecture for Federated Translational Inquires Network (SAFTINet): technology infrastructure for a Distributed Data Network. EGEMs Gener. Evid. Methods Improve Patient Outcomes. 2013. in press.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4371513</ArticleId><ArticleId IdType="pubmed">25848567</ArticleId></ArticleIdList></Reference><Reference><Citation>Ohno-Machado L, Agha Z, Bell DS, et al. pSCANNER: patient-centered Scalable National Network for Effectiveness Research. J Am Med Inform Assoc JAMIA. 2014;21:621&#x2013;626. doi: 10.1136/amiajnl-2014-002751.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/amiajnl-2014-002751</ArticleId><ArticleId IdType="pmc">PMC4078293</ArticleId><ArticleId IdType="pubmed">24780722</ArticleId></ArticleIdList></Reference><Reference><Citation>Murphy SN, Weber G, Mendis M, et al. Serving the enterprise and beyond with informatics for integrating biology and the bedside (i2b2) J Am Med Inform Assoc JAMIA. 2010;17:124&#x2013;130. doi: 10.1136/jamia.2009.000893.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/jamia.2009.000893</ArticleId><ArticleId IdType="pmc">PMC3000779</ArticleId><ArticleId IdType="pubmed">20190053</ArticleId></ArticleIdList></Reference><Reference><Citation>Brown JS, Lane K, Moore K, et al. Defining and evaluating possible database models to implement the FDA Sentinel initiative. 2009.https://www.brookings.edu/wp-content/uploads/2012/04/03_Brown.pdf. Accessed 15 Feb 2014.</Citation></Reference><Reference><Citation>Patil PS. Improved extraction mechanism in ETL process for building of a data warehouse. INFLIBNET Published Online First: 22 February 2013. http://ir.inflibnet.ac.in:8080/jspui/handle/10603/7023. Accessed 13 Nov 2014.</Citation></Reference><Reference><Citation>Devine E, Capurro D, van Eaton E, et al. Preparing electronic clinical data for quality improvement and comparative effectiveness research: the SCOAP CERTAIN automation and validation project. EGEMS. 2013;1:1025.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4371452</ArticleId><ArticleId IdType="pubmed">25848565</ArticleId></ArticleIdList></Reference><Reference><Citation>Suresh S, Gautam JP, Pancha G, et al. Method and architecture for automated optimization of ETL throughput in data warehousing applications. 2001.</Citation></Reference><Reference><Citation>Kushanoor A, Murali Krishna S, Vidya Sagar Reddy T. ETL process modeling in DWH using enhanced quality techniques. Int J Database Theory Appl. 2013;6:179&#x2013;198.</Citation></Reference><Reference><Citation>Peek N, Holmes JH, Sun J. Technical challenges for big data in biomedicine and health: data sources, infrastructure, and analytics. Yearb Med Inform. 2014;9:42&#x2013;7. doi:10.15265/IY-2014-0018</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4287098</ArticleId><ArticleId IdType="pubmed">25123720</ArticleId></ArticleIdList></Reference><Reference><Citation>Sandhu E, Weinstein S, McKethan A, et al. Secondary uses of electronic health record data: Benefits and barriers. Jt Comm J Qual Patient Saf. 2012;38:34&#x2013;40. doi: 10.1016/S1553-7250(12)38005-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1553-7250(12)38005-7</ArticleId><ArticleId IdType="pubmed">22324189</ArticleId></ArticleIdList></Reference><Reference><Citation>Schilling LM, Kwan BM, Drolshagen CT, et al. Scalable architecture for federated translational inquiries network (SAFTINet) technology infrastructure for a distributed data network. EGEMS. 2013;1:1027. doi: 10.13063/2327-9214.1027.</Citation><ArticleIdList><ArticleId IdType="doi">10.13063/2327-9214.1027</ArticleId><ArticleId IdType="pmc">PMC4371513</ArticleId><ArticleId IdType="pubmed">25848567</ArticleId></ArticleIdList></Reference><Reference><Citation>Observational Medical Outcomes Partnership . CDM and Standard Vocabularies (Version 4) 2012.</Citation></Reference><Reference><Citation>Schema Matching and Mapping. http://www.springer.com/computer/database+management+%26+information+retrieval/book/978-3-642-16517-7. Accessed 25 May 2014.</Citation></Reference><Reference><Citation>Fagin R. Proceedings of the twenty-fifth ACM SIGMOD-SIGACT-SIGART symposium on principles of database systems. New York: ACM; 2006. Inverting Schema Mappings; pp. 50&#x2013;59.</Citation></Reference><Reference><Citation>H&#xe4;yrinen K, Saranto K, Nyk&#xe4;nen P. Definition, structure, content, use and impacts of electronic health records: a review of the research literature. Int J Med Inf. 2008;77:291&#x2013;304. doi: 10.1016/j.ijmedinf.2007.09.001.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ijmedinf.2007.09.001</ArticleId><ArticleId IdType="pubmed">17951106</ArticleId></ArticleIdList></Reference><Reference><Citation>Madhavan J, Jeffery SR, Cohen S, et al. In Proc. of CIDR-07. 2007. Web-scale data integration: you can only afford to pay as you go.</Citation></Reference><Reference><Citation>Davidson SB, Overton C, Buneman P. Challenges in integrating biological data sources. J Comput Biol. 1995;2:557&#x2013;572. doi: 10.1089/cmb.1995.2.557.</Citation><ArticleIdList><ArticleId IdType="doi">10.1089/cmb.1995.2.557</ArticleId><ArticleId IdType="pubmed">8634908</ArticleId></ArticleIdList></Reference><Reference><Citation>Taniar D, Chen L, editors. Integrations of Data Warehousing, Data Mining and Database Technologies: Innovative Approaches. IGI Global 2011. http://www.igi-global.com/chapter/survey-extract-transform-load-technology/53076. Accessed 24 Sep 2014.</Citation></Reference><Reference><Citation>Stang PE, Ryan PB, Racoosin JA, et al. Advancing the science for active surveillance: rationale and design for the Observational Medical Outcomes Partnership. Ann Intern Med. 2010;153:600&#x2013;606. doi: 10.7326/0003-4819-153-9-201011020-00010.</Citation><ArticleIdList><ArticleId IdType="doi">10.7326/0003-4819-153-9-201011020-00010</ArticleId><ArticleId IdType="pubmed">21041580</ArticleId></ArticleIdList></Reference><Reference><Citation>Rothstein MA. Currents in contemporary ethics. Research privacy under HIPAA and the common rule. J Law Med Ethics. 2005;33:154&#x2013;159. doi: 10.1111/j.1748-720X.2005.tb00217.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1748-720X.2005.tb00217.x</ArticleId><ArticleId IdType="pubmed">15934672</ArticleId></ArticleIdList></Reference><Reference><Citation>Nass SJ, Levit LA, Gostin LO, et al. Beyond the HIPAA privacy rule: enhancing privacy, improving health through research. Washington, D.C.: National Academies Press; 2009.</Citation><ArticleIdList><ArticleId IdType="pubmed">20662116</ArticleId></ArticleIdList></Reference><Reference><Citation>Ness RB. Influence of the HIPAA privacy rule on health research. JAMA. 2007;298:2164&#x2013;2170. doi: 10.1001/jama.298.18.2164.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.298.18.2164</ArticleId><ArticleId IdType="pubmed">18000200</ArticleId></ArticleIdList></Reference><Reference><Citation>Herdman R, Moses HL, United States et al. Effect of the HIPAA privacy rule on health research: Proceedings of a workshop presented to the National Cancer Policy Forum. Washington D.C.: National Academies Press; 2006.</Citation></Reference><Reference><Citation>Selker HP, Pienta KJ. The importance of proposed changes in the &#x2018;Common Rule&#x2019; for clinical and translational researchers. Clin Transl Sci. 2011;4:312&#x2013;313. doi: 10.1111/j.1752-8062.2011.00352.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1752-8062.2011.00352.x</ArticleId><ArticleId IdType="pmc">PMC5439896</ArticleId><ArticleId IdType="pubmed">22029799</ArticleId></ArticleIdList></Reference><Reference><Citation>Wyatt L, Caufield B, Pol D. Principles for an ETL Benchmark. In: Nambiar R, Poess M, eds. Performance Evaluation and Benchmarking. Springer Berlin Heidelberg 2009. 183&#x2013;98.https://link.springer.com/book/10.1007%2F978-3-642-10424-4. Accessed 1 Dec 2014.</Citation></Reference><Reference><Citation>Sills MR, Kwan BM, Yawn BP, et al. Medical home characteristics and asthma control: a prospective, observational cohort study protocol. EGEMS Wash DC. 2013;1:1032.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4371502</ArticleId><ArticleId IdType="pubmed">25848577</ArticleId></ArticleIdList></Reference><Reference><Citation>Kwan BM, Sills MR, Graham D, et al. Stakeholder Engagement in a Patient-Reported Outcomes (PRO) Measure Implementation: A Report from the SAFTINet Practice-based Research Network (PBRN). J Am Board Fam Med JABFM. 2016;29:102&#x2013;15. doi:10.3122/jabfm.2016.01.150141.</Citation><ArticleIdList><ArticleId IdType="pubmed">26769882</ArticleId></ArticleIdList></Reference><Reference><Citation>Kahn MG, Raebel MA, Glanz JM, et al. A pragmatic framework for single-site and multisite data quality assessment in electronic health record-based clinical research. Med Care. 2012;50(Suppl):S21&#x2013;S29. doi: 10.1097/MLR.0b013e318257dd67.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/MLR.0b013e318257dd67</ArticleId><ArticleId IdType="pmc">PMC3833692</ArticleId><ArticleId IdType="pubmed">22692254</ArticleId></ArticleIdList></Reference><Reference><Citation>Legris P, Ingham J, Collerette P. Why do people use information technology? A critical review of the technology acceptance model. Inf Manag. 2003;40:191&#x2013;204. doi: 10.1016/S0378-7206(01)00143-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0378-7206(01)00143-4</ArticleId></ArticleIdList></Reference><Reference><Citation>Fagin R, Haas LM, Hern&#xe1;ndez M, et al. Clio: Schema Mapping Creation and Data Exchange. In: Borgida AT, Chaudhri VK, Giorgini P, et al., eds. Conceptual Modeling: Foundations and Applications. Springer Berlin Heidelberg 2009. 198&#x2013;236.http://link.springer.com/chapter/10.1007/978-3-642-02463-4_12. Accessed 11 Jun 2014.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/978-3-642-02463-4_12</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">29063555</PMID><DateCompleted><Year>2018</Year><Month>02</Month><Day>26</Day></DateCompleted><DateRevised><Year>2022</Year><Month>03</Month><Day>21</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">2364-0502</ISSN><JournalIssue CitedMedium="Internet"><Volume>26</Volume><Issue>1</Issue><PubDate><Year>2017</Year><Month>Aug</Month></PubDate></JournalIssue><Title>Yearbook of medical informatics</Title><ISOAbbreviation>Yearb Med Inform</ISOAbbreviation></Journal><ArticleTitle>Representing Knowledge Consistently Across Health Systems.</ArticleTitle><Pagination><StartPage>139</StartPage><EndPage>147</EndPage><MedlinePgn>139-147</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.15265/IY-2017-018</ELocationID><Abstract><AbstractText><b>Objectives:</b> Electronic health records (EHRs) have increasingly emerged as a powerful source of clinical data that can be leveraged for reuse in research and in modular health apps that integrate into diverse health information technologies. A key challenge to these use cases is representing the knowledge contained within data from different EHR systems in a uniform fashion. <b>Method:</b> We reviewed several recent studies covering the knowledge representation in the common data models for the Observational Medical Outcomes Partnership (OMOP) and its Observational Health Data Sciences and Informatics program, and the United States Patient Centered Outcomes Research Network (PCORNet). We also reviewed the Health Level 7 Fast Healthcare Interoperability Resource standard supporting app-like programs that can be used across multiple EHR and research systems. <b>Results:</b> There has been a recent growth in high-impact efforts to support quality-assured and standardized clinical data sharing across different institutions and EHR systems. We focused on three major efforts as part of a larger landscape moving towards shareable, transportable, and computable clinical data. <b>Conclusion:</b> The growth in approaches to developing common data models to support interoperable knowledge representation portends an increasing availability of high-quality clinical data in support of research. Building on these efforts will allow a future whereby significant portions of the populations in the world may be able to share their data for research.</AbstractText><CopyrightInformation>Georg Thieme Verlag KG Stuttgart.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Rosenbloom</LastName><ForeName>S T</ForeName><Initials>ST</Initials></Author><Author ValidYN="Y"><LastName>Carroll</LastName><ForeName>R J</ForeName><Initials>RJ</Initials></Author><Author ValidYN="Y"><LastName>Warner</LastName><ForeName>J L</ForeName><Initials>JL</Initials></Author><Author ValidYN="Y"><LastName>Matheny</LastName><ForeName>M E</ForeName><Initials>ME</Initials></Author><Author ValidYN="Y"><LastName>Denny</LastName><ForeName>J C</ForeName><Initials>JC</Initials></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>R01 HL130828</GrantID><Acronym>HL</Acronym><Agency>NHLBI NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2017</Year><Month>09</Month><Day>11</Day></ArticleDate></Article><MedlineJournalInfo><Country>Germany</Country><MedlineTA>Yearb Med Inform</MedlineTA><NlmUniqueID>9312666</NlmUniqueID><ISSNLinking>0943-4747</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D065709" MajorTopicYN="Y">Common Data Elements</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000073892" MajorTopicYN="Y">Health Information Interoperability</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D057208" MajorTopicYN="N">Health Level Seven</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008490" MajorTopicYN="N">Medical Informatics</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016347" MajorTopicYN="N">Medical Records Systems, Computerized</DescriptorName><QualifierName UI="Q000592" MajorTopicYN="Y">standards</QualifierName></MeshHeading></MeshHeadingList><CoiStatement>Disclosure The authors report no conflicts of interest in this work.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2017</Year><Month>10</Month><Day>25</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2017</Year><Month>10</Month><Day>25</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2018</Year><Month>2</Month><Day>27</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2017</Year><Month>8</Month><Day>1</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">29063555</ArticleId><ArticleId IdType="pmc">PMC6239235</ArticleId><ArticleId IdType="doi">10.15265/IY-2017-018</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Weber GM, Murphy SN, McMurry AJ, Macfadden D, Nigrin DJ, Churchill S et al.The Shared Health Research Information Network (SHRINE): a prototype federated query tool for clinical data repositories. J Am Med Inform Assoc. 2009;16:624&#x2013;30.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2744712</ArticleId><ArticleId IdType="pubmed">19567788</ArticleId></ArticleIdList></Reference><Reference><Citation>Gottesman O, Kuivaniemi H, Tromp G, Faucett WA, Li R, Manolio TA et al.The Electronic Medical Records and Genomics (eMERGE) Network: past, present, and future. Genet Med. 2013;15:761&#x2013;71.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3795928</ArticleId><ArticleId IdType="pubmed">23743551</ArticleId></ArticleIdList></Reference><Reference><Citation>Kho AN, Pacheco JA, Peissig PL, Rasmussen L, Newton KM, Weston N et al.Electronic medical records for genetic research: results of the eMERGE consortium. Sci Transl Med. 2011;03:79re1..</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3690272</ArticleId><ArticleId IdType="pubmed">21508311</ArticleId></ArticleIdList></Reference><Reference><Citation>Collins FS, Hudson KL, Briggs JP, Lauer MS. PCORnet: turning a dream into reality. J Am Med Inform Assoc. 2014;21:576&#x2013;7.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4078299</ArticleId><ArticleId IdType="pubmed">24821744</ArticleId></ArticleIdList></Reference><Reference><Citation>Fleurence RL, Curtis LH, Califf RM, Platt R, Selby JV, Brown JS. Launching PCORnet, a national patient-centered clinical research network. J Am Med Inform Assoc. 2014;21:578&#x2013;82.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4078292</ArticleId><ArticleId IdType="pubmed">24821743</ArticleId></ArticleIdList></Reference><Reference><Citation>Vogt TM, Lafata JE, Tolsma DD, Greene SM. The Role of Research in Integrated Health Care Systems: The HMO Research Network. Perm J. 2004;08:10&#x2013;7.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4690686</ArticleId><ArticleId IdType="pubmed">26705313</ArticleId></ArticleIdList></Reference><Reference><Citation>Klann JG, Abend A, Raghavan VA, Mandl KD, Murphy SN. Data interchange using i2b2. J Am Med Inform Assoc. 2016;23:909&#x2013;15.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4997035</ArticleId><ArticleId IdType="pubmed">26911824</ArticleId></ArticleIdList></Reference><Reference><Citation>Ogunyemi OI, Meeker D, Kim H-E, Ashish N, Farzaneh S, Boxwala A. Identifying appropriate reference data models for comparative effectiveness research (CER) studies based on data from clinical information systems. Med Care. 2013;51:S45&#x2013;52.</Citation><ArticleIdList><ArticleId IdType="pubmed">23774519</ArticleId></ArticleIdList></Reference><Reference><Citation>Jiang G, Evans J, Endle CM, Solbrig HR, Chute CG. Using Semantic Web technologies for the generation of domain-specific templates to support clinical study metadata standards. J Biomed Semant. 2016;07:10.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4778326</ArticleId><ArticleId IdType="pubmed">26949508</ArticleId></ArticleIdList></Reference><Reference><Citation>Why Hasn&#x2019;t Big Data Come to the Rescue in Clinical Data Unification? [Internet][cited 2017 Apr 7]. Available from:http://www.clinicalinformaticsnews.com/cln/comment/why-big-data-rescue-clinical-data.html</Citation></Reference><Reference><Citation>Chen PP-S. The Entity-relationship Model&#x2014;Toward a Unified View of Data. ACM Trans Database Syst. 1976;01:9&#x2013;36.</Citation></Reference><Reference><Citation>Nadkarni PM, Marenco L, Chen R, Skoufos E, Shepherd G, Miller P. Organization of Heterogeneous Scientific Data Using the EAV/CR Representation. J Am Med Inform Assoc. 1999;06:478&#x2013;93.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC61391</ArticleId><ArticleId IdType="pubmed">10579606</ArticleId></ArticleIdList></Reference><Reference><Citation>Overhage JM, Ryan PB, Reich CG, Hartzema AG, Stang PE. Validation of a common data model for active safety surveillance research. J Am Med Inform Assoc. 2012;19:54&#x2013;60.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3240764</ArticleId><ArticleId IdType="pubmed">22037893</ArticleId></ArticleIdList></Reference><Reference><Citation>FitzHenry F, Resnic FS, Robbins SL, Denton J, Nookala L, Meeker D et al.Creating a Common Data Model for Comparative Effectiveness with the Observational Medical Outcomes Partnership. Appl Clin Inform. 2015;06:536&#x2013;47.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4586341</ArticleId><ArticleId IdType="pubmed">26448797</ArticleId></ArticleIdList></Reference><Reference><Citation>Hripcsak G, Duke JD, Shah NH, Reich CG, Huser V, Schuemie MJ et al.Observational Health Data Sciences and Informatics (OHDSI): Opportunities for Observational Researchers. Stud Health Technol Inform. 2015;216:574&#x2013;8.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4815923</ArticleId><ArticleId IdType="pubmed">26262116</ArticleId></ArticleIdList></Reference><Reference><Citation>ACHILLES for data characterization [Internet]  Obs. Health Data Sci. Inform 2017. Available from:http://www.ohdsi.org/analytic-tools/achilles-for-data-characterization/</Citation></Reference><Reference><Citation>Hripcsak G, Ryan PB, Duke JD, Shah NH, Park RW, Huser V et al.Characterizing treatment pathways at scale using the OHDSI network. Proc Natl Acad Sci. 2016;113:7329&#x2013;36.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4941483</ArticleId><ArticleId IdType="pubmed">27274072</ArticleId></ArticleIdList></Reference><Reference><Citation>Yoon D, Ahn EK, Park MY, Cho SY, Ryan P, Schuemie MJ et al.Conversion and Data Quality Assessment of Electronic Health Record Data at a Korean Tertiary Teaching Hospital to a Common Data Model for Distributed Network Research. Healthc Inform Res. 2016;22:54&#x2013;8.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4756059</ArticleId><ArticleId IdType="pubmed">26893951</ArticleId></ArticleIdList></Reference><Reference><Citation>Boland MR, Shahn Z, Madigan D, Hripcsak G, Tatonetti NP. Birth month affects lifetime disease risk: a phenome-wide method. J Am Med Inform Assoc. 2015;22:1042&#x2013;53.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4986668</ArticleId><ArticleId IdType="pubmed">26041386</ArticleId></ArticleIdList></Reference><Reference><Citation>Boyce RD, Ryan PB, Nor&#xe9;n GN, Schuemie MJ, Reich C, Duke J et al.Bridging Islands of Information to Establish an Integrated Knowledge Base of Drugs and Health Outcomes of Interest. Drug Saf. 2014;37:557&#x2013;67.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4134480</ArticleId><ArticleId IdType="pubmed">24985530</ArticleId></ArticleIdList></Reference><Reference><Citation>Nelson SJ, Zeng K, Kilbourne J, Powell T, Moore R. Normalized names for clinical drugs: RxNorm at 6 years. J Am Med Inform Assoc. 2011;18:441&#x2013;8.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3128404</ArticleId><ArticleId IdType="pubmed">21515544</ArticleId></ArticleIdList></Reference><Reference><Citation>Li Y, Ryan PB, Wei Y, Friedman C. A Method to Combine Signals from Spontaneous Reporting Systems and Observational Healthcare Data to Detect Adverse Drug Reactions. Drug Saf. 2015;38:895&#x2013;908.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4579260</ArticleId><ArticleId IdType="pubmed">26153397</ArticleId></ArticleIdList></Reference><Reference><Citation>Voss EA, Boyce RD, Ryan PB, van der Lei J, Rijnbeek PR, Schuemie MJ.Accuracy of an Automated Knowledge Base for Identifying Drug Adverse Reactions. J Biomed Inform [Internet][cited 2017 Jan 3]; Available from:http://www.sciencedirect.com/science/article/pii/S1532046416301794</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5316295</ArticleId><ArticleId IdType="pubmed">27993747</ArticleId></ArticleIdList></Reference><Reference><Citation>Boyce RD, Handler SM, Karp JF, Perera S, Reynolds CF.Preparing Nursing Home Data from Multiple Sites for Clinical Research &#x2013; A Case Study Using Observational Health Data Sciences and Informatics. eGEMs [Internet] 2016[cited 2017 Jan 3];4. Available from:http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5108634/</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5108634</ArticleId><ArticleId IdType="pubmed">27891528</ArticleId></ArticleIdList></Reference><Reference><Citation>Garza M, Del Fiol G, Tenenbaum J, Walden A, Zozus MN. Evaluating common data models for use with a longitudinal community registry. J Biomed Inform. 2016;64:333&#x2013;41.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6810649</ArticleId><ArticleId IdType="pubmed">27989817</ArticleId></ArticleIdList></Reference><Reference><Citation>Compilation of Patient Protection and Affordable Care Act  Extracted sections concerning Patient-Centered Outcomes Research and the Authorization of the Patient-Centered Outcomes Research Institute (PCORI) [Internet]. pcori.org 2017. Available from:http://www.pcori.org/sites/default/files/PCORI_Authorizing_Legislation.pdf</Citation></Reference><Reference><Citation>Selby JV, Beal AC, Frank L. The Patient-Centered Outcomes Research Institute (PCORI) national priorities for research and initial research agenda. JAMA. 2012;307:1583&#x2013;4.</Citation><ArticleIdList><ArticleId IdType="pubmed">22511682</ArticleId></ArticleIdList></Reference><Reference><Citation>Curtis LH, Weiner MG, Boudreau DM, Cooper WO, Daniel GW, Nair VP et al.Design considerations, architecture, and use of the Mini-Sentinel distributed data system. Pharmacoepidemiol. Drug Saf. 2012;21 01:23&#x2013;31.</Citation><ArticleIdList><ArticleId IdType="pubmed">22262590</ArticleId></ArticleIdList></Reference><Reference><Citation>FDA&#x2019;s Sentinel Initiative [Internet] [cited 2017 Apr 7]. Available from:https://www.fda.gov/safety/fdassentinelinitiative/ucm2007250.htm</Citation></Reference><Reference><Citation>PCORnet Common Data Model 3.0 User Guide [Internet] 2017. Available from:http://pcornet.org/wp-content/uploads/2014/07/PCORnet_CDM_3_Lay_Guide_FINAL.pdf</Citation></Reference><Reference><Citation>PCORnet Community Rallies to Launch New Version of Common Data Model. pcori.org. 2017.</Citation></Reference><Reference><Citation>Johnston A, Jones WS, Hernandez AF. The ADAPTABLE Trial and Aspirin Dosing in Secondary Prevention for Patients with Coronary Artery Disease. Curr Cardiol Rep. 2016;18:81.</Citation><ArticleIdList><ArticleId IdType="pubmed">27423939</ArticleId></ArticleIdList></Reference><Reference><Citation>PCORnet Bariatric Study (PBS) [Internet]  ClinicalTrials.gov 2017. Available from:https://clinicaltrials.gov/ct2/show/NCT02741674</Citation></Reference><Reference><Citation>Short- and Long-Term Effects of Antibiotics on Childhood Growth (ABX) [Internet]  ClinicalTrials.gov 2017. Available from:https://clinicaltrials.gov/ct2/show/NCT02744846</Citation></Reference><Reference><Citation>Blumenthal D, Tavenner M. The &#x201c;Meaningful Use&#x201d; Regulation for Electronic Health Records. N Engl J Med. 2010;363:501&#x2013;4.</Citation><ArticleIdList><ArticleId IdType="pubmed">20647183</ArticleId></ArticleIdList></Reference><Reference><Citation>Common Clinical Data Set [Internet]  Off Natl Coord Health Inf Technol 2017. Available from:https://www.healthit.gov/sites/default/files/commonclinicaldataset_ml_11-4-15.pdf</Citation></Reference><Reference><Citation>D&#x2019;Amore JD, Mandel JC, Kreda DA, Swain A, Koromia GA, Sundareswaran S et al.Are Meaningful Use Stage 2 certified EHRs ready for interoperability? Findings from the SMART C-CDA Collaborative. J Am Med Inform Assoc. 2014;21:1060&#x2013;8.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4215060</ArticleId><ArticleId IdType="pubmed">24970839</ArticleId></ArticleIdList></Reference><Reference><Citation>Bender D, Sartipi K. HL7 FHIR: An Agile and RESTful approach to healthcare information exchange. IEEE 26th International Symposium on Computer-Based Medical Systems (CBMS) 2013:326&#x2013;31.</Citation></Reference><Reference><Citation>HL7 launches Argonaut Project to advance FHIR interoperability standard. Health Manag Technol. 2015;36:26.</Citation><ArticleIdList><ArticleId IdType="pubmed">26211233</ArticleId></ArticleIdList></Reference><Reference><Citation>Mandel JC, Kreda DA, Mandl KD, Kohane IS, Ramoni RB. SMART on FHIR: a standards-based, interoperable apps platform for electronic health records. J Am Med Inform Assoc. 2016;23:899&#x2013;908.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4997036</ArticleId><ArticleId IdType="pubmed">26911829</ArticleId></ArticleIdList></Reference><Reference><Citation>Mandl KD, Mandel JC, Kohane IS. Driving Innovation in Health Systems through an Apps-Based Information Economy. Cell Syst. 2015;01:8&#x2013;13.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4556429</ArticleId><ArticleId IdType="pubmed">26339683</ArticleId></ArticleIdList></Reference><Reference><Citation>Mandl KD, Kohane IS. Time for a Patient-Driven Health Information Economy? N Engl J Med. 2016;374:205&#x2013;8.</Citation><ArticleIdList><ArticleId IdType="pubmed">26789868</ArticleId></ArticleIdList></Reference><Reference><Citation>Pfiffner PB, Pinyol I, Natter MD, Mandl KD. C3-PRO: Connecting ResearchKit to the Health System Using i2b2 and FHIR. PloS One. 2016;11:e0152722..</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4816293</ArticleId><ArticleId IdType="pubmed">27031856</ArticleId></ArticleIdList></Reference><Reference><Citation>Wagholikar KB, Mandel JC, Klann JG, Wattanasin N, Mendis M, Chute CG SMART-on-FHIR implemented over i2b2. J Am Med Inform Assoc. 2016.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5391721</ArticleId><ArticleId IdType="pubmed">27274012</ArticleId></ArticleIdList></Reference><Reference><Citation>Bloomfield RA, Polo-Wood F, Mandel JC, Mandl KD. Opening the Duke electronic health record to apps: Implementing SMART on FHIR. Int J Med Inform. 2017;99:1&#x2013;10.</Citation><ArticleIdList><ArticleId IdType="pubmed">28118917</ArticleId></ArticleIdList></Reference><Reference><Citation>Kasthurirathne SN, Mamlin B, Grieve G, Biondich P. Towards Standardized Patient Data Exchange: Integrating a FHIR Based API for the Open Medical Record System. Stud Health Technol Inform. 2015;216:932.</Citation><ArticleIdList><ArticleId IdType="pubmed">26262234</ArticleId></ArticleIdList></Reference><Reference><Citation>Kasthurirathne SN, Mamlin B, Kumara H, Grieve G, Biondich P. Enabling Better Interoperability for HealthCare: Lessons in Developing a Standards Based Application Programing Interface for Electronic Medical Record Systems. J Med Syst. 2015;39:182.</Citation><ArticleIdList><ArticleId IdType="pubmed">26446013</ArticleId></ArticleIdList></Reference><Reference><Citation>PMI Cohort Program announces new name: the All of Us Research Program [Internet]  2016. Available from:https://www.nih.gov/allofus-research-program/pmi-cohort-program-announces-new-name-all-us-research-program</Citation></Reference><Reference><Citation>Alterovitz G, Warner J, Zhang P, Chen Y, Ullman-Cullere M, Kreda D et al.SMART on FHIR Genomics: facilitating standardized clinico-genomic apps. J Am Med Inform Assoc. 2015;22:1173&#x2013;8.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC11737838</ArticleId><ArticleId IdType="pubmed">26198304</ArticleId></ArticleIdList></Reference><Reference><Citation>Warner JL, Rioth MJ, Mandl KD, Mandel JC, Kreda DA, Kohane IS et al.SMART precision cancer medicine: a FHIR-based app to provide genomic information at the point of care. J Am Med Inform Assoc. 2016;23:701&#x2013;10.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6080684</ArticleId><ArticleId IdType="pubmed">27018265</ArticleId></ArticleIdList></Reference><Reference><Citation>Rimer BK.Improving Cancer-Related Outcomes with Connected Health [Internet] 2016. Nov. Available from:https://deainfo.nci.nih.gov/Advisory/pcp/annualReports/2016/ConnHealth_FullRpt.pdf</Citation></Reference><Reference><Citation>Kimura E, Ishihara K. Internal domain-specific language based on Arden Syntax and FHIR. Stud Health Technol Inform. 2015;216:955.</Citation><ArticleIdList><ArticleId IdType="pubmed">26262257</ArticleId></ArticleIdList></Reference><Reference><Citation>Gaebel J, Cypko MA, Lemke HU. Accessing Patient Information for Probabilistic Patient Models Using Existing Standards. Stud Health Technol Inform. 2016;223:107&#x2013;12.</Citation><ArticleIdList><ArticleId IdType="pubmed">27139392</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee J, Scott DJ, Villarroel M, Clifford GD, Saeed M, Mark RG. Open-access MIMIC-II database for intensive care research. Conf Proc IEEE Eng Med Biol Soc. 2011;2011:8315&#x2013;8.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6339457</ArticleId><ArticleId IdType="pubmed">22256274</ArticleId></ArticleIdList></Reference><Reference><Citation>Khalilia M, Choi M, Henderson A, Iyengar S, Braunstein M, Sun J. Clinical Predictive Modeling Development and Deployment through FHIR Web Services. AMIA Annu Symp Proc. 2015;2015:717&#x2013;26.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4765683</ArticleId><ArticleId IdType="pubmed">26958207</ArticleId></ArticleIdList></Reference><Reference><Citation>Doods J, Neuhaus P, Dugas M. Converting ODM Metadata to FHIR Questionnaire Resources. Stud Health Technol Inform. 2016;228:456&#x2013;60.</Citation><ArticleIdList><ArticleId IdType="pubmed">27577424</ArticleId></ArticleIdList></Reference><Reference><Citation>Ulrich H, Kock A-K, Duhm-Harbeck P, Habermann JK, Ingenerf J. Metadata Repository for Improved Data Sharing and Reuse Based on HL7 FHIR. Stud Health Technol Inform. 2016;228:162&#x2013;6.</Citation><ArticleIdList><ArticleId IdType="pubmed">27577363</ArticleId></ArticleIdList></Reference><Reference><Citation>Hochheiser H, Castine M, Harris D, Savova G, Jacobson RS. An information model for computable cancer phenotypes. BMC Med Inform Decis Mak. 2016;16:121.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5024416</ArticleId><ArticleId IdType="pubmed">27629872</ArticleId></ArticleIdList></Reference><Reference><Citation>Rinner C, Duftschmid G. Bridging the Gap between HL7 CDA and HL7 FHIR: A JSON Based Mapping. Stud Health Technol Inform. 2016;223:100&#x2013;6.</Citation><ArticleIdList><ArticleId IdType="pubmed">27139391</ArticleId></ArticleIdList></Reference><Reference><Citation>FHIR Maturity Model [Internet]  HL7 FHIR 2017. Available from:http://hl7.org/fhir/resource.html#maturity</Citation></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">29081385</PMID><DateCompleted><Year>2018</Year><Month>07</Month><Day>30</Day></DateCompleted><DateRevised><Year>2025</Year><Month>05</Month><Day>30</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1532-0480</ISSN><JournalIssue CitedMedium="Internet"><Volume>76</Volume><PubDate><Year>2017</Year><Month>Dec</Month></PubDate></JournalIssue><Title>Journal of biomedical informatics</Title><ISOAbbreviation>J Biomed Inform</ISOAbbreviation></Journal><ArticleTitle>Toward multimodal signal detection of adverse drug reactions.</ArticleTitle><Pagination><StartPage>41</StartPage><EndPage>49</EndPage><MedlinePgn>41-49</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.jbi.2017.10.013</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S1532-0464(17)30232-0</ELocationID><Abstract><AbstractText Label="OBJECTIVE" NlmCategory="OBJECTIVE">Improving mechanisms to detect adverse drug reactions (ADRs) is key to strengthening post-marketing drug safety surveillance. Signal detection is presently unimodal, relying on a single information source. Multimodal signal detection is based on jointly analyzing multiple information sources. Building on, and expanding the work done in prior studies, the aim of the article is to further research on multimodal signal detection, explore its potential benefits, and propose methods for its construction and evaluation.</AbstractText><AbstractText Label="MATERIAL AND METHODS" NlmCategory="METHODS">Four data sources are investigated; FDA's adverse event reporting system, insurance claims, the MEDLINE citation database, and the logs of major Web search engines. Published methods are used to generate and combine signals from each data source. Two distinct reference benchmarks corresponding to well-established and recently labeled ADRs respectively are used to evaluate the performance of multimodal signal detection in terms of area under the ROC curve (AUC) and lead-time-to-detection, with the latter relative to labeling revision dates.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">Limited to our reference benchmarks, multimodal signal detection provides AUC improvements ranging from 0.04 to 0.09 based on a widely used evaluation benchmark, and a comparative added lead-time of 7-22 months relative to labeling revision dates from a time-indexed benchmark.</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">The results support the notion that utilizing and jointly analyzing multiple data sources may lead to improved signal detection. Given certain data and benchmark limitations, the early stage of development, and the complexity of ADRs, it is currently not possible to make definitive statements about the ultimate utility of the concept. Continued development of multimodal signal detection requires a deeper understanding the data sources used, additional benchmarks, and further research on methods to generate and synthesize signals.</AbstractText><CopyrightInformation>Copyright &#xa9; 2017 Elsevier Inc. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Harpaz</LastName><ForeName>Rave</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Oracle Health Sciences, Bedford, MA, United States. Electronic address: rave.harpaz@oracle.com.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>DuMouchel</LastName><ForeName>William</ForeName><Initials>W</Initials><AffiliationInfo><Affiliation>Oracle Health Sciences, Bedford, MA, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Schuemie</LastName><ForeName>Martijn</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Janssen Research and Development, Titusville, NJ, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bodenreider</LastName><ForeName>Olivier</ForeName><Initials>O</Initials><AffiliationInfo><Affiliation>National Library of Medicine, NIH, Bethesda, MD, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Friedman</LastName><ForeName>Carol</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Columbia University, New York, NY, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Horvitz</LastName><ForeName>Eric</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Microsoft Research, Redmond, WA, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ripple</LastName><ForeName>Anna</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>National Library of Medicine, NIH, Bethesda, MD, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sorbello</LastName><ForeName>Alfred</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>U.S. FDA, Silver Spring, MD, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>White</LastName><ForeName>Ryen W</ForeName><Initials>RW</Initials><AffiliationInfo><Affiliation>Microsoft Research, Redmond, WA, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Winnenburg</LastName><ForeName>Rainer</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Stanford University, Stanford, CA, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Shah</LastName><ForeName>Nigam H</ForeName><Initials>NH</Initials><AffiliationInfo><Affiliation>Stanford University, Stanford, CA, United States.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>R01 GM101430</GrantID><Acronym>GM</Acronym><Agency>NIGMS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R01 LM012011</GrantID><Acronym>LM</Acronym><Agency>NLM NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>U01 FD004979</GrantID><Acronym>FD</Acronym><Agency>FDA HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>ZIA LM010007</GrantID><Acronym>ImNIH</Acronym><Agency>Intramural NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2017</Year><Month>11</Month><Day>01</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>J Biomed Inform</MedlineTA><NlmUniqueID>100970413</NlmUniqueID><ISSNLinking>1532-0464</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D016907" MajorTopicYN="Y">Adverse Drug Reaction Reporting Systems</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016208" MajorTopicYN="N">Databases, Factual</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014481" MajorTopicYN="N">United States</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014486" MajorTopicYN="N">United States Food and Drug Administration</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Adverse drug reactions</Keyword><Keyword MajorTopicYN="N">Drug safety</Keyword><Keyword MajorTopicYN="N">Multimodal</Keyword><Keyword MajorTopicYN="N">Pharmacovigilance</Keyword><Keyword MajorTopicYN="N">Signal detection</Keyword></KeywordList><CoiStatement>COMPETING FINANCIAL INTERESTS. The authors declare no competing financial interests. Rave Harpaz and William DuMouchel are employed by Oracle Health Sciences. Nigam H Shah is a Science Advisor to Apixio Inc. and Learning Health Inc. Carol Friedman consults for Health Fidelity Inc. Martijn Schuemie is employed by Janssen Research and Development. Eric Horvitz and Ryen W White are employed by Microsoft.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2017</Year><Month>1</Month><Day>14</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2017</Year><Month>10</Month><Day>14</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2017</Year><Month>10</Month><Day>24</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2017</Year><Month>10</Month><Day>31</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2018</Year><Month>7</Month><Day>31</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2017</Year><Month>10</Month><Day>31</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2021</Year><Month>10</Month><Day>10</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">29081385</ArticleId><ArticleId IdType="mid">NIHMS917722</ArticleId><ArticleId IdType="pmc">PMC8502488</ArticleId><ArticleId IdType="doi">10.1016/j.jbi.2017.10.013</ArticleId><ArticleId IdType="pii">S1532-0464(17)30232-0</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Prescription Drug User Fee Act (PDUFA V). http://www.fda.gov/ForIndustry/UserFees/PrescriptionDrugUserFee/ucm272170.htm.</Citation></Reference><Reference><Citation>REGULATION (EU) No 1235/2010 OF THE EUROPEAN PARLIAMENT AND OF THE COUNCIL of 15 December 2010. http://www.ema.europa.eu/ema/index.jsp?curl=pages/regulation/general/general_content_000492.jsp.</Citation></Reference><Reference><Citation>Food and Drug Administration Amendments Act (FDAAA) of 2007. http://www.fda.gov/regulatoryinformation/legislation/federalfooddrugandcosmeticactfdcact/significantamendmentstothefdcact/foodanddrugadministrationamendmentsactof2007/default.htm.</Citation></Reference><Reference><Citation>Altman RB, Khuri N, Salit M, Giacomini KM. Unmet needs: Research helps regulators do their jobs. Sci Transl Med. 2015;7:315ps22.</Citation><ArticleIdList><ArticleId IdType="pubmed">26606966</ArticleId></ArticleIdList></Reference><Reference><Citation>Califf RM, Ostroff S. FDA as a catalyst for translation. Science Translational Medicine. 2015;7:296ed9&#x2013;ed9.</Citation><ArticleIdList><ArticleId IdType="pubmed">26180098</ArticleId></ArticleIdList></Reference><Reference><Citation>Platt R, Wilson M, Chan KA, Benner JS, Marchibroda J, McClellan M. The New Sentinel Network - Improving the Evidence of Medical-Product Safety. New England Journal of Medicine. 2009;361:645&#x2013;7.</Citation><ArticleIdList><ArticleId IdType="pubmed">19635947</ArticleId></ArticleIdList></Reference><Reference><Citation>Wysowski DK, Swartz L. Adverse drug event surveillance and drug withdrawals in the United States, 1969&#x2013;2002: the importance of reporting suspected reactions. Arch Intern Med. 2005;165:1363&#x2013;9.</Citation><ArticleIdList><ArticleId IdType="pubmed">15983284</ArticleId></ArticleIdList></Reference><Reference><Citation>CIOMS Working Group VIII. Practical Aspects of Signal Detection in Pharmacovigilance: CIOMS; 2010.</Citation></Reference><Reference><Citation>Szarfman A, Machado SG, O&#x2019;Neill RT. Use of screening algorithms and computer systems to efficiently signal higher-than-expected combinations of drugs and events in the US FDA&#x2019;s spontaneous reports database. Drug Saf. 2002;25:381&#x2013;92.</Citation><ArticleIdList><ArticleId IdType="pubmed">12071774</ArticleId></ArticleIdList></Reference><Reference><Citation>Harpaz R, DuMouchel W, Shah NH, Madigan D, Ryan P, Friedman C. Novel data-mining methodologies for adverse drug event discovery and analysis. Clin Pharmacol Ther. 2012;91:1010&#x2013;21.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3675775</ArticleId><ArticleId IdType="pubmed">22549283</ArticleId></ArticleIdList></Reference><Reference><Citation>Vigibase Lindquist M., the WHO Global ICSR Database System: Basic Facts. Drug Information Journal. 2008;42:409&#x2013;19.</Citation></Reference><Reference><Citation>Lahat D, Adali T, Jutten C. Multimodal Data Fusion: An Overview of Methods, Challenges, and Prospects. Proceedings of the IEEE. 2015;103:1449&#x2013;77.</Citation></Reference><Reference><Citation>Stang PE, Ryan PB, Racoosin JA, Overhage JM, Hartzema AG, Reich C, et al. Advancing the Science for Active Surveillance: Rationale and Design for the Observational Medical Outcomes Partnership. Annals of Internal Medicine. 2010;153:600&#x2013;W206.</Citation><ArticleIdList><ArticleId IdType="pubmed">21041580</ArticleId></ArticleIdList></Reference><Reference><Citation>Coloma PM, Schuemie MJ, Trifiro G, Gini R, Herings R, Hippisley-Cox J, et al. Combining electronic healthcare databases in Europe to allow for large-scale drug safety monitoring: the EU-ADR Project. PharmacoepidemiolDrug Saf. 2011;20:1&#x2013;11.</Citation><ArticleIdList><ArticleId IdType="pubmed">21182150</ArticleId></ArticleIdList></Reference><Reference><Citation>LePendu P, Iyer SV, Bauer-Mehren A, Harpaz R, Mortensen JM, Podchiyska T, et al. Pharmacovigilance using clinical notes. Clin Pharmacol Ther. 2013;93:547&#x2013;55.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3846296</ArticleId><ArticleId IdType="pubmed">23571773</ArticleId></ArticleIdList></Reference><Reference><Citation>Haerian K, Varn D, Vaidya S, Ena L, Chase HS, Friedman C. Detection of pharmacovigilance-related adverse events using electronic health records and automated methods. Clin Pharmacol Ther. 2012;92:228&#x2013;34.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3685297</ArticleId><ArticleId IdType="pubmed">22713699</ArticleId></ArticleIdList></Reference><Reference><Citation>Nor&#xe9;n GN, Hopstadius J, Bate A, Star K, Edwards IR. Temporal pattern discovery in longitudinal electronic patient records. Data Mining and Knowledge Discovery. 2010;20:361&#x2013;87.</Citation></Reference><Reference><Citation>Avillach P, Dufour JC, Diallo G, Salvo F, Joubert M, Thiessard F, et al. Design and validation of an automated method to detect known adverse drug reactions in MEDLINE: a contribution from the EU-ADR project. J Am Med Inform Assoc. 2013;20:446&#x2013;52.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3628051</ArticleId><ArticleId IdType="pubmed">23195749</ArticleId></ArticleIdList></Reference><Reference><Citation>Pontes H, Clement M, Rollason V. Safety signal detection: the relevance of literature review. Drug Saf. 2014;37:471&#x2013;9.</Citation><ArticleIdList><ArticleId IdType="pubmed">24895178</ArticleId></ArticleIdList></Reference><Reference><Citation>Winnenburg R, Sorbello A, Ripple A, Harpaz R, Tonning J, Szarfman A, et al. Leveraging MEDLINE indexing for pharmacovigilance &#x2013; Inherent limitations and mitigation strategies. Journal of Biomedical Informatics. 2015;57:425&#x2013;35.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4775467</ArticleId><ArticleId IdType="pubmed">26342964</ArticleId></ArticleIdList></Reference><Reference><Citation>Sarker A, Ginn R, Nikfarjam A, O&#x2019;Connor K, Smith K, Jayaraman S, et al. Utilizing social media data for pharmacovigilance: A review. J Biomed Inform. 2015;54:202&#x2013;12.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4408239</ArticleId><ArticleId IdType="pubmed">25720841</ArticleId></ArticleIdList></Reference><Reference><Citation>Edwards IR, Lindquist M. Social Media and Networks in Pharmacovigilance. Drug Safety. 2011;34:267&#x2013;71.</Citation><ArticleIdList><ArticleId IdType="pubmed">21417499</ArticleId></ArticleIdList></Reference><Reference><Citation>Freifeld CC, Brownstein JS, Menone CM, Bao W, Filice R, Kass-Hout T, et al. Digital drug safety surveillance: monitoring pharmaceutical products in twitter. Drug Saf. 2014;37:343&#x2013;50.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4013443</ArticleId><ArticleId IdType="pubmed">24777653</ArticleId></ArticleIdList></Reference><Reference><Citation>Harpaz R, Callahan A, Tamang S, Low Y, Odgers D, Finlayson S, et al. Text mining for adverse drug events: the promise, challenges, and state of the art. Drug Saf. 2014;37:777&#x2013;90.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4217510</ArticleId><ArticleId IdType="pubmed">25151493</ArticleId></ArticleIdList></Reference><Reference><Citation>White RW, Harpaz R, Shah NH, DuMouchel W, Horvitz E. Toward enhanced pharmacovigilance using patient-generated data on the internet. Clin Pharmacol Ther. 2014;96:239&#x2013;46.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4111778</ArticleId><ArticleId IdType="pubmed">24713590</ArticleId></ArticleIdList></Reference><Reference><Citation>Yom-Tov E, Gabrilovich E. Postmarket Drug Surveillance Without Trial Costs: Discovery of Adverse Drug Reactions Through Large-Scale Analysis of Web Search Queries. J Med Internet Res. 2013;15:e124.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3713931</ArticleId><ArticleId IdType="pubmed">23778053</ArticleId></ArticleIdList></Reference><Reference><Citation>White RW, Tatonetti NP, Shah NH, Altman RB, Horvitz E. Web-scale pharmacovigilance: listening to signals from the crowd. J Am Med Inform Assoc. 2013;20:404&#x2013;8.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3628066</ArticleId><ArticleId IdType="pubmed">23467469</ArticleId></ArticleIdList></Reference><Reference><Citation>Abernethy DR, Woodcock J, Lesko LJ. Pharmacological mechanism-based drug safety assessment and prediction. Clin Pharmacol Ther. 2011;89:793&#x2013;7.</Citation><ArticleIdList><ArticleId IdType="pubmed">21490594</ArticleId></ArticleIdList></Reference><Reference><Citation>Harpaz R, Vilar S, Dumouchel W, Salmasian H, Haerian K, Shah NH, et al. Combing signals from spontaneous reports and electronic health records for detection of adverse drug reactions. J Am Med Inform Assoc. 2013;20:413&#x2013;9.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3628045</ArticleId><ArticleId IdType="pubmed">23118093</ArticleId></ArticleIdList></Reference><Reference><Citation>Li Y, Ryan P, Wei Y, Friedman C. A Method to Combine Signals from Spontaneous Reporting Systems and Observational Healthcare Data to Detect Adverse Drug Reactions. Drug Safety. 2015:1&#x2013;14.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4579260</ArticleId><ArticleId IdType="pubmed">26153397</ArticleId></ArticleIdList></Reference><Reference><Citation>Harpaz R, DuMouchel W, LePendu P, Shah NH. Empirical bayes model to combine signals of adverse drug reactions. Proceedings of the 19th ACM SIGKDD international conference on Knowledge discovery and data mining. Chicago, Illinois, USA: ACM; 2013. p. 1339&#x2013;47.</Citation></Reference><Reference><Citation>Xu R, Wang Q. Large-scale combining signals from both biomedical literature and the FDA Adverse Event Reporting System (FAERS) to improve post-marketing drug safety signal detection. BMC Bioinformatics. 2014;15:17.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3906761</ArticleId><ArticleId IdType="pubmed">24428898</ArticleId></ArticleIdList></Reference><Reference><Citation>Vilar S, Harpaz R, Chase HS, Costanzi S, Rabadan R, Friedman C. Facilitating adverse drug event detection in pharmacovigilance databases using molecular structure similarity: application to rhabdomyolysis. JAmMedInformAssoc. 2011;18 Suppl 1:i73&#x2013;i80.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3241177</ArticleId><ArticleId IdType="pubmed">21946238</ArticleId></ArticleIdList></Reference><Reference><Citation>Yeleswarapu S, Rao A, Joseph T, Saipradeep VG, Srinivasan R. A pipeline to extract drug-adverse event pairs from multiple data sources. BMC Med Inform Decis Mak. 2014;14:13.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3936866</ArticleId><ArticleId IdType="pubmed">24559132</ArticleId></ArticleIdList></Reference><Reference><Citation>Lopes P, Nunes T, Campos D, Furlong LI, Bauer-Mehren A, Sanz F, et al. Gathering and exploring scientific knowledge in pharmacovigilance. PLoS One. 2013;8:e83016.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3859628</ArticleId><ArticleId IdType="pubmed">24349421</ArticleId></ArticleIdList></Reference><Reference><Citation>MEDLINE. http://www.nlm.nih.gov/pubs/factsheets/medline.html.</Citation></Reference><Reference><Citation>Harpaz R, Dumouchel W, Lependu P, Bauer-Mehren A, Ryan P, Shah NH. Performance of pharmacovigilance signal-detection algorithms for the FDA adverse event reporting system. Clin Pharmacol Ther. 2013;93:539&#x2013;46.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3857139</ArticleId><ArticleId IdType="pubmed">23571771</ArticleId></ArticleIdList></Reference><Reference><Citation>IMEDS Research Lab. http://imeds.reaganudall.org/ResearchLab.</Citation></Reference><Reference><Citation>Medical Subject Headings (MeSH). http://www.nlm.nih.gov/mesh.</Citation></Reference><Reference><Citation>Ryan PB, Schuemie MJ, Welebob E, Duke J, Valentine S, Hartzema AG. Defining a reference set to support methodological research in drug safety. Drug Saf. 2013;36 Suppl 1:S33&#x2013;47.</Citation><ArticleIdList><ArticleId IdType="pubmed">24166222</ArticleId></ArticleIdList></Reference><Reference><Citation>Hauben M, Aronson JK, Ferner RE. Evidence of Misclassification of Drug-Event Associations Classified as Gold Standard &#x2018;Negative Controls&#x2019; by the Observational Medical Outcomes Partnership (OMOP). Drug Saf. 2016;39:421&#x2013;32.</Citation><ArticleIdList><ArticleId IdType="pubmed">26879560</ArticleId></ArticleIdList></Reference><Reference><Citation>Harpaz R, Odgers D, Gaskin G, DuMouchel W, Winnenburg R, Bodenreider O, et al. A time-indexed reference standard of adverse drug reactions. Sci Data. 2014;1:140043.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4306188</ArticleId><ArticleId IdType="pubmed">25632348</ArticleId></ArticleIdList></Reference><Reference><Citation>RxNorm. https://www.nlm.nih.gov/research/umls/rxnorm/.</Citation></Reference><Reference><Citation>Medical Dictionary for Regulatory Activities (MedDRA). http://www.meddra.org/.</Citation><ArticleIdList><ArticleId IdType="pubmed">10082069</ArticleId></ArticleIdList></Reference><Reference><Citation>Anatomical Therapeutic Chemical classification system (ATC). http://www.whocc.no/atc.</Citation></Reference><Reference><Citation>Systemized Nomenclature of Medicine Clinical Terms (SNOMED CT). http://www.ihtsdo.org/snomed-ct/.</Citation></Reference><Reference><Citation>Bate A, Lindquist M, Edwards IR, Olsson S, Orre R, Lansner A, et al. A Bayesian neural network method for adverse drug reaction signal generation. Eur J Clin Pharmacol. 1998;54:315&#x2013;21.</Citation><ArticleIdList><ArticleId IdType="pubmed">9696956</ArticleId></ArticleIdList></Reference><Reference><Citation>Noren GN, Bate A, Orre R, Edwards IR. Extending the methods used to screen the WHO drug safety database towards analysis of complex associations and improved accuracy for rare events. Stat Med. 2006;25:3740&#x2013;57.</Citation><ArticleIdList><ArticleId IdType="pubmed">16381072</ArticleId></ArticleIdList></Reference><Reference><Citation>DuMouchel W, Pregibon D. Empirical bayes screening for multi-item associations. Proceedings of the seventh ACM SIGKDD international conference on Knowledge discovery and data mining. 2001:67&#x2013;76.</Citation></Reference><Reference><Citation>Ryan PB, Schuemie MJ, Madigan D. Empirical performance of a self-controlled cohort method: lessons for developing a risk identification and analysis system. Drug Saf. 2013;36 Suppl 1:S95&#x2013;106.</Citation><ArticleIdList><ArticleId IdType="pubmed">24166227</ArticleId></ArticleIdList></Reference><Reference><Citation>Ryan PB, Stang PE, Overhage JM, Suchard MA, Hartzema AG, DuMouchel W, et al. A comparison of the empirical performance of methods for a risk identification system. Drug Saf. 2013;36 Suppl 1:S143&#x2013;58.</Citation><ArticleIdList><ArticleId IdType="pubmed">24166231</ArticleId></ArticleIdList></Reference><Reference><Citation>DerSimonian R, Laird N. Meta-analysis in clinical trials. Control Clin Trials. 1986;7:177&#x2013;88.</Citation><ArticleIdList><ArticleId IdType="pubmed">3802833</ArticleId></ArticleIdList></Reference><Reference><Citation>Lewis-Beck M, Bryman A, Futing Liao T. Proportional Reduction Of Error (PRE). In The SAGE Encyclopedia of Social Science Research Methods. 2004.</Citation></Reference><Reference><Citation>Airola TP Antti, Waegeman Willem, De Baets Bernard, Salakoski Tapio. A comparison of AUC estimators in small-sample studies. Proceedings of the 3rd International workshop on Machine Learning in Systems Biology. 2009:15&#x2013;23.</Citation></Reference><Reference><Citation>DeLong ER, DeLong DM, Clarke-Pearson DL. Comparing the areas under two or more correlated receiver operating characteristic curves: a nonparametric approach. Biometrics. 1988;44:837&#x2013;45.</Citation><ArticleIdList><ArticleId IdType="pubmed">3203132</ArticleId></ArticleIdList></Reference><Reference><Citation>White RW, Wang S, Pant A, Harpaz R, Shukla P, Sun W, et al. Early identification of adverse drug reactions from search log data. J Biomed Inform. 2016;59:42&#x2013;28.</Citation><ArticleIdList><ArticleId IdType="pubmed">26610385</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">29232365</PMID><DateCompleted><Year>2018</Year><Month>01</Month><Day>04</Day></DateCompleted><DateRevised><Year>2018</Year><Month>11</Month><Day>13</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Electronic">1932-6203</ISSN><JournalIssue CitedMedium="Internet"><Volume>12</Volume><Issue>12</Issue><PubDate><Year>2017</Year></PubDate></JournalIssue><Title>PloS one</Title><ISOAbbreviation>PLoS One</ISOAbbreviation></Journal><ArticleTitle>Monitoring compliance with standards of care for chronic diseases using healthcare administrative databases in Italy: Strengths and limitations.</ArticleTitle><Pagination><StartPage>e0188377</StartPage><MedlinePgn>e0188377</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">e0188377</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1371/journal.pone.0188377</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">A recent comprehensive report on healthcare quality in Italy published by the Organization of Economic Co-operation and Development (OECD) recommended that regular monitoring of quality of primary care by means of compliance with standards of care for chronic diseases is performed. A previous ecological study demonstrated that compliance with standards of care could be reliably estimated on regional level using administrative databases. This study compares estimates based on administrative data with estimates based on GP records for the same persons, to understand whether ecological fallacy played a role in the results of the previous study.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">We compared estimates of compliance with diagnostic and therapeutic standards of care for type 2 diabetes (T2DM), hypertension and ischaemic heart disease (IHD) from administrative data (IAD) with estimates from medical records (MR) for the same persons registered with 24 GP's in 2012. Data were linked at an individual level.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">32,688 persons entered the study, 12,673 having at least one of the three diseases according to at least one data source. Patients not detected by IAD were many, for all three conditions: adding MR increased the number of cases of T2DM, hypertension, and IHD by +40%, +42%, and +104%, respectively. IAD had imperfect sensitivity in detecting population compliance with therapies (adding MR increased the estimate, from +11.5% for statins to +14.7% for antithrombotics), and, more substantially, with diagnostic recommendations (adding MR increased the estimate, from +23.7% in glycated hemoglobin tests, to +50.5% in electrocardiogram). Patients not detected by IAD were less compliant with respect to those that IAD correctly identified (from -4.8 percentage points in proportion of IHD patients compliant with a yearly glycated hemoglobin test, to -40.1 points in the proportion of T2DM patients compliant with the same recommendation). IAD overestimated indicators of compliance with therapeutic standards (significant differences ranged from 3.3. to 3.6 percentage points) and underestimated indicators of compliance with diagnostic standards (significant differences ranged from -2.3 to -14.1 percentage points).</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">IAD overestimated the percentage of patients compliant with therapeutic standards by less than 6 percentage points, and underestimated the percentage of patients compliant with diagnostic standards by a maximum of 14 percentage points. Therefore, both discussions at local level between GP's and local health unit managers and discussions at central level between national and regional policy makers can be informed by indicators of compliance estimated by IAD, which, based on those results, have the ability of signalling critical or excellent clusters. However, this study found that estimates are partly flawed, because a high number of patients with chronic diseases are not detected by IAD, patients detected are not representative of the whole population of patients, and some categories of diagnostic tests are markedly underrecorded in IAD (up to 50% in the case of electrocardiograms). Those results call to caution when interpreting IAD estimates. Audits based on medical records, on the local level, and an interpretation taking into account information external to IAD, on the central level, are needed to assess a more comprehensive compliance with standards.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Gini</LastName><ForeName>Rosa</ForeName><Initials>R</Initials><Identifier Source="ORCID">0000-0002-6250-877X</Identifier><AffiliationInfo><Affiliation>Agenzia regionale di sanit&#xe0; della Toscana, Osservatorio di epidemiologia, Florence, Italy.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Medical Informatics, Erasmus Medical Center, Rotterdam, The Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Schuemie</LastName><ForeName>Martijn J</ForeName><Initials>MJ</Initials><AffiliationInfo><Affiliation>Janssen Research &amp; Development, Epidemiology, Titusville, New Jersey, United States of America.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Observational Health Data Sciences and Informatics (OHDSI), New York, New York, United States of America.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pasqua</LastName><ForeName>Alessandro</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Health Search, Italian College of General Practitioners and Primary Care, Florence, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Carlini</LastName><ForeName>Emanuele</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Consiglio Nazionale delle Ricerche, Istituto di Scienza e Tecnologie dell'Informazione, Pisa, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Profili</LastName><ForeName>Francesco</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Agenzia regionale di sanit&#xe0; della Toscana, Osservatorio di epidemiologia, Florence, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cricelli</LastName><ForeName>Iacopo</ForeName><Initials>I</Initials><AffiliationInfo><Affiliation>Genomedics, Florence, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Dazzi</LastName><ForeName>Patrizio</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Consiglio Nazionale delle Ricerche, Istituto di Scienza e Tecnologie dell'Informazione, Pisa, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Barletta</LastName><ForeName>Valentina</ForeName><Initials>V</Initials><AffiliationInfo><Affiliation>Agenzia regionale di sanit&#xe0; della Toscana, Osservatorio di epidemiologia, Florence, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Francesconi</LastName><ForeName>Paolo</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Agenzia regionale di sanit&#xe0; della Toscana, Osservatorio di epidemiologia, Florence, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lapi</LastName><ForeName>Francesco</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Health Search, Italian College of General Practitioners and Primary Care, Florence, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Donatini</LastName><ForeName>Andrea</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Assessorato Politiche per la Salute, Bologna, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Dal Co</LastName><ForeName>Giulia</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Agenzia Nazionale per il Servizi Sanitari Regionali, Rome, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Visca</LastName><ForeName>Modesta</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Agenzia Nazionale per il Servizi Sanitari Regionali, Rome, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bellentani</LastName><ForeName>Mariadonata</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Agenzia Nazionale per il Servizi Sanitari Regionali, Rome, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sturkenboom</LastName><ForeName>Miriam</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Agenzia regionale di sanit&#xe0; della Toscana, Osservatorio di epidemiologia, Florence, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Klazinga</LastName><ForeName>Niek</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Academic Medical Center, University of Amsterdam, Amsterdam, The Netherlands.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2017</Year><Month>12</Month><Day>12</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>PLoS One</MedlineTA><NlmUniqueID>101285081</NlmUniqueID><ISSNLinking>1932-6203</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D002908" MajorTopicYN="N">Chronic Disease</DescriptorName><QualifierName UI="Q000628" MajorTopicYN="Y">therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D003924" MajorTopicYN="N">Diabetes Mellitus, Type 2</DescriptorName><QualifierName UI="Q000628" MajorTopicYN="N">therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D019983" MajorTopicYN="Y">Guideline Adherence</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006973" MajorTopicYN="N">Hypertension</DescriptorName><QualifierName UI="Q000628" MajorTopicYN="N">therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D007558" MajorTopicYN="N">Italy</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017202" MajorTopicYN="N">Myocardial Ischemia</DescriptorName><QualifierName UI="Q000628" MajorTopicYN="N">therapy</QualifierName></MeshHeading></MeshHeadingList><CoiStatement><b>Competing Interests: </b>I Cricelli, A Pasqua and F Lapi are employed by Genomedics, which is a commercial company, and M J Schuemie is employed by Janssen Research and Development LLC, which is a commercial company. This does not alter our adherence to PLOS ONE policies on sharing data and materials.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2017</Year><Month>1</Month><Day>17</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2017</Year><Month>11</Month><Day>6</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2017</Year><Month>12</Month><Day>13</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2017</Year><Month>12</Month><Day>13</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2018</Year><Month>1</Month><Day>5</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2017</Year><Month>12</Month><Day>12</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">29232365</ArticleId><ArticleId IdType="pmc">PMC5726627</ArticleId><ArticleId IdType="doi">10.1371/journal.pone.0188377</ArticleId><ArticleId IdType="pii">PONE-D-16-51291</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>OECD. OECD Reviews of Health Care Quality. Italy 2014: Raising Standards. OECD Publishing; 2015.</Citation></Reference><Reference><Citation>Gini R, Schuemie MJ, Francesconi P, Lapi F, Cricelli I, Pasqua A, et al.
Can Italian Healthcare Administrative Databases Be Used to Compare Regions with Respect to Compliance with Standards of Care for Chronic Diseases?
PLoS ONE. 2014;9(5):e95419
doi: 10.1371/journal.pone.0095419
</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0095419</ArticleId><ArticleId IdType="pmc">PMC4015953</ArticleId><ArticleId IdType="pubmed">24816637</ArticleId></ArticleIdList></Reference><Reference><Citation>Gini R, Francesconi P, Mazzaglia G, Cricelli I, Pasqua A, Gallina P et al. Chronic disease prevalence from Italian administrative databases in the VALORE project: a validation through comparison of population estimates with general practice databases and national survey. BMC Public Health. 2013;13(1):15.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3551838</ArticleId><ArticleId IdType="pubmed">23297821</ArticleId></ArticleIdList></Reference><Reference><Citation>Gini R, Schuemie MJ, Mazzaglia G, Lapi F, Francesconi P, Pasqua A, et al.
Automatic identification of type 2 diabetes, hypertension, ischaemic heart disease, heart failure and their levels of severity from Italian General Practitioners&#x2019; electronic medical records: a validation study. BMJ Open. 2016. 
December;6(12):e012413
doi: 10.1136/bmjopen-2016-012413
</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmjopen-2016-012413</ArticleId><ArticleId IdType="pmc">PMC5168667</ArticleId><ArticleId IdType="pubmed">27940627</ArticleId></ArticleIdList></Reference><Reference><Citation>Gini R, Schuemie MJ, Pasqua A, Dazzi P, Carlini E, Coppola M et al. Identifying type 2 diabetes, hypertension and ischaemic heart disease from data sources with incomplete diagnostic information: a population-based validation study in Italian Administrative Databases. Chapter 3 in: Gini R. A Validation Odyssey: From big data to local intelligence. Erasmus University Rotterdam; 2016. Available from: hdl.handle.net/1765/93461.</Citation></Reference><Reference><Citation>Grading quality of evidence and strength of recommendations. BMJ. 2004;328(7454):1490
doi: 10.1136/bmj.328.7454.1490
</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.328.7454.1490</ArticleId><ArticleId IdType="pmc">PMC428525</ArticleId><ArticleId IdType="pubmed">15205295</ArticleId></ArticleIdList></Reference><Reference><Citation>Mazzaglia G, Ambrosioni E, Alacqua M, Filippi A, Sessa E, Immordino V, et al.
Adherence to Antihypertensive Medications and Cardiovascular Morbidity Among Newly Diagnosed Hypertensive Patients. Circulation. 2009;120(16):1598&#x2013;605. doi: 10.1161/CIRCULATIONAHA.108.830299
</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/CIRCULATIONAHA.108.830299</ArticleId><ArticleId IdType="pubmed">19805653</ArticleId></ArticleIdList></Reference><Reference><Citation>Sultana J, Italiano D, Spina E, Cricelli C, Lapi F, Pecchioli S, et al.
Changes in the prescribing pattern of antidepressant drugs in elderly patients: an Italian, nationwide, population-based study. Eur J Clin Pharmacol. 2014;70(4):469&#x2013;78. doi: 10.1007/s00228-013-1636-z
</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00228-013-1636-z</ArticleId><ArticleId IdType="pubmed">24425146</ArticleId></ArticleIdList></Reference><Reference><Citation>TheMatrix. The tool for easy observational health data management from CSV files. http://thematrix.isti.cnr.it/</Citation></Reference><Reference><Citation>Landis JR, Koch GG. The measurement of observer agreement for categorical data. Biometrics. 1977;33(1):159&#x2013;74.</Citation><ArticleIdList><ArticleId IdType="pubmed">843571</ArticleId></ArticleIdList></Reference><Reference><Citation>Sakshaug JW, Weir DR, Nicholas LH. Identifying diabetics in Medicare claims and survey data: implications for health services research. BMC Health Serv Res. 2014;14:150
doi: 10.1186/1472-6963-14-150
</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1472-6963-14-150</ArticleId><ArticleId IdType="pmc">PMC3975984</ArticleId><ArticleId IdType="pubmed">24693862</ArticleId></ArticleIdList></Reference><Reference><Citation>Hirsch AG, McAlearney AS. Measuring Diabetes Care Performance Using Electronic Health Record Data The Impact of Diabetes Definitions on Performance Measure Outcomes. American Journal of Medical Quality. 2013</Citation><ArticleIdList><ArticleId IdType="pubmed">24006028</ArticleId></ArticleIdList></Reference><Reference><Citation>Health Search. VIII Report Health Search. https://healthsearch.it/documenti/Archivio/Report/VIIIReport_2013-2014/VIII%20Report%20HS.pdf</Citation></Reference><Reference><Citation>Italian National Institute of Statistics. Condizioni di salute e ricorso ai servizi sanitari: informazioni sulla rilevazione. http://www.istat.it/it/archivio/7740</Citation></Reference><Reference><Citation>Chien AT, Eastman D, Li Z, Rosenthal MB. Impact of a pay for performance program to improve diabetes care in the safety net. Preventive Medicine. 2012;55, Supplement:S80&#x2013;5.</Citation><ArticleIdList><ArticleId IdType="pubmed">23046985</ArticleId></ArticleIdList></Reference><Reference><Citation>Visca M, Donatini A, Gini R, Federico B, Damiani G, Francesconi P, et al.
Group versus single handed primary care: a performance evaluation of the care delivered to chronic patients by Italian GPs. Health Policy. 2013;113(1&#x2013;2):188&#x2013;98. doi: 10.1016/j.healthpol.2013.05.016
</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.healthpol.2013.05.016</ArticleId><ArticleId IdType="pubmed">23800605</ArticleId></ArticleIdList></Reference><Reference><Citation>Barletta V, Profili F, Gini R, Grilli L, Rampichini C, Matarrese D, et al. Impact of Chronic Care Model on diabetes care in Tuscany: a controlled before-after study. Eur J Public Health. 2016. October.</Citation><ArticleIdList><ArticleId IdType="pubmed">28177456</ArticleId></ArticleIdList></Reference><Reference><Citation>McGovern MP, Boroujerdi MA, Taylor MW, Williams DJ, Hannaford PC, Lefevre KE, et al.
The effect of the UK incentive-based contract on the management of patients with coronary heart disease in primary care. Fam Pract. 2008. 
February
1;25(1):33&#x2013;9. doi: 10.1093/fampra/cmm073
</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/fampra/cmm073</ArticleId><ArticleId IdType="pubmed">18222938</ArticleId></ArticleIdList></Reference><Reference><Citation>NHS Digital. Business Rules for Quality and Outcomes Framework (QOF) 2016/17 Cardiovascular disease primary prevention (CVD-PP) http://content.digital.nhs.uk/media/23134/CVDPPv350/pdf/CVD_PP_v35.0.pdf (Accessed September 2017)</Citation></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">29295138</PMID><DateCompleted><Year>2018</Year><Month>06</Month><Day>05</Day></DateCompleted><DateRevised><Year>2018</Year><Month>12</Month><Day>02</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1879-8365</ISSN><JournalIssue CitedMedium="Internet"><Volume>245</Volume><PubDate><Year>2017</Year></PubDate></JournalIssue><Title>Studies in health technology and informatics</Title><ISOAbbreviation>Stud Health Technol Inform</ISOAbbreviation></Journal><ArticleTitle>Conversion of National Health Insurance Service-National Sample Cohort (NHIS-NSC) Database into Observational Medical Outcomes Partnership-Common Data Model (OMOP-CDM).</ArticleTitle><Pagination><StartPage>467</StartPage><EndPage>470</EndPage><MedlinePgn>467-470</MedlinePgn></Pagination><Abstract><AbstractText>It is increasingly necessary to generate medical evidence applicable to Asian people compared to those in Western countries. Observational Health Data Sciences a Informatics (OHDSI) is an international collaborative which aims to facilitate generating high-quality evidence via creating and applying open-source data analytic solutions to a large network of health databases across countries. We aimed to incorporate Korean nationwide cohort data into the OHDSI network by converting the national sample cohort into Observational Medical Outcomes Partnership-Common Data Model (OMOP-CDM). The data of 1.13 million subjects was converted to OMOP-CDM, resulting in average 99.1% conversion rate. The ACHILLES, open-source OMOP-CDM-based data profiling tool, was conducted on the converted database to visualize data-driven characterization and access the quality of data. The OMOP-CDM version of National Health Insurance Service-National Sample Cohort (NHIS-NSC) can be a valuable tool for multiple aspects of medical research by incorporation into the OHDSI research network.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>You</LastName><ForeName>Seng Chan</ForeName><Initials>SC</Initials><AffiliationInfo><Affiliation>Department of Biomedical Informatics, Ajou University School of Medicine, Suwon, Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lee</LastName><ForeName>Seongwon</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Center for Education Artificial Intelligence, Dankook University, Yongin, Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cho</LastName><ForeName>Soo-Yeon</ForeName><Initials>SY</Initials><AffiliationInfo><Affiliation>Department of Biomedical Informatics, Ajou University School of Medicine, Suwon, Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Park</LastName><ForeName>Hojun</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Department of Biomedical Informatics, Ajou University School of Medicine, Suwon, Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jung</LastName><ForeName>Sungjae</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Biomedical Informatics, Ajou University School of Medicine, Suwon, Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cho</LastName><ForeName>Jaehyeong</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Biomedical Informatics, Ajou University School of Medicine, Suwon, Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yoon</LastName><ForeName>Dukyong</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Department of Biomedical Informatics, Ajou University School of Medicine, Suwon, Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Park</LastName><ForeName>Rae Woong</ForeName><Initials>RW</Initials><AffiliationInfo><Affiliation>Department of Biomedical Informatics, Ajou University School of Medicine, Suwon, Korea.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>Netherlands</Country><MedlineTA>Stud Health Technol Inform</MedlineTA><NlmUniqueID>9214582</NlmUniqueID><ISSNLinking>0926-9630</ISSNLinking></MedlineJournalInfo><MeshHeadingList><MeshHeading><DescriptorName UI="D035843" MajorTopicYN="Y">Biomedical Research</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015331" MajorTopicYN="N">Cohort Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016208" MajorTopicYN="Y">Databases, Factual</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008490" MajorTopicYN="N">Medical Informatics</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009313" MajorTopicYN="Y">National Health Programs</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Database</Keyword><Keyword MajorTopicYN="N">Delivery of Health Care</Keyword><Keyword MajorTopicYN="N">Medical Informatics Application</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2018</Year><Month>1</Month><Day>4</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2018</Year><Month>1</Month><Day>4</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2018</Year><Month>6</Month><Day>6</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">29295138</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">29295227</PMID><DateCompleted><Year>2018</Year><Month>06</Month><Day>04</Day></DateCompleted><DateRevised><Year>2018</Year><Month>12</Month><Day>02</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1879-8365</ISSN><JournalIssue CitedMedium="Internet"><Volume>245</Volume><PubDate><Year>2017</Year></PubDate></JournalIssue><Title>Studies in health technology and informatics</Title><ISOAbbreviation>Stud Health Technol Inform</ISOAbbreviation></Journal><ArticleTitle>A Consensus-Based Approach for Harmonizing the OHDSI Common Data Model with HL7 FHIR.</ArticleTitle><Pagination><StartPage>887</StartPage><EndPage>891</EndPage><MedlinePgn>887-891</MedlinePgn></Pagination><Abstract><AbstractText>A variety of data models have been developed to provide a standardized data interface that supports organizing clinical research data into a standard structure for building the integrated data repositories. HL7 Fast Healthcare Interoperability Resources (FHIR) is emerging as a next generation standards framework for facilitating health care and electronic health records-based data exchange. The objective of the study was to design and assess a consensus-based approach for harmonizing the OHDSI CDM with HL7 FHIR. We leverage a FHIR W5 (Who, What, When, Where, and Why) Classification System for designing the harmonization approaches and assess their utility in achieving the consensus among curators using a standard inter-rater agreement measure. Moderate agreement was achieved for the model-level harmonization (kappa = 0.50) whereas only fair agreement was achieved for the property-level harmonization (kappa = 0.21). FHIR W5 is a useful tool in designing the harmonization approaches between data models and FHIR, and facilitating the consensus achievement.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Jiang</LastName><ForeName>Guoqian</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Department of Health Sciences Research, Mayo Clinic, Rochester, MN, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kiefer</LastName><ForeName>Richard C</ForeName><Initials>RC</Initials><AffiliationInfo><Affiliation>Department of Health Sciences Research, Mayo Clinic, Rochester, MN, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sharma</LastName><ForeName>Deepak K</ForeName><Initials>DK</Initials><AffiliationInfo><Affiliation>Department of Health Sciences Research, Mayo Clinic, Rochester, MN, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Prud'hommeaux</LastName><ForeName>Eric</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>W3C/MIT, Boston, MA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Solbrig</LastName><ForeName>Harold R</ForeName><Initials>HR</Initials><AffiliationInfo><Affiliation>Department of Health Sciences Research, Mayo Clinic, Rochester, MN, USA.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>R01 GM105688</GrantID><Acronym>GM</Acronym><Agency>NIGMS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>U01 CA180940</GrantID><Acronym>CA</Acronym><Agency>NCI NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>U01 HG009450</GrantID><Acronym>HG</Acronym><Agency>NHGRI NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>Netherlands</Country><MedlineTA>Stud Health Technol Inform</MedlineTA><NlmUniqueID>9214582</NlmUniqueID><ISSNLinking>0926-9630</ISSNLinking></MedlineJournalInfo><MeshHeadingList><MeshHeading><DescriptorName UI="D032921" MajorTopicYN="Y">Consensus</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D057286" MajorTopicYN="Y">Electronic Health Records</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Observational study</Keyword><Keyword MajorTopicYN="N">Reference standards</Keyword><Keyword MajorTopicYN="N">Vocabulary</Keyword><Keyword MajorTopicYN="N">controlled</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2018</Year><Month>1</Month><Day>4</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2018</Year><Month>1</Month><Day>4</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2018</Year><Month>6</Month><Day>5</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2018</Year><Month>5</Month><Day>8</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">29295227</ArticleId><ArticleId IdType="mid">NIHMS961581</ArticleId><ArticleId IdType="pmc">PMC5939955</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Huser V, Cimino JJ. Desiderata for healthcare integrated data repositories based on architectural comparison of three public repositories. AMIA Annual Symposium proceedings / AMIA Symposium AMIA Symposium. 2013;2013:648&#x2013;56. Epub 2014/02/20.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3900207</ArticleId><ArticleId IdType="pubmed">24551366</ArticleId></ArticleIdList></Reference><Reference><Citation>Wade TD, Zelarney PT, Hum RC, McGee S, Batson DH. Using patient lists to add value to integrated data repositories. Journal of biomedical informatics. 2014;52:72&#x2013;7. doi: 10.1016/j.jbi.2014.02.010. Epub 2014/02/19.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jbi.2014.02.010</ArticleId><ArticleId IdType="pmc">PMC4134416</ArticleId><ArticleId IdType="pubmed">24534444</ArticleId></ArticleIdList></Reference><Reference><Citation>MacKenzie SL, Wyatt MC, Schuff R, Tenenbaum JD, Anderson N. Practices and perspectives on building integrated data repositories: results from a 2010 CTSA survey. Journal of the American Medical Informatics Association : JAMIA. 2012;19(e1):e119&#x2013;24. doi: 10.1136/amiajnl-2011-000508. Epub 2012/03/23.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/amiajnl-2011-000508</ArticleId><ArticleId IdType="pmc">PMC3392848</ArticleId><ArticleId IdType="pubmed">22437072</ArticleId></ArticleIdList></Reference><Reference><Citation>The OMOP Common Data Model 2015. 2015 Sep 19; Available from:  http://omop.org/CDM.</Citation></Reference><Reference><Citation>OMOP Common Data Model V5.0.1 2016. 2016 Sep 19; Available from:  http://www.ohdsi.org/web/wiki/doku.php?id=documentation:cdm:single-page.</Citation></Reference><Reference><Citation>The PCORnet Common Data Model 2015. 2015 Sep 19; Available from:  http://www.pcornet.org/pcornet-common-data-model/</Citation></Reference><Reference><Citation>i2b2: Informatics for Integrating Biology and the Bedside 2015. 2015 Apr 16; Available from:  https://www.i2b2.org/</Citation></Reference><Reference><Citation>Klann JG, Murphy SN. Computing health quality measures using Informatics for Integrating Biology and the Bedside. Journal of medical Internet research. 2013;15(4):e75. doi: 10.2196/jmir.2493. Epub 2013/04/23.</Citation><ArticleIdList><ArticleId IdType="doi">10.2196/jmir.2493</ArticleId><ArticleId IdType="pmc">PMC3636801</ArticleId><ArticleId IdType="pubmed">23603227</ArticleId></ArticleIdList></Reference><Reference><Citation>Klann JG, Buck MD, Brown J, Hadley M, Elmore R, Weber GM, Murphy SN. Query Health: standards-based, cross-platform population health surveillance. Journal of the American Medical Informatics Association : JAMIA. 2014;21(4):650&#x2013;6. doi: 10.1136/amiajnl-2014-002707. Epub 2014/04/05.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/amiajnl-2014-002707</ArticleId><ArticleId IdType="pmc">PMC4078284</ArticleId><ArticleId IdType="pubmed">24699371</ArticleId></ArticleIdList></Reference><Reference><Citation>Weber GM, Murphy SN, McMurry AJ, Macfadden D, Nigrin DJ, Churchill S, Kohane IS. The Shared Health Research Information Network (SHRINE): a prototype federated query tool for clinical data repositories. Journal of the American Medical Informatics Association : JAMIA. 2009;16(5):624&#x2013;30. doi: 10.1197/jamia.M3191. Epub 2009/07/02.</Citation><ArticleIdList><ArticleId IdType="doi">10.1197/jamia.M3191</ArticleId><ArticleId IdType="pmc">PMC2744712</ArticleId><ArticleId IdType="pubmed">19567788</ArticleId></ArticleIdList></Reference><Reference><Citation>Daugherty SE, Wahba S, Fleurence R. Patient-powered research networks: building capacity for conducting patient-centered clinical outcomes research. Journal of the American Medical Informatics Association : JAMIA. 2014;21(4):583&#x2013;6. doi: 10.1136/amiajnl-2014-002758. Epub 2014/05/14.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/amiajnl-2014-002758</ArticleId><ArticleId IdType="pmc">PMC4078295</ArticleId><ArticleId IdType="pubmed">24821741</ArticleId></ArticleIdList></Reference><Reference><Citation>Athey BD, Braxenthaler M, Haas M, Guo Y. tranSMART: An Open Source and Community-Driven Informatics and Data Sharing Platform for Clinical and Translational Research. AMIA Joint Summits on Translational Science proceedings AMIA Summit on Translational Science. 2013;2013:6&#x2013;8. Epub 2013/12/05.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3814495</ArticleId><ArticleId IdType="pubmed">24303286</ArticleId></ArticleIdList></Reference><Reference><Citation>Scheufele E, Aronzon D, Coopersmith R, McDuffie MT, Kapoor M, Uhrich CA, Avitabile JE, Liu J, Housman D, Palchuk MB. tranSMART: An Open Source Knowledge Management and High Content Data Analytics Platform. AMIA Joint Summits on Translational Science proceedings AMIA Summit on Translational Science. 2014;2014:96&#x2013;101. Epub 2015/02/27.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4333702</ArticleId><ArticleId IdType="pubmed">25717408</ArticleId></ArticleIdList></Reference><Reference><Citation>Novak AJ, Asmann YW, Maurer MJ, Wang C, Slager SL, Hodge LS, Manske M, Price-Troska T, Yang ZZ, Zimmermann MT, Nowakowski GS, Ansell SM, Witzig TE, McPhail E, Ketterling R, Feldman AL, Dogan A, Link BK, Habermann TM, Cerhan JR. Whole-exome analysis reveals novel somatic genomic alterations associated with outcome in immunochemotherapy-treated diffuse large B-cell lymphoma. Blood Cancer J. 2015;5:e346. doi: 10.1038/bcj.2015.69. Epub 2015/09/01.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/bcj.2015.69</ArticleId><ArticleId IdType="pmc">PMC4558593</ArticleId><ArticleId IdType="pubmed">26314988</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang W, Wang C, Dawson DB, Thorland EC, Lundquist PA, Eckloff BW, Wu Y, Baheti S, Evans JM, Scherer SS, Dyck PJ, Klein CJ. Target-enrichment sequencing and copy number evaluation in inherited polyneuropathy. Neurology. 2016;86(19):1762&#x2013;71. doi: 10.1212/WNL.0000000000002659. Epub 2016/05/11.</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/WNL.0000000000002659</ArticleId><ArticleId IdType="pmc">PMC4862246</ArticleId><ArticleId IdType="pubmed">27164712</ArticleId></ArticleIdList></Reference><Reference><Citation>FHIR W5 Report 2016. 2016 Sep 19; Available from:  https://www.hl7.org/fhir/w5.html.</Citation></Reference><Reference><Citation>FHIR Record Lifecycle Events Implementation Guide 2016. 2016 Sep 19; Available from:  http://hl7.org/fhir/2016Sep/ehrsrle/ehrsrle.html.</Citation></Reference><Reference><Citation>Coyle JF, Mori AR, Huff SM. Standards for detailed clinical models as the basis for medical data exchange and decision support. International journal of medical informatics. 2003;69(2-3):157&#x2013;74. Epub 2003/06/18.</Citation><ArticleIdList><ArticleId IdType="pubmed">12810120</ArticleId></ArticleIdList></Reference><Reference><Citation>Jiang G, Evans J, Oniki TA, Coyle JF, Bain L, Huff SM, Kush RD, Chute CG. Harmonization of detailed clinical models with clinical study data standards. Methods of information in medicine. 2015;54(1):65&#x2013;74. doi: 10.3414/ME13-02-0019. Epub 2014/11/27.</Citation><ArticleIdList><ArticleId IdType="doi">10.3414/ME13-02-0019</ArticleId><ArticleId IdType="pubmed">25426730</ArticleId></ArticleIdList></Reference><Reference><Citation>Gamazon ER, Stranger BE. The impact of human copy number variation on gene expression. Brief Funct Genomics. 2015;14(5):352&#x2013;7. doi: 10.1093/bfgp/elv017. Epub 2015/04/30.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/bfgp/elv017</ArticleId><ArticleId IdType="pmc">PMC4592354</ArticleId><ArticleId IdType="pubmed">25922366</ArticleId></ArticleIdList></Reference><Reference><Citation>Fleiss' kappa 2016. 2016 Sep 22; Available from:  https://en.wikipedia.org/wiki/Fleiss'_kappa.</Citation></Reference><Reference><Citation>Hripcsak G, Ryan PB, Duke JD, Shah NH, Park RW, Huser V, Suchard MA, Schuemie MJ, DeFalco FJ, Perotte A, Banda JM, Reich CG, Schilling LM, Matheny ME, Meeker D, Pratt N, Madigan D. Characterizing treatment pathways at scale using the OHDSI network. Proc Natl Acad Sci U S A. 2016;113(27):7329&#x2013;36. doi: 10.1073/pnas.1510502113.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1510502113</ArticleId><ArticleId IdType="pmc">PMC4941483</ArticleId><ArticleId IdType="pubmed">27274072</ArticleId></ArticleIdList></Reference><Reference><Citation>OHDSI Vocabulary CDM 2016. 2016 Dec 15; Available from:  http://www.ohdsi.org/web/wiki/doku.php?id=documentation:cdm:standardized_vocabularies.</Citation></Reference><Reference><Citation>OHDSI Vocabulary Services 2016. 2016 Dec 15; Available from:  http://athena.ohdsi.org/</Citation></Reference><Reference><Citation>Choi M, Starr R, Braunstein M, Duke JD. OHDSI on FHIR platform development with OMOP CDM mapping to FHIR resources 2016. 2016 Dec 15; Available from:  http://www.ohdsi.org/web/wiki/lib/exe/fetch.php?media=resources:ohdsionfhir_gatech.pdf.</Citation></Reference><Reference><Citation>DAF-Research Profile List and Mappings from FHIR to PCORnet CDM and OMOP CDM 2017. 2017 Apr 6; Available from:  http://hl7.org/fhir/us/daf-research/2017Jan/daf-research-profile.html.</Citation></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">29295240</PMID><DateCompleted><Year>2018</Year><Month>06</Month><Day>04</Day></DateCompleted><DateRevised><Year>2018</Year><Month>12</Month><Day>02</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1879-8365</ISSN><JournalIssue CitedMedium="Internet"><Volume>245</Volume><PubDate><Year>2017</Year></PubDate></JournalIssue><Title>Studies in health technology and informatics</Title><ISOAbbreviation>Stud Health Technol Inform</ISOAbbreviation></Journal><ArticleTitle>An OMOP CDM-Based Relational Database of Clinical Research Eligibility Criteria.</ArticleTitle><Pagination><StartPage>950</StartPage><EndPage>954</EndPage><MedlinePgn>950-954</MedlinePgn></Pagination><Abstract><AbstractText>Eligibility criteria are important for clinical research protocols or clinical practice guidelines for determining who qualify for studies and to whom clinical evidence is applicable, but the free-text format is not amenable for computational processing. In this paper, we described a practical method for transforming free-text clinical research eligibility criteria of Alzheimer's clinical trials into a structured relational database compliant with standards for medical terminologies and clinical data models. We utilized a hybrid natural language processing system and a concept normalization tool to extract medical terms in clinical research eligibility criteria and represent them using the OMOP Common Data Model (CDM) v5. We created a database schema design to store syntactic relations to facilitate efficient cohort queries. We further discussed the potential of applying this method to trials on other diseases and the promise of using it to accelerate clinical research with electronic health records.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Si</LastName><ForeName>Yuqi</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Department of Biomedical Informatics, Columbia University, New York, NY, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Weng</LastName><ForeName>Chunhua</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Department of Biomedical Informatics, Columbia University, New York, NY, USA.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>R01 LM009886</GrantID><Acronym>LM</Acronym><Agency>NLM NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>Netherlands</Country><MedlineTA>Stud Health Technol Inform</MedlineTA><NlmUniqueID>9214582</NlmUniqueID><ISSNLinking>0926-9630</ISSNLinking></MedlineJournalInfo><MeshHeadingList><MeshHeading><DescriptorName UI="D015331" MajorTopicYN="N">Cohort Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016208" MajorTopicYN="Y">Databases, Factual</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D057286" MajorTopicYN="Y">Electronic Health Records</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009323" MajorTopicYN="Y">Natural Language Processing</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012015" MajorTopicYN="N">Reference Standards</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Clinical Research Informatics</Keyword><Keyword MajorTopicYN="N">Electronic Health Record</Keyword><Keyword MajorTopicYN="N">Relational Data Management</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2018</Year><Month>1</Month><Day>4</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2018</Year><Month>1</Month><Day>4</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2018</Year><Month>6</Month><Day>5</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2018</Year><Month>4</Month><Day>10</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">29295240</ArticleId><ArticleId IdType="mid">NIHMS955981</ArticleId><ArticleId IdType="pmc">PMC5893219</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Wu DT, Hanauer DA, Mei Q, Clark PM, An LC, Proulx J, Zeng QT, Vydiswaran VV, Collins-Thompson K, Zheng K. Assessing the readability of ClinicalTrials.gov. Journal of the American Medical Informatics Association. 2016 Mar 1;23(2):269&#x2013;75.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5009924</ArticleId><ArticleId IdType="pubmed">26269536</ArticleId></ArticleIdList></Reference><Reference><Citation>Tu SW, Peleg M, Carini S, Bobak M, Ross J, Rubin D, Sim I. A practical method for transforming free-text eligibility criteria into computable criteria. Journal of biomedical informatics. 2011 Apr 30;44(2):239&#x2013;50.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3129371</ArticleId><ArticleId IdType="pubmed">20851207</ArticleId></ArticleIdList></Reference><Reference><Citation>Levy-Fix G, Yaman A, Weng C. Proceedings of 2015 AMIA Joint Summits for Translational Science. San Francisco: 2015. Structuring Clinical Trial Eligibility Criteria with Common Data Model; pp. 194&#x2013;198.</Citation></Reference><Reference><Citation>Hripcsaka G, Dukeb JD, Shahc NH, Reichd CG, Husere V, Schuemief MJ, Suchardh MA, Parki RW, Wongf IC, Rijnbeekj PR. Observational Health Data Sciences and Informatics (OHDSI): Opportunities for Observational Researchers. Studies in health technology and informatics. 2015;216:574.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4815923</ArticleId><ArticleId IdType="pubmed">26262116</ArticleId></ArticleIdList></Reference><Reference><Citation>CLAMP: Clinical Language Annotation, Modeling and Processing Toolkit.  Available at  http://clamp.uth.edu. Accessd Nov 2016.</Citation></Reference><Reference><Citation>Kang T, Zhang S, Tang Y, Hruby GW, Rusanov A, Elhadad N, Weng C. EliIE: An open-source information extraction system for clinical trial eligibility criteria. Journal of the American Medical Informatics Association. 2017 Apr 1; doi: 10.1093/jamia/ocx019.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/jamia/ocx019</ArticleId><ArticleId IdType="pmc">PMC6259668</ArticleId><ArticleId IdType="pubmed">28379377</ArticleId></ArticleIdList></Reference><Reference><Citation>Usagi, an application to help create mappings between coding systems and the Vocabulary standard concepts.  Available at  https://github.com/OHDSI/usagi. Accessed Nov 2016.</Citation></Reference><Reference><Citation>Chang CC, Lin CJ. LIBSVM: a library for support vector machines. ACM Transactions on Intelligent Systems and Technology (TIST) 2011 Apr 1;2(3):27.</Citation></Reference><Reference><Citation>Django.  Available at  https://www.djangoproject.com/. Accessed Nov 2016.</Citation></Reference><Reference><Citation>RESTful Web services.  Available at  http://www.restapitutorial.com/. Accessed Dec 2016.</Citation></Reference><Reference><Citation>ClinicalTrial.gov.   http://www.clinicaltrials.gov/. Accessed Dec 2016.</Citation></Reference><Reference><Citation>Boland MR, Tu SW, Carini S, Sim I, Weng C. EliXR-TIME: a temporal knowledge representation for clinical research eligibility criteria. AMIA Summits Transl Sci Proc. 2012;2012:71&#x2013;80.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3392056</ArticleId><ArticleId IdType="pubmed">22779055</ArticleId></ArticleIdList></Reference><Reference><Citation>Hao T, Liu H, Weng C. Valx: a system for extracting and structuring numeric lab test comparison statements from text. Methods of information in medicine. 2016;55(3):266&#x2013;75.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5573874</ArticleId><ArticleId IdType="pubmed">26940748</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">29295408</PMID><DateCompleted><Year>2018</Year><Month>06</Month><Day>05</Day></DateCompleted><DateRevised><Year>2018</Year><Month>12</Month><Day>02</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1879-8365</ISSN><JournalIssue CitedMedium="Internet"><Volume>245</Volume><PubDate><Year>2017</Year></PubDate></JournalIssue><Title>Studies in health technology and informatics</Title><ISOAbbreviation>Stud Health Technol Inform</ISOAbbreviation></Journal><ArticleTitle>Building Interoperable FHIR-Based Vocabulary Mapping Services: A Case Study of OHDSI Vocabularies and Mappings.</ArticleTitle><Pagination><StartPage>1327</StartPage><MedlinePgn>1327</MedlinePgn></Pagination><Abstract><AbstractText>The OHDSI Common Data Model (CDM) is a deep information model, in which its vocabulary component plays a critical role in enabling consistent coding and query of clinical data. The objective of the study is to create methods and tools to expose the OHDSI vocabularies and mappings as the vocabulary mapping services using two HL7 FHIR core terminology resources ConceptMap and ValueSet. We discuss the benefits and challenges in building the FHIR-based terminology services.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Jiang</LastName><ForeName>Guoqian</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Department of Health Sciences Research, Mayo Clinic, Rochester, MN, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kiefer</LastName><ForeName>Richard</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>W3C/MIT, Boston, MA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Prud'hommeaux</LastName><ForeName>Eric</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>W3C/MIT, Boston, MA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Solbrig</LastName><ForeName>Harold R</ForeName><Initials>HR</Initials><AffiliationInfo><Affiliation>W3C/MIT, Boston, MA, USA.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>R01 GM105688</GrantID><Acronym>GM</Acronym><Agency>NIGMS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>U01 CA180940</GrantID><Acronym>CA</Acronym><Agency>NCI NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>U01 HG009450</GrantID><Acronym>HG</Acronym><Agency>NHGRI NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>Netherlands</Country><MedlineTA>Stud Health Technol Inform</MedlineTA><NlmUniqueID>9214582</NlmUniqueID><ISSNLinking>0926-9630</ISSNLinking></MedlineJournalInfo><MeshHeadingList><MeshHeading><DescriptorName UI="D057286" MajorTopicYN="Y">Electronic Health Records</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014825" MajorTopicYN="N">Vocabulary</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018875" MajorTopicYN="Y">Vocabulary, Controlled</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Controlled</Keyword><Keyword MajorTopicYN="N">Observational Study</Keyword><Keyword MajorTopicYN="N">Reference Standards</Keyword><Keyword MajorTopicYN="N">Vocabulary</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2018</Year><Month>1</Month><Day>4</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2018</Year><Month>1</Month><Day>4</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2018</Year><Month>6</Month><Day>6</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2018</Year><Month>5</Month><Day>8</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">29295408</ArticleId><ArticleId IdType="mid">NIHMS961862</ArticleId><ArticleId IdType="pmc">PMC5939959</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Hripcsak G, et al. Characterizing treatment pathways at scale using the OHDSI network. Proc Natl Acad Sci U S A. 2016 Jul 5;113(27):7329&#x2013;36.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4941483</ArticleId><ArticleId IdType="pubmed">27274072</ArticleId></ArticleIdList></Reference><Reference><Citation>HL7 FHIR.   http://hl7.org/fhir/2016Sep/index.html. Last visited at November 24, 2016.</Citation></Reference><Reference><Citation>OMOP CDM V5.0.1.   http://www.ohdsi.org/web/wiki/doku.php?id=documentation:cdm:single-page. Last visited at November 24, 2016.</Citation></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">29755826</PMID><DateRevised><Year>2023</Year><Month>11</Month><Day>12</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Print">2154-817X</ISSN><JournalIssue CitedMedium="Print"><Volume>2017</Volume><PubDate><Year>2017</Year><Month>Aug</Month></PubDate></JournalIssue><Title>KDD : proceedings. International Conference on Knowledge Discovery &amp; Data Mining</Title><ISOAbbreviation>KDD</ISOAbbreviation></Journal><ArticleTitle>Pharmacovigilance via Baseline Regularization with Large-Scale Longitudinal Observational Data.</ArticleTitle><Pagination><StartPage>1537</StartPage><EndPage>1546</EndPage><MedlinePgn>1537-1546</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1145/3097983.3097998</ELocationID><Abstract><AbstractText>Several prominent public health hazards [29] that occurred at the beginning of this century due to adverse drug events (ADEs) have raised international awareness of governments and industries about pharmacovigilance (PhV) [6,7], the science and activities to monitor and prevent adverse events caused by pharmaceutical products after they are introduced to the market. A major data source for PhV is large-scale longitudinal observational databases (LODs) [6] such as electronic health records (EHRs) and medical insurance claim databases. Inspired by the Self-Controlled Case Series (SCCS) model [27], arguably the leading method for ADE discovery from LODs, we propose baseline regularization, a regularized generalized linear model that leverages the diverse health profiles available in LODs across different <i>individuals</i> at different <i>times</i>. We apply the proposed method as well as SCCS to the Marshfield Clinic EHR. Experimental results suggest that the proposed method outperforms SCCS under various settings in identifying <i>benchmark</i> ADEs from the Observational Medical Outcomes Partnership ground truth [26].</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Kuang</LastName><ForeName>Zhaobin</ForeName><Initials>Z</Initials><AffiliationInfo><Affiliation>University of Wisconsin-Madison.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Peissig</LastName><ForeName>Peggy</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Marshfield Clinic.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Costa</LastName><ForeName>V&#xed;tor Santos</ForeName><Initials>VS</Initials><AffiliationInfo><Affiliation>Universidade do Porto.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Maclin</LastName><ForeName>Richard</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>University of Minnesota-Duluth.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Page</LastName><ForeName>David</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>University of Wisconsin-Madison.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>R01 GM097618</GrantID><Acronym>GM</Acronym><Agency>NIGMS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>U54 AI117924</GrantID><Acronym>AI</Acronym><Agency>NIAID NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>KDD</MedlineTA><NlmUniqueID>101523327</NlmUniqueID><ISSNLinking>2154-817X</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Adverse Drug Event Discovery</Keyword><Keyword MajorTopicYN="N">Baseline Regularization</Keyword><Keyword MajorTopicYN="N">Electronic Health Records</Keyword><Keyword MajorTopicYN="N">Longitudinal Data</Keyword><Keyword MajorTopicYN="N">Pharmacovigilance</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2018</Year><Month>5</Month><Day>15</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2018</Year><Month>5</Month><Day>15</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2018</Year><Month>5</Month><Day>15</Day><Hour>6</Hour><Minute>1</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2018</Year><Month>5</Month><Day>10</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">29755826</ArticleId><ArticleId IdType="mid">NIHMS879005</ArticleId><ArticleId IdType="pmc">PMC5945223</ArticleId><ArticleId IdType="doi">10.1145/3097983.3097998</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Laurent Condat. A direct algorithm for 1D total variation denoising. IEEE Signal Processing Letters. 2013;20(11):1054&#x2013;1057. 2013.</Citation></Reference><Reference><Citation>Davies P Laurie, Kovac Arne. Local extremes, runs, strings and multiresolution. Annals of Statistics. 2001;2001:1&#x2013;48.</Citation></Reference><Reference><Citation>Findlay Steven. Health policy briefs: The FDA&#x2019;s sentinel initiative. Health Affiaris. 2015 2015.</Citation></Reference><Reference><Citation>Friedman Jerome, Hastie Trevor, Tibshirani Rob. Regularization paths for generalized linear models via coordinate descent. Journal of statistical software. 2010;33(1):1. 2010.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2929880</ArticleId><ArticleId IdType="pubmed">20808728</ArticleId></ArticleIdList></Reference><Reference><Citation>Goodfellow Ian, Bengio Yoshua, Courville Aaron.  Deep learning. MIT Press; 2016.   http://www.deeplearningbook.org.</Citation></Reference><Reference><Citation>Harpaz Rave, DuMochel William, Shah Nigam H. Big data and adverse drug reaction detection. Clinical Pharmacology &amp; Therapeutics. 2015 2015.</Citation><ArticleIdList><ArticleId IdType="pubmed">26575203</ArticleId></ArticleIdList></Reference><Reference><Citation>Harpaz Rave, DuMouchel William, Shah Nigam H, Madigan David, Ryan Patrick, Friedman Carol. Novel data-mining methodologies for adverse drug event discovery and analysis. Clinical Pharmacology &amp; Therapeutics. 2012;91(6):1010&#x2013;1021. 2012.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3675775</ArticleId><ArticleId IdType="pubmed">22549283</ArticleId></ArticleIdList></Reference><Reference><Citation>Hastie Trevor, Tibshirani Robert, Wainwright Martin. Statistical learning with sparsity: the lasso and generalizations. CRC Press; 2015.</Citation></Reference><Reference><Citation>Hripcsak George, Duke Jon D, Shah Nigam H, Reich Christian G, Huser Vojtech, Schuemie Martijn J, Suchard Marc A, Park Rae Woong, Wong Ian Chi Kei, Rijnbeek Peter R, et al. Observational Health Data Sciences and Informatics (OHDSI): opportunities for observational researchers. Studies in Health Technology and Informatics. 2015;216(2015):574.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4815923</ArticleId><ArticleId IdType="pubmed">26262116</ArticleId></ArticleIdList></Reference><Reference><Citation>Johnson Nicholas A. A dynamic programming algorithm for the fused lasso and 10-segmentation. Journal of Computational and Graphical Statistics. 2013;22(2):246&#x2013;260. 2013.</Citation></Reference><Reference><Citation>Kuang Zhaobin, Thomson James, Caldwell Michael, Peissig Peggy, Stewart Ron, Page David. Baseline regularization for computational drug repositioning with longitudinal observational data. Proceedings of the Twenty-Fifth International Joint Conference on Artificial Intelligence (IJCAI-16) 2016:2521&#x2013;2528.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5382966</ArticleId><ArticleId IdType="pubmed">28392671</ArticleId></ArticleIdList></Reference><Reference><Citation>Madigan David, Raghavan Nandini, Dumouchel William, Nason Martha, Posse Christian, Ridgeway Greg. Likelihood-based data squashing: A modeling approach to instance construction. Data Mining and Knowledge Discovery. 2002;6(2):173&#x2013;190. 2002.</Citation></Reference><Reference><Citation>Madigan David, Schuemie Martijn J, Ryan Patrick B. Empirical performance of the case-control method: lessons for developing a risk identification and analysis system. Drug Safety. 2013;36(1):73&#x2013;82. 2013.</Citation><ArticleIdList><ArticleId IdType="pubmed">24166225</ArticleId></ArticleIdList></Reference><Reference><Citation>Mitchell Tom M. Machine learning. 1. MGH; 1997.</Citation></Reference><Reference><Citation>Murphy Kevin P. Machine learning: a probabilistic perspective. MIT press; 2012.</Citation></Reference><Reference><Citation>Nesterov Yu. Efficiency of coordinate descent methods on huge-scale optimization problems. SIAM Journal on Optimization. 2012;22(2):341&#x2013;362. 2012.</Citation></Reference><Reference><Citation>Nor&#xe9;n G Niklas, Bergvall Tomas, Ryan Patrick B, Juhlin Kristina, Schuemie Martijn J, Madigan David. Empirical performance of the calibrated self-controlled cohort analysis within temporal pattern discovery: lessons for developing a risk identification and analysis system. Drug Safety. 2013;36(1):107&#x2013;121. 2013.</Citation><ArticleIdList><ArticleId IdType="pubmed">24166228</ArticleId></ArticleIdList></Reference><Reference><Citation>Pena Javier, Tibshirani Ryan. Lecture notes in machine learning 10-725/statistics 36-725-convex optimization (fall 2016) 2016 2016.</Citation></Reference><Reference><Citation>Powell Valerie, Din Franklin M, Acharya Amit, Torres-Urquidy Miguel Humberto. Integration of medical and dental care and patient data. Vol. 3. Springer Science &amp; Business Media; 2012.</Citation></Reference><Reference><Citation>Ramdas Aaditya, Tibshirani Ryan J. Fast and flexible admm algorithms for trend filtering. Journal of Computational and Graphical Statistics. 2015 just-accepted 2015.</Citation></Reference><Reference><Citation>Robb Melissa A, Racoosin Judith A, Sherman Rachel E, Gross Thomas P, Ball Robert, Reichman Marsha E, Midthun Karen, Woodcock Janet. The US Food and Drug Administration&#x2019;s sentinel initiative: expanding the horizons of medical product safety. Pharmacoepidemiology and Drug Safety. 2012;21(S1):9&#x2013;11. 2012.</Citation><ArticleIdList><ArticleId IdType="pubmed">22262587</ArticleId></ArticleIdList></Reference><Reference><Citation>Ryan Patrick B, Madigan David, Stang Paul E, Overhage J Marc, Racoosin Judith A, Hartzema Abraham G. Empirical assessment of methods for risk identification in healthcare data: results from the experiments of the Observational Medical Outcomes Partnership. Statistics in Medicine. 2012;31(30):4401&#x2013;4415. 2012.</Citation><ArticleIdList><ArticleId IdType="pubmed">23015364</ArticleId></ArticleIdList></Reference><Reference><Citation>Ryan Patrick B, Schuemie Martijn J, Gruber Susan, Zorych Ivan, Madigan David. Empirical performance of a new user cohort method: lessons for developing a risk identification and analysis system. Drug Safety. 2013;36(1):59&#x2013;72. 2013.</Citation><ArticleIdList><ArticleId IdType="pubmed">24166224</ArticleId></ArticleIdList></Reference><Reference><Citation>Ryan Patrick B, Schuemie Martijn J, Madigan David. Empirical performance of a self-controlled cohort method: lessons for developing a risk identification and analysis system. Drug Safety. 2013;36(1):95&#x2013;106. 2013.</Citation><ArticleIdList><ArticleId IdType="pubmed">24166227</ArticleId></ArticleIdList></Reference><Reference><Citation>Schuemie Martijn J, Madigan David, Ryan Patrick B. Empirical performance of LGPS and LEOPARD: lessons for developing a risk identification and analysis system. Drug Safety. 2013;36(1):133&#x2013;142. 2013.</Citation><ArticleIdList><ArticleId IdType="pubmed">24166230</ArticleId></ArticleIdList></Reference><Reference><Citation>Simpson Shawn E. Self-controlled methods for postmarketing drug safety surveillance in large-scale longitudinal data. Columbia University; 2011.</Citation></Reference><Reference><Citation>Simpson Shawn E, Madigan David, Zorych Ivan, Schuemie Martijn J, Ryan Patrick B, Suchard Marc A. Multiple self-controlled case series for largescale longitudinal observational databases. Biometrics. 2013;69(4):893&#x2013;902. 2013.</Citation><ArticleIdList><ArticleId IdType="pubmed">24117144</ArticleId></ArticleIdList></Reference><Reference><Citation>Sra Suvrit, Nowozin Sebastian, Wright Stephen J. Optimization for machine learning. Mit Press; 2012.</Citation></Reference><Reference><Citation>Suchard Marc A, Simpson Shawn E, Zorych Ivan, Ryan Patrick, Madigan David. Massive parallelization of serial inference algorithms for a complex generalized linear model. ACM Transactions on Modeling and Computer Simulation (TOMACS) 2013;23(1):10. 2013.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4201181</ArticleId><ArticleId IdType="pubmed">25328363</ArticleId></ArticleIdList></Reference><Reference><Citation>Suchard Marc A, Zorych Ivan, Simpson Shawn E, Schuemie Martijn J, Ryan Patrick B, Madigan David. Empirical performance of the self-controlled case series design: lessons for developing a risk identification and analysis system. Drug Safety. 2013;36(1):83&#x2013;93. 2013.</Citation><ArticleIdList><ArticleId IdType="pubmed">24166226</ArticleId></ArticleIdList></Reference><Reference><Citation>Tibshirani Robert, Saunders Michael, Rosset Saharon, Zhu Ji, Knight Keith. Sparsity and smoothness via the fused lasso. Journal of the Royal Statistical Society: Series B (Statistical Methodology) 2005;67(1):91&#x2013;108. 2005.</Citation></Reference><Reference><Citation>Tseng Paul. Convergence of a block coordinate descent method for nondifferentiable minimization. Journal of optimization theory and applications. 2001;109(3):475&#x2013;494. 2001.</Citation></Reference><Reference><Citation>Wright Stephen J. Coordinate descent algorithms. Mathematical Programming. 2015;151(1):3&#x2013;34. 2015.</Citation></Reference><Reference><Citation>Xu Stanley, Zeng Chan, Newcomer Sophia, Nelson Jennifer, Glanz Jason. Use of fixed effects models to analyze self-controlled case series data in vaccine safety studies. Journal of Biometrics &amp; Biostatistics. 2012;2012:006.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3976179</ArticleId><ArticleId IdType="pubmed">24707443</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhao Tuo, Yu Mo, Wang Yiming, Arora Raman, Liu Han. Accelerated mini-batch randomized block coordinate descent method. Advances in Neural Information Processing Systems. 2014:3329&#x2013;3337.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4303186</ArticleId><ArticleId IdType="pubmed">25620860</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">29854108</PMID><DateCompleted><Year>2019</Year><Month>03</Month><Day>04</Day></DateCompleted><DateRevised><Year>2019</Year><Month>03</Month><Day>04</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Electronic">1942-597X</ISSN><JournalIssue CitedMedium="Internet"><Volume>2017</Volume><PubDate><Year>2017</Year></PubDate></JournalIssue><Title>AMIA ... Annual Symposium proceedings. AMIA Symposium</Title><ISOAbbreviation>AMIA Annu Symp Proc</ISOAbbreviation></Journal><ArticleTitle>Improving the 'Fitness for Purpose' of Common Data Models through Realism Based Ontology.</ArticleTitle><Pagination><StartPage>440</StartPage><EndPage>447</EndPage><MedlinePgn>440-447</MedlinePgn></Pagination><Abstract><AbstractText>Common data models are designed and built based on requirements that are aimed towards fitness for purpose. But when common data models are used as lenses through which reality is observed from the perspective according to which they are built, then they exhibit restrictions that distort such view. Realism-based ontology design, when done properly, does not have these limitations as its fitness for purpose is only determined by the degree to which reality is represented the way it is. Therefore, we can use the principles that realism-based ontologies adhere to, not only to design application ontologies serving some specific purpose, but also to assess whether and where common data models fall short in their representational adequacy and how they can be corrected. If a realism based ontological perspective on the portion of reality the some common data model is trying to represent is compared with the perspective of the common data model itself, it is possible to determine how the latter deviates from the former and to suggest solutions to correct the misrepresentations found. Applying this method to the common data model of the Observational Medical Outcomes Partnership, revealed two major categories of errors: one where relationships are restricted based on the constraints of the data model, and one where the representation of reality is oversimplified.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Blaisure</LastName><ForeName>Jonathan C</ForeName><Initials>JC</Initials><AffiliationInfo><Affiliation>Institute for Healthcare Informatics, University at Buffalo, Buffalo, New York, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Biomedical Informatics, University at Buffalo, Buffalo, New York, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ceusters</LastName><ForeName>Werner M</ForeName><Initials>WM</Initials><AffiliationInfo><Affiliation>Institute for Healthcare Informatics, University at Buffalo, Buffalo, New York, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Biomedical Informatics, University at Buffalo, Buffalo, New York, USA.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>UL1 TR001412</GrantID><Acronym>TR</Acronym><Agency>NCATS NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D052061">Research Support, N.I.H., Extramural</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2018</Year><Month>04</Month><Day>16</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>AMIA Annu Symp Proc</MedlineTA><NlmUniqueID>101209213</NlmUniqueID><ISSNLinking>1559-4076</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000077558" MajorTopicYN="N">Big Data</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D064229" MajorTopicYN="Y">Biological Ontologies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D065709" MajorTopicYN="Y">Common Data Elements</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016208" MajorTopicYN="Y">Databases, Factual</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D057286" MajorTopicYN="N">Electronic Health Records</DescriptorName><QualifierName UI="Q000458" MajorTopicYN="Y">organization &amp; administration</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016247" MajorTopicYN="N">Information Storage and Retrieval</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2018</Year><Month>6</Month><Day>2</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2018</Year><Month>6</Month><Day>2</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2019</Year><Month>3</Month><Day>5</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2018</Year><Month>4</Month><Day>16</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">29854108</ArticleId><ArticleId IdType="pmc">PMC5977618</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Ceusters W, Chiun Yu Hsu, Smith B. Clinical Data Wrangling using Ontological Realism and Referent Tracking. CEUR Workshop Proceedings. 2014;1237:27&#x2013;32.</Citation></Reference><Reference><Citation>Smith B, Ceusters W. Ontological realism: A methodology for coordinated evolution of scientific ontologies. Appl Ontol. 2010;5(3-4):139&#x2013;88.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3104413</ArticleId><ArticleId IdType="pubmed">21637730</ArticleId></ArticleIdList></Reference><Reference><Citation>Kohane IS, Churchill SE, Murphy SN. A translational engine at the national scale: Informatics for integrating biology and the bedside. Journal of the American Medical Informatics Association. 2012;19(2):181&#x2013;5.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3277623</ArticleId><ArticleId IdType="pubmed">22081225</ArticleId></ArticleIdList></Reference><Reference><Citation>FitzHenry F, Resnic FS, Robbins SL, Denton J, Nookala L, Meeker D, et al. Creating a Common Data Model for Comparative Effectiveness with the Observational Medical Outcomes Partnership. Appl Clin Inform. 2015;6(3):536&#x2013;47.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4586341</ArticleId><ArticleId IdType="pubmed">26448797</ArticleId></ArticleIdList></Reference><Reference><Citation>Califf RM. The Patient-Centered Outcomes Research Network: a national infrastructure for comparative effectiveness research. N C Med J. 2014;75(3):204&#x2013;10.</Citation><ArticleIdList><ArticleId IdType="pubmed">24830497</ArticleId></ArticleIdList></Reference><Reference><Citation>Ross TR, Ng D, Brown JS, Pardee R, Hornbrook MC, Hart G, et al. The HMO Research Network Virtual Data Warehouse: A Public Data Model to Support Collaboration. EGEMS (Washington DC) 2014;2(1):1049.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4371424</ArticleId><ArticleId IdType="pubmed">25848584</ArticleId></ArticleIdList></Reference><Reference><Citation>Souza T, Kush R, Evans JP. Global clinical data interchange standards are here! Drug Discov Today. 2007;12(3-4):174&#x2013;81.</Citation><ArticleIdList><ArticleId IdType="pubmed">17275739</ArticleId></ArticleIdList></Reference><Reference><Citation>Garza M, Del Fiol G, Tenenbaum J, Walden A, Zozus MN. Evaluating common data models for use with a longitudinal community registry. Journal of Biomedical Informatics. 2016;64:333&#x2013;41.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6810649</ArticleId><ArticleId IdType="pubmed">27989817</ArticleId></ArticleIdList></Reference><Reference><Citation>Ogunyemi OI, Meeker D, Kim HE, Ashish N, Farzaneh S, Boxwala A. Identifying appropriate reference data models for comparative effectiveness research (CER) studies based on data from clinical information systems. Medical care. 2013;51(8) Suppl 3:S45&#x2013;52.</Citation><ArticleIdList><ArticleId IdType="pubmed">23774519</ArticleId></ArticleIdList></Reference><Reference><Citation>Arp R, Smith B, Spear AD. Cambridge, Massachusetts: The MIT Press; 2015. Building ontologies with basic formal ontology.</Citation></Reference><Reference><Citation>Ceusters W. An information artifact ontology perspective on data collections and associated representational artifacts. Studies in health technology and informatics. 2012;180:68.</Citation><ArticleIdList><ArticleId IdType="pubmed">22874154</ArticleId></ArticleIdList></Reference><Reference><Citation>Scheuermann RH, Ceusters W, Smith B. Toward an ontological treatment of disease and diagnosis. Summit on translational bioinformatics</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3041577</ArticleId><ArticleId IdType="pubmed">21347182</ArticleId></ArticleIdList></Reference><Reference><Citation>Smith B, Ceusters W. Ontological realism: A methodology for coordinated evolution of scientific ontologies. Applied Ontology. 2010;5(3-4):139&#x2013;88.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3104413</ArticleId><ArticleId IdType="pubmed">21637730</ArticleId></ArticleIdList></Reference><Reference><Citation>Scheuermann RH, Ceusters W, Smith B. Toward an ontological treatment of disease and diagnosis. Summit on translational bioinformatics. 2009;2009:116&#x2013;20.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3041577</ArticleId><ArticleId IdType="pubmed">21347182</ArticleId></ArticleIdList></Reference><Reference><Citation>Overhage JM, Ryan PB, Reich CG, Hartzema AG, Stang PE. Validation of a common data model for active safety surveillance research. J Am Med Inform Assoc. 2012;19(1):54&#x2013;60.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3240764</ArticleId><ArticleId IdType="pubmed">22037893</ArticleId></ArticleIdList></Reference><Reference><Citation>Ceusters W. An information artifact ontology perspective on data collections and associated representational artifacts. Stud Health Technol Inform. 2012;180:68&#x2013;72.</Citation><ArticleIdList><ArticleId IdType="pubmed">22874154</ArticleId></ArticleIdList></Reference><Reference><Citation>Smith B, Ceusters W. Aboutness: Towards Foundations for the Information Artifact Ontology. International Conference on Biomedical Ontology; 2015 July 27-30; Lisbon, Portugal2015. pp. 47&#x2013;51.</Citation></Reference><Reference><Citation>Hogan WR, Ceusters W. Diagnosis, misdiagnosis, lucky guess, hearsay, and more: an ontological analysis. J Biomed Semantics. 2016;7(1):54.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5025551</ArticleId><ArticleId IdType="pubmed">27633888</ArticleId></ArticleIdList></Reference><Reference><Citation>Vitharana P. NEW YORK: ACM; 2003. Risks and challenges of component-based software development; pp. 67&#x2013;72.</Citation></Reference><Reference><Citation>OMOP CDM - Design Principles 2015 [OMOP Common Data Model]  Available from:  http://www.ohdsi.org/web/wiki/doku.php?id=documentation:cdm:design_principles.</Citation></Reference><Reference><Citation>Hripcsak G, Duke JD, Shah NH, Reich CG, Huser V, Schuemie MJ, et al. Observational Health Data Sciences and Informatics (OHDSI): Opportunities for Observational Researchers. Stud Health Technol Inform. 2015;216:574&#x2013;8.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4815923</ArticleId><ArticleId IdType="pubmed">26262116</ArticleId></ArticleIdList></Reference><Reference><Citation>Observational Medical Outcomes Partnership. OMOP Common Data Model Specification - Version 5. 2014. Oct 14, p. 69.</Citation></Reference><Reference><Citation>cubarkthik. OMOP CDM - PERSON table 2017.  Available from:  http://www.ohdsi.org/web/wiki/doku.php?id=documentation:cdm:person.</Citation></Reference><Reference><Citation>Smith B, Ceusters W. HL7 RIM: an incoherent standard. Stud Health Technol Inform. 2006;124:133&#x2013;8.</Citation><ArticleIdList><ArticleId IdType="pubmed">17108516</ArticleId></ArticleIdList></Reference><Reference><Citation>cgreich. OMOP CDM - PROVIDER table 2014.  Available from:  http://www.ohdsi.org/web/wiki/doku.php?id=documentation:cdm:provider.</Citation></Reference><Reference><Citation>Blaisure J, Ceusters W. Business Rules to Improve Secondary Data Use of Electronic Healthcare Systems. Stud Health Technol Inform; Informatics for Health 2017; April 24-26, 2017; Manchester Central, UK. 2017. pp. 303&#x2013;307.</Citation><ArticleIdList><ArticleId IdType="pubmed">28423803</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">29881733</PMID><DateRevised><Year>2022</Year><Month>04</Month><Day>10</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Print">2327-9214</ISSN><JournalIssue CitedMedium="Print"><Volume>5</Volume><Issue>1</Issue><PubDate><Year>2017</Year><Month>Jun</Month><Day>12</Day></PubDate></JournalIssue><Title>EGEMS (Washington, DC)</Title><ISOAbbreviation>EGEMS (Wash DC)</ISOAbbreviation></Journal><ArticleTitle>A Comparison of Data Quality Assessment Checks in Six Data Sharing Networks.</ArticleTitle><Pagination><StartPage>8</StartPage><MedlinePgn>8</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">8</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.5334/egems.223</ELocationID><Abstract><AbstractText Label="OBJECTIVE" NlmCategory="OBJECTIVE">To compare rule-based data quality (DQ) assessment approaches across multiple national clinical data sharing organizations.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">Six organizations with established data quality assessment (DQA) programs provided documentation or source code describing current DQ checks. DQ checks were mapped to the categories within the data verification context of the harmonized DQA terminology. To ensure all DQ checks were consistently mapped, conventions were developed and four iterations of mapping performed. Difficult-to-map DQ checks were discussed with research team members until consensus was achieved.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">Participating organizations provided 11,026 DQ checks, of which 99.97 percent were successfully mapped to a DQA category. Of the mapped DQ checks (N=11,023), 214 (1.94 percent) mapped to multiple DQA categories. The majority of DQ checks mapped to Atemporal Plausibility (49.60 percent), Value Conformance (17.84 percent), and Atemporal Completeness (12.98 percent) categories.</AbstractText><AbstractText Label="DISCUSSION" NlmCategory="CONCLUSIONS">Using the common DQA terminology, near-complete (99.97 percent) coverage across a wide range of DQA programs and specifications was reached. Comparing the distributions of mapped DQ checks revealed important differences between participating organizations. This variation may be related to the organization's stakeholder requirements, primary analytical focus, or maturity of their DQA program. Not within scope, mapping checks within the data validation context of the terminology may provide additional insights into DQA practice differences.</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">A common DQA terminology provides a means to help organizations and researchers understand the coverage of their current DQA efforts as well as highlight potential areas for additional DQA development. Sharing DQ checks between organizations could help expand the scope of DQA across clinical data networks.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Callahan</LastName><ForeName>Tiffany J</ForeName><Initials>TJ</Initials><AffiliationInfo><Affiliation>Computational Bioscience Program, University of Colorado Denver Anschutz Medical Campus.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bauck</LastName><ForeName>Alan E</ForeName><Initials>AE</Initials><AffiliationInfo><Affiliation>Kaiser Permanente Northwest.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bertoch</LastName><ForeName>David</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Children's Hospital Association.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Brown</LastName><ForeName>Jeff</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Harvard Pilgrim Health Care Institute.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Khare</LastName><ForeName>Ritu</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Department of Biomedical and Health Informatics, Children's Hospital of Philadelphia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ryan</LastName><ForeName>Patrick B</ForeName><Initials>PB</Initials><AffiliationInfo><Affiliation>Observational Health Data Sciences and Informatics.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Staab</LastName><ForeName>Jenny</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Kaiser Permanente Northwest.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zozus</LastName><ForeName>Meredith N</ForeName><Initials>MN</Initials><AffiliationInfo><Affiliation>Department of Biomedical Informatics, University of Arkansas for Medical Sciences.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kahn</LastName><ForeName>Michael G</ForeName><Initials>MG</Initials><AffiliationInfo><Affiliation>Department of Pediatrics, University of Colorado Denver Anschutz Medical Campus.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2017</Year><Month>06</Month><Day>12</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>EGEMS (Wash DC)</MedlineTA><NlmUniqueID>101629606</NlmUniqueID><ISSNLinking>2327-9214</ISSNLinking></MedlineJournalInfo></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2018</Year><Month>6</Month><Day>9</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2018</Year><Month>6</Month><Day>9</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2018</Year><Month>6</Month><Day>9</Day><Hour>6</Hour><Minute>1</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2017</Year><Month>6</Month><Day>12</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">29881733</ArticleId><ArticleId IdType="pmc">PMC5982846</ArticleId><ArticleId IdType="doi">10.5334/egems.223</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Wright A. Henkin S, Feblowitz J, McCoy AB, Bates DW, Sittig DF. Early results of the meaningful use program for electronic health records. N Engl J Med. 2013. February 21;368(8):779&#x2013;80.</Citation><ArticleIdList><ArticleId IdType="pubmed">23425186</ArticleId></ArticleIdList></Reference><Reference><Citation>Centers for Disease Control. Introduction: Meaningful Use [Internet]. [cited 2016 Jul 8]. Available from: http://www.cdc.gov/ehrmeaningfuluse/introduction.html</Citation></Reference><Reference><Citation>Centers for Medicare &amp; Medicaid Services. Data and Program Reports [Internet]. 2016.  [cited 2016 Jul 8]. Available from: https://www.cms.gov/Regulations-and-Guidance/Legislation/EHRIncentivePrograms/DataAndReports.html</Citation></Reference><Reference><Citation>Heisey-Grove D, Danehy L-N, Consolazio M, Lynch K, Mostashari F. A national study of challenges to electronic health record adoption and meaningful use. Med Care. 2014. February;52(2):144&#x2013;8.</Citation><ArticleIdList><ArticleId IdType="pubmed">24309669</ArticleId></ArticleIdList></Reference><Reference><Citation>Weng C, Appelbaum P, Hripcsak G, Kronish I, Busacca L, Davidson KW, et al. Using EHRs to integrate research with patient care: promises and challenges. J Am Med Inform Assoc JAMIA. 2012. October;19(5):684&#x2013;7</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3422845</ArticleId><ArticleId IdType="pubmed">22542813</ArticleId></ArticleIdList></Reference><Reference><Citation>Safran C, Bloomrosen M, Hammond WE, Labkoff S, Markel-Fox S, Tang PC, et al. Toward a national framework for the secondary use of health data: an American Medical Informatics Association White Paper. J Am Med Inform Assoc. 2007;14(1):1&#x2013;9.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2329823</ArticleId><ArticleId IdType="pubmed">17077452</ArticleId></ArticleIdList></Reference><Reference><Citation>Weiner MG, Embi PJ. Toward reuse of clinical data for research and quality improvement: the end of the beginning? Ann Intern Med. 2009;151(5):359&#x2013;60.</Citation><ArticleIdList><ArticleId IdType="pubmed">19638404</ArticleId></ArticleIdList></Reference><Reference><Citation>Hripcsak G, Albers DJ. Next-generation phenotyping of electronic health records. J Am Med Inform Assoc JAMIA. 2013. January 1;20(1):117&#x2013;21.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3555337</ArticleId><ArticleId IdType="pubmed">22955496</ArticleId></ArticleIdList></Reference><Reference><Citation>Hersh WR, Weiner MG, Embi PJ, Logan JR, Payne PRO, Bernstam EV, et al. Caveats for the use of operational electronic health record data in comparative effectiveness research. Med Care. 2013. August;51(8 Suppl 3):S30&#x2013;7.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3748381</ArticleId><ArticleId IdType="pubmed">23774517</ArticleId></ArticleIdList></Reference><Reference><Citation>Bae MD, Griffith S, Fan Y, Dunphy RN, Thompson MS, Parchman MHA, et al. The Challenges of Data Quality Evaluation in an EHR-based Data Registry. 2014.  [cited 2016 Jul 8]; Available from: http://repository.edm-forum.org/symposia/june2014/panels/15/</Citation></Reference><Reference><Citation>Brown JS, Kahn M, Toh S. Data quality assessment for comparative effectiveness research in distributed data networks. Med Care. 2013. August;51(8 Suppl 3):S22&#x2013;9.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4306391</ArticleId><ArticleId IdType="pubmed">23793049</ArticleId></ArticleIdList></Reference><Reference><Citation>Chan KS, Fowles JB, Weiner JP. Review: electronic health records and the reliability and validity of quality measures: a review of the literature. Med Care Res Rev MCRR. 2010. October;67(5):503&#x2013;27.</Citation><ArticleIdList><ArticleId IdType="pubmed">20150441</ArticleId></ArticleIdList></Reference><Reference><Citation>van der Lei J. Use and abuse of computer-stored medical records. Methods Inf Med. 1991. April;30(2):79&#x2013;80.</Citation><ArticleIdList><ArticleId IdType="pubmed">1857252</ArticleId></ArticleIdList></Reference><Reference><Citation>Burnum JF. The misinformation era: the fall of the medical record. Ann Intern Med. 1989. March 15;110(6):482&#x2013;4.</Citation><ArticleIdList><ArticleId IdType="pubmed">2919852</ArticleId></ArticleIdList></Reference><Reference><Citation>Botsis T, Hartvigsen G, Chen F, Weng C. Secondary Use of EHR: Data Quality Issues and Informatics Opportunities. AMIA Jt Summits Transl Sci Proc AMIA Summit Transl Sci. 2010;2010:1&#x2013;5.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3041534</ArticleId><ArticleId IdType="pubmed">21347133</ArticleId></ArticleIdList></Reference><Reference><Citation>Kahn MG, Raebel MA, Glanz JM, Riedlinger K, Steiner JF. A pragmatic framework for single-site and multisite data quality assessment in electronic health record-based clinical research. Med Care. 2012. July;50 Suppl:S21&#x2013;9.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3833692</ArticleId><ArticleId IdType="pubmed">22692254</ArticleId></ArticleIdList></Reference><Reference><Citation>Liaw ST, Rahimi A, Ray P, Taggart J, Dennis S, de Lusignan S, et al. Towards an ontology for data quality in integrated chronic disease management: a realist review of the literature. Int J Med Inf. 2013. January;82(1):10&#x2013;24.</Citation><ArticleIdList><ArticleId IdType="pubmed">23122633</ArticleId></ArticleIdList></Reference><Reference><Citation>Weiskopf NG, Hripcsak G, Swaminathan S, Weng C. Defining and measuring completeness of electronic health records for secondary use. J Biomed Inform. 2013. October;46(5):830&#x2013;6.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3810243</ArticleId><ArticleId IdType="pubmed">23820016</ArticleId></ArticleIdList></Reference><Reference><Citation>Weiskopf NG, Weng C. Methods and dimensions of electronic health record data quality assessment: enabling reuse for clinical research. J Am Med Inform Assoc JAMIA. 2013. January 1;20(1):144&#x2013;51.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3555312</ArticleId><ArticleId IdType="pubmed">22733976</ArticleId></ArticleIdList></Reference><Reference><Citation>Johnson SG, Speedie S, Simon G, Kumar V, Westra BL. A Data Quality Ontology for the Secondary Use of EHR Data. AMIA Annu Symp Proc AMIA Symp AMIA Symp. 2015;2015:1937&#x2013;46.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4765682</ArticleId><ArticleId IdType="pubmed">26958293</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen H, Hailey D, Wang N, Yu P. A review of data quality assessment methods for public health information systems. Int J Environ Res Public Health. 2014. May;11(5):5170&#x2013;207.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4053886</ArticleId><ArticleId IdType="pubmed">24830450</ArticleId></ArticleIdList></Reference><Reference><Citation>Long J, Richards J, Seko C.
The Canadian Institute for Health Information (CIHI) Data Quality Framework, Version 1: A Meta-Evaluation and Future Directions. In: Proceedings of the Sixth International Conference on Information Quality [Internet]
2001.  [cited 2016 Jul 8]. p. 370&#x2013;83. Available from: http://ssm-vm030.mit.edu/ICIQ/Documents/IQ%20Conference%202001/Papers/TheCanadianInstitute4HealthInfoDQFrame.pdf</Citation></Reference><Reference><Citation>Bauck A, Bachman D, Riedlinger K, Walker K, Luke S, Donovan J, et al. C-A1-02: Developing a Structure for Programmatic Quality Assurance Checks on the Virtual Data Warehouse. Clin Med Res. 2011;9(3-4):184&#x2013;184.</Citation></Reference><Reference><Citation>Hartzema AG, Reich CG, Ryan PB, Stang PE, Madigan D, Welebob E, et al. Managing data quality for a drug safety surveillance system. Drug Saf. 2013. October;36 Suppl 1:S49&#x2013;58.</Citation><ArticleIdList><ArticleId IdType="pubmed">24166223</ArticleId></ArticleIdList></Reference><Reference><Citation>Kahn M, Callahan T, Barnard J, Bauck A, Brown J, Davidson B, et al. A Harmonized Data Quality Assessment Terminology and Framework for the Secondary Use of Electronic Health Record Data. EGEMs Gener Evid Methods Improve Patient Outcomes [Internet]. 2016. 
September
11;4(1). Available from: http://repository.edm-forum.org/egems/vol4/iss1/18</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5051581</ArticleId><ArticleId IdType="pubmed">27713905</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang RY, Strong DM. Beyond accuracy: What data quality means to data consumers. J Manag Inf Syst. 1996;12(4):5&#x2013;33.</Citation></Reference><Reference><Citation>Center for Effectiveness &amp; Safety Research [Internet]. [cited 2016 Aug 24]. Available from: http://cesr.kp.org/en/</Citation></Reference><Reference><Citation>Ball R, Robb M, Anderson S, Dal Pan G. The FDA&#x2019;s sentinel initiative&#x2014;A comprehensive approach to medical product surveillance. Clin Pharmacol Ther. 2016. March 1;99(3):265&#x2013;8.</Citation><ArticleIdList><ArticleId IdType="pubmed">26667601</ArticleId></ArticleIdList></Reference><Reference><Citation>Behrman RE, Benner JS, Brown JS, McClellan M, Woodcock J, Platt R. Developing the Sentinel System &#x2014; A National Resource for Evidence Development. N Engl J Med. 2011. February 10;364(6):498&#x2013;9.</Citation><ArticleIdList><ArticleId IdType="pubmed">21226658</ArticleId></ArticleIdList></Reference><Reference><Citation>Utidjian LH, Khare R, Burrows E, Schulte G.
Identifying and Understanding Data Quality Issues in a Pediatric Distributed Research Network. In: 2015 AAP National Conference and Exhibition [Internet]
American Academy of Pediatrics; 2015 [cited 2016 Aug 24]. Available from: https://aap.confex.com/aap/2015/webprogrampress/Paper30131.html</Citation></Reference><Reference><Citation>PHIS [Internet]. [cited 2016 Aug 24]. Available from: https://www.childrenshospitals.org/programs-and-services/data-analytics-and-research/pediatric-analytic-solutions/pediatric-health-information-system</Citation></Reference><Reference><Citation>Bhattacharya S, Dunham AA, Cornish MA, Christian VA, Ginsburg GS, Tenenbaum JD, et al. The Measurement to Understand Reclassification of Disease of Cabarrus/Kannapolis (MURDOCK) Study Community Registry and Biorepository. Am J Transl Res. 2012;4(4):458&#x2013;70.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3493022</ArticleId><ArticleId IdType="pubmed">23145214</ArticleId></ArticleIdList></Reference><Reference><Citation>Hripcsak G, Duke JD, Shah NH, Reich CG, Huser V, Schuemie MJ, et al. Observational Health Data Sciences and Informatics (OHDSI): Opportunities for Observational Researchers. Stud Health Technol Inform. 2015;216:574&#x2013;8.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4815923</ArticleId><ArticleId IdType="pubmed">26262116</ArticleId></ArticleIdList></Reference><Reference><Citation>Overhage JM, Ryan PB, Reich CG, Hartzema AG, Stang PE. Validation of a common data model for active safety surveillance research. J Am Med Inform Assoc JAMIA. 2012;19(1):54&#x2013;60.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3240764</ArticleId><ArticleId IdType="pubmed">22037893</ArticleId></ArticleIdList></Reference><Reference><Citation>Baskarada S, Gao J, Koronios A.
Agile Maturity Model Approach to Assessing and Enhancing the Quality of Asset Information in Engineering Asset Management Information Systems [Internet]
Rochester, NY: Social Science Research Network; 2005. 
May [cited 2016 Aug 22]. Report No.: ID 2149356. Available from: http://papers.ssrn.com/abstract=2149356</Citation></Reference><Reference><Citation>Paulk M.
Capability maturity model for software. Encycl Softw Eng [Internet]. 1993.  [cited 2016 Jul 20]; Available from: http://onlinelibrarywiley.com/doi/10.1002/0471028959.sof589/full</Citation></Reference><Reference><Citation>Paulk M, Weber C, Garcia-Miller S, Chrissis MB, Bush M.
Key Practices of the Capability Maturity Model Version 1.1 [Internet]. Software Engineering Institute; 1993.  Available from: http://resources.sei.cmu.edu/library/asset-view.cfm?assetid=11965</Citation></Reference><Reference><Citation>Assessments of Health Outcomes Among Individuals Exposed to Medical Products | Mini-Sentinel [Internet]. [cited 2016 Aug 24]. Available from: http://mini-sentinel.org/assessments/medical_events/default.aspx</Citation></Reference><Reference><Citation>Fleurence RL, Curtis LH, Califf RM, Platt R, Selby JV, Brown JS. Launching PCORnet, a national patient-centered clinical research network. J Am Med Inform Assoc JAMIA. 2014. August;21(4):578&#x2013;82.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4078292</ArticleId><ArticleId IdType="pubmed">24821743</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">29881736</PMID><DateRevised><Year>2022</Year><Month>03</Month><Day>30</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Print">2327-9214</ISSN><JournalIssue CitedMedium="Print"><Volume>5</Volume><Issue>1</Issue><PubDate><Year>2017</Year><Month>Sep</Month><Day>04</Day></PubDate></JournalIssue><Title>EGEMS (Washington, DC)</Title><ISOAbbreviation>EGEMS (Wash DC)</ISOAbbreviation></Journal><ArticleTitle>Reporting Data Quality Assessment Results: Identifying Individual and Organizational Barriers and Solutions.</ArticleTitle><Pagination><StartPage>16</StartPage><MedlinePgn>16</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">16</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.5334/egems.214</ELocationID><Abstract><AbstractText Label="INTRODUCTION" NlmCategory="BACKGROUND">Electronic health record (EHR) data are known to have significant data quality issues, yet the practice and frequency of assessing EHR data is unknown. We sought to understand current practices and attitudes towards reporting data quality assessment (DQA) results by data professionals.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">The project was conducted in four Phases: (1) examined current DQA practices among informatics/CER stakeholders via engagement meeting (07/2014); (2) characterized organizations conducting DQA by interviewing key personnel and data management professionals (07-08/2014); (3) developed and administered an anonymous survey to data professionals (03-06/2015); and (4) validated survey results during a follow-up informatics/CER stakeholder engagement meeting (06/2016).</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">The first engagement meeting identified the theme of unintended consequences as a primary barrier to DQA. Interviewees were predominantly medical groups serving distributed networks with formalized DQAs. Consistent with the interviews, most survey (N=111) respondents utilized DQA processes/programs. A lack of resources and clear definitions of how to judge the quality of a dataset were the most commonly cited individual barriers. Vague quality action plans/expectations and data owners not trained in problem identification and problem-solving skills were the most commonly cited organizational barriers. Solutions included allocating resources for DQA, establishing standards and guidelines, and changing organizational culture.</AbstractText><AbstractText Label="DISCUSSION" NlmCategory="CONCLUSIONS">Several barriers affecting DQA and reporting were identified. Community alignment towards systematic DQA and reporting is needed to overcome these barriers.</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">Understanding barriers and solutions to DQA reporting is vital for establishing trust in the secondary use of EHR data for quality improvement and the pursuit of personalized medicine.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Callahan</LastName><ForeName>Tiffany</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>University of Colorado Anschutz Medical Campus.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Barnard</LastName><ForeName>Juliana</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>University of Colorado Anschutz Medical Campus.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Helmkamp</LastName><ForeName>Laura</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>University of Colorado Anschutz Medical Campus.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Maertens</LastName><ForeName>Julie</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>University of Colorado Anschutz Medical Campus.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kahn</LastName><ForeName>Michael</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>University of Colorado Anschutz Medical Campus.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2017</Year><Month>09</Month><Day>04</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>EGEMS (Wash DC)</MedlineTA><NlmUniqueID>101629606</NlmUniqueID><ISSNLinking>2327-9214</ISSNLinking></MedlineJournalInfo></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2018</Year><Month>6</Month><Day>9</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2018</Year><Month>6</Month><Day>9</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2018</Year><Month>6</Month><Day>9</Day><Hour>6</Hour><Minute>1</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2017</Year><Month>9</Month><Day>4</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">29881736</ArticleId><ArticleId IdType="pmc">PMC5982990</ArticleId><ArticleId IdType="doi">10.5334/egems.214</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Piai S, Claps M.
Bigger Data for Better Healthcare. IDC Health Insights [Internet]. 2013; Available from: http://www.intelcore.cz/content/dam/www/public/us/en/documents/white-papers/bigger-data-better-healthcare-idc-insights-white-paper.pdf</Citation></Reference><Reference><Citation>Office for Civil Rights. HITECH Act Enforcement Interim Final Rule [Internet]. HHS.gov. 2009.  [cited 2016 Jul 12]. Available from: http://www.hhs.gov/hipaa/for-professionals/special-topics/HITECH-act-enforcement-interim-final-rule/index.html</Citation></Reference><Reference><Citation>Blumenthal D. Launching HITECH. N Engl J Med. 2010. February 4;362(5):382&#x2013;5.</Citation><ArticleIdList><ArticleId IdType="pubmed">20042745</ArticleId></ArticleIdList></Reference><Reference><Citation>Assistant Secretary for Public Affairs, U.S. Department of Health and Human Services. The Affordable Care Act [Internet]. HHS.gov. 2015.  [cited 2016 Jul 12]. Available from: http://www.hhs.gov/healthcare/about-the-law/read-the-law/index.html</Citation></Reference><Reference><Citation>National Institutes of Health, U.S. Department of Health and Human Services. Recovery Act Grant Information &#x2013; Supported by the American Recovery &amp; Reinvestment Act of 2009 (ARRA) [Internet]. [cited 2016 Jul 12]. Available from: http://grants.nih.gov/recovery/</Citation></Reference><Reference><Citation>Holve E, Segal C. Infrastructure to support learning health systems: are we there yet? Innovative solutions and lessons learned from American Recovery and Reinvestment Act CER investments. J Comp Eff Res. 2014. November;3(6):635&#x2013;45.</Citation><ArticleIdList><ArticleId IdType="pubmed">25494570</ArticleId></ArticleIdList></Reference><Reference><Citation>Murdoch TB, Detsky AS. The inevitable application of big data to health care. JAMA. 2013. April 3;309(13):1351&#x2013;2.</Citation><ArticleIdList><ArticleId IdType="pubmed">23549579</ArticleId></ArticleIdList></Reference><Reference><Citation>Bietz MJ, Bloss CS, Calvert S, Godino JG, Gregory J, Claffey MP, et al. Opportunities and challenges in the use of personal health data for health research. J Am Med Inform Assoc JAMIA. 2016. April;23(e1):e42&#x2013;48.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4954630</ArticleId><ArticleId IdType="pubmed">26335984</ArticleId></ArticleIdList></Reference><Reference><Citation>Panahiazar M, Taslimitehrani V, Jadhav A, Pathak J. Empowering Personalized Medicine with Big Data and Semantic Web Technology: Promises, Challenges, and Use Cases. Proc IEEE Int Conf Big Data IEEE Int Conf Big Data. 2014. October;2014:790&#x2013;5.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4333680</ArticleId><ArticleId IdType="pubmed">25705726</ArticleId></ArticleIdList></Reference><Reference><Citation>Gray EA, Thorpe JH. Comparative effectiveness research and big data: balancing potential with legal and ethical considerations. J Comp Eff Res. 2015. January;4(1):61&#x2013;74.</Citation><ArticleIdList><ArticleId IdType="pubmed">25565069</ArticleId></ArticleIdList></Reference><Reference><Citation>Kahn M, Brown J, Chun A, Davidson B, Meeker D, Ryan P, et al. Transparent Reporting of Data Quality in Distributed Data Networks. EGEMs Gener Evid Methods Improve Patient Outcomes [Internet]. 2015. 
March
23;3(1). Available from: http://repository.edm-forum.org/egems/vol3/iss1/7</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4434997</ArticleId><ArticleId IdType="pubmed">25992385</ArticleId></ArticleIdList></Reference><Reference><Citation>Richesson RL, Horvath MM, Rusincovitch SA. Clinical Research Informatics and Electronic Health Record Data. Yearb Med Inform. 2014. August 15;9(1):215&#x2013;23.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4287078</ArticleId><ArticleId IdType="pubmed">25123746</ArticleId></ArticleIdList></Reference><Reference><Citation>Furlanello C. Emerging data waves in biomedicine: the challenge of reproducibility. Keynote Lecture presented at: Intelligent Data Analysis in Medicine and Pharmacology; 2012. Nov 22; Pavia, Italy.</Citation></Reference><Reference><Citation>Bellazzi R. Big Data and Biomedical Informatics: A Challenging Opportunity. Yearb Med Inform. 2014. May 22;9(1):8&#x2013;13.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4287065</ArticleId><ArticleId IdType="pubmed">24853034</ArticleId></ArticleIdList></Reference><Reference><Citation>JAMA authors retract (and replace) paper about moves and kids&#x2019; mental health [Internet]. Retraction Watch. 2016.  [cited 2016Jul13].Available from: http://retractionwatch.com/2016/06/17/jama-authors-retract-and-replace-paper-about-moves-and-kids-mental-health/</Citation></Reference><Reference><Citation>Kahn MG, Ranade D. The impact of electronic medical records data sources on an adverse drug event quality measure. J Am Med Inform Assoc JAMIA. 2010. April;17(2):185&#x2013;91.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3000787</ArticleId><ArticleId IdType="pubmed">20190062</ArticleId></ArticleIdList></Reference><Reference><Citation>Sittig DF, Singh H. Electronic Health Records and National Patient-Safety Goals. N Engl J Med. 2012. November 8;367(19):1854&#x2013;60.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3690003</ArticleId><ArticleId IdType="pubmed">23134389</ArticleId></ArticleIdList></Reference><Reference><Citation>McCoy AB, Wright A, Kahn MG, Shapiro JS, Bernstam EV, Sittig DF. Matching identifiers in electronic health records: implications for duplicate records and patient safety. BMJ Qual Saf 2013. March;22(3):219&#x2013;24.</Citation><ArticleIdList><ArticleId IdType="pubmed">23362505</ArticleId></ArticleIdList></Reference><Reference><Citation>Middleton B, Bloomrosen M, Dente MA, Hashmat B, Koppel R, Overhage JM, et al. Enhancing patient safety and quality of care by improving the usability of electronic health record systems: recommendations from AMIA. J Am Med Inform Assoc. 2013. June 1;20(e1):e2&#x2013;8.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3715367</ArticleId><ArticleId IdType="pubmed">23355463</ArticleId></ArticleIdList></Reference><Reference><Citation>Hersh WR, Weiner MG, Embi PJ, Logan JR, Payne PRO, Bernstam EV, et al. Caveats for the use of operational electronic health record data in comparative effectiveness research. Med Care. 2013. August;51(8 Suppl 3):S30&#x2013;37</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3748381</ArticleId><ArticleId IdType="pubmed">23774517</ArticleId></ArticleIdList></Reference><Reference><Citation>Randhawa GS. Building electronic data infrastructure for comparative effectiveness research: accomplishments, lessons learned and future steps. J Comp Eff Res. 2014. November;3(6):567&#x2013;72.</Citation><ArticleIdList><ArticleId IdType="pubmed">25494561</ArticleId></ArticleIdList></Reference><Reference><Citation>Siu LL, Lawler M, Haussler D, Knoppers BM, Lewin J, Vis DJ, et al. Facilitating a culture of responsible and effective sharing of cancer genome data. Nat Med. 2016. May;22(5):464&#x2013;71.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4995884</ArticleId><ArticleId IdType="pubmed">27149219</ArticleId></ArticleIdList></Reference><Reference><Citation>Kho AN, Rasmussen LV, Connolly JJ, Peissig PL, Starren J, Hakonarson H, et al. Practical challenges in integrating genomic data into the electronic health record. Genet Med. 2013. October;15(10):772&#x2013;8.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4201621</ArticleId><ArticleId IdType="pubmed">24071798</ArticleId></ArticleIdList></Reference><Reference><Citation>Friedman DJ, Parrish RG, Ross DA. Electronic Health Records and US Public Health: Current Realities and Future Promise. Am J Public Health. 2013. July 18;103(9):1560&#x2013;7</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3780677</ArticleId><ArticleId IdType="pubmed">23865646</ArticleId></ArticleIdList></Reference><Reference><Citation>Kahn MG, Raebel MA, Glanz JM, Riedlinger K, Steiner JF. A pragmatic framework for single-site and multisite data quality assessment in electronic health record-based clinical research. Med Care. 2012. July;50 Suppl:S21&#x2013;29.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3833692</ArticleId><ArticleId IdType="pubmed">22692254</ArticleId></ArticleIdList></Reference><Reference><Citation>Brown JS, Kahn M, Toh S. Data quality assessment for comparative effectiveness research in distributed data networks. Med Care. 2013. August;51(8 Suppl 3):S22&#x2013;29.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4306391</ArticleId><ArticleId IdType="pubmed">23793049</ArticleId></ArticleIdList></Reference><Reference><Citation>Kahn MG, Callahan TJ, Barnard JJ, Bauck A, Brown JS, Davidson B N, et al. A harmonized data quality assessment terminology for the secondary use of electronic health record data. eGEMs.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5051581</ArticleId><ArticleId IdType="pubmed">27713905</ArticleId></ArticleIdList></Reference><Reference><Citation>Sittig DF, Singh H. Legal, Ethical, and Financial Dilemmas in Electronic Health Record Adoption and Use. Pediatrics. 2011. April;127(4):e1042&#x2013;7.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3065078</ArticleId><ArticleId IdType="pubmed">21422090</ArticleId></ArticleIdList></Reference><Reference><Citation>Berger ML, Doban V. Big data, advanced analytics and the future of comparative effectiveness research. J Comp Eff Res. 2014. March;3(2):167&#x2013;76.</Citation><ArticleIdList><ArticleId IdType="pubmed">24645690</ArticleId></ArticleIdList></Reference><Reference><Citation>Harper E. Can big data transform electronic health records into learning health systems? Stud Health Technol Inform. 2014;201:470&#x2013;5.</Citation><ArticleIdList><ArticleId IdType="pubmed">24943583</ArticleId></ArticleIdList></Reference><Reference><Citation>Raghupathi W, Raghupathi V. Big data analytics in healthcare: promise and potential. Health Inf Sci Syst. 2014;2:3.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4341817</ArticleId><ArticleId IdType="pubmed">25825667</ArticleId></ArticleIdList></Reference><Reference><Citation>Bae C, Griffith S, Fan Y, Dunphy C, Thompson N, Parchman A, et al. The Challenges of Data Quality Evaluation in an EHR-based Data Registry. EDM Forum [Internet]. 2011; Available from: http://repository.academyhealth.org/symposia/june2014/panels/15</Citation></Reference><Reference><Citation>EDM Forum. Collaborative Projects &#x2013; EDM Forum Home [Internet]. [cited 2016 Jul 13]. Available from: http://www.edm-forum.org/edmhome/collaborate/collaborativeprojects</Citation></Reference><Reference><Citation>Chan KS, Fowles JB, Weiner JP. Review: electronic health records and the reliability and validity of quality measures: a review of the literature. Med Care Res Rev MCRR. 2010. October;67(5):503&#x2013;27.</Citation><ArticleIdList><ArticleId IdType="pubmed">20150441</ArticleId></ArticleIdList></Reference><Reference><Citation>Kahn MG, Raebel MA, Glanz JM, Riedlinger K, Steiner JF. A pragmatic framework for single-site and multisite data quality assessment in electronic health record-based clinical research. Med Care. 2012. July;50 Suppl:S21&#x2013;29.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3833692</ArticleId><ArticleId IdType="pubmed">22692254</ArticleId></ArticleIdList></Reference><Reference><Citation>Weiskopf NG, Weng C. Methods and dimensions of electronic health record data quality assessment: enabling reuse for clinical research. J Am Med Inform Assoc JAMIA. 2013. January 1;20(1):144&#x2013;51.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3555312</ArticleId><ArticleId IdType="pubmed">22733976</ArticleId></ArticleIdList></Reference><Reference><Citation>Weiskopf NG, Hripcsak G, Swaminathan S, Weng C. Defining and measuring completeness of electronic health records for secondary use. J Biomed Inform. 2013. October;46(5):830&#x2013;6.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3810243</ArticleId><ArticleId IdType="pubmed">23820016</ArticleId></ArticleIdList></Reference><Reference><Citation>Johnson SG, Speedie S, Simon G, Kumar V, Westra BL. A Data Quality Ontology for the Secondary Use of EHR Data. AMIA Annu Symp Proc AMIA Symp AMIA Symp. 2015;2015:1937&#x2013;46.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4765682</ArticleId><ArticleId IdType="pubmed">26958293</ArticleId></ArticleIdList></Reference><Reference><Citation>Zozus M, Hammond W, Green B, Kahn MG, Richesson R, Rusincovitch S.
Assessing Data Quality for Healthcare Systems Data Used in Clinical Research (Version 1.0) [Internet]. Available from: http://sites.duke.edu/rethinkingclinicaltrials/assessing-data-quality/</Citation></Reference><Reference><Citation>Graneheim UH, Lundman B. Qualitative content analysis in nursing research: concepts, procedures and measures to achieve trustworthiness. Nurse Educ Today. 2004. February;24(2):105&#x2013;12.</Citation><ArticleIdList><ArticleId IdType="pubmed">14769454</ArticleId></ArticleIdList></Reference><Reference><Citation>Mauthner NS, Doucet A. Reflexive Accounts and Accounts of Reflexivity in Qualitative Data Analysis. Sociology. 2003. August 1;37(3):413&#x2013;31.</Citation></Reference><Reference><Citation>Sebastian-Coleman L. Measuring Data Quality for Ongoing Improvement: A Data Quality Assessment Framework 1 edition Waltham, MA: Morgan Kaufmann; 2013. 376 p.</Citation></Reference><Reference><Citation>Khan M. An empirical study of barriers in implementing total quality management in service organizations in Pakistan. Asian J Bus Manag Stud. 2011;2(4):155&#x2013;61.</Citation></Reference><Reference><Citation>Dillman DA. Mail and Internet Surveys: The Tailored Design Method -- 2007 Update with New Internet, Visual, and MixedMode Guide John Wiley &amp; Sons; 2011. 572 p.</Citation></Reference><Reference><Citation>Harris PA, Taylor R, Thielke R, Payne J, Gonzalez N, Conde JG. Research electronic data capture (REDCap)--a metadata- driven methodology and workflow process for providing translational research informatics support. J Biomed Inform. 2009. April;42(2):377&#x2013;81.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2700030</ArticleId><ArticleId IdType="pubmed">18929686</ArticleId></ArticleIdList></Reference><Reference><Citation>Safran C, Bloomrosen M, Hammond WE, Labkoff S, Markel-Fox S, Tang PC, et al. Toward a national framework for the secondary use of health data: an American Medical Informatics Association White Paper. J Am Med Inform Assoc. 2007;14(1):1&#x2013;9.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2329823</ArticleId><ArticleId IdType="pubmed">17077452</ArticleId></ArticleIdList></Reference><Reference><Citation>Graber ML. The incidence of diagnostic error in medicine. BMJ Qual Saf. 2013. October 1;22(Suppl 2):ii21&#x2013;ii27.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3786666</ArticleId><ArticleId IdType="pubmed">23771902</ArticleId></ArticleIdList></Reference><Reference><Citation>Associations Between Communication Climate and the Frequency&#x2026; : Journal of Patient Safety [Internet]. LWW. [cited 2016 Dec 13]. Available from: http://journals.lww.com/journalpatientsafety/Fulltext/2013/09000/Associations_Between_Communication_Climate_and_the.3.aspx</Citation></Reference><Reference><Citation>Kahn M, Callahan T, Barnard J, Bauck A, Brown J, Davidson B, et al. A Harmonized Data Quality Assessment Terminology and Framework for the Secondary Use of Electronic Health Record Data. EGEMs Gener Evid Methods Improve Patient Outcomes [Internet]. 2016. 
September
11;4(1). Available from: http://repository.edm-forum.org/egems/vol4/iss1/18</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5051581</ArticleId><ArticleId IdType="pubmed">27713905</ArticleId></ArticleIdList></Reference><Reference><Citation>Callahan TJ, Bauck A, Bertoch D, Brown JS, Khare R, Ryan PB, et al. A Comparison Of Data Quality Assessment Checks In Six Data Sharing Networks. eGEMS. 2017;5(1):8 DOI: 10.13063/2327-9214.1287.</Citation><ArticleIdList><ArticleId IdType="doi">10.13063/2327-9214.1287</ArticleId><ArticleId IdType="pmc">PMC5982846</ArticleId><ArticleId IdType="pubmed">29881733</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">28815480</PMID><DateCompleted><Year>2018</Year><Month>10</Month><Day>09</Day></DateCompleted><DateRevised><Year>2022</Year><Month>03</Month><Day>17</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1179-1942</ISSN><JournalIssue CitedMedium="Internet"><Volume>41</Volume><Issue>1</Issue><PubDate><Year>2018</Year><Month>Jan</Month></PubDate></JournalIssue><Title>Drug safety</Title><ISOAbbreviation>Drug Saf</ISOAbbreviation></Journal><ArticleTitle>Evaluation of Electronic Healthcare Databases for Post-Marketing Drug Safety Surveillance and Pharmacoepidemiology in China.</ArticleTitle><Pagination><StartPage>125</StartPage><EndPage>137</EndPage><MedlinePgn>125-137</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1007/s40264-017-0589-z</ELocationID><Abstract><AbstractText Label="INTRODUCTION">Electronic healthcare databases (EHDs) are used increasingly for post-marketing drug safety surveillance and pharmacoepidemiology in Europe and North America. However, few studies have examined the potential of these data sources in China.</AbstractText><AbstractText Label="METHODS">Three major types of EHDs in China (i.e., a regional community-based database, a national claims database, and an electronic medical records [EMR] database) were selected for evaluation. Forty core variables were derived based on the US Mini-Sentinel (MS) Common Data Model (CDM) as well as the data features in China that would be desirable to support drug safety surveillance. An email survey of these core variables and eight general questions as well as follow-up inquiries on additional variables was conducted. These 40 core variables across the three EHDs and all variables in each EHD along with those in the US MS CDM and Observational Medical Outcomes Partnership (OMOP) CDM were compared for availability and labeled based on specific standards.</AbstractText><AbstractText Label="RESULTS">All of the EHDs' custodians confirmed their willingness to share their databases with academic institutions after appropriate approval was obtained. The regional community-based database contained 1.19&#xa0;million people in 2015 with 85% of core variables. Resampled annually nationwide, the national claims database included 5.4&#xa0;million people in 2014 with 55% of core variables, and the EMR database included 3&#xa0;million inpatients from 60 hospitals in 2015 with 80% of core variables. Compared with MS CDM or OMOP CDM, the proportion of variables across the three EHDs available or able to be transformed/derived from the original sources are 24-83% or 45-73%, respectively.</AbstractText><AbstractText Label="CONCLUSIONS">These EHDs provide potential value to post-marketing drug safety surveillance and pharmacoepidemiology in China. Future research is warranted to assess the quality and completeness of these EHDs or additional data sources in China.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Yang</LastName><ForeName>Yu</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Department of Epidemiology and Bio-Statistics, School of Public Health, Peking University Health Science Center, No.38 Xueyuan Road, Haidian District, Beijing, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhou</LastName><ForeName>Xiaofeng</ForeName><Initials>X</Initials><AffiliationInfo><Affiliation>Epidemiology, Pfizer Inc., New York, NY, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gao</LastName><ForeName>Shuangqing</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Beijing Brainpower Pharmacy Consulting Co. Ltd, Beijing, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lin</LastName><ForeName>Hongbo</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Center for Disease Control of Yinzhou, Ningbo, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Xie</LastName><ForeName>Yanming</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Institute of Basic Research in Clinical Medicine, China Academy of Chinese Medical Sciences, Beijing, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Feng</LastName><ForeName>Yuji</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Chinese Medical Doctor Association, Beijing, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Epidemiology and Real-World Data Analytics, Pfizer Investment Co. Ltd., Beijing, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Huang</LastName><ForeName>Kui</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Epidemiology, Pfizer Inc., New York, NY, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhan</LastName><ForeName>Siyan</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Epidemiology and Bio-Statistics, School of Public Health, Peking University Health Science Center, No.38 Xueyuan Road, Haidian District, Beijing, China. siyan-zhan@bjmu.edu.cn.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>81473067</GrantID><Agency>National Natural Science Foundation of China</Agency><Country>International</Country></Grant><Grant><GrantID>D151100002215002</GrantID><Agency>Major Project of Science and Technology Planning of Beijing</Agency><Country>International</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D023362">Evaluation Study</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>New Zealand</Country><MedlineTA>Drug Saf</MedlineTA><NlmUniqueID>9002928</NlmUniqueID><ISSNLinking>0114-5916</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000293" MajorTopicYN="N">Adolescent</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016907" MajorTopicYN="N">Adverse Drug Reaction Reporting Systems</DescriptorName><QualifierName UI="Q000592" MajorTopicYN="N">standards</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000369" MajorTopicYN="N">Aged, 80 and over</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002648" MajorTopicYN="N">Child</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002675" MajorTopicYN="N">Child, Preschool</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002681" MajorTopicYN="N" Type="Geographic">China</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D064420" MajorTopicYN="N">Drug-Related Side Effects and Adverse Reactions</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="Y">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D057286" MajorTopicYN="N">Electronic Health Records</DescriptorName><QualifierName UI="Q000592" MajorTopicYN="Y">standards</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007223" MajorTopicYN="N">Infant</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007231" MajorTopicYN="N">Infant, Newborn</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017063" MajorTopicYN="Y">Outcome Assessment, Health Care</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017891" MajorTopicYN="N">Pharmacoepidemiology</DescriptorName><QualifierName UI="Q000592" MajorTopicYN="N">standards</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011358" MajorTopicYN="N">Product Surveillance, Postmarketing</DescriptorName><QualifierName UI="Q000592" MajorTopicYN="Y">standards</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011795" MajorTopicYN="N">Surveys and Questionnaires</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D055815" MajorTopicYN="N">Young Adult</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>2017</Year><Month>8</Month><Day>18</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2018</Year><Month>10</Month><Day>10</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2017</Year><Month>8</Month><Day>18</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">28815480</ArticleId><ArticleId IdType="doi">10.1007/s40264-017-0589-z</ArticleId><ArticleId IdType="pii">10.1007/s40264-017-0589-z</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>AMIA Annu Symp Proc. 2015 Nov 05;2015 :1371-80</Citation><ArticleIdList><ArticleId IdType="pubmed">26958278</ArticleId></ArticleIdList></Reference><Reference><Citation>Front Med. 2014 Sep;8(3):294-9</Citation><ArticleIdList><ArticleId IdType="pubmed">25186248</ArticleId></ArticleIdList></Reference><Reference><Citation>Nature. 2007 Mar 22;446(7134):358-9</Citation><ArticleIdList><ArticleId IdType="pubmed">17377551</ArticleId></ArticleIdList></Reference><Reference><Citation>N Engl J Med. 2011 Feb 10;364(6):498-9</Citation><ArticleIdList><ArticleId IdType="pubmed">21226658</ArticleId></ArticleIdList></Reference><Reference><Citation>J Mark Access Health Policy. 2015 Jul 20;3:null</Citation><ArticleIdList><ArticleId IdType="pubmed">27123180</ArticleId></ArticleIdList></Reference><Reference><Citation>Drug Saf. 2015 Aug;38(8):749-65</Citation><ArticleIdList><ArticleId IdType="pubmed">26055920</ArticleId></ArticleIdList></Reference><Reference><Citation>Clin Epidemiol. 2017 Mar 16;9:167-178</Citation><ArticleIdList><ArticleId IdType="pubmed">28356772</ArticleId></ArticleIdList></Reference><Reference><Citation>Pharmacoepidemiol Drug Saf. 2012 Jan;21 Suppl 1:23-31</Citation><ArticleIdList><ArticleId IdType="pubmed">22262590</ArticleId></ArticleIdList></Reference><Reference><Citation>Clin Epidemiol. 2009 Aug 09;1:75-92</Citation><ArticleIdList><ArticleId IdType="pubmed">20865089</ArticleId></ArticleIdList></Reference><Reference><Citation>Circulation. 2006 May 9;113(18):2173-6</Citation><ArticleIdList><ArticleId IdType="pubmed">16684873</ArticleId></ArticleIdList></Reference><Reference><Citation>Curr Clin Pharmacol. 2014 May;9(2):130-8</Citation><ArticleIdList><ArticleId IdType="pubmed">24218995</ArticleId></ArticleIdList></Reference><Reference><Citation>N Engl J Med. 2009 Aug 13;361(7):645-7</Citation><ArticleIdList><ArticleId IdType="pubmed">19635947</ArticleId></ArticleIdList></Reference><Reference><Citation>Epidemiology. 2015 Nov;26(6):815-20</Citation><ArticleIdList><ArticleId IdType="pubmed">26133022</ArticleId></ArticleIdList></Reference><Reference><Citation>BMC Med Res Methodol. 2012 Nov 26;12:180</Citation><ArticleIdList><ArticleId IdType="pubmed">23181419</ArticleId></ArticleIdList></Reference><Reference><Citation>Pharmacoepidemiol Drug Saf. 2007 Apr;16(4):359-65</Citation><ArticleIdList><ArticleId IdType="pubmed">17019675</ArticleId></ArticleIdList></Reference><Reference><Citation>Drug Saf. 2013 Feb;36(2):119-34</Citation><ArticleIdList><ArticleId IdType="pubmed">23329543</ArticleId></ArticleIdList></Reference><Reference><Citation>Nat Med. 2005 May;11(5):465-6</Citation><ArticleIdList><ArticleId IdType="pubmed">15875044</ArticleId></ArticleIdList></Reference><Reference><Citation>Pharmacoepidemiol Drug Saf. 2012 Jan;21 Suppl 1:1-8</Citation><ArticleIdList><ArticleId IdType="pubmed">22262586</ArticleId></ArticleIdList></Reference><Reference><Citation>PLoS One. 2015 Feb 23;10(2):e0118777</Citation><ArticleIdList><ArticleId IdType="pubmed">25706944</ArticleId></ArticleIdList></Reference><Reference><Citation>Pharmacoepidemiol Drug Saf. 2016 Jul;25(7):749-54</Citation><ArticleIdList><ArticleId IdType="pubmed">27183900</ArticleId></ArticleIdList></Reference><Reference><Citation>Stud Health Technol Inform. 2009;150:190-4</Citation><ArticleIdList><ArticleId IdType="pubmed">19745295</ArticleId></ArticleIdList></Reference><Reference><Citation>Health Aff (Millwood). 2014 Jul;33(7):1178-86</Citation><ArticleIdList><ArticleId IdType="pubmed">25006144</ArticleId></ArticleIdList></Reference><Reference><Citation>Ann Intern Med. 2010 Nov 2;153(9):600-6</Citation><ArticleIdList><ArticleId IdType="pubmed">21041580</ArticleId></ArticleIdList></Reference><Reference><Citation>BMJ. 2004 Oct 9;329(7470):816</Citation><ArticleIdList><ArticleId IdType="pubmed">15472245</ArticleId></ArticleIdList></Reference><Reference><Citation>Clin Ther. 1998;20 Suppl C:C40-4</Citation><ArticleIdList><ArticleId IdType="pubmed">9915089</ArticleId></ArticleIdList></Reference><Reference><Citation>Pharmacoepidemiol Drug Saf. 2015 May;24(5):486-94</Citation><ArticleIdList><ArticleId IdType="pubmed">25623045</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">28898514</PMID><DateCompleted><Year>2018</Year><Month>12</Month><Day>11</Day></DateCompleted><DateRevised><Year>2022</Year><Month>12</Month><Day>07</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1463-1326</ISSN><JournalIssue CitedMedium="Internet"><Volume>20</Volume><Issue>3</Issue><PubDate><Year>2018</Year><Month>Mar</Month></PubDate></JournalIssue><Title>Diabetes, obesity &amp; metabolism</Title><ISOAbbreviation>Diabetes Obes Metab</ISOAbbreviation></Journal><ArticleTitle>Risk of lower extremity amputations in people with type 2 diabetes mellitus treated with sodium-glucose co-transporter-2 inhibitors in the USA: A retrospective cohort study.</ArticleTitle><Pagination><StartPage>582</StartPage><EndPage>589</EndPage><MedlinePgn>582-589</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1111/dom.13115</ELocationID><Abstract><AbstractText Label="AIMS">To examine the incidence of amputation in patients with type 2 diabetes mellitus (T2DM) treated with sodium glucose co-transporter 2 (SGLT2) inhibitors overall, and canagliflozin specifically, compared with non-SGLT2 inhibitor antihyperglycaemic agents (AHAs).</AbstractText><AbstractText Label="MATERIALS AND METHODS">Patients with T2DM newly exposed to SGLT2 inhibitors or non-SGLT2 inhibitor AHAs were identified using the Truven MarketScan database. The incidence of below-knee lower extremity (BKLE) amputation was calculated for patients treated with SGLT2 inhibitors, canagliflozin, or non-SGLT2 inhibitor AHAs. Patients newly exposed to canagliflozin and non-SGLT2 inhibitor AHAs were matched 1:1 on propensity scores, and a Cox proportional hazards model was used for comparative analysis. Negative controls (outcomes not believed to be associated with any AHA) were used to calibrate P values.</AbstractText><AbstractText Label="RESULTS">Between April 1, 2013 and October 31, 2016, 118&#x2009;018 new users of SGLT2 inhibitors, including 73&#x2009;024 of canagliflozin, and 226&#x2009;623 new users of non-SGLT2 inhibitor AHAs were identified. The crude incidence rates of BKLE amputation were 1.22, 1.26 and 1.87 events per 1000 person-years with SGLT2 inhibitors, canagliflozin and non-SGLT2 inhibitor AHAs, respectively. For the comparative analysis, 63&#x2009;845 new users of canagliflozin were matched with 63&#x2009;845 new users of non-SGLT2 inhibitor AHAs, resulting in well-balanced baseline covariates. The incidence rates of BKLE amputation were 1.18 and 1.12 events per 1000 person-years with canagliflozin and non-SGLT2 inhibitor AHAs, respectively; the hazard ratio was 0.98 (95% confidence interval 0.68-1.41; P&#x2009;=&#x2009;.92, calibrated P&#x2009;=&#x2009;.95).</AbstractText><AbstractText Label="CONCLUSIONS">This real-world study observed no evidence of increased risk of BKLE amputation for new users of canagliflozin compared with non-SGLT2 inhibitor AHAs in a broad population of patients with T2DM.</AbstractText><CopyrightInformation>&#xa9; 2017 The Authors. Diabetes, Obesity and Metabolism published by John Wiley &amp; Sons Ltd.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Yuan</LastName><ForeName>Zhong</ForeName><Initials>Z</Initials><Identifier Source="ORCID">0000-0002-5824-2040</Identifier><AffiliationInfo><Affiliation>Janssen Research &amp; Development, LLC, Titusville, New Jersey.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>DeFalco</LastName><ForeName>Frank J</ForeName><Initials>FJ</Initials><AffiliationInfo><Affiliation>Janssen Research &amp; Development, LLC, Raritan, New Jersey.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ryan</LastName><ForeName>Patrick B</ForeName><Initials>PB</Initials><AffiliationInfo><Affiliation>Janssen Research &amp; Development, LLC, Titusville, New Jersey.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Schuemie</LastName><ForeName>Martijn J</ForeName><Initials>MJ</Initials><AffiliationInfo><Affiliation>Janssen Research &amp; Development, LLC, Titusville, New Jersey.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Stang</LastName><ForeName>Paul E</ForeName><Initials>PE</Initials><AffiliationInfo><Affiliation>Janssen Research &amp; Development, LLC, Titusville, New Jersey.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Berlin</LastName><ForeName>Jesse A</ForeName><Initials>JA</Initials><AffiliationInfo><Affiliation>Johnson &amp; Johnson, Titusville, New Jersey.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Desai</LastName><ForeName>Mehul</ForeName><Initials>M</Initials><Identifier Source="ORCID">0000-0003-3489-1967</Identifier><AffiliationInfo><Affiliation>Janssen Research &amp; Development, LLC, Raritan, New Jersey.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rosenthal</LastName><ForeName>Norm</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Janssen Research &amp; Development, LLC, Raritan, New Jersey.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D003160">Comparative Study</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016448">Multicenter Study</PublicationType><PublicationType UI="D064888">Observational Study</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2017</Year><Month>10</Month><Day>11</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Diabetes Obes Metab</MedlineTA><NlmUniqueID>100883645</NlmUniqueID><ISSNLinking>1462-8902</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D007004">Hypoglycemic Agents</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000077203">Sodium-Glucose Transporter 2 Inhibitors</NameOfSubstance></Chemical><Chemical><RegistryNumber>0SAC974Z85</RegistryNumber><NameOfSubstance UI="D000068896">Canagliflozin</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000671" MajorTopicYN="N">Amputation, Surgical</DescriptorName><QualifierName UI="Q000706" MajorTopicYN="Y">statistics &amp; numerical data</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000068896" MajorTopicYN="N">Canagliflozin</DescriptorName><QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D003924" MajorTopicYN="N">Diabetes Mellitus, Type 2</DescriptorName><QualifierName UI="Q000188" MajorTopicYN="Y">drug therapy</QualifierName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D003925" MajorTopicYN="N">Diabetic Angiopathies</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000601" MajorTopicYN="N">surgery</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007004" MajorTopicYN="N">Hypoglycemic Agents</DescriptorName><QualifierName UI="Q000627" MajorTopicYN="Y">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D007866" MajorTopicYN="N">Leg</DescriptorName><QualifierName UI="Q000098" MajorTopicYN="N">blood supply</QualifierName><QualifierName UI="Q000601" MajorTopicYN="N">surgery</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012189" MajorTopicYN="N">Retrospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012307" MajorTopicYN="N">Risk Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000077203" MajorTopicYN="N">Sodium-Glucose Transporter 2 Inhibitors</DescriptorName><QualifierName UI="Q000627" MajorTopicYN="Y">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D014481" MajorTopicYN="N">United States</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">SGLT2 inhibitor</Keyword><Keyword MajorTopicYN="N">type 2 diabetes</Keyword></KeywordList><CoiStatement>Z. Y., F. J. D., P. B. R., M. J. S., P. E. S., M. D. and N. R. are full&#x2010;time employees of Janssen Research &amp; Development, LLC. J. A. B. is a full&#x2010;time employee of Johnson &amp; Johnson, LLC.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2017</Year><Month>7</Month><Day>17</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2017</Year><Month>8</Month><Day>28</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2017</Year><Month>9</Month><Day>1</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2017</Year><Month>9</Month><Day>13</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2018</Year><Month>12</Month><Day>12</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2017</Year><Month>9</Month><Day>13</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2018</Year><Month>3</Month><Day>5</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">28898514</ArticleId><ArticleId IdType="pmc">PMC5836890</ArticleId><ArticleId IdType="doi">10.1111/dom.13115</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>American Diabetes Association . Standards of medical care in diabetes&#x2010;2017. Diabetes Care. 2017;40(suppl 1):S1&#x2013;S135.</Citation><ArticleIdList><ArticleId IdType="pubmed">0</ArticleId></ArticleIdList></Reference><Reference><Citation>Boulton AJ, Vinik AI, Arezzo JC, et al. Diabetic neuropathies: a statement by the American Diabetes Association. Diabetes Care. 2005;28(4):956&#x2013;962.</Citation><ArticleIdList><ArticleId IdType="pubmed">15793206</ArticleId></ArticleIdList></Reference><Reference><Citation>
National Center for Chronic Disease Prevention. National diabetes statistics report
, 2017. 
https://www.cdc.gov/diabetes/pdfs/data/statistics/national&#x2010;diabetes&#x2010;statistics&#x2010;report.pdf. Accessed September 21, 2017.</Citation></Reference><Reference><Citation>
World Health Organization. Global report on diabetes
, 2016. 
http://apps.who.int/iris/bitstream/10665/204871/1/9789241565257_eng.pdf?ua=1. Accessed July 5, 2017.</Citation></Reference><Reference><Citation>Bruun C, Siersma V, Guassora AD, Holstein P, de Fine Olivarius N. Amputations and foot ulcers in patients newly diagnosed with type 2 diabetes mellitus and observed for 19 years. The role of age, gender and co&#x2010;morbidity. Diabet Med. 2013;30(8):964&#x2013;972.</Citation><ArticleIdList><ArticleId IdType="pubmed">23617411</ArticleId></ArticleIdList></Reference><Reference><Citation>Yesil S, Akinci B, Yener S, et al. Predictors of amputation in diabetics with foot ulcer: single center experience in a large Turkish cohort. Hormones (Athens). 2009;8(4):286&#x2013;295.</Citation><ArticleIdList><ArticleId IdType="pubmed">20045802</ArticleId></ArticleIdList></Reference><Reference><Citation>Lai YJ, Hu HY, Lin CH, Lee ST, Kuo SC, Chou P. Incidence and risk factors of lower extremity amputations in people with type 2 diabetes in Taiwan, 2001&#x2010;2010. J Diabetes. 2015;7(2):260&#x2013;267.</Citation><ArticleIdList><ArticleId IdType="pubmed">24823436</ArticleId></ArticleIdList></Reference><Reference><Citation>Zoungas S, Arima H, Gerstein HC, et al. Effects of intensive glucose control on microvascular outcomes in patients with type 2 diabetes: a meta&#x2010;analysis of individual participant data from randomised controlled trials. Lancet Diabetes Endocrinol. 2017;5(6):431&#x2013;437.</Citation><ArticleIdList><ArticleId IdType="pubmed">28365411</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhou ZY, Liu YK, Chen HL, Yang HL, Liu F. HbA1c and lower extremity amputation risk in patients with diabetes: a meta&#x2010;analysis. Int J Low Extrem Wounds. 2015;14(2):168&#x2013;177.</Citation><ArticleIdList><ArticleId IdType="pubmed">26130760</ArticleId></ArticleIdList></Reference><Reference><Citation>Abdul&#x2010;Ghani MA, Norton L, DeFronzo RA. Renal sodium&#x2010;glucose cotransporter inhibition in the management of type 2 diabetes mellitus. Am J Physiol Renal Physiol. 2015;309(11):F889&#x2013;F900.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4669360</ArticleId><ArticleId IdType="pubmed">26354881</ArticleId></ArticleIdList></Reference><Reference><Citation>Mudaliar S, Polidori D, Zambrowicz B, Henry RR. Sodium&#x2010;glucose cotransporter inhibitors: effects on renal and intestinal glucose transport: from bench to bedside. Diabetes Care. 2015;38(12):2344&#x2013;2353.</Citation><ArticleIdList><ArticleId IdType="pubmed">26604280</ArticleId></ArticleIdList></Reference><Reference><Citation>Rosenthal N, Meininger G, Ways K, et al. Canagliflozin: a sodium glucose co&#x2010;transporter 2 inhibitor for the treatment of type 2 diabetes mellitus. Ann N Y Acad Sci. 2015;1358(1):28&#x2013;43.</Citation><ArticleIdList><ArticleId IdType="pubmed">26305874</ArticleId></ArticleIdList></Reference><Reference><Citation>Davis PN, Ndefo UA, Oliver A. Dapagliflozin: a sodium glucose cotransporter 2 inhibitor for the treatment of diabetes mellitus. J Pharm Pract. 2016;29(2):165&#x2013;171.</Citation><ArticleIdList><ArticleId IdType="pubmed">25609661</ArticleId></ArticleIdList></Reference><Reference><Citation>Liakos A, Karagiannis T, Athanasiadou E, et al. Efficacy and safety of empagliflozin for type 2 diabetes: a systematic review and meta&#x2010;analysis. Diabetes Obes Metab. 2014;16(10):984&#x2013;993.</Citation><ArticleIdList><ArticleId IdType="pubmed">24766495</ArticleId></ArticleIdList></Reference><Reference><Citation>Neal B, Perkovic V, Mahaffey KW, et al. Canagliflozin and cardiovascular and renal events in type 2 diabetes. N Engl J Med. 2017;377(7):644&#x2013;657.</Citation><ArticleIdList><ArticleId IdType="pubmed">28605608</ArticleId></ArticleIdList></Reference><Reference><Citation>
US Food and Drug Administration
. FDA confirms increased risk of leg and foot amputations with the diabetes medicine canagliflozin (Invokana, Invokamet, Invokamet XR). 2017. 
https://www.fda.gov/downloads/Drugs/DrugSafety/UCM558427.pdf. Accessed August 9, 2017.</Citation></Reference><Reference><Citation>INVOKANA&#xae; (canagliflozin) tablets, for oral use [package insert]. Titusville, NJ: Janssen Pharmaceuticals; 2017.</Citation></Reference><Reference><Citation>
European Medicines Agency
. PRAC concludes that diabetes medicine canagliflozin may contribute to risk of toe amputation. Risk may also apply to other medicines in the same class. 2017. 
http://www.ema.europa.eu/docs/en_GB/document_library/Referrals_document/SGLT2_inhibitors_Canagliflozin_20/Recommendation_provided_by_Pharmacovigilance_Risk_Assessment_Committee/WC500221431.pdf. Accessed July 5, 2017.</Citation></Reference><Reference><Citation>
European Medicines Agency
. SGLT2 inhibitors: information on potential risk of toe amputation to be included in prescribing information. 2017. 
http://www.ema.europa.eu/docs/en_GB/document_library/Press_release/2017/02/WC500222191.pdf. Accessed May 26, 2017.</Citation></Reference><Reference><Citation>Genkin A, Lewis DD, Madigan D. Large&#x2010;scale Bayesian logistic regression for text categorization. Dent Tech. 2007;49(3):291&#x2013;304.</Citation></Reference><Reference><Citation>Tibshirani R. Regression shrinkage and selection via the lasso. J R Stat Soc Ser B Methodol. 1996;58(1):267&#x2013;288.</Citation></Reference><Reference><Citation>Rassen JA, Shelat AA, Myers J, Glynn RJ, Rothman KJ, Schneeweiss S. One&#x2010;to&#x2010;many propensity score matching in cohort studies. Pharmacoepidemiol Drug Saf. 2012;21(suppl 2):69&#x2013;80.</Citation><ArticleIdList><ArticleId IdType="pubmed">22552982</ArticleId></ArticleIdList></Reference><Reference><Citation>Austin PC. Optimal caliper widths for propensity&#x2010;score matching when estimating differences in means and differences in proportions in observational studies. Pharm Stat. 2011;10(2):150&#x2013;161.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3120982</ArticleId><ArticleId IdType="pubmed">20925139</ArticleId></ArticleIdList></Reference><Reference><Citation>Rosenbaum P, Rubin D. The central role of the propensity score in observational studies for causal effects. Biometrika. 1983;70(1):41&#x2013;55.</Citation></Reference><Reference><Citation>Schuemie MJ, Ryan PB, DuMouchel W, Suchard MA, Madigan D. Interpreting observational studies: why empirical calibration is needed to correct p&#x2010;values. Stat Med. 2014;33(2):209&#x2013;218.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4285234</ArticleId><ArticleId IdType="pubmed">23900808</ArticleId></ArticleIdList></Reference><Reference><Citation>Boyce RD, Ryan PB, Noren GN, et al. Bridging islands of information to establish an integrated knowledge base of drugs and health outcomes of interest. Drug Saf. 2014;37(8):557&#x2013;567.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4134480</ArticleId><ArticleId IdType="pubmed">24985530</ArticleId></ArticleIdList></Reference><Reference><Citation>Arnold BF, Ercumen A, Benjamin&#x2010;Chung J, Colford JM Jr. Brief report: negative controls to detect selection bias and measurement bias in epidemiologic studies. Epidemiology. 2016;27(5):637&#x2013;641.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4969055</ArticleId><ArticleId IdType="pubmed">27182642</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">29036387</PMID><DateRevised><Year>2022</Year><Month>04</Month><Day>09</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1527-974X</ISSN><JournalIssue CitedMedium="Internet"><Volume>25</Volume><Issue>3</Issue><PubDate><Year>2018</Year><Month>Mar</Month><Day>01</Day></PubDate></JournalIssue><Title>Journal of the American Medical Informatics Association : JAMIA</Title><ISOAbbreviation>J Am Med Inform Assoc</ISOAbbreviation></Journal><ArticleTitle>Uncovering exposures responsible for birth season - disease effects: a global study.</ArticleTitle><Pagination><StartPage>275</StartPage><EndPage>288</EndPage><MedlinePgn>275-288</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1093/jamia/ocx105</ELocationID><Abstract><AbstractText Label="OBJECTIVE" NlmCategory="OBJECTIVE">Birth month and climate impact lifetime disease risk, while the underlying exposures remain largely elusive. We seek to uncover distal risk factors underlying these relationships by probing the relationship between global exposure variance and disease risk variance by birth season.</AbstractText><AbstractText Label="MATERIAL AND METHODS" NlmCategory="METHODS">This study utilizes electronic health record data from 6 sites representing 10.5 million individuals in 3 countries (United States, South Korea, and Taiwan). We obtained birth month-disease risk curves from each site in a case-control manner. Next, we correlated each birth month-disease risk curve with each exposure. A meta-analysis was then performed of correlations across sites. This allowed us to identify the most significant birth month-exposure relationships supported by all 6 sites while adjusting for multiplicity. We also successfully distinguish relative age effects (a cultural effect) from environmental exposures.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">Attention deficit hyperactivity disorder was the only identified relative age association. Our methods identified several culprit exposures that correspond well with the literature in the field. These include a link between first-trimester exposure to carbon monoxide and increased risk of depressive disorder (R&#x2009;=&#x2009;0.725, confidence interval [95% CI], 0.529-0.847), first-trimester exposure to fine air particulates and increased risk of atrial fibrillation (R&#x2009;=&#x2009;0.564, 95% CI, 0.363-0.715), and decreased exposure to sunlight during the third trimester and increased risk of type 2 diabetes mellitus (R&#x2009;=&#x2009;-0.816, 95% CI, -0.5767, -0.929).</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">A global study of birth month-disease relationships reveals distal risk factors involved in causal biological pathways that underlie them.</AbstractText><CopyrightInformation>&#xa9; The Author 2017. Published by Oxford University Press on behalf of the American Medical Informatics Association.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Boland</LastName><ForeName>Mary Regina</ForeName><Initials>MR</Initials><AffiliationInfo><Affiliation>Department of Biostatistics, Epidemiology and Informatics, University of Pennsylvania, Philadelphia, PA, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Institute for Biomedical Informatics, University of Pennsylvania, Philadelphia, PA, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Center for Excellence in Environmental Toxicology, University of Pennsylvania, Philadelphia, PA, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Biomedical and Health Informatics, Children's Hospital of Philadelphia, Philadelphia, PA, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Biomedical Informatics, Columbia University, New York, NY, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Observational Health Data Sciences and Informatics, Columbia University, New York, NY, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Parhi</LastName><ForeName>Pradipta</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Department of Earth and Environmental Engineering, Columbia University, New York, NY, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Li</LastName><ForeName>Li</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Department of Genetics and Genomic Sciences, Icahn School of Medicine at Mount Sinai, New York, NY, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Institute for Next Generation Healthcare, Icahn School of Medicine at Mount Sinai, New York, NY, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Miotto</LastName><ForeName>Riccardo</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Department of Genetics and Genomic Sciences, Icahn School of Medicine at Mount Sinai, New York, NY, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Institute for Next Generation Healthcare, Icahn School of Medicine at Mount Sinai, New York, NY, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Carroll</LastName><ForeName>Robert</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Department of Biomedical Informatics, Vanderbilt University Medical Center, Nashville, TN, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Iqbal</LastName><ForeName>Usman</ForeName><Initials>U</Initials><AffiliationInfo><Affiliation>Observational Health Data Sciences and Informatics, Columbia University, New York, NY, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Masters Program in Global Health and Development Department, College of Public Health, Taipei Medical University, Taiwan.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>College of Medical Science and Technology, Taipei Medical University, Taiwan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Nguyen</LastName><ForeName>Phung-Anh Alex</ForeName><Initials>PA</Initials><AffiliationInfo><Affiliation>Observational Health Data Sciences and Informatics, Columbia University, New York, NY, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Masters Program in Global Health and Development Department, College of Public Health, Taipei Medical University, Taiwan.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>International Center for Health Information Technology, Taipei Medical University, Taiwan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Schuemie</LastName><ForeName>Martijn</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Observational Health Data Sciences and Informatics, Columbia University, New York, NY, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Janssen Research and Development, Raritan, NJ, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>You</LastName><ForeName>Seng Chan</ForeName><Initials>SC</Initials><AffiliationInfo><Affiliation>Observational Health Data Sciences and Informatics, Columbia University, New York, NY, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Biomedical Informatics, Ajou University School of Medicine, Republic of Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Smith</LastName><ForeName>Donahue</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Department of Biomedical Informatics, University of Washington, Seattle, Washington, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mooney</LastName><ForeName>Sean</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Biomedical Informatics, University of Washington, Seattle, Washington, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ryan</LastName><ForeName>Patrick</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Department of Biomedical Informatics, Columbia University, New York, NY, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Observational Health Data Sciences and Informatics, Columbia University, New York, NY, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Janssen Research and Development, Raritan, NJ, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Li</LastName><ForeName>Yu-Chuan Jack</ForeName><Initials>YJ</Initials><AffiliationInfo><Affiliation>Observational Health Data Sciences and Informatics, Columbia University, New York, NY, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>College of Medical Science and Technology, Taipei Medical University, Taiwan.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>International Center for Health Information Technology, Taipei Medical University, Taiwan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Park</LastName><ForeName>Rae Woong</ForeName><Initials>RW</Initials><AffiliationInfo><Affiliation>Observational Health Data Sciences and Informatics, Columbia University, New York, NY, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Biomedical Informatics, Ajou University School of Medicine, Republic of Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Denny</LastName><ForeName>Josh</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Biomedical Informatics, Vanderbilt University Medical Center, Nashville, TN, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Medicine, Vanderbilt University Medical Center, Nashville, TN, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Dudley</LastName><ForeName>Joel T</ForeName><Initials>JT</Initials><AffiliationInfo><Affiliation>Department of Genetics and Genomic Sciences, Icahn School of Medicine at Mount Sinai, New York, NY, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Institute for Next Generation Healthcare, Icahn School of Medicine at Mount Sinai, New York, NY, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hripcsak</LastName><ForeName>George</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Department of Biomedical Informatics, Columbia University, New York, NY, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Observational Health Data Sciences and Informatics, Columbia University, New York, NY, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gentine</LastName><ForeName>Pierre</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Department of Earth and Environmental Engineering, Columbia University, New York, NY, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tatonetti</LastName><ForeName>Nicholas P</ForeName><Initials>NP</Initials><AffiliationInfo><Affiliation>Department of Biomedical Informatics, Columbia University, New York, NY, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Observational Health Data Sciences and Informatics, Columbia University, New York, NY, USA.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>T15 LM007442</GrantID><Acronym>LM</Acronym><Agency>NLM NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>TL1 RR024158</GrantID><Acronym>RR</Acronym><Agency>NCRR NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>TL1 TR000082</GrantID><Acronym>TR</Acronym><Agency>NCATS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R01 GM107145</GrantID><Acronym>GM</Acronym><Agency>NIGMS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>UL1 TR000423</GrantID><Acronym>TR</Acronym><Agency>NCATS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>TL1 TR001875</GrantID><Acronym>TR</Acronym><Agency>NCATS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>OT3 TR002027</GrantID><Acronym>TR</Acronym><Agency>NCATS NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>J Am Med Inform Assoc</MedlineTA><NlmUniqueID>9430800</NlmUniqueID><ISSNLinking>1067-5027</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">attention deficit hyperactivity disorder</Keyword><Keyword MajorTopicYN="N">electronic health records</Keyword><Keyword MajorTopicYN="N">environmental exposure</Keyword><Keyword MajorTopicYN="N">pregnancy</Keyword><Keyword MajorTopicYN="N">seasons</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2017</Year><Month>5</Month><Day>1</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2017</Year><Month>8</Month><Day>24</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2017</Year><Month>9</Month><Day>5</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2017</Year><Month>10</Month><Day>17</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2017</Year><Month>10</Month><Day>17</Day><Hour>6</Hour><Minute>1</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2017</Year><Month>10</Month><Day>17</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2017</Year><Month>9</Month><Day>28</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">29036387</ArticleId><ArticleId IdType="pmc">PMC7282503</ArticleId><ArticleId IdType="doi">10.1093/jamia/ocx105</ArticleId><ArticleId IdType="pii">4265709</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Hippocrates, Galen.Hippocratic Writings and On The Natural Faculties. Chicago: Encyclopaedia Britannica;1952.</Citation></Reference><Reference><Citation>Jarup L. Health and environment information systems for exposure and disease mapping, and risk assessment.Environ Health Perspect. 2004;112:995&#x2013;97.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1247192</ArticleId><ArticleId IdType="pubmed">15198919</ArticleId></ArticleIdList></Reference><Reference><Citation>Boland MR,Parhi P,Gentine P,Tatonetti NP. Climate classification is an important factor in assessing quality-of-care across hospitals.Scientific Reports. 2017;71:4948.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5504082</ArticleId><ArticleId IdType="pubmed">28694475</ArticleId></ArticleIdList></Reference><Reference><Citation>Stillerman KP,Mattison DR,Giudice LC,Woodruff TJ. Environmental exposures and adverse pregnancy outcomes: a review of the science.Reprod Sci. 2008;157:631&#x2013;50.</Citation><ArticleIdList><ArticleId IdType="pubmed">18836129</ArticleId></ArticleIdList></Reference><Reference><Citation>Dolinoy DC,Weidman JR,Jirtle RL. Epigenetic gene regulation: linking early developmental environment to adult disease.Reprod Toxicol. 2007;233:297&#x2013;307.</Citation><ArticleIdList><ArticleId IdType="pubmed">17046196</ArticleId></ArticleIdList></Reference><Reference><Citation>Waldie KE,Poulton R,Kirk IJ,Silva PA. The effects of pre-and post-natal sunlight exposure on human growth: evidence from the Southern Hemisphere.Early Human Dev. 2000;601:35&#x2013;42.</Citation><ArticleIdList><ArticleId IdType="pubmed">11054582</ArticleId></ArticleIdList></Reference><Reference><Citation>Crowther CA. Eclampsia at Harare Maternity Hospital: an epidemiological study.South African Med J. 1985;6813:927&#x2013;29.</Citation><ArticleIdList><ArticleId IdType="pubmed">4081926</ArticleId></ArticleIdList></Reference><Reference><Citation>B&#xe1;nhidy F,Puh&#xf3; E,Czeizel AE. Maternal influenza during pregnancy and risk of congenital abnormalities in offspring.Birth Defects Res Part A: Clin Mol Teratol. 2005;7312:989&#x2013;96.</Citation><ArticleIdList><ArticleId IdType="pubmed">16323157</ArticleId></ArticleIdList></Reference><Reference><Citation>Raub JA,Mathieu-Nolf M,Hampson NB,Thom SR. Carbon monoxide poisoning&#x2014;a public health perspective.Toxicology. 2000;1451:1&#x2013;14.</Citation><ArticleIdList><ArticleId IdType="pubmed">10771127</ArticleId></ArticleIdList></Reference><Reference><Citation>Singh J. Nitrogen dioxide exposure alters neonatal development.Neurotoxicology. 1987;93:545&#x2013;49.</Citation><ArticleIdList><ArticleId IdType="pubmed">3200515</ArticleId></ArticleIdList></Reference><Reference><Citation>Maroziene L,Grazuleviciene R. Maternal exposure to low-level air pollution and pregnancy outcomes: a population-based study.Environ Health. 2002;11:1.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC149395</ArticleId><ArticleId IdType="pubmed">12495448</ArticleId></ArticleIdList></Reference><Reference><Citation>Salam MT,Millstein J,Li Y-F,Lurmann FW,Margolis HG,Gilliland FD. Birth outcomes and prenatal exposure to ozone, carbon monoxide, and particulate matter: results from the Children's Health Study.Environ Health Perspect. 2005:1638&#x2013;44.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1310931</ArticleId><ArticleId IdType="pubmed">16263524</ArticleId></ArticleIdList></Reference><Reference><Citation>Rogers JF,Thompson SJ,Addy CL,McKeown RE,Cowen DJ,Decoufle P. Association of very low birth weight with exposures to environmental sulfur dioxide and total suspended particulates.Am J Epidemiol. 2000;1516:602&#x2013;13.</Citation><ArticleIdList><ArticleId IdType="pubmed">10733042</ArticleId></ArticleIdList></Reference><Reference><Citation>Oke T. The heat island of the urban boundary layer: characteristics, causes and effects. In:Wind Climate in Cities. Dordrecht: Springer;1995: 81&#x2013;107.</Citation></Reference><Reference><Citation>Korsgaard J,Dahl R. Sensitivity to house dust mite and grass pollen in adults.Clin Exp Allergy. 1983;136:529&#x2013;36.</Citation><ArticleIdList><ArticleId IdType="pubmed">6640888</ArticleId></ArticleIdList></Reference><Reference><Citation>Zock J-P,Heinrich J,Jarvis D,et al.Distribution and determinants of house dust mite allergens in Europe: the European Community Respiratory Health Survey II.J Allergy Clin Immunol. 2006;1183:682&#x2013;90.</Citation><ArticleIdList><ArticleId IdType="pubmed">16950288</ArticleId></ArticleIdList></Reference><Reference><Citation>Harving H,Korsgaard J,Dahl R. House-dust mites and associated environmental conditions in Danish homes.Allergy. 1993;482:106&#x2013;09.</Citation><ArticleIdList><ArticleId IdType="pubmed">8457030</ArticleId></ArticleIdList></Reference><Reference><Citation>Bradford JB,Lauenroth WK,Burke IC,Paruelo JM. The influence of climate, soils, weather, and land use on primary production and biomass seasonality in the US Great Plains.Ecosystems. 2006;96:934&#x2013;50.</Citation></Reference><Reference><Citation>Stone CP.A glimpse at EHR implementation around the world: the lessons the US can learn Arlington, VA: Health Institute for E-Health Policy; 2014.</Citation></Reference><Reference><Citation>Boland M,Shahn Z,Madigan D,Hripcsak G,Tatonetti N. Birth month affects lifetime disease risk: a phenome-wide method.J Am Med Inform Assoc. 2015;22:1042&#x2013;53.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4986668</ArticleId><ArticleId IdType="pubmed">26041386</ArticleId></ArticleIdList></Reference><Reference><Citation>Li L,Boland MR,Miotto R,Tatonetti NP,Dudley JT. Replicating cardiovascular condition&#x2013;birth month associations.Scientific Reports. 2016;6:33166.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5021975</ArticleId><ArticleId IdType="pubmed">27624541</ArticleId></ArticleIdList></Reference><Reference><Citation>Melnikov V,Suvorova IY,Belisheva N. Central hemodynamics and arterial stiffness in adult humans depend on the conditions of early development in the Northern Kola Peninsula.Human Physiol. 2016;422:150&#x2013;55.</Citation></Reference><Reference><Citation>Melnikov VN. Life span of people who died from cardiovascular diseases in Siberia: a comparative study of two populations.Int J Circumpolar Health. 2003;623:296&#x2013;307.</Citation><ArticleIdList><ArticleId IdType="pubmed">14594204</ArticleId></ArticleIdList></Reference><Reference><Citation>Musch J,Grondin S. Unequal competition as an impediment to personal development: a review of the relative age effect in sport.Dev Rev. 2001;212:147&#x2013;67.</Citation></Reference><Reference><Citation>Olweus D. Bullying at school. In:Huesmann LR, ed.Aggressive Behavior: Current Perspectives. Boston: Springer;1994:97&#x2013;130.</Citation></Reference><Reference><Citation>Overhage JM,Ryan PB,Reich CG,Hartzema AG,Stang PE. Validation of a common data model for active safety surveillance research.J Am Med Inform Assoc. 2012;191:54&#x2013;60.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3240764</ArticleId><ArticleId IdType="pubmed">22037893</ArticleId></ArticleIdList></Reference><Reference><Citation>
Boland MR.
SeaWAS project code.GitHub Repository. 2015https://github.com/maryreginaboland/SeaWAS. Accessed from August 2015 - October 2016.</Citation></Reference><Reference><Citation>Boland MR,Hripcsak G,Ryan P,Tatonetti NP. A Climate-Wide Journey to Explore Mechanisms Underlying Birth Month-Disease Risk Associations: A Call for Collaboration.</Citation></Reference><Reference><Citation>Kottek M,Grieser J,Beck C,Rudolf B,Rubel F. World map of the K&#xf6;ppen-Geiger climate classification updated.Meteorologische Zeitschrift. 2006;153:259&#x2013;63.</Citation></Reference><Reference><Citation>K&#xf6;ppen W. The thermal zones of the Earth according to the duration of hot, moderate and cold periods and of the impact of heat on the organic world.Meteorol Z. 1884;20:351&#x2013;60.</Citation></Reference><Reference><Citation>Helsen WF,Van Winckel J,Williams AM. The relative age effect in youth soccer across Europe.J Sports Sci. 2005;236:629&#x2013;36.</Citation><ArticleIdList><ArticleId IdType="pubmed">16195011</ArticleId></ArticleIdList></Reference><Reference><Citation>M&#xfc;hlenweg AM. Young and innocent: international evidence on age effects within grades on victimization in elementary school.Econ Lett. 2010;1093:157&#x2013;60.</Citation></Reference><Reference><Citation>B&#xe9;rard A,Ramos E,Rey E,Blais L,St Andr&#xe9; M,Oraichi D. First trimester exposure to paroxetine and risk of cardiac malformations in infants: the importance of dosage.Birth Defects Res Part B: Dev Reprod Toxicol. 2007;801:18&#x2013;27.</Citation><ArticleIdList><ArticleId IdType="pubmed">17187388</ArticleId></ArticleIdList></Reference><Reference><Citation>Goldstein DJ. Effects of third trimester fluoxetine exposure on the newborn.J Clin Psychopharmacol. 1995;156:417&#x2013;20.</Citation><ArticleIdList><ArticleId IdType="pubmed">8748430</ArticleId></ArticleIdList></Reference><Reference><Citation>Hsieh W-S,Wu H-C,Jeng S-F,et al.Nationwide singleton birth weight percentiles by gestational age in Taiwan, 1998&#x2013;2002.Acta Paediatrica Taiwanica. 2006;471:25.</Citation><ArticleIdList><ArticleId IdType="pubmed">17016966</ArticleId></ArticleIdList></Reference><Reference><Citation>Lim JW,Lee JJ,Park CG,Sriram S,Lee K-S. Birth outcomes of Koreans by birthplace of infants and their mothers, the United States versus Korea, 1995-2004.J Korean Med Sci. 2010;259:1343&#x2013;51.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2923796</ArticleId><ArticleId IdType="pubmed">20808679</ArticleId></ArticleIdList></Reference><Reference><Citation>
CDC. 
Measuring Gestational Age in Vital Statistics Data: Transitioning to the Obstetric Estimate.National Vital Statistics Reports. 2015www.cdc.gov/nchs/data/nvsr/nvsr64/nvsr64_05.pdf. Accessed July 28, 2016.</Citation><ArticleIdList><ArticleId IdType="pubmed">26047089</ArticleId></ArticleIdList></Reference><Reference><Citation>DerSimonian R,Laird N. Meta-analysis in clinical trials.Controlled Clin Trials. 1986;73:177&#x2013;88.</Citation><ArticleIdList><ArticleId IdType="pubmed">3802833</ArticleId></ArticleIdList></Reference><Reference><Citation>Schulze R.Meta-analysis: A Comparison of Approaches. Boston: Hogrefe;2004.</Citation></Reference><Reference><Citation>Lalibert&#xe9; E,Lalibert&#xe9; ME. Package &#x201c;metacor.&#x201d; 2015.</Citation></Reference><Reference><Citation>Polderman TJC,Benyamin B,de Leeuw CA,et al.Meta-analysis of the heritability of human traits based on fifty years of twin studies.Nat Genet. 2015;477:702&#x2013;09.</Citation><ArticleIdList><ArticleId IdType="pubmed">25985137</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen M-H,Lan W-H,Bai Y-M,et al.Influence of relative age on diagnosis and treatment of attention-deficit hyperactivity disorder in Taiwanese children.J Pediatrics. 2016;172:162&#x2013;67.</Citation><ArticleIdList><ArticleId IdType="pubmed">26973148</ArticleId></ArticleIdList></Reference><Reference><Citation>Zo&#xeb;ga H,Valdimarsd&#xf3;ttir UA,Hern&#xe1;ndez-D&#xed;az S. Age, academic performance, and stimulant prescribing for ADHD: a nationwide cohort study.Pediatrics. 2012;1306:1012&#x2013;18.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3507253</ArticleId><ArticleId IdType="pubmed">23166340</ArticleId></ArticleIdList></Reference><Reference><Citation>Evans WN,Morrill MS,Parente ST. Measuring inappropriate medical diagnosis and treatment in survey data: the case of ADHD among school-age children.J Health Econ. 2010;295:657&#x2013;73.</Citation><ArticleIdList><ArticleId IdType="pubmed">20739076</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang C,Qiu C,Hu FB,et al.Maternal plasma 25-hydroxyvitamin D concentrations and the risk for gestational diabetes mellitus.PLoS ONE. 2008;311:e3753.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2582131</ArticleId><ArticleId IdType="pubmed">19015731</ArticleId></ArticleIdList></Reference><Reference><Citation>Clausen TD,Mathiesen ER,Hansen T,et al.High prevalence of type 2 diabetes and pre-diabetes in adult offspring of women with gestational diabetes mellitus or type 1 diabetes the role of intrauterine hyperglycemia.Diabetes Care. 2008;312:340&#x2013;46.</Citation><ArticleIdList><ArticleId IdType="pubmed">18000174</ArticleId></ArticleIdList></Reference><Reference><Citation>Scott-Phillips TC,Dickins TE,West SA. Evolutionary theory and the ultimate-proximate distinction in the human behavioral sciences.Perspect Psychol Sci. 2011;61:38&#x2013;47.</Citation><ArticleIdList><ArticleId IdType="pubmed">26162114</ArticleId></ArticleIdList></Reference><Reference><Citation>Laland KN,Sterelny K,Odling-Smee J,Hoppitt W,Uller T. Cause and effect in biology revisited: is Mayr&#x2019;s proximate-ultimate dichotomy still useful? Science. 2011;3346062:1512&#x2013;16.</Citation><ArticleIdList><ArticleId IdType="pubmed">22174243</ArticleId></ArticleIdList></Reference><Reference><Citation>Hales C,Barker D. Type 2 (non-insulin-dependent) diabetes mellitus: the thrifty phenotype hypothesis.Int J Epidemiol. 2013;425:1215&#x2013;22.</Citation><ArticleIdList><ArticleId IdType="pubmed">24159065</ArticleId></ArticleIdList></Reference><Reference><Citation>Hales CN,Barker DJ. Type 2 (non-insulin-dependent) diabetes mellitus: the thrifty phenotype hypothesis.Diabetologia. 1992;357:595&#x2013;601.</Citation><ArticleIdList><ArticleId IdType="pubmed">1644236</ArticleId></ArticleIdList></Reference><Reference><Citation>Joiner TE Jr,Pfaff JJ,Acres JG,Johnson F. Birth month and suicidal and depressive symptoms in Australians born in the Southern vs. the Northern hemisphere.Psychiatry Res. 2002;1121:89&#x2013;92.</Citation><ArticleIdList><ArticleId IdType="pubmed">12379455</ArticleId></ArticleIdList></Reference><Reference><Citation>Moffitt TE,Harrington H,Caspi A,et al.Depression and generalized anxiety disorder: cumulative and sequential comorbidity in a birth cohort followed prospectively to age 32 years.Arch General Psychiatry. 2007;646:651&#x2013;60.</Citation><ArticleIdList><ArticleId IdType="pubmed">17548747</ArticleId></ArticleIdList></Reference><Reference><Citation>Knobeloch L,Jackson R. Recognition of chronic carbon monoxide poisoning.Wis Med J. 1999;986:26&#x2013;29.</Citation><ArticleIdList><ArticleId IdType="pubmed">10605352</ArticleId></ArticleIdList></Reference><Reference><Citation>Mactutus C,Fechter L. Prenatal exposure to carbon monoxide: learning and memory deficits.Science. 1984;2234634:409&#x2013;11.</Citation><ArticleIdList><ArticleId IdType="pubmed">6691152</ArticleId></ArticleIdList></Reference><Reference><Citation>Mereu G,Cammalleri M,F&#xe0; M,et al.Prenatal exposure to a low concentration of carbon monoxide disrupts hippocampal long-term potentiation in rat offspring.J Pharmacol Exp Therapeutics. 2000;2942:728&#x2013;34.</Citation><ArticleIdList><ArticleId IdType="pubmed">10900254</ArticleId></ArticleIdList></Reference><Reference><Citation>Sapolsky RM. Depression, antidepressants, and the shrinking hippocampus.Proc Natl Acad Sci. 2001;9822:12320&#x2013;22.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC60045</ArticleId><ArticleId IdType="pubmed">11675480</ArticleId></ArticleIdList></Reference><Reference><Citation>Dominici F,Peng RD,Bell ML,et al.Fine particulate air pollution and hospital admission for cardiovascular and respiratory diseases.JAMA. 2006;29510:1127&#x2013;34.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3543154</ArticleId><ArticleId IdType="pubmed">16522832</ArticleId></ArticleIdList></Reference><Reference><Citation>Ito K,Mathes R,Ross Z,N&#xe1;das A,Thurston G,Matte T. Fine particulate matter constituents associated with cardiovascular hospitalizations and mortality in New York City.Env Health Perspect. 2011;1194:467.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3080927</ArticleId><ArticleId IdType="pubmed">21463978</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhou J,Ito K,Lall R,Lippmann M,Thurston G. Time-series analysis of mortality effects of fine particulate matter components in Detroit and Seattle.Env Health Perspect. 2011;1194:461.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3080926</ArticleId><ArticleId IdType="pubmed">21193387</ArticleId></ArticleIdList></Reference><Reference><Citation>Brook RD,Bard RL,Burnett RT,et al.Differences in blood pressure and vascular responses associated with ambient fine particulate matter exposures measured at the personal versus community level.Occup Environ Med. 2011;683:224&#x2013;30.</Citation><ArticleIdList><ArticleId IdType="pubmed">20935292</ArticleId></ArticleIdList></Reference><Reference><Citation>Miettola S,Hartikainen A-L,V&#xe4;&#xe4;r&#xe4;sm&#xe4;ki M,et al.Offspring&#x2019;s blood pressure and metabolic phenotype after exposure to gestational hypertension in utero.Eur J Epidemiol. 2013;281:87&#x2013;98.</Citation><ArticleIdList><ArticleId IdType="pubmed">23354981</ArticleId></ArticleIdList></Reference><Reference><Citation>Psaty BM,Manolio TA,Kuller LH,et al.Incidence of and risk factors for atrial fibrillation in older adults.Circulation. 1997;967:2455&#x2013;61.</Citation><ArticleIdList><ArticleId IdType="pubmed">9337224</ArticleId></ArticleIdList></Reference><Reference><Citation>Vinikoor-Imler LC,Gray SC,Edwards SE,Miranda ML. The effects of exposure to particulate matter and neighbourhood deprivation on gestational hypertension.Paediatric Perinatal Epidemiol. 2012;262:91&#x2013;100.</Citation><ArticleIdList><ArticleId IdType="pubmed">22324494</ArticleId></ArticleIdList></Reference><Reference><Citation>Levy O. Innate immunity of the newborn: basic mechanisms and clinical correlates.Nat Rev Immunol. 2007;75:379&#x2013;90.</Citation><ArticleIdList><ArticleId IdType="pubmed">17457344</ArticleId></ArticleIdList></Reference><Reference><Citation>Frickhofen N,Abkowitz JL,Safford M,et al.Persistent B19 parvovirus infection in patients infected with human immunodeficiency virus type 1 (HIV-1): a treatable cause of anemia in AIDS.Ann Int Med. 1990;11312:926&#x2013;33.</Citation><ArticleIdList><ArticleId IdType="pubmed">2173460</ArticleId></ArticleIdList></Reference><Reference><Citation>Collaboration TFS. Systematically missing confounders in individual participant data meta-analysis of observational cohort studies.Stats Med. 2009;288:1218.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2922684</ArticleId><ArticleId IdType="pubmed">19222087</ArticleId></ArticleIdList></Reference><Reference><Citation>Boland MR,Hripcsak G,Shen Y,Chung WK,Weng C. Defining a comprehensive verotype using electronic health records for personalized medicine.J Am Med Inform Assoc. 2013;20(e2):e232&#x2013;38.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3861934</ArticleId><ArticleId IdType="pubmed">24001516</ArticleId></ArticleIdList></Reference><Reference><Citation>Tarca A. International convergence of accounting practices: choosing between IAS and US GAAP.J Int Financial Manag Account. 2004;151:60&#x2013;91.</Citation></Reference><Reference><Citation>Boland MR,Karczewski KJ,Tatonetti NP. Ten simple rules to enable multi-site collaborations through data sharing.PLOS Comput Biol. 2017;131:e1005278.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5245793</ArticleId><ArticleId IdType="pubmed">28103227</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">29040596</PMID><DateRevised><Year>2024</Year><Month>08</Month><Day>02</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1527-974X</ISSN><JournalIssue CitedMedium="Internet"><Volume>25</Volume><Issue>3</Issue><PubDate><Year>2018</Year><Month>Mar</Month><Day>01</Day></PubDate></JournalIssue><Title>Journal of the American Medical Informatics Association : JAMIA</Title><ISOAbbreviation>J Am Med Inform Assoc</ISOAbbreviation></Journal><ArticleTitle>High-fidelity phenotyping: richness and freedom from bias.</ArticleTitle><Pagination><StartPage>289</StartPage><EndPage>294</EndPage><MedlinePgn>289-294</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1093/jamia/ocx110</ELocationID><Abstract><AbstractText>Electronic health record phenotyping is the use of raw electronic health record data to assert characterizations about patients. Researchers have been doing it since the beginning of biomedical informatics, under different names. Phenotyping will benefit from an increasing focus on fidelity, both in the sense of increasing richness, such as measured levels, degree or severity, timing, probability, or conceptual relationships, and in the sense of reducing bias. Research agendas should shift from merely improving binary assignment to studying and improving richer representations. The field is actively researching new temporal directions and abstract representations, including deep learning. The field would benefit from research in nonlinear dynamics, in combining mechanistic models with empirical data, including data assimilation, and in topology. The health care process produces substantial bias, and studying that bias explicitly rather than treating it as merely another source of noise would facilitate addressing it.</AbstractText><CopyrightInformation>&#xa9; The Author 2017. Published by Oxford University Press on behalf of the American Medical Informatics Association.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Hripcsak</LastName><ForeName>George</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Department of Biomedical Informatics, Columbia University Medical Center, New York, NY, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Albers</LastName><ForeName>David J</ForeName><Initials>DJ</Initials><AffiliationInfo><Affiliation>Department of Biomedical Informatics, Columbia University Medical Center, New York, NY, USA.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>R01 LM006910</GrantID><Acronym>LM</Acronym><Agency>NLM NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>U01 HG008680</GrantID><Acronym>HG</Acronym><Agency>NHGRI NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>J Am Med Inform Assoc</MedlineTA><NlmUniqueID>9430800</NlmUniqueID><ISSNLinking>1067-5027</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2017</Year><Month>6</Month><Day>16</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2017</Year><Month>8</Month><Day>7</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2017</Year><Month>9</Month><Day>6</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2017</Year><Month>10</Month><Day>19</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2017</Year><Month>10</Month><Day>19</Day><Hour>6</Hour><Minute>1</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2017</Year><Month>10</Month><Day>18</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2017</Year><Month>10</Month><Day>12</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">29040596</ArticleId><ArticleId IdType="pmc">PMC7282504</ArticleId><ArticleId IdType="doi">10.1093/jamia/ocx110</ArticleId><ArticleId IdType="pii">4484121</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Hripcsak G,Albers DJ. Next-generation phenotyping of electronic health records.J Am Med Inform. Assoc. 2013;20:117&#x2013;21.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3555337</ArticleId><ArticleId IdType="pubmed">22955496</ArticleId></ArticleIdList></Reference><Reference><Citation>Pathak J,Kho AN,Denny JC. Electronic health records&#x2013;driven phenotyping: challenges, recent advances, and perspectives.J Am Med Inform Assoc. 2013;20(e2):e206&#x2013;11.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3861925</ArticleId><ArticleId IdType="pubmed">24302669</ArticleId></ArticleIdList></Reference><Reference><Citation>Warner HR. Knowledge sectors for logical processing of patient data in the HELP system.Proc Annu Symp Comput Appl Med Care. 1978:401&#x2013;04.</Citation></Reference><Reference><Citation>Hripcsak G,Friedman C,Alderson PO,DuMouchel W,Johnson SB,Clayton PD. Unlocking clinical data from narrative reports: a study of natural language processing.Ann Intern Med. 1995;122:681&#x2013;88.</Citation><ArticleIdList><ArticleId IdType="pubmed">7702231</ArticleId></ArticleIdList></Reference><Reference><Citation>Newton KM,Peissig PL,Kho AN,et al.Validation of electronic medical record&#x2013;based phenotyping algorithms: results and lessons learned from the eMERGE network.J Am Med Inform Assoc. 2013;20(e1):e147&#x2013;54.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3715338</ArticleId><ArticleId IdType="pubmed">23531748</ArticleId></ArticleIdList></Reference><Reference><Citation>Rasmussen LV,Thompson WK,Pacheco JA,et al.Design patterns for the development of electronic health record&#x2013;driven phenotype extraction algorithms.J Biomed Inform. 2014;51:280&#x2013;86.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4194216</ArticleId><ArticleId IdType="pubmed">24960203</ArticleId></ArticleIdList></Reference><Reference><Citation>Rasmussen LV,Kiefer RC,Mo H,et al.A modular architecture for electronic health record&#x2013;driven phenotyping.AMIA Jt Summits Transl Sci Proc. 2015;147&#x2013;51.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4525215</ArticleId><ArticleId IdType="pubmed">26306258</ArticleId></ArticleIdList></Reference><Reference><Citation>Rea S,Pathak J,Savova G,et al.Building a robust, scalable and standards-driven infrastructure for secondary use of EHR data: the SHARPn project.J Biomed Inform. 2012;45:763&#x2013;71.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4905766</ArticleId><ArticleId IdType="pubmed">22326800</ArticleId></ArticleIdList></Reference><Reference><Citation>Conway M,Berg RL,Carrell D,et al.Analyzing the heterogeneity and complexity of Electronic Health Record oriented phenotyping algorithms.AMIA Annu Symp Proc. 2011;274&#x2013;83.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3243189</ArticleId><ArticleId IdType="pubmed">22195079</ArticleId></ArticleIdList></Reference><Reference><Citation>Overby CL,Pathak J,Gottesman O,et al.A collaborative approach to developing an electronic health record phenotyping algorithm for drug-induced liver injury.J Am Med Inform Assoc. 2013;20:e243&#x2013;52.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3861914</ArticleId><ArticleId IdType="pubmed">23837993</ArticleId></ArticleIdList></Reference><Reference><Citation>Morley KI,Wallace J,Denaxas SC,et al.Defining disease phenotypes using national linked electronic health records: a case study of atrial fibrillation.PLoS One. 2014;9:e110900.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4219705</ArticleId><ArticleId IdType="pubmed">25369203</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen Y,Carroll RJ,McPeek Hinz ER,Shah A,Eyler AE,Denny JC,Xu H. Applying active learning to high-throughput phenotyping algorithms for electronic health records data.J Am Med Inform Assoc. 2013;20:e253&#x2013;59.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3861916</ArticleId><ArticleId IdType="pubmed">23851443</ArticleId></ArticleIdList></Reference><Reference><Citation>Halpern Y,Choi Y,Horng S,Sontag D. Using anchors to estimate clinical state without labeled data.AMIA Annu Symp Proc. 2014;2014:606&#x2013;15.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4419996</ArticleId><ArticleId IdType="pubmed">25954366</ArticleId></ArticleIdList></Reference><Reference><Citation>Agarwal V,Lependu P,Podchiyska T,Barber R,Boland M,Hripcsak G,Shah N. Using narratives as a source to automatically learn phenotype models.1st Workshop on Data Mining for Medical Informatics: Electronic Phenotyping, Washington, DC;2014.</Citation></Reference><Reference><Citation>Halpern Y,Horng S,Choi Y,Sontag D. Electronic medical record phenotyping using the anchor and learn framework.J Am Med Inform Assoc. 2016;23:731&#x2013;40.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4926745</ArticleId><ArticleId IdType="pubmed">27107443</ArticleId></ArticleIdList></Reference><Reference><Citation>Agarwal V,Podchiyska T,Banda JM,et al.Learning statistical models of phenotypes using noisy labeled training data.J Am Med Inform Assoc. 2016;23:1166&#x2013;73.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5070523</ArticleId><ArticleId IdType="pubmed">27174893</ArticleId></ArticleIdList></Reference><Reference><Citation>LeCun Y,Bengio Y,Hinton G. Deep learning.Nature. 2015;521:436&#x2013;44.</Citation><ArticleIdList><ArticleId IdType="pubmed">26017442</ArticleId></ArticleIdList></Reference><Reference><Citation>Gottesman O,Kuivaniemi H,Tromp G,et al. ;eMERGE Network. The Electronic Medical Records and Genomics (eMERGE) Network: past, present, and future.Genet Med. 2013;1510:761&#x2013;71.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3795928</ArticleId><ArticleId IdType="pubmed">23743551</ArticleId></ArticleIdList></Reference><Reference><Citation>Hripcsak G,Duke JD,Shah NH,et al.Observational Health Data Sciences and Informatics (OHDSI): Opportunities for Observational Researchers.MEDINFO&#x2019;15; August 19&#x2013;23, S&#xe3;o Paulo, Brazil;2015.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4815923</ArticleId><ArticleId IdType="pubmed">26262116</ArticleId></ArticleIdList></Reference><Reference><Citation>Albers DJ,Levine ME,Gluckman BJ,Ginsberg H,Hripcsak G,Mamykina L. Personalized glucose forecasting for type 2 diabetics using data assimilation.PLOS Comput Biol. 2017;134:e1005232.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5409456</ArticleId><ArticleId IdType="pubmed">28448498</ArticleId></ArticleIdList></Reference><Reference><Citation>Weber GM,Mandl KD,Kohane IS. Finding the missing link for big biomedical data.JAMA. 2014;311:2479&#x2013;80.</Citation><ArticleIdList><ArticleId IdType="pubmed">24854141</ArticleId></ArticleIdList></Reference><Reference><Citation>Hung GC,Yang PC,Chang CC,Chiang JH,Chen YY. Predicting negative emotions based on mobile phone usage patterns: an exploratory study.JMIR Res Protoc. 2016;53:e160.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4997004</ArticleId><ArticleId IdType="pubmed">27511748</ArticleId></ArticleIdList></Reference><Reference><Citation>Mamykina L,Levine ME,Davidson PG,Smaldone AM,Elhadad N,Albers DJ. Data-driven health management: reasoning about personally generated data in diabetes with information technologies.J Am Med Inform Assoc. 2016;23:526&#x2013;31.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4901380</ArticleId><ArticleId IdType="pubmed">26984049</ArticleId></ArticleIdList></Reference><Reference><Citation>Denaxas SC,George J,Herrett E,et al.Data resource profile: cardiovascular disease research using linked bespoke studies and electronic health records (CALIBER).Int J Epidemiol. 2012;41:1625&#x2013;38.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3535749</ArticleId><ArticleId IdType="pubmed">23220717</ArticleId></ArticleIdList></Reference><Reference><Citation>Pivovarov R,Perotte AJ,Grave E,Angiolillo J,Wiggins CH,Elhadad N. Learning probabilistic phenotypes from heterogeneous EHR data.J Biomed Inform. 2015;58:156&#x2013;65.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8025140</ArticleId><ArticleId IdType="pubmed">26464024</ArticleId></ArticleIdList></Reference><Reference><Citation>
PheKB: a Knowledgebase for Discovering Phenotypes from Electronic Health Records.https://phekb.org. Accessed June 4, 2017.</Citation></Reference><Reference><Citation>Kirby JC,Speltz P,Rasmussen LV,et al.PheKB: a catalog and workflow for creating electronic phenotype algorithms for transportability.J Am Med Inform Assoc. 2016;23:1046&#x2013;52.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5070514</ArticleId><ArticleId IdType="pubmed">27026615</ArticleId></ArticleIdList></Reference><Reference><Citation>Shivade C,Raghavan P,Fosler-Lussier E,Embi PJ,Elhadad N,Johnson SB,Lai AM. A review of approaches to identifying patient phenotype cohorts using electronic health records.J Am Med Inform Assoc. 2014;21:221&#x2013;30.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3932460</ArticleId><ArticleId IdType="pubmed">24201027</ArticleId></ArticleIdList></Reference><Reference><Citation>Pathak J,Bailey KR,Beebe CE,et al.Normalization and standardization of electronic health records for high-throughput phenotyping: the SHARPn consortium.J Am Med Inform Assoc. 2013;20(e2):e341&#x2013;48.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3861933</ArticleId><ArticleId IdType="pubmed">24190931</ArticleId></ArticleIdList></Reference><Reference><Citation>Liao KP,Cai T,Savova GK,et al.Development of phenotype algorithms using electronic medical records and incorporating natural language processing.BMJ. 2015;350:h1885.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4707569</ArticleId><ArticleId IdType="pubmed">25911572</ArticleId></ArticleIdList></Reference><Reference><Citation>Yu S,Liao KP,Shaw SY,et al.Toward high-throughput phenotyping: unbiased automated feature extraction and selection from knowledge sources.J Am Med Inform Assoc. 2015;22:993&#x2013;1000.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4986664</ArticleId><ArticleId IdType="pubmed">25929596</ArticleId></ArticleIdList></Reference><Reference><Citation>Miotto R,Li L,Kidd BA,Dudley JT. Deep patient: an unsupervised representation to predict the future of patients from the electronic health records.Sci Rep. 2016;6:26094.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4869115</ArticleId><ArticleId IdType="pubmed">27185194</ArticleId></ArticleIdList></Reference><Reference><Citation>Albers D,Pivovarov R,Schmidt JM,Elhadad N,Hripcsak G. Model selection for EHR laboratory tests preserving healthcare context and underlying physiology (abstract).Proc AMIA Symp.2015;1&#x2013;2.</Citation></Reference><Reference><Citation>
Observational Health Data Sciences and Informatics (OHDSI).www.ohdsi.org. Accessed June 4, 2017.</Citation><ArticleIdList><ArticleId IdType="pubmed">0</ArticleId></ArticleIdList></Reference><Reference><Citation>Albers DJ,Hripcsak G. Using time-delayed mutual information to discover and interpret temporal correlation structure in complex populations.Chaos. 2012;22:013111.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3277606</ArticleId><ArticleId IdType="pubmed">22462987</ArticleId></ArticleIdList></Reference><Reference><Citation>Albers DJ,Hripcsak G. Estimation of time-delayed mutual information and bias for irregularly and sparsely sampled time-series.Chaos, Solutions, Fract. 2012;45;853&#x2013;60.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3332129</ArticleId><ArticleId IdType="pubmed">22536009</ArticleId></ArticleIdList></Reference><Reference><Citation>Albers DJ,Hripcsak G. A statistical dynamics approach to the study of human health data: resolving population scale diurnal variation in laboratory data.Phys Lett A. 2010;374:1159&#x2013;64.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2882798</ArticleId><ArticleId IdType="pubmed">20544004</ArticleId></ArticleIdList></Reference><Reference><Citation>Albers DJ,Hripcsak G,Schmidt M. Population physiology: leveraging electronic health record data to understand human endocrine dynamics.PLoS One. 2012;712:e48058.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3522687</ArticleId><ArticleId IdType="pubmed">23272040</ArticleId></ArticleIdList></Reference><Reference><Citation>Albers DJ,Elhadad N,Tabak E,Perotte A,Hripcsak G. Dynamical phenotyping: using temporal analysis of clinically collected physiologic data to stratify populations.PLoS One. 2014;96:e96443.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4059642</ArticleId><ArticleId IdType="pubmed">24933368</ArticleId></ArticleIdList></Reference><Reference><Citation>Claassen J,Albers D,Schmidt JM,et al.Nonconvulsive seizures in subarachnoid hemorrhage link inflammation and outcome.Ann Neurol. 2014;75:771&#x2013;81.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4084968</ArticleId><ArticleId IdType="pubmed">24771589</ArticleId></ArticleIdList></Reference><Reference><Citation>Jung K,Shah NH. Implications of non-stationarity on predictive modeling using EHRs.J Biomed Inform. 2015;58:168&#x2013;74.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4684770</ArticleId><ArticleId IdType="pubmed">26483171</ArticleId></ArticleIdList></Reference><Reference><Citation>Hagar Y,Albers D,Pivovarov R,Chase H,Dukic V,Elhadad N. Survival analysis with electronic health record data: experiments with chronic kidney disease.Statistical Analy Data Mining. 2014;7:385&#x2013;403.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8112603</ArticleId><ArticleId IdType="pubmed">33981381</ArticleId></ArticleIdList></Reference><Reference><Citation>Warner JL,Zollanvari A,Ding Q,Zhang P,Snyder GM,Alterovitz G. Temporal phenome analysis of a large electronic health record cohort enables identification of hospital-acquired complications.J Am Med Inform Assoc. 2013;20:e281&#x2013;87.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3861919</ArticleId><ArticleId IdType="pubmed">23907284</ArticleId></ArticleIdList></Reference><Reference><Citation>Hripcsak G,Albers DJ,Perotte A. Exploiting time in electronic health record correlations.J Am Med Inform Assoc. 2011;18 (Suppl 1): i109&#x2013;15.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3241180</ArticleId><ArticleId IdType="pubmed">22116643</ArticleId></ArticleIdList></Reference><Reference><Citation>Lasko TA,Denny JC,Levy MA. Computational phenotype discovery using unsupervised feature learning over noisy, sparse, and irregular clinical data.PLoS One. 2013;8:e66341.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3691199</ArticleId><ArticleId IdType="pubmed">23826094</ArticleId></ArticleIdList></Reference><Reference><Citation>Hauskrecht M,Visweswaran S,Cooper G,Clermont G. Data-driven identification of unusual clinical actions in the ICU.Annual American Medical Informatics Association Symposium, Washington, DC;2013;580.</Citation></Reference><Reference><Citation>
Liu Z,Hauskrecht M. 
Sparse linear dynamical system with its application in multivariate clinical time series.NIPS 2013 Workshop on Machine Learning for Clinical Data Analysis and Healthcare,December 2013; preprint available online athttps://arxiv.org/abs/1311.7071. Accessed October 4, 2017.</Citation></Reference><Reference><Citation>Liu Z,Hauskrecht M. Clinical time series prediction with a hierarchical dynamical system.The 14th Conference on Artificial Intelligence in Medicine, Murcia, Spain;2013;227&#x2013;37.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4422790</ArticleId><ArticleId IdType="pubmed">25534671</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang F,Lee N,Hu J,Sun J,Ebadollahi S. Towards heterogeneous temporal clinical event pattern discovery: a convolutional approach. In:KDD&#x2019;12,August 12&#x2013;16, 2012, Beijing, China;2012:453&#x2013;61.</Citation></Reference><Reference><Citation>Batal I,Valizadegan H,Cooper GF,Hauskrecht M. A pattern mining approach for classifying multivariate temporal data. In:Proc IEEE Int Conf Bioinformatics Biomed. 2011;358&#x2013;65.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3261774</ArticleId><ArticleId IdType="pubmed">22267987</ArticleId></ArticleIdList></Reference><Reference><Citation>Noren GN,Hopstadius J,Bate A,Star K,Edwards IR. Temporal pattern discovery in longitudinal electronic patient records.Data Min Knowl Discov. 2010;20:361&#x2013;87.</Citation></Reference><Reference><Citation>Shahar Y. A framework for knowledge-based temporal abstraction.Artif Intell. 1997;90(1&#x2013;2):79&#x2013;133.</Citation></Reference><Reference><Citation>Stacey M,McGregor C. Temporal abstraction in intelligent clinical data analysis: a survey.Artif Intell Med. 2007;39:1&#x2013;24.</Citation><ArticleIdList><ArticleId IdType="pubmed">17011175</ArticleId></ArticleIdList></Reference><Reference><Citation>Moskovitch R,Peek N,Shahar Y. Classification of ICU patients via temporal abstraction and temporal patterns mining.Notes of the Intelligent Data Analysis in Medicine and Pharmacology (IDAMAP 2009) Workshop. Verona, Italy;2009;35&#x2013;40.</Citation></Reference><Reference><Citation>Sohn S,Savova GK. Mayo Clinic smoking status classification system: extensions and improvements.AMIA Annu Symp Proc. 2009;2009:619&#x2013;23.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2815365</ArticleId><ArticleId IdType="pubmed">20351929</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhou L,Hripcsak G. Temporal reasoning with medical data &#x2013; a review with emphasis on medical natural language processing.J Biomed Inform. 2007;40:183&#x2013;202.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7357407</ArticleId><ArticleId IdType="pubmed">17317332</ArticleId></ArticleIdList></Reference><Reference><Citation>Hripcsak G,Elhadad N,Chen C,Zhou L,Morrison FP. Using empirical semantic correlation to interpret temporal assertions in clinical texts.J Am Med Inform Assoc. 2009;16:220&#x2013;27.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2649319</ArticleId><ArticleId IdType="pubmed">19074297</ArticleId></ArticleIdList></Reference><Reference><Citation>Hogan WR,Wagner MM. Accuracy of data in computer-based patient records.J Am Med Inform Assoc. 1997;4:342&#x2013;55.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC61252</ArticleId><ArticleId IdType="pubmed">9292840</ArticleId></ArticleIdList></Reference><Reference><Citation>Bengio Y,Courville A,Vincent P. Representation learning: a review and new perspectives.IEEE T Pattern Anal Mach Intell. 2013;35:1798&#x2013;828.</Citation><ArticleIdList><ArticleId IdType="pubmed">23787338</ArticleId></ArticleIdList></Reference><Reference><Citation>Blei DM,Ng AY,Jordan MI. Latent Dirichlet allocation.J Machine Learning Res. 2003;3:993&#x2013;1022.</Citation></Reference><Reference><Citation>Pivovarov R,Perotte AJ,Grave E,Angiolillo J,Wiggins CH,Elhadad N. Learning probabilistic phenotypes from heterogeneous EHR data.J Biomed Inform. 2015;58:156&#x2013;65.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8025140</ArticleId><ArticleId IdType="pubmed">26464024</ArticleId></ArticleIdList></Reference><Reference><Citation>Luo Y,Wang F,Szolovits P. Tensor factorization toward precision medicine.Brief Bioinform. 2017;18:511&#x2013;14.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6078180</ArticleId><ArticleId IdType="pubmed">26994614</ArticleId></ArticleIdList></Reference><Reference><Citation>Luo Y,Xin Y,Hochberg E,Joshi R,Uzuner O,Szolovits P. Subgraph augmented non-negative tensor factorization (SANTF) for modeling clinical narrative text.J Am Med Inform Assoc. 2015;22:1009&#x2013;19.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4986663</ArticleId><ArticleId IdType="pubmed">25862765</ArticleId></ArticleIdList></Reference><Reference><Citation>Law K,Stuart A,Zygalakis K. Data Assimilation. Cham, Switzerland: Springer;2015.</Citation></Reference><Reference><Citation>Kovatchev B,Breton M,Man C,Cobelli C. In silico preclinical trials: a proof of concept in closed-loop control of type 1 diabetes.J Diabetes Sci Technol. 2009;3:44&#x2013;55.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2681269</ArticleId><ArticleId IdType="pubmed">19444330</ArticleId></ArticleIdList></Reference><Reference><Citation>Carlsson G. Topology and data.Bull Am Mathematical Soc. 2009;462:255&#x2013;308.</Citation></Reference><Reference><Citation>Nicolau M,Levine AJ,Carlsson G. Topology based data analysis identifies a subgroup of breast cancers with a unique mutational profile and excellent survival.Proc Natl Acad Sci USA. 2011;10817:7265&#x2013;70.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3084136</ArticleId><ArticleId IdType="pubmed">21482760</ArticleId></ArticleIdList></Reference><Reference><Citation>Li L,Cheng WY,Glicksberg BS,et al.Identification of type 2 diabetes subgroups through topological analysis of patient similarity.Sci Transl Med. 2015;7:311ra174.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4780757</ArticleId><ArticleId IdType="pubmed">26511511</ArticleId></ArticleIdList></Reference><Reference><Citation>C&#xe1;mara PG,Levine AJ,Rabad&#xe1;n R. Inference of ancestral recombination graphs through topological data analysis.PLoS Comput Biol. 2016;128:e1005071.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4988722</ArticleId><ArticleId IdType="pubmed">27532298</ArticleId></ArticleIdList></Reference><Reference><Citation>Hripcsak G,Albers DJ. Correlating electronic health record concepts with healthcare process events.J Am Med Inform Assoc. 2013;20:e311&#x2013;18.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3861922</ArticleId><ArticleId IdType="pubmed">23975625</ArticleId></ArticleIdList></Reference><Reference><Citation>Albers DJ,Hripcsak G. An information-theoretic approach to the phenome (abstract).AMIA Summit on Translational Bioinformatics,March 15&#x2013;17; San Francisco;2009.</Citation></Reference><Reference><Citation>Pivovarov R,Albers DJ,Sepulveda JL,Elhadad N. Identifying and mitigating biases in EHR laboratory tests.J Biomed Inform. 2014;51:24&#x2013;34.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4194228</ArticleId><ArticleId IdType="pubmed">24727481</ArticleId></ArticleIdList></Reference><Reference><Citation>Weber GM,Kohane IS. Extracting physician group intelligence from electronic health records to support evidence based medicine.PLoS One. 2013;8:e64933.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3666978</ArticleId><ArticleId IdType="pubmed">23734227</ArticleId></ArticleIdList></Reference><Reference><Citation>Hripcsak G,Albers DJ,Perotte A. Parameterizing time in electronic health record studies.J Am Med Inform Assoc. 2015;224:794&#x2013;804.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6169471</ArticleId><ArticleId IdType="pubmed">25725004</ArticleId></ArticleIdList></Reference><Reference><Citation>Lasko TA. Nonstationary Gaussian process regression for evaluating clinical laboratory test sampling strategies.Proc 29th AAAI Conference on Artificial Intelligence 2015;1777&#x2013;83.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4472307</ArticleId><ArticleId IdType="pubmed">26097785</ArticleId></ArticleIdList></Reference><Reference><Citation>Hripcsak G,Knirsch C,Zhou L,Wilcox A,Melton GB. Bias associated with mining electronic health records.J Biomed Discov Collab. 2011;6:48&#x2013;52.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3149555</ArticleId><ArticleId IdType="pubmed">21647858</ArticleId></ArticleIdList></Reference><Reference><Citation>Levine ME,Albers DJ,Hripcsak G. Comparing lagged linear correlation, lagged regression, Granger causality, and vector autoregression for uncovering associations in EHR data.Proc AMIA Symp. 2017;2016:779&#x2013;88.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5333294</ArticleId><ArticleId IdType="pubmed">28269874</ArticleId></ArticleIdList></Reference><Reference><Citation>Albers DJ,Elhadad N,Tabak E,Perotte A,Hripcsak G. Dynamical phenotyping: using temporal analysis of clinically collected physiologic data to stratify populations.PLoS One. 2014;9:e96443.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4059642</ArticleId><ArticleId IdType="pubmed">24933368</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">29157113</PMID><DateCompleted><Year>2019</Year><Month>10</Month><Day>24</Day></DateCompleted><DateRevised><Year>2019</Year><Month>10</Month><Day>24</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1520-5711</ISSN><JournalIssue CitedMedium="Internet"><Volume>28</Volume><Issue>4</Issue><PubDate><Year>2018</Year></PubDate></JournalIssue><Title>Journal of biopharmaceutical statistics</Title><ISOAbbreviation>J Biopharm Stat</ISOAbbreviation></Journal><ArticleTitle>Assessing performance of sequential analysis methods for active drug safety surveillance using observational data.</ArticleTitle><Pagination><StartPage>668</StartPage><EndPage>681</EndPage><MedlinePgn>668-681</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1080/10543406.2017.1372776</ELocationID><Abstract><AbstractText>The routine use of sequential methods is well established in clinical studies. Recently, there has been increasing interest in applying these methods to prospectively monitor the safety of newly approved drugs through accrual of real-world data. However, the application to marketed drugs using real-world data has been limited and work is needed to determine which sequential approaches are most suited to such data. In this study, the conditional sequential sampling procedure (CSSP), a group sequential method, was compared with a log-linear model with Poisson distribution (LLMP) through a SAS procedure (PROC GENMOD) combined with an alpha-spending function on two large longitudinal US administrative health claims databases. Relative performance in identifying known drug-outcome associations was examined using a set of 50 well-studied drug-outcome pairs. The study finds that neither method correctly identified all pairs but that LLMP often provides better ability and shorter time for identifying the known drug-outcome associations with superior computational performance when compared with CSSP, albeit with more false positives. With the features of flexible confounding control and ease of implementation, LLMP may be a good alternative or complement to CSSP.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Zhou</LastName><ForeName>Xiaofeng</ForeName><Initials>X</Initials><AffiliationInfo><Affiliation>a Epidemiology , Worldwide Safety and Regulatory, Pfizer Inc , New York , NY , USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bao</LastName><ForeName>Warren</ForeName><Initials>W</Initials><AffiliationInfo><Affiliation>a Epidemiology , Worldwide Safety and Regulatory, Pfizer Inc , New York , NY , USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gaffney</LastName><ForeName>Mike</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>a Epidemiology , Worldwide Safety and Regulatory, Pfizer Inc , New York , NY , USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Shen</LastName><ForeName>Rongjun</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>a Epidemiology , Worldwide Safety and Regulatory, Pfizer Inc , New York , NY , USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Young</LastName><ForeName>Sarah</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>a Epidemiology , Worldwide Safety and Regulatory, Pfizer Inc , New York , NY , USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bate</LastName><ForeName>Andrew</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>a Epidemiology , Worldwide Safety and Regulatory, Pfizer Inc , New York , NY , USA.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2017</Year><Month>11</Month><Day>20</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>J Biopharm Stat</MedlineTA><NlmUniqueID>9200436</NlmUniqueID><ISSNLinking>1054-3406</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D016907" MajorTopicYN="N">Adverse Drug Reaction Reporting Systems</DescriptorName><QualifierName UI="Q000706" MajorTopicYN="Y">statistics &amp; numerical data</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016208" MajorTopicYN="N">Databases, Factual</DescriptorName><QualifierName UI="Q000706" MajorTopicYN="Y">statistics &amp; numerical data</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D064420" MajorTopicYN="N">Drug-Related Side Effects and Adverse Reactions</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007345" MajorTopicYN="N">Insurance Claim Review</DescriptorName><QualifierName UI="Q000706" MajorTopicYN="Y">statistics &amp; numerical data</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008137" MajorTopicYN="N">Longitudinal Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D064887" MajorTopicYN="N">Observational Studies as Topic</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName><QualifierName UI="Q000706" MajorTopicYN="Y">statistics &amp; numerical data</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011358" MajorTopicYN="N">Product Surveillance, Postmarketing</DescriptorName><QualifierName UI="Q000706" MajorTopicYN="Y">statistics &amp; numerical data</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012189" MajorTopicYN="N">Retrospective Studies</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Conditional sequential sampling procedure (CSSP)</Keyword><Keyword MajorTopicYN="N">drug safety signal detection</Keyword><Keyword MajorTopicYN="N">group sequential monitoring</Keyword><Keyword MajorTopicYN="N">log-linear model with Poisson distribution (LLMP)</Keyword><Keyword MajorTopicYN="N">longitudinal observational database</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>2017</Year><Month>11</Month><Day>22</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2019</Year><Month>10</Month><Day>28</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2017</Year><Month>11</Month><Day>22</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">29157113</ArticleId><ArticleId IdType="doi">10.1080/10543406.2017.1372776</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">29218922</PMID><DateCompleted><Year>2018</Year><Month>08</Month><Day>27</Day></DateCompleted><DateRevised><Year>2018</Year><Month>12</Month><Day>02</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">2335-6936</ISSN><JournalIssue CitedMedium="Internet"><Volume>23</Volume><PubDate><Year>2018</Year></PubDate></JournalIssue><Title>Pacific Symposium on Biocomputing. Pacific Symposium on Biocomputing</Title><ISOAbbreviation>Pac Symp Biocomput</ISOAbbreviation></Journal><ArticleTitle>Methods for examining data quality in healthcare integrated data repositories.</ArticleTitle><Pagination><StartPage>628</StartPage><EndPage>633</EndPage><MedlinePgn>628-633</MedlinePgn></Pagination><Abstract><AbstractText>This paper summarizes content of the workshop focused on data quality. The first speaker (VH) described data quality infrastructure and data quality evaluation methods currently in place within the Observational Data Science and Informatics (OHDSI) consortium. The speaker described in detail a data quality tool called Achilles Heel and latest development for extending this tool. Interim results of an ongoing Data Quality study within the OHDSI consortium were also presented. The second speaker (MK) described lessons learned and new data quality checks developed by the PEDsNet pediatric research network. The last two speakers (JB, RG) described tools developed by the Sentinel Initiative and University of Utah's service oriented framework. The workshop discussed at the end and throughout how data quality assessment can be advanced by combining best features of each network.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Huser</LastName><ForeName>Vojtech</ForeName><Initials>V</Initials><AffiliationInfo><Affiliation>National Library of Medicine, National Institutes of Health 8600 Rockville Pk, Bld 38a Bethesda, MD, 20852, USA, vojtech.huser@nih.gov.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kahn</LastName><ForeName>Michael G</ForeName><Initials>MG</Initials></Author><Author ValidYN="Y"><LastName>Brown</LastName><ForeName>Jeffrey S</ForeName><Initials>JS</Initials></Author><Author ValidYN="Y"><LastName>Gouripeddi</LastName><ForeName>Ramkiran</ForeName><Initials>R</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016423">Congress</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Pac Symp Biocomput</MedlineTA><NlmUniqueID>9711271</NlmUniqueID><ISSNLinking>2335-6928</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D019295" MajorTopicYN="N">Computational Biology</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName><QualifierName UI="Q000592" MajorTopicYN="N">standards</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D003199" MajorTopicYN="N">Computer Systems</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003257" MajorTopicYN="N">Consumer Product Safety</DescriptorName><QualifierName UI="Q000592" MajorTopicYN="N">standards</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000068598" MajorTopicYN="Y">Data Accuracy</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D057286" MajorTopicYN="N">Electronic Health Records</DescriptorName><QualifierName UI="Q000592" MajorTopicYN="N">standards</QualifierName><QualifierName UI="Q000706" MajorTopicYN="N">statistics &amp; numerical data</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018571" MajorTopicYN="N">Sentinel Surveillance</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014481" MajorTopicYN="N">United States</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2017</Year><Month>12</Month><Day>9</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2017</Year><Month>12</Month><Day>9</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2018</Year><Month>8</Month><Day>28</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">29218922</ArticleId><ArticleId IdType="pii">9789813235533_0059</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">29365340</PMID><DateCompleted><Year>2018</Year><Month>09</Month><Day>03</Day></DateCompleted><DateRevised><Year>2020</Year><Month>03</Month><Day>06</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1869-0327</ISSN><JournalIssue CitedMedium="Internet"><Volume>9</Volume><Issue>1</Issue><PubDate><Year>2018</Year><Month>Jan</Month></PubDate></JournalIssue><Title>Applied clinical informatics</Title><ISOAbbreviation>Appl Clin Inform</ISOAbbreviation></Journal><ArticleTitle>Towards Implementation of OMOP in a German University Hospital Consortium.</ArticleTitle><Pagination><StartPage>54</StartPage><EndPage>61</EndPage><MedlinePgn>54-61</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1055/s-0037-1617452</ELocationID><Abstract><AbstractText Label="BACKGROUND">In 2015, the German Federal Ministry of Education and Research initiated a large data integration and data sharing research initiative to improve the reuse of data from patient care and translational research. The Observational Medical Outcomes Partnership (OMOP) common data model and the Observational Health Data Sciences and Informatics (OHDSI) tools could be used as a core element in this initiative for harmonizing the terminologies used as well as facilitating the federation of research analyses across institutions.</AbstractText><AbstractText Label="OBJECTIVE">To realize an OMOP/OHDSI-based pilot implementation within a consortium of eight German university hospitals, evaluate the applicability to support data harmonization and sharing among them, and identify potential enhancement requirements.</AbstractText><AbstractText Label="METHODS">The vocabularies and terminological mapping required for importing the fact data were prepared, and the process for importing the data from the source files was designed. For eight German university hospitals, a virtual machine preconfigured with the OMOP database and the OHDSI tools as well as the jobs to import the data and conduct the analysis was provided. Last, a federated/distributed query to test the approach was executed.</AbstractText><AbstractText Label="RESULTS">While the mapping of ICD-10 German Modification succeeded with a rate of 98.8% of all terms for diagnoses, the procedures could not be mapped and hence an extension to the OMOP standard terminologies had to be made.Overall, the data of 3 million inpatients with approximately 26 million conditions, 21 million procedures, and 23 million observations have been imported.A federated query to identify a cohort of colorectal cancer patients was successfully executed and yielded 16,701 patient cases visualized in a Sunburst plot.</AbstractText><AbstractText Label="CONCLUSION">OMOP/OHDSI is a viable open source solution for data integration in a German research consortium. Once the terminology problems can be solved, researchers can build on an active community for further development.</AbstractText><CopyrightInformation>Schattauer GmbH Stuttgart.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Maier</LastName><ForeName>C</ForeName><Initials>C</Initials></Author><Author ValidYN="Y"><LastName>Lang</LastName><ForeName>L</ForeName><Initials>L</Initials></Author><Author ValidYN="Y"><LastName>Storf</LastName><ForeName>H</ForeName><Initials>H</Initials></Author><Author ValidYN="Y"><LastName>Vormstein</LastName><ForeName>P</ForeName><Initials>P</Initials></Author><Author ValidYN="Y"><LastName>Bieber</LastName><ForeName>R</ForeName><Initials>R</Initials></Author><Author ValidYN="Y"><LastName>Bernarding</LastName><ForeName>J</ForeName><Initials>J</Initials></Author><Author ValidYN="Y"><LastName>Herrmann</LastName><ForeName>T</ForeName><Initials>T</Initials></Author><Author ValidYN="Y"><LastName>Haverkamp</LastName><ForeName>C</ForeName><Initials>C</Initials></Author><Author ValidYN="Y"><LastName>Horki</LastName><ForeName>P</ForeName><Initials>P</Initials></Author><Author ValidYN="Y"><LastName>Laufer</LastName><ForeName>J</ForeName><Initials>J</Initials></Author><Author ValidYN="Y"><LastName>Berger</LastName><ForeName>F</ForeName><Initials>F</Initials></Author><Author ValidYN="Y"><LastName>H&#xf6;ning</LastName><ForeName>G</ForeName><Initials>G</Initials></Author><Author ValidYN="Y"><LastName>Fritsch</LastName><ForeName>H W</ForeName><Initials>HW</Initials></Author><Author ValidYN="Y"><LastName>Sch&#xfc;ttler</LastName><ForeName>J</ForeName><Initials>J</Initials></Author><Author ValidYN="Y"><LastName>Ganslandt</LastName><ForeName>T</ForeName><Initials>T</Initials></Author><Author ValidYN="Y"><LastName>Prokosch</LastName><ForeName>H U</ForeName><Initials>HU</Initials></Author><Author ValidYN="Y"><LastName>Sedlmayr</LastName><ForeName>M</ForeName><Initials>M</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2018</Year><Month>01</Month><Day>24</Day></ArticleDate></Article><MedlineJournalInfo><Country>Germany</Country><MedlineTA>Appl Clin Inform</MedlineTA><NlmUniqueID>101537732</NlmUniqueID><ISSNLinking>1869-0327</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D003299" MajorTopicYN="Y">Cooperative Behavior</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005858" MajorTopicYN="N" Type="Geographic">Germany</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006284" MajorTopicYN="Y">Health Plan Implementation</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006785" MajorTopicYN="Y">Hospitals, University</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017063" MajorTopicYN="Y">Outcome Assessment, Health Care</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011795" MajorTopicYN="N">Surveys and Questionnaires</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014825" MajorTopicYN="N">Vocabulary</DescriptorName></MeshHeading></MeshHeadingList><CoiStatement>Conflict of Interest: None.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2018</Year><Month>1</Month><Day>25</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2018</Year><Month>1</Month><Day>25</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2018</Year><Month>9</Month><Day>4</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2019</Year><Month>1</Month><Day>1</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">29365340</ArticleId><ArticleId IdType="pmc">PMC5801887</ArticleId><ArticleId IdType="doi">10.1055/s-0037-1617452</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Safran C, Bloomrosen M, Hammond W E et al.Toward a national framework for the secondary use of health data: an American Medical Informatics Association White Paper. J Am Med Inform Assoc. 2007;14(01):1&#x2013;9.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2329823</ArticleId><ArticleId IdType="pubmed">17077452</ArticleId></ArticleIdList></Reference><Reference><Citation>Overhage J M, Ryan P B, Reich C G, Hartzema A G, Stang P E. Validation of a common data model for active safety surveillance research. J Am Med Inform Assoc. 2012;19(01):54&#x2013;60.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3240764</ArticleId><ArticleId IdType="pubmed">22037893</ArticleId></ArticleIdList></Reference><Reference><Citation>Gaye A, Marcon Y, Isaeva J et al.DataSHIELD: taking the analysis to the data, not the data to the analysis. Int J Epidemiol. 2014;43(06):1929&#x2013;1944.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4276062</ArticleId><ArticleId IdType="pubmed">25261970</ArticleId></ArticleIdList></Reference><Reference><Citation>Hripcsak G, Duke J D, Shah N H et al.Observational Health Data Sciences and Informatics (OHDSI): Opportunities for Observational Researchers. Stud Health Technol Inform. 2015;216:574&#x2013;578.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4815923</ArticleId><ArticleId IdType="pubmed">26262116</ArticleId></ArticleIdList></Reference><Reference><Citation>OHDSI Homepage. Available at:https://www.ohdsi.org. Accessed October 14, 2017</Citation></Reference><Reference><Citation>Hripcsak G, Ryan P B, Duke J D et al.Characterizing treatment pathways at scale using the OHDSI network. Proc Natl Acad Sci U S A. 2016;113(27):7329&#x2013;7336.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4941483</ArticleId><ArticleId IdType="pubmed">27274072</ArticleId></ArticleIdList></Reference><Reference><Citation>Federal Ministry of Education and Research (BMBF).Medical Informatics Funding Scheme &#x2013; Networking data &#x2013; improving healthcare2015. Available at:https://www.gesundheitsforschung-bmbf.de/files/Medical_Informatics_Funding_Scheme.pdf. Accessed December 25, 2017</Citation></Reference><Reference><Citation>MIRACUM Homepage. Available at:https://www.miracum.org. Accessed July 25, 2017</Citation></Reference><Reference><Citation>Mahlke L, Lefering R, Siebert H, Windolf J, Roeder N, Franz D. Description of the severely injured in the DRG system: is treatment of the severely injured still affordable? [Article in German] Chirurg. 2013;84(11):978&#x2013;986.</Citation><ArticleIdList><ArticleId IdType="pubmed">23512224</ArticleId></ArticleIdList></Reference><Reference><Citation>Barufka S, Heller M, Prayon V, Fegert J M. Nonnative guidelines for allocating human resources in child and adolescent psychiatry using average values under convergence conditions instead of price determination - analysis of the data of university hospitals in Germany concerning the costs of calculating day and minute values according to Psych-PV and PEPP-System [Article in German] Z Kinder Jugendpsychiatr Psychother. 2015;43(06):397&#x2013;409.</Citation><ArticleIdList><ArticleId IdType="pubmed">26602045</ArticleId></ArticleIdList></Reference><Reference><Citation>Bauer C R, Ganslandt T, Baum B et al.Integrated Data Repository Toolkit (IDRT). A suite of programs to facilitate health analytics on heterogeneous medical data. Methods Inf Med. 2016;55(02):125&#x2013;135.</Citation><ArticleIdList><ArticleId IdType="pubmed">26534843</ArticleId></ArticleIdList></Reference><Reference><Citation>Klann J G, Abend A, Raghavan V A, Mandl K D, Murphy S N. Data interchange using i2b2. J Am Med Inform Assoc. 2016;23(05):909&#x2013;915.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4997035</ArticleId><ArticleId IdType="pubmed">26911824</ArticleId></ArticleIdList></Reference><Reference><Citation>Voss E A, Ma Q, Ryan P B. The impact of standardizing the definition of visits on the consistency of multi-database observational health research. BMC Medical Research Methodology. BioMed Central. 2015;15:13.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4369827</ArticleId><ArticleId IdType="pubmed">25887092</ArticleId></ArticleIdList></Reference><Reference><Citation>Sun H, Depraetere K, De Roo J et al.Semantic processing of EHR data for clinical research. J Biomed Inform. 2015;58:247&#x2013;259.</Citation><ArticleIdList><ArticleId IdType="pubmed">26515501</ArticleId></ArticleIdList></Reference><Reference><Citation>Hussain S, Sun H, Sinaci A et al.A framework for evaluating and utilizing medical terminology mappings. Stud Health Technol Inform. 2014;205:594&#x2013;598.</Citation><ArticleIdList><ArticleId IdType="pubmed">25160255</ArticleId></ArticleIdList></Reference><Reference><Citation>Schuemie M J, Gini R, Coloma P M et al.Replication of the OMOP experiment in Europe: evaluating methods for risk identification in electronic health record databases. Drug Saf. 2013;36 01:S159&#x2013;S169.</Citation><ArticleIdList><ArticleId IdType="pubmed">24166232</ArticleId></ArticleIdList></Reference><Reference><Citation>Makadia R, Ryan P B. Transforming the Premier Perspective Hospital Database into the Observational Medical Outcomes Partnership (OMOP) Common Data Model. EGEMS (Wash DC) 2014;2(01):1110.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4371500</ArticleId><ArticleId IdType="pubmed">25848597</ArticleId></ArticleIdList></Reference><Reference><Citation>Matcho A, Ryan P, Fife D, Reich C. Fidelity assessment of a clinical practice research datalink conversion to the OMOP common data model. Drug Saf. 2014;37(11):945&#x2013;959.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4206771</ArticleId><ArticleId IdType="pubmed">25187016</ArticleId></ArticleIdList></Reference><Reference><Citation>Fitz Henry F, Resnic F S, Robbins S L et al.Creating a Common Data Model for Comparative Effectiveness with the Observational Medical Outcomes Partnership. Appl Clin Inform. 2015;6(03):536&#x2013;547.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4586341</ArticleId><ArticleId IdType="pubmed">26448797</ArticleId></ArticleIdList></Reference><Reference><Citation>Yoon D, Ahn E K, Park M Y et al.Conversion and data quality assessment of electronic health record data at a Korean tertiary teaching hospital to a common data model for distributed network research. Healthc Inform Res. 2016;22(01):54&#x2013;58.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4756059</ArticleId><ArticleId IdType="pubmed">26893951</ArticleId></ArticleIdList></Reference><Reference><Citation>Gini R, Schuemie M, Brown J et al.Data Extraction and Management in Networks of Observational Health Care Databases for Scientific Research: A Comparison of EU-ADR, OMOP, Mini-Sentinel and MATRICE Strategies. EGEMS (Wash DC) 2016;4(01):1189.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4780748</ArticleId><ArticleId IdType="pubmed">27014709</ArticleId></ArticleIdList></Reference><Reference><Citation>Xu Y, Zhou X, Suehs B T et al.A comparative assessment of observational medical outcomes partnership and mini-sentinel common data models and analytics: implications for active drug safety surveillance. Drug Saf. 2015;38(08):749&#x2013;765.</Citation><ArticleIdList><ArticleId IdType="pubmed">26055920</ArticleId></ArticleIdList></Reference><Reference><Citation>Mandel J C, Kreda D A, Mandl K D, Kohane I S, Ramoni R B. SMART on FHIR: a standards-based, interoperable apps platform for electronic health records. J Am Med Inform Assoc. 2016;23(05):899&#x2013;908.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4997036</ArticleId><ArticleId IdType="pubmed">26911829</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">29389968</PMID><DateCompleted><Year>2018</Year><Month>03</Month><Day>13</Day></DateCompleted><DateRevised><Year>2019</Year><Month>12</Month><Day>10</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Electronic">1932-6203</ISSN><JournalIssue CitedMedium="Internet"><Volume>13</Volume><Issue>2</Issue><PubDate><Year>2018</Year></PubDate></JournalIssue><Title>PloS one</Title><ISOAbbreviation>PLoS One</ISOAbbreviation></Journal><ArticleTitle>Inferring pregnancy episodes and outcomes within a network of observational databases.</ArticleTitle><Pagination><StartPage>e0192033</StartPage><MedlinePgn>e0192033</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">e0192033</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1371/journal.pone.0192033</ELocationID><Abstract><AbstractText>Administrative claims and electronic health records are valuable resources for evaluating pharmaceutical effects during pregnancy. However, direct measures of gestational age are generally not available. Establishing a reliable approach to infer the duration and outcome of a pregnancy could improve pharmacovigilance activities. We developed and applied an algorithm to define pregnancy episodes in four observational databases: three US-based claims databases: Truven MarketScan&#xae; Commercial Claims and Encounters (CCAE), Truven MarketScan&#xae; Multi-state Medicaid (MDCD), and the Optum ClinFormatics&#xae; (Optum) database and one non-US database, the United Kingdom (UK) based Clinical Practice Research Datalink (CPRD). Pregnancy outcomes were classified as live births, stillbirths, abortions and ectopic pregnancies. Start dates were estimated using a derived hierarchy of available pregnancy markers, including records such as last menstrual period and nuchal ultrasound dates. Validation included clinical adjudication of 700 electronic Optum and CPRD pregnancy episode profiles to assess the operating characteristics of the algorithm, and a comparison of the algorithm's Optum pregnancy start estimates to starts based on dates of assisted conception procedures. Distributions of pregnancy outcome types were similar across all four data sources and pregnancy episode lengths found were as expected for all outcomes, excepting term lengths in episodes that used amenorrhea and urine pregnancy tests for start estimation. Validation survey results found highest agreement between reviewer chosen and algorithm operating characteristics for questions assessing pregnancy status and accuracy of outcome category with 99-100% agreement for Optum and CPRD. Outcome date agreement within seven days in either direction ranged from 95-100%, while start date agreement within seven days in either direction ranged from 90-97%. In Optum validation sensitivity analysis, a total of 73% of algorithm estimated starts for live births were in agreement with fertility procedure estimated starts within two weeks in either direction; ectopic pregnancy 77%, stillbirth 47%, and abortion 36%. An algorithm to infer live birth and ectopic pregnancy episodes and outcomes can be applied to multiple observational databases with acceptable accuracy for further epidemiologic research. Less accuracy was found for start date estimations in stillbirth and abortion outcomes in our sensitivity analysis, which may be expected given the nature of the outcomes.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Matcho</LastName><ForeName>Amy</ForeName><Initials>A</Initials><Identifier Source="ORCID">0000-0002-1016-8793</Identifier><AffiliationInfo><Affiliation>Epidemiology Analytics, Janssen Research and Development, LLC, Raritan, New Jersey, United States of America.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ryan</LastName><ForeName>Patrick</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Epidemiology, Janssen Research and Development, LLC, Titusville, New Jersey, United States of America.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Fife</LastName><ForeName>Daniel</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Epidemiology, Janssen Research and Development, LLC, Titusville, New Jersey, United States of America.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gifkins</LastName><ForeName>Dina</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Epidemiology, Janssen Research and Development, LLC, Titusville, New Jersey, United States of America.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Knoll</LastName><ForeName>Chris</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Epidemiology Analytics, Janssen Research and Development, LLC, Raritan, New Jersey, United States of America.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Friedman</LastName><ForeName>Andrew</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Global Labeling, Janssen Research and Development, LLC, Titusville, New Jersey, United States of America.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType><PublicationType UI="D023361">Validation Study</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2018</Year><Month>02</Month><Day>01</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>PLoS One</MedlineTA><NlmUniqueID>101285081</NlmUniqueID><ISSNLinking>1932-6203</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000465" MajorTopicYN="N">Algorithms</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016208" MajorTopicYN="Y">Databases, Factual</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011247" MajorTopicYN="N">Pregnancy</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011256" MajorTopicYN="Y">Pregnancy Outcome</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006113" MajorTopicYN="N" Type="Geographic">United Kingdom</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D055815" MajorTopicYN="N">Young Adult</DescriptorName></MeshHeading></MeshHeadingList><CoiStatement><b>Competing Interests: </b>I have read the journal&#x2019;s policy and the authors of this manuscript have the following competing interests: at the time of work the authors, AM, PR, DF, DG, CK and AF were full-time employees of Janssen Research and Development, LLC, 920 US Route 202, Raritan, NJ, 08869, USA and stockholders of Johnson &amp; Johnson. Janssen Research and Development is a unit of Johnson &amp; Johnson. Janssen Research and Development, LLC provided support in the form of salaries for authors (AM, PR, DF, DG, CK and AF) and access to pre-collected observational databases, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. PR is principal investigator at the Observational Health Data Sciences and Informatics collaboration, 622 W 168th Street, NY, NY 10032. The above do not alter our adherence to PLOS ONE policies on sharing data and materials.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2016</Year><Month>11</Month><Day>4</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2018</Year><Month>1</Month><Day>14</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2018</Year><Month>2</Month><Day>2</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2018</Year><Month>2</Month><Day>2</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2018</Year><Month>3</Month><Day>14</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2018</Year><Month>2</Month><Day>1</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">29389968</ArticleId><ArticleId IdType="pmc">PMC5794136</ArticleId><ArticleId IdType="doi">10.1371/journal.pone.0192033</ArticleId><ArticleId IdType="pii">PONE-D-16-43954</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Hornbrook MC, Whitlock EP, Berg CJ, Callaghan WM, Bachman DJ, Gold R
et al.
Development of an algorithm to identify pregnancy episodes in an integrated health care delivery system. Health services research. 2007;42(2):908&#x2013;27. doi: 10.1111/j.1475-6773.2006.00635.x
</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1475-6773.2006.00635.x</ArticleId><ArticleId IdType="pmc">PMC1955367</ArticleId><ArticleId IdType="pubmed">17362224</ArticleId></ArticleIdList></Reference><Reference><Citation>Andrade SE, Raebel MA, Morse AN, Davis RL, Chan KA, Finkelstein JA
et al.
Use of prescription medications with a potential for fetal harm among pregnant women. Pharmacoepidemiology and drug safety. 2006;15(8):546&#x2013;54. doi: 10.1002/pds.1235
</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/pds.1235</ArticleId><ArticleId IdType="pubmed">16586470</ArticleId></ArticleIdList></Reference><Reference><Citation>Hardy JR, Holford TR, Hall GC, Bracken MB. Strategies for identifying pregnancies in the automated medical records of the General Practice Research Database. Pharmacoepidemiology and drug safety. 2004;13(11):749&#x2013;59. doi: 10.1002/pds.935
</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/pds.935</ArticleId><ArticleId IdType="pubmed">15386720</ArticleId></ArticleIdList></Reference><Reference><Citation>Devine S, West S, Andrews E, Tennis P, Hammad TA, Eaton S
et al.
The identification of pregnancies within the general practice research database. Pharmacoepidemiology and drug safety. 2010;19(1):45&#x2013;50. doi: 10.1002/pds.1862
</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/pds.1862</ArticleId><ArticleId IdType="pubmed">19823973</ArticleId></ArticleIdList></Reference><Reference><Citation>Cea-Soriano L, Garcia Rodriguez LA, Fernandez Cantero O, Hernandez-Diaz S. Challenges of using primary care electronic medical records in the UK to study medications in pregnancy. Pharmacoepidemiology and drug safety. 2013;22(9):977&#x2013;85. doi: 10.1002/pds.3472
</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/pds.3472</ArticleId><ArticleId IdType="pubmed">23813653</ArticleId></ArticleIdList></Reference><Reference><Citation>Li Q, Andrade SE, Cooper WO, Davis RL, Dublin S, Hammad TA
et al.
Validation of an algorithm to estimate gestational age in electronic health plan databases. Pharmacoepidemiology and drug safety. 2013;22(5):524&#x2013;32. doi: 10.1002/pds.3407
</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/pds.3407</ArticleId><ArticleId IdType="pmc">PMC3644383</ArticleId><ArticleId IdType="pubmed">23335117</ArticleId></ArticleIdList></Reference><Reference><Citation>Margulis AV, Setoguchi S, Mittleman MA, Glynn RJ, Dormuth CR, Hernandez-Diaz S. Algorithms to estimate the beginning of pregnancy in administrative databases. Pharmacoepidemiology and drug safety. 2013;22(1):16&#x2013;24. doi: 10.1002/pds.3284
</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/pds.3284</ArticleId><ArticleId IdType="pmc">PMC3437228</ArticleId><ArticleId IdType="pubmed">22550030</ArticleId></ArticleIdList></Reference><Reference><Citation>Mikolajczyk RT, Kraut AA, Garbe E. Evaluation of pregnancy outcome records in the German Pharmacoepidemiological Research Database (GePaRD). Pharmacoepidemiology and drug safety. 2013;22(8):873&#x2013;80. doi: 10.1002/pds.3467
</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/pds.3467</ArticleId><ArticleId IdType="pubmed">23733705</ArticleId></ArticleIdList></Reference><Reference><Citation>Taylor LG, Thelus Jean R, Gordon G, Fram D, Coster T. Development of a mother-child database for drug exposure and adverse event detection in the Military Health System. Pharmacoepidemiology and drug safety. 2015;24(5):510&#x2013;7. doi: 10.1002/pds.3759
</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/pds.3759</ArticleId><ArticleId IdType="pubmed">25833769</ArticleId></ArticleIdList></Reference><Reference><Citation>Andrade SE, Reichman ME, Mott K, Pitts M, Kieswetter C, Dinatale M
et al.
Use of selective serotonin reuptake inhibitors (SSRIs) in women delivering liveborn infants and other women of child-bearing age within the U.S. Food and Drug Administration&#x2019;s Mini-Sentinel program. Archives of women&#x2019;s mental health. 2016. 
doi: 10.1007/s00737-016-0637-1
</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00737-016-0637-1</ArticleId><ArticleId IdType="pubmed">27178125</ArticleId></ArticleIdList></Reference><Reference><Citation>Observational Health Data Sciences and Informatics. OMOP Common Data Model. 2016. http://www.ohdsi.org/data-standardization/the-common-data-model/. Accessed July 2016.</Citation></Reference><Reference><Citation>Matcho A, Ryan P, Fife D, Reich C. Fidelity assessment of a clinical practice research datalink conversion to the OMOP common data model. Drug safety. 2014. 
doi: 10.1007/s40264-014-0214-3
</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s40264-014-0214-3</ArticleId><ArticleId IdType="pmc">PMC4206771</ArticleId><ArticleId IdType="pubmed">25187016</ArticleId></ArticleIdList></Reference><Reference><Citation>Voss EA, Makadia R, Matcho A, Ma Q, Knoll C, Schuemie M
et al.
Feasibility and utility of applications of the common data model to multiple, disparate observational health databases. Journal of the American Medical Informatics Association: JAMIA. 2015;22(3):553&#x2013;64. doi: 10.1093/jamia/ocu023
</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/jamia/ocu023</ArticleId><ArticleId IdType="pmc">PMC4457111</ArticleId><ArticleId IdType="pubmed">25670757</ArticleId></ArticleIdList></Reference><Reference><Citation>Reich C, Ryan PB, Stang PE, Rocca M. Evaluation of alternative standardized terminologies for medical conditions within a network of observational healthcare databases. Journal of biomedical informatics. 2012;45(4):689&#x2013;96. doi: 10.1016/j.jbi.2012.05.002
</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jbi.2012.05.002</ArticleId><ArticleId IdType="pubmed">22683994</ArticleId></ArticleIdList></Reference><Reference><Citation>Scholes D, Yu O, Raebel MA, Trabert B, Holt VL. Improving automated case finding for ectopic pregnancy using a classification algorithm. Human reproduction (Oxford, England). 2011;26(11):3163&#x2013;8. doi: 10.1093/humrep/der299
</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/humrep/der299</ArticleId><ArticleId IdType="pmc">PMC3196880</ArticleId><ArticleId IdType="pubmed">21911435</ArticleId></ArticleIdList></Reference><Reference><Citation>Sanderson S, Tatt ID, Higgins JP. Tools for assessing quality and susceptibility to bias in observational studies in epidemiology: a systematic review and annotated bibliography. International journal of epidemiology. 2007;36(3):666&#x2013;76. doi: 10.1093/ije/dym018
</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/ije/dym018</ArticleId><ArticleId IdType="pubmed">17470488</ArticleId></ArticleIdList></Reference><Reference><Citation>Shamliyan T, Kane RL, Dickinson S. A systematic review of tools used to assess the quality of observational studies that examine incidence or prevalence and risk factors for diseases. Journal of clinical epidemiology. 2010;63(10):1061&#x2013;70. doi: 10.1016/j.jclinepi.2010.04.014
</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jclinepi.2010.04.014</ArticleId><ArticleId IdType="pubmed">20728045</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">29468602</PMID><DateCompleted><Year>2018</Year><Month>10</Month><Day>02</Day></DateCompleted><DateRevised><Year>2018</Year><Month>11</Month><Day>13</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1179-1942</ISSN><JournalIssue CitedMedium="Internet"><Volume>41</Volume><Issue>6</Issue><PubDate><Year>2018</Year><Month>Jun</Month></PubDate></JournalIssue><Title>Drug safety</Title><ISOAbbreviation>Drug Saf</ISOAbbreviation></Journal><ArticleTitle>Time Series Disturbance Detection for Hypothesis-Free Signal Detection in Longitudinal Observational Databases.</ArticleTitle><Pagination><StartPage>565</StartPage><EndPage>577</EndPage><MedlinePgn>565-577</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1007/s40264-018-0640-8</ELocationID><Abstract><AbstractText Label="INTRODUCTION" NlmCategory="BACKGROUND">Signal detection remains a cornerstone activity of pharmacovigilance. Routine quantitative signal detection primarily focuses on screening of spontaneous reports. In striving to enhance quantitative signal detection capability further, other data streams are being considered for their potential contribution as sources of emerging signals, one of which is longitudinal observational databases, including electronic medical record (EMR) and transactional insurance claims databases. Quantitative signal detection on such databases is a nascent field-with published methods being primarily based either on individual metrics, which may not effectively represent the complexity of the longitudinal records and their necessary variation for analysis for drug-outcome pairs, or on visualization discovery approaches leveraging multiple aspects of the records, which are not particularly tractable to high-throughput hypothesis-free signal detection. One extensively tested example of the latter is chronographs.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">We apply a disturbance detection algorithm to chronographs using UK EMR The Health Improvement Network (THIN) data. The algorithm utilizes autoregressive integrated moving average (ARIMA)-based time series methodology designed to find disturbances that occur outside the normal pattern trends of the ARIMA model for the chronograph. Chronographs currently highlight drug-event pairs as potentially worthy of further clinical assessment, via filter-based increases in disproportionality scores from before to after the index drug exposure, tested across a range of case and control windows.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">We replicate the findings on six exemplar chronographs from a previous publication, and show how disturbances can be effectively detected across this set of pairs. Further, 692 disturbances were detected in analysis of all 384 individual READ code outcomes ever recorded 50 or more times for patients prescribed sibutramine. The disturbances are algorithmically further broken into subsets of clinical interest.</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">Overall, the disturbance algorithm approach shows promising capacity for detecting outliers, and shows tractability of the algorithmic approach for large-scale screening. The method offers an array of pattern types for detection and clinical review.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Whalen</LastName><ForeName>Ed</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Pfizer Inc, 235 East 42nd St., New York, NY, USA. ed.whalen@pfizer.com.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hauben</LastName><ForeName>Manfred</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Pfizer Inc, 235 East 42nd St., New York, NY, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>New York University School of Medicine, New York, NY, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bate</LastName><ForeName>Andrew</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Pfizer Inc, 235 East 42nd St., New York, NY, USA.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>New Zealand</Country><MedlineTA>Drug Saf</MedlineTA><NlmUniqueID>9002928</NlmUniqueID><ISSNLinking>0114-5916</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D016907" MajorTopicYN="N">Adverse Drug Reaction Reporting Systems</DescriptorName><QualifierName UI="Q000706" MajorTopicYN="N">statistics &amp; numerical data</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016208" MajorTopicYN="N">Databases, Factual</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D064420" MajorTopicYN="N">Drug-Related Side Effects and Adverse Reactions</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="Y">diagnosis</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D057286" MajorTopicYN="N">Electronic Health Records</DescriptorName><QualifierName UI="Q000706" MajorTopicYN="N">statistics &amp; numerical data</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008137" MajorTopicYN="N">Longitudinal Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D064887" MajorTopicYN="N">Observational Studies as Topic</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D060735" MajorTopicYN="Y">Pharmacovigilance</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>2018</Year><Month>2</Month><Day>23</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2018</Year><Month>10</Month><Day>3</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2018</Year><Month>2</Month><Day>23</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">29468602</ArticleId><ArticleId IdType="doi">10.1007/s40264-018-0640-8</ArticleId><ArticleId IdType="pii">10.1007/s40264-018-0640-8</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Drug Saf. 2012 Jan 1;35(1):79-84</Citation><ArticleIdList><ArticleId IdType="pubmed">22136184</ArticleId></ArticleIdList></Reference><Reference><Citation>Stud Health Technol Inform. 2011;166:25-30</Citation><ArticleIdList><ArticleId IdType="pubmed">21685607</ArticleId></ArticleIdList></Reference><Reference><Citation>Eur J Clin Pharmacol. 1998 Jun;54(4):315-21</Citation><ArticleIdList><ArticleId IdType="pubmed">9696956</ArticleId></ArticleIdList></Reference><Reference><Citation>Pharmacoepidemiol Drug Saf. 2007 Apr;16(4):393-401</Citation><ArticleIdList><ArticleId IdType="pubmed">17066486</ArticleId></ArticleIdList></Reference><Reference><Citation>Drug Saf. 2016 Apr;39(4):347-54</Citation><ArticleIdList><ArticleId IdType="pubmed">26798053</ArticleId></ArticleIdList></Reference><Reference><Citation>Expert Opin Drug Saf. 2017 Jun;16(6):721-732</Citation><ArticleIdList><ArticleId IdType="pubmed">28490262</ArticleId></ArticleIdList></Reference><Reference><Citation>Expert Rev Clin Pharmacol. 2015 Jan;8(1):95-102</Citation><ArticleIdList><ArticleId IdType="pubmed">25487079</ArticleId></ArticleIdList></Reference><Reference><Citation>Inform Prim Care. 2011;19(4):251-5</Citation><ArticleIdList><ArticleId IdType="pubmed">22828580</ArticleId></ArticleIdList></Reference><Reference><Citation>Drug Saf. 2015 Jan;38(1):87-100</Citation><ArticleIdList><ArticleId IdType="pubmed">25539877</ArticleId></ArticleIdList></Reference><Reference><Citation>Drug Saf. 2013 Oct;36 Suppl 1:S107-21</Citation><ArticleIdList><ArticleId IdType="pubmed">24166228</ArticleId></ArticleIdList></Reference><Reference><Citation>Drug Saf. 2003;26(14):1049-55</Citation><ArticleIdList><ArticleId IdType="pubmed">14583065</ArticleId></ArticleIdList></Reference><Reference><Citation>Drug Saf. 2007;30(7):623-5</Citation><ArticleIdList><ArticleId IdType="pubmed">17604417</ArticleId></ArticleIdList></Reference><Reference><Citation>J Clin Hypertens (Greenwich). 2003 Jul-Aug;5(4):291-4, 297</Citation><ArticleIdList><ArticleId IdType="pubmed">12939574</ArticleId></ArticleIdList></Reference><Reference><Citation>Ann Pharmacother. 2004 Oct;38(10):1625-30</Citation><ArticleIdList><ArticleId IdType="pubmed">15304626</ArticleId></ArticleIdList></Reference><Reference><Citation>Stat Methods Med Res. 2013 Feb;22(1):57-69</Citation><ArticleIdList><ArticleId IdType="pubmed">21705438</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">29495212</PMID><DateCompleted><Year>2018</Year><Month>05</Month><Day>01</Day></DateCompleted><DateRevised><Year>2018</Year><Month>12</Month><Day>02</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Print">0254-6450</ISSN><JournalIssue CitedMedium="Print"><Volume>39</Volume><Issue>2</Issue><PubDate><Year>2018</Year><Month>Feb</Month><Day>10</Day></PubDate></JournalIssue><Title>Zhonghua liu xing bing xue za zhi = Zhonghua liuxingbingxue zazhi</Title><ISOAbbreviation>Zhonghua Liu Xing Bing Xue Za Zhi</ISOAbbreviation></Journal><ArticleTitle>[Data harmonization and sharing in study cohorts of respiratory diseases].</ArticleTitle><Pagination><StartPage>233</StartPage><EndPage>239</EndPage><MedlinePgn>233-239</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.3760/cma.j.issn.0254-6450.2018.02.019</ELocationID><Abstract><AbstractText><b>Objective:</b> Chronic obstructive pulmonary disease, asthma, interstitial lung disease and pulmonary thromboembolism are the most common and severe respiratory diseases, which seriously jeopardizing the health of the Chinese citizens. Large-scale prospective cohort studies are needed to explore the relationships between potential risk factors and respiratory disease outcomes and to observe disease prognoses through long-term follow-ups. We aimed to develop a common data model (CDM) for cohort studies on respiratory diseases, in order to harmonize and facilitate the exchange, pooling, sharing, and storing of data from multiple sources to serve the purpose of reusing or uniforming those follow-up data appeared in the cohorts. <b>Methods:</b> The process of developing this CDM of respiratory diseases would follow the steps as: &#x2460;Reviewing the international standards, including the Clinical Data Interchange Standards Consortium (CDISC), Clinical Data Acquisition Standards Harmonization (CDASH) and the Observational Medical Outcomes Partnership (OMOP) CDM; &#x2461;Summarizing four cohort studies of respiratory diseases recruited in this research and assessing the data availability; &#x2462;Developing a CDM related to respiratory diseases. <b>Results:</b> Data on recruited cohorts shared a few similar domains but with various schema. The cohorts also shared homogeneous data collection purposes for future follow-up studies, making the harmonization of current and future data feasible. The derived CDM would include two parts: &#x2460;thirteen common domains for all the four cohorts and derived variables from disparate questions with a common schema, &#x2461;additional domains designed upon disease-specific research needs, as well as additional variables that were disease-specific but not initially included in the common domains. <b>Conclusion:</b> Data harmonization appeared essential for sharing, comparing and pooled analyses, both retrospectively and prospectively. CDM was needed to convert heterogeneous data from multiple studies into one harmonized dataset. The use of a CDM in multicenter respiratory cohort studies would make the constant collection of uniformed data possible, so to guarantee the data exchange and sharing in the future.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Sun</LastName><ForeName>Y X</ForeName><Initials>YX</Initials><AffiliationInfo><Affiliation>Department of Epidemiology and Biostatistics, School of Public Health, Peking University, Beijing 100191, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pei</LastName><ForeName>Z C</ForeName><Initials>ZC</Initials></Author><Author ValidYN="Y"><LastName>Zhan</LastName><ForeName>S Y</ForeName><Initials>SY</Initials></Author></AuthorList><Language>chi</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>China</Country><MedlineTA>Zhonghua Liu Xing Bing Xue Za Zhi</MedlineTA><NlmUniqueID>8208604</NlmUniqueID><ISSNLinking>0254-6450</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D003625" MajorTopicYN="N">Data Collection</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName><QualifierName UI="Q000592" MajorTopicYN="Y">standards</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016208" MajorTopicYN="N">Databases, Factual</DescriptorName><QualifierName UI="Q000592" MajorTopicYN="Y">standards</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D003695" MajorTopicYN="N">Delivery of Health Care</DescriptorName><QualifierName UI="Q000458" MajorTopicYN="Y">organization &amp; administration</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D033181" MajorTopicYN="Y">Information Dissemination</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D029424" MajorTopicYN="Y">Pulmonary Disease, Chronic Obstructive</DescriptorName></MeshHeading></MeshHeadingList><OtherAbstract Type="Publisher" Language="chi"><AbstractText><b>&#x76ee;&#x7684;&#xff1a;</b> &#x6162;&#x6027;&#x963b;&#x585e;&#x6027;&#x80ba;&#x75be;&#x75c5;&#x3001;&#x54ee;&#x5598;&#x3001;&#x95f4;&#x8d28;&#x6027;&#x80ba;&#x75be;&#x75c5;&#x548c;&#x80ba;&#x8840;&#x6813;&#x6813;&#x585e;&#x75c7;&#x662f;&#x91cd;&#x5927;&#x547c;&#x5438;&#x7cfb;&#x7edf;&#x75be;&#x75c5;&#xff0c;&#x4e25;&#x91cd;&#x5371;&#x5bb3;&#x6211;&#x56fd;&#x5c45;&#x6c11;&#x5065;&#x5eb7;&#xff0c;&#x6574;&#x5408;&#x5e76;&#x5f00;&#x5c55;&#x5927;&#x89c4;&#x6a21;&#x4eba;&#x7fa4;&#x961f;&#x5217;&#x7814;&#x7a76;&#x6709;&#x52a9;&#x4e8e;&#x89c2;&#x5bdf;&#x75be;&#x75c5;&#x7684;&#x66b4;&#x9732;&#x3001;&#x53d1;&#x75c5;&#x4e0e;&#x8f6c;&#x5f52;&#x60c5;&#x51b5;&#x3002;&#x672c;&#x7814;&#x7a76;&#x9488;&#x5bf9;&#x6211;&#x56fd;&#x793e;&#x533a;&#x4e0e;&#x4e34;&#x5e8a;&#x961f;&#x5217;&#x8d44;&#x6e90;&#x7684;&#x591a;&#x6e90;&#x5f02;&#x6784;&#x73b0;&#x72b6;&#xff0c;&#x5236;&#x5b9a;&#x547c;&#x5438;&#x7cfb;&#x7edf;&#x75be;&#x75c5;&#x4e13;&#x75c5;&#x961f;&#x5217;&#xff08;&#x547c;&#x5438;&#x4e13;&#x75c5;&#x961f;&#x5217;&#xff09;&#x6570;&#x636e;&#x6807;&#x51c6;&#xff0c;&#x4e3a;&#x89e3;&#x51b3;&#x591a;&#x6e90;&#x5f02;&#x6784;&#x6570;&#x636e;&#x6240;&#x81f4;&#x5171;&#x4eab;&#x969c;&#x788d;&#xff0c;&#x4ee5;&#x53ca;&#x9879;&#x76ee;&#x6700;&#x5927;&#x7a0b;&#x5ea6;&#x5f00;&#x5c55;&#x6570;&#x636e;&#x4ea4;&#x6362;&#x3001;&#x6574;&#x5408;&#x3001;&#x5171;&#x4eab;&#x3001;&#x50a8;&#x5b58;&#x4e0e;&#x5229;&#x7528;&#x63d0;&#x4f9b;&#x601d;&#x8def;&#x4e0e;&#x65b9;&#x6cd5;&#x3002; <b>&#x65b9;&#x6cd5;&#xff1a;</b> &#x547c;&#x5438;&#x4e13;&#x75c5;&#x961f;&#x5217;&#x6570;&#x636e;&#x6807;&#x51c6;&#x5236;&#x5b9a;&#x601d;&#x8def;&#xff1a;&#x2460;&#x5b66;&#x4e60;&#x3001;&#x53c2;&#x8003;&#x56fd;&#x9645;&#x6807;&#x51c6;&#xff0c;&#x5305;&#x62ec;&#x4e34;&#x5e8a;&#x6570;&#x636e;&#x4ea4;&#x6362;&#x6807;&#x51c6;&#x534f;&#x4f1a;&#xff08;CDISC&#xff09;&#x7684;CDASH&#x6a21;&#x578b;&#xff0c;&#x89c2;&#x5bdf;&#x6027;&#x533b;&#x7597;&#x7ed3;&#x679c;&#x5408;&#x4f5c;&#x7ec4;&#x7ec7;&#xff08;OMOP&#xff09;&#x7684;CDM&#x901a;&#x7528;&#x6570;&#x636e;&#x6a21;&#x578b;&#xff1b;&#x2461;&#x6574;&#x7406;&#x3001;&#x5f52;&#x7eb3;&#x6240;&#x7eb3;&#x5165;&#x7684;4&#x4e2a;&#x547c;&#x5438;&#x4e13;&#x75c5;&#x961f;&#x5217;&#x8d44;&#x6e90;&#xff0c;&#x8bc4;&#x4f30;&#x5404;&#x961f;&#x5217;&#x8d44;&#x6e90;&#x95f4;&#x7684;&#x540c;&#x8d28;&#x6027;&#x4e0e;&#x6574;&#x5408;&#x7684;&#x53ef;&#x80fd;&#x6027;&#xff1b;&#x2462;&#x4e13;&#x5bb6;&#x8ba8;&#x8bba;&#xff0c;&#x5efa;&#x7acb;&#x547c;&#x5438;&#x4e13;&#x75c5;&#x961f;&#x5217;&#x6570;&#x636e;&#x6807;&#x51c6;&#x3002; <b>&#x7ed3;&#x679c;&#xff1a;</b> &#x7814;&#x7a76;&#x7eb3;&#x5165;&#x7684;&#x73b0;&#x6709;&#x547c;&#x5438;&#x4e13;&#x75c5;&#x961f;&#x5217;&#x53d8;&#x91cf;&#x6a21;&#x5757;&#x540c;&#x8d28;&#x6027;&#x8f83;&#x597d;&#xff0c;&#x57fa;&#x672c;&#x7ed3;&#x6784;&#x76f8;&#x4f3c;&#xff0c;&#x5177;&#x6709;&#x6570;&#x636e;&#x6574;&#x5408;&#x7684;&#x53ef;&#x884c;&#x6027;&#x3002;&#x53c2;&#x8003;&#x56fd;&#x9645;&#x6807;&#x51c6;&#xff0c;&#x7ecf;&#x4e13;&#x5bb6;&#x8ba8;&#x8bba;&#xff0c;&#x9879;&#x76ee;&#x7ec4;&#x6784;&#x5efa;&#x547c;&#x5438;&#x4e13;&#x75c5;&#x961f;&#x5217;&#x7684;&#x6570;&#x636e;&#x6807;&#x51c6;&#x6982;&#x5ff5;&#x6846;&#x67b6;&#xff0c;&#x7531;&#x547c;&#x5438;&#x4e13;&#x75c5;&#x961f;&#x5217;&#x901a;&#x7528;&#x6570;&#x636e;&#x6807;&#x51c6;&#x53ca;&#x75be;&#x75c5;&#x7279;&#x5f02;&#x6570;&#x636e;&#x6807;&#x51c6;&#x4e24;&#x90e8;&#x5206;&#x6784;&#x6210;&#xff0c;&#x5176;&#x4e2d;&#x901a;&#x7528;&#x6570;&#x636e;&#x6807;&#x51c6;&#x9488;&#x5bf9;&#x5404;&#x4e13;&#x75c5;&#x961f;&#x5217;&#x4e2d;&#x5747;&#x6709;&#x6d89;&#x53ca;&#x3001;&#x80fd;&#x591f;&#x7edf;&#x4e00;&#x6807;&#x51c6;&#x7684;&#x95ee;&#x9898;&#x6216;&#x7814;&#x7a76;&#x53d8;&#x91cf;&#xff1b;&#x7279;&#x5f02;&#x6570;&#x636e;&#x6807;&#x51c6;&#x5219;&#x4e3a;&#x5404;&#x75be;&#x75c5;&#x7279;&#x6709;&#x7684;&#x95ee;&#x9898;&#x3002;&#x7ecf;&#x6620;&#x5c04;&#x5339;&#x914d;&#xff0c;&#x8ba4;&#x4e3a;&#x8be5;&#x6807;&#x51c6;&#x4e0e;&#x5404;&#x73b0;&#x6709;&#x4e13;&#x75c5;&#x961f;&#x5217;&#x7684;&#x53d8;&#x91cf;&#x6a21;&#x5757;&#x5339;&#x914d;&#x826f;&#x597d;&#xff0c;&#x6807;&#x51c6;&#x53ef;&#x884c;&#x3002; <b>&#x7ed3;&#x8bba;&#xff1a;</b> &#x6570;&#x636e;&#x6807;&#x51c6;&#x5efa;&#x7acb;&#x540e;&#xff0c;&#x5728;&#x56de;&#x987e;&#x6027;&#x6574;&#x5408;&#x73b0;&#x6709;&#x961f;&#x5217;&#x8d44;&#x6e90;&#x7684;&#x540c;&#x65f6;&#xff0c;&#x4f7f;&#x4e0d;&#x540c;&#x9879;&#x76ee;&#x4ee5;&#x76f8;&#x540c;&#x7684;&#x5b9a;&#x4e49;&#x548c;&#x6807;&#x51c6;&#x5f00;&#x5c55;&#x957f;&#x671f;&#x968f;&#x8bbf;&#xff0c;&#x6536;&#x96c6;&#x6838;&#x5fc3;&#x6570;&#x636e;&#x96c6;&#xff0c;&#x4e3a;&#x672a;&#x6765;&#x5f00;&#x5c55;&#x591a;&#x4e2d;&#x5fc3;&#x7814;&#x7a76;&#x626b;&#x9664;&#x56e0;&#x6570;&#x636e;&#x6807;&#x51c6;&#x4e0d;&#x4e00;&#x5bfc;&#x81f4;&#x7684;&#x6570;&#x636e;&#x5171;&#x4eab;&#x969c;&#x788d;&#xff0c;&#x66f4;&#x6709;&#x5229;&#x4e8e;&#x591a;&#x6e90;&#x7684;&#x6574;&#x5408;&#x4e0e;&#x5171;&#x4eab;&#x3002;.</AbstractText></OtherAbstract><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Cohort study of respiratory diseases</Keyword><Keyword MajorTopicYN="N">Common data model</Keyword><Keyword MajorTopicYN="N">Data harmonization</Keyword><Keyword MajorTopicYN="N">Data sharing</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2018</Year><Month>3</Month><Day>2</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2018</Year><Month>3</Month><Day>2</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2018</Year><Month>5</Month><Day>2</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">29495212</ArticleId><ArticleId IdType="doi">10.3760/cma.j.issn.0254-6450.2018.02.019</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">29531023</PMID><DateCompleted><Year>2018</Year><Month>07</Month><Day>30</Day></DateCompleted><DateRevised><Year>2018</Year><Month>11</Month><Day>14</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1091-6490</ISSN><JournalIssue CitedMedium="Internet"><Volume>115</Volume><Issue>11</Issue><PubDate><Year>2018</Year><Month>Mar</Month><Day>13</Day></PubDate></JournalIssue><Title>Proceedings of the National Academy of Sciences of the United States of America</Title><ISOAbbreviation>Proc Natl Acad Sci U S A</ISOAbbreviation></Journal><ArticleTitle>Empirical confidence interval calibration for population-level effect estimation studies in observational healthcare data.</ArticleTitle><Pagination><StartPage>2571</StartPage><EndPage>2577</EndPage><MedlinePgn>2571-2577</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1073/pnas.1708282114</ELocationID><Abstract><AbstractText>Observational healthcare data, such as electronic health records and administrative claims, offer potential to estimate effects of medical products at scale. Observational studies have often been found to be nonreproducible, however, generating conflicting results even when using the same database to answer the same question. One source of discrepancies is error, both random caused by sampling variability and systematic (for example, because of confounding, selection bias, and measurement error). Only random error is typically quantified but converges to zero as databases become larger, whereas systematic error persists independent from sample size and therefore, increases in relative importance. Negative controls are exposure-outcome pairs, where one believes no causal effect exists; they can be used to detect multiple sources of systematic error, but interpreting their results is not always straightforward. Previously, we have shown that an empirical null distribution can be derived from a sample of negative controls and used to calibrate <i>P</i> values, accounting for both random and systematic error. Here, we extend this work to calibration of confidence intervals (CIs). CIs require positive controls, which we synthesize by modifying negative controls. We show that our CI calibration restores nominal characteristics, such as 95% coverage of the true effect size by the 95% CI. We furthermore show that CI calibration reduces disagreement in replications of two pairs of conflicting observational studies: one related to dabigatran, warfarin, and gastrointestinal bleeding and one related to selective serotonin reuptake inhibitors and upper gastrointestinal bleeding. We recommend CI calibration to improve reproducibility of observational studies.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Schuemie</LastName><ForeName>Martijn J</ForeName><Initials>MJ</Initials><Identifier Source="ORCID">0000-0002-0817-5361</Identifier><AffiliationInfo><Affiliation>Observational Health Data Sciences and Informatics, New York, NY 10032; schuemie@ohdsi.org.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Epidemiology Analytics, Janssen Research &amp; Development, Titusville, NJ 08560.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hripcsak</LastName><ForeName>George</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Observational Health Data Sciences and Informatics, New York, NY 10032.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Biomedical Informatics, Columbia University, New York, NY 10032.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Medical Informatics Services, New York-Presbyterian Hospital, New York, NY 10032.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ryan</LastName><ForeName>Patrick B</ForeName><Initials>PB</Initials><AffiliationInfo><Affiliation>Observational Health Data Sciences and Informatics, New York, NY 10032.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Epidemiology Analytics, Janssen Research &amp; Development, Titusville, NJ 08560.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Biomedical Informatics, Columbia University, New York, NY 10032.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Madigan</LastName><ForeName>David</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Observational Health Data Sciences and Informatics, New York, NY 10032.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Statistics, Columbia University, New York, NY 10027.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Suchard</LastName><ForeName>Marc A</ForeName><Initials>MA</Initials><AffiliationInfo><Affiliation>Observational Health Data Sciences and Informatics, New York, NY 10032.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Biomathematics, University of California, Los Angeles, CA 90095.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Biostatistics, University of California, Los Angeles, CA 90095.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Human Genetics, University of California, Los Angeles, CA 90095.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>R01 LM006910</GrantID><Acronym>LM</Acronym><Agency>NLM NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D052061">Research Support, N.I.H., Extramural</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType><PublicationType UI="D013486">Research Support, U.S. Gov't, Non-P.H.S.</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Proc Natl Acad Sci U S A</MedlineTA><NlmUniqueID>7505876</NlmUniqueID><ISSNLinking>0027-8424</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D015982" MajorTopicYN="Y">Bias</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002138" MajorTopicYN="N">Calibration</DescriptorName><QualifierName UI="Q000592" MajorTopicYN="Y">standards</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016001" MajorTopicYN="N">Confidence Intervals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006302" MajorTopicYN="N">Health Services Research</DescriptorName><QualifierName UI="Q000592" MajorTopicYN="Y">standards</QualifierName><QualifierName UI="Q000706" MajorTopicYN="Y">statistics &amp; numerical data</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D064887" MajorTopicYN="Y">Observational Studies as Topic</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012107" MajorTopicYN="N">Research Design</DescriptorName><QualifierName UI="Q000592" MajorTopicYN="N">standards</QualifierName><QualifierName UI="Q000706" MajorTopicYN="N">statistics &amp; numerical data</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">calibration</Keyword><Keyword MajorTopicYN="N">observational studies</Keyword><Keyword MajorTopicYN="N">systematic error</Keyword></KeywordList><CoiStatement>Conflict of interest statement: M.J.S. and P.B.R. are full-time employees and shareholders of Janssen Research &amp; Development.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>2018</Year><Month>3</Month><Day>14</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2018</Year><Month>7</Month><Day>31</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2018</Year><Month>3</Month><Day>14</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2018</Year><Month>3</Month><Day>13</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">29531023</ArticleId><ArticleId IdType="pmc">PMC5856503</ArticleId><ArticleId IdType="doi">10.1073/pnas.1708282114</ArticleId><ArticleId IdType="pii">1708282114</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Overhage JM, Ryan PB, Schuemie MJ, Stang PE. Desideratum for evidence based epidemiology. Drug Saf. 2013;1(36 Suppl):S5&#x2013;S14.</Citation><ArticleIdList><ArticleId IdType="pubmed">24166219</ArticleId></ArticleIdList></Reference><Reference><Citation>Prasad V, Jena AB. Prespecified falsification end points: Can they validate true observational associations? JAMA. 2013;309:241&#x2013;242.</Citation><ArticleIdList><ArticleId IdType="pubmed">23321761</ArticleId></ArticleIdList></Reference><Reference><Citation>Dusetzina SB, Brookhart MA, Maciejewski ML. Control outcomes and exposures for improving internal validity of nonrandomized studies. Health Serv Res. 2015;50:1432&#x2013;1451.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4600355</ArticleId><ArticleId IdType="pubmed">25598384</ArticleId></ArticleIdList></Reference><Reference><Citation>Arnold BF, Ercumen A. Negative control outcomes: A tool to detect bias in randomized trials. JAMA. 2016;316:2597&#x2013;2598.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5428075</ArticleId><ArticleId IdType="pubmed">28027378</ArticleId></ArticleIdList></Reference><Reference><Citation>Lipsitch M, Tchetgen Tchetgen E, Cohen T. Negative controls: A tool for detecting confounding and bias in observational studies. Epidemiology. 2010;21:383&#x2013;388.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3053408</ArticleId><ArticleId IdType="pubmed">20335814</ArticleId></ArticleIdList></Reference><Reference><Citation>Arnold BF, Ercumen A, Benjamin-Chung J, Colford JM. Brief report: Negative controls to detect selection bias and measurement bias in epidemiologic studies. Epidemiology. 2016;27:637&#x2013;641.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4969055</ArticleId><ArticleId IdType="pubmed">27182642</ArticleId></ArticleIdList></Reference><Reference><Citation>Zaadstra BM, Chorus AM, vanBuuren S, Kalsbeek H, vanNoort JM. Selective association of multiple sclerosis with infectious mononucleosis. Mult Scler. 2008;14:307&#x2013;313.</Citation><ArticleIdList><ArticleId IdType="pubmed">18208871</ArticleId></ArticleIdList></Reference><Reference><Citation>Tchetgen Tchetgen E. The control outcome calibration approach for causal inference with unobserved confounding. Am J Epidemiol. 2014;179:633&#x2013;640.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3927977</ArticleId><ArticleId IdType="pubmed">24363326</ArticleId></ArticleIdList></Reference><Reference><Citation>Flanders WD, Strickland MJ, Klein M. A new method for partial correction of residual confounding in time-series and other observational studies. Am J Epidemiol. 2017;185:941&#x2013;949.</Citation><ArticleIdList><ArticleId IdType="pubmed">28430842</ArticleId></ArticleIdList></Reference><Reference><Citation>Schuemie MJ, Ryan PB, DuMouchel W, Suchard MA, Madigan D. Interpreting observational studies: Why empirical calibration is needed to correct p-values. Stat Med. 2014;33:209&#x2013;218.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4285234</ArticleId><ArticleId IdType="pubmed">23900808</ArticleId></ArticleIdList></Reference><Reference><Citation>Schuemie MJ, Hripcsak G, Ryan PB, Madigan D, Suchard MA. Robust empirical calibration of p-values using observational data. Stat Med. 2016;35:3883&#x2013;3888.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5108459</ArticleId><ArticleId IdType="pubmed">27592566</ArticleId></ArticleIdList></Reference><Reference><Citation>Southworth MR, Reichman ME, Unger EF. Dabigatran and postmarketing reports of bleeding. N Engl J Med. 2013;368:1272&#x2013;1274.</Citation><ArticleIdList><ArticleId IdType="pubmed">23484796</ArticleId></ArticleIdList></Reference><Reference><Citation>Graham DJ, et al. Stroke, bleeding, and mortality risks in elderly medicare beneficiaries treated with dabigatran or rivaroxaban for nonvalvular atrial fibrillation. JAMA Intern Med. 2016;176:1662&#x2013;1671.</Citation><ArticleIdList><ArticleId IdType="pubmed">27695821</ArticleId></ArticleIdList></Reference><Reference><Citation>Tata LJ, et al. Does concurrent prescription of selective serotonin reuptake inhibitors and non-steroidal anti-inflammatory drugs substantially increase the risk of upper gastrointestinal bleeding? Aliment Pharmacol Ther. 2005;22:175&#x2013;181.</Citation><ArticleIdList><ArticleId IdType="pubmed">16091054</ArticleId></ArticleIdList></Reference><Reference><Citation>Voss EA, et al. Accuracy of an automated knowledge base for identifying drug adverse reactions. J Biomed Inform. 2016;66:72&#x2013;81.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5316295</ArticleId><ArticleId IdType="pubmed">27993747</ArticleId></ArticleIdList></Reference><Reference><Citation>Noren GN, Caster O, Juhlin K, Lindquist M. Zoo or Savannah? Choice of training ground for evidence-based pharmacovigilance. Drug Saf. 2014;37:655&#x2013;659.</Citation><ArticleIdList><ArticleId IdType="pubmed">25005708</ArticleId></ArticleIdList></Reference><Reference><Citation>Tibshirani R. Regression shrinkage and selection via the lasso. J R Stat Soc Series B Stat Methodol. 1996;73:267&#x2013;288.</Citation></Reference><Reference><Citation>Suchard MA, Simpson SE, Zorych I, Ryan P, Madigan D. Massive parallelization of serial inference algorithms for a complex generalized linear model. ACM Trans Model Comput Simul. 2013;23:1&#x2013;17.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4201181</ArticleId><ArticleId IdType="pubmed">25328363</ArticleId></ArticleIdList></Reference><Reference><Citation>van Staa TP, Parkinson J. Response to: Validation studies of the health improvement network (THIN) database for pharmacoepidemiology research by Lewis et al. Pharmacoepidemiol Drug Saf. 2008;17:103&#x2013;104.</Citation><ArticleIdList><ArticleId IdType="pubmed">18092305</ArticleId></ArticleIdList></Reference><Reference><Citation>Herrett E, et al. Data resource profile: Clinical practice research datalink (CPRD) Int J Epidemiol. 2015;44:827&#x2013;836.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4521131</ArticleId><ArticleId IdType="pubmed">26050254</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">29687963</PMID><DateCompleted><Year>2019</Year><Month>12</Month><Day>13</Day></DateCompleted><DateRevised><Year>2023</Year><Month>01</Month><Day>24</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1600-6143</ISSN><JournalIssue CitedMedium="Internet"><Volume>18</Volume><Issue>6</Issue><PubDate><Year>2018</Year><Month>Jun</Month></PubDate></JournalIssue><Title>American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons</Title><ISOAbbreviation>Am J Transplant</ISOAbbreviation></Journal><ArticleTitle>Expanding transplant outcomes research opportunities through the use of a common data model.</ArticleTitle><Pagination><StartPage>1321</StartPage><EndPage>1327</EndPage><MedlinePgn>1321-1327</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1111/ajt.14892</ELocationID><Abstract><AbstractText>The volume of solid organ transplant in the United States is increasing, providing improved quality of life and survival for patients with organ failure. The growth of transplant requires a systematized management of transplant outcomes assessment, especially with the movement toward value-based care. However, there are several challenges to analyzing outcomes in the current registry-based, transplant reporting system: (1) longitudinal data points are difficult to capture in outcomes models; (2)&#xa0;data elements are restricted to those that already exist in the registry data; and (3)&#xa0;there is a delay in the release of outcomes report. In this article, we propose an informatics approach to solve these problems by using a "common data model" to integrate disparate data sources, data elements, and temporal data points. Adopting such a framework can enable multicenter outcomes analyses among transplant centers, nationally and internationally.</AbstractText><CopyrightInformation>&#xa9; 2018 The American Society of Transplantation and the American Society of Transplant Surgeons.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Cho</LastName><ForeName>Sylvia</ForeName><Initials>S</Initials><Identifier Source="ORCID">0000-0002-0263-0343</Identifier><AffiliationInfo><Affiliation>Department of Biomedical Informatics, Columbia University Medical Center, New York, NY, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mohan</LastName><ForeName>Sumit</ForeName><Initials>S</Initials><Identifier Source="ORCID">0000-0002-5305-9685</Identifier><AffiliationInfo><Affiliation>Division of Nephrology, Department of Medicine, Columbia University College of Physicians &amp; Surgeons, New York, NY, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Epidemiology, Columbia University Mailman School of Public Health, New York, NY, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>The Columbia University Renal Epidemiology (CURE) Group, New York, NY, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Husain</LastName><ForeName>Syed Ali</ForeName><Initials>SA</Initials><Identifier Source="ORCID">0000-0002-1823-0117</Identifier><AffiliationInfo><Affiliation>Division of Nephrology, Department of Medicine, Columbia University College of Physicians &amp; Surgeons, New York, NY, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>The Columbia University Renal Epidemiology (CURE) Group, New York, NY, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Natarajan</LastName><ForeName>Karthik</ForeName><Initials>K</Initials><Identifier Source="ORCID">0000-0002-9066-9431</Identifier><AffiliationInfo><Affiliation>Department of Biomedical Informatics, Columbia University Medical Center, New York, NY, USA.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>R01 DK114893</GrantID><Acronym>DK</Acronym><Agency>NIDDK NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>T15 LM007079</GrantID><Acronym>LM</Acronym><Agency>NLM NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>U01 DK116066</GrantID><Acronym>DK</Acronym><Agency>NIDDK NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D052061">Research Support, N.I.H., Extramural</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType><PublicationType UI="D013487">Research Support, U.S. Gov't, P.H.S.</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2018</Year><Month>05</Month><Day>22</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Am J Transplant</MedlineTA><NlmUniqueID>100968638</NlmUniqueID><ISSNLinking>1600-6135</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000077558" MajorTopicYN="N">Big Data</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008962" MajorTopicYN="Y">Models, Theoretical</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014180" MajorTopicYN="Y">Transplantation</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016896" MajorTopicYN="Y">Treatment Outcome</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">United Network for Organ Sharing (UNOS)</Keyword><Keyword MajorTopicYN="N">clinical research/practice</Keyword><Keyword MajorTopicYN="N">health services and outcomes research</Keyword><Keyword MajorTopicYN="N">informatics</Keyword><Keyword MajorTopicYN="N">organ transplantation in general</Keyword><Keyword MajorTopicYN="N">registry/registry analysis</Keyword></KeywordList><CoiStatement><b>Disclosure</b>. The authors of this manuscript have no conflicts of interest to disclose as described by the American Journal of Transplantation.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2017</Year><Month>12</Month><Day>15</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2018</Year><Month>4</Month><Day>9</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2018</Year><Month>4</Month><Day>15</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2018</Year><Month>4</Month><Day>25</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2019</Year><Month>12</Month><Day>18</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2018</Year><Month>4</Month><Day>25</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2019</Year><Month>6</Month><Day>1</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">29687963</ArticleId><ArticleId IdType="mid">NIHMS962208</ArticleId><ArticleId IdType="pmc">PMC6070138</ArticleId><ArticleId IdType="doi">10.1111/ajt.14892</ArticleId><ArticleId IdType="pii">S1600-6135(22)09563-6</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Griny&#xf3; JM. Why is organ transplantation clinically important? Cold Spring Harb Perspect Med. 2013;3(6):a014985.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3662355</ArticleId><ArticleId IdType="pubmed">23732857</ArticleId></ArticleIdList></Reference><Reference><Citation>United Network for Organ Sharing.  [Accessed February 17, 2017];US organ transplants, deceased donors set record in 2016.   https://www.unos.org/us-organ-transplants-set-record-in-2016/. Published 2017.</Citation></Reference><Reference><Citation>Lin H-M, Kauffman HM, McBride MA, et al. Center-specific graft and patient survival rates: 1997 United Network for Organ Sharing (UNOS) report. JAMA. 1998;280(13):1153&#x2013;1160.</Citation><ArticleIdList><ArticleId IdType="pubmed">9777815</ArticleId></ArticleIdList></Reference><Reference><Citation>Srinivas TR, Taber DJ, Su Z, et al. Big data, predictive analytics and quality improvement in kidney transplantation- a proof of concept. Am J Transplant. 2016 Nov; doi: 10.1111/ajt.14099.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/ajt.14099</ArticleId><ArticleId IdType="pubmed">27804279</ArticleId></ArticleIdList></Reference><Reference><Citation>Krumholz HM. Outcomes research. Circulation. 2008;118(3):309&#x2013;318.</Citation><ArticleIdList><ArticleId IdType="pubmed">18625906</ArticleId></ArticleIdList></Reference><Reference><Citation>Ladner DP, Alonso EM, Butt Z, et al. NUTORC&#x2014;a transdisciplinary health services and outcomes research team in transplantation. Transl Behav Med. 2012;2(4):446&#x2013;458.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3647618</ArticleId><ArticleId IdType="pubmed">23667403</ArticleId></ArticleIdList></Reference><Reference><Citation>Howard RJ, Cornell DL, Schold JD. CMS oversight, OPOs and transplant centers and the law of unintended consequences. Clin Transplant. 2009;23(6):778&#x2013;783.</Citation><ArticleIdList><ArticleId IdType="pubmed">20447183</ArticleId></ArticleIdList></Reference><Reference><Citation>Schold JD, Phelan M, Buccini LD. Utility of Ecological Risk Factors for Evaluation of Transplant Center Performance. Am J Transplant. 2016</Citation><ArticleIdList><ArticleId IdType="pubmed">27696682</ArticleId></ArticleIdList></Reference><Reference><Citation>American Society of Transplant Surgeons.  [Accessed November 30, 2017];RAPID: Real-time Analytics and Process Improvement Dashboard.   http://asts.org/resources/knowledge-base/rapid-real-time-analytics-and-process-improvement-dashboard#.WiAdk7Q-fUo.</Citation></Reference><Reference><Citation>American Society of Nephrology.  [Accessed November 30, 2017];Data Harmonization in Kidney Transplant.   https://www.asn-online.org/khi/project.aspx?ID=52.</Citation></Reference><Reference><Citation>Dickinson DM, Ellison MD, Webb RL. Data sources and structure. Am J Transplant. 2003;3(s4):13&#x2013;28.</Citation><ArticleIdList><ArticleId IdType="pubmed">12694047</ArticleId></ArticleIdList></Reference><Reference><Citation>Massie AB, Kuricka LM, Segev DL. Big data in organ transplantation: registries and administrative claims. Am J Transplant. 2014;14(8):1723&#x2013;1730.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4387865</ArticleId><ArticleId IdType="pubmed">25040084</ArticleId></ArticleIdList></Reference><Reference><Citation>Bhatti NK, Karimi Galougahi K, Paz Y, et al. Diagnosis and Management of Cardiovascular Disease in Advanced and End-Stage Renal Disease. J Am Heart Assoc. 2016;5(8) doi: 10.1161/JAHA.116.003648.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/JAHA.116.003648</ArticleId><ArticleId IdType="pmc">PMC5015288</ArticleId><ArticleId IdType="pubmed">27491836</ArticleId></ArticleIdList></Reference><Reference><Citation>Lentine KL, Costa SP, Weir MR, et al. Cardiac disease evaluation and management among kidney and liver transplantation candidates: a scientific statement from the American Heart Association and the American College of Cardiology Foundation: endorsed by the American Society of Transplant Surgeons, American Society of Transplantation, and National Kidney Foundation. Circulation. 2012;126(5):617&#x2013;663. doi: 10.1161/CIR.0b013e31823eb07a.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/CIR.0b013e31823eb07a</ArticleId><ArticleId IdType="pubmed">22753303</ArticleId></ArticleIdList></Reference><Reference><Citation>Ogunyemi OI, Meeker D, Kim H-E, Ashish N, Farzaneh S, Boxwala A. Identifying appropriate reference data models for comparative effectiveness research (CER) studies based on data from clinical information systems. Med Care. 2013;51:S45&#x2013;S52.</Citation><ArticleIdList><ArticleId IdType="pubmed">23774519</ArticleId></ArticleIdList></Reference><Reference><Citation>Embi PJ, Kaufman SE, Payne PRO. Biomedical informatics and outcomes research. Circulation. 2009;120(23):2393&#x2013;2399.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2814875</ArticleId><ArticleId IdType="pubmed">19996023</ArticleId></ArticleIdList></Reference><Reference><Citation>Hripcsak G, Ryan PB, Duke JD, et al. Characterizing treatment pathways at scale using the OHDSI network. Proc Natl Acad Sci. 2016;113(27):7329&#x2013;7336.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4941483</ArticleId><ArticleId IdType="pubmed">27274072</ArticleId></ArticleIdList></Reference><Reference><Citation>Duke JD, Ryan PB, Suchard MA, et al. Risk of angioedema associated with levetiracetam compared with phenytoin: Findings of the observational health data sciences and informatics research network. Epilepsia. 2017;58(8)</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6632067</ArticleId><ArticleId IdType="pubmed">28681416</ArticleId></ArticleIdList></Reference><Reference><Citation>Rijnbeek PR. Converting to a Common Data Model: What is Lost in Translation? Drug Saf. 2014;37(11):893&#x2013;896.</Citation><ArticleIdList><ArticleId IdType="pubmed">25187018</ArticleId></ArticleIdList></Reference><Reference><Citation>Matcho A, Ryan P, Fife D, Reich C. Fidelity assessment of a clinical practice research datalink conversion to the OMOP common data model. Drug Saf. 2014;37(11):945&#x2013;959.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4206771</ArticleId><ArticleId IdType="pubmed">25187016</ArticleId></ArticleIdList></Reference><Reference><Citation>Kahn MG, Batson D, Schilling LM. Data model considerations for clinical effectiveness researchers. Med Care. 2012;50</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3824370</ArticleId><ArticleId IdType="pubmed">22692260</ArticleId></ArticleIdList></Reference><Reference><Citation>Reich C, Ryan P, Belenkaya R, Natarajan K, Blacketer C.  [Accessed January 30, 2018];OMOP Common Data Model v5.3 Specifications.   https://github.com/OHDSI/CommonDataModel/wiki.</Citation></Reference><Reference><Citation>Hripcsak G, Duke JD, Shah NH, et al. Observational Health Data Sciences and Informatics (OHDSI): opportunities for observational researchers. Stud Health Technol Inform. 2015;216:574.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4815923</ArticleId><ArticleId IdType="pubmed">26262116</ArticleId></ArticleIdList></Reference><Reference><Citation>Banda JM, Halpern Y, Sontag D, Shah NH. Electronic phenotyping with APHRODITE and the Observational Health Sciences and Informatics (OHDSI) data network. AMIA Summits Transl Sci Proc. 2017;2017:48.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5543379</ArticleId><ArticleId IdType="pubmed">28815104</ArticleId></ArticleIdList></Reference><Reference><Citation>Observational Health Data Sciences and Informatics.  [Accessed December 9, 2017];OHDSI Collaborators.   https://www.ohdsi.org/who-we-are/collaborators/</Citation></Reference><Reference><Citation> [Accessed November 6, 2017];About the All of Us Research Program.   https://allofus.nih.gov/about/about-all-us-research-program.</Citation></Reference><Reference><Citation> [Accessed November 6, 2017];Electronic Medical Records and Genomics (eMERGE) Network.   https://emerge.mc.vanderbilt.edu/</Citation></Reference><Reference><Citation>Observational Health Data Sciences and Informatics (OHDSI)  [Accessed December 7, 2017];Propensity Score Evaluation.   https://github.com/OHDSI/PropensityScoreEvaluation.</Citation></Reference><Reference><Citation>Observational Health Data Sciences and Informatics (OHDSI)  [Accessed December 7, 2017];Patient Level Prediction.   https://github.com/OHDSI/PatientLevelPrediction.</Citation></Reference><Reference><Citation>Observational Health Data Sciences and Informatics (OHDSI)  [Accessed December 9, 2017];OHDSI Natural Language Processing Working Group.   http://www.ohdsi.org/web/wiki/doku.php?id=projects:workgroups:nlp-wg.</Citation></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">29718407</PMID><DateCompleted><Year>2019</Year><Month>11</Month><Day>27</Day></DateCompleted><DateRevised><Year>2020</Year><Month>11</Month><Day>10</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1527-974X</ISSN><JournalIssue CitedMedium="Internet"><Volume>25</Volume><Issue>8</Issue><PubDate><Year>2018</Year><Month>Aug</Month><Day>01</Day></PubDate></JournalIssue><Title>Journal of the American Medical Informatics Association : JAMIA</Title><ISOAbbreviation>J Am Med Inform Assoc</ISOAbbreviation></Journal><ArticleTitle>Design and implementation of a standardized framework to generate and evaluate patient-level prediction models using observational healthcare data.</ArticleTitle><Pagination><StartPage>969</StartPage><EndPage>975</EndPage><MedlinePgn>969-975</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1093/jamia/ocy032</ELocationID><Abstract><AbstractText Label="OBJECTIVE">To develop a conceptual prediction model framework containing standardized steps and describe the corresponding open-source software developed to consistently implement the framework across computational environments and observational healthcare databases to enable model sharing and reproducibility.</AbstractText><AbstractText Label="METHODS">Based on existing best practices we propose a 5 step standardized framework for: (1) transparently defining the problem; (2) selecting suitable datasets; (3) constructing variables from the observational data; (4) learning the predictive model; and (5) validating the model performance. We implemented this framework as open-source software utilizing the Observational Medical Outcomes Partnership Common Data Model to enable convenient sharing of models and reproduction of model evaluation across multiple observational datasets. The software implementation contains default covariates and classifiers but the framework enables customization and extension.</AbstractText><AbstractText Label="RESULTS">As a proof-of-concept, demonstrating the transparency and ease of model dissemination using the software, we developed prediction models for 21 different outcomes within a target population of people suffering from depression across 4 observational databases. All 84 models are available in an accessible online repository to be implemented by anyone with access to an observational database in the Common Data Model format.</AbstractText><AbstractText Label="CONCLUSIONS">The proof-of-concept study illustrates the framework's ability to develop reproducible models that can be readily shared and offers the potential to perform extensive external validation of models, and improve their likelihood of clinical uptake. In future work the framework will be applied to perform an "all-by-all" prediction analysis to assess the observational data prediction domain across numerous target populations, outcomes and time, and risk settings.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Reps</LastName><ForeName>Jenna M</ForeName><Initials>JM</Initials><AffiliationInfo><Affiliation>Janssen Research and Development, Raritan, NJ, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Schuemie</LastName><ForeName>Martijn J</ForeName><Initials>MJ</Initials><AffiliationInfo><Affiliation>Janssen Research and Development, Raritan, NJ, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Suchard</LastName><ForeName>Marc A</ForeName><Initials>MA</Initials><AffiliationInfo><Affiliation>Department of Biomathematics, UCLA School of Medicine, CA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ryan</LastName><ForeName>Patrick B</ForeName><Initials>PB</Initials><AffiliationInfo><Affiliation>Janssen Research and Development, Raritan, NJ, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rijnbeek</LastName><ForeName>Peter R</ForeName><Initials>PR</Initials><AffiliationInfo><Affiliation>Department of Medical Informatics, Erasmus University Medical Center, Rotterdam,The Netherlands.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013486">Research Support, U.S. Gov't, Non-P.H.S.</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>J Am Med Inform Assoc</MedlineTA><NlmUniqueID>9430800</NlmUniqueID><ISSNLinking>1067-5027</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D066264" MajorTopicYN="N">Datasets as Topic</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006301" MajorTopicYN="N">Health Services Needs and Demand</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000069550" MajorTopicYN="Y">Machine Learning</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008962" MajorTopicYN="N">Models, Theoretical</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D019370" MajorTopicYN="Y">Observation</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D064887" MajorTopicYN="N">Observational Studies as Topic</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011379" MajorTopicYN="Y">Prognosis</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018570" MajorTopicYN="N">Risk Assessment</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012984" MajorTopicYN="Y">Software</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016896" MajorTopicYN="N">Treatment Outcome</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2017</Year><Month>5</Month><Day>30</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2018</Year><Month>3</Month><Day>15</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2018</Year><Month>5</Month><Day>3</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2019</Year><Month>11</Month><Day>28</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2018</Year><Month>5</Month><Day>3</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2018</Year><Month>4</Month><Day>27</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">29718407</ArticleId><ArticleId IdType="pmc">PMC6077830</ArticleId><ArticleId IdType="doi">10.1093/jamia/ocy032</ArticleId><ArticleId IdType="pii">4989437</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Collins GS, Mallett S, Omar O et al. . Developing risk prediction models for type 2 diabetes: a systematic review of methodology and reporting. BMC Med 2011;9:103.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3180398</ArticleId><ArticleId IdType="pubmed">21902820</ArticleId></ArticleIdList></Reference><Reference><Citation>Collins GS, Omar O, Shanyinde M et al. . A systematic review finds prediction models for chronic kidney were poorly reported and often developed using inappropriate methods. J Clin Epidemiol 2013;66:268&#x2013;277.</Citation><ArticleIdList><ArticleId IdType="pubmed">23116690</ArticleId></ArticleIdList></Reference><Reference><Citation>Collins GS, de Groot JA, Dutton S et al. . External validation of multivariable prediction models: a systematic review of methodological conduct and reporting. BMC Med Res Methodol 2014;141:1.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3999945</ArticleId><ArticleId IdType="pubmed">24645774</ArticleId></ArticleIdList></Reference><Reference><Citation>Goldstein BA, Navar AM, Pencina MJ et al. . Opportunities and challenges in developing risk prediction models with electronic health records data: a systematic review. J Am Med Inform Assoc 2017;241:198&#x2013;208.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5201180</ArticleId><ArticleId IdType="pubmed">27189013</ArticleId></ArticleIdList></Reference><Reference><Citation>Collins GS, Reitsma JB, Altman DG et al. . Transparent reporting of a multivariable prediction model for individual prognosis or diagnosis (TRIPOD): the TRIPOD statement. BMC Med 2015;131:1&#x2013;9.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4284921</ArticleId><ArticleId IdType="pubmed">25563062</ArticleId></ArticleIdList></Reference><Reference><Citation>Hemingway H, Croft P, Perel P et al. . Prognosis research strategy (PROGRESS) 1: a framework for researching clinical outcomes. BMJ 2013;346:e5595.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3565687</ArticleId><ArticleId IdType="pubmed">23386360</ArticleId></ArticleIdList></Reference><Reference><Citation>Riley RD, Hayden JA, Steyerberg EW et al. . Prognosis Research Strategy (PROGRESS) 2: prognostic factor research. PLoS Med 2013;102:e1001380.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3564757</ArticleId><ArticleId IdType="pubmed">23393429</ArticleId></ArticleIdList></Reference><Reference><Citation>Steyerberg EW, Moons KG, van der Windt DA et al. . Prognosis Research Strategy (PROGRESS) 3: prognostic model research. PLoS Med 2013;102:e1001381.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3564751</ArticleId><ArticleId IdType="pubmed">23393430</ArticleId></ArticleIdList></Reference><Reference><Citation>Hingorani AD, van der Windt DA, Riley RD et al. . Prognosis research strategy (PROGRESS) 4: stratified medicine research. BMJ 2013;346:e5793.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3565686</ArticleId><ArticleId IdType="pubmed">23386361</ArticleId></ArticleIdList></Reference><Reference><Citation>Hripcsak G, Duke JD, Shah NH et al. . Observational health data sciences and informatics (OHDSI): opportunities for observational researchers. Stud Health Technol Inform 2015;216:574&#x2013;578.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4815923</ArticleId><ArticleId IdType="pubmed">26262116</ArticleId></ArticleIdList></Reference><Reference><Citation>Overhage JM, Ryan PB, Reich CG et al. . Validation of a common data model for active safety surveillance research. J Am Med Inform Assoc 2012;191:54&#x2013;60.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3240764</ArticleId><ArticleId IdType="pubmed">22037893</ArticleId></ArticleIdList></Reference><Reference><Citation>Hripcsak G, Ryan PB, Duke JD et al. . Characterizing treatment pathways at scale using the OHDSI network. PNAS 2016;11327:7329&#x2013;7336.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4941483</ArticleId><ArticleId IdType="pubmed">27274072</ArticleId></ArticleIdList></Reference><Reference><Citation>
Schuemie MJ, Suchard MA. 
SqlRender: Rendering Parameterized SQL and Translation to Dialects. R Package Version 1.2.0. 2017. 
https://CRAN.R-project.org/package=SqlRender. Accessed February 1, 2017.</Citation></Reference><Reference><Citation>
Schuemie MJ, Suchard MA DatabaseConnector: A Wrapper Around RJDBC Containing Drivers for Various DBMSs. R Package Version 1.10.0. 2017. 
https://github.com/OHDSI/DatabaseConnector. Accessed February 1, 2017.</Citation></Reference><Reference><Citation>Suchard MA, Simpson SE, Zorych I et al. . Massive parallelization of serial inference algorithms for complex generalized linear models. ACM Transact Model Comput Simulation 2013;231:10&#x2013;32.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4201181</ArticleId><ArticleId IdType="pubmed">25328363</ArticleId></ArticleIdList></Reference><Reference><Citation>Deng H, Bai Y, Shantsila A et al. . Clinical scores for outcomes of rhythm control or arrhythmia progression in patients with atrial fibrillation: a systematic review. Clin Res Cardiol 2017;10610:813&#x2013;823.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5613037</ArticleId><ArticleId IdType="pubmed">28560516</ArticleId></ArticleIdList></Reference><Reference><Citation>Schnabel RB, Sullivan LM, Levy D et al. . Development of a risk score for atrial fibrillation (Framingham Heart Study): a community-based cohort study. Lancet 2009;373.9665:739&#x2013;745.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2764235</ArticleId><ArticleId IdType="pubmed">19249635</ArticleId></ArticleIdList></Reference><Reference><Citation>Empana JP, Ducimeti&#xe8;re P, Arveiler D et al. . Are the Framingham and PROCAM coronary heart disease risk functions applicable to different European populations? The PRIME Study. Eur Heart J 2003;24.21:1903&#x2013;1911.</Citation><ArticleIdList><ArticleId IdType="pubmed">14585248</ArticleId></ArticleIdList></Reference><Reference><Citation>Weng SF, Reps J, Kai J, Garibaldi JM, Qureshi N. Can machine-learning improve cardiovascular risk prediction using routine clinical data?. PLoS One 2017;12.4:e0174944.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5380334</ArticleId><ArticleId IdType="pubmed">28376093</ArticleId></ArticleIdList></Reference><Reference><Citation>Voss EA, Makadia R, Matcho A et al. . Feasibility and utility of applications of the common data model to multiple, disparate observational health databases. J Am Med Inform Assoc 2015;223:553&#x2013;564.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4457111</ArticleId><ArticleId IdType="pubmed">25670757</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">29726424</PMID><DateCompleted><Year>2018</Year><Month>06</Month><Day>11</Day></DateCompleted><DateRevised><Year>2018</Year><Month>12</Month><Day>02</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1879-8365</ISSN><JournalIssue CitedMedium="Internet"><Volume>248</Volume><PubDate><Year>2018</Year></PubDate></JournalIssue><Title>Studies in health technology and informatics</Title><ISOAbbreviation>Stud Health Technol Inform</ISOAbbreviation></Journal><ArticleTitle>A Clinical Data Warehouse Based on OMOP and i2b2 for Austrian Health Claims Data.</ArticleTitle><Pagination><StartPage>94</StartPage><EndPage>99</EndPage><MedlinePgn>94-99</MedlinePgn></Pagination><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">To develop simulation models for healthcare related questions clinical data can be reused.</AbstractText><AbstractText Label="OBJECTIVES" NlmCategory="OBJECTIVE">Develop a clinical data warehouse to harmonize different data sources in a standardized manner and get a reproducible interface for clinical data reuse.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">The Kimball life cycle for the development of data warehouse was used. The development is split into the technical, the data and the business intelligence pathway.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">Sample data was persisted in the Observational Medical Outcomes Partnership (OMOP) Common Data Model (CDM). The i2b2 clinical data warehouse tools were used to query the OMOP CDM by applying the new i2b2 multi-fact table feature.</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">A clinical data warehouse was set up and sample data, data dimensions and ontologies for Austrian health claims data were created. The ability of the standardized data access layer to create and apply simulation models will be evaluated next.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Rinner</LastName><ForeName>Christoph</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Center for Medical Statistics, Informatics and Intelligent Systems, Medical University of Vienna, Austria.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gezgin</LastName><ForeName>Deniz</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Center for Medical Statistics, Informatics and Intelligent Systems, Medical University of Vienna, Austria.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wendl</LastName><ForeName>Christopher</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Center for Medical Statistics, Informatics and Intelligent Systems, Medical University of Vienna, Austria.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gall</LastName><ForeName>Walter</ForeName><Initials>W</Initials><AffiliationInfo><Affiliation>Center for Medical Statistics, Informatics and Intelligent Systems, Medical University of Vienna, Austria.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>Netherlands</Country><MedlineTA>Stud Health Technol Inform</MedlineTA><NlmUniqueID>9214582</NlmUniqueID><ISSNLinking>0926-9630</ISSNLinking></MedlineJournalInfo><MeshHeadingList><MeshHeading><DescriptorName UI="D001317" MajorTopicYN="N">Austria</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000073458" MajorTopicYN="Y">Data Warehousing</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016208" MajorTopicYN="Y">Databases, Factual</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003695" MajorTopicYN="N">Delivery of Health Care</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016247" MajorTopicYN="Y">Information Storage and Retrieval</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Secondary use</Keyword><Keyword MajorTopicYN="N">clinical data warehousing</Keyword><Keyword MajorTopicYN="N">standardized health data</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2018</Year><Month>5</Month><Day>5</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2018</Year><Month>5</Month><Day>5</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2018</Year><Month>6</Month><Day>12</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">29726424</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">29735409</PMID><DateCompleted><Year>2018</Year><Month>11</Month><Day>07</Day></DateCompleted><DateRevised><Year>2018</Year><Month>11</Month><Day>07</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1879-0887</ISSN><JournalIssue CitedMedium="Internet"><Volume>127</Volume><Issue>3</Issue><PubDate><Year>2018</Year><Month>Jun</Month></PubDate></JournalIssue><Title>Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology</Title><ISOAbbreviation>Radiother Oncol</ISOAbbreviation></Journal><ArticleTitle>Comparison of survival and prognostic factors in patients treated with stereotactic body radiotherapy for oligometastases or oligoprogression.</ArticleTitle><Pagination><StartPage>493</StartPage><EndPage>500</EndPage><MedlinePgn>493-500</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.radonc.2018.04.022</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S0167-8140(18)30213-5</ELocationID><Abstract><AbstractText Label="BACKGROUND AND PURPOSE">Clinical challenges arise in the oligoprogressive (OP) state with little evidence to support the use of ablative strategies. Our aim is to report on outcomes and prognostic variables following stereotactic body radiotherapy (SBRT) for OP and oligometastases (OM).</AbstractText><AbstractText Label="MATERIAL AND METHODS">Overall (OS) and progression-free survivals (PFS) were calculated for 163 patients for 209 lesions (106 OM and 57 OP) treated with SBRT over 9&#x202f;years. OS and PFS comparisons were calculated using the Kaplan-Meier actuarial survival and log rank methods. Uni, multi-variate analyses and cumulative incidences of local failure were performed using the Cox modelling and Gray's test respectively.</AbstractText><AbstractText Label="RESULTS">The median OS and PFS was 37 and 15&#x202f;months versus 21.7 and 6.4&#x202f;months in the OM and OP groups respectively (P&#x202f;=&#x202f;0.02 and P&#x202f;=&#x202f;0.01). Performance status (&#x2a7e;2 HR 2.95) and number of metastases (1/2 vs &#x2a7e;3 HR 1.88) were independent prognosticators for survival. The 1/2-year PFS were 55%/25% versus 22%/6% in the OM and OP cohorts. Patterns of first relapse were four times higher outside the irradiated field and OP status (p&#x202f;=&#x202f;0.03), &#x2a7e;3 metastasis (p&#x202f;=&#x202f;0.002) and concurrent systemic therapy (p&#x202f;=&#x202f;0.001) conferred a greater risk. Time to second-line treatment was 20 vs 11&#x202f;months in the OM and OP groups (P&#x202f;=&#x202f;0.001).</AbstractText><AbstractText Label="CONCLUSION">Survival and distant relapse following SBRT to OM/OP is determined by the extent of metastatic disease and performance status. Future research should address the benefit of integrating SBRT with systemic therapies to allow deferral or continuation of therapeutic agents.</AbstractText><CopyrightInformation>Crown Copyright &#xa9; 2018. Published by Elsevier B.V. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Pembroke</LastName><ForeName>Catherine A</ForeName><Initials>CA</Initials><AffiliationInfo><Affiliation>Velindre Cancer Centre, Cardiff, United Kingdom. Electronic address: Catherine.a.pembroke@wales.nhs.uk.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Fortin</LastName><ForeName>Bernard</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Department of Radiation Oncology, H&#xf4;pital Maisonneuve-Rosemont, Montreal, Canada. Electronic address: bfortin.hmr@sss.gouv.qc.ca.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kopek</LastName><ForeName>Neil</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Department of Radiation Oncology, McGill University Health Centre, Montreal, Canada. Electronic address: neil.kopek@mcgill.ca.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2018</Year><Month>05</Month><Day>04</Day></ArticleDate></Article><MedlineJournalInfo><Country>Ireland</Country><MedlineTA>Radiother Oncol</MedlineTA><NlmUniqueID>8407192</NlmUniqueID><ISSNLinking>0167-8140</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018572" MajorTopicYN="N">Disease-Free Survival</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009362" MajorTopicYN="N">Neoplasm Metastasis</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009369" MajorTopicYN="N">Neoplasms</DescriptorName><QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName><QualifierName UI="Q000532" MajorTopicYN="Y">radiotherapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011379" MajorTopicYN="N">Prognosis</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016016" MajorTopicYN="N">Proportional Hazards Models</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016634" MajorTopicYN="N">Radiosurgery</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="Y">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012189" MajorTopicYN="N">Retrospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016896" MajorTopicYN="N">Treatment Outcome</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Oligometastases</Keyword><Keyword MajorTopicYN="N">Oligoprogression</Keyword><Keyword MajorTopicYN="N">SBRT</Keyword><Keyword MajorTopicYN="N">Stereotactic radiotherapy</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2018</Year><Month>1</Month><Day>15</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2018</Year><Month>4</Month><Day>17</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2018</Year><Month>4</Month><Day>18</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2018</Year><Month>5</Month><Day>8</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2018</Year><Month>11</Month><Day>8</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2018</Year><Month>5</Month><Day>9</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">29735409</ArticleId><ArticleId IdType="doi">10.1016/j.radonc.2018.04.022</ArticleId><ArticleId IdType="pii">S0167-8140(18)30213-5</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">29760661</PMID><DateRevised><Year>2020</Year><Month>10</Month><Day>01</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Print">1663-9812</ISSN><JournalIssue CitedMedium="Print"><Volume>9</Volume><PubDate><Year>2018</Year></PubDate></JournalIssue><Title>Frontiers in pharmacology</Title><ISOAbbreviation>Front Pharmacol</ISOAbbreviation></Journal><ArticleTitle>A Semantic Transformation Methodology for the Secondary Use of Observational Healthcare Data in Postmarketing Safety Studies.</ArticleTitle><Pagination><StartPage>435</StartPage><MedlinePgn>435</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">435</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3389/fphar.2018.00435</ELocationID><Abstract><AbstractText><b>Background:</b> Utilization of the available observational healthcare datasets is key to complement and strengthen the postmarketing safety studies. Use of common data models (CDM) is the predominant approach in order to enable large scale systematic analyses on disparate data models and vocabularies. Current CDM transformation practices depend on proprietarily developed Extract-Transform-Load (ETL) procedures, which require knowledge both on the semantics and technical characteristics of the source datasets and target CDM. <b>Purpose:</b> In this study, our aim is to develop a modular but coordinated transformation approach in order to separate semantic and technical steps of transformation processes, which do not have a strict separation in traditional ETL approaches. Such an approach would discretize the operations to extract data from source electronic health record systems, alignment of the source, and target models on the semantic level and the operations to populate target common data repositories. <b>Approach:</b> In order to separate the activities that are required to transform heterogeneous data sources to a target CDM, we introduce a semantic transformation approach composed of three steps: (1) transformation of source datasets to Resource Description Framework (RDF) format, (2) application of semantic conversion rules to get the data as instances of ontological model of the target CDM, and (3) population of repositories, which comply with the specifications of the CDM, by processing the RDF instances from step 2. The proposed approach has been implemented on real healthcare settings where Observational Medical Outcomes Partnership (OMOP) CDM has been chosen as the common data model and a comprehensive comparative analysis between the native and transformed data has been conducted. <b>Results:</b> Health records of ~1 million patients have been successfully transformed to an OMOP CDM based database from the source database. Descriptive statistics obtained from the source and target databases present analogous and consistent results. <b>Discussion and Conclusion:</b> Our method goes beyond the traditional ETL approaches by being more declarative and rigorous. Declarative because the use of RDF based mapping rules makes each mapping more transparent and understandable to humans while retaining logic-based computability. Rigorous because the mappings would be based on computer readable semantics which are amenable to validation through logic-based inference methods.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Pacaci</LastName><ForeName>Anil</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Software Research &amp; Development and Consultancy Corp., Ankara, Turkey.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>David R. Cheriton School of Computer Science, University of Waterloo, Waterloo, ON, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gonul</LastName><ForeName>Suat</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Software Research &amp; Development and Consultancy Corp., Ankara, Turkey.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Computer Engineering, Middle East Technical University, Ankara, Turkey.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sinaci</LastName><ForeName>A Anil</ForeName><Initials>AA</Initials><AffiliationInfo><Affiliation>Software Research &amp; Development and Consultancy Corp., Ankara, Turkey.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yuksel</LastName><ForeName>Mustafa</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Software Research &amp; Development and Consultancy Corp., Ankara, Turkey.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Laleci Erturkmen</LastName><ForeName>Gokce B</ForeName><Initials>GB</Initials><AffiliationInfo><Affiliation>Software Research &amp; Development and Consultancy Corp., Ankara, Turkey.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2018</Year><Month>04</Month><Day>30</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Front Pharmacol</MedlineTA><NlmUniqueID>101548923</NlmUniqueID><ISSNLinking>1663-9812</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">common data model</Keyword><Keyword MajorTopicYN="N">healthcare datasets</Keyword><Keyword MajorTopicYN="N">pharmacovigilance</Keyword><Keyword MajorTopicYN="N">postmarketing safety study</Keyword><Keyword MajorTopicYN="N">semantic transformation</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2017</Year><Month>12</Month><Day>14</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2018</Year><Month>4</Month><Day>12</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2018</Year><Month>5</Month><Day>16</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2018</Year><Month>5</Month><Day>16</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2018</Year><Month>5</Month><Day>16</Day><Hour>6</Hour><Minute>1</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2018</Year><Month>4</Month><Day>30</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">29760661</ArticleId><ArticleId IdType="pmc">PMC5937227</ArticleId><ArticleId IdType="doi">10.3389/fphar.2018.00435</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Benson K., Hartz A. J. (2000). A comparison of observational studies and randomized, controlled trials. N. Engl. J. Med. 342, 1878&#x2013;1886. 10.1056/NEJM200006223422506</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJM200006223422506</ArticleId><ArticleId IdType="pubmed">10861324</ArticleId></ArticleIdList></Reference><Reference><Citation>Bizer C., Seaborne A. (2004). D2RQ-treating non-RDF databases as virtual RDF graphs, in Proceedings of the 3rd International Semantic Web Conference (ISWC2004) (Hiroshima: ).</Citation></Reference><Reference><Citation>Brewer T., Colditz G. A. (1999). Postmarketing surveillance and adverse drug reactions. JAMA 281, 824&#x2013;829.</Citation><ArticleIdList><ArticleId IdType="pubmed">10071004</ArticleId></ArticleIdList></Reference><Reference><Citation>Bright R. A., Nelson R. C. (2002). Automated support for pharmacovigilance: a proposed system. Pharmacoepidemiol. Drug Saf. 11, 121&#x2013;125. 10.1002/pds.684</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/pds.684</ArticleId><ArticleId IdType="pubmed">11998536</ArticleId></ArticleIdList></Reference><Reference><Citation>Coorevits P., Sundgren M., Klein G. O., Bahr A., Claerhout B., Kalra D., et al. . (2013). Electronic health records: new opportunities for clinical research. J. Intern. Med. 274, 547&#x2013;560. 10.1111/joim.12119</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/joim.12119</ArticleId><ArticleId IdType="pubmed">23952476</ArticleId></ArticleIdList></Reference><Reference><Citation>El Akkaoui Z. E., Zim&#xe1;nyi E., Maz&#xf3;n J.-N., Trujillo J. (2013). A BPMN-based design and maintenance framework for ETL processes. Int. J. Data Warehousing Mining 9, 46&#x2013;72. 10.4018/jdwm.2013070103</Citation><ArticleIdList><ArticleId IdType="doi">10.4018/jdwm.2013070103</ArticleId></ArticleIdList></Reference><Reference><Citation>Furberg C. D., Levin A. A., Gross P. A., Shapiro R. S., Strom B. L. (2006). The FDA and drug safety: a proposal for sweeping changes. Arch. Intern. Med. 166, 1938&#x2013;1942. 10.1001/archinte.166.18.1938</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/archinte.166.18.1938</ArticleId><ArticleId IdType="pubmed">17030825</ArticleId></ArticleIdList></Reference><Reference><Citation>Hert M., Reif G., Gall H. C. (2011). A comparison of RDB-to-RDF mapping languages, in Proceedings of the 7th International Conference on Semantic Systems (ACM) (Graz: ).</Citation></Reference><Reference><Citation>Jiang G., Hommeaux E. P., Xiao G., Solbrig H. R. (2017). Developing a semantic web-based framework for executing the clinical quality language using FHIR, in Proceedings of the 10th International Conference on Semantic Web Applications and Tools for the Life Sciences, Vol. 42 (Rome: ).</Citation></Reference><Reference><Citation>Kunz R., Oxman A. D. (1998). The unpredictability paradox: review of empirical comparisons of randomised and non-randomised clinical trials. BMJ 317, 1185&#x2013;1190. 10.1136/bmj.317.7167.1185</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.317.7167.1185</ArticleId><ArticleId IdType="pmc">PMC28700</ArticleId><ArticleId IdType="pubmed">9794851</ArticleId></ArticleIdList></Reference><Reference><Citation>Laleci Erturkmen G. B., Dogac A., Yuksel M. (2012). SALUS: Scalable, Standard based Interoperability Framework for Sustainable Proactive Post Market Safety Studies. MIE.</Citation></Reference><Reference><Citation>Liao K. P., Cai T., Savova G. K., Murphy S. N., Karlson E. W., Ananthakrishnan A. N., et al. . (2015). Development of phenotype algorithms using electronic medical records and incorporating natural language processing. BMJ 350:h1885. 10.1136/bmj.h1885</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.h1885</ArticleId><ArticleId IdType="pmc">PMC4707569</ArticleId><ArticleId IdType="pubmed">25911572</ArticleId></ArticleIdList></Reference><Reference><Citation>Matcho A., Ryan P., Fife D., Reich C. (2014). Fidelity assessment of a clinical practice research datalink conversion to the OMOP common data model. Drug Saf. 37, 945&#x2013;959. 10.1007/s40264-014-0214-3</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s40264-014-0214-3</ArticleId><ArticleId IdType="pmc">PMC4206771</ArticleId><ArticleId IdType="pubmed">25187016</ArticleId></ArticleIdList></Reference><Reference><Citation>Michel F., Montagnat J., Faron-Zucker C. (2014). A Survey of RDB to RDF Translation Approaches and Tools. Diss. I3S.</Citation></Reference><Reference><Citation>Moses L. E. (1995). Measuring effects without randomized trials? Options, problems, challenges. Med. Care 33, AS8&#x2013;AS14.</Citation><ArticleIdList><ArticleId IdType="pubmed">7723464</ArticleId></ArticleIdList></Reference><Reference><Citation>Nebeker J. R., Barach P., Samore M. H. (2004). Clarifying adverse drug events: a clinician's guide to terminology, documentation, and reporting. Ann. Intern. Med. 140, 795&#x2013;801. 10.7326/0003-4819-140-10-200405180-00009</Citation><ArticleIdList><ArticleId IdType="doi">10.7326/0003-4819-140-10-200405180-00009</ArticleId><ArticleId IdType="pubmed">15148066</ArticleId></ArticleIdList></Reference><Reference><Citation>Nor&#xe9;n G. N., Hopstadius J., Bate A. (2013). Shrinkage observed-to-expected ratios for robust and transparent large-scale pattern discovery. Stat. Methods Med. Res. 22, 57&#x2013;69. 10.1177/0962280211403604</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/0962280211403604</ArticleId><ArticleId IdType="pmc">PMC6331976</ArticleId><ArticleId IdType="pubmed">21705438</ArticleId></ArticleIdList></Reference><Reference><Citation>Oliveira B., Belo O. (2012). BPMN patterns for ETL conceptual modelling and validation, in International Symposium on Methodologies for Intelligent Systems (Berlin; Heidelberg: Springer; ).</Citation></Reference><Reference><Citation>OMOP CDM (2013). Specifications version 4.0 and OMOP Standard Vocabulary Specification version 4.4.</Citation></Reference><Reference><Citation>Overhage J. M., Ryan P. B., Reich C. G., Hartzema A. G., Stang P. E. (2012). Validation of a common data model for active safety surveillance research. J. Am. Med. Inform. Assoc. 19, 54&#x2013;60. 10.1136/amiajnl-2011-000376</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/amiajnl-2011-000376</ArticleId><ArticleId IdType="pmc">PMC3240764</ArticleId><ArticleId IdType="pubmed">22037893</ArticleId></ArticleIdList></Reference><Reference><Citation>Pacaci A. (2015). Semantic Transformation Framework to Enable Statistical Research On Medical Summaries. Master's thesis, Middle East Technical University. Available online at: http://etd.lib.metu.edu.tr/upload/12618833/index.pdf</Citation></Reference><Reference><Citation>Piazza-Hepp T., Kennedy D. (1995). Reporting of adverse events to MedWatch. Am. J. Heal. Syst. Pharm. 52, 1436&#x2013;1439.</Citation><ArticleIdList><ArticleId IdType="pubmed">7671043</ArticleId></ArticleIdList></Reference><Reference><Citation>Reisinger S. J., Ryan P. B., O'Hara D. J., Powell G. E., Painter J. L., Pattishall E. N., et al. . (2010). Development and evaluation of a common data model enabling active drug safety surveillance using disparate healthcare databases. J. Am. Med. Inform. Assoc. 17, 652&#x2013;662. 10.1136/jamia.2009.002477</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/jamia.2009.002477</ArticleId><ArticleId IdType="pmc">PMC3000752</ArticleId><ArticleId IdType="pubmed">20962127</ArticleId></ArticleIdList></Reference><Reference><Citation>Salvadores M., Alexander P. R., Musen M. A., Noy N. F. (2013). BioPortal as a dataset of linked biomedical ontologies and terminologies in RDF. Semant. Web 4, 277&#x2013;284. 10.3233/SW-2012-0086</Citation><ArticleIdList><ArticleId IdType="doi">10.3233/SW-2012-0086</ArticleId><ArticleId IdType="pmc">PMC4159173</ArticleId><ArticleId IdType="pubmed">25214827</ArticleId></ArticleIdList></Reference><Reference><Citation>Santos M. R., Bax M. P., Kalra D. (2010). Building a logical EHR architecture based on ISO 13606 standard and semantic web technologies. Stud. Health Technol. Inform. 160, 161&#x2013;165. 10.3233/978-1-60750-588-4-161</Citation><ArticleIdList><ArticleId IdType="doi">10.3233/978-1-60750-588-4-161</ArticleId><ArticleId IdType="pubmed">20841670</ArticleId></ArticleIdList></Reference><Reference><Citation>Singh R., Singh K. (2010). A descriptive classification of causes of data quality problems in data warehousing. Int. J. Comput. Sci. Issues 7, 41&#x2013;50.</Citation></Reference><Reference><Citation>Solbrig H. R., Prud'hommeaux E., Grieve G., McKenzie L., Mandel J. C., Sharma D. K., et al. . (2017). Modeling and validating HL7 FHIR profiles using semantic web Shape Expressions (ShEx). J. Biomed. Inform. 67, 90&#x2013;100. 10.1016/j.jbi.2017.02.009</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jbi.2017.02.009</ArticleId><ArticleId IdType="pmc">PMC5502481</ArticleId><ArticleId IdType="pubmed">28213144</ArticleId></ArticleIdList></Reference><Reference><Citation>Suling M., Pigeot I. (2012). Signal detection and monitoring based on longitudinal healthcare data. Pharmaceutics 4, 607&#x2013;640. 10.3390/pharmaceutics4040607</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/pharmaceutics4040607</ArticleId><ArticleId IdType="pmc">PMC3834930</ArticleId><ArticleId IdType="pubmed">24300373</ArticleId></ArticleIdList></Reference><Reference><Citation>Tziovara V., Vassiliadis P., Simitsis A. (2007). Deciding the physical implementation of ETL workflows, in Proceedings of the ACM Tenth International Workshop on Data Warehousing and OLAP (ACM) (Lisbon: ).</Citation></Reference><Reference><Citation>World Health Organization. (2002). The Importance of Pharmacovigilance.</Citation><ArticleIdList><ArticleId IdType="pubmed">0</ArticleId></ArticleIdList></Reference><Reference><Citation>Wysowski D. K., Swartz L. (2005). Adverse drug event surveillance and drug withdrawals in the United States, 1969-2002: the importance of reporting suspected reactions. Arch. Intern. Med. 165, 1363&#x2013;1369. 10.1001/archinte.165.12.1363</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/archinte.165.12.1363</ArticleId><ArticleId IdType="pubmed">15983284</ArticleId></ArticleIdList></Reference><Reference><Citation>Yosemite Manifesto  (2016). Available online at: http://yosemitemanifesto.org/</Citation></Reference><Reference><Citation>Yuksel M., Gonul S., Laleci Erturkmen G. B., Sinaci A. A., Invernizzi P., Facchinetti S., et al. . (2016). An interoperability platform enabling reuse of electronic health records for signal verification studies. BioMed Res. Int. 2016:6741418. 10.1155/2016/6741418</Citation><ArticleIdList><ArticleId IdType="doi">10.1155/2016/6741418</ArticleId><ArticleId IdType="pmc">PMC4830705</ArticleId><ArticleId IdType="pubmed">27123451</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhou X., Murugesan S., Bhullar H., Liu Q., Cai B., Wentworth C., et al. . (2013). An evaluation of the THIN database in the OMOP common data model for active drug safety surveillance. Drug Saf. 36, 119&#x2013;134. 10.1007/s40264-012-0009-3</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s40264-012-0009-3</ArticleId><ArticleId IdType="pubmed">23329543</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">29779949</PMID><DateCompleted><Year>2019</Year><Month>03</Month><Day>13</Day></DateCompleted><DateRevised><Year>2021</Year><Month>01</Month><Day>09</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1097-4172</ISSN><JournalIssue CitedMedium="Internet"><Volume>173</Volume><Issue>7</Issue><PubDate><Year>2018</Year><Month>Jun</Month><Day>14</Day></PubDate></JournalIssue><Title>Cell</Title><ISOAbbreviation>Cell</ISOAbbreviation></Journal><ArticleTitle>Disease Heritability Inferred from Familial Relationships Reported in Medical Records.</ArticleTitle><Pagination><StartPage>1692</StartPage><EndPage>1704.e11</EndPage><MedlinePgn>1692-1704.e11</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.cell.2018.04.032</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S0092-8674(18)30525-7</ELocationID><Abstract><AbstractText>Heritability is essential for understanding the biological causes of disease but requires laborious patient recruitment and phenotype ascertainment. Electronic health records (EHRs) passively capture a wide range of clinically relevant data and provide a resource for studying the heritability of traits that are not typically accessible. EHRs contain next-of-kin information collected via patient emergency contact forms, but until now, these data have gone unused in research. We mined emergency contact data at three academic medical centers and identified 7.4 million familial relationships while maintaining patient privacy. Identified relationships were consistent with genetically derived relatedness. We used EHR data to compute heritability estimates for 500 disease phenotypes. Overall, estimates were consistent with the literature and between sites. Inconsistencies were indicative of limitations and opportunities unique to EHR research. These analyses provide a validation of the use of EHRs for genetics and disease research.</AbstractText><CopyrightInformation>Copyright &#xa9; 2018 Elsevier Inc. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Polubriaginof</LastName><ForeName>Fernanda C G</ForeName><Initials>FCG</Initials><AffiliationInfo><Affiliation>Department of Biomedical Informatics, Columbia University, New York, NY, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Vanguri</LastName><ForeName>Rami</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Department of Biomedical Informatics, Columbia University, New York, NY, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Quinnies</LastName><ForeName>Kayla</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Department of Biomedical Informatics, Columbia University, New York, NY, USA; Institute for Genomic Medicine, Columbia University, New York, NY, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Belbin</LastName><ForeName>Gillian M</ForeName><Initials>GM</Initials><AffiliationInfo><Affiliation>Department of Genetics and Genomic Sciences, Mount Sinai Health System, New York, NY, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yahi</LastName><ForeName>Alexandre</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Biomedical Informatics, Columbia University, New York, NY, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Salmasian</LastName><ForeName>Hojjat</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Department of Biomedical Informatics, Columbia University, New York, NY, USA; Value Institute, NewYork-Presbyterian Hospital, New York, NY, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lorberbaum</LastName><ForeName>Tal</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Department of Biomedical Informatics, Columbia University, New York, NY, USA; Department of Physiology and Cellular Biophysics, Columbia University, New York, NY, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Nwankwo</LastName><ForeName>Victor</ForeName><Initials>V</Initials><AffiliationInfo><Affiliation>Department of Biomedical Informatics, Columbia University, New York, NY, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Li</LastName><ForeName>Li</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Department of Genetics and Genomic Sciences, Mount Sinai Health System, New York, NY, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Shervey</LastName><ForeName>Mark M</ForeName><Initials>MM</Initials><AffiliationInfo><Affiliation>Department of Genetics and Genomic Sciences, Mount Sinai Health System, New York, NY, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Glowe</LastName><ForeName>Patricia</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Department of Genetics and Genomic Sciences, Mount Sinai Health System, New York, NY, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ionita-Laza</LastName><ForeName>Iuliana</ForeName><Initials>I</Initials><AffiliationInfo><Affiliation>Mailman School of Public Health, Columbia University, New York, NY, USA; Department of Biostatistics, Columbia University, New York, NY, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Simmerling</LastName><ForeName>Mary</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Medicine, Weill Cornell Medicine, Cornell University, New York, NY, USA; Quality and Patient Safety, NewYork-Presbyterian Hospital, New York, NY, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hripcsak</LastName><ForeName>George</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Department of Biomedical Informatics, Columbia University, New York, NY, USA; Medical Informatics Services, NewYork-Presbyterian Hospital, New York, NY; Observational Health Data Sciences and Informatics (OHDSI), New York, NY, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bakken</LastName><ForeName>Suzanne</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Biomedical Informatics, Columbia University, New York, NY, USA; School of Nursing, Columbia University, New York, NY, USA; Data Science Institute, Columbia University, New York, NY, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Goldstein</LastName><ForeName>David</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Institute for Genomic Medicine, Columbia University, New York, NY, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kiryluk</LastName><ForeName>Krzysztof</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Department of Medicine, Columbia University, New York, NY, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kenny</LastName><ForeName>Eimear E</ForeName><Initials>EE</Initials><AffiliationInfo><Affiliation>Department of Genetics and Genomic Sciences, Mount Sinai Health System, New York, NY, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Dudley</LastName><ForeName>Joel</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Genetics and Genomic Sciences, Mount Sinai Health System, New York, NY, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Vawdrey</LastName><ForeName>David K</ForeName><Initials>DK</Initials><AffiliationInfo><Affiliation>Department of Biomedical Informatics, Columbia University, New York, NY, USA; Value Institute, NewYork-Presbyterian Hospital, New York, NY, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tatonetti</LastName><ForeName>Nicholas P</ForeName><Initials>NP</Initials><AffiliationInfo><Affiliation>Department of Biomedical Informatics, Columbia University, New York, NY, USA; Institute for Genomic Medicine, Columbia University, New York, NY, USA; Observational Health Data Sciences and Informatics (OHDSI), New York, NY, USA; Department of Medicine, Columbia University, New York, NY, USA; Department of Systems Biology, Columbia University, New York, NY, USA; Data Science Institute, Columbia University, New York, NY, USA. Electronic address: nick.tatonetti@columbia.edu.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>R01 MH106910</GrantID><Acronym>MH</Acronym><Agency>NIMH NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R01 DK105124</GrantID><Acronym>DK</Acronym><Agency>NIDDK NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R01 LM006910</GrantID><Acronym>LM</Acronym><Agency>NLM NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R01 HS022961</GrantID><Acronym>HS</Acronym><Agency>AHRQ HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R01 HS021816</GrantID><Acronym>HS</Acronym><Agency>AHRQ HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R01 GM107145</GrantID><Acronym>GM</Acronym><Agency>NIGMS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>U01 HG008680</GrantID><Acronym>HG</Acronym><Agency>NHGRI NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>OT3 TR002027</GrantID><Acronym>TR</Acronym><Agency>NCATS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R01 MH095797</GrantID><Acronym>MH</Acronym><Agency>NIMH NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D052061">Research Support, N.I.H., Extramural</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType><PublicationType UI="D013486">Research Support, U.S. Gov't, Non-P.H.S.</PublicationType><PublicationType UI="D013487">Research Support, U.S. Gov't, P.H.S.</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2018</Year><Month>05</Month><Day>17</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Cell</MedlineTA><NlmUniqueID>0413066</NlmUniqueID><ISSNLinking>0092-8674</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><CommentsCorrectionsList><CommentsCorrections RefType="CommentIn"><RefSource>Nat Rev Genet. 2018 Jul;19(7):403. doi: 10.1038/s41576-018-0021-2.</RefSource><PMID Version="1">29795126</PMID></CommentsCorrections><CommentsCorrections RefType="CommentIn"><RefSource>Cell. 2018 Jun 14;173(7):1568-1570. doi: 10.1016/j.cell.2018.05.053.</RefSource><PMID Version="1">29906443</PMID></CommentsCorrections></CommentsCorrectionsList><MeshHeadingList><MeshHeading><DescriptorName UI="D000465" MajorTopicYN="N">Algorithms</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016208" MajorTopicYN="N">Databases, Factual</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D057286" MajorTopicYN="Y">Electronic Health Records</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005195" MajorTopicYN="N">Family Relations</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D030342" MajorTopicYN="N">Genetic Diseases, Inborn</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005838" MajorTopicYN="N">Genotype</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D010375" MajorTopicYN="N">Pedigree</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D010641" MajorTopicYN="N">Phenotype</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D019655" MajorTopicYN="N">Quantitative Trait, Heritable</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">data mining</Keyword><Keyword MajorTopicYN="N">disease heritability</Keyword><Keyword MajorTopicYN="N">electronic health record</Keyword><Keyword MajorTopicYN="N">familial relationships</Keyword><Keyword MajorTopicYN="N">family history</Keyword><Keyword MajorTopicYN="N">genetics</Keyword><Keyword MajorTopicYN="N">observational databases</Keyword></KeywordList><CoiStatement><b>Declaration of Interests</b>. The authors declare no competing interests.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2017</Year><Month>11</Month><Day>30</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2018</Year><Month>3</Month><Day>4</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2018</Year><Month>4</Month><Day>23</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2018</Year><Month>5</Month><Day>22</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2019</Year><Month>3</Month><Day>14</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2018</Year><Month>5</Month><Day>22</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2019</Year><Month>6</Month><Day>14</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">29779949</ArticleId><ArticleId IdType="mid">NIHMS969055</ArticleId><ArticleId IdType="pmc">PMC6015747</ArticleId><ArticleId IdType="doi">10.1016/j.cell.2018.04.032</ArticleId><ArticleId IdType="pii">S0092-8674(18)30525-7</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Almasy L, Blangero J. Multipoint quantitative-trait linkage analysis in general pedigrees. American Journal of Human Genetics. 1998;62:1198&#x2013;1211.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1377101</ArticleId><ArticleId IdType="pubmed">9545414</ArticleId></ArticleIdList></Reference><Reference><Citation>Aronson SJ, Rehm HL. Building the foundation for genomics in precision medicine. Nature. 2015;526:336&#x2013;342.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5669797</ArticleId><ArticleId IdType="pubmed">26469044</ArticleId></ArticleIdList></Reference><Reference><Citation>Bederson JB, Awad IA, Wiebers DO, Piepgras D, Haley EC, Brott T, Hademenos G, Chyatte D, Rosenwasser R, Caroselli C. Recommendations for the management of patients with unruptured intracranial aneurysms - A statement for healthcare professionals from the Stroke Council of the American Heart Association. Circulation. 2000;102:2300&#x2013;2308.</Citation><ArticleIdList><ArticleId IdType="pubmed">11056108</ArticleId></ArticleIdList></Reference><Reference><Citation>Birkhead GS, Klompas M, Shah NR. Uses of electronic health records for public health surveillance to advance public health. Annu Rev Public Health. 2015;36:345&#x2013;359.</Citation><ArticleIdList><ArticleId IdType="pubmed">25581157</ArticleId></ArticleIdList></Reference><Reference><Citation>Boland MR, Shahn Z, Madigan D, Hripcsak G, Tatonetti NP. Birth month affects lifetime disease risk: a phenome-wide method. Journal of the American Medical Informatics Association : JAMIA. 2015;22:1042&#x2013;1053.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4986668</ArticleId><ArticleId IdType="pubmed">26041386</ArticleId></ArticleIdList></Reference><Reference><Citation>Bronfenbrenner U, Ceci SJ. Nature-nurture reconceptualized in developmental perspective: a bioecological model. Psychol Rev. 1994;101:568&#x2013;586.</Citation><ArticleIdList><ArticleId IdType="pubmed">7984707</ArticleId></ArticleIdList></Reference><Reference><Citation>Castellani C, Picci L, Tamanini A, Girardi P, Rizzotti P, Assael BM. Association between carrier screening and incidence of cystic fibrosis. Jama. 2009;302:2573&#x2013;2579.</Citation><ArticleIdList><ArticleId IdType="pubmed">20009057</ArticleId></ArticleIdList></Reference><Reference><Citation>Chatterjee N, Shi J, Garc&#xed;a-Closas M. Developing and evaluating polygenic risk prediction models for stratified disease prevention. Nature Reviews Genetics. 2016;17:392&#x2013;406.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6021129</ArticleId><ArticleId IdType="pubmed">27140283</ArticleId></ArticleIdList></Reference><Reference><Citation>Dupuis A, Hamilton D, Cole DEC, Corey M. Cystic Fibrosis Birth Rates in Canada: A Decreasing Trend since the Onset of Genetic Testing. The Journal of Pediatrics. 2005;147:312&#x2013;315.</Citation><ArticleIdList><ArticleId IdType="pubmed">16182667</ArticleId></ArticleIdList></Reference><Reference><Citation>Ge T, Chen CY, Neale BM, Sabuncu MR, Smoller JW. Phenome-wide heritability analysis of the UK Biobank. PLoS Genet. 2017;13:e1006711&#x2013;e1006721.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5400281</ArticleId><ArticleId IdType="pubmed">28388634</ArticleId></ArticleIdList></Reference><Reference><Citation>Guttmacher AE, Collins FS, Carmona RH. The family history&#x2013;more important than ever. N Engl J Med. 2004;351:2333&#x2013;2336.</Citation><ArticleIdList><ArticleId IdType="pubmed">15564550</ArticleId></ArticleIdList></Reference><Reference><Citation>Harden KP, Turkheimer E, Loehlin JC. Genotype by environment interaction in adolescents&#x2019; cognitive aptitude. Behav Genet. 2007;37:273&#x2013;283.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2903846</ArticleId><ArticleId IdType="pubmed">16977503</ArticleId></ArticleIdList></Reference><Reference><Citation>Hripcsak G, Albers DJ. Next-generation phenotyping of electronic health records. Journal of the American Medical Informatics Association : JAMIA. 2013;20:117&#x2013;121.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3555337</ArticleId><ArticleId IdType="pubmed">22955496</ArticleId></ArticleIdList></Reference><Reference><Citation>Hripcsak G, Ryan PB, Duke JD, Shah NH, Park RW, Huser V, Suchard MA, Schuemie MJ, DeFalco FJ, Perotte A, et al. Characterizing treatment pathways at scale using the OHDSI network. Proc Natl Acad Sci USA. 2016;113:7329&#x2013;7336.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4941483</ArticleId><ArticleId IdType="pubmed">27274072</ArticleId></ArticleIdList></Reference><Reference><Citation>Kaplan RM, Chambers DA, Glasgow RE. Big Data and Large Sample Size: A Cautionary Note on the Potential for Bias. Clinical and Translational Science. 2014;7:342&#x2013;346.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5439816</ArticleId><ArticleId IdType="pubmed">25043853</ArticleId></ArticleIdList></Reference><Reference><Citation>Lorberbaum T, Sampson KJ, Woosley RL, Kass RS, Tatonetti NP. An Integrative Data Science Pipeline to Identify Novel Drug Interactions that Prolong the QT Interval. Drug Saf. 2016;39:433&#x2013;441.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4835515</ArticleId><ArticleId IdType="pubmed">26860921</ArticleId></ArticleIdList></Reference><Reference><Citation>Mayer J, Kitchner T, Ye Z, Zhou Z, He M, Schrodi SJ, Hebbring SJ. Use of an electronic medical record to create the marshfield clinic twin/multiple birth cohort. Genet Epidemiol. 2014;38:692&#x2013;698.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4384889</ArticleId><ArticleId IdType="pubmed">25250975</ArticleId></ArticleIdList></Reference><Reference><Citation>Mucci LA, Hjelmborg JB, Harris JR, Czene K, Havelick DJ, Scheike T, Graff RE, Holst K, M&#xf6;ller S, Unger RH, et al. Familial Risk and Heritability of Cancer Among Twins in Nordic Countries. Jama. 2016;315:68&#x2013;69.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5498110</ArticleId><ArticleId IdType="pubmed">26746459</ArticleId></ArticleIdList></Reference><Reference><Citation>Pietil&#xe4;inen KH, S&#xf6;derlund S, Rissanen A, Nakanishi S, Jauhiainen M, Taskinen MR, Kaprio J. HDL subspecies in young adult twins: heritability and impact of overweight. Obesity (Silver Spring) 2009;17:1208&#x2013;1214.</Citation><ArticleIdList><ArticleId IdType="pubmed">19584879</ArticleId></ArticleIdList></Reference><Reference><Citation>Polderman TJC, Benyamin B, de Leeuw CA, Sullivan PF, van Bochoven A, Visscher PM, Posthuma D. Meta-analysis of the heritability of human traits based on fifty years of twin studies. Nature Publishing Group. 2015;47:702&#x2013;709.</Citation><ArticleIdList><ArticleId IdType="pubmed">25985137</ArticleId></ArticleIdList></Reference><Reference><Citation>Polubriaginof F, Tatonetti NP, Vawdrey DK. An Assessment of Family History Information Captured in an Electronic Health Record. AMIA Annu Symp Proc. 2015;2015:2035&#x2013;2042.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4765557</ArticleId><ArticleId IdType="pubmed">26958303</ArticleId></ArticleIdList></Reference><Reference><Citation>Pordes R, Petravick D, Kramer B, Olson D, Livny M, Roy A, Avery P, Blackburn K, Wenaus T, W&#xfc;rthwein F, et al. The open science grid. J Phys: Conf Ser. 2007;78:012057.</Citation></Reference><Reference><Citation>Purcell S, Neale B, Todd-Brown K, Thomas L, Ferreira MAR, Bender D, Maller J, Sklar P, de Bakker PIW, Daly MJ, et al. PLINK: A Tool Set for Whole-Genome Association and Population-Based Linkage Analyses. The American Journal of Human Genetics. 2007;81:559&#x2013;575.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1950838</ArticleId><ArticleId IdType="pubmed">17701901</ArticleId></ArticleIdList></Reference><Reference><Citation>Ritchie MD, de Andrade M, Kuivaniemi H. The foundation of precision medicine: integration of electronic health records with genomics through basic, clinical, and translational research. Front Genet. 2015;6:104.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4362332</ArticleId><ArticleId IdType="pubmed">25852745</ArticleId></ArticleIdList></Reference><Reference><Citation>Scotet V, Dugu&#xe9;p&#xe9;roux I, Saliou P, Rault G, Roussey M, Audr&#xe9;zet MP, F&#xe9;rec C. Evidence for decline in the incidence of cystic fibrosis: a 35-year observational study in Brittany, France. Orphanet Journal of Rare Diseases. 2012;7:14.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3310838</ArticleId><ArticleId IdType="pubmed">22380742</ArticleId></ArticleIdList></Reference><Reference><Citation>Sfiligoi I, Bradley DC, Holzman B, Mhashilkar P, Padhi S, W&#xfc;rthwein F. The Pilot Way to Grid Resources Using glideinWMS (IEEE) 2009</Citation></Reference><Reference><Citation>Slieker MG, Uiterwaal CSPM, Sinaasappel M, Heijerman HGM, van der Laag J, van der Ent CK. Birth Prevalence and Survival in Cystic Fibrosis: A National Cohort Study in the Netherlands. Chest. 2005;128:2309&#x2013;2315.</Citation><ArticleIdList><ArticleId IdType="pubmed">16236889</ArticleId></ArticleIdList></Reference><Reference><Citation>Souren NY, Paulussen ADC, Loos RJF, Gielen M, Beunen G, Fagard R, Derom C, Vlietinck R, Zeegers MP. Anthropometry, carbohydrate and lipid metabolism in the East Flanders Prospective Twin Survey: heritabilities. Diabetologia. 2007;50:2107&#x2013;2116.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2039867</ArticleId><ArticleId IdType="pubmed">17694296</ArticleId></ArticleIdList></Reference><Reference><Citation>Suarez R. Breaching Doctor-Patient Confidentiality: Confusion among Physicians about Involuntary Disclosure of Genetic Information. S Cal Interdisc LJ 2011</Citation></Reference><Reference><Citation>Tatonetti NP, Ye PP, Daneshjou R, Altman RB. Data-driven prediction of drug effects and interactions. Sci Transl Med. 2012;4:125ra31&#x2013;125ra31.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3382018</ArticleId><ArticleId IdType="pubmed">22422992</ArticleId></ArticleIdList></Reference><Reference><Citation>Tenesa A, Haley CS. The heritability of human disease: estimation, uses and abuses. Nature Reviews Genetics. 2013;14:139&#x2013;149.</Citation><ArticleIdList><ArticleId IdType="pubmed">23329114</ArticleId></ArticleIdList></Reference><Reference><Citation>Turkheimer E, Haley A, Waldron M, D&#x2019;Onofrio B, Gottesman II. Socioeconomic status modifies heritability of IQ in young children. Psychol Sci. 2003;14:623&#x2013;628.</Citation><ArticleIdList><ArticleId IdType="pubmed">14629696</ArticleId></ArticleIdList></Reference><Reference><Citation>United States. Health Insurance Portability and Accountability Act of 1996. Public Law. 1996:104&#x2013;191.</Citation><ArticleIdList><ArticleId IdType="pubmed">16477734</ArticleId></ArticleIdList></Reference><Reference><Citation>Visscher PM, Hill WG, Wray NR. Heritability in the genomics era&#x2013;concepts and misconceptions. Nature Reviews Genetics. 2008;9:255&#x2013;266.</Citation><ArticleIdList><ArticleId IdType="pubmed">18319743</ArticleId></ArticleIdList></Reference><Reference><Citation>Wei WQ, Denny JC. Extracting research-quality phenotypes from electronic health records to support precision medicine. Genome Med. 2015;7:41.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4416392</ArticleId><ArticleId IdType="pubmed">25937834</ArticleId></ArticleIdList></Reference><Reference><Citation>Weiskopf NG, Weng C. Methods and dimensions of electronic health record data quality assessment: enabling reuse for clinical research. Journal of the American Medical Informatics Association. 2013;20:144&#x2013;151.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3555312</ArticleId><ArticleId IdType="pubmed">22733976</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">29786922</PMID><DateCompleted><Year>2018</Year><Month>11</Month><Day>14</Day></DateCompleted><DateRevised><Year>2023</Year><Month>09</Month><Day>26</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1520-6394</ISSN><JournalIssue CitedMedium="Internet"><Volume>35</Volume><Issue>7</Issue><PubDate><Year>2018</Year><Month>Jul</Month></PubDate></JournalIssue><Title>Depression and anxiety</Title><ISOAbbreviation>Depress Anxiety</ISOAbbreviation></Journal><ArticleTitle>Finding factors that predict treatment-resistant depression: Results of a cohort study.</ArticleTitle><Pagination><StartPage>668</StartPage><EndPage>673</EndPage><MedlinePgn>668-673</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1002/da.22774</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Treatment for depressive disorders often requires subsequent interventions. Patients who do not respond to antidepressants have treatment-resistant depression (TRD). Predicting who will develop TRD may help healthcare providers make more effective treatment decisions. We sought to identify factors that predict TRD in a real-world setting using claims databases.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">A retrospective cohort study was conducted in a US claims database of adult subjects with newly diagnosed and treated depression with no mania, dementia, and psychosis. The index date was the date of antidepressant dispensing. The outcome was TRD, defined as having at least three distinct antidepressants or one antidepressant and one antipsychotic within 1 year after the index date. Predictors were age, gender, medical conditions, medications, and procedures 1 year before the index date.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">Of 230,801 included patients, 10.4% developed TRD within 1 year. TRD patients at baseline were younger; 10.87% were between 18 and 19&#xa0;years old versus 7.64% in the no-TRD group, risk ratio (RR)&#xa0;=&#xa0;1.42 (95% confidence interval [CI] 1.37-1.48). TRD patients were more likely to have an anxiety disorder at baseline than non-TRD patients, RR&#xa0;=&#xa0;1.38 (95% CI 1.35-1.14). At 3.68, fatigue had the highest RR (95% CI 3.18-4.25). TRD patients had substance use disorders, psychiatric conditions, insomnia, and pain more often at baseline than non-TRD patients.</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">Ten percent of subjects newly diagnosed and treated for depression developed TRD within a year. They were younger and suffered more frequently from fatigue, substance use disorders, anxiety, psychiatric conditions, insomnia, and pain than non-TRD patients.</AbstractText><CopyrightInformation>&#xa9; 2018 The Authors. Depression and Anxiety published by Wiley Periodicals, Inc.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Cepeda</LastName><ForeName>M Soledad</ForeName><Initials>MS</Initials><Identifier Source="ORCID">0000-0002-5159-6217</Identifier><AffiliationInfo><Affiliation>Department of Epidemiology, Janssen Research and Development, Titusville, Florida.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Reps</LastName><ForeName>Jenna</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Epidemiology, Janssen Research and Development, Titusville, Florida.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ryan</LastName><ForeName>Patrick</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Department of Epidemiology, Janssen Research and Development, Titusville, Florida.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2018</Year><Month>05</Month><Day>22</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Depress Anxiety</MedlineTA><NlmUniqueID>9708816</NlmUniqueID><ISSNLinking>1091-4269</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000928">Antidepressive Agents</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D014150">Antipsychotic Agents</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000293" MajorTopicYN="N">Adolescent</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000367" MajorTopicYN="N">Age Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000928" MajorTopicYN="N">Antidepressive Agents</DescriptorName><QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D014150" MajorTopicYN="N">Antipsychotic Agents</DescriptorName><QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D001008" MajorTopicYN="N">Anxiety Disorders</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="Y">epidemiology</QualifierName><QualifierName UI="Q000523" MajorTopicYN="N">psychology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015331" MajorTopicYN="N">Cohort Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015897" MajorTopicYN="N">Comorbidity</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D061218" MajorTopicYN="N">Depressive Disorder, Treatment-Resistant</DescriptorName><QualifierName UI="Q000188" MajorTopicYN="N">drug therapy</QualifierName><QualifierName UI="Q000453" MajorTopicYN="Y">epidemiology</QualifierName><QualifierName UI="Q000523" MajorTopicYN="N">psychology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005221" MajorTopicYN="N">Fatigue</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="Y">epidemiology</QualifierName><QualifierName UI="Q000523" MajorTopicYN="N">psychology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016017" MajorTopicYN="N">Odds Ratio</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D010146" MajorTopicYN="N">Pain</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="Y">epidemiology</QualifierName><QualifierName UI="Q000523" MajorTopicYN="N">psychology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012189" MajorTopicYN="N">Retrospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012307" MajorTopicYN="N">Risk Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007319" MajorTopicYN="N">Sleep Initiation and Maintenance Disorders</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="Y">epidemiology</QualifierName><QualifierName UI="Q000523" MajorTopicYN="N">psychology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D019966" MajorTopicYN="N">Substance-Related Disorders</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="Y">epidemiology</QualifierName><QualifierName UI="Q000523" MajorTopicYN="N">psychology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D055815" MajorTopicYN="N">Young Adult</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">epidemiology</Keyword><Keyword MajorTopicYN="N">observational studies</Keyword><Keyword MajorTopicYN="N">prediction</Keyword><Keyword MajorTopicYN="N">real world evidence</Keyword><Keyword MajorTopicYN="N">risk factors</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2017</Year><Month>11</Month><Day>7</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2018</Year><Month>3</Month><Day>16</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2018</Year><Month>4</Month><Day>23</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2018</Year><Month>5</Month><Day>23</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2018</Year><Month>11</Month><Day>15</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2018</Year><Month>5</Month><Day>23</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2018</Year><Month>7</Month><Day>23</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">29786922</ArticleId><ArticleId IdType="pmc">PMC6055726</ArticleId><ArticleId IdType="doi">10.1002/da.22774</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Addington, A. M. , Gallo, J. J. , Ford, D. E. , &amp; Eaton, W. W. (2001). Epidemiology of unexplained fatigue and major depression in the community: The Baltimore ECA follow&#x2010;up, 1981&#x2013;1994. Psychological Medicine, 31(6), 1037&#x2013;1044.</Citation><ArticleIdList><ArticleId IdType="pubmed">11513371</ArticleId></ArticleIdList></Reference><Reference><Citation>Al&#x2010;Harbi, K. S. (2012). Treatment&#x2010;resistant depression: Therapeutic trends, challenges, and future directions. Patient Preference and Adherence, 6, 369&#x2013;388. 10.2147/PPA.S29716</Citation><ArticleIdList><ArticleId IdType="doi">10.2147/PPA.S29716</ArticleId><ArticleId IdType="pmc">PMC3363299</ArticleId><ArticleId IdType="pubmed">22654508</ArticleId></ArticleIdList></Reference><Reference><Citation>Bennabi, D. , Aouizerate, B. , El&#x2010;Hage, W. , Doumy, O. , Moliere, F. , Courtet, P. , &#x2026; Haffen, E. (2015). Risk factors for treatment resistance in unipolar depression: A systematic review. Journal of Affective Disorders, 171, 137&#x2013;141. 10.1016/j.jad.2014.09.020</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jad.2014.09.020</ArticleId><ArticleId IdType="pubmed">25305428</ArticleId></ArticleIdList></Reference><Reference><Citation>Berlim, M. T. , &amp; Turecki, G. (2007). What is the meaning of treatment resistant/refractory major depression (TRD)? A systematic review of current randomized trials. European Neuropsychopharmacology, 17(11), 696&#x2013;707. 10.1016/j.euroneuro.2007.03.009</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.euroneuro.2007.03.009</ArticleId><ArticleId IdType="pubmed">17521891</ArticleId></ArticleIdList></Reference><Reference><Citation>Blazer, D. G. , Kessler, R. C. , McGonagle, K. A. , &amp; Swartz, M. S. (1994). The prevalence and distribution of major depression in a national community sample: The National Comorbidity Survey. The American Journal of Psychiatry, 151(7), 979&#x2013;986.</Citation><ArticleIdList><ArticleId IdType="pubmed">8010383</ArticleId></ArticleIdList></Reference><Reference><Citation>Cepeda, M. S. , Fife, D. , Kihm, M. A. , Mastrogiovanni, G. , &amp; Yuan, Y. (2013). Comparison of the risks of shopping behavior and opioid abuse between tapentadol and oxycodone and association of shopping behavior and opioid abuse. The Clinical Journal of Pain, 30(12):1051&#x2013;1056. 10.1097/AJP.0000000000000067</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/AJP.0000000000000067</ArticleId><ArticleId IdType="pmc">PMC4232297</ArticleId><ArticleId IdType="pubmed">24370606</ArticleId></ArticleIdList></Reference><Reference><Citation>Cepeda, M. S. , Reps, J. , Fife, D. , Blacketer, C. , Stang, P. , &amp; Ryan, P. (2018). Finding treatment&#x2010;resistant depression in real&#x2010;world data: How a data&#x2010;driven approach compares with expert&#x2010;based heuristics. Depression and Anxiety, 35(3), 220&#x2013;228. 10.1002/da.22705</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/da.22705</ArticleId><ArticleId IdType="pmc">PMC5873404</ArticleId><ArticleId IdType="pubmed">29244906</ArticleId></ArticleIdList></Reference><Reference><Citation>Cepeda, M. S. , Stang, P. , Blacketer, C. , Kent, J. M. , &amp; Wittenberg, G. M. (2016). Clinical relevance of sleep duration: Results from a cross&#x2010;sectional analysis using NHANES. Journal of Clinical Sleep Medicine, 12(6):813&#x2013;819.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4877313</ArticleId><ArticleId IdType="pubmed">26951419</ArticleId></ArticleIdList></Reference><Reference><Citation>Cepeda, M. S. , Stang, P. , &amp; Makadia, R. (2016). Depression is associated with high levels of C reactive protein and low levels of exhaled nitric oxide: Results of a large population based study on NHANES. The Journal of Clinical Psychiatry, 77(12):1666&#x2013;1671.</Citation><ArticleIdList><ArticleId IdType="pubmed">27337107</ArticleId></ArticleIdList></Reference><Reference><Citation>Conway, C. R. , George, M. S. , &amp; Sackeim, H. A. (2017). Toward an evidence&#x2010;based, operational definition of treatment&#x2010;resistant depression: When enough is enough. JAMA Psychiatry, 74(1), 9&#x2013;10. 10.1001/jamapsychiatry.2016.2586</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamapsychiatry.2016.2586</ArticleId><ArticleId IdType="pubmed">27784055</ArticleId></ArticleIdList></Reference><Reference><Citation>De Carlo, V. , Calati, R. , &amp; Serretti, A. (2016). Socio&#x2010;demographic and clinical predictors of non&#x2010;response/non&#x2010;remission in treatment resistant depressed patients: A systematic review. Psychiatry Research, 240, 421&#x2013;430. 10.1016/j.psychres.2016.04.034</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.psychres.2016.04.034</ArticleId><ArticleId IdType="pubmed">27155594</ArticleId></ArticleIdList></Reference><Reference><Citation>Fife, D. , Reps, J. , Cepeda, M. S. , Stang, P. E. , Blacketer, M. , &amp; Singh, J. (2017). Treatment resistant depression incidence estimates from studies of health insurance databases depend strongly on the details of the operating definition. submitted for publication.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6076365</ArticleId><ArticleId IdType="pubmed">30094377</ArticleId></ArticleIdList></Reference><Reference><Citation>Gaynes, B. (2016). Recognizing and assessing risk factors for difficult&#x2010;to&#x2010;treat depression and treatment&#x2010;resistant depression. Journal of Clinical Psychiatry, 77(9), e1154 10.4088/JCP.14077cc2c</Citation><ArticleIdList><ArticleId IdType="doi">10.4088/JCP.14077cc2c</ArticleId><ArticleId IdType="pubmed">27780329</ArticleId></ArticleIdList></Reference><Reference><Citation>Hajian&#x2010;Tilaki, K. (2013). Receiver operating characteristic (ROC) curve analysis for medical diagnostic test evaluation. Caspian Journal of Internal Medicine, 4(2), 627&#x2013;635.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3755824</ArticleId><ArticleId IdType="pubmed">24009950</ArticleId></ArticleIdList></Reference><Reference><Citation>Hripcsak, G. , Duke, J. D. , Shah, N. H. , Reich, C. G. , Huser, V. , Schuemie, M. J. , &#x2026; Ryan, P. B. (2015). Observational Health Data Sciences and Informatics (OHDSI): opportunities for observational researchers. Studies in Health Technology and Informatics, 216, 574&#x2013;578.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4815923</ArticleId><ArticleId IdType="pubmed">26262116</ArticleId></ArticleIdList></Reference><Reference><Citation>Jakubovski, E. , &amp; Bloch, M. H. (2014). Prognostic subgroups for citalopram response in the STAR*D trial. Journal of Clinical Psychiatry, 75(7), 738&#x2013;747. 10.4088/JCP.13m08727</Citation><ArticleIdList><ArticleId IdType="doi">10.4088/JCP.13m08727</ArticleId><ArticleId IdType="pmc">PMC4471174</ArticleId><ArticleId IdType="pubmed">24912106</ArticleId></ArticleIdList></Reference><Reference><Citation>Kautzky, A. , Baldinger&#x2010;Melich, P. , Kranz, G. S. , Vanicek, T. , Souery, D. , Montgomery, S. , &#x2026; Kasper, S. (2017). A new prediction model for evaluating treatment&#x2010;resistant depression. Journal of Clinical Psychiatry, 78(2), 215&#x2013;222. 10.4088/JCP.15m10381</Citation><ArticleIdList><ArticleId IdType="doi">10.4088/JCP.15m10381</ArticleId><ArticleId IdType="pubmed">28068461</ArticleId></ArticleIdList></Reference><Reference><Citation>Kubitz, N. , Mehra, M. , Potluri, R. C. , Garg, N. , &amp; Cossrow, N. (2013). Characterization of treatment resistant depression episodes in a cohort of patients from a US commercial claims database. PLoS One, 8(10), e76882 10.1371/journal.pone.0076882</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0076882</ArticleId><ArticleId IdType="pmc">PMC3799999</ArticleId><ArticleId IdType="pubmed">24204694</ArticleId></ArticleIdList></Reference><Reference><Citation>Lanquillon, S. , Krieg, J. C. , Bening&#x2010;Abu&#x2010;Shach, U. , &amp; Vedder, H. (2000). Cytokine production and treatment response in major depressive disorder. Neuropsychopharmacology, 22(4), 370&#x2013;379. 10.1016/s0893-133x(99)00134-7</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/s0893-133x(99)00134-7</ArticleId><ArticleId IdType="pubmed">10700656</ArticleId></ArticleIdList></Reference><Reference><Citation>Marin, H. , &amp; Menza, M. A. (2004). Specific treatment of residual fatigue in depressed patients. Psychiatry (Edgmont), 1(2), 12&#x2013;18.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3012615</ArticleId><ArticleId IdType="pubmed">21197374</ArticleId></ArticleIdList></Reference><Reference><Citation>Pratt, L. A. , &amp; Brody, D. J. (2008). Depression in the United States household population, 2005&#x2013;2006. NCHS Data Brief (7), 1&#x2013;8.</Citation><ArticleIdList><ArticleId IdType="pubmed">19389321</ArticleId></ArticleIdList></Reference><Reference><Citation>Reich, C. , Ryan, P. B. , Stang, P. E. , &amp; Rocca, M. (2012). Evaluation of alternative standardized terminologies for medical conditions within a network of observational healthcare databases. Journal of Biomedical Informatics, 45(4), 689&#x2013;696. 10.1016/j.jbi.2012.05.002</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jbi.2012.05.002</ArticleId><ArticleId IdType="pubmed">22683994</ArticleId></ArticleIdList></Reference><Reference><Citation>Reps, J. , Schuemie, M. , Suchard, M. A. , Ryan, P. B. , &amp; Rijnbeek, P. (2017). Patient Level Prediction: Package for patient level prediction using data in the OMOP Common Data Model.</Citation></Reference><Reference><Citation>Rush, A. J. , Trivedi, M. H. , Wisniewski, S. R. , Nierenberg, A. A. , Stewart, J. W. , Warden, D. , &#x2026; Fava, M. (2006). Acute and longer&#x2010;term outcomes in depressed outpatients requiring one or several treatment steps: A STAR*D report. American Journal of Psychiatry, 163(11), 1905&#x2013;1917. 10.1176/ajp.2006.163.11.1905</Citation><ArticleIdList><ArticleId IdType="doi">10.1176/ajp.2006.163.11.1905</ArticleId><ArticleId IdType="pubmed">17074942</ArticleId></ArticleIdList></Reference><Reference><Citation>Rush, A. J. , Trivedi, M. H. , Wisniewski, S. R. , Stewart, J. W. , Nierenberg, A. A. , Thase, M. E. , &#x2026; Star D. Study Team (2006). Bupropion&#x2010;SR, sertraline, or venlafaxine&#x2010;XR after failure of SSRIs for depression. The New England Journal of Medicine, 354(12), 1231&#x2013;1242. 10.1056/NEJMoa052963</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa052963</ArticleId><ArticleId IdType="pubmed">16554525</ArticleId></ArticleIdList></Reference><Reference><Citation>Rush, A. J. , Warden, D. , Wisniewski, S. R. , Fava, M. , Trivedi, M. H. , Gaynes, B. N. , &amp; Nierenberg, A. A. (2009). STAR*D: Revising conventional wisdom. CNS Drugs, 23(8), 627&#x2013;647. 10.2165/00023210-200923080-00001</Citation><ArticleIdList><ArticleId IdType="doi">10.2165/00023210-200923080-00001</ArticleId><ArticleId IdType="pubmed">19594193</ArticleId></ArticleIdList></Reference><Reference><Citation>Russell, J. M. , Hawkins, K. , Ozminkowski, R. J. , Orsini, L. , Crown, W. H. , Kennedy, S. , &#x2026; Rush, A. J. (2004). The cost consequences of treatment&#x2010;resistant depression. Journal of Clinical Psychiatry, 65(3), 341&#x2013;347.</Citation><ArticleIdList><ArticleId IdType="pubmed">15096073</ArticleId></ArticleIdList></Reference><Reference><Citation>Simon, G. E. , &amp; Perlis, R. H. (2010). Personalized medicine for depression: Can we match patients with treatments? The American Journal of Psychiatry, 167(12), 1445&#x2013;1455. 10.1176/appi.ajp.2010.09111680</Citation><ArticleIdList><ArticleId IdType="doi">10.1176/appi.ajp.2010.09111680</ArticleId><ArticleId IdType="pmc">PMC3723328</ArticleId><ArticleId IdType="pubmed">20843873</ArticleId></ArticleIdList></Reference><Reference><Citation>Souery, D. , Oswald, P. , Massat, I. , Bailer, U. , Bollen, J. , Demyttenaere, K. , &#x2026; Mendlewicz, J. (2007). Clinical factors associated with treatment resistance in major depressive disorder: Results from a European multicenter study. Journal of Clinical Psychiatry, 68(7), 1062&#x2013;1070.</Citation><ArticleIdList><ArticleId IdType="pubmed">17685743</ArticleId></ArticleIdList></Reference><Reference><Citation>Stang, P. E. , Ryan, P. B. , Racoosin, J. A. , Overhage, J. M. , Hartzema, A. G. , Reich, C. , &#x2026; Woodcock, J. (2010). Advancing the science for active surveillance: Rationale and design for the observational medical outcomes partnership. Annals of Internal Medicine, 153(9), 600&#x2013;606. 10.7326/0003-4819-153-9-201011020-00010</Citation><ArticleIdList><ArticleId IdType="doi">10.7326/0003-4819-153-9-201011020-00010</ArticleId><ArticleId IdType="pubmed">21041580</ArticleId></ArticleIdList></Reference><Reference><Citation>Steyerberg, E. W. , Eijkemans, M. J. , Harrell, F. E., Jr. , &amp; Habbema, J. D. (2000). Prognostic modelling with logistic regression analysis: A comparison of selection and estimation methods in small data sets. Statistics in Medicine, 19(8), 1059&#x2013;1079.</Citation><ArticleIdList><ArticleId IdType="pubmed">10790680</ArticleId></ArticleIdList></Reference><Reference><Citation>Suchard, M. A. , Simpson, S. E. , Zorych, I. , Ryan, P. , &amp; Madigan, D. (2013). Massive parallelization of serial inference algorithms for a complex generalized linear model. ACM Transactions on Modeling and Computer Simulation, 23(1), 1&#x2013;17. 10.1145/2414416.2414791</Citation><ArticleIdList><ArticleId IdType="doi">10.1145/2414416.2414791</ArticleId><ArticleId IdType="pmc">PMC4201181</ArticleId><ArticleId IdType="pubmed">25328363</ArticleId></ArticleIdList></Reference><Reference><Citation>Targum, S. D. , &amp; Fava, M. (2011). Fatigue as a residual symptom of depression. Innovations in Clinical Neuroscience, 8(10), 40&#x2013;43.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3225130</ArticleId><ArticleId IdType="pubmed">22132370</ArticleId></ArticleIdList></Reference><Reference><Citation>Tibshirani, R. (1996). Regression shrinkage and selection via the lasso. Journal of the Royal Statistical Society. Series B (Methodological), 58(1), 267&#x2013;288.</Citation></Reference><Reference><Citation>van Loo, H. M. , Cai, T. , Gruber, M. J. , Li, J. , de Jonge, P. , Petukhova, M. , &#x2026; Kessler, R. C. (2014). Major depressive disorder subtypes to predict long&#x2010;term course. Depression and Anxiety, 31(9), 765&#x2013;777. 10.1002/da.22233</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/da.22233</ArticleId><ArticleId IdType="pmc">PMC5125445</ArticleId><ArticleId IdType="pubmed">24425049</ArticleId></ArticleIdList></Reference><Reference><Citation>van Mill, J. G. , Vogelzangs, N. , van Someren, E. J. , Hoogendijk, W. J. , &amp; Penninx, B. W. (2014). Sleep duration, but not insomnia, predicts the 2&#x2010;year course of depressive and anxiety disorders. Journal of Clinical Psychiatry, 75(2), 119&#x2013;126. 10.4088/JCP.12m08047</Citation><ArticleIdList><ArticleId IdType="doi">10.4088/JCP.12m08047</ArticleId><ArticleId IdType="pubmed">24345733</ArticleId></ArticleIdList></Reference><Reference><Citation>Voss, E. A. , Makadia, R. , Matcho, A. , Ma, Q. , Knoll, C. , Schuemie, M. , &#x2026; Ryan, P. B. (2015). Feasibility and utility of applications of the common data model to multiple, disparate observational health databases. Journal of the American Medical Informatics Association, 22(3), 553&#x2013;564. 10.1093/jamia/ocu023</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/jamia/ocu023</ArticleId><ArticleId IdType="pmc">PMC4457111</ArticleId><ArticleId IdType="pubmed">25670757</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu, C. H. , Erickson, S. R. , Piette, J. D. , &amp; Balkrishnan, R. (2012). The association of race, comorbid anxiety, and antidepressant adherence among Medicaid enrollees with major depressive disorder. Research in Social and Administrative Pharmacy, 8(3), 193&#x2013;205. 10.1016/j.sapharm.2011.04.002</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.sapharm.2011.04.002</ArticleId><ArticleId IdType="pubmed">21955808</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">29888090</PMID><DateRevised><Year>2020</Year><Month>09</Month><Day>30</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Print">2153-4063</ISSN><JournalIssue CitedMedium="Print"><Volume>2017</Volume><PubDate><Year>2018</Year></PubDate></JournalIssue><Title>AMIA Joint Summits on Translational Science proceedings. AMIA Joint Summits on Translational Science</Title><ISOAbbreviation>AMIA Jt Summits Transl Sci Proc</ISOAbbreviation></Journal><ArticleTitle>The Data Gap in the EHR for Clinical Research Eligibility Screening.</ArticleTitle><Pagination><StartPage>320</StartPage><EndPage>329</EndPage><MedlinePgn>320-329</MedlinePgn></Pagination><Abstract><AbstractText>Much effort has been devoted to leverage EHR data for matching patients into clinical trials. However, EHRs may not contain all important data elements for clinical research eligibility screening. To better design research-friendly EHRs, an important step is to identify data elements frequently used for eligibility screening but not yet available in EHRs. This study fills this knowledge gap. Using the Alzheimer's disease domain as an example, we performed text mining on the eligibility criteria text in Clinicaltrials.gov to identify frequently used eligibility criteria concepts. We compared them to the EHR data elements of a cohort of Alzheimer's Disease patients to assess the data gap by usingthe OMOP Common Data Model to standardize the representations for both criteria concepts and EHR data elements. We identified the most common SNOMED CT concepts used in Alzheimer 's Disease trials, andfound 40% of common eligibility criteria concepts were not even defined in the concept space in the EHR dataset for a cohort of Alzheimer 'sDisease patients, indicating a significant data gap may impede EHR-based eligibility screening. The results of this study can be useful for designing targeted research data collection forms to help fill the data gap in the EHR.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Butler</LastName><ForeName>Alex</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Biomedical Informatics, Columbia University, New York City, New York.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wei</LastName><ForeName>Wei</ForeName><Initials>W</Initials><AffiliationInfo><Affiliation>Department of Biomedical Informatics, Columbia University, New York City, New York.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yuan</LastName><ForeName>Chi</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Department of Biomedical Informatics, Columbia University, New York City, New York.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kang</LastName><ForeName>Tian</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Department of Biomedical Informatics, Columbia University, New York City, New York.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Si</LastName><ForeName>Yuqi</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>The University of Texas Health Science Center at Houston, Houston, Texas.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Weng</LastName><ForeName>Chunhua</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Department of Biomedical Informatics, Columbia University, New York City, New York.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>R01 LM009886</GrantID><Acronym>LM</Acronym><Agency>NLM NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>T35 HL007616</GrantID><Acronym>HL</Acronym><Agency>NHLBI NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>UL1 TR001873</GrantID><Acronym>TR</Acronym><Agency>NCATS NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2018</Year><Month>05</Month><Day>18</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>AMIA Jt Summits Transl Sci Proc</MedlineTA><NlmUniqueID>101539486</NlmUniqueID></MedlineJournalInfo></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2018</Year><Month>6</Month><Day>12</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2018</Year><Month>6</Month><Day>12</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2018</Year><Month>6</Month><Day>12</Day><Hour>6</Hour><Minute>1</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2018</Year><Month>5</Month><Day>18</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">29888090</ArticleId><ArticleId IdType="pmc">PMC5961795</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Gul RB, Ali PA. Clinical trials: the challenge of recruitment and retention of participants. Journal of Clinical Nursing. 2010;19(1-2):227&#x2013;233.</Citation><ArticleIdList><ArticleId IdType="pubmed">20500260</ArticleId></ArticleIdList></Reference><Reference><Citation>Penberthy LT, Dahman BA, Petkov VI, DeShazo JP. Effort Required in Eligibility Screening for Clinical Trials. Journal of Oncology Practice. 2012;8(6):365&#x2013;370.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3500483</ArticleId><ArticleId IdType="pubmed">23598846</ArticleId></ArticleIdList></Reference><Reference><Citation>Joseph RR. Viewpoints and concerns of a clinical trial participant. Cancer. 1994;74(S9):2692&#x2013;2693.</Citation><ArticleIdList><ArticleId IdType="pubmed">7954288</ArticleId></ArticleIdList></Reference><Reference><Citation>Campillo-Gimenez B, Buscail C, Zekri O, et al. Improving the pre-screening of eligible patients in order to increase enrollment in cancer clinical trials. Trials. 2015;16</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4301877</ArticleId><ArticleId IdType="pubmed">25592642</ArticleId></ArticleIdList></Reference><Reference><Citation>Joseph G, Dohan D. Recruiting minorities where they receive care: Institutional barriers to cancer clinical trials recruitment in a safety-net hospital. Contemp Clin Trials. 2009;30(6):552&#x2013;559.</Citation><ArticleIdList><ArticleId IdType="pubmed">19580887</ArticleId></ArticleIdList></Reference><Reference><Citation>Penberthy L, Brown R, Puma F, Dahman B. Automated matching software for clinical trials eligibility: Measuring efficiency and flexibility. Contemporary Clinical Trials. 2010;31(3):207&#x2013;217.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4387843</ArticleId><ArticleId IdType="pubmed">20230913</ArticleId></ArticleIdList></Reference><Reference><Citation>Ni Y, Wright J, Perentesis J, et al. Increasing the efficiency of trial-patient matching: automated clinical trial eligibility Pre-screening for pediatric oncology patients. BMC Medical Informatics and Decision Making. 2015;15</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4407835</ArticleId><ArticleId IdType="pubmed">25881112</ArticleId></ArticleIdList></Reference><Reference><Citation>K&#xf6;pcke F, Lubgan D, Fietkau R, et al. Evaluating predictive modeling algorithms to assess patient eligibility for clinical trials from routine data. BMC Medical Informatics and Decision Making. 2013;13(1):134.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4029400</ArticleId><ArticleId IdType="pubmed">24321610</ArticleId></ArticleIdList></Reference><Reference><Citation>Thadani SR WC, Bigger JT, Ennever JF, Wajngurt D. Electronic screening improves efficiency in clinical trial recruitment. J Am Med Inform Assoc. 2009;16(6):869&#x2013;873.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3002129</ArticleId><ArticleId IdType="pubmed">19717797</ArticleId></ArticleIdList></Reference><Reference><Citation>Weng C, Batres C, Borda T, et al. A Real-Time Screening Alert Improves Patient Recruitment Efficiency. AMIA Annual Symposium Proceedings. 2011;2011:1489&#x2013;1498.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3243166</ArticleId><ArticleId IdType="pubmed">22195213</ArticleId></ArticleIdList></Reference><Reference><Citation>Paulson ML, Weng C. Desiderata for Major Eligibility Criteria in Breast Cancer Clinical Trials. AMIA Annu Symp Proc. 2015;2015:2025&#x2013;2034.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4765677</ArticleId><ArticleId IdType="pubmed">26958302</ArticleId></ArticleIdList></Reference><Reference><Citation>Kang T, Zhang S, Tang Y, et al. EliIE: An open-source information extraction system for clinical trial eligibility criteria. Journal of the American Medical Informatics Association: JAMIA. 2017</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6259668</ArticleId><ArticleId IdType="pubmed">28379377</ArticleId></ArticleIdList></Reference><Reference><Citation>Si Y, Weng C. An OMOP CDM-based Relational Database of Clinical Research Eligibility Criteria. Medinfo 2017. 2017 Hangzhou, China.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5893219</ArticleId><ArticleId IdType="pubmed">29295240</ArticleId></ArticleIdList></Reference><Reference><Citation>Overhage JM RP, Reich CG, Hartzema AG, Stang PE. Validation of a common data model for active safety surveillance research. J Am Med Inform Assoc. 2011;19(1):54&#x2013;60.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3240764</ArticleId><ArticleId IdType="pubmed">22037893</ArticleId></ArticleIdList></Reference><Reference><Citation>Hripcsak G DJ, Shah NH, Reich CG, Huser V, Schuemie MJ, Suchard MA, Park RW, Wong IC, Rijnbeek PR, Van Der Lei J. Observational Health Data Sciences and Informatics (OHDSI): opportunities for observational researchers. Stud Health Technol Inform. 2015;216:574&#x2013;578.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4815923</ArticleId><ArticleId IdType="pubmed">26262116</ArticleId></ArticleIdList></Reference><Reference><Citation>McCarty CA CR, Chute CG, Kullo IJ, Jarvik GP, Larson EB, Li R, Masys DR, Ritchie MD, Roden DM, Struewing JP. The eMERGE network: a consortium of biorepositories linked to electronic medical records data for conducting genomic studies. BMC Med Genomics. 2011;4(1)</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3038887</ArticleId><ArticleId IdType="pubmed">21269473</ArticleId></ArticleIdList></Reference><Reference><Citation>Stearns MQ PC, Spackman KA, Wang AY. SNOMED clinical terms: overview of the development process and project status. Proceedings of the AMIA Symposium. 2001</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2243297</ArticleId><ArticleId IdType="pubmed">11825268</ArticleId></ArticleIdList></Reference><Reference><Citation>Weng C, Tu SW, Sim I, Richesson R. Formal representation of eligibility criteria: A literature review. Journal of biomedical informatics. 2010;43(3):451&#x2013;467.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2878905</ArticleId><ArticleId IdType="pubmed">20034594</ArticleId></ArticleIdList></Reference><Reference><Citation>Varghese J, Dugas M. Frequency analysis of medical concepts in clinical trials and their coverage in MeSH and SNOMED-CT. Methods of information in medicine. 2015;54(1):83&#x2013;92.</Citation><ArticleIdList><ArticleId IdType="pubmed">25346408</ArticleId></ArticleIdList></Reference><Reference><Citation>Bodenreider O. The unified medical language system (UMLS): integrating biomedical terminology. Nucleic Acids Res. 2004;32(suppl_1):D267&#x2013;270.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC308795</ArticleId><ArticleId IdType="pubmed">14681409</ArticleId></ArticleIdList></Reference><Reference><Citation>Aronson AR. Effective mapping of biomedical text to the UMLS Metathesaurus: the MetaMap program. Proceedings of the AMIA Symposium. 2001:17&#x2013;21.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2243666</ArticleId><ArticleId IdType="pubmed">11825149</ArticleId></ArticleIdList></Reference><Reference><Citation>Aronson A, Lang F. An overview of MetaMap: historical perspective and recent advances. J Am Med Inform Assoc. 2010;17(3):229&#x2013;236.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2995713</ArticleId><ArticleId IdType="pubmed">20442139</ArticleId></ArticleIdList></Reference><Reference><Citation>Williams CA TT, Mosley-Williams AD. Usability of a computer-assisted interview system for the unaided self-entry of patient data in an urban rheumatology clinic. J Am Med Inform Assoc. 2004;11(4):249&#x2013;259.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC436071</ArticleId><ArticleId IdType="pubmed">15064286</ArticleId></ArticleIdList></Reference><Reference><Citation>Gon&#xe7;alves RS, Tu SW, Nyulas CI, Tierney MJ, Musen MA. An ontology-driven tool for structured data acquisition using Web forms. Journal of Biomedical Semantics. 2017;8(1):26.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5540339</ArticleId><ArticleId IdType="pubmed">28764813</ArticleId></ArticleIdList></Reference><Reference><Citation>Wuerdeman L VL, Pizziferri L, Tsurikova R, Harris C, Feygin R, Epstein M, Meyers K, Wald JS, Lansky D, Bates DW. How accurate is information that patients contribute to their electronic health record? AMIA Annual Symposium Proceedings. 2005 Washington, DC.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1560697</ArticleId><ArticleId IdType="pubmed">16779157</ArticleId></ArticleIdList></Reference><Reference><Citation>Archer N, Fevrier-Thomas U, Lokker C, McKibbon KA, Straus SE. Personal health records: a scoping review. Journal of the American Medical Informatics Association: JAMIA. 2011;18(4):515&#x2013;522.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3128401</ArticleId><ArticleId IdType="pubmed">21672914</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu LS, Shih PC, Hayes GR. Barriers to the adoption and use of personal health record systems. Proceedings of the 2011 iConference; 2011; Seattle, Washington, USA.</Citation></Reference><Reference><Citation>Sheehan J, Hirschfeld S, Foster E, et al. Improving the value of clinical research through the use of Common Data Elements. Clinical Trials. 2016;13(6):671&#x2013;676.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5133155</ArticleId><ArticleId IdType="pubmed">27311638</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu Y, Denny JC, Rosenbloom ST, Miller RA, Giuse DA, Xu H. A comparative study of current clinical natural language processing systems on handling abbreviations in discharge summaries. AMIA Annual Symposium Proceedings. 2012;2012:997&#x2013;1003.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3540461</ArticleId><ArticleId IdType="pubmed">23304375</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">29920885</PMID><DateCompleted><Year>2019</Year><Month>05</Month><Day>10</Day></DateCompleted><DateRevised><Year>2021</Year><Month>03</Month><Day>10</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1399-5618</ISSN><JournalIssue CitedMedium="Internet"><Volume>20</Volume><Issue>8</Issue><PubDate><Year>2018</Year><Month>Dec</Month></PubDate></JournalIssue><Title>Bipolar disorders</Title><ISOAbbreviation>Bipolar Disord</ISOAbbreviation></Journal><ArticleTitle>Comprehensive comparison of monotherapies for psychiatric hospitalization risk in bipolar disorders.</ArticleTitle><Pagination><StartPage>761</StartPage><EndPage>771</EndPage><MedlinePgn>761-771</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1111/bdi.12665</ELocationID><Abstract><AbstractText Label="OBJECTIVES">This study compared 29 drugs for risk of psychiatric hospitalization in bipolar disorders, addressing the evidence gap on the &gt;50 drugs used by US patients for treatment.</AbstractText><AbstractText Label="METHODS">The Truven Health Analytics MarketScan<sup>&#xae;</sup> database was used to identify 190&#xa0;894 individuals with bipolar or schizoaffective disorder who filled a prescription for one of 29 drugs of interest: lithium, first- or second-generation antipsychotics, mood-stabilizing anticonvulsants, and antidepressants. Competing risks regression survival analysis was used to compare drugs for risk of psychiatric hospitalization, adjusting for patient age, sex, comorbidities, and pretreatment medications. Other competing risks were ending monotherapy and non-psychiatric hospitalization.</AbstractText><AbstractText Label="RESULTS">Three drugs were associated with significantly lower risk of psychiatric hospitalization than lithium: valproate (relative risk [RR]&#xa0;=&#xa0;0.80, P&#xa0;=&#xa0;3.20&#xa0;&#xd7;&#xa0;10<sup>-4</sup> ), aripiprazole (RR&#xa0;=&#xa0;0.80, P&#xa0;=&#xa0;3.50&#xa0;&#xd7;&#xa0;10<sup>-4</sup> ), and bupropion (RR&#xa0;=&#xa0;0.80, P&#xa0;=&#xa0;2.80&#xa0;&#xd7;&#xa0;10<sup>-4</sup> ). Eight drugs were associated with significantly higher risk of psychiatric hospitalization: haloperidol (RR&#xa0;=&#xa0;1.57, P&#xa0;=&#xa0;9.40&#xa0;&#xd7;&#xa0;10<sup>-4</sup> ), clozapine (RR&#xa0;=&#xa0;1.52, P&#xa0;=&#xa0;.017), fluoxetine (RR&#xa0;=&#xa0;1.17, P&#xa0;=&#xa0;3.70&#xa0;&#xd7;&#xa0;10<sup>-3</sup> ), sertraline (RR&#xa0;=&#xa0;1.17, P&#xa0;=&#xa0;3.20&#xa0;&#xd7;&#xa0;10<sup>-3</sup> ), citalopram (RR&#xa0;=&#xa0;1.14, P&#xa0;=&#xa0;.013), duloxetine (RR =&#xa0;1.24, P&#xa0;=&#xa0;5.10&#xa0;&#xd7;&#xa0;10<sup>-4</sup> ), venlafaxine (RR&#xa0;=&#xa0;1.33; P&#xa0;=&#xa0;1.00&#xa0;&#xd7;&#xa0;10<sup>-6</sup> ), and ziprasidone (RR&#xa0;=&#xa0;1.25; P&#xa0;=&#xa0;6.20&#xa0;&#xd7;&#xa0;10<sup>-3</sup> ).</AbstractText><AbstractText Label="CONCLUSIONS">This largest reported retrospective observational study on bipolar disorders pharmacotherapy to date demonstrates that the majority of patients end monotherapy within 2&#xa0;months after treatment start. The risk of psychiatric hospitalization varied almost two-fold across individual medications. The data add to the evidence favoring lithium and mood stabilizer use in short-term bipolar disorder management. The findings that the dopaminergic drugs aripiprazole and bupropion had better outcomes than other members of their respective classes and that antidepressant outcomes may vary by baseline mood polarity merit further investigation.</AbstractText><CopyrightInformation>&#xa9; 2018 The Authors. Bipolar Disorders Published by John Wiley &amp; Sons Ltd.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Nestsiarovich</LastName><ForeName>Anastasiya</ForeName><Initials>A</Initials><Identifier Source="ORCID">0000-0002-5558-2381</Identifier><AffiliationInfo><Affiliation>Center for Global Health, Department of Internal Medicine, University of New Mexico Health Sciences Center, Albuquerque, NM, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mazurie</LastName><ForeName>Aur&#xe9;lien J</ForeName><Initials>AJ</Initials><AffiliationInfo><Affiliation>TwoFoldChange Consulting, Bozeman, MT, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hurwitz</LastName><ForeName>Nathaniel G</ForeName><Initials>NG</Initials><AffiliationInfo><Affiliation>New Mexico Behavioral Health Institute, Las Vegas, NM, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kerner</LastName><ForeName>Berit</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Semel Institute for Neuroscience and Human Behavior, David Geffen School of Medicine, University of California, Los Angeles, CA, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Witten/Herdecke University, Witten, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Nelson</LastName><ForeName>Stuart J</ForeName><Initials>SJ</Initials><AffiliationInfo><Affiliation>University of New Mexico Health Sciences Library and Informatics Center, Albuquerque, NM, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Division of Translational Informatics, Department of Internal Medicine, University of New Mexico Health Sciences Center, Albuquerque, NM, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Crisanti</LastName><ForeName>Annette S</ForeName><Initials>AS</Initials><AffiliationInfo><Affiliation>Department of Psychiatry &amp; Behavioral Sciences, University of New Mexico Health Sciences Center, Albuquerque, NM, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tohen</LastName><ForeName>Mauricio</ForeName><Initials>M</Initials><Identifier Source="ORCID">0000-0001-8049-4351</Identifier><AffiliationInfo><Affiliation>Department of Psychiatry &amp; Behavioral Sciences, University of New Mexico Health Sciences Center, Albuquerque, NM, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Krall</LastName><ForeName>Ronald L</ForeName><Initials>RL</Initials><AffiliationInfo><Affiliation>University of Pittsburgh School of Medicine, Pittsburgh, PA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Perkins</LastName><ForeName>Douglas J</ForeName><Initials>DJ</Initials><AffiliationInfo><Affiliation>Center for Global Health, Department of Internal Medicine, University of New Mexico Health Sciences Center, Albuquerque, NM, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lambert</LastName><ForeName>Christophe G</ForeName><Initials>CG</Initials><Identifier Source="ORCID">0000-0003-1994-2893</Identifier><AffiliationInfo><Affiliation>Center for Global Health, Department of Internal Medicine, University of New Mexico Health Sciences Center, Albuquerque, NM, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Division of Translational Informatics, Department of Internal Medicine, University of New Mexico Health Sciences Center, Albuquerque, NM, USA.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><DataBankList CompleteYN="Y"><DataBank><DataBankName>ClinicalTrials.gov</DataBankName><AccessionNumberList><AccessionNumber>NCT02893371</AccessionNumber></AccessionNumberList></DataBank></DataBankList><GrantList CompleteYN="Y"><Grant><GrantID>UL1 TR001449</GrantID><Acronym>TR</Acronym><Agency>NCATS NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2018</Year><Month>06</Month><Day>19</Day></ArticleDate></Article><MedlineJournalInfo><Country>Denmark</Country><MedlineTA>Bipolar Disord</MedlineTA><NlmUniqueID>100883596</NlmUniqueID><ISSNLinking>1398-5647</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000927">Anticonvulsants</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000928">Antidepressive Agents</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D018692">Antimanic Agents</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D014150">Antipsychotic Agents</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D018020">Lithium Compounds</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000927" MajorTopicYN="N">Anticonvulsants</DescriptorName><QualifierName UI="Q000627" MajorTopicYN="Y">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000928" MajorTopicYN="N">Antidepressive Agents</DescriptorName><QualifierName UI="Q000627" MajorTopicYN="Y">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D018692" MajorTopicYN="N">Antimanic Agents</DescriptorName><QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D014150" MajorTopicYN="N">Antipsychotic Agents</DescriptorName><QualifierName UI="Q000627" MajorTopicYN="Y">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D001714" MajorTopicYN="N">Bipolar Disorder</DescriptorName><QualifierName UI="Q000188" MajorTopicYN="Y">drug therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006760" MajorTopicYN="N">Hospitalization</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018020" MajorTopicYN="N">Lithium Compounds</DescriptorName><QualifierName UI="Q000627" MajorTopicYN="Y">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011618" MajorTopicYN="N">Psychotic Disorders</DescriptorName><QualifierName UI="Q000188" MajorTopicYN="N">drug therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012189" MajorTopicYN="N">Retrospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012306" MajorTopicYN="N">Risk</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">bipolar disorder</Keyword><Keyword MajorTopicYN="N">comparative effectiveness</Keyword><Keyword MajorTopicYN="N">competing risks</Keyword><Keyword MajorTopicYN="N">drug</Keyword><Keyword MajorTopicYN="N">hospitalization</Keyword><Keyword MajorTopicYN="N">schizoaffective</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>2018</Year><Month>6</Month><Day>20</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2019</Year><Month>5</Month><Day>11</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2018</Year><Month>6</Month><Day>20</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2019</Year><Month>6</Month><Day>20</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">29920885</ArticleId><ArticleId IdType="pmc">PMC6586061</ArticleId><ArticleId IdType="doi">10.1111/bdi.12665</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Kim E, You M, Pikalov A, Van&#x2010;Tran Q, Jing Y. One&#x2010;year risk of psychiatric hospitalization and associated treatment costs in bipolar disorder treated with atypical antipsychotics: a retrospective claims database analysis. BMC Psychiatry. 2011;7:6.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3036592</ArticleId><ArticleId IdType="pubmed">21214937</ArticleId></ArticleIdList></Reference><Reference><Citation>Woo YS, Bahk W&#x2010;M, Jung Y&#x2010;E, et&#xa0;al. One&#x2010;year rehospitalization rates of patients with first&#x2010;episode bipolar mania receiving lithium or valproate and adjunctive atypical antipsychotics. Psychiatry Clin Neurosci. 2014;68:418&#x2010;424.</Citation><ArticleIdList><ArticleId IdType="pubmed">24506520</ArticleId></ArticleIdList></Reference><Reference><Citation>Kessing LV, Hellmund G, Andersen PK. An observational nationwide register based cohort study on lamotrigine versus lithium in bipolar disorder. J Psychopharmacol. 2012;26:644&#x2010;652.</Citation><ArticleIdList><ArticleId IdType="pubmed">21948935</ArticleId></ArticleIdList></Reference><Reference><Citation>Licht RW, Vestergaard P, Brodersen A. Long&#x2010;term outcome of patients with bipolar disorder commenced on lithium prophylaxis during hospitalization: a complete 15&#x2010;year register&#x2010;based follow&#x2010;up. Bipolar Disord. 2008;10:79&#x2010;86.</Citation><ArticleIdList><ArticleId IdType="pubmed">18199244</ArticleId></ArticleIdList></Reference><Reference><Citation>Spanemberg L, Massuda R, Lovato L, et&#xa0;al. Pharmacological treatment of bipolar depression: qualitative systematic review of double&#x2010;blind randomized clinical trials. Psychiatr Q. 2012;83:161&#x2010;175.</Citation><ArticleIdList><ArticleId IdType="pubmed">21927937</ArticleId></ArticleIdList></Reference><Reference><Citation>Miura T, Noma H, Furukawa TA, et&#xa0;al. Comparative efficacy and tolerability of pharmacological treatments in the maintenance treatment of bipolar disorder: a systematic review and network meta&#x2010;analysis. Lancet Psychiatry. 2014;1:351&#x2010;359.</Citation><ArticleIdList><ArticleId IdType="pubmed">26360999</ArticleId></ArticleIdList></Reference><Reference><Citation>Quint JB. Health research data for the real world: the MarketScan databases. Ann Arbor, MI: Truven Health Analytics; 2015.</Citation></Reference><Reference><Citation>Voss EA, Makadia R, Matcho A, et&#xa0;al. Feasibility and utility of applications of the common data model to multiple, disparate observational health databases. J Am Med Inform Assoc. 2015;22:553&#x2010;564.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4457111</ArticleId><ArticleId IdType="pubmed">25670757</ArticleId></ArticleIdList></Reference><Reference><Citation>Fine JP, Gray RJ. A proportional hazards model for the subdistribution of a competing risk. J Am Stat Assoc. 1999;94:496&#x2010;509.</Citation></Reference><Reference><Citation>van Walraven C, McAlister FA. Competing risk bias was common in Kaplan&#x2010;Meier risk estimates published in prominent medical journals. J Clin Epidemiol. 2016;69:e8.</Citation><ArticleIdList><ArticleId IdType="pubmed">26232083</ArticleId></ArticleIdList></Reference><Reference><Citation>Lambert CG, Mazurie AJ, Lauve NR, et&#xa0;al. Hypothyroidism risk compared among nine common bipolar disorder therapies in a large US cohort. Bipolar Disord. 2016;18:247&#x2010;260.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5089566</ArticleId><ArticleId IdType="pubmed">27226264</ArticleId></ArticleIdList></Reference><Reference><Citation>Guo JJ, Keck PE Jr, Li H, Jang R, Kelton CML. Treatment costs and health care utilization for patients with bipolar disorder in a large managed care population. Value Health. 2008;11:416&#x2010;423.</Citation><ArticleIdList><ArticleId IdType="pubmed">18179673</ArticleId></ArticleIdList></Reference><Reference><Citation>Bauer MS, Miller CJ, Li M, Bajor LA, Lee A. A population&#x2010;based study of the comparative effectiveness of second&#x2010;generation antipsychotics vs older antimanic agents in bipolar disorder. Bipolar Disord. 2016;18:481&#x2010;489.</Citation><ArticleIdList><ArticleId IdType="pubmed">27650468</ArticleId></ArticleIdList></Reference><Reference><Citation>Joas E, Karanti A, Song J, Goodwin GM, Lichtenstein P, Land&#xe9;n M. Pharmacological treatment and risk of psychiatric hospital admission in bipolar disorder. Br J Psychiatry. 2017;210:197&#x2010;202.</Citation><ArticleIdList><ArticleId IdType="pubmed">28104736</ArticleId></ArticleIdList></Reference><Reference><Citation>Li X&#x2010;B, Tang Y&#x2010;L, Wang C&#x2010;Y, de Leon J. Clozapine for treatment&#x2010;resistant bipolar disorder: a systematic review. Bipolar Disord. 2015;17:235&#x2010;247.</Citation><ArticleIdList><ArticleId IdType="pubmed">25346322</ArticleId></ArticleIdList></Reference><Reference><Citation>Bowden CL, Calabrese JR, McElroy SL, et&#xa0;al. A randomized, placebo&#x2010;controlled 12&#x2010;month trial of divalproex and lithium in treatment of outpatients with bipolar I disorder. Divalproex Maintenance Study Group. Arch Gen Psychiatry. 2000;57:481&#x2010;489.</Citation><ArticleIdList><ArticleId IdType="pubmed">10807488</ArticleId></ArticleIdList></Reference><Reference><Citation>Lin C&#x2010;H, Huang C&#x2010;W, Chen C&#x2010;C, Hsu Y&#x2010;F, Chang W&#x2010;H, Lane H&#x2010;Y. Time to rehospitalization in patients with bipolar I disorder on lithium or valproate with adjunctive antipsychotics. Psychopharmacology. 2008;200:301&#x2010;303.</Citation><ArticleIdList><ArticleId IdType="pubmed">18566801</ArticleId></ArticleIdList></Reference><Reference><Citation>BALANCE investigators and collaborators ; Geddes JR, Goodwin GM, Rendell J, et&#xa0;al. Lithium plus valproate combination therapy versus monotherapy for relapse prevention in bipolar I disorder (BALANCE): a randomised open&#x2010;label trial. Lancet. 2010;375:385&#x2010;395.</Citation><ArticleIdList><ArticleId IdType="pubmed">20092882</ArticleId></ArticleIdList></Reference><Reference><Citation>Bowden CL, Mosolov S, Hranov L, et&#xa0;al. Efficacy of valproate versus lithium in mania or mixed mania: a randomized, open 12&#x2010;week trial. Int Clin Psychopharmacol. 2010;25:60&#x2010;67.</Citation><ArticleIdList><ArticleId IdType="pubmed">20101186</ArticleId></ArticleIdList></Reference><Reference><Citation>Jing Y, Johnston SS, Fowler R, Bates JA, Forbes RA, Hebden T. Comparison of second&#x2010;generation antipsychotic treatment on psychiatric hospitalization in Medicaid beneficiaries with bipolar disorder. J Med Econ. 2011;14:777&#x2010;786.</Citation><ArticleIdList><ArticleId IdType="pubmed">21954966</ArticleId></ArticleIdList></Reference><Reference><Citation>Bergeson JG, Kalsekar I, Jing Y, You M, Forbes RA, Hebden T. Medical care costs and hospitalization in patients with bipolar disorder treated with atypical antipsychotics. Am Health Drug Benefits. 2012;5:379&#x2010;386.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4031693</ArticleId><ArticleId IdType="pubmed">24991334</ArticleId></ArticleIdList></Reference><Reference><Citation>Buoli M, Serati M, Altamura AC. Is the combination of a mood stabilizer plus an antipsychotic more effective than mono&#x2010;therapies in long&#x2010;term treatment of bipolar disorder? A systematic review J Affect Disord. 2014;152&#x2013;154:12&#x2010;18.</Citation><ArticleIdList><ArticleId IdType="pubmed">24041717</ArticleId></ArticleIdList></Reference><Reference><Citation>Stahl SM, Pradko JF, Haight BR, Modell JG, Rockett CB, Learned&#x2010;Coughlin S. A review of the neuropharmacology of bupropion, a dual norepinephrine and dopamine reuptake inhibitor. Prim Care Companion J Clin Psychiatry. 2004;6:159&#x2010;166.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC514842</ArticleId><ArticleId IdType="pubmed">15361919</ArticleId></ArticleIdList></Reference><Reference><Citation>Patel K, Allen S, Haque MN, Angelescu I, Baumeister D, Tracy DK. Bupropion: a systematic review and meta&#x2010;analysis of effectiveness as an antidepressant. Ther Adv Psychopharmacol. 2016;6:99&#x2010;144.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4837968</ArticleId><ArticleId IdType="pubmed">27141292</ArticleId></ArticleIdList></Reference><Reference><Citation>Li D&#x2010;J, Tseng P&#x2010;T, Chen Y&#x2010;W, Wu C&#x2010;K, Lin P&#x2010;Y. Significant treatment effect of bupropion in patients with bipolar disorder but Similar phase&#x2010;shifting rate as other antidepressants: a meta&#x2010;analysis following the PRISMA guidelines. Medicine. 2016;95:e3165.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4998539</ArticleId><ArticleId IdType="pubmed">27043678</ArticleId></ArticleIdList></Reference><Reference><Citation>Leverich GS, Altshuler LL, Frye MA, et&#xa0;al. Risk of switch in mood polarity to hypomania or mania in patients with bipolar depression during acute and continuation trials of venlafaxine, sertraline, and bupropion as adjuncts to mood stabilizers. Am J Psychiatry. 2006;163:232&#x2010;239.</Citation><ArticleIdList><ArticleId IdType="pubmed">16449476</ArticleId></ArticleIdList></Reference><Reference><Citation>Truman CJ, Goldberg JF, Ghaemi SN, et&#xa0;al. Self&#x2010;reported history of manic/hypomanic switch associated with antidepressant use: data from the Systematic Treatment Enhancement Program for Bipolar Disorder (STEP&#x2010;BD). J Clin Psychiatry. 2007;68:1472&#x2010;1479.</Citation><ArticleIdList><ArticleId IdType="pubmed">17960960</ArticleId></ArticleIdList></Reference><Reference><Citation>Cressman AM, Macdonald EM, Huang A, et&#xa0;al. Prescription stimulant use and hospitalization for psychosis or mania: a population&#x2010;based study. J Clin Psychopharmacol. 2015;35:667&#x2010;671.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4898903</ArticleId><ArticleId IdType="pubmed">26485338</ArticleId></ArticleIdList></Reference><Reference><Citation>Patel NC, Crismon ML, Pondrom M. Rehospitalization rates of patients with bipolar disorder discharged on a mood stabilizer versus a mood stabilizer plus an atypical or typical antipsychotic. J Behav Health Serv Res. 2005;32:438&#x2010;445.</Citation><ArticleIdList><ArticleId IdType="pubmed">16215452</ArticleId></ArticleIdList></Reference><Reference><Citation>Lang K, Korn J, Muser E, Choi JC, Abouzaid S, Menzin J. Predictors of medication nonadherence and hospitalization in Medicaid patients with bipolar I disorder given long&#x2010;acting or oral antipsychotics. J Med Econ. 2011;14:217&#x2010;226.</Citation><ArticleIdList><ArticleId IdType="pubmed">21370989</ArticleId></ArticleIdList></Reference><Reference><Citation>Hochman E, Krivoy A, Schaffer A, Weizman A, Valevski A. Antipsychotic adjunctive therapy to mood stabilizers and 1&#x2010;year rehospitalization rates in bipolar disorder: a cohort study. Bipolar Disord. 2016;18:684&#x2010;691.</Citation><ArticleIdList><ArticleId IdType="pubmed">27933713</ArticleId></ArticleIdList></Reference><Reference><Citation>Hamilton JE, Passos IC, de Azevedo CT, et&#xa0;al. Predictors of psychiatric readmission among patients with bipolar disorder at an academic safety&#x2010;net hospital. Aust N Z J Psychiatry. 2016;50:584&#x2010;593.</Citation><ArticleIdList><ArticleId IdType="pubmed">26377747</ArticleId></ArticleIdList></Reference><Reference><Citation>Shim IH, Woo YS, Wang H&#x2010;R, Bahk W&#x2010;M. Predictors of a shorter time to hospitalization in patients with bipolar disorder: medication during the acute and maintenance phases and other clinical factors. Clin Psychopharmacol Neurosci. 2017;15:248&#x2010;255.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5565086</ArticleId><ArticleId IdType="pubmed">28783934</ArticleId></ArticleIdList></Reference><Reference><Citation>Dickerson F, Severance E, Yolken R. The microbiome, immunity, and schizophrenia and bipolar disorder. Brain Behav Immun. 2017;62:46&#x2010;52.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5503102</ArticleId><ArticleId IdType="pubmed">28003152</ArticleId></ArticleIdList></Reference><Reference><Citation>Fornaro M, Anastasia A, Novello S, et&#xa0;al. Incidence, prevalence and clinical correlates of antidepressant&#x2010;emergent mania in bipolar depression: a systematic review and meta&#x2010;analysis. Bipolar Disord. 2018;20:195&#x2010;227. 10.1111/bdi.12612</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/bdi.12612</ArticleId><ArticleId IdType="pubmed">29441650</ArticleId></ArticleIdList></Reference><Reference><Citation>Malhi GS, Gessler D, Outhred T. The use of lithium for the treatment of bipolar disorder: recommendations from clinical practice guidelines. J Affect Disord. 2017;1:266&#x2010;280.</Citation><ArticleIdList><ArticleId IdType="pubmed">28437764</ArticleId></ArticleIdList></Reference><Reference><Citation>Weinstock LM, Gaudiano BA, Epstein&#x2010;Lubow G, Tezanos K, Celis&#x2010;Dehoyos CE, Miller IW. Medication burden in bipolar disorder: a chart review of patients at psychiatric hospital admission. Psychiatry Res. 2014;216:24&#x2010;30.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3968952</ArticleId><ArticleId IdType="pubmed">24534121</ArticleId></ArticleIdList></Reference><Reference><Citation>Golden JC, Goethe JW, Woolley SB. Complex psychotropic polypharmacy in bipolar disorder across varying mood polarities: a prospective cohort study of 2712 inpatients. J Affect Disord. 2017;15:6&#x2010;10.</Citation><ArticleIdList><ArticleId IdType="pubmed">28628769</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">29938883</PMID><DateCompleted><Year>2019</Year><Month>04</Month><Day>15</Day></DateCompleted><DateRevised><Year>2024</Year><Month>09</Month><Day>22</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1463-1326</ISSN><JournalIssue CitedMedium="Internet"><Volume>20</Volume><Issue>11</Issue><PubDate><Year>2018</Year><Month>Nov</Month></PubDate></JournalIssue><Title>Diabetes, obesity &amp; metabolism</Title><ISOAbbreviation>Diabetes Obes Metab</ISOAbbreviation></Journal><ArticleTitle>Comparative effectiveness of canagliflozin, SGLT2 inhibitors and non-SGLT2 inhibitors on the risk of hospitalization for heart failure and amputation in patients with type 2 diabetes mellitus: A real-world meta-analysis of 4 observational databases (OBSERVE-4D).</ArticleTitle><Pagination><StartPage>2585</StartPage><EndPage>2597</EndPage><MedlinePgn>2585-2597</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1111/dom.13424</ELocationID><Abstract><AbstractText Label="AIMS">Sodium glucose co-transporter 2 inhibitors (SGLT2i) are indicated for treatment of type 2 diabetes mellitus (T2DM); some SGLT2i have reported cardiovascular benefit, and some have reported risk of below-knee lower extremity (BKLE) amputation. This study examined the real-world comparative effectiveness within the SGLT2i class and compared with non-SGLT2i antihyperglycaemic agents.</AbstractText><AbstractText Label="MATERIALS AND METHODS">Data from 4 large US administrative claims databases were used to characterize risk and provide population-level estimates of canagliflozin's effects on hospitalization for heart failure (HHF) and BKLE amputation vs other SGLT2i and non-SGLT2i in T2DM patients. Comparative analyses using a propensity score-adjusted new-user cohort design examined relative hazards of outcomes across all new users and a subpopulation with established cardiovascular disease.</AbstractText><AbstractText Label="RESULTS">Across the 4 databases (142&#x2009;800 new users of canagliflozin, 110&#x2009;897 new users of other SGLT2i, 460&#x2009;885 new users of non-SGLT2i), the meta-analytic hazard ratio estimate for HHF with canagliflozin vs non-SGLT2i was 0.39 (95% CI, 0.26-0.60) in the on-treatment analysis. The estimate for BKLE amputation with canagliflozin vs non-SGLT2i was 0.75 (95% CI, 0.40-1.41) in the on-treatment analysis and 1.01 (95% CI, 0.93-1.10) in the intent-to-treat analysis. Effects in the subpopulation with established cardiovascular disease were similar for both outcomes. No consistent differences were observed between canagliflozin and other SGLT2i.</AbstractText><AbstractText Label="CONCLUSIONS">In this large comprehensive analysis, canagliflozin and other SGLT2i demonstrated HHF benefits consistent with clinical trial data, but showed no increased risk of BKLE amputation vs non-SGLT2i. HHF and BKLE amputation results were similar in the subpopulation with established cardiovascular disease. This study helps further characterize the potential benefits and harms of SGLT2i in routine clinical practice to complement evidence from clinical trials and prior observational studies.</AbstractText><CopyrightInformation>&#xa9; 2018 The Authors. Diabetes, Obesity and Metabolism published by John Wiley &amp; Sons Ltd.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Ryan</LastName><ForeName>Patrick B</ForeName><Initials>PB</Initials><Identifier Source="ORCID">0000-0002-9727-2138</Identifier><AffiliationInfo><Affiliation>Janssen Research &amp; Development, LLC, Titusville, New Jersey.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Buse</LastName><ForeName>John B</ForeName><Initials>JB</Initials><Identifier Source="ORCID">0000-0002-9723-3876</Identifier><AffiliationInfo><Affiliation>University of North Carolina School of Medicine, Department of Medicine, Chapel Hill, North Carolina.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Schuemie</LastName><ForeName>Martijn J</ForeName><Initials>MJ</Initials><Identifier Source="ORCID">0000-0002-0817-5361</Identifier><AffiliationInfo><Affiliation>Janssen Research &amp; Development, LLC, Titusville, New Jersey.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>DeFalco</LastName><ForeName>Frank</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Janssen Research &amp; Development, LLC, Raritan, New Jersey.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yuan</LastName><ForeName>Zhong</ForeName><Initials>Z</Initials><Identifier Source="ORCID">0000-0002-5824-2040</Identifier><AffiliationInfo><Affiliation>Janssen Research &amp; Development, LLC, Titusville, New Jersey.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Stang</LastName><ForeName>Paul E</ForeName><Initials>PE</Initials><Identifier Source="ORCID">0000-0002-9528-9657</Identifier><AffiliationInfo><Affiliation>Janssen Research &amp; Development, LLC, Titusville, New Jersey.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Berlin</LastName><ForeName>Jesse A</ForeName><Initials>JA</Initials><Identifier Source="ORCID">0000-0002-9810-745X</Identifier><AffiliationInfo><Affiliation>Johnson &amp; Johnson, Titusville, New Jersey.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rosenthal</LastName><ForeName>Norman</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Janssen Research &amp; Development, LLC, Raritan, New Jersey.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>UL1 TR002489</GrantID><Acronym>TR</Acronym><Agency>NCATS NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D003160">Comparative Study</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D017418">Meta-Analysis</PublicationType><PublicationType UI="D052061">Research Support, N.I.H., Extramural</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2018</Year><Month>06</Month><Day>25</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Diabetes Obes Metab</MedlineTA><NlmUniqueID>100883645</NlmUniqueID><ISSNLinking>1462-8902</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000077203">Sodium-Glucose Transporter 2 Inhibitors</NameOfSubstance></Chemical><Chemical><RegistryNumber>0SAC974Z85</RegistryNumber><NameOfSubstance UI="D000068896">Canagliflozin</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><CommentsCorrectionsList><CommentsCorrections RefType="CommentIn"><RefSource>Diabetes Obes Metab. 2019 Feb;21(2):444-445. doi: 10.1111/dom.13509.</RefSource><PMID Version="1">30136414</PMID></CommentsCorrections></CommentsCorrectionsList><MeshHeadingList><MeshHeading><DescriptorName UI="D000293" MajorTopicYN="N">Adolescent</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000369" MajorTopicYN="N">Aged, 80 and over</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000671" MajorTopicYN="N">Amputation, Surgical</DescriptorName><QualifierName UI="Q000706" MajorTopicYN="Y">statistics &amp; numerical data</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000068896" MajorTopicYN="N">Canagliflozin</DescriptorName><QualifierName UI="Q000627" MajorTopicYN="Y">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D019992" MajorTopicYN="N">Databases as Topic</DescriptorName><QualifierName UI="Q000706" MajorTopicYN="N">statistics &amp; numerical data</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D003924" MajorTopicYN="Y">Diabetes Mellitus, Type 2</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName><QualifierName UI="Q000188" MajorTopicYN="N">drug therapy</QualifierName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D003925" MajorTopicYN="N">Diabetic Angiopathies</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000517" MajorTopicYN="N">prevention &amp; control</QualifierName><QualifierName UI="Q000628" MajorTopicYN="N">therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D017719" MajorTopicYN="N">Diabetic Foot</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName><QualifierName UI="Q000517" MajorTopicYN="N">prevention &amp; control</QualifierName><QualifierName UI="Q000601" MajorTopicYN="N">surgery</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006333" MajorTopicYN="Y">Heart Failure</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName><QualifierName UI="Q000517" MajorTopicYN="N">prevention &amp; control</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006760" MajorTopicYN="N">Hospitalization</DescriptorName><QualifierName UI="Q000706" MajorTopicYN="Y">statistics &amp; numerical data</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D064887" MajorTopicYN="N">Observational Studies as Topic</DescriptorName><QualifierName UI="Q000706" MajorTopicYN="N">statistics &amp; numerical data</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012189" MajorTopicYN="N">Retrospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012307" MajorTopicYN="N">Risk Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000077203" MajorTopicYN="N">Sodium-Glucose Transporter 2 Inhibitors</DescriptorName><QualifierName UI="Q000627" MajorTopicYN="Y">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016896" MajorTopicYN="N">Treatment Outcome</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D055815" MajorTopicYN="N">Young Adult</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">SGLT2 inhibitor</Keyword><Keyword MajorTopicYN="N">type 2 diabetes</Keyword></KeywordList><CoiStatement>Canagliflozin was developed by Janssen Research &amp; Development, LLC, in collaboration with Mitsubishi Tanabe Pharma Corporation. P. B. R., M. J. S., F. D., Z. Y., P. E. S. and N. R. are full&#x2010;time employees of Janssen Research &amp; Development, LLC. J. A. B. is a full&#x2010;time employee of Johnson &amp; Johnson, LLC. J. B. B. has received contracted consulting fees, paid to his institution, and travel support from Adocia, AstraZeneca, Dexcom, Elcelyx Therapeutics, Eli Lilly, Intarcia Therapeutics, Lexicon, Metavention, NovaTarg, Novo Nordisk, Sanofi, Senseonics and vTv Therapeutics; has received grant support from AstraZeneca, Boehringer Ingelheim, Johnson &amp; Johnson, Lexicon, Novo Nordisk, Sanofi, Theracos and vTv Therapeutics; holds stock options in Mellitus Health and PhaseBio; has served on the board of the AstraZeneca HealthCare Foundation; and is supported by a grant from the National Institutes of Health (UL1TR002489).</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2018</Year><Month>5</Month><Day>3</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2018</Year><Month>6</Month><Day>1</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2018</Year><Month>6</Month><Day>12</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2018</Year><Month>6</Month><Day>26</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2019</Year><Month>4</Month><Day>16</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2018</Year><Month>6</Month><Day>26</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2018</Year><Month>11</Month><Day>7</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">29938883</ArticleId><ArticleId IdType="pmc">PMC6220807</ArticleId><ArticleId IdType="doi">10.1111/dom.13424</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Neal B, Perkovic V, Mahaffey KW, et al. Canagliflozin and cardiovascular and renal events in type 2 diabetes. N Engl J Med. 2017;377:644&#x2010;657.</Citation><ArticleIdList><ArticleId IdType="pubmed">28605608</ArticleId></ArticleIdList></Reference><Reference><Citation>
Neal B, Perkovic V, Mahaffey KW, de Zeeuw D, Fulcher G, Matthews DR. The Integrated Results of the CANVAS Program. Presented at: The 77th Scientific Sessions of the American Diabetes Association (ADA); June 12, 2017; San Diego, CA. https://professional.diabetes.org/sites/professional.diabetes.org/files/media/2017_press_program_ppt_neal-final.pdf. Accessed December 5, 2017.</Citation></Reference><Reference><Citation>Zinman B, Wanner C, Lachin JM, et al. Empagliflozin, cardiovascular outcomes, and mortality in type 2 diabetes. N Engl J Med. 2015;373:2117&#x2010;2128.</Citation><ArticleIdList><ArticleId IdType="pubmed">26378978</ArticleId></ArticleIdList></Reference><Reference><Citation>Inzucchi SE, Iliev H, Pfarr E, Zinman B. Empagliflozin and assessment of lower&#x2010;limb amputations in the EMPA&#x2010;REG OUTCOME trial. Diabetes Care. 2018;41:e4&#x2010;e5.</Citation><ArticleIdList><ArticleId IdType="pubmed">29133344</ArticleId></ArticleIdList></Reference><Reference><Citation>Kosiborod M, Cavender MA, Fu AZ, et al. Lower risk of heart failure and death in patients initiated on SGLT&#x2010;2 inhibitors versus other glucose&#x2010;lowering drugs: the CVD&#x2010;REAL Study. Circulation. 2017;136:249&#x2010;259.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5515629</ArticleId><ArticleId IdType="pubmed">28522450</ArticleId></ArticleIdList></Reference><Reference><Citation>Patorno E, Goldfine AB, Schneeweiss S, et al. Cardiovascular outcomes associated with canagliflozin versus other non&#x2010;gliflozin antidiabetic drugs: population based cohort study. BMJ. 2018;360:k119.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5799855</ArticleId><ArticleId IdType="pubmed">29437648</ArticleId></ArticleIdList></Reference><Reference><Citation>Yuan Z, Defalco FJ, Ryan PB, et al. Risk of lower extremity amputations in patients with type 2 diabetes mellitus treated with SGLT2 inhibitors in the United States: a retrospective cohort study. Diabetes Obes Metab. 2018;20:582&#x2010;589.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5836890</ArticleId><ArticleId IdType="pubmed">28898514</ArticleId></ArticleIdList></Reference><Reference><Citation>Udell JA, Yuan Z, Rush T, Sicignano NM, Galitz M, Rosenthal N. Cardiovascular outcomes and risks after initiation of a sodium glucose co&#x2010;transporter 2 inhibitor: results from the EASEL population&#x2010;based cohort study. Circulation. 2017;137:1450&#x2010;1459.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5895161</ArticleId><ArticleId IdType="pubmed">29133607</ArticleId></ArticleIdList></Reference><Reference><Citation>Schuemie MJ, Ryan PB, DuMouchel W, Suchard MA, Madigan D. Interpreting observational studies: why empirical calibration is needed to correct p&#x2010;values. Stat Med. 2014;33:209&#x2010;218.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4285234</ArticleId><ArticleId IdType="pubmed">23900808</ArticleId></ArticleIdList></Reference><Reference><Citation>Ryan PB, Schuemie MJ, Welebob E, Duke J, Valentine S, Hartzema AG. Defining a reference set to support methodological research in drug safety. Drug Saf. 2013;36(suppl 1):S33&#x2010;S47.</Citation><ArticleIdList><ArticleId IdType="pubmed">24166222</ArticleId></ArticleIdList></Reference><Reference><Citation>Suchard MA, Simpson SE, Zorych I, Ryan P, Madigan D. Massive parallelization of serial inference algorithms for a complex generalized linear model. ACM Trans Model Comput Simul. 2013;23:1&#x2010;17. 10.1145/2414416.2414791.</Citation><ArticleIdList><ArticleId IdType="doi">10.1145/2414416.2414791</ArticleId><ArticleId IdType="pmc">PMC4201181</ArticleId><ArticleId IdType="pubmed">25328363</ArticleId></ArticleIdList></Reference><Reference><Citation>Mittal S, Madigan D, Burd RS, Suchard MA. High&#x2010;dimensional, massive sample&#x2010;size cox proportional hazards regression for survival analysis. Biostatistics. 2014;15:207&#x2010;221.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3944969</ArticleId><ArticleId IdType="pubmed">24096388</ArticleId></ArticleIdList></Reference><Reference><Citation>IntHout J, Ioannidis JP, Borm GF. The Hartung&#x2010;Knapp&#x2010;Sidik&#x2010;Jonkman method for random effects meta&#x2010;analysis is straightforward and considerably outperforms the standard DerSimonian&#x2010;Laird method. BMC Med Res Methodol. 2014;14:25.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4015721</ArticleId><ArticleId IdType="pubmed">24548571</ArticleId></ArticleIdList></Reference><Reference><Citation>Council for International Organizations for Medical Sciences (CIOMS)Evidence Synthesis and Meta&#x2010;Analysis for Drug Safety: Report of CIOMS Working Group X. Geneva, Switzerland: CIOMS; 2016.</Citation></Reference><Reference><Citation>Higgins JP, Thompson SG, Deeks JJ, Altman DG. Measuring inconsistency in meta&#x2010;analyses. BMJ. 2003;327:557&#x2010;560.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC192859</ArticleId><ArticleId IdType="pubmed">12958120</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">29939268</PMID><DateCompleted><Year>2019</Year><Month>06</Month><Day>10</Day></DateCompleted><DateRevised><Year>2019</Year><Month>12</Month><Day>10</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1464-3685</ISSN><JournalIssue CitedMedium="Internet"><Volume>47</Volume><Issue>6</Issue><PubDate><Year>2018</Year><Month>Dec</Month><Day>01</Day></PubDate></JournalIssue><Title>International journal of epidemiology</Title><ISOAbbreviation>Int J Epidemiol</ISOAbbreviation></Journal><ArticleTitle>Evaluating large-scale propensity score performance through real-world and synthetic data experiments.</ArticleTitle><Pagination><StartPage>2005</StartPage><EndPage>2014</EndPage><MedlinePgn>2005-2014</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1093/ije/dyy120</ELocationID><Abstract><AbstractText Label="BACKGROUND">Propensity score adjustment is a popular approach for confounding control in observational studies. Reliable frameworks are needed to determine relative propensity score performance in large-scale studies, and to establish optimal propensity score model selection methods.</AbstractText><AbstractText Label="METHODS">We detail a propensity score evaluation framework that includes synthetic and real-world data experiments. Our synthetic experimental design extends the 'plasmode' framework and simulates survival data under known effect sizes, and our real-world experiments use a set of negative control outcomes with presumed null effect sizes. In reproductions of two published cohort studies, we compare two propensity score estimation methods that contrast in their model selection approach: L1-regularized regression that conducts a penalized likelihood regression, and the 'high-dimensional propensity score' (hdPS) that employs a univariate covariate screen. We evaluate methods on a range of outcome-dependent and outcome-independent metrics.</AbstractText><AbstractText Label="RESULTS">L1-regularization propensity score methods achieve superior model fit, covariate balance and negative control bias reduction compared with the hdPS. Simulation results are mixed and fluctuate with simulation parameters, revealing a limitation of simulation under the proportional hazards framework. Including regularization with the hdPS reduces commonly reported non-convergence issues but has little effect on propensity score performance.</AbstractText><AbstractText Label="CONCLUSIONS">L1-regularization incorporates all covariates simultaneously into the propensity score model and offers propensity score performance superior to the hdPS marginal screen.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Tian</LastName><ForeName>Yuxi</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Department of Biomathematics, David Geffen School of Medicine at UCLA, University of California, Los Angeles, CA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Schuemie</LastName><ForeName>Martijn J</ForeName><Initials>MJ</Initials><AffiliationInfo><Affiliation>Epidemiology Department, Janssen Research and Development LLC, Titusville, NJ, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Suchard</LastName><ForeName>Marc A</ForeName><Initials>MA</Initials><AffiliationInfo><Affiliation>Department of Biomathematics, David Geffen School of Medicine at UCLA, University of California, Los Angeles, CA, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Biostatistics, UCLA Fielding School of Public Health, University of California, Los Angeles, CA, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Human Genetics, David Geffen School of Medicine at UCLA, University of California, Los Angeles, CA, USA.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>F31 LM012636</GrantID><Acronym>LM</Acronym><Agency>NLM NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D052061">Research Support, N.I.H., Extramural</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType><PublicationType UI="D013486">Research Support, U.S. Gov't, Non-P.H.S.</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Int J Epidemiol</MedlineTA><NlmUniqueID>7802871</NlmUniqueID><ISSNLinking>0300-5771</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000465" MajorTopicYN="N">Algorithms</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015982" MajorTopicYN="N">Bias</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015986" MajorTopicYN="N">Confounding Factors, Epidemiologic</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016015" MajorTopicYN="N">Logistic Models</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D064887" MajorTopicYN="Y">Observational Studies as Topic</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName><QualifierName UI="Q000592" MajorTopicYN="N">standards</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D057216" MajorTopicYN="Y">Propensity Score</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012107" MajorTopicYN="Y">Research Design</DescriptorName><QualifierName UI="Q000592" MajorTopicYN="N">standards</QualifierName><QualifierName UI="Q000706" MajorTopicYN="N">statistics &amp; numerical data</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D018401" MajorTopicYN="N">Sample Size</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="accepted"><Year>2018</Year><Month>5</Month><Day>24</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2018</Year><Month>6</Month><Day>26</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2019</Year><Month>6</Month><Day>14</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2018</Year><Month>6</Month><Day>26</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2019</Year><Month>12</Month><Day>1</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">29939268</ArticleId><ArticleId IdType="pmc">PMC6280944</ArticleId><ArticleId IdType="doi">10.1093/ije/dyy120</ArticleId><ArticleId IdType="pii">5043131</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Hripcsak G, Ryan PB, Duke JD. et al. Characterizing treatment pathways at scale using the OHDSI network. Proc Natl Acad Sci USA 2016;113:7329&#x2013;36.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4941483</ArticleId><ArticleId IdType="pubmed">27274072</ArticleId></ArticleIdList></Reference><Reference><Citation>Brookhart MA, St&#xfc;rmer T, Glynn RJ, Rassen J, Schneeweiss S.. Confounding control in healthcare database research: challenges and potential approaches. Med Care 2010;48:S114&#x2013;20.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4024462</ArticleId><ArticleId IdType="pubmed">20473199</ArticleId></ArticleIdList></Reference><Reference><Citation>Ryan PB, Madigan D, Stang PE, Marc Overhage J, Racoosin JA, Hartzema AG.. Empirical assessment of methods for risk identification in healthcare data: results from the experiments of the Observational Medical Outcomes Partnership. Stat Med 2012;31:4401&#x2013;15.</Citation><ArticleIdList><ArticleId IdType="pubmed">23015364</ArticleId></ArticleIdList></Reference><Reference><Citation>Rubin DB. Estimating causal effects from large data sets using propensity scores. Ann Intern Med 1997;127:757&#x2013;63.</Citation><ArticleIdList><ArticleId IdType="pubmed">9382394</ArticleId></ArticleIdList></Reference><Reference><Citation>Rosenbaum PR, Rubin DB.. The central role of the propensity score in observational studies for causal effects. Biometrika 1983;70:41&#x2013;55.</Citation></Reference><Reference><Citation>Austin PC. An introduction to propensity score methods for reducing the effects of confounding in observational studies. Multivar Behav Res 2011;46:399&#x2013;424.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3144483</ArticleId><ArticleId IdType="pubmed">21818162</ArticleId></ArticleIdList></Reference><Reference><Citation>Imbens GW, Rubin DB.. Causal Inference in Statistics, Social, and Biomedical Sciences. Cambridge, UK: Cambridge University Press, 2015.</Citation></Reference><Reference><Citation>Rubin DB, Thomas N.. Matching using estimated propensity scores: relating theory to practice. Biometrics 1996;52:249&#x2013;64.</Citation><ArticleIdList><ArticleId IdType="pubmed">8934595</ArticleId></ArticleIdList></Reference><Reference><Citation>Franklin JM, Eddings W, Austin PC, Stuart EA, Schneeweiss S.. Comparing the performance of propensity score methods in healthcare database studies with rare outcomes. Stat Med 2017;36:1946&#x2013;63.</Citation><ArticleIdList><ArticleId IdType="pubmed">28208229</ArticleId></ArticleIdList></Reference><Reference><Citation>Austin PC. The performance of different propensity score methods for estimating marginal hazard ratios. Stat Med 2013;32:2837&#x2013;49.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3747460</ArticleId><ArticleId IdType="pubmed">23239115</ArticleId></ArticleIdList></Reference><Reference><Citation>Schneeweiss S, Eddings W, Glynn RJ, Patorno E, Rassen J, Franklin JM.. Variable selection for confounding adjustment in high-dimensional covariate spaces when analyzing healthcare databases. Epidemiology 2017;28:237&#x2013;48.</Citation><ArticleIdList><ArticleId IdType="pubmed">27779497</ArticleId></ArticleIdList></Reference><Reference><Citation>Franklin JM, Eddings W, Glynn RJ, Schneeweiss S.. Regularized regression versus the high-dimensional propensity score for confounding adjustment in secondary database analyses. Am J Epidemiol 2015;182:651&#x2013;59.</Citation><ArticleIdList><ArticleId IdType="pubmed">26233956</ArticleId></ArticleIdList></Reference><Reference><Citation>
King G, Nielsen R. Why Propensity Scores Should not be Used for Matching. Working Paper, 2015.  Available from http://j.mp/2ovYGsW</Citation></Reference><Reference><Citation>Greenland S, Mansournia MA, Altman DG.. Sparse data bias: a problem hiding in plain sight. BMJ 2016;352:i1981..</Citation><ArticleIdList><ArticleId IdType="pubmed">27121591</ArticleId></ArticleIdList></Reference><Reference><Citation>Schneeweiss S, Rassen JA, Glynn RJ, Avorn J, Mogun H, Brookhart MA.. High-dimensional propensity score adjustment in studies of treatment effects using health care claims data. Epidemiology 2009;20:512&#x2013;22.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3077219</ArticleId><ArticleId IdType="pubmed">19487948</ArticleId></ArticleIdList></Reference><Reference><Citation>Rassen JA, Glynn RJ, Brookhart MA, Schneeweiss S.. Covariate selection in high-dimensional propensity score analyses of treatment effects in small samples. Am J Epidemiol 2011;173:1404&#x2013;13.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3145392</ArticleId><ArticleId IdType="pubmed">21602301</ArticleId></ArticleIdList></Reference><Reference><Citation>Imai K, Ratkovic M.. Covariate balancing propensity score. J R Stat Soc B 2014;76:243&#x2013;63.</Citation></Reference><Reference><Citation>Shortreed SM, Ertefaie A.. Outcome-adaptive lasso: variable selection for causal inference. Biometrics 2017;73:1111&#x2013;22.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5591052</ArticleId><ArticleId IdType="pubmed">28273693</ArticleId></ArticleIdList></Reference><Reference><Citation>Mansournia MA, Geroldinger A, Greenland S, Heinze G.. Separation in logistic regression&#x2013;causes, consequences, and control. Am J Epidemiol 2018;187:864&#x2013;70.</Citation><ArticleIdList><ArticleId IdType="pubmed">29020135</ArticleId></ArticleIdList></Reference><Reference><Citation>Tibshirani R. Regression shrinkage and selection via the lasso. J R Stat Soc B 1996;57:267&#x2013;88.</Citation></Reference><Reference><Citation>Ryan PB, Schuemie MJ, Gruber S, Zorych I, Madigan D.. Empirical performance of a new user cohort method: Lessons for developing a risk identification and analysis system. Drug Saf 2013;36:59&#x2013;72.</Citation><ArticleIdList><ArticleId IdType="pubmed">24166224</ArticleId></ArticleIdList></Reference><Reference><Citation>Greenland S. Invited commentary: variable selection versus shrinkage in the control of multiple confounders. Am J Epidemiol 2007;167:523&#x2013;29.</Citation><ArticleIdList><ArticleId IdType="pubmed">18227100</ArticleId></ArticleIdList></Reference><Reference><Citation>Graham DJ, Reichman ME, Wernecke M. et al. Cardiovascular, bleeding, and mortality risks in elderly Medicare patients treated with dabigatran or warfarin for non-valvular atrial fibrillation. Circulation 2015;131:157&#x2013;64.</Citation><ArticleIdList><ArticleId IdType="pubmed">25359164</ArticleId></ArticleIdList></Reference><Reference><Citation>Garbe E, Kloss S, Suling M, Pigeot I, Schneeweiss S.. High-dimensional versus conventional propensity scores in a comparative effectiveness study of coxibs and reduced upper gastrointestinal complications. Eur J Clin Pharmacol 2013;69:549&#x2013;57.</Citation><ArticleIdList><ArticleId IdType="pubmed">22763756</ArticleId></ArticleIdList></Reference><Reference><Citation>Bender R, Augustin T, Blettner M.. Generating survival times to simulate Cox proportional hazards models. Stat Med 2005;24:1713&#x2013;23.</Citation><ArticleIdList><ArticleId IdType="pubmed">15724232</ArticleId></ArticleIdList></Reference><Reference><Citation>Franklin JM, Schneeweiss S, Polinski JM, Rassen JA.. Plasmode simulation for the evaluation of pharmacoepidemiologic methods in complex healthcare databases. Comput Stat Data Anal 2014;72:219&#x2013;26.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3935334</ArticleId><ArticleId IdType="pubmed">24587587</ArticleId></ArticleIdList></Reference><Reference><Citation>Vaughan LK, Divers J, Padilla MA. et al. The use of plasmodes as a supplement to simulations: A simple example evaluating individual admixture estimation methodologies. Comput Stat Data Anal 2009;53:1755&#x2013;66.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2678733</ArticleId><ArticleId IdType="pubmed">20161321</ArticleId></ArticleIdList></Reference><Reference><Citation>Lipsitch M, Tchetgen ET, Cohen T.. Negative controls: a tool for detecting confounding and bias in observational studies. Epidemiology 2010;21:383&#x2013;88.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3053408</ArticleId><ArticleId IdType="pubmed">20335814</ArticleId></ArticleIdList></Reference><Reference><Citation>Schuemie MJ, Ryan PB, DuMouchel W, Suchard MA, Madigan D.. Interpreting observational studies: why empirical calibration is needed to correct p-values. Stat Med 2014;33:209&#x2013;18.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4285234</ArticleId><ArticleId IdType="pubmed">23900808</ArticleId></ArticleIdList></Reference><Reference><Citation>Voss EA, Boyce RD, Ryan PB, van der Lei J, Rijnbeek PR, Schuemie MJ.. Accuracy of an automated knowledge base for identifying drug adverse reactions. J Biomed Inform 2017;66:72&#x2013;81.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5316295</ArticleId><ArticleId IdType="pubmed">27993747</ArticleId></ArticleIdList></Reference><Reference><Citation>Overhage JM, Ryan PB, Reich CG, Hartzema AG, Stang PE.. Validation of a common data model for active safety surveillance research. J Am Med Inform Assoc 2011;19:54&#x2013;60.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3240764</ArticleId><ArticleId IdType="pubmed">22037893</ArticleId></ArticleIdList></Reference><Reference><Citation>Hripcsak G, Duke JD, Shah NH. et al. Observational health data sciences and informatics (OHDSI): Opportunities for observational researchers. Stud Health Technol Inform 2015;216:574.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4815923</ArticleId><ArticleId IdType="pubmed">26262116</ArticleId></ArticleIdList></Reference><Reference><Citation>Walker AM. Observation and Inference: An introduction to the Methods of Epidemiology. Newton Lower Falls: Epidemiology Resources Inc; 1991.</Citation></Reference><Reference><Citation>
Connolly JG, Maro JC, Wang SV. 
et al. Development, applications, and methodological challenges to the use of propensity score matching approaches in FDA's sentinel program [Internet]. FDA Sentinel Reports; 2016. Available from: https://www.sentinelinitiative.org/sites/default/files/Methods/Sentinel-Methods_PSM-Approaches-in-Sentinel.pdf (12 June 2018, date last accessed).</Citation></Reference><Reference><Citation>Zhou M, Wang SV, Leonard CE. et al. Sentinel modular program for propensity score&#x2013;matched cohort analyses: application to glyburide, glipizide, and serious hypoglycemia. Epidemiology 2017;28:838&#x2013;46.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6554646</ArticleId><ArticleId IdType="pubmed">28682851</ArticleId></ArticleIdList></Reference><Reference><Citation>Suchard MA, Simpson SE, Zorych I, Ryan P, Madigan D.. Massive parallelization of serial inference algorithms for a complex generalized linear model. ACM Trans Model Comput Simul 2013;23:1.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4201181</ArticleId><ArticleId IdType="pubmed">25328363</ArticleId></ArticleIdList></Reference><Reference><Citation>
Schuemie MJ, Suchard MA, Ryan PB.. 
CohortMethod: New-User Cohort Method with Large Scale Propensity and Outcome Models. R package version 2.6.2, 2018. Available from: http://github.com/OHDSI/CohortMethod</Citation></Reference><Reference><Citation>Austin PC. Assessing balance in measured baseline covariates when using many-to-one matching on the propensity-score. Pharmacoepidemiol Drug Saf 2008;17:1218&#x2013;25.</Citation><ArticleIdList><ArticleId IdType="pubmed">18972455</ArticleId></ArticleIdList></Reference><Reference><Citation>Franklin JM, Rassen JA, Ackermann D, Bartels DB, Schneeweiss S.. Metrics for covariate balance in cohort studies of causal effects. Stat Med 2014;33:1685&#x2013;99.</Citation><ArticleIdList><ArticleId IdType="pubmed">24323618</ArticleId></ArticleIdList></Reference><Reference><Citation>Gail MH, Wieand S, Piantadosi S.. Biased estimates of treatment effect in randomized experiments with nonlinear regressions and omitted covariates. Biometrika 1984;71:431&#x2013;44.</Citation></Reference><Reference><Citation>Weitzen S, Lapane KL, Toledano AY, Hume AL, Mor V.. Weaknesses of goodness-of-fit tests for evaluating propensity score models: The case of the omitted confounder. Pharmacoepidemiol Drug Saf 2005;14:227&#x2013;38.</Citation><ArticleIdList><ArticleId IdType="pubmed">15386700</ArticleId></ArticleIdList></Reference><Reference><Citation>Austin PC. Balance diagnostics for comparing the distribution of baseline covariates between treatment groups in propensity-score matched samples. Stat Med 2009;28:3083&#x2013;107.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3472075</ArticleId><ArticleId IdType="pubmed">19757444</ArticleId></ArticleIdList></Reference><Reference><Citation>Austin PC, Grootendorst P, Anderson GM.. A comparison of the ability of different propensity score models to balance measured variables between treated and untreated subjects: a Monte Carlo study. Stat Med 2007;26:734&#x2013;53.</Citation><ArticleIdList><ArticleId IdType="pubmed">16708349</ArticleId></ArticleIdList></Reference><Reference><Citation>Westreich D, Cole SR, Funk MJ, Brookhart MA, St&#xfc;rmer T.. The role of the c-statistic in variable selection for propensity score models. Pharmacoepidemiol Drug Saf 2011;20:317&#x2013;20.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3081361</ArticleId><ArticleId IdType="pubmed">21351315</ArticleId></ArticleIdList></Reference><Reference><Citation>Kumamaru H, Gagne JJ, Glynn RJ, Setoguchi S, Schneeweiss S.. Comparison of high-dimensional confounder summary scores in comparative studies of newly marketed medications. J Clin Epidemiol 2016;76:200&#x2013;08.</Citation><ArticleIdList><ArticleId IdType="pubmed">26931292</ArticleId></ArticleIdList></Reference><Reference><Citation>Rubin DB. For objective causal inference, design trumps analysis. Ann Appl Stat 2008;2:808&#x2013;40.</Citation></Reference><Reference><Citation>Ding P, Vanderweele T, Robins J.. Instrumental variables as bias amplifiers with general outcome and confounding. Biometrika 2017;104:291&#x2013;302.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5636691</ArticleId><ArticleId IdType="pubmed">29033459</ArticleId></ArticleIdList></Reference><Reference><Citation>Brookhart MA, Schneeweiss S, Rothman KJ, Glynn RJ, Avorn J, St&#xfc;rmer T.. Variable selection for propensity score models. Am J Epidemiol 2006;163:1149&#x2013;56.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1513192</ArticleId><ArticleId IdType="pubmed">16624967</ArticleId></ArticleIdList></Reference><Reference><Citation>Westreich D, Lessler J, Funk MJ.. Propensity score estimation: machine learning and classification methods as alternatives to logistic regression. J Clin Epidemiol 2010;63:826..</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2907172</ArticleId><ArticleId IdType="pubmed">20630332</ArticleId></ArticleIdList></Reference><Reference><Citation>Greenland S, Mansournia MA.. Penalization, bias reduction, and default priors in logistic and related categorical and survival regressions. Stat Med 2015;34:3133&#x2013;43.</Citation><ArticleIdList><ArticleId IdType="pubmed">26011599</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">30010902</PMID><DateCompleted><Year>2019</Year><Month>12</Month><Day>11</Day></DateCompleted><DateRevised><Year>2023</Year><Month>10</Month><Day>06</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1527-974X</ISSN><JournalIssue CitedMedium="Internet"><Volume>25</Volume><Issue>10</Issue><PubDate><Year>2018</Year><Month>Oct</Month><Day>01</Day></PubDate></JournalIssue><Title>Journal of the American Medical Informatics Association : JAMIA</Title><ISOAbbreviation>J Am Med Inform Assoc</ISOAbbreviation></Journal><ArticleTitle>Learning predictive models of drug side-effect relationships from distributed representations of literature-derived semantic predications.</ArticleTitle><Pagination><StartPage>1339</StartPage><EndPage>1350</EndPage><MedlinePgn>1339-1350</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1093/jamia/ocy077</ELocationID><Abstract><AbstractText Label="OBJECTIVE">The aim of this work is to leverage relational information extracted from biomedical literature using a novel synthesis of unsupervised pretraining, representational composition, and supervised machine learning for drug safety monitoring.</AbstractText><AbstractText Label="METHODS">Using&#x2009;&#x2248;80 million concept-relationship-concept triples extracted from the literature using the SemRep Natural Language Processing system, distributed vector representations (embeddings) were generated for concepts as functions of their relationships utilizing two unsupervised representational approaches. Embeddings for drugs and side effects of interest from two widely used reference standards were then composed to generate embeddings of drug/side-effect pairs, which were used as input for supervised machine learning. This methodology was developed and evaluated using cross-validation strategies and compared to contemporary approaches. To qualitatively assess generalization, models trained on the Observational Medical Outcomes Partnership (OMOP) drug/side-effect reference set were evaluated against a list of&#x2009;&#x2248;1100 drugs from an online database.</AbstractText><AbstractText Label="RESULTS">The employed method improved performance over previous approaches. Cross-validation results advance the state of the art (AUC 0.96; F1 0.90 and AUC 0.95; F1 0.84 across the two sets), outperforming methods utilizing literature and/or spontaneous reporting system data. Examination of predictions for unseen drug/side-effect pairs indicates the ability of these methods to generalize, with over tenfold label support enrichment in the top 100 predictions versus the bottom 100 predictions.</AbstractText><AbstractText Label="DISCUSSION AND CONCLUSION">Our methods can assist the pharmacovigilance process using information from the biomedical literature. Unsupervised pretraining generates a rich relationship-based representational foundation for machine learning techniques to classify drugs in the context of a putative side effect, given known examples.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Mower</LastName><ForeName>Justin</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Baylor College of Medicine, Quantitative and Computational Biosciences, Houston, Texas, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Subramanian</LastName><ForeName>Devika</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Department of Computer Science, Rice University, Houston, Texas, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cohen</LastName><ForeName>Trevor</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>School of Biomedical Informatics, University of Texas Health Science Center Houston, Texas, USA.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>R01 LM011563</GrantID><Acronym>LM</Acronym><Agency>NLM NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>T15 LM007093</GrantID><Acronym>LM</Acronym><Agency>NLM NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D052061">Research Support, N.I.H., Extramural</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>J Am Med Inform Assoc</MedlineTA><NlmUniqueID>9430800</NlmUniqueID><ISSNLinking>1067-5027</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D057225" MajorTopicYN="N">Data Mining</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016206" MajorTopicYN="Y">Databases, Bibliographic</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D064420" MajorTopicYN="Y">Drug-Related Side Effects and Adverse Reactions</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009323" MajorTopicYN="Y">Natural Language Processing</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D060735" MajorTopicYN="Y">Pharmacovigilance</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011358" MajorTopicYN="N">Product Surveillance, Postmarketing</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012660" MajorTopicYN="N">Semantics</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000069553" MajorTopicYN="Y">Supervised Machine Learning</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2018</Year><Month>1</Month><Day>24</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2018</Year><Month>6</Month><Day>5</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2018</Year><Month>7</Month><Day>17</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2019</Year><Month>12</Month><Day>18</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2018</Year><Month>7</Month><Day>17</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2019</Year><Month>7</Month><Day>11</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">30010902</ArticleId><ArticleId IdType="pmc">PMC6454491</ArticleId><ArticleId IdType="doi">10.1093/jamia/ocy077</ArticleId><ArticleId IdType="pii">5052182</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Ryan PB, Schuemie MJ, Welebob E, et al. Defining a reference set to support methodological research in drug safety. Drug Saf 2013; 36 (S1): 33&#x2013;47.</Citation><ArticleIdList><ArticleId IdType="pubmed">24166222</ArticleId></ArticleIdList></Reference><Reference><Citation>Meyboom RH, Hekster YA, Egberts AC, et al. Causal or casual? The role of causality assessment in pharmacovigilance. Drug Saf 1997; 176: 374&#x2013;89.</Citation><ArticleIdList><ArticleId IdType="pubmed">9429837</ArticleId></ArticleIdList></Reference><Reference><Citation>Harpaz R, Callahan A, Tamang S, et al. Text mining for adverse drug events: the promise, challenges, and state of the art. Drug Saf 2014; 3710: 777&#x2013;90.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4217510</ArticleId><ArticleId IdType="pubmed">25151493</ArticleId></ArticleIdList></Reference><Reference><Citation>
Swanson DR, Smalheiser NR. Undiscovered public knowledge: a ten-year update. In: KDD. 1996: 295&#x2013;8. https://ocs.aaai.org/Papers/KDD/1996/KDD96-051.pdf. Accessed July 13, 2017.</Citation></Reference><Reference><Citation>Cohen AM, Hersh WR.. A survey of current work in biomedical text mining. Brief Bioinform 2005; 61: 57&#x2013;71.</Citation><ArticleIdList><ArticleId IdType="pubmed">15826357</ArticleId></ArticleIdList></Reference><Reference><Citation>
National Center for Health Statistics. Health, United States, 2016: With Chartbook on Long-term Trends in Health. Hyattsville, MD; 2017. 
https://www.cdc.gov/nchs/data/hus/hus16.pdf. Accessed July 10, 2017.</Citation><ArticleIdList><ArticleId IdType="pubmed">28910066</ArticleId></ArticleIdList></Reference><Reference><Citation>
Hing E, Rui P, Palso K. National Ambulatory Medical Care Survey: 2013 State and National Summary Tables. 2014. 
http://www.cdc.gov/nchs/ahcd/ahcd_products.htm. Accessed July 10, 2017.</Citation></Reference><Reference><Citation>
Center for Disease Control and Prevention. National Hospital Ambulatory Medical Care Survey: 2011 Outpatient Department Summary Tables. 2012. 
https://www.cdc.gov/nchs/data/ahcd/nhamcs_outpatient/2011_opd_web_tables.pdf. Accessed July 10, 2017.</Citation></Reference><Reference><Citation>
Rui P, Kang K, Albert M.. 
National Hospital Ambulatory Medical Care Survey: 2013 Emergency Department Summary Tables
2014. 
http://www.cdc.gov/nchs/data/ahcd/nhamcs_emergency/2013_ed_web_tables.pdf. Accessed July 10, 2017.</Citation></Reference><Reference><Citation>Watanabe JH, McInnis T, Hirsch JD.. Cost of prescription drug-related morbidity and mortality. Ann Pharmacother 2018; 1060028018765159.</Citation><ArticleIdList><ArticleId IdType="pubmed">29577766</ArticleId></ArticleIdList></Reference><Reference><Citation>Stausberg J. International prevalence of adverse drug events in hospitals: an analysis of routine data from England, Germany, and the USA. BMC Health Serv Res 2014; 141: 125..</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3984698</ArticleId><ArticleId IdType="pubmed">24620750</ArticleId></ArticleIdList></Reference><Reference><Citation>Bourgeois FT, Shannon MW, Valim C, et al. Adverse drug events in the outpatient setting: an 11-year national analysis. Pharmacoepidemiol Drug Saf 2010; 199: 901&#x2013;10.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2932855</ArticleId><ArticleId IdType="pubmed">20623513</ArticleId></ArticleIdList></Reference><Reference><Citation>Coloma PM, Trifir&#xf2; G, Patadia V, et al. Postmarketing safety surveillance: where does signal detection using electronic healthcare records fit into the big picture? Drug Saf 2013; 36: 183&#x2013;97.</Citation><ArticleIdList><ArticleId IdType="pubmed">23377696</ArticleId></ArticleIdList></Reference><Reference><Citation>
FDA. Postmarket Drug Safety Information for Patients and Providers&#x2014;Information for Healthcare Professionals: Valdecoxib (Marketed as Bextra). https://www.fda.gov/Drugs/DrugSafety/PostmarketDrugSafetyInformationforPatientsandProviders/ucm124649.htm Accessed July 11, 2017.</Citation></Reference><Reference><Citation>Ray WA, Griffin MR, Stein CM.. Cardiovascular toxicity of Valdecoxib. N Engl J Med 2004; 35126: 2767.</Citation><ArticleIdList><ArticleId IdType="pubmed">15608086</ArticleId></ArticleIdList></Reference><Reference><Citation>Downing NS, Shah ND, Aminawung JA, et al. Postmarket safety events among novel therapeutics approved by the US Food and Drug Administration between 2001 and 2010. JAMA 2017; 31718: 1854&#x2013;63.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5815036</ArticleId><ArticleId IdType="pubmed">28492899</ArticleId></ArticleIdList></Reference><Reference><Citation>Sultana J, Cutroneo P, Trifir&#xf2; G.. Clinical and economic burden of adverse drug reactions. J Pharmacol Pharmacother 2013; 45: 73&#x2013;7.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3853675</ArticleId><ArticleId IdType="pubmed">24347988</ArticleId></ArticleIdList></Reference><Reference><Citation>
World Health Organization. The Importance of Pharmacovigilance. 2002. 
http://apps.who.int/iris/bitstream/10665/42493/1/a75646.pdf. Accessed July 10, 2017.</Citation></Reference><Reference><Citation>
Center for Drug Evaluation and Research. Questions and Answers on FDA&#x2019;s Adverse Event Reporting System (FAERS). 2016. https://www.fda.gov/drugs/guidancecomplianceregulatoryinformation/surveillance/adversedrugeffects/ Accessed July 19, 2017.</Citation></Reference><Reference><Citation>
Center for Drug Evaluation and Research. FDA Adverse Events Reporting System (FAERS)&#x2014;Reports Received and Reports Entered into FAERS by Year. https://www.fda.gov/Drugs/GuidanceComplianceRegulatoryInformation/Surveillance/AdverseDrugEffects/ucm070434.htm Accessed July 16, 2017.</Citation></Reference><Reference><Citation>Hazell L, Shakir SAW.. Under-reporting of adverse drug reactions: a systematic review. Drug Saf 2006; 295: 385&#x2013;96.</Citation><ArticleIdList><ArticleId IdType="pubmed">16689555</ArticleId></ArticleIdList></Reference><Reference><Citation>Lopez-Gonzalez E, Herdeiro MT, Figueiras A.. Determinants of under-reporting of adverse drug reactions: a systematic review. Drug Saf 2009; 321: 19&#x2013;31.</Citation><ArticleIdList><ArticleId IdType="pubmed">19132802</ArticleId></ArticleIdList></Reference><Reference><Citation>Sakaeda T, Tamon A, Kadoyama K, et al. Data mining of the public version of the FDA adverse event reporting system. Int J Med Sci 2013; 107: 796&#x2013;803.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3689877</ArticleId><ArticleId IdType="pubmed">23794943</ArticleId></ArticleIdList></Reference><Reference><Citation>Pariente A, Gregoire F, Fourrier-Reglat A, et al. Impact of safety alerts on measures of disproportionality in spontaneous reporting databases: the notoriety bias. Drug Saf 2007; 3010: 891&#x2013;8.</Citation><ArticleIdList><ArticleId IdType="pubmed">17867726</ArticleId></ArticleIdList></Reference><Reference><Citation>Naidu RP. Causality assessment: a brief insight into practices in pharmaceutical industry. Perspect Clin Res 2013; 44: 233&#x2013;6.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3835968</ArticleId><ArticleId IdType="pubmed">24312892</ArticleId></ArticleIdList></Reference><Reference><Citation>Harpaz R, DuMouchel W, LePendu P, et al. Performance of pharmacovigilance signal-detection algorithms for the FDA adverse event reporting system. Clin Pharmacol Ther 2013; 936: 539&#x2013;46.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3857139</ArticleId><ArticleId IdType="pubmed">23571771</ArticleId></ArticleIdList></Reference><Reference><Citation>Li Y, Ryan PB, Wei Y, et al. A method to combine signals from spontaneous reporting systems and observational healthcare data to detect adverse drug reactions. Drug Saf 2015; 3810: 895&#x2013;908.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4579260</ArticleId><ArticleId IdType="pubmed">26153397</ArticleId></ArticleIdList></Reference><Reference><Citation>Natsiavas P, Koutkias V, Maglaveras N. Exploring the capacity of open, linked data sources to assess adverse drug reaction signals. In: Semantic Web applications and tools for life sciences (SWAT4LS) International Conference, held at Cambridge, England Dec. 7-10th 2015. 2015: 224&#x2013;6.</Citation></Reference><Reference><Citation>Koutkias VG, Jaulent M-C.. Computational approaches for pharmacovigilance signal detection: toward integrated and semantically enriched frameworks. Drug Saf 2015; 383: 219&#x2013;232.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4374117</ArticleId><ArticleId IdType="pubmed">25749722</ArticleId></ArticleIdList></Reference><Reference><Citation>Food and Drug Administration. Guidance for Industry: Good Pharmacovigilance Practices and Pharmacoepidemiologic Assessment. Rockville, MD: Food and Drug Administration; 2005.</Citation></Reference><Reference><Citation>
European Medicines Agency. Good Pharmacovigilance Practices. http://www.ema.europa.eu/ema/index.jsp?curl=pages/regulation/document_listing/document_listing_000345.jsp Accessed July 20, 2017.</Citation></Reference><Reference><Citation>Zweigenbaum P, Demner-Fushman D, Yu H, et al. Frontiers of biomedical text mining: current progress. Brief Bioinform 2007; 85: 358&#x2013;75.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2516302</ArticleId><ArticleId IdType="pubmed">17977867</ArticleId></ArticleIdList></Reference><Reference><Citation>Rebholz-Schuhmann D, Oellrich A, Hoehndorf R.. Text-mining solutions for biomedical research: enabling integrative biology. Nat Rev Genet 2012; 1312: 829&#x2013;39.</Citation><ArticleIdList><ArticleId IdType="pubmed">23150036</ArticleId></ArticleIdList></Reference><Reference><Citation>Cohen T, Schvaneveldt R, Widdows D.. Reflective random indexing and indirect inference: a scalable method for discovery of implicit connections. J Biomed Inform 2010; 432: 240&#x2013;56.</Citation><ArticleIdList><ArticleId IdType="pubmed">19761870</ArticleId></ArticleIdList></Reference><Reference><Citation>Swanson DR, Smalheiser NR.. An interactive system for finding complementary literatures: a stimulus to scientific discovery. Artif Intell 1997; 912: 183&#x2013;203.</Citation></Reference><Reference><Citation>Henry S, McInnes BT.. Literature based discovery: models, methods, and trends. J Biomed Inform 2017; 74: 20&#x2013;32.</Citation><ArticleIdList><ArticleId IdType="pubmed">28838802</ArticleId></ArticleIdList></Reference><Reference><Citation>Voss EA, Boyce RD, Ryan PB, et al. Accuracy of an automated knowledge base for identifying drug adverse reactions. J Biomed Inform 2017; 66: 72&#x2013;81.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5316295</ArticleId><ArticleId IdType="pubmed">27993747</ArticleId></ArticleIdList></Reference><Reference><Citation>Winnenburg R, Shah NH.. Generalized enrichment analysis improves the detection of adverse drug events from the biomedical literature. BMC Bioinformatics 2016; 171: 250..</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4918084</ArticleId><ArticleId IdType="pubmed">27333889</ArticleId></ArticleIdList></Reference><Reference><Citation>Swanson DR. Fish oil, Raynaud&#x2019;s syndrome, and undiscovered public knowledge. Perspect Biol Med 1986; 301: 7&#x2013;18.</Citation><ArticleIdList><ArticleId IdType="pubmed">3797213</ArticleId></ArticleIdList></Reference><Reference><Citation>Swanson DR. Migraine and magnesium: eleven neglected connections. Perspect Biol Med 1988; 314: 526&#x2013;57.</Citation><ArticleIdList><ArticleId IdType="pubmed">3075738</ArticleId></ArticleIdList></Reference><Reference><Citation>DiGiacomo RA, Kremer JM, Shah DM.. Fish-oil dietary supplementation in patients with Raynaud&#x2019;s phenomenon: a double-blind, controlled, prospective study. Am J Med 1989; 862: 158&#x2013;64.</Citation><ArticleIdList><ArticleId IdType="pubmed">2536517</ArticleId></ArticleIdList></Reference><Reference><Citation>
Hristovski D, Burgun-Parenthoine A, Avillach P,
et al. Towards using literature-based discovery to explain drug adverse effects. In: 24th International Conference of the European Federation for Medical Informatics Quality of Life through Quality of Information MIE. 2012. 
http://person.hst.aau.dk/ska/mie2012/AllPresentations/422.pdf. Accessed July 18, 2017.</Citation></Reference><Reference><Citation>Rindflesch TC, Fiszman M.. The interaction of domain knowledge and linguistic structure in natural language processing: interpreting hypernymic propositions in biomedical text. J Biomed Inform 2003; 366: 462&#x2013;77.</Citation><ArticleIdList><ArticleId IdType="pubmed">14759819</ArticleId></ArticleIdList></Reference><Reference><Citation>Hristovski D, Friedman C, Rindflesch TC, et al.. Exploiting semantic relations for literature-based discovery. In: AMIA Annual Symposium Proceedings, 2006, held in Washington, DC, USA Nov. 11&#x2013;15.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1839258</ArticleId><ArticleId IdType="pubmed">17238361</ArticleId></ArticleIdList></Reference><Reference><Citation>
Song D, Bruza P, Cole R. Concept Learning and Information Inferencing on a High-Dimensional Semantic Space. 2004. 
http://oro.open.ac.uk/35506/. Accessed October12, 2017.</Citation></Reference><Reference><Citation>
Gordon MD, Dumais S. Using Latent Semantic Indexing for Literature Based Discovery. 1998. 
https://deepblue.lib.umich.edu/handle/2027.42/34255. Accessed October12, 2017.</Citation></Reference><Reference><Citation>Cohen T, Widdows D, Schvaneveldt RW, et al. Discovering discovery patterns with predication-based semantic indexing. J Biomed Inform 2012; 456: 1049&#x2013;65.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3590916</ArticleId><ArticleId IdType="pubmed">22841748</ArticleId></ArticleIdList></Reference><Reference><Citation>Lever J, Gakkhar S, Gottlieb M, et al. A collaborative filtering based approach to biomedical knowledge discovery. Bioinformatics. doi:10.1093/bioinformatics/btx613.</Citation><ArticleIdList><ArticleId IdType="pubmed">29028901</ArticleId></ArticleIdList></Reference><Reference><Citation>Ahlers CB, Hristovski D, Kilicoglu H, et al. Using the literature-based discovery paradigm to investigate drug mechanisms. AMIA Annu Symp Proc 2007; 2007: 6&#x2013;10.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2655783</ArticleId><ArticleId IdType="pubmed">18693787</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang R, Adam TJ, Simon G, et al. Mining biomedical literature to explore interactions between cancer drugs and dietary supplements. AMIA Jt Summits Transl Sci Proc 2015; 2015: 69&#x2013;73.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4525230</ArticleId><ArticleId IdType="pubmed">26306241</ArticleId></ArticleIdList></Reference><Reference><Citation>Cohen T, Widdows D, De Vine L, et al. Many paths lead to discovery: analogical retrieval of cancer therapies In: 6th International Symposium, QI 2012, Paris, France, June 27-29, 2012, Revised Selected Papers. Paris, France: Springer; 2012: 90&#x2013;101.</Citation></Reference><Reference><Citation>
Cohen T, Widdows D, Schvaneveldt RW,
et al. Discovery at a distance: farther journeys in predication space. In: Bioinformatics and Biomedicine Workshops (BIBMW), 2012 IEEE International Conference on IEEE. 2012: 218&#x2013;25. http://ieeexplore.ieee.org/abstract/document/6470307/. Accessed July 18, 2017.</Citation></Reference><Reference><Citation>Shang N, Xu H, Rindflesch TC, et al. Identifying plausible adverse drug reactions using knowledge extracted from the literature. J Biomed Inform 2014; 52: 293&#x2013;310.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4261011</ArticleId><ArticleId IdType="pubmed">25046831</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu M, Wu Y, Chen Y, et al. Large-scale prediction of adverse drug reactions using chemical, biological, and phenotypic properties of drugs. J Am Med Inform Assoc 2012; 19 (e1): e28&#x2013;35.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3392844</ArticleId><ArticleId IdType="pubmed">22718037</ArticleId></ArticleIdList></Reference><Reference><Citation>Caster O, Sandberg L, Bergvall T, et al. vigiRank for statistical signal detection in pharmacovigilance: first results from prospective real-world use. Pharmacoepidemiol Drug Saf 2017; 268: 1006&#x2013;10.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5575476</ArticleId><ArticleId IdType="pubmed">28653790</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang L-C, Wu X, Chen JY.. Predicting adverse drug reaction profiles by integrating protein interaction networks with drug structures. Proteomics 2013; 132: 313&#x2013;24.</Citation><ArticleIdList><ArticleId IdType="pubmed">23184540</ArticleId></ArticleIdList></Reference><Reference><Citation>Jamal S, Goyal S, Shanker A, et al. Predicting neurological adverse drug reactions based on biological, chemical and phenotypic properties of drugs using machine learning models. Sci Rep 2017; 71: 872.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5429831</ArticleId><ArticleId IdType="pubmed">28408735</ArticleId></ArticleIdList></Reference><Reference><Citation>
Bengio Y, Courville AC, Vincent P. Unsupervised feature learning and deep learning: a review and new perspectives. CoRR Abs120655382012; 1. https://pdfs.semanticscholar.org/f8c8/619ea7d68e604e40b814b40c72888a755e95.pdf. Accessed October 12, 2017.</Citation></Reference><Reference><Citation>Erhan D, Bengio Y, Courville A, et al. Why does unsupervised pre-training help deep learning? J Mach Learn Res 2010; 11: 625&#x2013;60.</Citation></Reference><Reference><Citation>Bengio Y, Courville A, Vincent P.. Representation learning: a review and new perspectives. IEEE Trans Pattern Anal Mach Intell 2013; 358: 1798&#x2013;828.</Citation><ArticleIdList><ArticleId IdType="pubmed">23787338</ArticleId></ArticleIdList></Reference><Reference><Citation>
Sun C, Shrivastava A, Singh S,
et al. Revisiting unreasonable effectiveness of data in deep learning era. ArXiv170702968 Cs.2017. 
http://arxiv.org/abs/1707.02968. Accessed July 19, 2017.</Citation></Reference><Reference><Citation>
Khodak M, Risteski A, Fellbaum C,
et al. Extending and improving wordnet via unsupervised word embeddings. ArXiv170500217 Cs
2017. 
http://arxiv.org/abs/1705.00217.</Citation></Reference><Reference><Citation>Mower J, Subramanian D, Shang N, et al. Classification-by-analogy: using vector representations of implicit relationships to identify plausibly causal drug/side-effect relationships. AMIA Annu Symp Proc 2016; 2016: 1940&#x2013;9.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5333205</ArticleId><ArticleId IdType="pubmed">28269953</ArticleId></ArticleIdList></Reference><Reference><Citation>Cohen T, Widdows D.. Embedding of semantic predications. J Biomed Inform 2017; 68: 150&#x2013;66.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5441848</ArticleId><ArticleId IdType="pubmed">28284761</ArticleId></ArticleIdList></Reference><Reference><Citation>Cohen T, Schvaneveldt RW, Rindflesch TC. Predication-based semantic indexing: permutations as a means to encode predications in semantic space. In: AMIA San Francisco, US: AMIA Annual Symposium Proceedings; 2009.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2815384</ArticleId><ArticleId IdType="pubmed">20351833</ArticleId></ArticleIdList></Reference><Reference><Citation>Widdows D, Cohen T.. Reasoning with vectors: a continuous model for fast robust inference. Log J IGPL Interest Group Pure Appl Log 2015; 232: 141&#x2013;73.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4646228</ArticleId><ArticleId IdType="pubmed">26582967</ArticleId></ArticleIdList></Reference><Reference><Citation>Cohen T, Widdows D, Schvaneveldt R, et al. Finding Schizophrenia&#x2019;s prozac emergent relational similarity in predication space In: Quantum Interaction. Berlin, Heidelberg: Springer; 2011: 48&#x2013;59. doi:10.1007/978-3-642-24971-6_6.</Citation></Reference><Reference><Citation>Kilicoglu H, Shin D, Fiszman M, et al. SemMedDB: a PubMed-scale repository of biomedical semantic predications. Bioinforma Oxf Engl 2012; 2823: 3158&#x2013;60.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3509487</ArticleId><ArticleId IdType="pubmed">23044550</ArticleId></ArticleIdList></Reference><Reference><Citation>Widdows D, Ferraro K.. Semantic vectors: a scalable open source package and online technology management application. In: Proceedings of the International Conference on Language Resources and Evaluation, LREC 2008, 26 May - 1 June 2008, Marrakech, Morocco.</Citation></Reference><Reference><Citation>Kanerva P. Binary spatter-coding of ordered K-tuples. Artif Neural Networks&#x2014;ICANN 96, Bochum, Germany: Artificial Neural Networks - ICANN 96 (Springer). 1996: 869&#x2013;73.</Citation></Reference><Reference><Citation>
Gayler RW, Wales R. Connections, Binding, Unification and Analogical Promiscuity. 1998. http://cogprints.org/500. Accessed July 10, 2017.</Citation></Reference><Reference><Citation>Plate TA. Holographic Reduced Representation: Distributed Representation for cognitive structures, Chicago, IL: University of Chicago Press. 2003.</Citation></Reference><Reference><Citation>Rachkovskij DA, Kussul EM.. Binding and normalization of binary sparse distributed representations by context-dependent thinning. Neural Comput 2001; 132: 411&#x2013;52.</Citation></Reference><Reference><Citation>Coloma PM, Avillach P, Salvo F, et al. A reference standard for evaluation of methods for drug safety signal detection using electronic healthcare record databases. Drug Saf 2013; 361: 13&#x2013;23.</Citation><ArticleIdList><ArticleId IdType="pubmed">23315292</ArticleId></ArticleIdList></Reference><Reference><Citation>Pedregosa F, Varoquaux G, Gramfort A, et al. Scikit-learn: machine learning in python. Front Neuroinform 2014; 8: 2825&#x2013;30.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3930868</ArticleId><ArticleId IdType="pubmed">24600388</ArticleId></ArticleIdList></Reference><Reference><Citation>
Continuum Analytics. Anaconda Python Distribution. https://www.anaconda.com/. Accessed October 12, 2017.</Citation></Reference><Reference><Citation>van der Maaten L, Hinton G.. Visualizing data using t-SNE. J Mach Learn Res 2008; 9: 2579&#x2013;605.</Citation></Reference><Reference><Citation>Kuhn M, Campillos M, Letunic I, et al. A side effect resource to capture phenotypic effects of drugs. Mol Syst Biol 2010; 6: 343..</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2824526</ArticleId><ArticleId IdType="pubmed">20087340</ArticleId></ArticleIdList></Reference><Reference><Citation>Kuhn M, Letunic I, Jensen LJ, et al. The SIDER database of drugs and side effects. Nucleic Acids Res 2016; 44 (D1): D1075&#x2013;79. Accessed October 12, 2017.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4702794</ArticleId><ArticleId IdType="pubmed">26481350</ArticleId></ArticleIdList></Reference><Reference><Citation>Wei W-Q, Cronin RM, Xu H, et al. Development and evaluation of an ensemble resource linking medications to their indications. J Am Med Inform Assoc 2013; 205: 954&#x2013;61.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3756263</ArticleId><ArticleId IdType="pubmed">23576672</ArticleId></ArticleIdList></Reference><Reference><Citation>B&#xf6;hm R, Hehn L, von Herdegen T, et al. OpenVigil FDA&#x2014;Inspection of U.S. American Adverse Drug Events Pharmacovigilance Data and Novel Clinical Applications. PLoS One 2016; 116: e0157753.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4915658</ArticleId><ArticleId IdType="pubmed">27326858</ArticleId></ArticleIdList></Reference><Reference><Citation>Evans SJ, Waller PC, Davis S.. Use of proportional reporting ratios (PRRs) for signal generation from spontaneous adverse drug reaction reports. Pharmacoepidemiol Drug Saf 2001; 106: 483&#x2013;6.</Citation><ArticleIdList><ArticleId IdType="pubmed">11828828</ArticleId></ArticleIdList></Reference><Reference><Citation>Porro GB, Pace F.. 5 Ulcerogenic drugs and upper gastrointestinal bleeding. Bailli&#xe8;res Clin Gastroenterol 1988; 22: 309&#x2013;27.</Citation><ArticleIdList><ArticleId IdType="pubmed">3044465</ArticleId></ArticleIdList></Reference><Reference><Citation>Duggirala HJ, Tonning JM, Smith E, et al. Use of data mining at the food and drug administration. J Am Med Inform Assoc 2016; 232: 428&#x2013;34.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC11740535</ArticleId><ArticleId IdType="pubmed">26209436</ArticleId></ArticleIdList></Reference><Reference><Citation>Wattenberg M, Vi&#xe9;gas F, Johnson I.. How to use t-SNE effectively. Distill 2016; 1: e2.</Citation></Reference><Reference><Citation>Harpaz R, Odgers D, Gaskin G, et al. A time-indexed reference standard of adverse drug reactions. Sci Data 2014; 1: 140043..</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4306188</ArticleId><ArticleId IdType="pubmed">25632348</ArticleId></ArticleIdList></Reference><Reference><Citation>Nor&#xe9;n GN, Caster O, Juhlin K, et al. Zoo or savannah? Choice of training ground for evidence-based pharmacovigilance. Drug Saf 2014; 379: 655&#x2013;9.</Citation><ArticleIdList><ArticleId IdType="pubmed">25005708</ArticleId></ArticleIdList></Reference><Reference><Citation>Harpaz R, DuMouchel W, Shah NH.. Comment on: &#x201c;Zoo or savannah? Choice of training ground for evidence-based pharmacovigilance&#x201d;. Drug Saf 2015; 381: 113&#x2013;4.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4706737</ArticleId><ArticleId IdType="pubmed">25432779</ArticleId></ArticleIdList></Reference><Reference><Citation>Harpaz R, DuMouchel W, Schuemie M, et al. Toward multimodal signal detection of adverse drug reactions. J Biomed Inform 2017; doi:10.1016/j.jbi.2017.10.013.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8502488</ArticleId><ArticleId IdType="pubmed">29081385</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">30016814</PMID><DateCompleted><Year>2018</Year><Month>10</Month><Day>22</Day></DateCompleted><DateRevised><Year>2024</Year><Month>04</Month><Day>02</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">2511-705X</ISSN><JournalIssue CitedMedium="Internet"><Volume>57</Volume><Issue>S 01</Issue><PubDate><Year>2018</Year><Month>Jul</Month></PubDate></JournalIssue><Title>Methods of information in medicine</Title><ISOAbbreviation>Methods Inf Med</ISOAbbreviation></Journal><ArticleTitle>MIRACUM: Medical Informatics in Research and Care in University Medicine.</ArticleTitle><Pagination><StartPage>e82</StartPage><EndPage>e91</EndPage><MedlinePgn>e82-e91</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.3414/ME17-02-0025</ELocationID><Abstract><AbstractText Label="INTRODUCTION">This article is part of the Focus Theme of Methods of Information in Medicine on the German Medical Informatics Initiative. Similar to other large international data sharing networks (e.g. OHDSI, PCORnet, eMerge, RD-Connect) MIRACUM is a consortium of academic and hospital partners as well as one industrial partner in eight German cities which have joined forces to create interoperable data integration centres (DIC) and make data within those DIC available for innovative new IT solutions in patient care and medical research.</AbstractText><AbstractText Label="OBJECTIVES">Sharing data shall be supported by common interoperable tools and services, in order to leverage the power of such data for biomedical discovery and moving towards a learning health system. This paper aims at illustrating the major building blocks and concepts which MIRACUM will apply to achieve this goal.</AbstractText><AbstractText Label="GOVERNANCE AND POLICIES">Besides establishing an efficient governance structure within the MIRACUM consortium (based on the steering board, a central administrative office, the general MIRACUM assembly, six working groups and the international scientific advisory board), defining DIC governance rules and data sharing policies, as well as establishing (at each MIRACUM DIC site, but also for MIRACUM in total) use and access committees are major building blocks for the success of such an endeavor.</AbstractText><AbstractText Label="ARCHITECTURAL FRAMEWORK AND METHODOLOGY">The MIRACUM DIC architecture builds on a comprehensive ecosystem of reusable open source tools (MIRACOLIX), which are linkable and interoperable amongst each other, but also with the existing software environment of the MIRACUM hospitals. Efficient data protection measures, considering patient consent, data harmonization and a MIRACUM metadata repository as well as a common data model are major pillars of this framework. The methodological approach for shared data usage relies on a federated querying and analysis concept.</AbstractText><AbstractText Label="USE CASES">MIRACUM aims at proving the value of their DIC with three use cases: IT support for patient recruitment into clinical trials, the development and routine care implementation of a clinico-molecular predictive knowledge tool, and molecular-guided therapy recommendations in molecular tumor boards.</AbstractText><AbstractText Label="RESULTS">Based on the MIRACUM DIC release in the nine months conceptual phase first large scale analysis for stroke and colorectal cancer cohorts have been pursued.</AbstractText><AbstractText Label="DISCUSSION">Beyond all technological challenges successfully applying the MIRACUM tools for the enrichment of our knowledge about diagnostic and therapeutic concepts, thus supporting the concept of a Learning Health System will be crucial for the acceptance and sustainability in the medical community and the MIRACUM university hospitals.</AbstractText><CopyrightInformation>Schattauer GmbH.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Prokosch</LastName><ForeName>Hans-Ulrich</ForeName><Initials>HU</Initials></Author><Author ValidYN="Y"><LastName>Acker</LastName><ForeName>Till</ForeName><Initials>T</Initials></Author><Author ValidYN="Y"><LastName>Bernarding</LastName><ForeName>Johannes</ForeName><Initials>J</Initials></Author><Author ValidYN="Y"><LastName>Binder</LastName><ForeName>Harald</ForeName><Initials>H</Initials></Author><Author ValidYN="Y"><LastName>Boeker</LastName><ForeName>Martin</ForeName><Initials>M</Initials></Author><Author ValidYN="Y"><LastName>Boerries</LastName><ForeName>Melanie</ForeName><Initials>M</Initials></Author><Author ValidYN="Y"><LastName>Daumke</LastName><ForeName>Philipp</ForeName><Initials>P</Initials></Author><Author ValidYN="Y"><LastName>Ganslandt</LastName><ForeName>Thomas</ForeName><Initials>T</Initials></Author><Author ValidYN="Y"><LastName>Hesser</LastName><ForeName>J&#xfc;rgen</ForeName><Initials>J</Initials></Author><Author ValidYN="Y"><LastName>H&#xf6;ning</LastName><ForeName>Gunther</ForeName><Initials>G</Initials></Author><Author ValidYN="Y"><LastName>Neumaier</LastName><ForeName>Michael</ForeName><Initials>M</Initials></Author><Author ValidYN="Y"><LastName>Marquardt</LastName><ForeName>Kurt</ForeName><Initials>K</Initials></Author><Author ValidYN="Y"><LastName>Renz</LastName><ForeName>Harald</ForeName><Initials>H</Initials></Author><Author ValidYN="Y"><LastName>Rothk&#xf6;tter</LastName><ForeName>Hermann-Josef</ForeName><Initials>HJ</Initials></Author><Author ValidYN="Y"><LastName>Schade-Brittinger</LastName><ForeName>Carmen</ForeName><Initials>C</Initials></Author><Author ValidYN="Y"><LastName>Schm&#xfc;cker</LastName><ForeName>Paul</ForeName><Initials>P</Initials></Author><Author ValidYN="Y"><LastName>Sch&#xfc;ttler</LastName><ForeName>J&#xfc;rgen</ForeName><Initials>J</Initials></Author><Author ValidYN="Y"><LastName>Sedlmayr</LastName><ForeName>Martin</ForeName><Initials>M</Initials></Author><Author ValidYN="Y"><LastName>Serve</LastName><ForeName>Hubert</ForeName><Initials>H</Initials></Author><Author ValidYN="Y"><LastName>Sohrabi</LastName><ForeName>Keywan</ForeName><Initials>K</Initials></Author><Author ValidYN="Y"><LastName>Storf</LastName><ForeName>Holger</ForeName><Initials>H</Initials></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>German Federal Ministry of Education and Research (BMBF)</GrantID><Agency>FKZ 01ZZ1606A-H</Agency><Country>International</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2018</Year><Month>07</Month><Day>17</Day></ArticleDate></Article><MedlineJournalInfo><Country>Germany</Country><MedlineTA>Methods Inf Med</MedlineTA><NlmUniqueID>0210453</NlmUniqueID><ISSNLinking>0026-1270</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D035843" MajorTopicYN="Y">Biomedical Research</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D054976" MajorTopicYN="N">Clinical Governance</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003695" MajorTopicYN="Y">Delivery of Health Care</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007722" MajorTopicYN="N">Health Knowledge, Attitudes, Practice</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006785" MajorTopicYN="Y">Hospitals, University</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D033181" MajorTopicYN="N">Information Dissemination</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008490" MajorTopicYN="Y">Medical Informatics</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018579" MajorTopicYN="N">Patient Selection</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D057766" MajorTopicYN="N">Policy</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D057386" MajorTopicYN="N">Search Engine</DescriptorName></MeshHeading></MeshHeadingList><CoiStatement>Disclosure The authors report no conflicts of interest in this work.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2018</Year><Month>7</Month><Day>18</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2018</Year><Month>7</Month><Day>18</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2018</Year><Month>10</Month><Day>23</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2018</Year><Month>10</Month><Day>10</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">30016814</ArticleId><ArticleId IdType="pmc">PMC6178200</ArticleId><ArticleId IdType="doi">10.3414/ME17-02-0025</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Meystre SM, Lovis C, B&#xfc;rkle T, Tognola G, Budrionis A, Lehmann CU. Clinical Data Reuse or Secondary Use: Current Status and Potential Future Progress. Yearb Med Inform. 2017;26(01):38&#x2013;52.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6239225</ArticleId><ArticleId IdType="pubmed">28480475</ArticleId></ArticleIdList></Reference><Reference><Citation>Hripcsak G, Ryan PB, Duke JD, Shah NH, Park RW, Huser V, Suchard MA, Schuemie MJ, DeFalco FJ, Perotte A, Banda JM, Reich CG, Schilling LM, Matheny ME, Meeker D, Pratt N, Madigan D. Characterizing treatment pathways at scale using the OHDSI network. Proc Natl Acad Sci U S A. 2016;113(27):7329&#x2013;7336.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4941483</ArticleId><ArticleId IdType="pubmed">27274072</ArticleId></ArticleIdList></Reference><Reference><Citation>Hripcsak G, Duke JD, Shah NH, Reich CG, Huser V, Schuemie MJ, Suchard MA, Park RW, Wong IC, Rijnbeek PR, van der Lei J, Pratt N, Nor&#xe9;n GN, Li YC, Stang PE, Madigan D, Ryan PB. Observational Health Data Sciences and Informatics (OHDSI): Opportunities for Observational Researchers. Stud Health Technol Inform. 2015;216:574&#x2013;578.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4815923</ArticleId><ArticleId IdType="pubmed">26262116</ArticleId></ArticleIdList></Reference><Reference><Citation>Collins FS, Hudson KL, Briggs JP, Lauer MS. PCORnet: turning a dream into reality. J Am Med Inform Assoc. 2014;21(04):576&#x2013;577.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4078299</ArticleId><ArticleId IdType="pubmed">24821744</ArticleId></ArticleIdList></Reference><Reference><Citation>Fleurence RL, Curtis LH, Califf RM, Platt R, Selby JV, Brown JS. Launching PCORnet, a national patient-centered clinical research network. J Am Med Inform Assoc. 2014;21(04):578&#x2013;582.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4078292</ArticleId><ArticleId IdType="pubmed">24821743</ArticleId></ArticleIdList></Reference><Reference><Citation>beMERGE Network . Gottesman O, Kuivaniemi H, Tromp G, Faucett WA, Li R, Manolio TA, Sanderson SC, Kannry J, Zinberg R, Basford MA, Brilliant M, Carey DJ, Chisholm RL, Chute CG, Connolly JJ, Crosslin D, Denny JC, Gallego CJ, Haines JL, Hakonarson H, Harley J, Jarvik GP, Kohane I, Kullo IJ, Larson EB, McCarty C, Ritchie MD, Roden DM, Smith ME, B&#xf6;ttinger EP, Williams MS. The Electronic Medical Records and Genomics (eMERGE) Network: past, present, and future. Genet Med. 2013;15(10):761&#x2013;771.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3795928</ArticleId><ArticleId IdType="pubmed">23743551</ArticleId></ArticleIdList></Reference><Reference><Citation>Gainotti S, Torreri P, Wang CM, Reihs R, Mueller H, Heslop E, Roos M, Badowska DM, de Paulis F, Kodra Y, Carta C, Mart&#xec;n EL, Miller VR, Filocamo M, Mora M, Thompson M, Rubinstein Y, Posada de la Paz M, Monaco L, Lochm&#xfc;ller H, Taruscio D.The RD-Connect Registry &amp; Biobank Finder: a tool for sharing aggregated data and metadata among rare disease researchers. Eur J Hum Genet 2018. Forthcoming. doi:10.1038/s41431&#x2013;017&#x2013;0085-z.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5945774</ArticleId><ArticleId IdType="pubmed">29396563</ArticleId></ArticleIdList></Reference><Reference><Citation>Biobanking and Biomolecular Resources Infrastructure &#x2013;European Research Infrastructure Consortium[cited 2018 Mar 28]. Available from:http://www.bbmri-eric.eu/</Citation></Reference><Reference><Citation>ELIXIR: A distributed infrastructure for lifescience information[cited 2018 Mar 28]. Available from:https://www.elixir-europe.org/</Citation></Reference><Reference><Citation>other founding members of DTL Data (see Acknowledgements) . Eijssen L, Evelo C, Kok R, Mons B, Hooft R. The Dutch Techcentre for Life Sciences: Enabling data-intensive life science research in the Netherlands. Version 2. F1000Res. 2015;04:33.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4743138</ArticleId><ArticleId IdType="pubmed">26913186</ArticleId></ArticleIdList></Reference><Reference><Citation>Wilkinson MD, Dumontier M, Aalbersberg IJ, Appleton G, Axton M, Baak A, Blomberg N, Boiten JW, da Silva Santos LB, Bourne PE, Bouwman J, Brookes AJ, Clark T, Crosas M, Dillo I, Dumon O, Edmunds S, Evelo CT, Finkers R, Gonzalez-Beltran A, Gray AJ, Groth P, Goble C, Grethe JS, Heringa J, tHoen PA, Hooft R, Kuhn T, Kok R, Kok J, Lusher SJ, Martone ME, Mons A, Packer AL, Persson B, Rocca-Serra P, Roos M, van Schaik R, Sansone SA, Schultes E, Sengstag T, Slater T, Strawn G, Swertz MA, Thompson M, van der Lei J, van Mulligen E, Velterop J, Waagmeester A, Wittenburg P, Wolstencroft K, Zhao J, Mons B. The FAIR Guiding Principles for scientific data management and stewardship. Sci Data. 2016;03:160018.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4792175</ArticleId><ArticleId IdType="pubmed">26978244</ArticleId></ArticleIdList></Reference><Reference><Citation>Semler SC, Wissing F, Heyder R.German Medical Informatics Initiative: A national approach to integrating health data from patient care and medical research Methods Inf Med 201857(Open):e50&#x2013;e56..</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6178199</ArticleId><ArticleId IdType="pubmed">30016818</ArticleId></ArticleIdList></Reference><Reference><Citation>MIRACUM (Medical Informatics for Research and Care in University Medicine)[cited 2018 Mar 28]. Available from:http://www.miracum.org/</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6178200</ArticleId><ArticleId IdType="pubmed">30016814</ArticleId></ArticleIdList></Reference><Reference><Citation>Pommerening K, Drepper J, Helbing K, Ganslandt T. Berlin: Medizinische Wissenschaftliche Verlagsgesellschaft; 2014. Leitfaden zum Datenschutz in medizinischen Forschungsprojekten. TMF Schriftenreihe.</Citation></Reference><Reference><Citation>Christoph J, Griebel L, Leb I, Engel I, K&#xf6;pcke F, Toddenroth D, Prokosch HU, Laufer J, Marquardt K, Sedlmayr M. Secure Secondary Use of Clinical Data with Cloud-based NLP Services. Towards a Highly Scalable Research Infrastructure. Methods Inf Med. 2015;54(03):276&#x2013;282.</Citation><ArticleIdList><ArticleId IdType="pubmed">25377309</ArticleId></ArticleIdList></Reference><Reference><Citation>Bialke M, Bahls T, Havemann C, Piegsa J, Weitmann K, Wegner T, Hoffmann W. MOSAIC &#x2013; A Modular Approach to Data Management in Epidemiological Studies. Methods Inf Med. 2015;54(04):364&#x2013;371.</Citation><ArticleIdList><ArticleId IdType="pubmed">26196494</ArticleId></ArticleIdList></Reference><Reference><Citation>Murphy SN, Weber G, Mendis M, Gainer V, Chueh HC, Churchill S, Kohane I. Serving the enterprise and beyond with informatics for integrating biology and the bedside (i2b2) J Am Med Inform Assoc. 2010;17(02):124&#x2013;130.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3000779</ArticleId><ArticleId IdType="pubmed">20190053</ArticleId></ArticleIdList></Reference><Reference><Citation>Kohane IS, Churchill SE, Murphy SN. A translational engine at the national scale: informatics for integrating biology and the bedside. J Am Med Inform Assoc. 2012;19(02):181&#x2013;185.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3277623</ArticleId><ArticleId IdType="pubmed">22081225</ArticleId></ArticleIdList></Reference><Reference><Citation>Scheufele E, Aronzon D, Coopersmith R, McDuffie MT, Kapoor M, Uhrich CA, Avitabile JE, Liu J, Housman D, Palchuk MB. tranSMART: An Open Source Knowledge Management and High Content Data Analytics Platform. AMIA Jt Summits Transl Sci Proc. 2014;2014:96&#x2013;101.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4333702</ArticleId><ArticleId IdType="pubmed">25717408</ArticleId></ArticleIdList></Reference><Reference><Citation>Christoph J, Knell C, Naschberger E, St&#xfc;rzl M, Maier C, Prokosch HU, Sedlmayr M. Two years of tranSMART in a university hospital for translational research and education. Stud Health Technol Inform. 2017;236:70&#x2013;79.</Citation><ArticleIdList><ArticleId IdType="pubmed">28508781</ArticleId></ArticleIdList></Reference><Reference><Citation>Christoph J, Knell C, Bosserhoff A, Naschberger E, St&#xfc;rzl M, R&#xfc;bner M, Seuss H, Ruh M, Prokosch HU, Sedlmayr B. Usability and Suitability of the Omics-Integrating Analysis Platform tranSMART for Translational Research and Education. ACI. 2017;08(04):1173&#x2013;1183.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5802312</ArticleId><ArticleId IdType="pubmed">29270954</ArticleId></ArticleIdList></Reference><Reference><Citation>Marcus DS, Archie KA, Olsen TR, Ramaratnam M. The open-source neuroimaging research enterprise. J Digit Imaging. 2007;20 01:130&#x2013;138.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2039786</ArticleId><ArticleId IdType="pubmed">17710494</ArticleId></ArticleIdList></Reference><Reference><Citation>Herrick R, Horton W, Olsen T, McKay M, Archie KA, Marcus DS.XNAT Central: Open sourcing imaging research data NeuroImage 2016124Part B:1093&#x2013;1096.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4965359</ArticleId><ArticleId IdType="pubmed">26143202</ArticleId></ArticleIdList></Reference><Reference><Citation>He S, Yong M, Matthews PM, Guo Y. tranSMARTXNAT Connector tranSMART-XNAT connector &#x2013; image selection based on clinical phenotypes and genetic profiles. Bioinformatics. 2016. p. btw714..</Citation><ArticleIdList><ArticleId IdType="pubmed">28025201</ArticleId></ArticleIdList></Reference><Reference><Citation>Doiron D, Burton P, Marcon Y, Gaye A, Wolffenbuttel BH, Perola M, Stolk RP, Foco L, Minelli C, Waldenberger M, Holle R, Kval&#xf8;y K, Hillege HL, Tass&#xe9; AM, Ferretti V, Fortier I. Data harmonization and federated analysis of population-based studies: the BioSHaRE project. Emerg Themes Epidemiol. 2013;10(01):12.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4175511</ArticleId><ArticleId IdType="pubmed">24257327</ArticleId></ArticleIdList></Reference><Reference><Citation>Fortier I, Burton PR, Robson PJ, Ferretti V, Little J, L&#x2019;Heureux F, Deschenes M, Knoppers BM, Doiron D, Keers JC, Linksted P, Harris JR, Lachance G, Boileau C, Pedersen NL, Hamilton CM, Hveem K, Borugian MJ, Gallagher RP, McLaughlin J, Parker L, Potter JD, Gallacher J, Kaaks R, Liu B, Sprosen T, Vilain A, Atkinson SA, Rengifo A, Morton R, Metspalu A, Wichmann HE, Tremblay M, Chisholm RL, Garcia-Montero A, Hillege H, Litton JE, Palmer LJ, Perola M, Wolffenbuttel BH, Peltonen L, Hudson TJ. Quality, quantity and harmony: the DataSHaPER approach to integrating data across bioclinical studies. Int J Epidemiol. 2010;39(05):1383&#x2013;1393.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2972444</ArticleId><ArticleId IdType="pubmed">20813861</ArticleId></ArticleIdList></Reference><Reference><Citation>Howe D, Costanzo M, Fey P, Gojobori T, Hannick L, Hide W, Hill DP, Kania R, Schaeffer M, St Pierre S.Big data: the future of biocuration Nature 2008455(7209):47&#x2013;50.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2819144</ArticleId><ArticleId IdType="pubmed">18769432</ArticleId></ArticleIdList></Reference><Reference><Citation>Spjuth O, Krestyaninova M, Hastings J, Shen HY, Heikkinen J, Waldenberger M, Langhammer A, Ladenvall C, Esko T, Persson M&#xc5;, Heggland J, Dietrich J, Ose S, Gieger C, Ried JS, Peters A, Fortier I, de Geus EJ, Klovins J, Zaharenko L, Willemsen G, Hottenga JJ, Litton JE, Karvanen J, Boomsma DI, Groop L, Rung J, Palmgren J, Pedersen NL, McCarthy MI, van Duijn CM, Hveem K, Metspalu A, Ripatti S, Prokopenko I, Harris JR. Harmonising and linking biomedical and clinical data across disparate data archives to enable integrative cross-biobank research. Eur J Hum Genet. 2016;24(04):521&#x2013;528.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4929882</ArticleId><ArticleId IdType="pubmed">26306643</ArticleId></ArticleIdList></Reference><Reference><Citation>Kadioglu D, Weingardt P, &#xdc;ckert F, Wagner T.Samply.MDR &#x2013; Ein Open-Source-Metadaten-Repository. HEC 2016: Health &#x2013; Exploring Complexity Joint Conference of GMDS, DGEpi, IEA-EEF, EFMI; M&#xfc;nchen: 28.08.-02.09.2016. D&#xfc;sseldorf: German Medical Science GMS Publishing House;2016. DocAbstr. 425.</Citation></Reference><Reference><Citation>Lablans M, Kadioglu D, Muscholl M, &#xdc;ckert F. Exploiting Distributed, Heterogeneous and Sensitive Data Stocks while Maintaining the Owner&#x2019;s Data Sovereignty. Methods Inf Med. 2015;54(04):346&#x2013;352.</Citation><ArticleIdList><ArticleId IdType="pubmed">26196653</ArticleId></ArticleIdList></Reference><Reference><Citation>Storf H, Schaaf J, Kadioglu D, G&#xf6;bel J, Wagner TOF, &#xdc;ckert F.[Registries for rare diseases: OSSE &#x2013; An open-source framework for technical implementation]. Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz 2017. Mar 13. doi: 10.1007/s00103&#x2013;017&#x2013;2536&#x2013;7.</Citation><ArticleIdList><ArticleId IdType="pubmed">28289778</ArticleId></ArticleIdList></Reference><Reference><Citation>Garza M, Del Fiol G, Tenenbaum J, Walden A, Zozus MN. Evaluating common data models for use with a longitudinal community registry. J Biomed Inform. 2016;64:333&#x2013;341.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6810649</ArticleId><ArticleId IdType="pubmed">27989817</ArticleId></ArticleIdList></Reference><Reference><Citation>MIRACUM Metadata Repository. M-MDR[cited 2018 Mar 28]. Available from:http://mdr.miracum.de/</Citation></Reference><Reference><Citation>Mate S, Kadioglu D, Majeed RW, St&#xf6;hr MR, Folz M, Vormstein P, Storf H, Brucker DP, Keune D, Zerbe N, Hummel M, Senghas K, Prokosch HU, Lablans M. Proof-of-Concept Integration of Heterogeneous Biobank IT Infrastructures into a Hybrid Biobanking Network. Stud Health Technol Inform. 2017;243:100&#x2013;104.</Citation><ArticleIdList><ArticleId IdType="pubmed">28883179</ArticleId></ArticleIdList></Reference><Reference><Citation>Mate S, Vormstein P, Kadioglu D, Majeed RW, Lablans M, Prokosch HU, Storf H. On-The-Fly Query Translation Between i2b2 and Samply in the German Biobank Node (GBN) Prototypes. Stud Health Technol Inform. 2017;243:42&#x2013;46.</Citation><ArticleIdList><ArticleId IdType="pubmed">28883167</ArticleId></ArticleIdList></Reference><Reference><Citation>Gaye A, Marcon Y, Isaeva J, LaFlamme P, Turner A, Jones EM, Minion J, Boyd AW, Newby CJ, Nuotio ML, Wilson R, Butters O, Murtagh B, Demir I, Doiron D, Giepmans L, Wallace SE, Budin-Lj&#xf8;sne I, Oliver Schmidt C, Boffetta P, Boniol M, Bota M, Carter KW, deKlerk N, Dibben C, Francis RW, Hiekkalinna T, Hveem K, Kval&#xf8;y K, Millar S, Perry IJ, Peters A, Phillips CM, Popham F, Raab G, Reischl E, Sheehan N, Waldenberger M, Perola M, van den Heuvel E, Macleod J, Knoppers BM, Stolk RP, Fortier I, Harris JR, Woffenbuttel BH, Murtagh MJ, Ferretti V, Burton PR. DataSHIELD: taking the analysis to the data, not the data to the analysis. Int J Epidemiol. 2014;43(06):1929&#x2013;1944.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4276062</ArticleId><ArticleId IdType="pubmed">25261970</ArticleId></ArticleIdList></Reference><Reference><Citation>Cuggia M, Besana P, Glasspool D. Comparing semi-automatic systems for recruitment of patients to clinical trials. Int J Med Inform. 2011;80(06):371&#x2013;388.</Citation><ArticleIdList><ArticleId IdType="pubmed">21459664</ArticleId></ArticleIdList></Reference><Reference><Citation>Dilts DM, Sandler AB. Invisible barriers to clinical trials: the impact of structural, infrastructural, and procedural barriers to opening oncology clinical trials. J Clin Oncol. 2006;24:4545&#x2013;4552.</Citation><ArticleIdList><ArticleId IdType="pubmed">17008693</ArticleId></ArticleIdList></Reference><Reference><Citation>Campbell MK, Snowdon C, Francis Det al.Recruitment to randomised trials: strategies for trial enrollment and participation study. The STEPS study Health Technol Assess 200711iii,ix&#x2013;105.</Citation><ArticleIdList><ArticleId IdType="pubmed">17999843</ArticleId></ArticleIdList></Reference><Reference><Citation>Trinczek B, K&#xf6;pcke F, Leusch T, Majeed RW, Schreiweis B, Wenk J, Bergh B, Ohmann C, R&#xf6;hrig R, Prokosch HU, Dugas M. Design and multicentric implementation of a generic software architecture for patient recruitment systems re-using existing HIS tools and routine patient data. Appl Clin Inform. 2014;05(01):264&#x2013;283.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3974260</ArticleId><ArticleId IdType="pubmed">24734138</ArticleId></ArticleIdList></Reference><Reference><Citation>Schreiweis B, Trinczek B, K&#xf6;pcke F, Leusch T, Majeed RW, Wenk J, Bergh B, Ohmann C, R&#xf6;hrig R, Dugas M, Prokosch HU. Comparison of electronic health record system functionalities to support the patient recruitment process in clinical trials. Int J Med Inform. 2014;83(11):860&#x2013;868.</Citation><ArticleIdList><ArticleId IdType="pubmed">25189709</ArticleId></ArticleIdList></Reference><Reference><Citation>K&#xf6;pcke F, Trinczek B, Majeed RW, Schreiweis B, Wenk J, Leusch T, Ganslandt T, Ohmann C, Bergh B, R&#xf6;hrig R, Dugas M, Prokosch HU. Evaluation of data completeness in the electronic health record for the purpose of patient recruitment into clinical trials: a retrospective analysis of element presence. BMC Med Inform Decis Mak. 2013;13:37.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3606452</ArticleId><ArticleId IdType="pubmed">23514203</ArticleId></ArticleIdList></Reference><Reference><Citation>De Moor G, Sundgren M, Kalra D, Schmidt A, Dugas M, Claerhout B, Karakoyun T, Ohmann C, Lastic PY, Ammour N, Kush R, Dupont D, Cuggia M, Daniel C, Thienpont G, Coorevits P. Using electronic health records for clinical research: the case of the EHR4CR project. J Biomed Inform. 2015;53:162&#x2013;173.</Citation><ArticleIdList><ArticleId IdType="pubmed">25463966</ArticleId></ArticleIdList></Reference><Reference><Citation>Doods J, Lafitte C, Ulliac-Sagnes N, Proeve J, Botteri F, Walls R, Sykes A, Dugas M, Fritz F. A European inventory of data elements for patient recruitment. Stud Health Technol Inform. 2015;210:506&#x2013;510.</Citation><ArticleIdList><ArticleId IdType="pubmed">25991199</ArticleId></ArticleIdList></Reference><Reference><Citation>Khalilia M, Choi M, Henderson A, Iyengar S, Braunstein M, Sun J. Clinical Predictive Modeling Development and Deployment through FHIR Web Services. AMIA Annu Symp Proc. 2015;2015:717&#x2013;726.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4765683</ArticleId><ArticleId IdType="pubmed">26958207</ArticleId></ArticleIdList></Reference><Reference><Citation>Hinderer M, Boeker M, Wagner SA, Binder H, &#xdc;ckert F, H&#xfc;lsemann JL, Neumaier M, Schade-Brittinger C, Acker T, Prokosch HU, Sedlmayr B. The experience of physicians in pharmacogenomic clinical decision support within eight German University Hospitals. Pharmacogenomics. 2017;18(08):773&#x2013;785.</Citation><ArticleIdList><ArticleId IdType="pubmed">28593816</ArticleId></ArticleIdList></Reference><Reference><Citation>Hinderer M, B&#xf6;rries M, Haller F, Wagner S, Sollfrank S, Acker T, Prokosch HU, Christoph J. Supporting Molecular Tumor Boards in Molecularguided Decision-making &#x2013; the Current Status of Five German University Hospitals. Stud Health Technol Inform. 2017;236:48&#x2013;54.</Citation><ArticleIdList><ArticleId IdType="pubmed">28508778</ArticleId></ArticleIdList></Reference><Reference><Citation>Hinderer M, Boeker M, Wagner SA, Lablans M, Newe S, H&#xfc;lsemann JL, Neumaier M, Binder H, Renz H, Acker T, Prokosch HU, Sedlmayr M. Integrating clinical decision support systems for pharmacogenomic testing into clinical routine &#x2013; a scoping review of designs of user-system interactions in recent system development. BMC Med Inform Decis Mak. 2017;17(01):81.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5461630</ArticleId><ArticleId IdType="pubmed">28587608</ArticleId></ArticleIdList></Reference><Reference><Citation>Klann JG, Abend A, Raghavan VA, Mandl KD, Murphy SN. Data interchange using i2b2. J Am Med Inform Assoc. 2016;23(05):909&#x2013;915.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4997035</ArticleId><ArticleId IdType="pubmed">26911824</ArticleId></ArticleIdList></Reference><Reference><Citation>Haverkamp C, Gansland T, Horki P, Boeker M, D&#xf6;rfler A, Schwab S, Berkefeld J, Pfeilschifter W, Niesen W-D, Egger K, Kaps M, Brockmann MA, Neumaier-Probst E, Szabo K, Skalej M, Bien S, Best C, Prokosch U, Urbach H. Regional differences in thrombectomy rates: secondary use of billing codes in the MIRACUM (Medical Informatics for Research and Care in University Medicine) Consortium. Clin Neuroradiol. 2018;28(02):225&#x2013;234.</Citation><ArticleIdList><ArticleId IdType="pubmed">29313057</ArticleId></ArticleIdList></Reference><Reference><Citation>Maier C, Lang L, Storf H, Vormstein P, Bieber R, Bernarding J, Herrmann T, Haverkamp C, Horki P, Laufer J, Berger F, H&#xf6;ning G, Fritsch HW, Sch&#xfc;ttler J, Ganslandt T, Prokosch HU, Sedlmayr M. Towards implementation of OMOP in a German university hospital consortium. Appl Clin Inform. 2018;09(01):54&#x2013;61.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5801887</ArticleId><ArticleId IdType="pubmed">29365340</ArticleId></ArticleIdList></Reference><Reference><Citation>Available from:http://www.medizininformatikinitiative.de/de/konsortien/hd4cr-konzeptphase[cited 2018 Mar 22].</Citation></Reference><Reference><Citation>Prasser F, Kohlmayer F, Lautenschl&#xe4;ger R, Kuhn KA. ARX &#x2013; A Comprehensive Tool for Anonymizing Biomedical Data. AMIA Annu Symp Proc. 2014;2014:984&#x2013;993.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4419984</ArticleId><ArticleId IdType="pubmed">25954407</ArticleId></ArticleIdList></Reference><Reference><Citation>Prasser F, Kohlmayer F, Kuhn KA. Efficient and effective pruning strategies for health data de-identification. BMC Medical Informatics and Decision Making. 2016;16:49.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4851781</ArticleId><ArticleId IdType="pubmed">27130179</ArticleId></ArticleIdList></Reference><Reference><Citation>Friedman C, Rubin J, Brown J, Buntin M, Corn M, Etheredge L, Gunter C, Musen M, Platt R, Stead W, Sullivan K, Van Houweling D. Toward a science of learning systems: a research agenda for the highfunctioning Learning Health System. J Am Med Inform Assoc. 2015;22(01):43&#x2013;50.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4433378</ArticleId><ArticleId IdType="pubmed">25342177</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">30082302</PMID><DateRevised><Year>2024</Year><Month>03</Month><Day>30</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1471-2962</ISSN><JournalIssue CitedMedium="Internet"><Volume>376</Volume><Issue>2128</Issue><PubDate><Year>2018</Year><Month>Sep</Month><Day>13</Day></PubDate></JournalIssue><Title>Philosophical transactions. Series A, Mathematical, physical, and engineering sciences</Title><ISOAbbreviation>Philos Trans A Math Phys Eng Sci</ISOAbbreviation></Journal><ArticleTitle>Improving reproducibility by using high-throughput observational studies with empirical calibration.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">20170356</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1098/rsta.2017.0356</ELocationID><Abstract><AbstractText>Concerns over reproducibility in science extend to research using existing healthcare data; many observational studies investigating the same topic produce conflicting results, even when using the same data. To address this problem, we propose a paradigm shift. The current paradigm centres on generating one estimate at a time using a unique study design with unknown reliability and publishing (or not) one estimate at a time. The new paradigm advocates for high-throughput observational studies using consistent and standardized methods, allowing evaluation, calibration and unbiased dissemination to generate a more reliable and complete evidence base. We demonstrate this new paradigm by comparing all depression treatments for a set of outcomes, producing 17&#x2009;718 hazard ratios, each using methodology on par with current best practice. We furthermore include control hypotheses to evaluate and calibrate our evidence generation process. Results show good transitivity and consistency between databases, and agree with four out of the five findings from clinical trials. The distribution of effect size estimates reported in the literature reveals an absence of small or null effects, with a sharp cut-off at <i>p</i>&#x2009;=&#x2009;0.05. No such phenomena were observed in our results, suggesting more complete and more reliable evidence.This article is part of a discussion meeting issue 'The growing ubiquity of algorithms in society: implications, impacts and innovations'.</AbstractText><CopyrightInformation>&#xa9; 2018 The Authors.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Schuemie</LastName><ForeName>Martijn J</ForeName><Initials>MJ</Initials><Identifier Source="ORCID">0000-0002-0817-5361</Identifier><AffiliationInfo><Affiliation>Observational Health Data Sciences and Informatics (OHDSI), New&#xa0;York, NY 10032, USA schuemie@ohdsi.org.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Epidemiology Analytics, Janssen Research and Development, Titusville, NJ 08560, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ryan</LastName><ForeName>Patrick B</ForeName><Initials>PB</Initials><AffiliationInfo><Affiliation>Observational Health Data Sciences and Informatics (OHDSI), New&#xa0;York, NY 10032, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Epidemiology Analytics, Janssen Research and Development, Titusville, NJ 08560, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Biomedical Informatics, Columbia University Medical Center, New&#xa0;York, NY 10032, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hripcsak</LastName><ForeName>George</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Observational Health Data Sciences and Informatics (OHDSI), New&#xa0;York, NY 10032, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Biomedical Informatics, Columbia University Medical Center, New&#xa0;York, NY 10032, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Medical Informatics Services, New York-Presbyterian Hospital, New York, NY 10032, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Madigan</LastName><ForeName>David</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Observational Health Data Sciences and Informatics (OHDSI), New&#xa0;York, NY 10032, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Statistics, Columbia University, New York, NY 10027, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Suchard</LastName><ForeName>Marc A</ForeName><Initials>MA</Initials><AffiliationInfo><Affiliation>Observational Health Data Sciences and Informatics (OHDSI), New&#xa0;York, NY 10032, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Biomathematics, University of California, Los&#xa0;Angeles, CA 90095, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Biostatistics, University of California, Los&#xa0;Angeles, CA 90095, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Human Genetics, University of California, Los&#xa0;Angeles, CA 90095, USA.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>R01 LM006910</GrantID><Acronym>LM</Acronym><Agency>NLM NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>U01 HG008680</GrantID><Acronym>HG</Acronym><Agency>NHGRI NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Philos Trans A Math Phys Eng Sci</MedlineTA><NlmUniqueID>101133385</NlmUniqueID><ISSNLinking>1364-503X</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">medicine</Keyword><Keyword MajorTopicYN="N">observational research</Keyword><Keyword MajorTopicYN="N">publication bias</Keyword><Keyword MajorTopicYN="N">reproducibility</Keyword></KeywordList><CoiStatement>We declare we have no competing interests.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="accepted"><Year>2018</Year><Month>5</Month><Day>8</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2018</Year><Month>8</Month><Day>8</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2018</Year><Month>8</Month><Day>8</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2018</Year><Month>8</Month><Day>8</Day><Hour>6</Hour><Minute>1</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2018</Year><Month>8</Month><Day>6</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">30082302</ArticleId><ArticleId IdType="pmc">PMC6107542</ArticleId><ArticleId IdType="doi">10.1098/rsta.2017.0356</ArticleId><ArticleId IdType="pii">rsta.2017.0356</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Baker M. 2016. 1,500 scientists lift the lid on reproducibility. Nature 533, 452&#x2013;454. (10.1038/533452a)</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/533452a</ArticleId><ArticleId IdType="pubmed">27225100</ArticleId></ArticleIdList></Reference><Reference><Citation>Ioannidis JP. 2005. Why most published research findings are false. PLoS Med. 2, e124 (10.1371/journal.pmed.0020124)</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pmed.0020124</ArticleId><ArticleId IdType="pmc">PMC1182327</ArticleId><ArticleId IdType="pubmed">16060722</ArticleId></ArticleIdList></Reference><Reference><Citation>Munaf&#xf2; MR, et al. 2017. A manifesto for reproducible science. Nat. Hum. Behav. 1, 0021 (10.1038/s41562-016-0021)</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41562-016-0021</ArticleId><ArticleId IdType="pmc">PMC7610724</ArticleId><ArticleId IdType="pubmed">33954258</ArticleId></ArticleIdList></Reference><Reference><Citation>Dal-R&#xe9; R, Ioannidis JP, Bracken MB, Buffler PA, Chan A-W, Franco EL, La Vecchia C, Weiderpass E. 2014. Making prospective registration of observational research a reality. Sci. Transl. Med. 6, 224cm1 (10.1126/scitranslmed.3007513)</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/scitranslmed.3007513</ArticleId><ArticleId IdType="pubmed">24553383</ArticleId></ArticleIdList></Reference><Reference><Citation>Hripcsak G, et al. 2016. Characterizing treatment pathways at scale using the OHDSI network. Proc. Natl Acad. Sci. USA 113, 7329&#x2013;7336. (10.1073/pnas.1510502113)</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1510502113</ArticleId><ArticleId IdType="pmc">PMC4941483</ArticleId><ArticleId IdType="pubmed">27274072</ArticleId></ArticleIdList></Reference><Reference><Citation>Schuemie MJ, Hripcsak G, Ryan PB, Madigan D, Suchard MA. et al. 2018. Empirical confidence interval calibration for population-level effect estimation studies in observational healthcare data. Proc. Natl Acad. Sci. USA 9, 201708282 (10.1073/pnas.1708282114)</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1708282114</ArticleId><ArticleId IdType="pmc">PMC5856503</ArticleId><ArticleId IdType="pubmed">29531023</ArticleId></ArticleIdList></Reference><Reference><Citation>WHO. 2017. WHO fact sheet: depression.</Citation></Reference><Reference><Citation>Hernan MA, Robins JM. 2016. Using big data to emulate a target trial when a randomized trial is not available. Am. J. Epidemiol. 183, 758&#x2013;764. (10.1093/aje/kwv254)</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/aje/kwv254</ArticleId><ArticleId IdType="pmc">PMC4832051</ArticleId><ArticleId IdType="pubmed">26994063</ArticleId></ArticleIdList></Reference><Reference><Citation>Rosenbaum PR, Rubin DB. 1983. The central role of the propensity score in observational studies for causal effects. Biometrika 70, 41&#x2013;55. (10.1093/biomet/70.1.41)</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/biomet/70.1.41</ArticleId></ArticleIdList></Reference><Reference><Citation>Suchard MA, Simpson SE, Zorych I, Ryan P, Madigan D. 2013. Massive parallelization of serial inference algorithms for a complex generalized linear model. ACM Trans. Model. Comput. Simul. 23, 1&#x2013;17. (10.1145/2414416.2414791)</Citation><ArticleIdList><ArticleId IdType="doi">10.1145/2414416.2414791</ArticleId><ArticleId IdType="pmc">PMC4201181</ArticleId><ArticleId IdType="pubmed">25328363</ArticleId></ArticleIdList></Reference><Reference><Citation>Voss EA, Boyce RD, Ryan PB, van der Lei J, Rijnbeek PR, Schuemie MJ. 2016. Accuracy of an automated knowledge base for identifying drug adverse reactions. J. Biomed. Inform. 66, 72&#x2013;81. (10.1016/j.jbi.2016.12.005)</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jbi.2016.12.005</ArticleId><ArticleId IdType="pmc">PMC5316295</ArticleId><ArticleId IdType="pubmed">27993747</ArticleId></ArticleIdList></Reference><Reference><Citation>Avillach P, et al. 2013. Design and validation of an automated method to detect known adverse drug reactions in MEDLINE: a contribution from the EU-ADR project. J. Am. Med. Inform. Assoc. 20, 446&#x2013;452. (10.1136/amiajnl-2012-001083)</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/amiajnl-2012-001083</ArticleId><ArticleId IdType="pmc">PMC3628051</ArticleId><ArticleId IdType="pubmed">23195749</ArticleId></ArticleIdList></Reference><Reference><Citation>Kilicoglu H, Rosemblat G, Fiszman M, Rindflesch TC. 2011. Constructing a semantic predication gold standard from the biomedical literature. BMC Bioinformatics 12, 486 (10.1186/1471-2105-12-486)</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1471-2105-12-486</ArticleId><ArticleId IdType="pmc">PMC3281188</ArticleId><ArticleId IdType="pubmed">22185221</ArticleId></ArticleIdList></Reference><Reference><Citation>US Food &amp; Drug Administration. 2016. 
FDA adverse event reporting system (FAERS). cited 2016; See http://www.fda.gov/Drugs/GuidanceComplianceRegulatoryInformation/Surveillance/AdverseDrugEffects/</Citation></Reference><Reference><Citation>Duke J, Friedlin J, Li X. 2013. Consistency in the safety labeling of bioequivalent medications. Pharmacoepidemiol. Drug Saf. 22, 294&#x2013;301. (10.1002/pds.3351)</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/pds.3351</ArticleId><ArticleId IdType="pubmed">23042584</ArticleId></ArticleIdList></Reference><Reference><Citation>Wisniewski AF, et al. 2016. Good signal detection practices: evidence from IMI PROTECT. Drug Saf. 39, 469&#x2013;490. (10.1007/s40264-016-0405-1)</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s40264-016-0405-1</ArticleId><ArticleId IdType="pmc">PMC4871909</ArticleId><ArticleId IdType="pubmed">26951233</ArticleId></ArticleIdList></Reference><Reference><Citation>Noren GN, Caster O, Juhlin K, Lindquist M. 2014. Zoo or savannah? Choice of training ground for evidence-based pharmacovigilance. Drug Saf. 37, 655&#x2013;659. (10.1007/s40264-014-0198-z)</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s40264-014-0198-z</ArticleId><ArticleId IdType="pubmed">25005708</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee YC, Lin C-H, Lin M-S, Lu Y, Chang C-H, Lin J-W. 2016. Comparison of the effects of serotonin-norepinephrine reuptake inhibitors versus selective serotonin reuptake inhibitors on cerebrovascular events. J. Clin. Psychiatry 77, e1&#x2013;e7. (10.4088/JCP.14m09394)</Citation><ArticleIdList><ArticleId IdType="doi">10.4088/JCP.14m09394</ArticleId><ArticleId IdType="pubmed">26845272</ArticleId></ArticleIdList></Reference><Reference><Citation>Duke JD, et al. 2017. Risk of angioedema associated with levetiracetam compared with phenytoin: findings of the observational health data sciences and informatics research network. Epilepsia 58, e101&#x2013;e106. (10.1111/epi.13828)</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/epi.13828</ArticleId><ArticleId IdType="pmc">PMC6632067</ArticleId><ArticleId IdType="pubmed">28681416</ArticleId></ArticleIdList></Reference><Reference><Citation>Ramcharran D, Qiu H, Schuemie MJ, Ryan PB. 2017. Atypical antipsychotics and the risk of falls and fractures among older adults: an emulation analysis and an evaluation of additional confounding control strategies. J. Clin. Psychopharmacol. 37, 162&#x2013;168. (10.1097/JCP.0000000000000647)</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/JCP.0000000000000647</ArticleId><ArticleId IdType="pubmed">28225746</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang Y, Desai M, Ryan PB, Defalco FJ, Schuemie MJ, Stang PE, Berlin JA, Yuan Z. 2017. Incidence of diabetic ketoacidosis among patients with type 2 diabetes mellitus treated with SGLT2 inhibitors and other antihyperglycemic agents. Diabetes Res. Clin. Pract. 128, 83&#x2013;90. (10.1016/j.diabres.2017.04.004)</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.diabres.2017.04.004</ArticleId><ArticleId IdType="pubmed">28448895</ArticleId></ArticleIdList></Reference><Reference><Citation>Madigan D, Ryan PB, Schuemie M, Stang PE, Overhage JM, Hartzema AG, Suchard MA, Dumouchel W, Berlin JA. 2013. Evaluating the impact of database heterogeneity on observational study results. Am. J. Epidemiol. 178, 645&#x2013;651. (10.1093/aje/kwt010)</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/aje/kwt010</ArticleId><ArticleId IdType="pmc">PMC3736754</ArticleId><ArticleId IdType="pubmed">23648805</ArticleId></ArticleIdList></Reference><Reference><Citation>Higgins JPT, Thompson SG, Deeks JJ, Altman DG. 2003. Measuring inconsistency in meta-analyses. BMJ 327, 557&#x2013;560. (10.1136/bmj.327.7414.557)</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.327.7414.557</ArticleId><ArticleId IdType="pmc">PMC192859</ArticleId><ArticleId IdType="pubmed">12958120</ArticleId></ArticleIdList></Reference><Reference><Citation>Gartlehner G, et al. 2008. Drug class review: second generation antidepressants. Final report update 4. Portland, OR: Oregon Health &amp; Science University.</Citation></Reference><Reference><Citation>Cipriani A, La Ferla T, Furukawa TA, Signoretti A, Nakagawa A, Churchill R, McGuire H, Barbui C. 2010. Sertraline versus other antidepressive agents for depression. Cochrane Database Syst. Rev. 4, CD006117 (10.1002/14651858.CD006117)</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/14651858.CD006117</ArticleId><ArticleId IdType="pmc">PMC4163971</ArticleId><ArticleId IdType="pubmed">20393946</ArticleId></ArticleIdList></Reference><Reference><Citation>Gelenberg AJ, et al. 2010. Practice guideline for the treatment of patients with major depressive disorder third edition. Am. J. Psychiatry 167, 1 (10.1176/appi.ajp.2009.09111601)</Citation><ArticleIdList><ArticleId IdType="doi">10.1176/appi.ajp.2009.09111601</ArticleId><ArticleId IdType="pubmed">10767867</ArticleId></ArticleIdList></Reference><Reference><Citation>Walker PW, Cole JO, Gardner EA, Hughes AR, Johnston JA, Batey SR, Lineberry CG. 1993. Improvement in fluoxetine-associated sexual dysfunction in patients switched to bupropion. J. Clin. Psychiatry 54, 459&#x2013;465.</Citation><ArticleIdList><ArticleId IdType="pubmed">8276736</ArticleId></ArticleIdList></Reference><Reference><Citation>Schuemie MJ, Ryan PB, Dumouchel W, Suchard MA, Madigan D. 2014. Interpreting observational studies: why empirical calibration is needed to correct p-values. Stat. Med. 33, 209&#x2013;218. (10.1002/sim.5925)</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/sim.5925</ArticleId><ArticleId IdType="pmc">PMC4285234</ArticleId><ArticleId IdType="pubmed">23900808</ArticleId></ArticleIdList></Reference><Reference><Citation>Cardwell CR, Abnet CC, Cantwell MM, Murray LJ. 2010. Exposure to oral bisphosphonates and risk of esophageal cancer. JAMA 304, 657&#x2013;663. (10.1001/jama.2010.1098)</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2010.1098</ArticleId><ArticleId IdType="pmc">PMC3513370</ArticleId><ArticleId IdType="pubmed">20699457</ArticleId></ArticleIdList></Reference><Reference><Citation>de Vries F, De Vries C, Cooper C, Leufkens B, Van Staa T-P. 2006. Reanalysis of two studies with contrasting results on the association between statin use and fracture risk: the general practice research database. Int. J. Epidemiol. 35, 1301&#x2013;1308. (10.1093/ije/dyl147)</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/ije/dyl147</ArticleId><ArticleId IdType="pubmed">17053011</ArticleId></ArticleIdList></Reference><Reference><Citation>Green J, Czanner G, Reeves G, Watson J, Wise L, Beral V. 2010. Oral bisphosphonates and risk of cancer of oesophagus, stomach, and colorectum: case-control analysis within a UK primary care cohort. BMJ 341, c4444 (10.1136/bmj.c4444)</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.c4444</ArticleId><ArticleId IdType="pmc">PMC2933354</ArticleId><ArticleId IdType="pubmed">20813820</ArticleId></ArticleIdList></Reference><Reference><Citation>Grodstein F, Stampfer MJ, Manson JAE, Colditz GA, Willett WC, Rosner B, Speizer FE, Hennekens CH. 1996. Postmenopausal estrogen and progestin use and the risk of cardiovascular disease. N Engl. J. Med. 335, 453&#x2013;461. (10.1056/NEJM199608153350701)</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJM199608153350701</ArticleId><ArticleId IdType="pubmed">8672166</ArticleId></ArticleIdList></Reference><Reference><Citation>Manson JE, et al. 2003. Estrogen plus progestin and the risk of coronary heart disease. N Engl. J. Med. 349, 523&#x2013;534. (10.1056/NEJMoa030808)</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa030808</ArticleId><ArticleId IdType="pubmed">12904517</ArticleId></ArticleIdList></Reference><Reference><Citation>Mayes LC, Horwitz RI, Feinstein AR. 1988. A collection of 56 topics with contradictory results in case-control research. Int. J. Epidemiol. 17, 680&#x2013;685. (10.1093/ije/17.3.680)</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/ije/17.3.680</ArticleId><ArticleId IdType="pubmed">3272133</ArticleId></ArticleIdList></Reference><Reference><Citation>Meier CR, Schlienger RG, Kraenzlin ME, Schlegel B, Jick H. 2000. HMG-CoA reductase inhibitors and the risk of fractures. JAMA 283, 3205&#x2013;3210. (10.1001/jama.283.24.3205)</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.283.24.3205</ArticleId><ArticleId IdType="pubmed">10866867</ArticleId></ArticleIdList></Reference><Reference><Citation>van Staa TP, Wegman S, de Vries F, Leufkens B, Cooper C. 2001. Use of statins and risk of fractures. JAMA 285, 1850&#x2013;1855. (10.1001/jama.285.14.1850)</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.285.14.1850</ArticleId><ArticleId IdType="pubmed">11308398</ArticleId></ArticleIdList></Reference><Reference><Citation>Varas-Lorenzo C, Garc&#xed;a-Rodr&#xed;guez LA, Perez-Gutthann S, Duque-Oliart A. 2000. Hormone replacement therapy and incidence of acute myocardial infarction. A population-based nested case-control study. Circulation 101, 2572&#x2013;2578. (10.1161/01.CIR.101.22.2572)</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/01.CIR.101.22.2572</ArticleId><ArticleId IdType="pubmed">10840007</ArticleId></ArticleIdList></Reference><Reference><Citation>Wilson PW, Garrison RJ, Castelli WP. 1986. Postmenopausal estrogen use, cigarette smoking, and cardiovascular morbidity in women over 50. The Framingham study. N Engl. J. Med. 313, 1038&#x2013;1043. (10.1056/NEJM198510243131702)</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJM198510243131702</ArticleId><ArticleId IdType="pubmed">2995808</ArticleId></ArticleIdList></Reference><Reference><Citation>Arnold BF, Ercumen A, Benjamin-Chung J, Colford JM.. 2016. Brief report: negative controls to detect selection bias and measurement bias in epidemiologic studies. Epidemiology 27, 637&#x2013;641. (10.1097/EDE.0000000000000504)</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/EDE.0000000000000504</ArticleId><ArticleId IdType="pmc">PMC4969055</ArticleId><ArticleId IdType="pubmed">27182642</ArticleId></ArticleIdList></Reference><Reference><Citation>Desai JR, Hyde CL, Kabadi S, St Louis M, Bonato V, Katrina Loomis A, Galaznik A, Berger ML. 2017. Utilization of positive and negative controls to examine comorbid associations in observational database studies. Med. Care 55, 244&#x2013;251. (10.1097/MLR.0000000000000640)</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/MLR.0000000000000640</ArticleId><ArticleId IdType="pmc">PMC5318155</ArticleId><ArticleId IdType="pubmed">27787351</ArticleId></ArticleIdList></Reference><Reference><Citation>Farrington CP. 1995. Relative incidence estimation from case series for vaccine safety evaluation. Biometrics 51, 228&#x2013;235. (10.2307/2533328)</Citation><ArticleIdList><ArticleId IdType="doi">10.2307/2533328</ArticleId><ArticleId IdType="pubmed">7766778</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">30085008</PMID><DateCompleted><Year>2019</Year><Month>12</Month><Day>11</Day></DateCompleted><DateRevised><Year>2020</Year><Month>11</Month><Day>10</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1527-974X</ISSN><JournalIssue CitedMedium="Internet"><Volume>25</Volume><Issue>10</Issue><PubDate><Year>2018</Year><Month>Oct</Month><Day>01</Day></PubDate></JournalIssue><Title>Journal of the American Medical Informatics Association : JAMIA</Title><ISOAbbreviation>J Am Med Inform Assoc</ISOAbbreviation></Journal><ArticleTitle>Web services for data warehouses: OMOP and PCORnet on i2b2.</ArticleTitle><Pagination><StartPage>1331</StartPage><EndPage>1338</EndPage><MedlinePgn>1331-1338</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1093/jamia/ocy093</ELocationID><Abstract><AbstractText Label="OBJECTIVE">Healthcare organizations use research data models supported by projects and tools that interest them, which often means organizations must support the same data in multiple models. The healthcare research ecosystem would benefit if tools and projects could be adopted independently from the underlying data model. Here, we introduce the concept of a reusable application programming interface (API) for healthcare and show that the i2b2 API can be adapted to support diverse patient-centric data models.</AbstractText><AbstractText Label="MATERIALS AND METHODS">We develop methodology for extending i2b2's pre-existing API to query additional data models, using i2b2's recent "multi-fact-table querying" feature. Our method involves developing data-model-specific i2b2 ontologies and mapping these to query non-standard table structure.</AbstractText><AbstractText Label="RESULTS">We implement this methodology to query OMOP and PCORnet models, which we validate with the i2b2 query tool. We implement the entire PCORnet data model and a five-domain subset of the OMOP model. We also demonstrate that additional, ancillary data model columns can be modeled and queried as i2b2 "modifiers."</AbstractText><AbstractText Label="DISCUSSION">i2b2's REST API can be used to query multiple healthcare data models, enabling shared tooling to have a choice of backend data stores. This enables separation between data model and software tooling for some of the more popular open analytic data models in healthcare.</AbstractText><AbstractText Label="CONCLUSION">This methodology immediately allows querying OMOP and PCORnet using the i2b2 API. It is released as an open-source set of Docker images, and also on the i2b2 community wiki.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Klann</LastName><ForeName>Jeffrey G</ForeName><Initials>JG</Initials><AffiliationInfo><Affiliation>Research Information Science and Computing, Partners Healthcare, Boston, Massachusetts, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Harvard Medical School, Boston, Massachusetts, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Medicine, Massachusetts General Hospital, Boston, Massachusetts, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Phillips</LastName><ForeName>Lori C</ForeName><Initials>LC</Initials><AffiliationInfo><Affiliation>Research Information Science and Computing, Partners Healthcare, Boston, Massachusetts, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Herrick</LastName><ForeName>Christopher</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Research Information Science and Computing, Partners Healthcare, Boston, Massachusetts, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Joss</LastName><ForeName>Matthew A H</ForeName><Initials>MAH</Initials><AffiliationInfo><Affiliation>Research Information Science and Computing, Partners Healthcare, Boston, Massachusetts, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wagholikar</LastName><ForeName>Kavishwar B</ForeName><Initials>KB</Initials><AffiliationInfo><Affiliation>Research Information Science and Computing, Partners Healthcare, Boston, Massachusetts, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Medicine, Massachusetts General Hospital, Boston, Massachusetts, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Murphy</LastName><ForeName>Shawn N</ForeName><Initials>SN</Initials><AffiliationInfo><Affiliation>Research Information Science and Computing, Partners Healthcare, Boston, Massachusetts, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Harvard Medical School, Boston, Massachusetts, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Neurology, Massachusetts General Hospital, Boston, Massachusetts, USA.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>R00 LM011575</GrantID><Acronym>LM</Acronym><Agency>NLM NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>U54 HG007963</GrantID><Acronym>HG</Acronym><Agency>NHGRI NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R01 HG009174</GrantID><Acronym>HG</Acronym><Agency>NHGRI NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D052061">Research Support, N.I.H., Extramural</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>J Am Med Inform Assoc</MedlineTA><NlmUniqueID>9430800</NlmUniqueID><ISSNLinking>1067-5027</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000077558" MajorTopicYN="Y">Big Data</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D035843" MajorTopicYN="N">Biomedical Research</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000073458" MajorTopicYN="N">Data Warehousing</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="Y">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016208" MajorTopicYN="N">Databases, Factual</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D057286" MajorTopicYN="Y">Electronic Health Records</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D020407" MajorTopicYN="Y">Internet</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008962" MajorTopicYN="N">Models, Theoretical</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012984" MajorTopicYN="N">Software</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018875" MajorTopicYN="N">Vocabulary, Controlled</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2018</Year><Month>1</Month><Day>7</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2018</Year><Month>6</Month><Day>28</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2018</Year><Month>8</Month><Day>8</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2019</Year><Month>12</Month><Day>18</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2018</Year><Month>8</Month><Day>8</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2018</Year><Month>7</Month><Day>30</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">30085008</ArticleId><ArticleId IdType="pmc">PMC6188504</ArticleId><ArticleId IdType="doi">10.1093/jamia/ocy093</ArticleId><ArticleId IdType="pii">5061849</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>OHDSI | Observational Health Data Sciences and Informatics. http://www.ohdsi.org/ Accessed July 29, 2015.</Citation></Reference><Reference><Citation>Hripcsak G, Duke JD, Shah NH, et al. Observational Health Data Sciences and Informatics (OHDSI): opportunities for observational researchers. Stud Health Technol Inform 2015; 216: 574&#x2013;8.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4815923</ArticleId><ArticleId IdType="pubmed">26262116</ArticleId></ArticleIdList></Reference><Reference><Citation>
OHDSI. resources: data_network. Observational Health Data Sciences and Informatics. http://www.ohdsi.org/web/wiki/doku.php?id=resources: data_network Accessed April 18, 2018.</Citation></Reference><Reference><Citation>
All of Us Research Program. National Institutes of Health (NIH). https://allofus.nih.gov/ Accessed March 6, 2017.</Citation></Reference><Reference><Citation>Collins FS, Hudson KL, Briggs JP, et al. PCORnet: turning a dream into reality. J Am Med Inform Assoc 2014; 214: 576&#x2013;7.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4078299</ArticleId><ArticleId IdType="pubmed">24821744</ArticleId></ArticleIdList></Reference><Reference><Citation>PCORnet Common Data Model (CDM). PCORnet. http://www.pcornet.org/pcornet-common-data-model/ Accessed March 6, 2017.</Citation></Reference><Reference><Citation>Murphy SN, Weber G, Mendis M, et al. Serving the enterprise and beyond with Informatics for Integrating Biology and the Bedside (i2b2). J Am Med Inform Assoc 2010; 172: 124&#x2013;30.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3000779</ArticleId><ArticleId IdType="pubmed">20190053</ArticleId></ArticleIdList></Reference><Reference><Citation>McMurry AJ, Murphy SN, MacFadden D, et al. SHRINE: enabling nationally scalable multi-site disease studies. PLoS One 2013; 83: e55811.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3591385</ArticleId><ArticleId IdType="pubmed">23533569</ArticleId></ArticleIdList></Reference><Reference><Citation>CTSA Consortium Tackling Clinical Trial Recruitment Roadblocks. National Center for Advancing Translational Sciences. 2015. https://ncats.nih.gov/pubs/features/ctsa-act Accessed September 21, 2016.</Citation></Reference><Reference><Citation>i2b2 Community Plugins. GitHub. https://github.com/i2b2plugins Accessed January 6, 2018.</Citation></Reference><Reference><Citation>Klann JG, Abend A, Raghavan VA, et al. Data interchange using i2b2. J Am Med Inform Assoc 2016; 235: 909&#x2013;15.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4997035</ArticleId><ArticleId IdType="pubmed">26911824</ArticleId></ArticleIdList></Reference><Reference><Citation>Murphy SN, Mendis M, Hackett K, et al. Architecture of the Open-source Clinical Research Chart from Informatics for Integrating Biology and the Bedside. AMIA Annu Symp Proc 2007; 2007: 548&#x2013;52.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2655844</ArticleId><ArticleId IdType="pubmed">18693896</ArticleId></ArticleIdList></Reference><Reference><Citation>Wagholikar KB, Mandel JC, Klann JG, et al. SMART-on-FHIR implemented over i2b2. J Am Med Inform Assoc 2017; 242: 398.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5391721</ArticleId><ArticleId IdType="pubmed">27274012</ArticleId></ArticleIdList></Reference><Reference><Citation>Klann JG, Murphy SN.. Computing health quality measures using Informatics for Integrating Biology and the Bedside. J Med Internet Res 2013; 154: e75.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3636801</ArticleId><ArticleId IdType="pubmed">23603227</ArticleId></ArticleIdList></Reference><Reference><Citation>Klann JG, Mendis M, Phillips LC, et al. Taking advantage of continuity of care documents to populate a research repository. J Am Med Inform Assoc 2014; 22 (2): 370&#x2013;9.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6080729</ArticleId><ArticleId IdType="pubmed">25352566</ArticleId></ArticleIdList></Reference><Reference><Citation>Wattanasin N, Porter A, Ubaha S, et al. Apps to display patient data, making SMART available in the i2b2 platform. AMIA Annu Symp Proc 2012; 2012: 960&#x2013;9.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3540423</ArticleId><ArticleId IdType="pubmed">23304371</ArticleId></ArticleIdList></Reference><Reference><Citation>Kenneth Fisher. UNPIVOT a table using CROSS APPLY. SQL Studies. 2013. 
https://sqlstudies.com/2013/04/01/unpivot-a-table-using-cross-apply/ Accessed April 23, 2018.</Citation></Reference><Reference><Citation>unpivot and PostgreSQL - Stack Overflow. https://stackoverflow.com/questions/1128737/unpivot-and-postgresql Accessed April 23, 2018.</Citation></Reference><Reference><Citation>Accessible Research Commons for Health Github. GitHub. https://github.com/ARCH-commons Accessed March 6, 2017.</Citation></Reference><Reference><Citation>
Phillips L. NCBO Extraction Tool Version 2.0. NCBO Ontology Tools for i2b2. https://community.i2b2.org/wiki/display/NCBO/NCBO+Extraction+Tool+version+2.0 Accessed December 4, 2014.</Citation></Reference><Reference><Citation>CommonDataModel: Definition and DDLs for the OMOP Common Data Model (CDM). Observational Health Data Sciences and Informatics 2017. https://github.com/OHDSI/CommonDataModel Accessed December 22, 2017.</Citation></Reference><Reference><Citation>i2b2 on OMOP - Release 1.7.09. https://community.i2b2.org/wiki/display/OMOP/Release+1.7.09 Accessed November 15, 2017.</Citation></Reference><Reference><Citation>
Klann JG, Joss M. i2b2-on-PCORnet: Scripts and Documentation for Implementing. Accessible Research Commons for Health 2017. 
https://github.com/ARCH-commons/arch-utils/tree/master/i2b2_on_PCORnet Accessed January 4, 2018.</Citation></Reference><Reference><Citation>ETL-CMS: Workproducts to ETL CMS datasets into OMOP Common Data Model. Observational Health Data Sciences and Informatics 2017. 
https://github.com/OHDSI/ETL-CMS Accessed January 7, 2018.</Citation></Reference><Reference><Citation>
pcori/omop i2b2 demo. https://github.com/waghsk/i2b2-quickstart/wiki/pcori-demo Accessed November 15, 2017.</Citation></Reference><Reference><Citation>
Install dockerized i2b2 on PCORnet/OMOP. https://github.com/ARCH-commons/arch-utils/wiki/Install-dockerized-i2b2-on-PCORnet Accessed November 15, 2017.</Citation></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">30100761</PMID><DateRevised><Year>2022</Year><Month>03</Month><Day>18</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Print">1179-1349</ISSN><JournalIssue CitedMedium="Print"><Volume>10</Volume><PubDate><Year>2018</Year></PubDate></JournalIssue><Title>Clinical epidemiology</Title><ISOAbbreviation>Clin Epidemiol</ISOAbbreviation></Journal><ArticleTitle>Applying a common data model to Asian databases for multinational pharmacoepidemiologic studies: opportunities and challenges.</ArticleTitle><Pagination><StartPage>875</StartPage><EndPage>885</EndPage><MedlinePgn>875-885</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.2147/CLEP.S149961</ELocationID><Abstract><AbstractText Label="OBJECTIVE" NlmCategory="OBJECTIVE">The goal of the Asian Pharmacoepidemiology Network is to study the effectiveness and safety of medications commonly used in Asia using databases from individual Asian countries. An efficient infrastructure to support multinational pharmacoepidemiologic studies is critical to this effort.</AbstractText><AbstractText Label="STUDY DESIGN AND SETTING" NlmCategory="METHODS">We converted data from the Japan Medical Data Center database, Taiwan's National Health Insurance Research Database, Hong Kong's Clinical Data Analysis and Reporting System, South Korea's Ajou University School of Medicine database, and the US Medicare 5% sample to the Observational Medical Outcome Partnership common data model (CDM).</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">We completed and documented the process for the CDM conversion. The coordinating center and participating sites reviewed the documents and refined the conversions based on the comments. The time required to convert data to the CDM varied widely across sites and included conversion to standard terminology codes and refinements of the conversion based on reviews. We mapped 97.2%, 86.7%, 92.6%, and 80.1% of domestic drug codes from the USA, Taiwan, Hong Kong, and Korea to RxNorm, respectively. The mapping rate from Japanese domestic drug codes to RxNorm (70.7%) was lower than from other countries, and we mapped remaining unmapped drugs to Anatomical Therapeutic Chemical Classification System codes. Because the native databases used international procedure coding systems for which mapping tables have been established, we were able to map &gt;90% of diagnosis and procedure codes to standard terminology codes.</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">The CDM established the foundation and reinforced collaboration for multinational pharmacoepidemiologic studies in Asia. Mapping of terminology codes was the greatest challenge, because of differences in health systems, cultures, and coding systems.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Lai</LastName><ForeName>Edward Chia-Cheng</ForeName><Initials>EC</Initials><AffiliationInfo><Affiliation>School of Pharmacy, Institute of Clinical Pharmacy and Pharmaceutical Sciences, National Cheng Kung University, Tainan, Taiwan.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Pharmacy, National Cheng Kung University Hospital, Tainan, Taiwan.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Health Outcome Research Center, National Cheng-Kung University, Tainan, Taiwan.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Duke Clinical Research Institute, Duke University School of Medicine, Durham, NC, USA, soko.setoguchi@rutgers.edu.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ryan</LastName><ForeName>Patrick</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Janssen Research &amp; Development, LLC, Titusville, NJ, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhang</LastName><ForeName>Yinghong</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Duke Clinical Research Institute, Duke University School of Medicine, Durham, NC, USA, soko.setoguchi@rutgers.edu.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Schuemie</LastName><ForeName>Martijn</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Janssen Research &amp; Development, LLC, Titusville, NJ, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hardy</LastName><ForeName>N Chantelle</ForeName><Initials>NC</Initials><AffiliationInfo><Affiliation>Duke Clinical Research Institute, Duke University School of Medicine, Durham, NC, USA, soko.setoguchi@rutgers.edu.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kamijima</LastName><ForeName>Yukari</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>NPO Drug Safety Research Unit Japan, Tokyo, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kimura</LastName><ForeName>Shinya</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Japan Medical Data Center Co.,Ltd, Tokyo, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kubota</LastName><ForeName>Kiyoshi</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>NPO Drug Safety Research Unit Japan, Tokyo, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Man</LastName><ForeName>Kenneth Kc</ForeName><Initials>KK</Initials><AffiliationInfo><Affiliation>Centre for Safe Medication Practice and Research, Department of Pharmacology and Pharmacy, University of Hong Kong, Hong Kong, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Research Department of Practice and Policy, UCL School of Pharmacy, London, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cho</LastName><ForeName>Soo Yeon</ForeName><Initials>SY</Initials><AffiliationInfo><Affiliation>Department of Biomedical Informatics, School of Medicine, Ajou University, Suwon, Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Park</LastName><ForeName>Rae Woong</ForeName><Initials>RW</Initials><AffiliationInfo><Affiliation>Department of Biomedical Informatics, School of Medicine, Ajou University, Suwon, Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Stang</LastName><ForeName>Paul</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Janssen Research &amp; Development, LLC, Titusville, NJ, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Su</LastName><ForeName>Chien-Chou</ForeName><Initials>CC</Initials><AffiliationInfo><Affiliation>School of Pharmacy, Institute of Clinical Pharmacy and Pharmaceutical Sciences, National Cheng Kung University, Tainan, Taiwan.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Health Outcome Research Center, National Cheng-Kung University, Tainan, Taiwan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wong</LastName><ForeName>Ian Ck</ForeName><Initials>IC</Initials><AffiliationInfo><Affiliation>Centre for Safe Medication Practice and Research, Department of Pharmacology and Pharmacy, University of Hong Kong, Hong Kong, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Research Department of Practice and Policy, UCL School of Pharmacy, London, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kao</LastName><ForeName>Yea-Huei Yang</ForeName><Initials>YY</Initials><AffiliationInfo><Affiliation>School of Pharmacy, Institute of Clinical Pharmacy and Pharmaceutical Sciences, National Cheng Kung University, Tainan, Taiwan.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Health Outcome Research Center, National Cheng-Kung University, Tainan, Taiwan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Setoguchi</LastName><ForeName>Soko</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Duke Clinical Research Institute, Duke University School of Medicine, Durham, NC, USA, soko.setoguchi@rutgers.edu.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Institute for Health, Rutgers University and Department of Medicine, Rutgers Robert Wood Johnson Medical School, New Brunswick, NJ, USA, soko.setoguchi@rutgers.edu.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2018</Year><Month>07</Month><Day>27</Day></ArticleDate></Article><MedlineJournalInfo><Country>New Zealand</Country><MedlineTA>Clin Epidemiol</MedlineTA><NlmUniqueID>101531700</NlmUniqueID><ISSNLinking>1179-1349</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">clinical coding</Keyword><Keyword MajorTopicYN="N">computer communication networks</Keyword><Keyword MajorTopicYN="N">feasibility studies</Keyword><Keyword MajorTopicYN="N">pharmacoepidemiology</Keyword><Keyword MajorTopicYN="N">pharmacovigilance</Keyword></KeywordList><CoiStatement>Disclosure The authors report no conflicts of interest in this work.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2018</Year><Month>8</Month><Day>14</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2018</Year><Month>8</Month><Day>14</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2018</Year><Month>8</Month><Day>14</Day><Hour>6</Hour><Minute>1</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2018</Year><Month>7</Month><Day>27</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">30100761</ArticleId><ArticleId IdType="pmc">PMC6067778</ArticleId><ArticleId IdType="doi">10.2147/CLEP.S149961</ArticleId><ArticleId IdType="pii">clep-10-875</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Lai E, Stang P, Kao Yang Y, Kubota K, Wong IC, Setoguchi S. International multi-database pharmacoepidemiology: potentials and pitfalls. Curr Epidemiol Rep. 2015;2(4):229&#x2013;238.</Citation></Reference><Reference><Citation>Lai EC, Man KK, Chaiyakunapruk N, et al. Databases in the Asia-Pacific Region: the potential for a distributed network approach. Epidemiology. 2015;26(6):815&#x2013;820.</Citation><ArticleIdList><ArticleId IdType="pubmed">26133022</ArticleId></ArticleIdList></Reference><Reference><Citation>Voss EA, Makadia R, Matcho A, et al. Feasibility and utility of applications of the common data model to multiple, disparate observational health databases. J Am Med Inform Assoc. 2015;22(3):553&#x2013;564.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4457111</ArticleId><ArticleId IdType="pubmed">25670757</ArticleId></ArticleIdList></Reference><Reference><Citation>Andersen M, Bergman U, Choi NK, et al. The Asian Pharmacoepidemiology Network (AsPEN): promoting multinational collaboration for pharmacoepidemiologic research in Asia. Pharmacoepidemiol Drug Saf. 2013;22(7):700&#x2013;704.</Citation><ArticleIdList><ArticleId IdType="pubmed">23653370</ArticleId></ArticleIdList></Reference><Reference><Citation>Pratt N, Andersen M, Bergman U, et al. Multi-country rapid adverse drug event assessment: the Asian Pharmacoepidemiology Network (AsPEN) antipsychotic and acute hyperglycaemia study. Pharmacoepidemiol Drug Saf. 2013;22(9):915&#x2013;924.</Citation><ArticleIdList><ArticleId IdType="pubmed">23696036</ArticleId></ArticleIdList></Reference><Reference><Citation>Roughead EE, Chan EW, Choi NK, et al. Variation in association between thiazolidinediones and heart failure across ethnic groups: retrospective analysis of large healthcare claims databases in six countries. Drug Saf. 2015;38(9):823&#x2013;831.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4561996</ArticleId><ArticleId IdType="pubmed">26216600</ArticleId></ArticleIdList></Reference><Reference><Citation>Pratt N, Chan EW, Choi NK, et al. Prescription sequence symmetry analysis: assessing risk, temporality, and consistency for adverse drug reactions across datasets in five countries. Pharmacoepidemiol Drug Saf. 2015;24(8):858&#x2013;864.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4690514</ArticleId><ArticleId IdType="pubmed">25907076</ArticleId></ArticleIdList></Reference><Reference><Citation>OHDSI [homepage on the Internet]  The Observational Health Data Sciences and Informatics. 2017.  [Accessed September 23, 2017].  Available from:  https://www.ohdsi.org/</Citation></Reference><Reference><Citation>homepage on the Internet Tawian National Health Insurance Administration. 2017.  [Accessed September 23, 2017].  Available from:  http://www.nhi.gov.tw/</Citation></Reference><Reference><Citation>Stang PE, Ryan PB, Racoosin JA, et al. Advancing the science for active surveillance: rationale and design for the Observational Medical Outcomes Partnership. Ann Intern Med. 2010;153(9):600&#x2013;606.</Citation><ArticleIdList><ArticleId IdType="pubmed">21041580</ArticleId></ArticleIdList></Reference><Reference><Citation>Xu Y, Zhou X, Suehs BT, et al. A comparative assessment of Observational Medical Outcomes Partnership and Mini-Sentinel common data models and analytics: implications for active drug safety surveillance. Drug Saf. 2015;38(8):749&#x2013;765.</Citation><ArticleIdList><ArticleId IdType="pubmed">26055920</ArticleId></ArticleIdList></Reference><Reference><Citation>Overhage JM, Ryan PB, Reich CG, Hartzema AG, Stang PE. Validation of a common data model for active safety surveillance research. J Am Med Inform Assoc. 2012;19(1):54&#x2013;60.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3240764</ArticleId><ArticleId IdType="pubmed">22037893</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhou X, Murugesan S, Bhullar H, et al. An evaluation of the THIN database in the OMOP Common Data Model for active drug safety surveillance. Drug Saf. 2013;36(2):119&#x2013;134.</Citation><ArticleIdList><ArticleId IdType="pubmed">23329543</ArticleId></ArticleIdList></Reference><Reference><Citation>National Library of Medicine [homepage on the Internet]  National Institutes of Health.  [Accessed September 23, 2017].  Available from:  http://www.nlm.nih.gov/</Citation></Reference><Reference><Citation>SNOMED [homepage on the Internet]  NOMED International.  [Accessed September 23, 2017].  Available from:  https://www.snomed.org/</Citation></Reference><Reference><Citation>WHO Collaborating Center for Drug Statistics Methodology [homepage on the Internet]  Anatomical Therapeutic Chemical (ATC) Classification System.  [Accessed August 11, 2016].  Available from:  http://www.whocc.no.</Citation></Reference><Reference><Citation>Hsieh SC, Lai JN, Lee CF, Hu FC, Tseng WL, Wang JD. The prescribing of Chinese herbal products in Taiwan: a cross-sectional analysis of the national health insurance reimbursement database. Pharmacoepidemiol Drug Saf. 2008;17(6):609&#x2013;619.</Citation><ArticleIdList><ArticleId IdType="pubmed">18481335</ArticleId></ArticleIdList></Reference><Reference><Citation>Ryan PB, Madigan D, Stang PE, Overhage JM, Racoosin JA, Hartzema AG. Empirical assessment of methods for risk identification in healthcare data: results from the experiments of the Observational Medical Outcomes Partnership. Stat Med. 2012;31(30):4401&#x2013;4415.</Citation><ArticleIdList><ArticleId IdType="pubmed">23015364</ArticleId></ArticleIdList></Reference><Reference><Citation>Hripcsak G, Duke JD, Shah NH, et al. Observational Health Data Sciences and Informatics (OHDSI): opportunities for observational researchers. Stud Health Technol Inform. 2015;216:574&#x2013;578.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4815923</ArticleId><ArticleId IdType="pubmed">26262116</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">30172760</PMID><DateCompleted><Year>2019</Year><Month>11</Month><Day>19</Day></DateCompleted><DateRevised><Year>2019</Year><Month>11</Month><Day>19</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1532-0480</ISSN><JournalIssue CitedMedium="Internet"><Volume>86</Volume><PubDate><Year>2018</Year><Month>Oct</Month></PubDate></JournalIssue><Title>Journal of biomedical informatics</Title><ISOAbbreviation>J Biomed Inform</ISOAbbreviation></Journal><ArticleTitle>Methodological variations in lagged regression for detecting physiologic drug effects in EHR data.</ArticleTitle><Pagination><StartPage>149</StartPage><EndPage>159</EndPage><MedlinePgn>149-159</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.jbi.2018.08.014</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S1532-0464(18)30173-4</ELocationID><Abstract><AbstractText>We studied how lagged linear regression can be used to detect the physiologic effects of drugs from data in the electronic health record (EHR). We systematically examined the effect of methodological variations ((i) time series construction, (ii) temporal parameterization, (iii) intra-subject normalization, (iv) differencing (lagged rates of change achieved by taking differences between consecutive measurements), (v) explanatory variables, and (vi) regression models) on performance of lagged linear methods in this context. We generated two gold standards (one knowledge-base derived, one expert-curated) for expected pairwise relationships between 7 drugs and 4 labs, and evaluated how the 64 unique combinations of methodological perturbations reproduce the gold standards. Our 28 cohorts included patients in the Columbia University Medical Center/NewYork-Presbyterian Hospital clinical database, and ranged from 2820 to 79,514 patients with between 8 and 209 average time points per patient. The most accurate methods achieved AUROC of 0.794 for knowledge-base derived gold standard (95%CI [0.741, 0.847]) and 0.705 for expert-curated gold standard (95% CI [0.629, 0.781]). We observed a mean AUROC of 0.633 (95%CI [0.610, 0.657], expert-curated gold standard) across all methods that re-parameterize time according to sequence and use either a joint autoregressive model with time-series differencing or an independent lag model without differencing. The complement of this set of methods achieved a mean AUROC close to 0.5, indicating the importance of these choices. We conclude that time-series analysis of EHR data will likely rely on some of the beneficial pre-processing and modeling methodologies identified, and will certainly benefit from continued careful analysis of methodological perturbations. This study found that methodological variations, such as pre-processing and representations, have a large effect on results, exposing the importance of thoroughly evaluating these components when comparing machine-learning methods.</AbstractText><CopyrightInformation>Copyright &#xa9; 2018 Elsevier Inc. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Levine</LastName><ForeName>Matthew E</ForeName><Initials>ME</Initials><AffiliationInfo><Affiliation>Department of Biomedical Informatics, Columbia University Medical Center, 622 W. 168th Street, Presbyterian Building 20th Floor, New York, NY 10032, United States; Observational Health Data Sciences and Informatics (OHDSI), New York, NY, United States. Electronic address: mel2193@cumc.columbia.edu.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Albers</LastName><ForeName>David J</ForeName><Initials>DJ</Initials><AffiliationInfo><Affiliation>Department of Biomedical Informatics, Columbia University Medical Center, 622 W. 168th Street, Presbyterian Building 20th Floor, New York, NY 10032, United States; Observational Health Data Sciences and Informatics (OHDSI), New York, NY, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hripcsak</LastName><ForeName>George</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Department of Biomedical Informatics, Columbia University Medical Center, 622 W. 168th Street, Presbyterian Building 20th Floor, New York, NY 10032, United States; Observational Health Data Sciences and Informatics (OHDSI), New York, NY, United States; NewYork-Presbyterian Hospital, 622 W. 168th Street, New York, NY 10032, United States.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>R01 LM006910</GrantID><Acronym>LM</Acronym><Agency>NLM NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D052061">Research Support, N.I.H., Extramural</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2018</Year><Month>08</Month><Day>30</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>J Biomed Inform</MedlineTA><NlmUniqueID>100970413</NlmUniqueID><ISSNLinking>1532-0464</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D004364">Pharmaceutical Preparations</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000046" MajorTopicYN="N">Academic Medical Centers</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D019540" MajorTopicYN="N">Area Under Curve</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003625" MajorTopicYN="N">Data Collection</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016208" MajorTopicYN="N">Databases, Factual</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004358" MajorTopicYN="N">Drug Therapy</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="Y">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D057286" MajorTopicYN="Y">Electronic Health Records</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016014" MajorTopicYN="N">Linear Models</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000069550" MajorTopicYN="Y">Machine Learning</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009519" MajorTopicYN="N" Type="Geographic">New York City</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004364" MajorTopicYN="Y">Pharmaceutical Preparations</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012372" MajorTopicYN="N">ROC Curve</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012044" MajorTopicYN="N">Regression Analysis</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015203" MajorTopicYN="N">Reproducibility of Results</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D013997" MajorTopicYN="N">Time Factors</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2018</Year><Month>1</Month><Day>3</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2018</Year><Month>7</Month><Day>20</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2018</Year><Month>8</Month><Day>29</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2018</Year><Month>9</Month><Day>3</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2019</Year><Month>11</Month><Day>20</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2018</Year><Month>9</Month><Day>3</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2019</Year><Month>10</Month><Day>1</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">30172760</ArticleId><ArticleId IdType="mid">NIHMS1507969</ArticleId><ArticleId IdType="pmc">PMC6207533</ArticleId><ArticleId IdType="doi">10.1016/j.jbi.2018.08.014</ArticleId><ArticleId IdType="pii">S1532-0464(18)30173-4</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Hripcsak G and Albers DJ, &#x201c;Next-generation phenotyping of electronic health records,&#x201d; Journal of the American Medical Informatics Association, vol. 20, no. 1, pp. 117&#x2013;121, Jan. 2013.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3555337</ArticleId><ArticleId IdType="pubmed">22955496</ArticleId></ArticleIdList></Reference><Reference><Citation>Hripcsak G et al., &#x201c;Observational Health Data Sciences and Informatics (OHDSI): Opportunities for Observational Researchers,&#x201d; Stud Health Technol Inform, vol. 216, pp. 574&#x2013;578, 2015.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4815923</ArticleId><ArticleId IdType="pubmed">26262116</ArticleId></ArticleIdList></Reference><Reference><Citation>Bates DW, Evans RS, Murff H, Stetson PD, Pizziferri L, and Hripcsak G, &#x201c;Detecting Adverse Events Using Information Technology,&#x201d; J Am Med Inform Assoc, vol. 10, no. 2, pp. 115&#x2013;128, Mar. 2003.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC150365</ArticleId><ArticleId IdType="pubmed">12595401</ArticleId></ArticleIdList></Reference><Reference><Citation>Ho T-B, Le L, Thai DT, and Taewijit S, &#x201c;Data-driven Approach to Detect and Predict Adverse Drug Reactions,&#x201d; Current Pharmaceutical Design, vol. 22, no. 23, pp. 3498&#x2013;3526, Jun. 2016.</Citation><ArticleIdList><ArticleId IdType="pubmed">27157416</ArticleId></ArticleIdList></Reference><Reference><Citation>Sohn S, Kocher J-PA, Chute CG, and Savova GK, &#x201c;Drug side effect extraction from clinical narratives of psychiatry and psychology patients,&#x201d; J Am Med Inform Assoc, vol. 18, no. Suppl 1, pp. i144&#x2013;i149, Dec. 2011.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3241172</ArticleId><ArticleId IdType="pubmed">21946242</ArticleId></ArticleIdList></Reference><Reference><Citation>Sohn S et al., &#x201c;Comprehensive temporal information detection from clinical text: medical events, time, and TLINK identification,&#x201d; J Am Med Inform Assoc, vol. 20, no. 5, pp. 836&#x2013;842, Sep. 2013.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3756269</ArticleId><ArticleId IdType="pubmed">23558168</ArticleId></ArticleIdList></Reference><Reference><Citation>Golder S, Norman G, and Loke YK, &#x201c;Systematic review on the prevalence, frequency and comparative value of adverse events data in social media,&#x201d; Br J Clin Pharmacol, vol. 80, no. 4, pp. 878&#x2013;888, Oct. 2015.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4594731</ArticleId><ArticleId IdType="pubmed">26271492</ArticleId></ArticleIdList></Reference><Reference><Citation>Hripcsak G et al., &#x201c;Characterizing treatment pathways at scale using the OHDSI network,&#x201d; PNAS, vol. 113, no. 27, pp. 7329&#x2013;7336, May 2016.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4941483</ArticleId><ArticleId IdType="pubmed">27274072</ArticleId></ArticleIdList></Reference><Reference><Citation>Schuemie MJ, Ryan PB, Hripcsak G, Madigan D, and Suchard MA, &#x201c;A systematic approach to improving the reliability and scale of evidence from health care data,&#x201d; arXiv:1803 10791 [stat], Mar. 2018.</Citation></Reference><Reference><Citation>Lasko TA, Denny JC, and Levy MA, &#x201c;Computational Phenotype Discovery Using Unsupervised Feature Learning over Noisy, Sparse, and Irregular Clinical Data,&#x201d; PLoS ONE, vol. 8, no. 6, p. e66341, Jun. 2013.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3691199</ArticleId><ArticleId IdType="pubmed">23826094</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu Z and Hauskrecht M, &#x201c;Learning Linear Dynamical Systems from Multivariate Time Series: A Matrix Factorization Based Framework,&#x201d; Proc SIAM Int Conf Data Min, vol. 2016, pp. 810&#x2013;818, May 2016.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5098501</ArticleId><ArticleId IdType="pubmed">27830108</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu Z and Hauskrecht M, &#x201c;Learning Adaptive Forecasting Models from Irregularly Sampled Multivariate Clinical Data,&#x201d; Proc Conf AAAI Artif Intell, vol. 2016, pp. 1273&#x2013;1279, Feb. 2016.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4980099</ArticleId><ArticleId IdType="pubmed">27525189</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang F, Lee N, Hu J, Sun J, and Ebadollahi S, &#x201c;Towards heterogeneous temporal clinical event pattern discovery: a convolutional approach,&#x201d; in Proceedings of the 18th ACM SIGKDD international conference on Knowledge discovery and data mining, 2012, pp. 453&#x2013;461.</Citation></Reference><Reference><Citation>Batal I, Valizadegan H, Cooper GF, and Hauskrecht M, &#x201c;A Pattern Mining Approach for Classifying Multivariate Temporal Data,&#x201d; Proceedings (IEEE Int Conf Bioinformatics Biomed), vol. 2011, pp. 358&#x2013;365, Nov. 2011.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3261774</ArticleId><ArticleId IdType="pubmed">22267987</ArticleId></ArticleIdList></Reference><Reference><Citation>Nor&#xe9;n GN, Hopstadius J, Bate A, Star K, and Edwards IR, &#x201c;Temporal pattern discovery in longitudinal electronic patient records,&#x201d; Data Mining and Knowledge Discovery, vol. 20, no. 3, pp. 361&#x2013;387, May 2010.</Citation></Reference><Reference><Citation>Moskovitch R and Shahar Y, &#x201c;Medical temporal-knowledge discovery via temporal abstraction.,&#x201d; in AMIA, 2009.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2815492</ArticleId><ArticleId IdType="pubmed">20351898</ArticleId></ArticleIdList></Reference><Reference><Citation>Moskovitch R and Shahar Y, &#x201c;Classification of multivariate time series via temporal abstraction and time intervals mining,&#x201d; Knowledge and Information Systems, vol. 45, no. 1, pp. 35&#x2013;74, Oct. 2015.</Citation></Reference><Reference><Citation>Ramati M and Shahar Y, &#x201c;Irregular-time Bayesian Networks,&#x201d; in Proceedings of the Twenty-Sixth Conference on Uncertainty in Artificial Intelligence, Arlington, Virginia, United States, 2010, pp. 484&#x2013;491.</Citation></Reference><Reference><Citation>Albers DJ and Hripcsak G, &#x201c;Using time-delayed mutual information to discover and interpret temporal correlation structure in complex populations,&#x201d; Chaos: An Interdisciplinary Journal of Nonlinear Science, vol. 22, no. 1, p. 013111, 2012.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3277606</ArticleId><ArticleId IdType="pubmed">22462987</ArticleId></ArticleIdList></Reference><Reference><Citation>Albers DJ and Hripcsak G, &#x201c;Estimation of time-delayed mutual information and bias for irregularly and sparsely sampled time-series,&#x201d; Chaos, Solitons &amp; Fractals, vol. 45, no. 6, pp. 853&#x2013;860, Jun. 2012.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3332129</ArticleId><ArticleId IdType="pubmed">22536009</ArticleId></ArticleIdList></Reference><Reference><Citation>Albers DJ, Elhadad N, Tabak E, Perotte A, and Hripcsak G, &#x201c;Dynamical Phenotyping: Using Temporal Analysis of Clinically Collected Physiologic Data to Stratify Populations,&#x201d; PLOS ONE, vol. 9, no. 6, p. e96443, Jun. 2014.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4059642</ArticleId><ArticleId IdType="pubmed">24933368</ArticleId></ArticleIdList></Reference><Reference><Citation>Albers DJ, Hripcsak G, and Schmidt M, &#x201c;Population Physiology: Leveraging Electronic Health Record Data to Understand Human Endocrine Dynamics,&#x201d; PLoS ONE, vol. 7, no. 12, p. e48058, Dec. 2012.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3522687</ArticleId><ArticleId IdType="pubmed">23272040</ArticleId></ArticleIdList></Reference><Reference><Citation>Hripcsak G and Albers DJ, &#x201c;High-fidelity phenotyping: richness and freedom from bias,&#x201d; J Am Med Inform Assoc</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7282504</ArticleId><ArticleId IdType="pubmed">29040596</ArticleId></ArticleIdList></Reference><Reference><Citation>Hripcsak G, Albers DJ, and Perotte A, &#x201c;Parameterizing time in electronic health record studies,&#x201d; Journal of the American Medical Informatics Association, vol. 22, no. 4, pp. 794&#x2013;804, Jul. 2015.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6169471</ArticleId><ArticleId IdType="pubmed">25725004</ArticleId></ArticleIdList></Reference><Reference><Citation>Hripcsak G, Albers DJ, and Perotte A, &#x201c;Exploiting time in electronic health record correlations,&#x201d; Journal of the American Medical Informatics Association, vol. 18, no. Supplement 1, pp. i109&#x2013;i115, Dec. 2011.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3241180</ArticleId><ArticleId IdType="pubmed">22116643</ArticleId></ArticleIdList></Reference><Reference><Citation>Levine ME, Albers DJ, and Hripcsak G, &#x201c;Comparing lagged linear correlation, lagged regression, Granger causality, and vector autoregression for uncovering associations in EHR data,&#x201d; AMIA Annu Symp Proc, vol. 2016, pp. 779&#x2013;788, Feb. 2017.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5333294</ArticleId><ArticleId IdType="pubmed">28269874</ArticleId></ArticleIdList></Reference><Reference><Citation>Hripcsak G and Albers DJ, &#x201c;Correlating electronic health record concepts with healthcare process events,&#x201d; Journal of the American Medical Informatics Association, vol. 20, no. e2, pp. e311&#x2013;e318, Dec. 2013.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3861922</ArticleId><ArticleId IdType="pubmed">23975625</ArticleId></ArticleIdList></Reference><Reference><Citation>Pivovarov R, Albers DJ, Sepulveda JL, and Elhadad N, &#x201c;Identifying and mitigating biases in EHR laboratory tests,&#x201d; Journal of Biomedical Informatics, vol. 51, no. Supplement C, pp. 24&#x2013;34, Oct. 2014.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4194228</ArticleId><ArticleId IdType="pubmed">24727481</ArticleId></ArticleIdList></Reference><Reference><Citation>Pivovarov R, Albers DJ, Hripcsak G, Sepulveda JL, and Elhadad N, &#x201c;Temporal trends of hemoglobin A1c testing,&#x201d; J Am Med Inform Assoc, vol. 21, no. 6, pp. 1038&#x2013;1044, Dec. 2014.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4215045</ArticleId><ArticleId IdType="pubmed">24928176</ArticleId></ArticleIdList></Reference><Reference><Citation>Albers DJ and Hripcsak G, &#x201c;A statistical dynamics approach to the study of human health data: Resolving population scale diurnal variation in laboratory data,&#x201d; Physics Letters A, vol. 374, no. 9, pp. 1159&#x2013;1164, Feb. 2010.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2882798</ArticleId><ArticleId IdType="pubmed">20544004</ArticleId></ArticleIdList></Reference><Reference><Citation>Little RJA and Rubin DB, Statistical Analysis with Missing Data: Little/Statistical Analysis with Missing Data Hoboken, NJ, USA: John Wiley &amp; Sons, Inc., 2002.</Citation></Reference><Reference><Citation>Enders CK, Applied missing data analysis New York: Guilford Press, 2010.</Citation></Reference><Reference><Citation>Shannon CE, &#x201c;Communication in the presence of noise,&#x201d; Proceedings of the IEEE, vol. 72, no. 9, pp. 1192&#x2013;1201, Sep. 1984.</Citation></Reference><Reference><Citation>Shannon CE, &#x201c;A Mathematical Theory of Communication,&#x201d; SIGMOBILE Mob. Comput. Commun. Rev, vol. 5, no. 1, pp. 3&#x2013;55, Jan. 2001.</Citation></Reference><Reference><Citation>Lyons RG, Understanding digital signal processing, 3rd ed. Upper Saddle River, NJ: Prentice Hall, 2011.</Citation></Reference><Reference><Citation>Harris FJ, &#x201c;On the use of windows for harmonic analysis with the discrete Fourier transform,&#x201d; Proceedings of the IEEE, vol. 66, no. 1, pp. 51&#x2013;83, Jan. 1978.</Citation></Reference><Reference><Citation>Hamilton JD, Time series analysis, vol. 2 Princeton university press; Princeton, 1994.</Citation></Reference><Reference><Citation>Dickey DA and Fuller WA, &#x201c;Distribution of the Estimators for Autoregressive Time Series With a Unit Root,&#x201d; Journal of the American Statistical Association, vol. 74, no. 366, pp. 427&#x2013;431, 1979.</Citation></Reference><Reference><Citation>Box GEP, Jenkins GM, Reinsel GC, and Ljung GM, Time Series Analysis: Forecasting and Control John Wiley &amp; Sons, 2015.</Citation></Reference><Reference><Citation>Granger CWJ and Newbold P, &#x201c;Spurious regressions in econometrics,&#x201d; Journal of Econometrics, vol. 2, no. 2, pp. 111&#x2013;120, Jul. 1974.</Citation></Reference><Reference><Citation>Box GEP and Cox DR, &#x201c;An Analysis of Transformations,&#x201d; Journal of the Royal Statistical Society. Series B (Methodological), vol. 26, no. 2, pp. 211&#x2013;252, 1964.</Citation></Reference><Reference><Citation>Trees HLV, Detection, Estimation, and Modulation Theory: Radar-Sonar Signal Processing and Gaussian Signals in Noise Melbourne, FL, USA: Krieger Publishing Co., Inc., 1992.</Citation></Reference><Reference><Citation>Boyce RD et al., &#x201c;Bridging Islands of Information to Establish an Integrated Knowledge Base of Drugs and Health Outcomes of Interest,&#x201d; Drug Saf, vol. 37, no. 8, pp. 557&#x2013;567, Aug. 2014.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4134480</ArticleId><ArticleId IdType="pubmed">24985530</ArticleId></ArticleIdList></Reference><Reference><Citation>Efron B, &#x201c;Bootstrap Methods: Another Look at the Jackknife,&#x201d; Ann. Statist, vol. 7, no. 1, pp. 1&#x2013;26, Jan. 1979.</Citation></Reference><Reference><Citation>Granger CWJ, &#x201c;Investigating Causal Relations by Econometric Models and Cross-spectral Methods,&#x201d; Econometrica, vol. 37, no. 3, pp. 424&#x2013;438, 1969.</Citation></Reference><Reference><Citation>Kay SM, &#x201c;Statistical signal processing,&#x201d; Estimation Theory, vol. 1, 1993.</Citation></Reference><Reference><Citation>Hayashi F, Econometrics Princeton University Press, 2011.</Citation></Reference><Reference><Citation>Rusanov A, Weiskopf NG, Wang S, and Weng C, &#x201c;Hidden in plain sight: bias towards sick patients when sampling patients with sufficient electronic health record data for research,&#x201d; BMC medical informatics and decision making, vol. 14, no. 1, p. 1, 2014.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4062889</ArticleId><ArticleId IdType="pubmed">24916006</ArticleId></ArticleIdList></Reference><Reference><Citation>Albers DJ, Elhadad N, Claassen J, Perotte R, Goldstein A, and Hripcsak G, &#x201c;Estimating summary statistics for electronic health record laboratory data for use in high-throughput phenotyping algorithms,&#x201d; J Biomed Inform, vol. 78, pp. 87&#x2013;101, Feb. 2018.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5856130</ArticleId><ArticleId IdType="pubmed">29369797</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">30306907</PMID><DateCompleted><Year>2019</Year><Month>08</Month><Day>28</Day></DateCompleted><DateRevised><Year>2019</Year><Month>08</Month><Day>28</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1879-8365</ISSN><JournalIssue CitedMedium="Internet"><Volume>255</Volume><PubDate><Year>2018</Year></PubDate></JournalIssue><Title>Studies in health technology and informatics</Title><ISOAbbreviation>Stud Health Technol Inform</ISOAbbreviation></Journal><ArticleTitle>Common Data Models (CDMs) to Enhance International Big Data Analytics: A Diabetes Use Case to Compare Three CDMs.</ArticleTitle><Pagination><StartPage>60</StartPage><EndPage>64</EndPage><MedlinePgn>60-64</MedlinePgn></Pagination><Abstract><AbstractText>Common data models (CDM) have enabled the simultaneous analysis of disparate and large data sources. A literature review identified three relevant CDMs: The Observational Medical Outcomes Partnership (OMOP) was the most cited; next the Sentinel; and then the Patient Centered Outcomes Research Institute (PCORI). We tested these three CDMs with fifteen pre-defined criteria for a diabetes cohort study use case, assessing the benefit (good diabetes control), risk (hypoglycaemia) and cost effectiveness of recently licenced medications. We found all three CDMs have a useful role in planning collaborative research and enhance analysis of data cross jurisdiction. However, the number of pre-defined criteria achieved by these three CDMs varied. OMOP met 14/15, Sentinel 13/15, and PCORI 10/15. None met the privacy level we specified, and most of the other gaps were clinical and cost outcome related data.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Liyanage</LastName><ForeName>Harshana</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Department of Clinical &amp; Experimental Medicine, University of Surrey, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Liaw</LastName><ForeName>Siaw-Teng</ForeName><Initials>ST</Initials><AffiliationInfo><Affiliation>School of Public Health &amp; Community Medicine, UNSW Medicine Australia, Ingham Institute of Applied Medical Research, NSW, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jonnagaddala</LastName><ForeName>Jitendra</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>School of Public Health &amp; Community Medicine, UNSW Medicine Australia, Ingham Institute of Applied Medical Research, NSW, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hinton</LastName><ForeName>William</ForeName><Initials>W</Initials><AffiliationInfo><Affiliation>Department of Clinical &amp; Experimental Medicine, University of Surrey, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>de Lusignan</LastName><ForeName>Simon</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Clinical &amp; Experimental Medicine, University of Surrey, UK.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>Netherlands</Country><MedlineTA>Stud Health Technol Inform</MedlineTA><NlmUniqueID>9214582</NlmUniqueID><ISSNLinking>0926-9630</ISSNLinking></MedlineJournalInfo><MeshHeadingList><MeshHeading><DescriptorName UI="D000077558" MajorTopicYN="Y">Big Data</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015331" MajorTopicYN="N">Cohort Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000078332" MajorTopicYN="N">Data Analysis</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003920" MajorTopicYN="Y">Diabetes Mellitus</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016247" MajorTopicYN="N">Information Storage and Retrieval</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Common data models</Keyword><Keyword MajorTopicYN="N">Costs and cost analysis</Keyword><Keyword MajorTopicYN="N">Diabetes Mellitus</Keyword><Keyword MajorTopicYN="N">Medical record systems</Keyword><Keyword MajorTopicYN="N">Organization and administration</Keyword><Keyword MajorTopicYN="N">computerized</Keyword><Keyword MajorTopicYN="N">data harmonisation</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2018</Year><Month>10</Month><Day>12</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2018</Year><Month>10</Month><Day>12</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2019</Year><Month>8</Month><Day>29</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">30306907</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">30306935</PMID><DateCompleted><Year>2019</Year><Month>08</Month><Day>28</Day></DateCompleted><DateRevised><Year>2021</Year><Month>02</Month><Day>02</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1879-8365</ISSN><JournalIssue CitedMedium="Internet"><Volume>255</Volume><PubDate><Year>2018</Year></PubDate></JournalIssue><Title>Studies in health technology and informatics</Title><ISOAbbreviation>Stud Health Technol Inform</ISOAbbreviation></Journal><ArticleTitle>Biomedical Informatics Investigator.</ArticleTitle><Pagination><StartPage>195</StartPage><EndPage>199</EndPage><MedlinePgn>195-199</MedlinePgn></Pagination><Abstract><AbstractText>The BMI Investigator is a computer human interface built in .Net which allows simultaneous query of structured data such as demographics, administrative codes, medications (coded in RxNorm), laboratory test results (coded in LOINC) and formerly unstructured data in clinical notes (coded in SNOMED CT). The ontology terms identified using SNOMED are all coded as either positive, negative or uncertain assertions. They are then where applicable built into compositional expressions and stored in both a graph database and a triple store. The SNOMED CT codes are stored in a NOSQL database, Berkley DB, and the structured data is stored in SQL using the OMOP/OHDSI format. The BMI investigator also lets you develop models for cohort selection (data driven recruitment to clinical trials) and automated retrospective research using genomic criteria and we are adding image feature data currently to the system. We performed a usability experiment and the users identified some usability flaws which were used to improve the software. Overall, the BMI Investigator was felt to be usable by subject matter experts. Next steps for the software are to integrate genomic criteria and image features into the query engine.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Elkin</LastName><ForeName>Peter L</ForeName><Initials>PL</Initials><AffiliationInfo><Affiliation>Department of Biomedical Informatics, Jacobs School of Medicine and Biomedical Sciences, University at Buffalo, SUNY, New York, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mullin</LastName><ForeName>Sarah</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Biomedical Informatics, Jacobs School of Medicine and Biomedical Sciences, University at Buffalo, SUNY, New York, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sakilay</LastName><ForeName>Sylvester</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Biomedical Informatics, Jacobs School of Medicine and Biomedical Sciences, University at Buffalo, SUNY, New York, USA.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>R01 LM012595</GrantID><Acronym>LM</Acronym><Agency>NLM NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R21 AA026954</GrantID><Acronym>AA</Acronym><Agency>NIAAA NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>T15 LM012495</GrantID><Acronym>LM</Acronym><Agency>NLM NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>UL1 TR001412</GrantID><Acronym>TR</Acronym><Agency>NCATS NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>Netherlands</Country><MedlineTA>Stud Health Technol Inform</MedlineTA><NlmUniqueID>9214582</NlmUniqueID><ISSNLinking>0926-9630</ISSNLinking></MedlineJournalInfo><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016247" MajorTopicYN="N">Information Storage and Retrieval</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012189" MajorTopicYN="N">Retrospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D062245" MajorTopicYN="Y">RxNorm</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012984" MajorTopicYN="Y">Software</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D039061" MajorTopicYN="Y">Systematized Nomenclature of Medicine</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018875" MajorTopicYN="N">Vocabulary, Controlled</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Automated retrospective research</Keyword><Keyword MajorTopicYN="N">Clinical Research Informatics</Keyword><Keyword MajorTopicYN="N">Ontology</Keyword><Keyword MajorTopicYN="N">Recruitment to clinical trials</Keyword><Keyword MajorTopicYN="N">clinical genomic trial recruitment</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2018</Year><Month>10</Month><Day>12</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2018</Year><Month>10</Month><Day>12</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2019</Year><Month>8</Month><Day>29</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2021</Year><Month>1</Month><Day>30</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">30306935</ArticleId><ArticleId IdType="mid">NIHMS1655784</ArticleId><ArticleId IdType="pmc">PMC7847179</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Elkin PL, Bailey KR, Chute CG. A randomized controlled trial of automated term composition. Proc AMIA Symp. 1998:765&#x2013;9.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2232145</ArticleId><ArticleId IdType="pubmed">9929322</ArticleId></ArticleIdList></Reference><Reference><Citation>PLElkin, Froehling D, Bauer BA, Wahner-Roedler D, Rosenbloom ST, Bailey K, Brown S. Aequus communis sententia:defining levels of interoperability Stud Health Technol Inform 2007;129(1):725&#x2013;9.</Citation><ArticleIdList><ArticleId IdType="pubmed">17911812</ArticleId></ArticleIdList></Reference><Reference><Citation>Elkin PL, Brown SH, Chute CG. Guideline for health informatics: controlled health vocabularies--vocabulary structure and high-level indicators. Stud Health Technol Inform. 2001;84(Pt 1):191&#x2013;5.</Citation><ArticleIdList><ArticleId IdType="pubmed">11604731</ArticleId></ArticleIdList></Reference><Reference><Citation>Elkin PL, Ruggieri AP, Brown SH, Buntrock J, Bauer BA, Wahner-Roedler D, Litin S, Beinborn J, Bailey K, Bergstrom L, A randomized controlled trial of the accuracy of clinical record retrieval using SNOMED-RT as compared with ICD9- CM. Proc AMIA Symp. 2001:159&#x2013;63.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2243271</ArticleId><ArticleId IdType="pubmed">11825173</ArticleId></ArticleIdList></Reference><Reference><Citation>Elkin PL, Brown SH, Lincoln MJ, Hogarth M, Rector A. A formal representation for messages containing compositional expressions. Int J Med Inform. 2003;71(2&#x2013;3):89&#x2013;102.</Citation><ArticleIdList><ArticleId IdType="pubmed">14519402</ArticleId></ArticleIdList></Reference><Reference><Citation>Elkin PL, Brown SH, Carter J, Bauer BA, Wahner-Roedler D, Bergstrom L, Pittelkow M, Rosse C,. Guideline and quality indicators for development, purchase and use of controlled health vocabularies. Int J Med Inform. 2002;68(1&#x2013;3):175&#x2013;86.</Citation><ArticleIdList><ArticleId IdType="pubmed">12467801</ArticleId></ArticleIdList></Reference><Reference><Citation>Elkin PL, Trusko BE, Koppel R, Speroff T, Mohrer D, Sakji S, Gurewitz I, Tuttle M, Brown S. Secondary use of clinical data. Stud Health Technol Inform. 2010;155:14&#x2013;29.</Citation><ArticleIdList><ArticleId IdType="pubmed">20543306</ArticleId></ArticleIdList></Reference><Reference><Citation>Murff HJ, FitzHenry F, Matheny ME, Gentry N, Kotter KL, Crimin K, Dittus R, Rosen A, Ekin PL, Brown SH, Speroff T. Automated identification of postoperative complications within an electronic medical record using natural language processing. JAMA. 2011;306(8):848&#x2013;55.</Citation><ArticleIdList><ArticleId IdType="pubmed">21862746</ArticleId></ArticleIdList></Reference><Reference><Citation>Elkin PL, Froehling DA, Wahner-Roedler DL, Brown SH, Bailey KR. Comparison of natural language processing biosurveillance methods for identifying influenza from encounter notes. Ann Intern Med. 2012;156(1 Pt 1):11&#x2013;8.</Citation><ArticleIdList><ArticleId IdType="pubmed">22213490</ArticleId></ArticleIdList></Reference><Reference><Citation>Rosenbloom ST, Miller RA, Johnson KB, Elkin PL, Brown SH. Interface terminologies: facilitating direct entry of clinical data into electronic health record systems. J Am Med Inform Assoc. 2006;13(3):277&#x2013;88.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1513664</ArticleId><ArticleId IdType="pubmed">16501181</ArticleId></ArticleIdList></Reference><Reference><Citation>Brown SH, Husser CS, Wahner-Roedler D, Bailey S, Nugent L, Porter K, Bauer B, Elkin PL. Using SNOMED CT as a reference terminology to cross map two highly pre-coordinated classification systems. Stud Health Technol Inform. 2007;129(Pt 1):636&#x2013;9.</Citation><ArticleIdList><ArticleId IdType="pubmed">17911794</ArticleId></ArticleIdList></Reference><Reference><Citation>Matheny ME, Fitzhenry F, Speroff T, Green JK, Griffith ML, Vasilevskis EE, Fielstein E, Elkin PL, Brown SH. Detection of infectious symptoms from VA emergency department and primary care clinical documentation. Int J Med Inform. 2012;81(3):143&#x2013;56.</Citation><ArticleIdList><ArticleId IdType="pubmed">22244191</ArticleId></ArticleIdList></Reference><Reference><Citation>Rosenbloom ST, Brown SH, Froehling D, Bauer BA, Wahner-Roedler DL, Gregg WM, Elkin PL Using SNOMED CT to represent two interface terminologies. J Am Med Inform Assoc. 2009;16(1):81&#x2013;8.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2605600</ArticleId><ArticleId IdType="pubmed">18952944</ArticleId></ArticleIdList></Reference><Reference><Citation>Elkin PL, Carter JS, Nabar M, Tuttle M, Lincoln M, Brown SH. Drug knowledge expressed as computable semantic triples. Stud Health Technol Inform. 2011;166:38&#x2013;47.</Citation><ArticleIdList><ArticleId IdType="pubmed">21685609</ArticleId></ArticleIdList></Reference><Reference><Citation>Sinha S, Jensen M, Mullin S, Elkin PL. Safe Opioid Prescription: A SMART on FHIR Approach to Clinical Decision Support. Online J Public Health Inform. 2017;9(2):e193.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5630280</ArticleId><ArticleId IdType="pubmed">29026458</ArticleId></ArticleIdList></Reference><Reference><Citation>Schlegel DR, Crowner C, Lehoullier F, Elkin PL. HTP-NLP: A New NLP System for High Throughput Phenotyping. Stud Health Technol Inform. 2017;235:276&#x2013;80.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7767581</ArticleId><ArticleId IdType="pubmed">28423797</ArticleId></ArticleIdList></Reference><Reference><Citation>Ceusters W, Elkin P, Smith B. Negative findings in electronic health records and biomedical ontologies: a realist approach. Int J Med Inform. 2007;76 Suppl 3:S326&#x2013;33.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2211452</ArticleId><ArticleId IdType="pubmed">17369081</ArticleId></ArticleIdList></Reference><Reference><Citation>Beuscart-Zephir MC, Elkin P, Pelayo S. Human factors engineering for clinical applications. Stud Health Technol Inform. 2006;124:685&#x2013;90.</Citation><ArticleIdList><ArticleId IdType="pubmed">17108595</ArticleId></ArticleIdList></Reference><Reference><Citation>Ammenwerth E, Talmon J, Ash JS, Bates DW, Beuscart-Zephir MC, Duhamel A, Elkin PL, Gardner R, Geissbuhler A. Impact of CPOE on mortality rates--contradictory findings, important messages. Methods Inf Med. 2006;45(6):586&#x2013;93.</Citation><ArticleIdList><ArticleId IdType="pubmed">17149499</ArticleId></ArticleIdList></Reference><Reference><Citation>Husser CS, Buchhalter JR, Raffo OS, Shabo A, Brown SH, Lee KE, Elkin PL. Standardization of microarray and pharmacogenomics data. Methods Mol Biol. 2006;316:111&#x2013;57.</Citation><ArticleIdList><ArticleId IdType="pubmed">16671403</ArticleId></ArticleIdList></Reference><Reference><Citation>Pelayo S, Anceaux F, Rogalski J, Elkin P, Beuscart-Zephir MC. A comparison of the impact of CPOE implementation and organizational determinants on doctor-nurse communications and cooperation. Int J Med Inform. 2013;82(12):e321&#x2013;30.</Citation><ArticleIdList><ArticleId IdType="pubmed">22999779</ArticleId></ArticleIdList></Reference><Reference><Citation>Elkin PL. Human Factors Engineering in HI: So What? Who Cares? and What&#x2019;s in It for You? Healthc Inform Res. 2012;18(4):237&#x2013;41.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3548152</ArticleId><ArticleId IdType="pubmed">23346473</ArticleId></ArticleIdList></Reference><Reference><Citation>Beuscart-Zephir MC, Elkin P, Pelayo S, Beuscart R. The human factors engineering approach to biomedical informatics projects: state of the art, results, benefits and challenges. Yearb Med Inform. 2007:109&#x2013;27.</Citation><ArticleIdList><ArticleId IdType="pubmed">17700914</ArticleId></ArticleIdList></Reference><Reference><Citation>Chopra G, Kaushik S, Elkin PL, Samudrala R. Combating Ebola with Repurposed Therapeutics Using the CANDO Platform. Molecules. 2016;21(12).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5958544</ArticleId><ArticleId IdType="pubmed">27898018</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">30395248</PMID><DateCompleted><Year>2019</Year><Month>11</Month><Day>29</Day></DateCompleted><DateRevised><Year>2020</Year><Month>11</Month><Day>10</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1527-974X</ISSN><JournalIssue CitedMedium="Internet"><Volume>25</Volume><Issue>12</Issue><PubDate><Year>2018</Year><Month>Dec</Month><Day>01</Day></PubDate></JournalIssue><Title>Journal of the American Medical Informatics Association : JAMIA</Title><ISOAbbreviation>J Am Med Inform Assoc</ISOAbbreviation></Journal><ArticleTitle>Effect of vocabulary mapping for conditions on phenotype cohorts.</ArticleTitle><Pagination><StartPage>1618</StartPage><EndPage>1625</EndPage><MedlinePgn>1618-1625</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1093/jamia/ocy124</ELocationID><Abstract><AbstractText Label="OBJECTIVE">To study the effect on patient cohorts of mapping condition (diagnosis) codes from source billing vocabularies to a clinical vocabulary.</AbstractText><AbstractText Label="MATERIALS AND METHODS">Nine International Classification of Diseases, Ninth Revision, Clinical Modification (ICD9-CM) concept sets were extracted from eMERGE network phenotypes, translated to Systematized Nomenclature of Medicine - Clinical Terms concept sets, and applied to patient data that were mapped from source ICD9-CM and ICD10-CM codes to Systematized Nomenclature of Medicine - Clinical Terms codes using Observational Health Data Sciences and Informatics (OHDSI) Observational Medical Outcomes Partnership (OMOP) vocabulary mappings. The original ICD9-CM concept set and a concept set extended to ICD10-CM were used to create patient cohorts that served as gold standards.</AbstractText><AbstractText Label="RESULTS">Four phenotype concept sets were able to be translated to Systematized Nomenclature of Medicine - Clinical Terms without ambiguities and were able to perform perfectly with respect to the gold standards. The other 5 lost performance when 2 or more ICD9-CM or ICD10-CM codes mapped to the same Systematized Nomenclature of Medicine - Clinical Terms code. The patient cohorts had a total error (false positive and false negative) of up to 0.15% compared to querying ICD9-CM source data and up to 0.26% compared to querying ICD9-CM and ICD10-CM data. Knowledge engineering was required to produce that performance; simple automated methods to generate concept sets had errors up to 10% (one outlier at 250%).</AbstractText><AbstractText Label="DISCUSSION">The translation of data from source vocabularies to Systematized Nomenclature of Medicine - Clinical Terms (SNOMED CT) resulted in very small error rates that were an order of magnitude smaller than other error sources.</AbstractText><AbstractText Label="CONCLUSION">It appears possible to map diagnoses from disparate vocabularies to a single clinical vocabulary and carry out research using a single set of definitions, thus improving efficiency and transportability of research.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Hripcsak</LastName><ForeName>George</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Department of Biomedical Informatics, Columbia University, New York, New York, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Observational Health Data Sciences and Informatics (OHDSI), New York, New York, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Medical Informatics Services, NewYork-Presbyterian Hospital, New York, New York, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Levine</LastName><ForeName>Matthew E</ForeName><Initials>ME</Initials><AffiliationInfo><Affiliation>Department of Biomedical Informatics, Columbia University, New York, New York, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Observational Health Data Sciences and Informatics (OHDSI), New York, New York, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Shang</LastName><ForeName>Ning</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Department of Biomedical Informatics, Columbia University, New York, New York, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Observational Health Data Sciences and Informatics (OHDSI), New York, New York, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ryan</LastName><ForeName>Patrick B</ForeName><Initials>PB</Initials><AffiliationInfo><Affiliation>Department of Biomedical Informatics, Columbia University, New York, New York, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Observational Health Data Sciences and Informatics (OHDSI), New York, New York, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Epidemiology Analytics, Janssen Research and Development, Titusville, New Jersey, USA.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>R01 LM006910</GrantID><Acronym>LM</Acronym><Agency>NLM NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>U01 HG008680</GrantID><Acronym>HG</Acronym><Agency>NHGRI NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D052061">Research Support, N.I.H., Extramural</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>J Am Med Inform Assoc</MedlineTA><NlmUniqueID>9430800</NlmUniqueID><ISSNLinking>1067-5027</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D038801" MajorTopicYN="Y">International Classification of Diseases</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D064887" MajorTopicYN="N">Observational Studies as Topic</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D039061" MajorTopicYN="Y">Systematized Nomenclature of Medicine</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018875" MajorTopicYN="N">Vocabulary, Controlled</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2018</Year><Month>4</Month><Day>27</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2018</Year><Month>9</Month><Day>3</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2018</Year><Month>11</Month><Day>6</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2019</Year><Month>11</Month><Day>30</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2018</Year><Month>11</Month><Day>6</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2018</Year><Month>11</Month><Day>3</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">30395248</ArticleId><ArticleId IdType="pmc">PMC6289550</ArticleId><ArticleId IdType="doi">10.1093/jamia/ocy124</ArticleId><ArticleId IdType="pii">5159502</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>International Classification of Diseases, Ninth Revision, Clinical Modification (ICD-9-CM), National Center for Health Statistics. http://www.cdc.gov/nchs/icd/icd9cm.htm Accessed April 24, 2018.</Citation></Reference><Reference><Citation>International Classification of Diseases, Tenth Revision, Clinical Modification (ICD-10-CM), National Center for Health Statistics. http://www.cdc.gov/nchs/icd/icd10cm.htm Accessed April 24, 2018.</Citation></Reference><Reference><Citation>
SNOMED CT. http://www.snomed.org/snomed-ct Accessed April 24, 2018.</Citation></Reference><Reference><Citation>
MedDRA. Medical dictionary for regulatory activities. http://www.meddra.org/ Accessed April 24, 2018.</Citation></Reference><Reference><Citation>RCD (Read Codes) &#x2013; Synopsis. https://www.nlm.nih.gov/research/umls/sourcereleasedocs/current/RCD/ Accessed April 24, 2018.</Citation></Reference><Reference><Citation>Hripcsak G, Duke JD, Shah NH, et al. Observational Health Data Sciences and Informatics (OHDSI): Opportunities for Observational Researchers MEDINFO&#x2019;15; August 19&#x2013;23, 2015; S&#xe3;o Paulo, Brazil.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4815923</ArticleId><ArticleId IdType="pubmed">26262116</ArticleId></ArticleIdList></Reference><Reference><Citation>Hripcsak G, Ryan PB, Duke JD, et al. Characterizing treatment pathways at scale using the OHDSI network. Proc Natl Acad Sci USA 2016; 113 (27): 7329&#x2013;36.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4941483</ArticleId><ArticleId IdType="pubmed">27274072</ArticleId></ArticleIdList></Reference><Reference><Citation>Overhage JM, Ryan PB, Reich CG, Hartzema AG, Stang PE.. Validation of a common data model for active safety surveillance research. J Am Med Inform Assoc 2012; 19 (1): 54&#x2013;60.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3240764</ArticleId><ArticleId IdType="pubmed">22037893</ArticleId></ArticleIdList></Reference><Reference><Citation>Unified Medical Language System (UMLS) Metathesaurus - Mapping Projects. https://www.nlm.nih.gov/research/umls/knowledge_sources/metathesaurus/mapping_projects/index.html Accessed June 15, 2018.</Citation></Reference><Reference><Citation>Reich C, Ryan PB, Stang PE, Rocca M.. Evaluation of alternative standardized terminologies for medical conditions within a network of observational healthcare databases. J Biomed Inform 2012; 45 (4): 689&#x2013;96.</Citation><ArticleIdList><ArticleId IdType="pubmed">22683994</ArticleId></ArticleIdList></Reference><Reference><Citation>Newton KM, Peissig PL, Kho AN, et al. Validation of electronic medical record&#x2013;based phenotyping algorithms: results and lessons learned from the eMERGE network. J Am Med Inform Assoc 2013; 20 (e1): e147&#x2013;54.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3715338</ArticleId><ArticleId IdType="pubmed">23531748</ArticleId></ArticleIdList></Reference><Reference><Citation>
The eMERGE Network. Type 2 diabetes mellitus. https://phekb.org/phenotype/type-2-diabetes-mellitus Accessed April 24, 2018.</Citation></Reference><Reference><Citation>
The eMERGE Network. Appendicitis. https://phekb.org/phenotype/appendicitis Accessed April 24, 2018.</Citation></Reference><Reference><Citation>
The eMERGE Network. ADHD phenotype algorithm. https://phekb.org/phenotype/adhd-phenotype-algorithm Accessed April 24, 2018.</Citation></Reference><Reference><Citation>
The eMERGE Network. Cataracts. https://phekb.org/phenotype/cataracts Accessed April 24, 2018.</Citation></Reference><Reference><Citation>
The eMERGE Network. Crohn&#x2019;s disease&#x2014;demonstration project. https://phekb.org/phenotype/crohns-disease-demonstration-project Accessed April 24, 2018.</Citation></Reference><Reference><Citation>
The eMERGE Network. Rheumatoid arthritis (RA). https://phekb.org/phenotype/rheumatoid-arthritis-ra Accessed April 24, 2018.</Citation></Reference><Reference><Citation>eMERGE Network. Heart failure (HF) with differentiation between preserved and reduced ejection fraction. https://phekb.org/phenotype/heart-failure-hf-differentiation-between-preserved-and-reduced-ejection-fraction Accessed April 24, 2018.</Citation></Reference><Reference><Citation>Hogan WR, Wagner MM.. Accuracy of data in computer-based patient records. J Am Med Inform Assoc 1997; 4 (5): 342&#x2013;55.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC61252</ArticleId><ArticleId IdType="pubmed">9292840</ArticleId></ArticleIdList></Reference><Reference><Citation>Wilcox AB, Chen YH, Hripcsak G.. Minimizing electronic health record patient-note mismatches. J Am Med Inform Assoc 2011; 18 (4): 511&#x2013;4.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3128397</ArticleId><ArticleId IdType="pubmed">21486875</ArticleId></ArticleIdList></Reference><Reference><Citation>Defalco FJ, Ryan PB, Soledad Cepeda M.. Applying standardized drug terminologies to observational healthcare databases: a case study on opioid exposure. Health Serv Outcomes Res Methodol 2013; 13 (1): 58&#x2013;67.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3566397</ArticleId><ArticleId IdType="pubmed">23396660</ArticleId></ArticleIdList></Reference><Reference><Citation>Cartagena FP, Schaeffer M, Rifai D, Doroshenko V, Goldberg HS.. Leveraging the NLM map from SNOMED CT to ICD-10-CM to facilitate adoption of ICD-10-CM. J Am Med Inform Assoc 2015; 22 (3): 659&#x2013;70.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC11737388</ArticleId><ArticleId IdType="pubmed">25769685</ArticleId></ArticleIdList></Reference><Reference><Citation>Bodenreider O. The Unified Medical Language System (UMLS): integrating biomedical terminology. Nucleic Acids Res 2004; 32 (90001): 267D&#x2013;D270.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC308795</ArticleId><ArticleId IdType="pubmed">14681409</ArticleId></ArticleIdList></Reference><Reference><Citation>Fung KW, Richesson R, Smerek M, et al. Preparing for the ICD-10-CM transition: automated methods for translating ICD codes in clinical phenotype definitions. eGEMs 2016; 4 (1): 4&#x2013;1211.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4862764</ArticleId><ArticleId IdType="pubmed">27195309</ArticleId></ArticleIdList></Reference><Reference><Citation>Bodenreider O. Using SNOMED CT in combination with MedDRA for reporting signal detection and adverse drug reactions reporting. AMIA Annu Symp Proc 2009; 2009: 45&#x2013;9.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2815504</ArticleId><ArticleId IdType="pubmed">20351820</ArticleId></ArticleIdList></Reference><Reference><Citation>Elkin PL, Ruggieri AP, Brown SH, et al. A randomized controlled trial of the accuracy of clinical record retrieval using SNOMED-RT as compared with ICD9-CM. Proc AMIA Symp 2001; 159&#x2013;63.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2243271</ArticleId><ArticleId IdType="pubmed">11825173</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">30421323</PMID><DateCompleted><Year>2019</Year><Month>03</Month><Day>04</Day></DateCompleted><DateRevised><Year>2020</Year><Month>02</Month><Day>07</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1573-689X</ISSN><JournalIssue CitedMedium="Internet"><Volume>42</Volume><Issue>12</Issue><PubDate><Year>2018</Year><Month>Nov</Month><Day>13</Day></PubDate></JournalIssue><Title>Journal of medical systems</Title><ISOAbbreviation>J Med Syst</ISOAbbreviation></Journal><ArticleTitle>Analysis of treatment pathways for three chronic diseases using OMOP CDM.</ArticleTitle><Pagination><StartPage>260</StartPage><MedlinePgn>260</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">260</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1007/s10916-018-1076-5</ELocationID><Abstract><AbstractText>The present study examined treatment pathways (the ordered sequence of medications that a patient is prescribed) for three chronic diseases (hypertension, type 2 diabetes, and depression), compared the pathways with recommendations from guidelines, discussed differences and standardization of medications in different medical institutions, explored population diversification and changes of clinical treatment, and provided clinical big data analysis-based data support for the development and study of drugs in China. In order to run the "Treatment Pathways in Chronic Disease" protocol in Chinese data sources,we have built a large data research and analysis platform for Chinese clinical medical data. Data sourced from the Clinical Data Repository (CDR) of the First Affiliated Hospital of Nanjing Medical University was extracted, transformed, and loaded into an observational medical outcomes partnership common data model (OMOP CDM) Ver. 5.0. Diagnosis and medication information for patients with hypertension, type 2 diabetes, and depression from 2005 to 2015 were extracted for observational research to obtain treatment pathways for the three diseases. The most common medications used to treat diabetes and hypertension were metformin and acarbose, respectively, at 28.5 and 20.9% as first-line medication. New drugs were emerging for depression; therefore, the favorite medication changed accordingly. Most patients with these three diseases had different treatment pathways from other patients with the same diseases. The proportions of monotherapy increased for the three diseases, especially in recent years. The recommendations presented in guidelines show some predominance. High-quality, effective guidelines incorporating domestic facts should be established to further guide medication and improve therapy at local hospitals. Medical institutions at all levels could improve the quality of medical services, and further standardize medications in the future. This research is the first application of the CDM model and OHDSI software in China, which were used to study, treatment pathways for three chronic diseases (hypertension, type 2 diabetes and depression), compare the pathways with recommendations from guidelines, discuss differences and standardization of medications in different medical institutions, demonstrate the urgent need for quality national guidelines, explores population diversification and changes of clinical treatment, and provide clinical big data analysis-based data support for the development and study of drugs in China.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Zhang</LastName><ForeName>Xin</ForeName><Initials>X</Initials><AffiliationInfo><Affiliation>Department of Information, the First Affiliated Hospital, Nanjing Medical University, No.300 Guang Zhou Road, Nanjing, 210029, Jiangsu, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Institute of Medical Informatics and Management, Nanjing Medical University, No.300 Guang Zhou Road, Nanjing, 210029, Jiangsu, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>School of Biomedical Engineering and Informatics, Nanjing Medical University, 101Longmian Avenue, Nanjing, 211166, Jiangsu, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wang</LastName><ForeName>Li</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Department of Medical Informatics, Medical School, Nantong University, 19 Qixiu Road, Nantong, 226001, Jiangsu, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Miao</LastName><ForeName>Shumei</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Information, the First Affiliated Hospital, Nanjing Medical University, No.300 Guang Zhou Road, Nanjing, 210029, Jiangsu, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Institute of Medical Informatics and Management, Nanjing Medical University, No.300 Guang Zhou Road, Nanjing, 210029, Jiangsu, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Xu</LastName><ForeName>Hua</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>School of Biomedical Informatics, the University of Texas Health Science Center at Houston, Houston, TX, 77030, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yin</LastName><ForeName>Yuechuchu</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Department of Information, the First Affiliated Hospital, Nanjing Medical University, No.300 Guang Zhou Road, Nanjing, 210029, Jiangsu, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Institute of Medical Informatics and Management, Nanjing Medical University, No.300 Guang Zhou Road, Nanjing, 210029, Jiangsu, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhu</LastName><ForeName>Yueshi</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Department of Information, the First Affiliated Hospital, Nanjing Medical University, No.300 Guang Zhou Road, Nanjing, 210029, Jiangsu, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Institute of Medical Informatics and Management, Nanjing Medical University, No.300 Guang Zhou Road, Nanjing, 210029, Jiangsu, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Dai</LastName><ForeName>Zuolei</ForeName><Initials>Z</Initials><AffiliationInfo><Affiliation>Department of Information, the First Affiliated Hospital, Nanjing Medical University, No.300 Guang Zhou Road, Nanjing, 210029, Jiangsu, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Institute of Medical Informatics and Management, Nanjing Medical University, No.300 Guang Zhou Road, Nanjing, 210029, Jiangsu, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Shan</LastName><ForeName>Tao</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Department of Information, the First Affiliated Hospital, Nanjing Medical University, No.300 Guang Zhou Road, Nanjing, 210029, Jiangsu, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Institute of Medical Informatics and Management, Nanjing Medical University, No.300 Guang Zhou Road, Nanjing, 210029, Jiangsu, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jing</LastName><ForeName>Shenqi</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Information, the First Affiliated Hospital, Nanjing Medical University, No.300 Guang Zhou Road, Nanjing, 210029, Jiangsu, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Institute of Medical Informatics and Management, Nanjing Medical University, No.300 Guang Zhou Road, Nanjing, 210029, Jiangsu, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wang</LastName><ForeName>Jian</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Information, the First Affiliated Hospital, Nanjing Medical University, No.300 Guang Zhou Road, Nanjing, 210029, Jiangsu, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Institute of Medical Informatics and Management, Nanjing Medical University, No.300 Guang Zhou Road, Nanjing, 210029, Jiangsu, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhang</LastName><ForeName>Xiaoliang</ForeName><Initials>X</Initials><AffiliationInfo><Affiliation>Department of Information, the First Affiliated Hospital, Nanjing Medical University, No.300 Guang Zhou Road, Nanjing, 210029, Jiangsu, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Institute of Medical Informatics and Management, Nanjing Medical University, No.300 Guang Zhou Road, Nanjing, 210029, Jiangsu, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Huang</LastName><ForeName>Zhongqiu</ForeName><Initials>Z</Initials><AffiliationInfo><Affiliation>Department of Information, the First Affiliated Hospital, Nanjing Medical University, No.300 Guang Zhou Road, Nanjing, 210029, Jiangsu, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Institute of Medical Informatics and Management, Nanjing Medical University, No.300 Guang Zhou Road, Nanjing, 210029, Jiangsu, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wang</LastName><ForeName>Zhongmin</ForeName><Initials>Z</Initials><AffiliationInfo><Affiliation>Department of Information, the First Affiliated Hospital, Nanjing Medical University, No.300 Guang Zhou Road, Nanjing, 210029, Jiangsu, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Institute of Medical Informatics and Management, Nanjing Medical University, No.300 Guang Zhou Road, Nanjing, 210029, Jiangsu, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Guo</LastName><ForeName>Jianjun</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Information, the First Affiliated Hospital, Nanjing Medical University, No.300 Guang Zhou Road, Nanjing, 210029, Jiangsu, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Institute of Medical Informatics and Management, Nanjing Medical University, No.300 Guang Zhou Road, Nanjing, 210029, Jiangsu, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Liu</LastName><ForeName>Yun</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Department of Information, the First Affiliated Hospital, Nanjing Medical University, No.300 Guang Zhou Road, Nanjing, 210029, Jiangsu, China. liuyun@njmu.edu.cn.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Institute of Medical Informatics and Management, Nanjing Medical University, No.300 Guang Zhou Road, Nanjing, 210029, Jiangsu, China. liuyun@njmu.edu.cn.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>School of Biomedical Engineering and Informatics, Nanjing Medical University, 101Longmian Avenue, Nanjing, 211166, Jiangsu, China. liuyun@njmu.edu.cn.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>2018YFC1314900</GrantID><Agency>the National key Research &amp; Development plan of Ministry of Science and Technology of the People's Republic of China</Agency><Country/></Grant><Grant><GrantID>2018YFC1314901</GrantID><Agency>the National key Research &amp; Development plan of Ministry of Science and Technology of the People's Republic of China</Agency><Country/></Grant><Grant><GrantID>2018YFC0116900</GrantID><Agency>the National key Research &amp; Development plan of Ministry of Science and Technology of the People's Republic of China</Agency><Country/></Grant><Grant><GrantID>BE2016002-4</GrantID><Agency>the 2016 industry prospecting and common key technology key projects of Jiangsu Province Science and Technology Department</Agency><Country/></Grant><Grant><GrantID>X201401</GrantID><Agency>the 2014 information projects of Jiangsu Province Health and Life Committee</Agency><Country/></Grant><Grant><GrantID>201608003</GrantID><Agency>The 2016 projects of Nanjing Science Bureau</Agency><Country/></Grant><Grant><GrantID>2018YFC0116902</GrantID><Agency>the National key Research &amp; Development plan of Ministry of Science and Technology of the People's Republic of China</Agency><Country/></Grant><Grant><GrantID>81873915</GrantID><Agency>the national science foundation of China</Agency><Country/></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2018</Year><Month>11</Month><Day>13</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>J Med Syst</MedlineTA><NlmUniqueID>7806056</NlmUniqueID><ISSNLinking>0148-5598</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D002681" MajorTopicYN="N" Type="Geographic">China</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002908" MajorTopicYN="N">Chronic Disease</DescriptorName><QualifierName UI="Q000188" MajorTopicYN="Y">drug therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D019091" MajorTopicYN="Y">Critical Pathways</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016208" MajorTopicYN="N">Databases, Factual</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D057286" MajorTopicYN="N">Electronic Health Records</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008962" MajorTopicYN="Y">Models, Theoretical</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D019370" MajorTopicYN="N">Observation</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Chronic diseases</Keyword><Keyword MajorTopicYN="N">OHDSI</Keyword><Keyword MajorTopicYN="N">OMOP Common Data Model (CDM)</Keyword><Keyword MajorTopicYN="N">Treatment pathways</Keyword></KeywordList><CoiStatement>The authors have no conflict of interests regarding the publication of this paper.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2018</Year><Month>1</Month><Day>23</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2018</Year><Month>9</Month><Day>19</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2018</Year><Month>11</Month><Day>14</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2018</Year><Month>11</Month><Day>14</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2019</Year><Month>3</Month><Day>5</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2018</Year><Month>11</Month><Day>13</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">30421323</ArticleId><ArticleId IdType="pmc">PMC6244882</ArticleId><ArticleId IdType="doi">10.1007/s10916-018-1076-5</ArticleId><ArticleId IdType="pii">10.1007/s10916-018-1076-5</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>WHO, Global status report on noncommunicable diseases 2014, WHO Press, Geneva, Switzerland</Citation></Reference><Reference><Citation>Brenner R, Rimoldi SF. Arterial Hypertension-when are which combination therapies useful [J] Ther Lmsch. 2012;69(5):305&#x2013;313. doi: 10.1024/0040-5930/a000290.</Citation><ArticleIdList><ArticleId IdType="doi">10.1024/0040-5930/a000290</ArticleId><ArticleId IdType="pubmed">22547363</ArticleId></ArticleIdList></Reference><Reference><Citation>Committee of Exports on Rational Drug Use, National Health and Family Planning Commission of the P.R. CHINA. Chinese Medical Doctor Association Hypertension Specialized Committee Guidelines for rational use of hypertension. Chinese Journal of Frontier medicine (electronic version). 2015;7(6):22&#x2013;64.</Citation></Reference><Reference><Citation>National Center for Cardiovascular Disease, China Report on Cardiovascular Diseases in China [M]. Beijing: EnEcyclopedia of China Publishing House, 2015: 11-15, 2014.</Citation></Reference><Reference><Citation>International Diabetes Federation.IDF Diabetes Atlas 7th edition. [EB/OL]. [2017-08-15]. http://www.diabetesatlas.org/</Citation></Reference><Reference><Citation>WHO. Global report on diabetes. [EB/OL]. [2017-08-16]. www.who.int/diabetes/global-report</Citation></Reference><Reference><Citation>Chinese Diabetes Society China Guideline for Type 2 Diabetes (2010) Chinese Journal of Diabetes. 2012;20(1):81&#x2013;117.</Citation></Reference><Reference><Citation>Grimaccia F, Kanavos P. Cost, outcomes, treatment pathways and challenges for diabetes care in Italy. Grimaccia and Kanavos Globalization and Health. 2014;10:58. doi: 10.1186/1744-8603-10-58.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1744-8603-10-58</ArticleId><ArticleId IdType="pmc">PMC4110929</ArticleId><ArticleId IdType="pubmed">25024101</ArticleId></ArticleIdList></Reference><Reference><Citation>Yu X, Yufang B, Weiqing W. Prevalence and control of diabetes in Chinese adults-the interpretation of a 2010 China Noncommunicable Disease Surveillance report. Chinese Journal of Endocrinology and Metabolism. 2014;30(3):184&#x2013;186.</Citation></Reference><Reference><Citation>WHO. Preventing suicide: A global imperative, WHO Press, Geneva, Switzerland, 2014</Citation></Reference><Reference><Citation>Hripcsak G, Ryanc PB, Dukec JD, et al. Characterizing treatment pathways at scale using the OHDSI network[J] PNAS. 2016;113(27):7329&#x2013;7336. doi: 10.1073/pnas.1510502113.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1510502113</ArticleId><ArticleId IdType="pmc">PMC4941483</ArticleId><ArticleId IdType="pubmed">27274072</ArticleId></ArticleIdList></Reference><Reference><Citation>Silverman SL. From randomized controlled trials to observational studies [J] Am J Med. 2009;122(2):114&#x2013;120. doi: 10.1016/j.amjmed.2008.09.030.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.amjmed.2008.09.030</ArticleId><ArticleId IdType="pubmed">19185083</ArticleId></ArticleIdList></Reference><Reference><Citation>Jia-shuang HE, Xiao-dan XIAO. Thinking about the Application of OMOP CDM in the Clinical Research. China Digital Medicine. 2016;11(3):72&#x2013;74.</Citation></Reference><Reference><Citation>OMOP Common Data Model. Available at https://www.ohdsi.org/data-standardization/the-common-data-model/ (Accessed January 10, 2018).</Citation></Reference><Reference><Citation>Population-level estimation of comparative risks of Celecoxib versus non-selective NSAIDs. Available at http://www.ohdsi.org/web/wiki/doku.php?id=research:celecoxib_vs_nsnsaids (Accessed January 16, 2018).</Citation></Reference><Reference><Citation>Drug Utilization in Children. Available at http://www.ohdsi.org/web/wiki/doku.php?id=research:drugs_in_peds (Accessed January 16, 2018).</Citation></Reference><Reference><Citation>Data Quality Study. Available at http://www.ohdsi.org/web/wiki/doku.php?id=research:dqstudy (Accessed January 16, 2018).</Citation></Reference><Reference><Citation>Chinese Diabetes Society. Guidelines for the prevention and treatment of type 2 diabetes mellitus in China (2013 Edition). Chin J Diabetes, 8, 22(8):2-42, 2014</Citation></Reference><Reference><Citation>American Diabetes Association Standards of medical care in diabetes&#x2014;2014[J] Diabetes Care. 2014;37(Suppl 1):S14&#x2013;S80. doi: 10.2337/dc14-S014.</Citation><ArticleIdList><ArticleId IdType="doi">10.2337/dc14-S014</ArticleId><ArticleId IdType="pubmed">24357209</ArticleId></ArticleIdList></Reference><Reference><Citation>Committee of Exports on Rational Drug Use, National Health and Familiy Planning Commission of the P.R. China. Chinese Medical Doctor Association Hypertension Specialized Committee. Guidelines for rational use of hypertension. Beijing: People's Medical Publishing House. 978-7-117-21142-0, 2015</Citation></Reference><Reference><Citation>Michael A. Weber,Ernesto L. Schiffrin,William B. et.al. Clinical Practice Guidelines for the Management of Hypertension in the Community[J]. J Clin Hypertens. (1), 2014.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8031779</ArticleId><ArticleId IdType="pubmed">24341872</ArticleId></ArticleIdList></Reference><Reference><Citation>James Paul A., Oparil Suzanne, Carter Barry L., Cushman William C., Dennison-Himmelfarb Cheryl, Handler Joel, Lackland Daniel T., LeFevre Michael L., MacKenzie Thomas D., Ogedegbe Olugbenga, Smith Sidney C., Svetkey Laura P., Taler Sandra J., Townsend Raymond R., Wright Jackson T., Narva Andrew S., Ortiz Eduardo. 2014 Evidence-Based Guideline for the Management of High Blood Pressure in Adults. JAMA. 2014;311(5):507. doi: 10.1001/jama.2013.284427.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2013.284427</ArticleId><ArticleId IdType="pubmed">24352797</ArticleId></ArticleIdList></Reference><Reference><Citation>WHO Collaborating Centre for Drug Statistics Methodology ATC: Structure and principles. Available at www.whocc.no/atc/structure_and_principles/. Accessed August 23, 2017.</Citation></Reference><Reference><Citation>Alan J G, Marlene P F, John C M, et al. Practice Guideline for the treatment of Patients With Major Depressive Disorder[M]. The American Psychiatric Association (APA). 2010.</Citation></Reference><Reference><Citation>Lingjiang Li, Xin Ma. Guidelines for the prevention and treatment of depressive disorders in China (Second Edition) [M]. China medical electronic audio-visual press. June, 2015.</Citation></Reference><Reference><Citation>Observational Health Data Sciences and Informatics (OHDSI). Treatment Pathways in Chronic Disease. Available at www.ohdsi.org/web/wiki/doku.php?id=research:treatment_pathways_in_chronic_disease. (Accessed August 23, 2017).</Citation></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">30480666</PMID><DateCompleted><Year>2019</Year><Month>04</Month><Day>04</Day></DateCompleted><DateRevised><Year>2024</Year><Month>09</Month><Day>22</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">2052-4463</ISSN><JournalIssue CitedMedium="Internet"><Volume>5</Volume><PubDate><Year>2018</Year><Month>Nov</Month><Day>27</Day></PubDate></JournalIssue><Title>Scientific data</Title><ISOAbbreviation>Sci Data</ISOAbbreviation></Journal><ArticleTitle>Columbia Open Health Data, clinical concept prevalence and co-occurrence from electronic health records.</ArticleTitle><Pagination><StartPage>180273</StartPage><MedlinePgn>180273</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">180273</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1038/sdata.2018.273</ELocationID><Abstract><AbstractText>Columbia Open Health Data (COHD) is a publicly accessible database of electronic health record (EHR) prevalence and co-occurrence frequencies between conditions, drugs, procedures, and demographics. COHD was derived from Columbia University Irving Medical Center's Observational Health Data Sciences and Informatics (OHDSI) database. The lifetime dataset, derived from all records, contains 36,578 single concepts (11,952 conditions, 12,334 drugs, and 10,816 procedures) and 32,788,901 concept pairs from 5,364,781 patients. The 5-year dataset, derived from records from 2013-2017, contains 29,964 single concepts (10,159 conditions, 10,264 drugs, and 8,270 procedures) and 15,927,195 concept pairs from 1,790,431 patients. Exclusion of rare concepts (count&#x2009;&#x2264;&#x2009;10) and Poisson randomization enable data sharing by eliminating risks to patient privacy. EHR prevalences are informative of healthcare consumption rates. Analysis of co-occurrence frequencies via relative frequency analysis and observed-expected frequency ratio are informative of associations between clinical concepts, useful for biomedical research tasks such as drug repurposing and pharmacovigilance. COHD is publicly accessible through a web application-programming interface (API) and downloadable from the Figshare repository. The code is available on GitHub.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Ta</LastName><ForeName>Casey N</ForeName><Initials>CN</Initials><AffiliationInfo><Affiliation>Department of Biomedical Informatics, Columbia University, NY, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Dumontier</LastName><ForeName>Michel</ForeName><Initials>M</Initials><Identifier Source="ORCID">0000-0003-4727-9435</Identifier><AffiliationInfo><Affiliation>Institute of Data Science, Maastricht University, Maastricht, The Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hripcsak</LastName><ForeName>George</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Department of Biomedical Informatics, Columbia University, NY, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tatonetti</LastName><ForeName>Nicholas P</ForeName><Initials>NP</Initials><AffiliationInfo><Affiliation>Department of Biomedical Informatics, Columbia University, NY, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Systems Biology, Columbia University, NY, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Medicine, Columbia University, NY, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Weng</LastName><ForeName>Chunhua</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Department of Biomedical Informatics, Columbia University, NY, USA.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><DataBankList CompleteYN="Y"><DataBank><DataBankName>figshare</DataBankName><AccessionNumberList><AccessionNumber>10.6084/m9.figshare.c.4151252</AccessionNumber></AccessionNumberList></DataBank></DataBankList><GrantList CompleteYN="Y"><Grant><GrantID>OT3 TR002027</GrantID><Acronym>TR</Acronym><Agency>NCATS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R01 GM107145</GrantID><Acronym>GM</Acronym><Agency>NIGMS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R01 LM006910</GrantID><Acronym>LM</Acronym><Agency>NLM NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R01 LM009886</GrantID><Acronym>LM</Acronym><Agency>NLM NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D064886">Dataset</PublicationType><PublicationType UI="D052061">Research Support, N.I.H., Extramural</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2018</Year><Month>11</Month><Day>27</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Sci Data</MedlineTA><NlmUniqueID>101640192</NlmUniqueID><ISSNLinking>2052-4463</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000078332" MajorTopicYN="N">Data Analysis</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D057225" MajorTopicYN="N">Data Mining</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016208" MajorTopicYN="Y">Databases, Factual</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D057286" MajorTopicYN="Y">Electronic Health Records</DescriptorName><QualifierName UI="Q000706" MajorTopicYN="N">statistics &amp; numerical data</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D010361" MajorTopicYN="N">Patients</DescriptorName><QualifierName UI="Q000706" MajorTopicYN="N">statistics &amp; numerical data</QualifierName></MeshHeading></MeshHeadingList><CoiStatement>The authors declare no competing interests.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2018</Year><Month>7</Month><Day>9</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2018</Year><Month>10</Month><Day>16</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2018</Year><Month>11</Month><Day>28</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2018</Year><Month>11</Month><Day>28</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2019</Year><Month>4</Month><Day>5</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2018</Year><Month>11</Month><Day>27</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">30480666</ArticleId><ArticleId IdType="pmc">PMC6257042</ArticleId><ArticleId IdType="doi">10.1038/sdata.2018.273</ArticleId><ArticleId IdType="pii">sdata2018273</ArticleId></ArticleIdList><ReferenceList><Title>Data Citations</Title><Reference><Citation>Ta C. N., Dumontier M., Hripcsak G., Tatonetti N. P., Weng C. 2018. figshare. https://doi.org/10.6084/m9.figshare.c.4151252</Citation><ArticleIdList><ArticleId IdType="doi">10.6084/m9.figshare.c.4151252</ArticleId><ArticleId IdType="pmc">PMC6257042</ArticleId><ArticleId IdType="pubmed">30480666</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Reference><Citation>Ross J. S., Lehman R. &amp; Gross C. P. The importance of clinical trial data sharing: toward more open science. Circ. Cardiovasc. Qual. Outcomes 5, 238&#x2013;240 (2012).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3318983</ArticleId><ArticleId IdType="pubmed">22438465</ArticleId></ArticleIdList></Reference><Reference><Citation>Olson S. &amp; Downey A. S. Sharing Clinical Research Data: Workshop Summary. National Academies Press, (2013).</Citation><ArticleIdList><ArticleId IdType="pubmed">23700647</ArticleId></ArticleIdList></Reference><Reference><Citation>Lo B. Sharing clinical trial data: maximizing benefits, minimizing risk. JAMA 313, 793&#x2013;794 (2015).</Citation><ArticleIdList><ArticleId IdType="pubmed">25594500</ArticleId></ArticleIdList></Reference><Reference><Citation>Benitez K. &amp; Malin B. Evaluating re-identification risks with respect to the HIPAA privacy rule. J. Am. Med. Inform. Assoc 17, 169&#x2013;177 (2010).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3000773</ArticleId><ArticleId IdType="pubmed">20190059</ArticleId></ArticleIdList></Reference><Reference><Citation>Ward M. M. Estimating disease prevalence and incidence using administrative data: some assembly required. J. Rheumatol. 40, 1241&#x2013;1243 (2013).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4159744</ArticleId><ArticleId IdType="pubmed">23908527</ArticleId></ArticleIdList></Reference><Reference><Citation>Goldacre M., Kurina L., Yeates D., Seagroatt V. &amp; Gill L. Use of large medical databases to study associations between diseases. QJM Int. J. Med 93, 669&#x2013;675 (2000).</Citation><ArticleIdList><ArticleId IdType="pubmed">11029477</ArticleId></ArticleIdList></Reference><Reference><Citation>Cao H, Markatou M, Melton G. B, Chiang M. F. &amp; Hripcsak G. Mining a clinical data warehouse to discover disease-finding associations using co-occurrence statistics. AMIA. Annu. Symp. Proc. 2005, 106&#x2013;110 (2005).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1560759</ArticleId><ArticleId IdType="pubmed">16779011</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang X., Hripcsak G., Markatou M. &amp; Friedman C. Active computerized pharmacovigilance using natural language processing, statistics, and electronic health records: a feasibility study. J. Am. Med. Inform. Assoc 16, 328&#x2013;337 (2009).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2732239</ArticleId><ArticleId IdType="pubmed">19261932</ArticleId></ArticleIdList></Reference><Reference><Citation>Grant B. F., Stinson F. S., Dawson D. A., Chou S. P. &amp; Ruan W. J. Co-occurrence of DSM-IV personality disorders in the United States: results from the National Epidemiologic Survey on Alcohol and Related Conditions. Compr. Psychiatry 46, 1&#x2013;5 (2005).</Citation><ArticleIdList><ArticleId IdType="pubmed">15714187</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee P. G., Cigolle C. &amp; Blaum C. The co&#x2010;occurrence of chronic diseases and geriatric syndromes: The Health and Retirement Study. J. Am. Geriatr. Soc 57, 511&#x2013;516 (2009).</Citation><ArticleIdList><ArticleId IdType="pubmed">19187416</ArticleId></ArticleIdList></Reference><Reference><Citation>Siegel R. L., Miller K. D. &amp; Jemal A. Cancer statistics, 2018. CA. Cancer J. Clin. 68, 7&#x2013;30 (2018).</Citation><ArticleIdList><ArticleId IdType="pubmed">29313949</ArticleId></ArticleIdList></Reference><Reference><Citation>Wir&#xe9;hn A.-B. E., Karlsson H. M. &amp; Carstensen J. M. Estimating disease prevalence using a population-based administrative healthcare database. Scand. J. Public Health 35, 424&#x2013;431 (2007).</Citation><ArticleIdList><ArticleId IdType="pubmed">17786807</ArticleId></ArticleIdList></Reference><Reference><Citation>Naughton C., Bennett K. &amp; Feely J. Prevalence of chronic disease in the elderly based on a national pharmacy claims database. Age Ageing 35, 633&#x2013;636 (2006).</Citation><ArticleIdList><ArticleId IdType="pubmed">17047009</ArticleId></ArticleIdList></Reference><Reference><Citation>Viol&#xe1;n C. et al. Comparison of the information provided by electronic health records data and a population health survey to estimate prevalence of selected health conditions and multimorbidity. BMC Public Health 13, 251 (2013).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3659017</ArticleId><ArticleId IdType="pubmed">23517342</ArticleId></ArticleIdList></Reference><Reference><Citation>Ornstein S. M., Nietert P. J., Jenkins R. G. &amp; Litvin C. B. The prevalence of chronic diseases and multimorbidity in primary care practice: a PPRNet report. J. Am. Board Fam. Med. 26, 518&#x2013;524 (2013).</Citation><ArticleIdList><ArticleId IdType="pubmed">24004703</ArticleId></ArticleIdList></Reference><Reference><Citation>Bhattacharya M., Jurkovitz C. &amp; Shatkay H. Co-occurrence of medical conditions: exposing patterns through probabilistic topic modeling of SNOMED codes. J. Biomed. Inform. 82, 31&#x2013;40 (2018).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6510486</ArticleId><ArticleId IdType="pubmed">29655947</ArticleId></ArticleIdList></Reference><Reference><Citation>Hripcsak G. et al. Observational Health Data Sciences and Informatics (OHDSI): opportunities for observational researchers. Stud. Health Technol. Inform. 216, 574&#x2013;578 (2015).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4815923</ArticleId><ArticleId IdType="pubmed">26262116</ArticleId></ArticleIdList></Reference><Reference><Citation>Finlayson S. G., LePendu P. &amp; Shah N. H. Building the graph of medicine from millions of clinical narratives. Sci. Data 1, 140032 (2014).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4322575</ArticleId><ArticleId IdType="pubmed">25977789</ArticleId></ArticleIdList></Reference><Reference><Citation>Census Bureau U. S.
American FactFinder
https://factfinder.census.gov/bkmk/table/1.0/en/DEC/10_DP/DPDP1/1600000US3651000?slice=GEO~1600000US3651000 (2018).</Citation></Reference><Reference><Citation>Bulmer M. G. Principles of Statistics. Dover Publications, (2012).</Citation></Reference><Reference><Citation>Wallentin L. et al. Efficacy and safety of dabigatran compared with warfarin at different levels of international normalised ratio control for stroke prevention in atrial fibrillation: an analysis of the RE-LY trial. The Lancet 376, 975&#x2013;983 (2010).</Citation><ArticleIdList><ArticleId IdType="pubmed">20801496</ArticleId></ArticleIdList></Reference><Reference><Citation>Gonzales R. Uncomplicated acute bronchitis. Ann. Intern. Med. 133, 981&#x2013;991 (2000).</Citation><ArticleIdList><ArticleId IdType="pubmed">11119400</ArticleId></ArticleIdList></Reference><Reference><Citation>Rodrigo G. J. &amp; Castro-Rodriguez J. A. Anticholinergics in the treatment of children and adults with acute asthma: a systematic review with meta-analysis. Thorax 60, 740&#x2013;746 (2005).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1747524</ArticleId><ArticleId IdType="pubmed">16055613</ArticleId></ArticleIdList></Reference><Reference><Citation>Licker M., Fauconnet P., Villiger Y. &amp; Tschopp J.-M. Acute lung injury and outcomes after thoracic surgery. Curr. Opin. Anesthesiol 22, 61&#x2013;67 (2009).</Citation><ArticleIdList><ArticleId IdType="pubmed">19295294</ArticleId></ArticleIdList></Reference><Reference><Citation>Warrington K. J., Moder K. G. &amp; Brutinel W. M. The shrinking lungs syndrome in systemic lupus erythematosus. Mayo Clin. Proc. 75, 467&#x2013;472 (2000).</Citation><ArticleIdList><ArticleId IdType="pubmed">10807075</ArticleId></ArticleIdList></Reference><Reference><Citation>Jha A. K. Meaningful use of electronic health records: the road ahead. JAMA 304, 1709&#x2013;1710 (2010).</Citation><ArticleIdList><ArticleId IdType="pubmed">20959581</ArticleId></ArticleIdList></Reference><Reference><Citation>Nwankwo T., Yoon S. S., Burt V. &amp; Gu Q. Hypertension among adults in the United States: National Health and Nutrition Examination Survey, 2011&#x2013;2012. NCHS Data Brief 133, 1&#x2013;8 (2013).</Citation><ArticleIdList><ArticleId IdType="pubmed">24171916</ArticleId></ArticleIdList></Reference><Reference><Citation>Kuklina E, Shaw K. &amp; Hong Y. Vital signs: prevalence, treatment, and control of high levels of low-density lipoprotein cholesterol &#x2014; United States, 1999&#x2013;2002 and 2005&#x2013;2008. Morb. Mortal. Wkly. Rep. 60, 109&#x2013;114 (2011).</Citation><ArticleIdList><ArticleId IdType="pubmed">21293326</ArticleId></ArticleIdList></Reference><Reference><Citation>National Institute of Dental and Craniofacial Research. Dental Caries (Tooth Decay) in Adults (Age 20 to 64)
https://www.nidcr.nih.gov/research/data-statistics/dental-caries/adults (2018).</Citation></Reference><Reference><Citation>Scheurwegs E., Luyckx K., Luyten L. &amp; Daelemans W. &amp; Van den Bulcke. T. Data integration of structured and unstructured sources for assigning clinical codes to patient stays. J. Am. Med. Inform. Assoc. 23, e11&#x2013;e19 (2016).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4954635</ArticleId><ArticleId IdType="pubmed">26316458</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang Y. et al. Early detection of heart failure with varying prediction windows by structured and unstructured data in electronic health records. in Eng in Med and Biol Soc, 2015 Annual Conference IEEE 2530&#x2013;2533 10.1109/EMBC.2015.7318907. (2015)).</Citation><ArticleIdList><ArticleId IdType="doi">10.1109/EMBC.2015.7318907</ArticleId><ArticleId IdType="pmc">PMC5233460</ArticleId><ArticleId IdType="pubmed">26736807</ArticleId></ArticleIdList></Reference><Reference><Citation>Chang J. T. &amp; Altman R. B. Extracting and characterizing gene&#x2013;drug relationships from the literature. Pharmacogenet. Genomics 14, 577&#x2013;586 (2004).</Citation><ArticleIdList><ArticleId IdType="pubmed">15475731</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen E. S., Hripcsak G., Xu H., Markatou M. &amp; Friedman C. Automated acquisition of disease&#x2013;drug knowledge from biomedical and clinical documents: an initial study. J. Am. Med. Inform. Assoc 15, 87&#x2013;98 (2008).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2274872</ArticleId><ArticleId IdType="pubmed">17947625</ArticleId></ArticleIdList></Reference><Reference><Citation>Mendon&#xe7;a E. A. &amp; Cimino J. J. Automated knowledge extraction from MEDLINE citations. Proc. AMIA Symp 575&#x2013;579 (2000).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2244129</ArticleId><ArticleId IdType="pubmed">11079949</ArticleId></ArticleIdList></Reference><Reference><Citation>McCoy A. B. et al. Matching identifiers in electronic health records: implications for duplicate records and patient safety. BMJ Qual Saf 22, 219&#x2013;224 (2013).</Citation><ArticleIdList><ArticleId IdType="pubmed">23362505</ArticleId></ArticleIdList></Reference><Reference><Citation>Hripcsak G., Levine M. E., Shang N. &amp; Ryan P. B. Effect of vocabulary mapping for conditions on phenotype cohorts. J. Am. Med. Inform. Assoc, In press 10.1093/jamia/ocy124 (2018).</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/jamia/ocy124</ArticleId><ArticleId IdType="pmc">PMC6289550</ArticleId><ArticleId IdType="pubmed">30395248</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">30526572</PMID><DateCompleted><Year>2019</Year><Month>06</Month><Day>27</Day></DateCompleted><DateRevised><Year>2019</Year><Month>06</Month><Day>27</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1472-6947</ISSN><JournalIssue CitedMedium="Internet"><Volume>18</Volume><Issue>Suppl 5</Issue><PubDate><Year>2018</Year><Month>Dec</Month><Day>07</Day></PubDate></JournalIssue><Title>BMC medical informatics and decision making</Title><ISOAbbreviation>BMC Med Inform Decis Mak</ISOAbbreviation></Journal><ArticleTitle>Preliminary exploration of survival analysis using the OHDSI common data model: a case study of intrahepatic cholangiocarcinoma.</ArticleTitle><Pagination><StartPage>116</StartPage><MedlinePgn>116</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">116</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1186/s12911-018-0686-7</ELocationID><Abstract><AbstractText Label="BACKGROUND">Data heterogeneity is a common phenomenon related to the secondary use of electronic health records (EHR) data from different sources. The Observational Health Data Sciences and Informatics (OHDSI) Common Data Model (CDM) organizes healthcare data into standard data structures using concepts that are explicitly and formally specified through standard vocabularies, thereby facilitating large-scale analysis. The objective of this study is to design, develop, and evaluate generic survival analysis routines built using the OHDSI CDM.</AbstractText><AbstractText Label="METHODS">We used intrahepatic cholangiocarcinoma (ICC) patient data to implement CDM-based survival analysis methods. Our methods comprise the following modules: 1) Mapping local terms to standard OHDSI concepts. The analytical expression of variables and values related to demographic characteristics, medical history, smoking status, laboratory results, and tumor feature data. These data were mapped to standard OHDSI concepts through a manual analysis; 2) Loading patient data into the CDM using the concept mappings; 3) Developing an R interface that supports the portable survival analysis on top of OHDSI CDM, and comparing the CDM-based analysis results with those using traditional statistical analysis methods.</AbstractText><AbstractText Label="RESULTS">Our dataset contained 346 patients diagnosed with ICC. The collected clinical data contains 115 variables, of which 75 variables were mapped to the OHDSI concepts. These concepts mainly belong to four domains: condition, observation, measurement, and procedure. The corresponding standard concepts are scattered in six vocabularies: ICD10CM, ICD10PCS, SNOMED, LOINC, NDFRT, and READ. We loaded a total of 25,950 patient data records into the OHDSI CDM database. However, 40 variables failed to map to the OHDSI CDM as they mostly belong to imaging data and pathological data.</AbstractText><AbstractText Label="CONCLUSIONS">Our study demonstrates that conducting survival analysis using the OHDSI CDM is feasible and can produce reusable analysis routines. However, challenges to be overcome include 1) semantic loss caused by inaccurate mapping and value normalization; 2) incomplete OHDSI vocabularies describing imaging data, pathological data, and modular data representation.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Hong</LastName><ForeName>Na</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Department of Health Sciences Research, Mayo Clinic, Rochester, MN, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhang</LastName><ForeName>Ning</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Integrated TCM &amp; Western Medicine Department, 302 Military Hospital, Beijing, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wu</LastName><ForeName>Huawei</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Chengdu Library and Information Center, University of Chinese Academy of Sciences, Chengdu, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lu</LastName><ForeName>Shanshan</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Comprehensive Liver Cancer Center, 302 Military Hospital, Beijing, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yu</LastName><ForeName>Yue</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Department of Health Sciences Research, Mayo Clinic, Rochester, MN, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hou</LastName><ForeName>Li</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Institute of Medical Information, Chinese Academy of Medical Sciences, Beijing, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lu</LastName><ForeName>Yinying</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Comprehensive Liver Cancer Center, 302 Military Hospital, Beijing, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Liu</LastName><ForeName>Hongfang</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Department of Health Sciences Research, Mayo Clinic, Rochester, MN, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jiang</LastName><ForeName>Guoqian</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Department of Health Sciences Research, Mayo Clinic, Rochester, MN, USA. Jiang.guoqian@mayo.edu.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>U01 HG009450</GrantID><Acronym>HG</Acronym><Agency>NHGRI NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D052061">Research Support, N.I.H., Extramural</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2018</Year><Month>12</Month><Day>07</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>BMC Med Inform Decis Mak</MedlineTA><NlmUniqueID>101088682</NlmUniqueID><ISSNLinking>1472-6947</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000077558" MajorTopicYN="Y">Big Data</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018281" MajorTopicYN="Y">Cholangiocarcinoma</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D057286" MajorTopicYN="Y">Electronic Health Records</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016247" MajorTopicYN="Y">Information Storage and Retrieval</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007256" MajorTopicYN="Y">Information Systems</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016019" MajorTopicYN="Y">Survival Analysis</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Intrahepatic cholangiocarcinoma</Keyword><Keyword MajorTopicYN="N">Multi-center analysis</Keyword><Keyword MajorTopicYN="N">OHDSI CDM</Keyword><Keyword MajorTopicYN="N">R</Keyword><Keyword MajorTopicYN="N">Survival analysis</Keyword></KeywordList><CoiStatement>ETHICS APPROVAL AND CONSENT TO PARTICIPATE: This study was approval by ethics review committee at 302 Military Hospital. All patients were included based on their consent forms. COMPETING INTERESTS: The authors declare that they have no competing interests. PUBLISHER&#x2019;S NOTE: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2018</Year><Month>12</Month><Day>12</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2018</Year><Month>12</Month><Day>12</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2019</Year><Month>6</Month><Day>30</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2018</Year><Month>12</Month><Day>7</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">30526572</ArticleId><ArticleId IdType="pmc">PMC6284277</ArticleId><ArticleId IdType="doi">10.1186/s12911-018-0686-7</ArticleId><ArticleId IdType="pii">10.1186/s12911-018-0686-7</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Lu CL, Wang S, Ji Z, Wu Y, Xiong L, Jiang X, Ohno-Machado L. WebDISCO: a web service for distributed cox model learning without patient-level data sharing. J. Am. Med. Inform. Assoc. 2015;22(6):1212&#x2013;1219.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5009917</ArticleId><ArticleId IdType="pubmed">26159465</ArticleId></ArticleIdList></Reference><Reference><Citation>Adams TD, Davidson LE, Litwin SE, Kim J, Kolotkin RL, Nanjee MN, Gutierrez JM, Frogley SJ, Ibele AR, Brinton EA, et al. Weight and metabolic outcomes 12 years after gastric bypass. N Engl J Med. 2017;377(12):1143&#x2013;1155. doi: 10.1056/NEJMoa1700459.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa1700459</ArticleId><ArticleId IdType="pmc">PMC5737957</ArticleId><ArticleId IdType="pubmed">28930514</ArticleId></ArticleIdList></Reference><Reference><Citation>Ruzic M, Pellicano R, Fabri M, Luzza F, Boccuto L, Brkic S, Abenavoli L. Hepatitis C virus-induced hepatocellular carcinoma: a narrative review. Panminerva Med. 2018.</Citation><ArticleIdList><ArticleId IdType="pubmed">29856183</ArticleId></ArticleIdList></Reference><Reference><Citation>Nahon P, Layese R, Bourcier V, Cagnot C, Marcellin P, Guyader D, Pol S, Larrey D, De Ledinghen V, Ouzan D, et al. Incidence of hepatocellular carcinoma after direct antiviral therapy for HCV in patients with cirrhosis included in surveillance programs. Gastroenterology. 2018.</Citation><ArticleIdList><ArticleId IdType="pubmed">30031138</ArticleId></ArticleIdList></Reference><Reference><Citation>Finkelmeier F, Dultz G, Peiffer KH, Kronenberger B, Krauss F, Zeuzem S, Sarrazin C, Vermehren J, Waidmann O. Risk of de novo hepatocellular carcinoma after HCV treatment with direct-acting antivirals. Liver Cancer. 2018;7(2):190&#x2013;204. doi: 10.1159/000486812.</Citation><ArticleIdList><ArticleId IdType="doi">10.1159/000486812</ArticleId><ArticleId IdType="pmc">PMC5985411</ArticleId><ArticleId IdType="pubmed">29888208</ArticleId></ArticleIdList></Reference><Reference><Citation>Calvaruso V, Cabibbo G, Cacciola I, Petta S, Madonia S, Bellia A, Tine F, Distefano M, Licata A, Giannitrapani L, et al. Incidence of hepatocellular carcinoma in patients with HCV-associated cirrhosis treated with direct-acting antiviral agents. Gastroenterology. 2018;155(2):411&#x2013;421. doi: 10.1053/j.gastro.2018.04.008.</Citation><ArticleIdList><ArticleId IdType="doi">10.1053/j.gastro.2018.04.008</ArticleId><ArticleId IdType="pubmed">29655836</ArticleId></ArticleIdList></Reference><Reference><Citation>Abou-Alfa GK, Meyer T, Cheng AL, El-Khoueiry AB, Rimassa L, Ryoo BY, Cicin I, Merle P, Chen Y, Park JW, et al. Cabozantinib in patients with advanced and progressing hepatocellular carcinoma. N Engl J Med. 2018;379(1):54&#x2013;63. doi: 10.1056/NEJMoa1717002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa1717002</ArticleId><ArticleId IdType="pmc">PMC7523244</ArticleId><ArticleId IdType="pubmed">29972759</ArticleId></ArticleIdList></Reference><Reference><Citation>Martin-Sanchez FJ, Aguiar-Pulido V, Lopez-Campos GH, Peek N, Sacchi L. Secondary use and analysis of big data collected for patient care. Yearbook of medical informatics. 2017;26(1):28&#x2013;37. doi: 10.15265/IY-2017-008.</Citation><ArticleIdList><ArticleId IdType="doi">10.15265/IY-2017-008</ArticleId><ArticleId IdType="pmc">PMC6239231</ArticleId><ArticleId IdType="pubmed">28480474</ArticleId></ArticleIdList></Reference><Reference><Citation>Hripcsak G, Duke JD, Shah NH, Reich CG, Huser V, Schuemie MJ, Suchard MA, Park RW, Wong IC, Rijnbeek PR, et al. Observational health data sciences and informatics (OHDSI): opportunities for observational researchers. Stud Health Technol Inform. 2015;216:574&#x2013;578.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4815923</ArticleId><ArticleId IdType="pubmed">26262116</ArticleId></ArticleIdList></Reference><Reference><Citation>Waitman LR, Aaronson LS, Nadkarni PM, Connolly DW, Campbell JR. The Greater Plains collaborative: a PCORnet clinical research data network. J. Am. Med. Inform. Assoc. 2014;21(4):637&#x2013;641. doi: 10.1136/amiajnl-2014-002756.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/amiajnl-2014-002756</ArticleId><ArticleId IdType="pmc">PMC4078294</ArticleId><ArticleId IdType="pubmed">24778202</ArticleId></ArticleIdList></Reference><Reference><Citation>Hong N, Li Z, Kiefer RC, Robertson MS, Goode EL, Wang C, Jiang G. Building an i2b2-based integrated data repository for Cancer research: a case study of ovarian Cancer registry. In: VLDB workshop on data management and analytics for medicine and healthcare. Cham: Springer; 2016. p. 121&#x2013;35.</Citation></Reference><Reference><Citation>Vashisht R, Jung K, Shah N. Learning effective treatment pathways for Type-2 diabetes from a clinical data warehouse. AMIA Annu Symp Proc. 2016;2016:2036&#x2013;2042.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5333256</ArticleId><ArticleId IdType="pubmed">28269963</ArticleId></ArticleIdList></Reference><Reference><Citation>Hripcsak G, Ryan PB, Duke JD, Shah NH, Park RW, Huser V, Suchard MA, Schuemie MJ, DeFalco FJ, Perotte A, et al. Characterizing treatment pathways at scale using the OHDSI network. Proc Natl Acad Sci U S A. 2016;113(27):7329&#x2013;7336. doi: 10.1073/pnas.1510502113.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1510502113</ArticleId><ArticleId IdType="pmc">PMC4941483</ArticleId><ArticleId IdType="pubmed">27274072</ArticleId></ArticleIdList></Reference><Reference><Citation>Buuren SV, Groothuis-Oudshoorn K. Mice: multivariate imputation by chained equations in R. J Stat Softw. 2011;451&#x2013;68.</Citation></Reference><Reference><Citation>Shah AD, Bartlett JW, Carpenter J, Nicholas O, Hemingway H. Comparison of random forest and parametric imputation models for imputing missing data using MICE: a CALIBER study. Am J Epidemiol. 2014;179(6):764&#x2013;774. doi: 10.1093/aje/kwt312.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/aje/kwt312</ArticleId><ArticleId IdType="pmc">PMC3939843</ArticleId><ArticleId IdType="pubmed">24589914</ArticleId></ArticleIdList></Reference><Reference><Citation>Goel MK, Khanna P, Kishore J. Understanding survival analysis: Kaplan-Meier estimate. Int J Ayurveda Res. 2010;1(4):274&#x2013;278. doi: 10.4103/0974-7788.76794.</Citation><ArticleIdList><ArticleId IdType="doi">10.4103/0974-7788.76794</ArticleId><ArticleId IdType="pmc">PMC3059453</ArticleId><ArticleId IdType="pubmed">21455458</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">30540837</PMID><DateCompleted><Year>2019</Year><Month>05</Month><Day>06</Day></DateCompleted><DateRevised><Year>2022</Year><Month>12</Month><Day>07</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Electronic">1932-6203</ISSN><JournalIssue CitedMedium="Internet"><Volume>13</Volume><Issue>12</Issue><PubDate><Year>2018</Year></PubDate></JournalIssue><Title>PloS one</Title><ISOAbbreviation>PLoS One</ISOAbbreviation></Journal><ArticleTitle>Penetration of new antidiabetic medications in East Asian countries and the United States: A cross-national comparative study.</ArticleTitle><Pagination><StartPage>e0208796</StartPage><MedlinePgn>e0208796</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">e0208796</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1371/journal.pone.0208796</ELocationID><Abstract><AbstractText Label="BACKGROUND">The number of patients with diabetes is increasing particularly in Asia-Pacific region. Many of them are treated with antidiabetics. As the basis of the studies on the benefit and harm of antidiabetic drugs in the region, the information on patterns of market penetration of new classes of antidiabetic medications is important in providing context for subsequent research and analyzing and interpreting results.</AbstractText><AbstractText Label="METHODS">We compared penetration patterns of dipeptidyl peptidase-4 (DPP-4) inhibitors in Taiwan, Hong Kong, Japan, and the United States. We used the Taiwan National Health Insurance Research Database, a random sample of the Hong Kong Clinical Data Analysis and Reporting System, the Japan Medical Data Center database, and a 5% random sample of the US Medicare database converted to the Observational Medical Outcomes Partnership's Common Data Model to identify new users of oral antidiabetic medications. We standardized prevalence and incidence rates of medication use by age and sex to those in the 2010 Taiwanese population. We compared age, sex, comorbid conditions, and concurrent medications between new users of DPP-4 inhibitors and biguanides.</AbstractText><AbstractText Label="RESULTS">Use of DPP-4 inhibitors 1 year after market entry was highest in Japan and lowest in Hong Kong. New users had more heart failure, hyperlipidemia, and renal failure than biguanide users in Taiwan, Hong Kong, and the United States while the proportions were similar in Japan. In a country with low penetration of DPP-4 inhibitors (eg, Hong Kong), users had diabetes with multiple comorbid conditions compared with biguanidine users. In a country with high penetration (eg, Japan), the proportion of users with comorbid conditions was similar to that of biguanide users.</AbstractText><AbstractText Label="CONCLUSIONS">We observed a marked difference of the penetration patterns of newly marketed antidiabetics in different countries in Asia. Those results will provide the basic information useful in the future studies.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Kubota</LastName><ForeName>Kiyoshi</ForeName><Initials>K</Initials><Identifier Source="ORCID">0000-0001-6092-8685</Identifier><AffiliationInfo><Affiliation>NPO Drug Safety Research Unit Japan, Tokyo, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kamijima</LastName><ForeName>Yukari</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>NPO Drug Safety Research Unit Japan, Tokyo, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kao Yang</LastName><ForeName>Yea-Huei</ForeName><Initials>YH</Initials><AffiliationInfo><Affiliation>Institute of Clinical Pharmacy and Pharmaceutical Sciences, College of Medicine, National Cheng Kung University, Tainan, Taiwan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kimura</LastName><ForeName>Shinya</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Japan Medical Data Center, Tokyo, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chia-Cheng Lai</LastName><ForeName>Edward</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Duke Clinical Research Institute, Duke University School of Medicine, Durham, North Carolina, United States of America.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Man</LastName><ForeName>Kenneth K C</ForeName><Initials>KKC</Initials><AffiliationInfo><Affiliation>Centre for Safe Medication Practice and Research, Department of Pharmacology and Pharmacy, University of Hong Kong, Hong Kong, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Research Department of Practice and Policy, UCL School of Pharmacy, London, United Kingdom.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ryan</LastName><ForeName>Patrick</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Janssen Research &amp; Development, LLC, Titusville, New Jersey, United States of America.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Schuemie</LastName><ForeName>Martijn</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Janssen Research &amp; Development, LLC, Titusville, New Jersey, United States of America.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Stang</LastName><ForeName>Paul</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Janssen Research &amp; Development, LLC, Titusville, New Jersey, United States of America.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Su</LastName><ForeName>Chien-Chou</ForeName><Initials>CC</Initials><AffiliationInfo><Affiliation>Institute of Clinical Pharmacy and Pharmaceutical Sciences, College of Medicine, National Cheng Kung University, Tainan, Taiwan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wong</LastName><ForeName>Ian C K</ForeName><Initials>ICK</Initials><Identifier Source="ORCID">0000-0001-8242-0014</Identifier><AffiliationInfo><Affiliation>Centre for Safe Medication Practice and Research, Department of Pharmacology and Pharmacy, University of Hong Kong, Hong Kong, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Research Department of Practice and Policy, UCL School of Pharmacy, London, United Kingdom.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhang</LastName><ForeName>Yinghong</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Duke Clinical Research Institute, Duke University School of Medicine, Durham, North Carolina, United States of America.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Setoguchi</LastName><ForeName>Soko</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Duke Clinical Research Institute, Duke University School of Medicine, Durham, North Carolina, United States of America.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Epidemiology, Rutgers School of Public Health, New Brunswick, United States of America.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016430">Clinical Trial</PublicationType><PublicationType UI="D003160">Comparative Study</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016448">Multicenter Study</PublicationType><PublicationType UI="D064888">Observational Study</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2018</Year><Month>12</Month><Day>12</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>PLoS One</MedlineTA><NlmUniqueID>101285081</NlmUniqueID><ISSNLinking>1932-6203</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D054873">Dipeptidyl-Peptidase IV Inhibitors</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D007004">Hypoglycemic Agents</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000293" MajorTopicYN="N">Adolescent</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000367" MajorTopicYN="N">Age Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000369" MajorTopicYN="N">Aged, 80 and over</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002648" MajorTopicYN="N">Child</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002675" MajorTopicYN="N">Child, Preschool</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003920" MajorTopicYN="N">Diabetes Mellitus</DescriptorName><QualifierName UI="Q000188" MajorTopicYN="Y">drug therapy</QualifierName><QualifierName UI="Q000191" MajorTopicYN="N">economics</QualifierName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D054873" MajorTopicYN="N">Dipeptidyl-Peptidase IV Inhibitors</DescriptorName><QualifierName UI="Q000008" MajorTopicYN="Y">administration &amp; dosage</QualifierName><QualifierName UI="Q000191" MajorTopicYN="N">economics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005202" MajorTopicYN="N" Type="Geographic">Asia, Eastern</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007004" MajorTopicYN="N">Hypoglycemic Agents</DescriptorName><QualifierName UI="Q000008" MajorTopicYN="Y">administration &amp; dosage</QualifierName><QualifierName UI="Q000191" MajorTopicYN="N">economics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D007223" MajorTopicYN="N">Infant</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007231" MajorTopicYN="N">Infant, Newborn</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015995" MajorTopicYN="N">Prevalence</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012737" MajorTopicYN="N">Sex Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014481" MajorTopicYN="N" Type="Geographic">United States</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading></MeshHeadingList><CoiStatement>This work was supported by a research agreement between Duke University and Janssen Research &amp; Development, LLC. Among authors, P Ryan, M Schuemie, and P Stang are employees of Janssen, a company that developed canagliflozin for treatment of Type 2 diabetes. This does not alter our adherence to PLOS ONE policies on sharing data and material.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2018</Year><Month>2</Month><Day>26</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2018</Year><Month>11</Month><Day>26</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2018</Year><Month>12</Month><Day>13</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2018</Year><Month>12</Month><Day>13</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2019</Year><Month>5</Month><Day>7</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2018</Year><Month>12</Month><Day>12</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">30540837</ArticleId><ArticleId IdType="pmc">PMC6291148</ArticleId><ArticleId IdType="doi">10.1371/journal.pone.0208796</ArticleId><ArticleId IdType="pii">PONE-D-18-06212</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>International Diabetes Federation. IDF Diabetes Atlas Eighth Edition 2017. Available from: http://www.idf.org/idf-diabetes-atlas-seventh-edition.</Citation></Reference><Reference><Citation>Ryd&#xe9;n L, Grant PJ, Anker SD, Berne C, Cosentino F, Danchin N. et al.
ESC guidelines on diabetes, pre-diabetes, and cardiovascular diseases developed in collaboration with the EASD. Eur Heart J. 2013: 34, 3035&#x2013;3087. 10.1093/eurheartj/eht108
</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/eurheartj/eht108</ArticleId><ArticleId IdType="pubmed">23996285</ArticleId></ArticleIdList></Reference><Reference><Citation>Wolffenbuttel BH, Landgraf R. A
1-year multicenter randomized double-blind comparison of repaglinide and glyburide for the treatment of type 2 diabetes. Diabetes Care
1999: 22, 463&#x2013;467. 10.2337/diacare.22.3.463
</Citation><ArticleIdList><ArticleId IdType="doi">10.2337/diacare.22.3.463</ArticleId><ArticleId IdType="pubmed">10097930</ArticleId></ArticleIdList></Reference><Reference><Citation>The DREAM (Diabetes REduction Assessment with ramipril and rosiglitazone Medication) Trial Investigators, Gerstein HC, Yusuf S, Bosch J, Pogue J, Sheridan P. et al.
Effect of rosiglitazone on the frequency of diabetes in patients with impaired glucose tolerance or impaired fasting glucose: a randomised controlled trial. Lancet
2006: 368,1096&#x2013;1105. 10.1016/S0140-6736(06)69420-8
</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(06)69420-8</ArticleId><ArticleId IdType="pubmed">16997664</ArticleId></ArticleIdList></Reference><Reference><Citation>Pratley RE, Nauck M, Bailey T, Montanya E, Cuddihy R, Filetti S. et al.
Liraglutide versus sitagliptin for patients with type 2 diabetes who did not have adequate glycaemic control with metformin: a 26-week, randomised, parallel-group, open-label trial. Lancet
2010: 375, 1447&#x2013;1456. 10.1016/S0140-6736(10)60307-8
</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(10)60307-8</ArticleId><ArticleId IdType="pubmed">20417856</ArticleId></ArticleIdList></Reference><Reference><Citation>Defronzo RA, Ranter RE, Han J, Kim DD, Fineman MS, Baron AD. Effects of exenatide (Exendin-4) on glycemic control and weight over 30 weeks in metformin-treated patients with type 2 diabetes. Diabetes Care
2005: 28, 1092&#x2013;1100. 10.2337/diacare.28.5.1092
</Citation><ArticleIdList><ArticleId IdType="doi">10.2337/diacare.28.5.1092</ArticleId><ArticleId IdType="pubmed">15855572</ArticleId></ArticleIdList></Reference><Reference><Citation>Cefalu WT, Leiter LA, Yoon KH, Arias P, Niskanen L, Xie J. et al.
Efficacy and safety of canagliflozin versus glimepiride in patients with type 2 diabetes inadequately controlled with metformin (CANTATA-SU): 52 week results from a randomised, double-blind, phase 3 non-inferiority trial. Lancet
2013: 382, 941&#x2013;950. 10.1016/S0140-6736(13)60683-2
</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(13)60683-2</ArticleId><ArticleId IdType="pubmed">23850055</ArticleId></ArticleIdList></Reference><Reference><Citation>Shah BR, Victor JC, Chiu M, Tu JV, Anand SS, Austin PC. et al.
Cardiovascular complications and mortality after diabetes diagnosis for South Asian and Chinese patients: a population-based cohort study. Diabetes Care
2013: 36, 2670&#x2013;2676. 10.2337/dc12-2105
</Citation><ArticleIdList><ArticleId IdType="doi">10.2337/dc12-2105</ArticleId><ArticleId IdType="pmc">PMC3747942</ArticleId><ArticleId IdType="pubmed">23637350</ArticleId></ArticleIdList></Reference><Reference><Citation>International Society for Pharmacoepidemiology. AsPEN, Asian Pharmacoepidemiology Network. Available from: https://www.pharmacoepi.org/communities/sigs/aspen/.</Citation></Reference><Reference><Citation>Asian Pharmacoepidemiology Network. Surveillance of Health Care in Asian Network (SCAN) Project. Available from: http://aspennet.asia/activities/activity6.html.</Citation></Reference><Reference><Citation>National Health Insurance Research Database. Available from: http://nhird.nhri.org.tw/.</Citation></Reference><Reference><Citation>Wong AY, Root A, Douglas IJ, Chui CS, Chan EW, Ghebremichael-Weldeselassie Y. et al.
Cardiovascular outcomes associated with use of clarithromycin: population based study. BMJ
2016: 352, h6926
10.1136/bmj.h6926
</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.h6926</ArticleId><ArticleId IdType="pubmed">26768836</ArticleId></ArticleIdList></Reference><Reference><Citation>Kimura S., Sato T., Ikeda S., Noda M, Nakayama T. Development of a database of health insurance claims: standardization of disease classifications and anonymous record linkage. J Epidemiol. 2010: 20, 413&#x2013;419. 10.2188/jea.JE20090066
</Citation><ArticleIdList><ArticleId IdType="doi">10.2188/jea.JE20090066</ArticleId><ArticleId IdType="pmc">PMC3900837</ArticleId><ArticleId IdType="pubmed">20699602</ArticleId></ArticleIdList></Reference><Reference><Citation>Dubberke ER, Olsen MA, Stwalley D, Kelly CP, Gerding DN, Young-Xu Y. et al.
Identification of Medicare recipients at highest risk for clostridium difficile infection in the US by population attributable risk analysis. PLoS ONE
2016: 11, e0146822
10.1371/journal.pone.0146822
</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0146822</ArticleId><ArticleId IdType="pmc">PMC4747338</ArticleId><ArticleId IdType="pubmed">26859403</ArticleId></ArticleIdList></Reference><Reference><Citation>Chirikos TN. Medicare and the Social Security Disability Insurance program. Health Aff. (Millwood) 1995: 14, 244&#x2013;252.</Citation><ArticleIdList><ArticleId IdType="pubmed">8690350</ArticleId></ArticleIdList></Reference><Reference><Citation>Observational Health Data Sciences and Informatics. OMOP Common Data Model. Available from: http://www.ohdsi.org/data-standardization/the-common-data-model/.</Citation></Reference><Reference><Citation>Mamdani M, Sykora K, Li P, Normand SL, Streiner DL, Austin PC. et al.
Reader&#x2019;s guide to critical appraisal of cohort studies: 2. Assessing potential for confounding. BMJ
2005: 330, 960&#x2013;962. 10.1136/bmj.330.7497.960
</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.330.7497.960</ArticleId><ArticleId IdType="pmc">PMC556348</ArticleId><ArticleId IdType="pubmed">15845982</ArticleId></ArticleIdList></Reference><Reference><Citation>International Society for Pharmacoepidemiology. Guidelines for good pharmacoepidemiology practice (GPP) (2015). Available from: https://www.pharmacoepi.org/resources/policies/guidelines-08027/.</Citation></Reference><Reference><Citation>The PLOS Medicine editors. Observational studies: getting clear about transparency. PLoS Med
2014: 11, e1001711
10.1371/journal.pmed.1001711
</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pmed.1001711</ArticleId><ArticleId IdType="pmc">PMC4144975</ArticleId><ArticleId IdType="pubmed">25158064</ArticleId></ArticleIdList></Reference><Reference><Citation>Chang CH, Jiang YD, Chung CH, Ho LT, Chuang LM. National trends in anti-diabetic treatment in Taiwan, 2000&#x2013;2009. J Formos Med Assoc. 2012: 111, 617&#x2013;624. 10.1016/j.jfma.2012.09.009
</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jfma.2012.09.009</ArticleId><ArticleId IdType="pubmed">23217597</ArticleId></ArticleIdList></Reference><Reference><Citation>Hasan SS, Clavarino AM, Mamun AA, Kairuz T. A comparative drug utilisation study of the treatment of diabetes in Malaysia and Australia. Australas Med J.2015: 8, 179&#x2013;188. 10.4066/AMJ.2015.2330
</Citation><ArticleIdList><ArticleId IdType="doi">10.4066/AMJ.2015.2330</ArticleId><ArticleId IdType="pmc">PMC4496718</ArticleId><ArticleId IdType="pubmed">26213581</ArticleId></ArticleIdList></Reference><Reference><Citation>American Diabetes Association. Approaches to glycemic treatment. Diabetes Care
2016: 39 (Suppl 1), S52&#x2013;S59. 10.2337/dc16-S010
</Citation><ArticleIdList><ArticleId IdType="doi">10.2337/dc16-S010</ArticleId><ArticleId IdType="pubmed">26696682</ArticleId></ArticleIdList></Reference><Reference><Citation>Japan Diabetes Society. Treatment Guide for Diabetes 2012&#x2013;2013. Tokyo, Bunkodo, 2013. Available from: http://www.jds.or.jp/modules/publication/index.php?content_id = 1.</Citation></Reference><Reference><Citation>Noda M, Noto H. Standard treatment manual for diabetes (in Japanese). Available from: http://ncgm-dm.jp/center/manual.html.</Citation></Reference><Reference><Citation>Iizuka T. Experts' agency problems: evidence from the prescription drug market in Japan. Rand J Econ. 2007;38:844&#x2013;862.</Citation><ArticleIdList><ArticleId IdType="pubmed">18478669</ArticleId></ArticleIdList></Reference><Reference><Citation>Iizuka T. Physician Agency and Adoption of Generic Pharmaceuticals. Am Econ Rev. 2012;102:2826&#x2013;2858.</Citation><ArticleIdList><ArticleId IdType="pubmed">29522299</ArticleId></ArticleIdList></Reference><Reference><Citation>Ministry of Health Labour and Welfare. Survey of Medical Care Activities in Public Health Insurance 2010 (in Japanese). Available from: https://www.mhlw.go.jp/toukei/saikin/hw/sinryo/tyosa10/dl/ingai.pdf.</Citation></Reference><Reference><Citation>Marcum ZA, Driessen J, Thorpe CT, Donohue JM, Gellad WF. Regional variation in use of a new class of antidiabetic medication among medicare beneficiaries: the case of incretin mimetics. Ann Pharmacother. 2015. 
49:285&#x2013;292. 10.1177/1060028014563951
</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/1060028014563951</ArticleId><ArticleId IdType="pmc">PMC4876962</ArticleId><ArticleId IdType="pubmed">25515869</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">30646124</PMID><DateCompleted><Year>2019</Year><Month>09</Month><Day>26</Day></DateCompleted><DateRevised><Year>2022</Year><Month>12</Month><Day>07</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">2574-3805</ISSN><JournalIssue CitedMedium="Internet"><Volume>1</Volume><Issue>4</Issue><PubDate><Year>2018</Year><Month>Aug</Month><Day>03</Day></PubDate></JournalIssue><Title>JAMA network open</Title><ISOAbbreviation>JAMA Netw Open</ISOAbbreviation></Journal><ArticleTitle>Association of Hemoglobin A1c Levels With Use of Sulfonylureas, Dipeptidyl Peptidase 4 Inhibitors, and Thiazolidinediones in Patients With Type 2 Diabetes Treated With Metformin: Analysis From the Observational Health Data Sciences and Informatics Initiative.</ArticleTitle><Pagination><StartPage>e181755</StartPage><MedlinePgn>e181755</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">e181755</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1001/jamanetworkopen.2018.1755</ELocationID><Abstract><AbstractText Label="IMPORTANCE">Consensus around an efficient second-line treatment option for type 2 diabetes (T2D) remains ambiguous. The availability of electronic medical records and insurance claims data, which capture routine medical practice, accessed via the Observational Health Data Sciences and Informatics network presents an opportunity to generate evidence for the effectiveness of second-line treatments.</AbstractText><AbstractText Label="OBJECTIVE">To identify which drug classes among sulfonylureas, dipeptidyl peptidase 4 (DPP-4) inhibitors, and thiazolidinediones are associated with reduced hemoglobin A1c (HbA1c) levels and lower risk of myocardial infarction, kidney disorders, and eye disorders in patients with T2D treated with metformin as a first-line therapy.</AbstractText><AbstractText Label="DESIGN, SETTING, AND PARTICIPANTS">Three retrospective, propensity-matched, new-user cohort studies with replication across 8 sites were performed from 1975 to 2017. Medical data of 246&#x202f;558&#x202f;805 patients from multiple countries from the Observational Health Data Sciences and Informatics (OHDSI) initiative were included and medical data sets were transformed into a unified common data model, with analysis done using open-source analytical tools. Participants included patients with T2D receiving metformin with at least 1 prior HbA1c laboratory test who were then prescribed either sulfonylureas, DPP-4 inhibitors, or thiazolidinediones. Data analysis was conducted from 2015 to 2018.</AbstractText><AbstractText Label="EXPOSURES">Treatment with sulfonylureas, DPP-4 inhibitors, or thiazolidinediones starting at least 90 days after the initial prescription of metformin.</AbstractText><AbstractText Label="MAIN OUTCOMES AND MEASURES">The primary outcome is the first observation of the reduction of HbA1c level to 7% of total hemoglobin or less after prescription of a second-line drug. Secondary outcomes are myocardial infarction, kidney disorder, and eye disorder after prescription of a second-line drug.</AbstractText><AbstractText Label="RESULTS">A total of 246&#x202f;558&#x202f;805 patients (126&#x202f;977&#x202f;785 women [51.5%]) were analyzed. Effectiveness of sulfonylureas, DPP-4 inhibitors, and thiazolidinediones prescribed after metformin to lower HbA1c level to 7% or less of total hemoglobin remained indistinguishable in patients with T2D. Patients treated with sulfonylureas compared with DPP-4 inhibitors had a small increased consensus hazard ratio of myocardial infarction (1.12; 95% CI, 1.02-1.24) and eye disorders (1.15; 95% CI, 1.11-1.19) in the meta-analysis. Hazard of observing kidney disorders after treatment with sulfonylureas, DPP-4 inhibitors, or thiazolidinediones was equally likely.</AbstractText><AbstractText Label="CONCLUSIONS AND RELEVANCE">The examined drug classes did not differ in lowering HbA1c and in hazards of kidney disorders in patients with T2D treated with metformin as a first-line therapy. Sulfonylureas had a small, higher observed hazard of myocardial infarction and eye disorders compared with DPP-4 inhibitors in the meta-analysis. The OHDSI collaborative network can be used to conduct a large international study examining the effectiveness of second-line treatment choices made in clinical management of T2D.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Vashisht</LastName><ForeName>Rohit</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Observational Health Data Sciences and Informatics, New York, New York.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Center for Biomedical Informatics Research, Stanford University School of Medicine, Stanford, California.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jung</LastName><ForeName>Kenneth</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Observational Health Data Sciences and Informatics, New York, New York.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Center for Biomedical Informatics Research, Stanford University School of Medicine, Stanford, California.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Schuler</LastName><ForeName>Alejandro</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Observational Health Data Sciences and Informatics, New York, New York.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Center for Biomedical Informatics Research, Stanford University School of Medicine, Stanford, California.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Banda</LastName><ForeName>Juan M</ForeName><Initials>JM</Initials><AffiliationInfo><Affiliation>Observational Health Data Sciences and Informatics, New York, New York.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Center for Biomedical Informatics Research, Stanford University School of Medicine, Stanford, California.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Park</LastName><ForeName>Rae Woong</ForeName><Initials>RW</Initials><AffiliationInfo><Affiliation>Observational Health Data Sciences and Informatics, New York, New York.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Biomedical Sciences, Ajou University Graduate School of Medicine, Suwon, Gyeonggi-do, Republic of Korea.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Biomedical Informatics, Ajou University School of Medicine, Suwon, Gyeonggi-do, Republic of Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jin</LastName><ForeName>Sanghyung</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Observational Health Data Sciences and Informatics, New York, New York.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Biomedical Informatics, Ajou University School of Medicine, Suwon, Gyeonggi-do, Republic of Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Li</LastName><ForeName>Li</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>The Institute of Next Generation of Healthcare, Icahn School of Medicine at Mount Sinai, New York, New York.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Dudley</LastName><ForeName>Joel T</ForeName><Initials>JT</Initials><AffiliationInfo><Affiliation>The Institute of Next Generation of Healthcare, Icahn School of Medicine at Mount Sinai, New York, New York.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Johnson</LastName><ForeName>Kipp W</ForeName><Initials>KW</Initials><AffiliationInfo><Affiliation>The Institute of Next Generation of Healthcare, Icahn School of Medicine at Mount Sinai, New York, New York.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Shervey</LastName><ForeName>Mark M</ForeName><Initials>MM</Initials><AffiliationInfo><Affiliation>The Institute of Next Generation of Healthcare, Icahn School of Medicine at Mount Sinai, New York, New York.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Xu</LastName><ForeName>Hua</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Observational Health Data Sciences and Informatics, New York, New York.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>School of Biomedical Informatics, The University of Texas Health Science Center at Houston, Houston.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wu</LastName><ForeName>Yonghui</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Observational Health Data Sciences and Informatics, New York, New York.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Health Outcome and Policy, College of Medicine, University of Florida, Gainesville.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Natrajan</LastName><ForeName>Karthik</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Observational Health Data Sciences and Informatics, New York, New York.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>New York-Presbyterian Hospital, New York.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Biomedical Informatics, Columbia University, New York, New York.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hripcsak</LastName><ForeName>George</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Observational Health Data Sciences and Informatics, New York, New York.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Biomedical Informatics, Columbia University, New York, New York.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jin</LastName><ForeName>Peng</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Observational Health Data Sciences and Informatics, New York, New York.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Biomedical Informatics, Columbia University, New York, New York.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Van Zandt</LastName><ForeName>Mui</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Observational Health Data Sciences and Informatics, New York, New York.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>IQVIA, Durham, North Carolina.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Reckard</LastName><ForeName>Anthony</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Observational Health Data Sciences and Informatics, New York, New York.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>IQVIA, Durham, North Carolina.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Reich</LastName><ForeName>Christian G</ForeName><Initials>CG</Initials><AffiliationInfo><Affiliation>Observational Health Data Sciences and Informatics, New York, New York.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>IQVIA, Durham, North Carolina.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Weaver</LastName><ForeName>James</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Observational Health Data Sciences and Informatics, New York, New York.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Janssen Research and Development, Raritan, New Jersey.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Schuemie</LastName><ForeName>Martijn J</ForeName><Initials>MJ</Initials><AffiliationInfo><Affiliation>Janssen Research and Development, Raritan, New Jersey.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ryan</LastName><ForeName>Patrick B</ForeName><Initials>PB</Initials><AffiliationInfo><Affiliation>Observational Health Data Sciences and Informatics, New York, New York.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Biomedical Informatics, Columbia University, New York, New York.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Janssen Research and Development, Raritan, New Jersey.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Callahan</LastName><ForeName>Alison</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Observational Health Data Sciences and Informatics, New York, New York.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Center for Biomedical Informatics Research, Stanford University School of Medicine, Stanford, California.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Shah</LastName><ForeName>Nigam H</ForeName><Initials>NH</Initials><AffiliationInfo><Affiliation>Observational Health Data Sciences and Informatics, New York, New York.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Center for Biomedical Informatics Research, Stanford University School of Medicine, Stanford, California.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>R01 GM101430</GrantID><Acronym>GM</Acronym><Agency>NIGMS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R25 CA180993</GrantID><Acronym>CA</Acronym><Agency>NCI NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R01 LM006910</GrantID><Acronym>LM</Acronym><Agency>NLM NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R01 LM011369</GrantID><Acronym>LM</Acronym><Agency>NLM NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R01 DK098242</GrantID><Acronym>DK</Acronym><Agency>NIDDK NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D064888">Observational Study</PublicationType><PublicationType UI="D052061">Research Support, N.I.H., Extramural</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2018</Year><Month>08</Month><Day>03</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>JAMA Netw Open</MedlineTA><NlmUniqueID>101729235</NlmUniqueID><ISSNLinking>2574-3805</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D054873">Dipeptidyl-Peptidase IV Inhibitors</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D006442">Glycated Hemoglobin A</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D007004">Hypoglycemic Agents</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D013453">Sulfonylurea Compounds</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D045162">Thiazolidinediones</NameOfSubstance></Chemical><Chemical><RegistryNumber>9100L32L2N</RegistryNumber><NameOfSubstance UI="D008687">Metformin</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D015331" MajorTopicYN="N">Cohort Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003924" MajorTopicYN="N">Diabetes Mellitus, Type 2</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="Y">blood</QualifierName><QualifierName UI="Q000188" MajorTopicYN="Y">drug therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D054873" MajorTopicYN="N">Dipeptidyl-Peptidase IV Inhibitors</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName><QualifierName UI="Q000627" MajorTopicYN="Y">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006442" MajorTopicYN="N">Glycated Hemoglobin</DescriptorName><QualifierName UI="Q000032" MajorTopicYN="Y">analysis</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007004" MajorTopicYN="N">Hypoglycemic Agents</DescriptorName><QualifierName UI="Q000627" MajorTopicYN="Y">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008687" MajorTopicYN="N">Metformin</DescriptorName><QualifierName UI="Q000627" MajorTopicYN="Y">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D013453" MajorTopicYN="N">Sulfonylurea Compounds</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName><QualifierName UI="Q000627" MajorTopicYN="Y">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D045162" MajorTopicYN="N">Thiazolidinediones</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName><QualifierName UI="Q000627" MajorTopicYN="Y">therapeutic use</QualifierName></MeshHeading></MeshHeadingList><CoiStatement><b>Conflict of Interest Disclosures:</b> Dr Dudley has received consulting fees or honoraria from Janssen Pharmaceuticals, GlaxoSmithKline, AstraZeneca, and Hoffman-La Roche; is a scientific advisor to LAM Therapeutics; and holds equity in NuMedii Inc, Ayasdi Inc, and Ontomics Inc. Dr Xu reported grants from the National Institutes of Health and the Cancer Prevention and Research Institute of Texas during the conduct of the study and personal fees from Hebta LLC, Melax Technologies Inc, and More Health Inc outside the submitted work. Dr Wu reported grants from the Cancer Prevention and Research Institute of Texas during the conduct of the study and grants from the National Institutes of Health outside the submitted work. Dr Schuemie reported personal fees and was a shareholder at Janssen Research and Development during the conduct of the study. Drs Callahan and Shah reported grants from National Institutes of Health during the conduct of the study. Dr Ryan and Mr Weaver are employees of Janssen Research and Development. No other disclosures were reported.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2019</Year><Month>1</Month><Day>16</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2019</Year><Month>1</Month><Day>16</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2019</Year><Month>9</Month><Day>27</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2018</Year><Month>8</Month><Day>24</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">30646124</ArticleId><ArticleId IdType="pmc">PMC6324274</ArticleId><ArticleId IdType="doi">10.1001/jamanetworkopen.2018.1755</ArticleId><ArticleId IdType="pii">2698083</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Menke A, Casagrande S, Geiss L, Cowie CC. Prevalence of and trends in diabetes among adults in the United States, 1988-2012. JAMA. 2015;314(10):-. doi:10.1001/jama.2015.10029</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2015.10029</ArticleId><ArticleId IdType="pubmed">26348752</ArticleId></ArticleIdList></Reference><Reference><Citation>Ogurtsova K, da Rocha Fernandes JD, Huang Y, et al. . IDF diabetes atlas: global estimates for the prevalence of diabetes for 2015 and 2040. Diabetes Res Clin Pract. 2017;128:40-50. doi:10.1016/j.diabres.2017.03.024</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.diabres.2017.03.024</ArticleId><ArticleId IdType="pubmed">28437734</ArticleId></ArticleIdList></Reference><Reference><Citation>Lin P-J, Kent DM, Winn A, Cohen JT, Neumann PJ. Multiple chronic conditions in type 2 diabetes mellitus: prevalence and consequences. Am J Manag Care. 2015;21(1):e23-e34.</Citation><ArticleIdList><ArticleId IdType="pubmed">25880265</ArticleId></ArticleIdList></Reference><Reference><Citation>Struijs JN, Baan CA, Schellevis FG, Westert GP, van den Bos GAM. Comorbidity in patients with diabetes mellitus: impact on medical health care utilization. BMC Health Serv Res. 2006;6(1):84. doi:10.1186/1472-6963-6-84</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1472-6963-6-84</ArticleId><ArticleId IdType="pmc">PMC1534031</ArticleId><ArticleId IdType="pubmed">16820048</ArticleId></ArticleIdList></Reference><Reference><Citation>Adriaanse MC, Drewes HW, van der Heide I, Struijs JN, Baan CA. The impact of comorbid chronic conditions on quality of life in type 2 diabetes patients. Qual Life Res. 2016;25(1):175-182. doi:10.1007/s11136-015-1061-0</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11136-015-1061-0</ArticleId><ArticleId IdType="pmc">PMC4706581</ArticleId><ArticleId IdType="pubmed">26267523</ArticleId></ArticleIdList></Reference><Reference><Citation>Marathe PH, Gao HX, Close KL. American Diabetes Association standards of medical care in diabetes 2017. J Diabetes. 2017;9(4):320-324. doi:10.1111/1753-0407.12524</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/1753-0407.12524</ArticleId><ArticleId IdType="pubmed">28070960</ArticleId></ArticleIdList></Reference><Reference><Citation>Garber AJ, Abrahamson MJ, Barzilay JI, et al. . Consensus statement by the American Association of Clinical Endocrinologists and American College of Endocrinology on the comprehensive type 2 diabetes management algorithm&#x2014;2017 executive summary. Endocr Pract. 2017;23(2):207-238. doi:10.4158/EP161682.CS</Citation><ArticleIdList><ArticleId IdType="doi">10.4158/EP161682.CS</ArticleId><ArticleId IdType="pubmed">28095040</ArticleId></ArticleIdList></Reference><Reference><Citation>Stewart WF, Shah NR, Selna MJ, Paulus RA, Walker JM. Bridging the inferential gap: the electronic health record and clinical evidence. Health Aff (Millwood). 2007;26(2):w181-w191. doi:10.1377/hlthaff.26.2.w181</Citation><ArticleIdList><ArticleId IdType="doi">10.1377/hlthaff.26.2.w181</ArticleId><ArticleId IdType="pmc">PMC2670472</ArticleId><ArticleId IdType="pubmed">17259202</ArticleId></ArticleIdList></Reference><Reference><Citation>Hripcsak G, Duke JD, Shah NH, et al. . Observational health data sciences and informatics (OHDSI): opportunities for observational researchers. Stud Health Technol Inform. 2015;216:574-578.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4815923</ArticleId><ArticleId IdType="pubmed">26262116</ArticleId></ArticleIdList></Reference><Reference><Citation>Hripcsak G, Ryan PB, Duke JD, et al. . Characterizing treatment pathways at scale using the OHDSI network. Proc Natl Acad Sci U S A. 2016;113(27):7329-7336. doi:10.1073/pnas.1510502113</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1510502113</ArticleId><ArticleId IdType="pmc">PMC4941483</ArticleId><ArticleId IdType="pubmed">27274072</ArticleId></ArticleIdList></Reference><Reference><Citation>American Diabetes Association Standards of Medical Care in Diabetes&#x2014;2017. Danvers, MA: Diabetes Care; 2017. doi:10.2337/dc17-S001</Citation><ArticleIdList><ArticleId IdType="doi">10.2337/dc17-S001</ArticleId></ArticleIdList></Reference><Reference><Citation>Reusch JEB, Manson JE. Management of type 2 diabetes in 2017: getting to goal. JAMA. 2017;317(10):1015-1016. doi:10.1001/jama.2017.0241</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2017.0241</ArticleId><ArticleId IdType="pmc">PMC5894353</ArticleId><ArticleId IdType="pubmed">28249081</ArticleId></ArticleIdList></Reference><Reference><Citation>Bennett WL, Maruthur NM, Singh S, et al. . Comparative effectiveness and safety of medications for type 2 diabetes: an update including new drugs and 2-drug combinations. Ann Intern Med. 2011;154(9):602-613. doi:10.7326/0003-4819-154-9-201105030-00336</Citation><ArticleIdList><ArticleId IdType="doi">10.7326/0003-4819-154-9-201105030-00336</ArticleId><ArticleId IdType="pmc">PMC3733115</ArticleId><ArticleId IdType="pubmed">21403054</ArticleId></ArticleIdList></Reference><Reference><Citation>FitzHenry F, Resnic FS, Robbins SL, et al. . Creating a common data model for comparative effectiveness with the observational medical outcomes partnership. Appl Clin Inform. 2015;6(3):536-547. doi:10.4338/ACI-2014-12-CR-0121</Citation><ArticleIdList><ArticleId IdType="doi">10.4338/ACI-2014-12-CR-0121</ArticleId><ArticleId IdType="pmc">PMC4586341</ArticleId><ArticleId IdType="pubmed">26448797</ArticleId></ArticleIdList></Reference><Reference><Citation>Observational Health Data Sciences and Informatics 
OHDSI Standardized Vocabularies. https://github.com/OHDSI/CommonDataModel/wiki/Standardized-Vocabularies. Accessed June 8, 2018.</Citation></Reference><Reference><Citation>Stuart EA. Matching methods for causal inference: a review and a look forward. Stat Sci. 2010;25(1):1-21. doi:10.1214/09-STS313</Citation><ArticleIdList><ArticleId IdType="doi">10.1214/09-STS313</ArticleId><ArticleId IdType="pmc">PMC2943670</ArticleId><ArticleId IdType="pubmed">20871802</ArticleId></ArticleIdList></Reference><Reference><Citation>Austin PC. Optimal caliper widths for propensity-score matching when estimating differences in means and differences in proportions in observational studies. Pharm Stat. 2011;10(2):150-161. doi:10.1002/pst.433</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/pst.433</ArticleId><ArticleId IdType="pmc">PMC3120982</ArticleId><ArticleId IdType="pubmed">20925139</ArticleId></ArticleIdList></Reference><Reference><Citation>Montgomery JM, Nyhan B, Torres M. 
How conditioning on post-treatment variables can ruin your experiment and what to do about it In: Annual Meeting of the Midwest Political Science Association; 2016; Chicago, IL: 
http://www.dartmouth.edu/~nyhan/post-treatment-bias.pdf. Accessed May 25, 2018.</Citation></Reference><Reference><Citation>Abadie A, Imbens GW. Bias-corrected matching estimators for average treatment effects. J Bus Econ Stat. 2011;29(1):1-11. doi:10.1198/jbes.2009.07333</Citation><ArticleIdList><ArticleId IdType="doi">10.1198/jbes.2009.07333</ArticleId></ArticleIdList></Reference><Reference><Citation>Madigan D, Stang PE, Berlin JA, et al. . A systematic statistical approach to evaluating evidence from observational studies. Annu Rev Stat Appl. 2014;1(1):11-39. doi:10.1146/annurev-statistics-022513-115645</Citation><ArticleIdList><ArticleId IdType="doi">10.1146/annurev-statistics-022513-115645</ArticleId></ArticleIdList></Reference><Reference><Citation>Lipsitch M, Tchetgen Tchetgen E, Cohen T. Negative controls: a tool for detecting confounding and bias in observational studies. Epidemiology. 2010;21(3):383-388. doi:10.1097/EDE.0b013e3181d61eeb</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/EDE.0b013e3181d61eeb</ArticleId><ArticleId IdType="pmc">PMC3053408</ArticleId><ArticleId IdType="pubmed">20335814</ArticleId></ArticleIdList></Reference><Reference><Citation>Schuemie MJ, Ryan PB, DuMouchel W, Suchard MA, Madigan D. Interpreting observational studies: why empirical calibration is needed to correct p-values. Stat Med. 2014;33(2):209-218. doi:10.1002/sim.5925</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/sim.5925</ArticleId><ArticleId IdType="pmc">PMC4285234</ArticleId><ArticleId IdType="pubmed">23900808</ArticleId></ArticleIdList></Reference><Reference><Citation>R Development Core Team R: A Language and Environment for Statistical Computing. Vienna, Austria: The R Foundation for Statistical Computing; 2011.</Citation></Reference><Reference><Citation>von Elm E, Altman DG, Egger M, Pocock SJ, G&#xf8;tzsche PC, Vandenbroucke JP; STROBE Initiative . The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies. PLoS Med. 2007;4(10):e296. doi:10.1371/journal.pmed.0040296</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pmed.0040296</ArticleId><ArticleId IdType="pmc">PMC2020495</ArticleId><ArticleId IdType="pubmed">17941714</ArticleId></ArticleIdList></Reference><Reference><Citation>American Diabetes Association Standards of medical care in diabetes. Diabetes Care. 2005;28(suppl 1):S4-S36. doi:10.2337/diacare.28.suppl_1.S4</Citation><ArticleIdList><ArticleId IdType="doi">10.2337/diacare.28.suppl_1.S4</ArticleId><ArticleId IdType="pubmed">15618112</ArticleId></ArticleIdList></Reference><Reference><Citation>Rothwell PM. External validity of randomised controlled trials: &#x201c;to whom do the results of this trial apply?&#x201d; Lancet. 2005;365(9453):82-93. doi:10.1016/S0140-6736(04)17670-8</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(04)17670-8</ArticleId><ArticleId IdType="pubmed">15639683</ArticleId></ArticleIdList></Reference><Reference><Citation>Bothwell LE, Greene JA, Podolsky SH, Jones DS. Assessing the gold standard&#x2014;lessons from the history of RCTs. N Engl J Med. 2016;374(22):2175-2181. doi:10.1056/NEJMms1604593</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMms1604593</ArticleId><ArticleId IdType="pubmed">27248626</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">30815088</PMID><DateCompleted><Year>2019</Year><Month>09</Month><Day>27</Day></DateCompleted><DateRevised><Year>2020</Year><Month>06</Month><Day>23</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Electronic">1942-597X</ISSN><JournalIssue CitedMedium="Internet"><Volume>2018</Volume><PubDate><Year>2018</Year></PubDate></JournalIssue><Title>AMIA ... Annual Symposium proceedings. AMIA Symposium</Title><ISOAbbreviation>AMIA Annu Symp Proc</ISOAbbreviation></Journal><ArticleTitle>Clinical Concept Value Sets and Interoperability in Health Data Analytics.</ArticleTitle><Pagination><StartPage>480</StartPage><EndPage>489</EndPage><MedlinePgn>480-489</MedlinePgn></Pagination><Abstract><AbstractText>This paper focuses on <i>value sets</i> as an essential component in the health analytics ecosystem. We discuss shared repositories of reusable value sets and offer recommendations for their further development and adoption. In order to motivate these contributions, we explain how value sets fit into specific analytic tasks and the health analytics landscape more broadly; their growing importance and ubiquity with the advent of Common Data Models, Distributed Research Networks, and the availability of higher order, reusable analytic resources like electronic phenotypes and electronic clinical quality measures; the formidable barriers to value set reuse; and our introduction of a concept-agnostic orientation to vocabulary collections. The costs of ad hoc value set management and the benefits of value set reuse are described or implied throughout. Our standards, infrastructure, and design recommendations are not systematic or comprehensive but invite further work to support value set reuse for health analytics. <i>The views represented in the paper do not necessarily represent the views of the institutions or of all the co-authors</i>.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Gold</LastName><ForeName>Sigfried</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>University of Maryland, College Park.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Observational Health Data Sciences and Informatics.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Batch</LastName><ForeName>Andrea</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>University of Maryland, College Park.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>McClure</LastName><ForeName>Robert</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>MD Partners, Lafayette, CO.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jiang</LastName><ForeName>Guoqian</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Mayo Clinic, Rochester, MN.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Observational Health Data Sciences and Informatics.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kharrazi</LastName><ForeName>Hadi</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Johns Hopkins University, Baltimore, MD.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Saripalle</LastName><ForeName>Rishi</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Illinois State University; Normal, IL.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Huser</LastName><ForeName>Vojtech</ForeName><Initials>V</Initials><AffiliationInfo><Affiliation>National Library of Medicine, Bethesda, MD.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Observational Health Data Sciences and Informatics.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Weng</LastName><ForeName>Chunhua</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Columbia University, New York, NY.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Observational Health Data Sciences and Informatics.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Roderer</LastName><ForeName>Nancy</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>University of Maryland, College Park.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Szarfman</LastName><ForeName>Ana</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Center for Drug Evaluation and Research, US Food and Drug Administration, Silver Spring, MD.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Elmqvist</LastName><ForeName>Niklas</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>University of Maryland, College Park.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gotz</LastName><ForeName>David</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>University of North Carolina, Chapel Hill, NC.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>R01 LM009886</GrantID><Acronym>LM</Acronym><Agency>NLM NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D052060">Research Support, N.I.H., Intramural</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2018</Year><Month>12</Month><Day>05</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>AMIA Annu Symp Proc</MedlineTA><NlmUniqueID>101209213</NlmUniqueID><ISSNLinking>1559-4076</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000077488" MajorTopicYN="Y">Data Science</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000073892" MajorTopicYN="Y">Health Information Interoperability</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016247" MajorTopicYN="N">Information Storage and Retrieval</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000075403" MajorTopicYN="N">Semantic Web</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018875" MajorTopicYN="Y">Vocabulary, Controlled</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2019</Year><Month>3</Month><Day>1</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2019</Year><Month>3</Month><Day>1</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2019</Year><Month>9</Month><Day>29</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2018</Year><Month>12</Month><Day>5</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">30815088</ArticleId><ArticleId IdType="pmc">PMC6371254</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Jiang G, Solbrig HR, Chute CG. Quality evaluation of cancer study Common Data Elements using the UMLS Semantic Network. J Biomed Inform. 2011 Dec;44(Suppl 1):S78&#x2013;85.</Citation><ArticleIdList><ArticleId IdType="pubmed">21840422</ArticleId></ArticleIdList></Reference><Reference><Citation>Jiang G, Solbrig HR, Chute CG. Quality evaluation of value sets from cancer study common data elements using the UMLS semantic groups. J Am Med Inform Assoc. 2012 Jun;19(e1):e129&#x2013;36.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3392855</ArticleId><ArticleId IdType="pubmed">22511016</ArticleId></ArticleIdList></Reference><Reference><Citation>Peterson KJ, Jiang G, Brue SM, Liu H. Leveraging Terminology Services for Extract-Transform-Load Processes: A User-Centered Approach. AMIA Annu Symp Proc. 2016;2016:1010&#x2013;9.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5333225</ArticleId><ArticleId IdType="pubmed">28269898</ArticleId></ArticleIdList></Reference><Reference><Citation>Bodenreider O, Nguyen D, Chiang P, Chuang P, Madden M, Winnenburg R. The NLM value set authority center. Stud Health Technol Inform. 2013;192:1224.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4300102</ArticleId><ArticleId IdType="pubmed">23920998</ArticleId></ArticleIdList></Reference><Reference><Citation>Jiang G, Kiefer R, Prud&#x2019;hommeaux E, Solbrig HR. Building Interoperable FHIR-Based Vocabulary Mapping Services: A Case Study of OHDSI Vocabularies and Mappings. Stud Health Technol Inform. 2017;245:1327.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5939959</ArticleId><ArticleId IdType="pubmed">29295408</ArticleId></ArticleIdList></Reference><Reference><Citation>Richesson RL, Sun J, Pathak J, Kho AN, Denny JC. Clinical phenotyping in selected national networks: demonstrating the need for high-throughput, portable, and computational methods. Artif Intell Med. 2016 Jul;71:57&#x2013;61.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5480212</ArticleId><ArticleId IdType="pubmed">27506131</ArticleId></ArticleIdList></Reference><Reference><Citation>Mo H, Jiang G, Pacheco JA, Kiefer R, Rasmussen LV, Pathak J. A Decompositional Approach to Executing Quality Data Model Algorithms on the i2b2 Platform. AMIA Jt Summits Transl Sci Proc. 2016 Jul 20;2016:167&#x2013;75.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5001760</ArticleId><ArticleId IdType="pubmed">27570665</ArticleId></ArticleIdList></Reference><Reference><Citation>Brown JS, Kahn M, Toh S. Data quality assessment for comparative effectiveness research in distributed data networks. Med Care. 2013 Aug;51(8 Suppl 3):S22&#x2013;9.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4306391</ArticleId><ArticleId IdType="pubmed">23793049</ArticleId></ArticleIdList></Reference><Reference><Citation>Rosenbloom ST, Carroll RJ, Warner JL, Matheny ME, Denny JC. Representing Knowledge Consistently Across Health Systems. Yearb Med Inform. 2017 Aug;26(1):139&#x2013;47.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6239235</ArticleId><ArticleId IdType="pubmed">29063555</ArticleId></ArticleIdList></Reference><Reference><Citation>Mo H, Thompson WK, Rasmussen LV, Pacheco JA, Jiang G, Kiefer R. Desiderata for computable representations of electronic health records-driven phenotype algorithms. J Am Med Inform Assoc. 2015 Nov;22(6):1220&#x2013;30.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4639716</ArticleId><ArticleId IdType="pubmed">26342218</ArticleId></ArticleIdList></Reference><Reference><Citation>Kirby JC, Speltz P, Rasmussen LV, Basford M, Gottesman O, Peissig PL. PheKB: a catalog and workflow for creating electronic phenotype algorithms for transportability. J Am Med Inform Assoc. 2016 Nov;23(6):1046&#x2013;52.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5070514</ArticleId><ArticleId IdType="pubmed">27026615</ArticleId></ArticleIdList></Reference><Reference><Citation>HL7 Standards Product Brief - HL7 Specification: Characteristics of a Formal Value Set Definition, Release 1 [Internet]  [cited 2018 Mar 8]. Available from:  http://www.hl7.org/implement/standards/product_brief.cfm?product_id=437.</Citation></Reference><Reference><Citation>Centers for Medicare &amp; Medicaid Services, Office of the National Coordinator for Health Information Technology. Statin Therapy for the Prevention and Treatment of Cardiovascular Disease [Internet]. eCQI Resource Center. 2017.  [cited 2018 Mar 3]. Available from:  https://ecqi.healthit.gov/ecqm/measures/cms347v1.</Citation></Reference><Reference><Citation>Winnenburg R, Bodenreider O. Metrics for assessing the quality of value sets in clinical quality measures. AMIA Annu Symp Proc. 2013 Nov 16;2013:1497&#x2013;505.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3900160</ArticleId><ArticleId IdType="pubmed">24551422</ArticleId></ArticleIdList></Reference><Reference><Citation>Goss FR, Zhou L, Plasek JM, Broverman C, Robinson G, Middleton B. Evaluating standard terminologies for encoding allergy information. J Am Med Inform Assoc. 2013 Sep;20(5):969&#x2013;79.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3756252</ArticleId><ArticleId IdType="pubmed">23396542</ArticleId></ArticleIdList></Reference><Reference><Citation>Richesson RL, Nadkarni P. Data standards for clinical research data collection forms: current status and challenges. J Am Med Inform Assoc. 2011 May 1;18(3):341&#x2013;6.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3078665</ArticleId><ArticleId IdType="pubmed">21486890</ArticleId></ArticleIdList></Reference><Reference><Citation>Rector AL, Qamar R, Marley T. Binding ontologies and coding systems to electronic health records and messages. Appl Ontol. 2009;4(1):51&#x2013;69.</Citation></Reference><Reference><Citation>Tu SW, Campbell JR, Glasgow J, Nyman MA, McClure R, McClay J. The SAGE Guideline Model: achievements and overview. J Am Med Inform Assoc. 2007;14(5):589&#x2013;98.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1975799</ArticleId><ArticleId IdType="pubmed">17600098</ArticleId></ArticleIdList></Reference><Reference><Citation>Rector AL. What&#x2019;s in a code? Towards a formal account of the relation of ontologies and coding systems. Stud Health Technol Inform. 2007;129(Pt 1):730&#x2013;4.</Citation><ArticleIdList><ArticleId IdType="pubmed">17911813</ArticleId></ArticleIdList></Reference><Reference><Citation>Reisinger SJ, Ryan PB, O&#x2019;Hara DJ, Powell GE, Painter JL, Pattishall EN. Development and evaluation of a common data model enabling active drug safety surveillance using disparate healthcare databases. J Am Med Inform Assoc. 2010 Nov;17(6):652&#x2013;62.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3000752</ArticleId><ArticleId IdType="pubmed">20962127</ArticleId></ArticleIdList></Reference><Reference><Citation>Overhage JM, Ryan PB, Reich CG, Hartzema AG, Stang PE. Validation of a common data model for active safety surveillance research. J Am Med Inform Assoc. 2012 Jan;19(1):54&#x2013;60.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3240764</ArticleId><ArticleId IdType="pubmed">22037893</ArticleId></ArticleIdList></Reference><Reference><Citation>Garza M, Del Fiol G, Tenenbaum J, Walden A, Zozus MN. Evaluating common data models for use with a longitudinal community registry. J Biomed Inform. 2016 Dec;64:333&#x2013;41.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6810649</ArticleId><ArticleId IdType="pubmed">27989817</ArticleId></ArticleIdList></Reference><Reference><Citation>Kahn MG. 04-EHR data methodologies in clinical research: perspectives from the field. Session 1: Semantic harmonization: definition; content; ontologies. Common data models for sharing EHR data across settings. Health Sciences Library Photograph Collection and Special Collections, University of Colorado Anschutz Medical Campus, Health Sciences Library; Series V: School of Medicine Publications [Internet] 2007.  Available from:  https://dspace.library.colostate.edu/handle/10968/737.</Citation></Reference><Reference><Citation>Kuehn BM. FDA&#x2019;s Foray Into Big Data Still Maturing. JAMA. 2016 May 10;315(18):1934&#x2013;6.</Citation><ArticleIdList><ArticleId IdType="pubmed">27097048</ArticleId></ArticleIdList></Reference><Reference><Citation>Velentgas P, Bohn RL, Brown JS, Chan KA, Gladowski P, Holick CN. A distributed research network model for post-marketing safety studies: the Meningococcal Vaccine Study. Pharmacoepidemiol Drug Saf. 2008 Dec;17(12):1226&#x2013;34.</Citation><ArticleIdList><ArticleId IdType="pubmed">18956428</ArticleId></ArticleIdList></Reference><Reference><Citation>Brown JS, Kulldorff M, Chan KA, Davis RL, Graham D, Pettus PT. Early detection of adverse drug events within population-based health networks: application of sequential testing methods. Pharmacoepidemiol Drug Saf. 2007 Dec;16(12):1275&#x2013;84.</Citation><ArticleIdList><ArticleId IdType="pubmed">17955500</ArticleId></ArticleIdList></Reference><Reference><Citation>Schneeweiss S. A basic study design for expedited safety signal evaluation based on electronic healthcare data. Pharmacoepidemiol Drug Saf. 2010 Aug;19(8):858&#x2013;68.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2917262</ArticleId><ArticleId IdType="pubmed">20681003</ArticleId></ArticleIdList></Reference><Reference><Citation>Huser V, Cimino JJ. Desiderata for healthcare integrated data repositories based on architectural comparison of three public repositories. AMIA Annu Symp Proc. 2013 Nov 16;2013:648&#x2013;56.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3900207</ArticleId><ArticleId IdType="pubmed">24551366</ArticleId></ArticleIdList></Reference><Reference><Citation>Stang PE, Ryan PB, Racoosin JA, Overhage JM, Hartzema AG, Reich C. Advancing the science for active surveillance: rationale and design for the Observational Medical Outcomes Partnership. Ann Intern Med. 2010 Nov 2;153(9):600&#x2013;6.</Citation><ArticleIdList><ArticleId IdType="pubmed">21041580</ArticleId></ArticleIdList></Reference><Reference><Citation>Bakken S. An informatics infrastructure is essential for evidence-based practice. J Am Med Inform Assoc. 2001 May;8(3):199&#x2013;201.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC131027</ArticleId><ArticleId IdType="pubmed">11320064</ArticleId></ArticleIdList></Reference><Reference><Citation>Bowker GC, Star SL. Springer: Community computing and support systems; 1998. Building information infrastructures for social worlds&#x2014;The role of classifications and standards; pp. 231&#x2013;48..</Citation></Reference><Reference><Citation>Becnel LB, Hastak S, Ver Hoef W, Milius RP, Slack M, Wold D. BRIDG: a domain information model for translational and clinical protocol-driven research. J Am Med Inform Assoc. 2017 Sep 1;24(5):882&#x2013;90..</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6259662</ArticleId><ArticleId IdType="pubmed">28339791</ArticleId></ArticleIdList></Reference><Reference><Citation>DeFalco FJ, Ryan PB, Soledad Cepeda M. Applying standardized drug terminologies to observational healthcare databases: a case study on opioid exposure. Health Serv Outcomes Res Methodol. 2013 Mar 1;13(1):58&#x2013;67.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3566397</ArticleId><ArticleId IdType="pubmed">23396660</ArticleId></ArticleIdList></Reference><Reference><Citation>Curtis LH, Weiner MG, Boudreau DM, Cooper WO, Daniel GW, Nair VP. Design considerations, architecture, and use of the Mini-Sentinel distributed data system. Pharmacoepidemiol Drug Saf. 2012 Jan;21(Suppl 1):23&#x2013;31.</Citation><ArticleIdList><ArticleId IdType="pubmed">22262590</ArticleId></ArticleIdList></Reference><Reference><Citation>DeFalco F. OHDSI Architecture Workgroup [Internet]. Observational Health Data Science and Informatics Wiki. [cited 2018 Mar 3]  Available from:  http://www.ohdsi.org/web/wiki/doku.php?id=projects:workgroups:architecture_wg.</Citation></Reference><Reference><Citation>Cimino JJ. Desiderata for controlled medical vocabularies in the twenty-first century. Methods Inf Med. 1998;37(4-5):394&#x2013;403.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3415631</ArticleId><ArticleId IdType="pubmed">9865037</ArticleId></ArticleIdList></Reference><Reference><Citation>Cimino JJ. In defense of the Desiderata. J Biomed Inform. 2006 Jun;39(3):299&#x2013;306.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7185649</ArticleId><ArticleId IdType="pubmed">16386470</ArticleId></ArticleIdList></Reference><Reference><Citation>Lanier J. 2014. Who Owns the Future? Simon and Schuster; p. 411.</Citation></Reference><Reference><Citation>Dean Beaulieu N, Epstein AM. National Committee on Quality Assurance health-plan accreditation: predictors, correlates of performance, and market impact. Med Care. 2002 Apr;40(4):325&#x2013;37.</Citation><ArticleIdList><ArticleId IdType="pubmed">12021688</ArticleId></ArticleIdList></Reference><Reference><Citation>National Drug Code Directory [Internet] U.S. Food &amp; Drug Administration. [cited 2018 Jun 27].  Available from:  https://www.fda.gov/Drugs/InformationOnDrugs/ucm142438.htm.</Citation></Reference><Reference><Citation>Murphy SN, Weber G, Mendis M, Gainer V, Chueh HC, Churchill S. Serving the enterprise and beyond with informatics for integrating biology and the bedside (i2b2). J Am Med Inform Assoc. 2010 Mar;17(2):124&#x2013;30.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3000779</ArticleId><ArticleId IdType="pubmed">20190053</ArticleId></ArticleIdList></Reference><Reference><Citation>Organization WH, Others. 2006. History of the development of the ICD. World Health Organization.</Citation></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">30815195</PMID><DateCompleted><Year>2020</Year><Month>01</Month><Day>27</Day></DateCompleted><DateRevised><Year>2020</Year><Month>03</Month><Day>09</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Electronic">1942-597X</ISSN><JournalIssue CitedMedium="Internet"><Volume>2018</Volume><PubDate><Year>2018</Year></PubDate></JournalIssue><Title>AMIA ... Annual Symposium proceedings. AMIA Symposium</Title><ISOAbbreviation>AMIA Annu Symp Proc</ISOAbbreviation></Journal><ArticleTitle>Identifying Cases of Metastatic Prostate Cancer Using Machine Learning on Electronic Health Records.</ArticleTitle><Pagination><StartPage>1498</StartPage><EndPage>1504</EndPage><MedlinePgn>1498-1504</MedlinePgn></Pagination><Abstract><AbstractText>Cancer stage is rarely captured in structured form in the electronic health record (EHR). We evaluate the performance of a classifier, trained on structured EHR data, in identifying prostate cancer patients with metastatic disease. Using EHR data for a cohort of 5,861 prostate cancer patients mapped to the Observational Health Data Sciences and Informatics (OHDSI) data model, we constructed feature vectors containing frequency counts of conditions, procedures, medications, observations and laboratory values. Staging information from the California Cancer Registry was used as the ground-truth. For identifying patients with metastatic disease, a random forest model achieved precision and recall of 0.90, 0.40 using data within 12 months of diagnosis. This compared to precision 0.33, recall 0.54 for an ICD code-based query. High-precision classifiers using hundreds of structured data elements significantly outperform ICD queries, and may assist in identifying cohorts for observational research or clinical trial matching.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Seneviratne</LastName><ForeName>Martin G</ForeName><Initials>MG</Initials><AffiliationInfo><Affiliation>Department of Biomedical Informatics, Stanford School of Medicine, CA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Banda</LastName><ForeName>Juan M</ForeName><Initials>JM</Initials><AffiliationInfo><Affiliation>Department of Biomedical Informatics, Stanford School of Medicine, CA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Brooks</LastName><ForeName>James D</ForeName><Initials>JD</Initials><AffiliationInfo><Affiliation>Department of Urology, Stanford School of Medicine, CA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Shah</LastName><ForeName>Nigam H</ForeName><Initials>NH</Initials><AffiliationInfo><Affiliation>Department of Biomedical Informatics, Stanford School of Medicine, CA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hernandez-Boussard</LastName><ForeName>Tina M</ForeName><Initials>TM</Initials><AffiliationInfo><Affiliation>Department of Biomedical Informatics, Stanford School of Medicine, CA.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>R01 CA183962</GrantID><Acronym>CA</Acronym><Agency>NCI NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R01 LM011369</GrantID><Acronym>LM</Acronym><Agency>NLM NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D052061">Research Support, N.I.H., Extramural</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2018</Year><Month>12</Month><Day>05</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>AMIA Annu Symp Proc</MedlineTA><NlmUniqueID>101209213</NlmUniqueID><ISSNLinking>1559-4076</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D002140" MajorTopicYN="N" Type="Geographic">California</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015331" MajorTopicYN="N">Cohort Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D057286" MajorTopicYN="Y">Electronic Health Records</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016247" MajorTopicYN="N">Information Storage and Retrieval</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D038801" MajorTopicYN="N">International Classification of Diseases</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000069550" MajorTopicYN="Y">Machine Learning</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008490" MajorTopicYN="N">Medical Informatics</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009362" MajorTopicYN="N">Neoplasm Metastasis</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D009367" MajorTopicYN="N">Neoplasm Staging</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="Y">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000075082" MajorTopicYN="N">Proof of Concept Study</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011471" MajorTopicYN="N">Prostatic Neoplasms</DescriptorName><QualifierName UI="Q000473" MajorTopicYN="Y">pathology</QualifierName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2019</Year><Month>3</Month><Day>1</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2019</Year><Month>3</Month><Day>1</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2020</Year><Month>1</Month><Day>28</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2018</Year><Month>12</Month><Day>5</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">30815195</ArticleId><ArticleId IdType="pmc">PMC6371284</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>National Quality Forum. 2008. NQF 0386 Oncology: Cancer Stage Documented - Measure Submission and Evaluation Worksheet.</Citation></Reference><Reference><Citation>Evans TL, Gabriel PE, Shulman LN. Cancer Staging in Electronic Health Records: Strategies to Improve Documentation of These Critical Data. J Oncol Pract. 2016;12:137&#x2013;139.</Citation><ArticleIdList><ArticleId IdType="pubmed">26869653</ArticleId></ArticleIdList></Reference><Reference><Citation>Warner JL, Levy MA, Neuss MN, Warner JL, Levy MA, Neuss MN. ReCAP: Feasibility and Accuracy of Extracting Cancer Stage Information From Narrative Electronic Health Record Data. J Oncol Pract. 2016;12:157&#x2013;8. e169&#x2013;7.</Citation><ArticleIdList><ArticleId IdType="pubmed">26306621</ArticleId></ArticleIdList></Reference><Reference><Citation>Strauss JA, Chao CR, Kwan ML, Ahmed SA, Schottinger JE, Quinn VP. Identifying primary and recurrent cancers using a SAS-based natural language processing algorithm. J Am Med Inform Assoc. 2013;20:349&#x2013;355.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3638182</ArticleId><ArticleId IdType="pubmed">22822041</ArticleId></ArticleIdList></Reference><Reference><Citation>Nguyen AN, Lawley MJ, Hansen DP, Bowman RV, Clarke BE, Duhig EE. Symbolic rule-based classification of lung cancer stages from free-text pathology reports. J Am Med Inform Assoc. 2010;17:440&#x2013;445.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2995652</ArticleId><ArticleId IdType="pubmed">20595312</ArticleId></ArticleIdList></Reference><Reference><Citation>Coden A, Savova G, Sominsky I, Tanenblatt M, Masanz J, Schuler K. Automatically extracting cancer disease characteristics from pathology reports into a Disease Knowledge Representation Model. J Biomed Inform. 2009;42:937&#x2013;949.</Citation><ArticleIdList><ArticleId IdType="pubmed">19135551</ArticleId></ArticleIdList></Reference><Reference><Citation>Yim W-W, Yetisgen M, Harris WP, Kwan SW. Natural Language Processing in Oncology: A Review. JAMA Oncol. 2016;2:797&#x2013;804.</Citation><ArticleIdList><ArticleId IdType="pubmed">27124593</ArticleId></ArticleIdList></Reference><Reference><Citation>Hripcsak G, Duke JD, Shah NH, Reich CG, Huser V, Schuemie MJ. Observational Health Data Sciences and Informatics (OHDSI): Opportunities for Observational Researchers. Stud Health Technol Inform. 2015;216:574&#x2013;578.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4815923</ArticleId><ArticleId IdType="pubmed">26262116</ArticleId></ArticleIdList></Reference><Reference><Citation>Banda JM, Halpern Y, Sontag D, Shah NH. AMIA Jt Summits Transl Sci Proc. 2017. Electronic phenotyping with APHRODITE and the Observational Health Sciences and Informatics (OHDSI) data network; pp. 48&#x2013;57.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5543379</ArticleId><ArticleId IdType="pubmed">28815104</ArticleId></ArticleIdList></Reference><Reference><Citation>APHRODITE. In: Observational Health Data Sciences and Informatics [Internet]  Available:  https://github.com/OHDSI/Aphrodite.</Citation></Reference><Reference><Citation>Siegel RL, Miller KD, Jemal A. Cancer statistics, 2018. CA Cancer J Clin. 2018;68:7&#x2013;30.</Citation><ArticleIdList><ArticleId IdType="pubmed">29313949</ArticleId></ArticleIdList></Reference><Reference><Citation>Survival Rates for Prostate Cancer. In: American Cancer Society [Internet] 2017. Dec 18,  Available:  https://www.cancer.org/cancer/prostate-cancer/detection-diagnosis-staging/survival-rates.html.</Citation></Reference><Reference><Citation>Seneviratne MG, Seto T, Blayney DW, Brooks JD, Hernandez-Boussard TM. Architecture and Implementation of a Clinical Research Data Warehouse for Prostate Cancer. eGEMS. 2018;6(1)</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6078122</ArticleId><ArticleId IdType="pubmed">30094285</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">30738946</PMID><DateCompleted><Year>2020</Year><Month>06</Month><Day>19</Day></DateCompleted><DateRevised><Year>2020</Year><Month>06</Month><Day>19</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1532-0480</ISSN><JournalIssue CitedMedium="Internet"><Volume>91</Volume><PubDate><Year>2019</Year><Month>Mar</Month></PubDate></JournalIssue><Title>Journal of biomedical informatics</Title><ISOAbbreviation>J Biomed Inform</ISOAbbreviation></Journal><ArticleTitle>ADEpedia-on-OHDSI: A next generation pharmacovigilance signal detection platform using the OHDSI common data model.</ArticleTitle><Pagination><StartPage>103119</StartPage><MedlinePgn>103119</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.jbi.2019.103119</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S1532-0464(19)30037-1</ELocationID><Abstract><AbstractText Label="OBJECTIVE">Supplementing the Spontaneous Reporting System (SRS) with Electronic Health Record (EHR) data for adverse drug reaction detection could augment sample size, increase population heterogeneity and cross-validate results for pharmacovigilance research. The difference in the underlying data structures and terminologies between SRS and EHR data presents challenges when attempting to integrate the two into a single database. The Observational Health Data Sciences and Informatics (OHDSI) collaboration provides a Common Data Model (CDM) for organizing and standardizing EHR data to support large-scale observational studies. The objective of the study is to develop and evaluate an informatics platform known as ADEpedia-on-OHDSI, where spontaneous reporting data from FDA's Adverse Event Reporting System (FAERS) is converted into the OHDSI CDM format towards building a next generation pharmacovigilance signal detection platform.</AbstractText><AbstractText Label="METHODS">An extraction, transformation and loading (ETL) tool was designed, developed, and implemented to convert FAERS data into the OHDSI CDM format. A comprehensive evaluation, including overall ETL evaluation, mapping quality evaluation of drug names to RxNorm, and an evaluation of transformation and imputation quality, was then performed to assess the mapping accuracy and information loss using the FAERS data collected between 2012 and 2017. Previously published findings related to vascular safety profile of triptans were validated using ADEpedia-on-OHDSI in pharmacovigilance research. For the triptan-related vascular event detection, signals were detected by Reporting Odds Ratio (ROR) in high-level group terms (HLGT) level, high-level terms (HLT) level and preferred term (PT) level using the original FAERS data and CDM-based FAERS respectively. In addition, six standardized MedDRA queries (SMQs) related to vascular events were applied.</AbstractText><AbstractText Label="RESULTS">A total of 4,619,362 adverse event cases were loaded into 8 tables in the OHDSI CDM. For drug name mapping, 93.9% records and 47.0% unique names were matched with RxNorm codes. Mapping accuracy of drug names was 96% based on a manual verification of randomly sampled 500 unique mappings. Information loss evaluation showed that more than 93% of the data is loaded into the OHDSI CDM for most fields, with the exception of drug route data (66%). The replication study detected 5, 18, 47 and 6, 18, 50 triptan-related vascular event signals in MedDRA HLGT level, HLT level, and PT level for the original FAERS data and CDM-based FAERS respectively. The signal detection scores of six standardized MedDRA queries (SMQs) of vascular events in the raw data study were found to be lower than those scores in the CDM study.</AbstractText><AbstractText Label="CONCLUSION">The outcome of this work would facilitate seamless integration and combined analyses of both SRS and EHR data for pharmacovigilance in ADEpedia-on-OHDSI, our platform for next generation pharmacovigilance.</AbstractText><CopyrightInformation>Copyright &#xa9; 2019 Elsevier Inc. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Yu</LastName><ForeName>Yue</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Department of Health Sciences Research, Mayo Clinic, Rochester, MN, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ruddy</LastName><ForeName>Kathryn J</ForeName><Initials>KJ</Initials><AffiliationInfo><Affiliation>Department of Oncology, Mayo Clinic, Rochester, MN, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hong</LastName><ForeName>Na</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Department of Health Sciences Research, Mayo Clinic, Rochester, MN, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tsuji</LastName><ForeName>Shintaro</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Health Sciences Research, Mayo Clinic, Rochester, MN, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wen</LastName><ForeName>Andrew</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Health Sciences Research, Mayo Clinic, Rochester, MN, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Shah</LastName><ForeName>Nilay D</ForeName><Initials>ND</Initials><AffiliationInfo><Affiliation>Department of Health Sciences Research, Mayo Clinic, Rochester, MN, USA; Robert D. and Patricia E. Kern Center for the Science of Health Care Delivery, Mayo Clinic, Rochester, MN, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jiang</LastName><ForeName>Guoqian</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Department of Health Sciences Research, Mayo Clinic, Rochester, MN, USA. Electronic address: Jiang.Guoqian@mayo.edu.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>U01 HG009450</GrantID><Acronym>HG</Acronym><Agency>NHGRI NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D052061">Research Support, N.I.H., Extramural</PublicationType><PublicationType UI="D013487">Research Support, U.S. Gov't, P.H.S.</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2019</Year><Month>02</Month><Day>07</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>J Biomed Inform</MedlineTA><NlmUniqueID>100970413</NlmUniqueID><ISSNLinking>1532-0464</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D016907" MajorTopicYN="Y">Adverse Drug Reaction Reporting Systems</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003198" MajorTopicYN="Y">Computer Simulation</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D060735" MajorTopicYN="Y">Pharmacovigilance</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014481" MajorTopicYN="N" Type="Geographic">United States</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Data Standardization</Keyword><Keyword MajorTopicYN="N">ETL tool</Keyword><Keyword MajorTopicYN="N">FAERS</Keyword><Keyword MajorTopicYN="N">OHDSI Common Data Model</Keyword><Keyword MajorTopicYN="N">Pharmacovigilance</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>2019</Year><Month>2</Month><Day>11</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2020</Year><Month>6</Month><Day>20</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2019</Year><Month>2</Month><Day>11</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2020</Year><Month>3</Month><Day>1</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">30738946</ArticleId><ArticleId IdType="mid">NIHMS1521934</ArticleId><ArticleId IdType="pmc">PMC6432939</ArticleId><ArticleId IdType="doi">10.1016/j.jbi.2019.103119</ArticleId><ArticleId IdType="pii">S1532-0464(19)30037-1</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Harpaz R, et al., Novel Data-Mining Methodologies for Adverse Drug Event Discovery and Analysis. Clinical Pharmacology &amp; Therapeutics, 2012. 91(6): p. 1010&#x2013;1021.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3675775</ArticleId><ArticleId IdType="pubmed">22549283</ArticleId></ArticleIdList></Reference><Reference><Citation>Harpaz R, DuMochel W, and Shah NH, Big Data and Adverse Drug Reaction Detection. Clin Pharmacol Ther, 2016. 99(3): p. 268&#x2013;70.</Citation><ArticleIdList><ArticleId IdType="pubmed">26575203</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhou X, et al., An evaluation of the THIN database in the OMOP Common Data Model for active drug safety surveillance. Drug Saf, 2013. 36(2): p. 119&#x2013;34.</Citation><ArticleIdList><ArticleId IdType="pubmed">23329543</ArticleId></ArticleIdList></Reference><Reference><Citation>Garza M, et al., Evaluating common data models for use with a longitudinal community registry. Journal of Biomedical Informatics, 2016. 64: p. 333&#x2013;341.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6810649</ArticleId><ArticleId IdType="pubmed">27989817</ArticleId></ArticleIdList></Reference><Reference><Citation>Voss EA, et al., Accuracy of an automated knowledge base for identifying drug adverse reactions. Journal of Biomedical Informatics, 2017. 66: p. 72&#x2013;81.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5316295</ArticleId><ArticleId IdType="pubmed">27993747</ArticleId></ArticleIdList></Reference><Reference><Citation>Li Y, et al., A Method to Combine Signals from Spontaneous Reporting Systems and Observational Healthcare Data to Detect Adverse Drug Reactions. Drug Safety, 2015. 38(10): p. 895&#x2013;908.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4579260</ArticleId><ArticleId IdType="pubmed">26153397</ArticleId></ArticleIdList></Reference><Reference><Citation>Boyce RD, et al., Preparing Nursing Home Data from Multiple Sites for Clinical Research - A Case Study Using Observational Health Data Sciences and Informatics. EGEMS (Wash DC), 2016. 4(1): p. 1252.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5108634</ArticleId><ArticleId IdType="pubmed">27891528</ArticleId></ArticleIdList></Reference><Reference><Citation>Rosenbloom ST, et al., Representing Knowledge Consistently Across Health Systems. Yearb Med Inform, 2017. 26(1): p. 139&#x2013;147.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6239235</ArticleId><ArticleId IdType="pubmed">29063555</ArticleId></ArticleIdList></Reference><Reference><Citation>Hripcsak G, et al., Observational Health Data Sciences and Informatics (OHDSI): Opportunities for Observational Researchers. Stud Health Technol Inform, 2015. 216: p. 574&#x2013;8.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4815923</ArticleId><ArticleId IdType="pubmed">26262116</ArticleId></ArticleIdList></Reference><Reference><Citation>Hardoon SL, et al., Trends in longer-term survival following an acute myocardial infarction and prescribing of evidenced-based medications in primary care in the UK from 1991: a longitudinal population-based study. J Epidemiol Community Health, 2011. 65(9): p. 770&#x2013;4.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3173802</ArticleId><ArticleId IdType="pubmed">20515898</ArticleId></ArticleIdList></Reference><Reference><Citation>Overhage JM, et al., Validation of a common data model for active safety surveillance research. J Am Med Inform Assoc, 2012. 19(1): p. 54&#x2013;60.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3240764</ArticleId><ArticleId IdType="pubmed">22037893</ArticleId></ArticleIdList></Reference><Reference><Citation>Matcho A, et al., Fidelity assessment of a clinical practice research datalink conversion to the OMOP common data model. Drug Saf, 2014. 37(11): p. 945&#x2013;59.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4206771</ArticleId><ArticleId IdType="pubmed">25187016</ArticleId></ArticleIdList></Reference><Reference><Citation>Schlienger RG, Jick H, and Meier CR, Use of nonsteroidal anti-inflammatory drugs and the risk of first-time acute myocardial infarction. British Journal of Clinical Pharmacology, 2002. 54(3): p. 327&#x2013;332.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1874430</ArticleId><ArticleId IdType="pubmed">12236854</ArticleId></ArticleIdList></Reference><Reference><Citation>Jiang G, Solbrig HR, and Chute CG, ADEpedia: a scalable and standardized knowledge base of Adverse Drug Events using semantic web technology. AMIA Annu Symp Proc, 2011. 2011: p. 607&#x2013;16.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3243176</ArticleId><ArticleId IdType="pubmed">22195116</ArticleId></ArticleIdList></Reference><Reference><Citation>Jiang G, et al., ADEpedia 2.0: Integration of Normalized Adverse Drug Events (ADEs) Knowledge from the UMLS. AMIA Jt Summits Transl Sci Proc, 2013. 2013: p. 100&#x2013;4.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3845793</ArticleId><ArticleId IdType="pubmed">24303245</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang L, et al., Standardizing adverse drug event reporting data. J Biomed Semantics, 2014. 5: p. 36.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4142531</ArticleId><ArticleId IdType="pubmed">25157320</ArticleId></ArticleIdList></Reference><Reference><Citation>Banda JM, et al., A curated and standardized adverse drug event resource to accelerate drug safety research. Sci Data, 2016. 3: p. 160026.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4872271</ArticleId><ArticleId IdType="pubmed">27193236</ArticleId></ArticleIdList></Reference><Reference><Citation>FDA. FAERS. Available from: https://www.fda.gov/Drugs/GuidanceComplianceRegulatoryInformation/Surveillance/AdverseDrugEffects/ucm082193.htm.</Citation></Reference><Reference><Citation>Cohen J, A Coefficient of Agreement for Nominal Scales. Educational &amp; Psychological Measurement, 1960. 20(1): p. 37&#x2013;46.</Citation></Reference><Reference><Citation>Roberto G, et al., Triptans and serious adverse vascular events: data mining of the FDA Adverse Event Reporting System database. Cephalalgia, 2014. 34(1): p. 5&#x2013;13.</Citation><ArticleIdList><ArticleId IdType="pubmed">23921799</ArticleId></ArticleIdList></Reference><Reference><Citation>Bate A, et al., A Bayesian neural network method for adverse drug reaction signal generation. Eur J Clin Pharmacol, 1998. 54(4): p. 315&#x2013;21.</Citation><ArticleIdList><ArticleId IdType="pubmed">9696956</ArticleId></ArticleIdList></Reference><Reference><Citation>Pearson RK, et al., Influence of the MedDRA hierarchy on pharmacovigilance data mining results. Int J Med Inform, 2009. 78(12): p. e97&#x2013;e103.</Citation><ArticleIdList><ArticleId IdType="pubmed">19230751</ArticleId></ArticleIdList></Reference><Reference><Citation>Landis JR and Koch GG, The measurement of observer agreement for categorical data. Biometrics, 1977. 33(1): p. 159&#x2013;74.</Citation><ArticleIdList><ArticleId IdType="pubmed">843571</ArticleId></ArticleIdList></Reference><Reference><Citation>OHDSI. ATLAS. Available from: www.ohdsi.org/web/atlas/.</Citation></Reference><Reference><Citation>OHDSI. Usagi. Available from: https://github.com/OHDSI/Usagi.</Citation></Reference><Reference><Citation>Bodenreider O, Using SNOMED CT in combination with MedDRA for reporting signal detection and adverse drug reactions reporting. AMIA Annu Symp Proc, 2009. 2009: p. 45&#x2013;9.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2815504</ArticleId><ArticleId IdType="pubmed">20351820</ArticleId></ArticleIdList></Reference><Reference><Citation>Yu Y, et al., Developing A Standards-based Signal Detection and Validation Framework of Immune-related Adverse Events Using the OHDSI Common Data Model, in AMIA Annu Symp Proc. 2018. (In press)</Citation></Reference></ReferenceList></PubmedData></PubmedArticle>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">30753493</PMID><DateCompleted><Year>2020</Year><Month>02</Month><Day>26</Day></DateCompleted><DateRevised><Year>2024</Year><Month>08</Month><Day>02</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1527-974X</ISSN><JournalIssue CitedMedium="Internet"><Volume>26</Volume><Issue>4</Issue><PubDate><Year>2019</Year><Month>Apr</Month><Day>01</Day></PubDate></JournalIssue><Title>Journal of the American Medical Informatics Association : JAMIA</Title><ISOAbbreviation>J Am Med Inform Assoc</ISOAbbreviation></Journal><ArticleTitle>Criteria2Query: a natural language interface to clinical databases for cohort definition.</ArticleTitle><Pagination><StartPage>294</StartPage><EndPage>305</EndPage><MedlinePgn>294-305</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1093/jamia/ocy178</ELocationID><Abstract><AbstractText Label="OBJECTIVE">Cohort definition is a bottleneck for conducting clinical research and depends on subjective decisions by domain experts. Data-driven cohort definition is appealing but requires substantial knowledge of terminologies and clinical data models. Criteria2Query is a natural language interface that facilitates human-computer collaboration for cohort definition and execution using clinical databases.</AbstractText><AbstractText Label="MATERIALS AND METHODS">Criteria2Query uses a hybrid information extraction pipeline combining machine learning and rule-based methods to systematically parse eligibility criteria text, transforms it first into a structured criteria representation and next into sharable and executable clinical data queries represented as SQL queries conforming to the OMOP Common Data Model. Users can interactively review, refine, and execute queries in the ATLAS web application. To test effectiveness, we evaluated 125 criteria across different disease domains from ClinicalTrials.gov and 52 user-entered criteria. We evaluated F1 score and accuracy against 2 domain experts and calculated the average computation time for fully automated query formulation. We conducted an anonymous survey evaluating usability.</AbstractText><AbstractText Label="RESULTS">Criteria2Query achieved 0.795 and 0.805 F1 score for entity recognition and relation extraction, respectively. Accuracies for negation detection, logic detection, entity normalization, and attribute normalization were 0.984, 0.864, 0.514 and 0.793, respectively. Fully automatic query formulation took 1.22 seconds/criterion. More than 80% (11+ of 13) of users would use Criteria2Query in their future cohort definition tasks.</AbstractText><AbstractText Label="CONCLUSIONS">We contribute a novel natural language interface to clinical databases. It is open source and supports fully automated and interactive modes for autonomous data-driven cohort definition by researchers with minimal human effort. We demonstrate its promising user friendliness and usability.</AbstractText><CopyrightInformation>&#xa9; The Author(s) 2019. Published by Oxford University Press on behalf of the American Medical Informatics Association.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Yuan</LastName><ForeName>Chi</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Department of Biomedical Informatics, Columbia University, New York, New York, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Computer Science and Technology, Nanjing University of Science and Technology, Nanjing, Jiangsu Province, P.R. China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ryan</LastName><ForeName>Patrick B</ForeName><Initials>PB</Initials><AffiliationInfo><Affiliation>Department of Biomedical Informatics, Columbia University, New York, New York, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Epidemiology Analytics, Janssen Research and Development, Titusville, New Jersey, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ta</LastName><ForeName>Casey</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Department of Biomedical Informatics, Columbia University, New York, New York, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Guo</LastName><ForeName>Yixuan</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Department of Biomedical Informatics, Columbia University, New York, New York, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Li</LastName><ForeName>Ziran</ForeName><Initials>Z</Initials><AffiliationInfo><Affiliation>Department of Biomedical Informatics, Columbia University, New York, New York, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hardin</LastName><ForeName>Jill</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Epidemiology Analytics, Janssen Research and Development, Titusville, New Jersey, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Makadia</LastName><ForeName>Rupa</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Epidemiology Analytics, Janssen Research and Development, Titusville, New Jersey, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jin</LastName><ForeName>Peng</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Department of Biomedical Informatics, Columbia University, New York, New York, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Shang</LastName><ForeName>Ning</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Department of Biomedical Informatics, Columbia University, New York, New York, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kang</LastName><ForeName>Tian</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Department of Biomedical Informatics, Columbia University, New York, New York, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Weng</LastName><ForeName>Chunhua</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Department of Biomedical Informatics, Columbia University, New York, New York, USA.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>OT3 TR002027</GrantID><Acronym>TR</Acronym><Agency>NCATS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R01 LM009886</GrantID><Acronym>LM</Acronym><Agency>NLM NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R35 GM131905</GrantID><Acronym>GM</Acronym><Agency>NIGMS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>UL1 TR001873</GrantID><Acronym>TR</Acronym><Agency>NCATS NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D052061">Research Support, N.I.H., Extramural</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>J Am Med Inform Assoc</MedlineTA><NlmUniqueID>9430800</NlmUniqueID><ISSNLinking>1067-5027</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D002986" MajorTopicYN="Y">Clinical Trials as Topic</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D019992" MajorTopicYN="Y">Databases as Topic</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004608" MajorTopicYN="N">Eligibility Determination</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="Y">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016247" MajorTopicYN="N">Information Storage and Retrieval</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="Y">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000069550" MajorTopicYN="N">Machine Learning</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009323" MajorTopicYN="Y">Natural Language Processing</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018579" MajorTopicYN="Y">Patient Selection</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014584" MajorTopicYN="Y">User-Computer Interface</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">cohort definition</Keyword><Keyword MajorTopicYN="N">common data model</Keyword><Keyword MajorTopicYN="N">natural language interfaces to database</Keyword><Keyword MajorTopicYN="N">natural language processing</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2018</Year><Month>9</Month><Day>7</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2018</Year><Month>11</Month><Day>16</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2018</Year><Month>11</Month><Day>29</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2019</Year><Month>2</Month><Day>13</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2020</Year><Month>2</Month><Day>27</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2019</Year><Month>2</Month><Day>13</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2019</Year><Month>2</Month><Day>7</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">30753493</ArticleId><ArticleId IdType="pmc">PMC6402359</ArticleId><ArticleId IdType="doi">10.1093/jamia/ocy178</ArticleId><ArticleId IdType="pii">5308980</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>H&#xe4;yrinen K, Saranto K, Nyk&#xe4;nen P.. Definition, structure, content, use and impacts of electronic health records: a review of the research literature. Int J Med Inf 2008; 77: 291&#x2013;304.</Citation><ArticleIdList><ArticleId IdType="pubmed">17951106</ArticleId></ArticleIdList></Reference><Reference><Citation>Penberthy L, Brown R, Puma F, et al. Automated matching software for clinical trials eligibility: measuring efficiency and flexibility. Contemp Clin Trials 2010; 31 (3): 207&#x2013;17.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4387843</ArticleId><ArticleId IdType="pubmed">20230913</ArticleId></ArticleIdList></Reference><Reference><Citation>Thadani SR, Weng C, Bigger JT, et al. Electronic screening improves efficiency in clinical trial recruitment. J Am Med Inform Assoc 2009; 16 (6): 869&#x2013;73.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3002129</ArticleId><ArticleId IdType="pubmed">19717797</ArticleId></ArticleIdList></Reference><Reference><Citation>Penberthy LT, Dahman BA, Petkov VI, et al. Effort required in eligibility screening for clinical trials. J Oncol Pract 2012; 8 (6): 365&#x2013;70.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3500483</ArticleId><ArticleId IdType="pubmed">23598846</ArticleId></ArticleIdList></Reference><Reference><Citation>Musen MA, Rohn JA, Fagan LM, et al. Knowledge engineering for a clinical trial advice system: uncovering errors in protocol specification. Bull Cancer 1987; 74: 291&#x2013;6.</Citation><ArticleIdList><ArticleId IdType="pubmed">3620734</ArticleId></ArticleIdList></Reference><Reference><Citation>Weng C. Optimizing clinical research participant selection with informatics. Trends Pharmacol Sci 2015; 36 (11): 706&#x2013;9.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4686428</ArticleId><ArticleId IdType="pubmed">26549161</ArticleId></ArticleIdList></Reference><Reference><Citation>Kang T, Zhang S, Tang Y, et al. EliIE: an open-source information extraction system for clinical trial eligibility criteria. J Am Med Inform Assoc 2017; 24 (6): 1062&#x2013;71.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6259668</ArticleId><ArticleId IdType="pubmed">28379377</ArticleId></ArticleIdList></Reference><Reference><Citation>Friedman CP. A &#x201c;fundamental theorem&#x201d; of biomedical informatics. J Am Med Inform Assoc JAMIA 2009; 16 (2): 169&#x2013;70.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2649317</ArticleId><ArticleId IdType="pubmed">19074294</ArticleId></ArticleIdList></Reference><Reference><Citation>Weng C, Tu SW, Sim I, et al. Formal representation of eligibility criteria: a literature review. J Biomed Inform 2010; 43 (3): 451&#x2013;67.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2878905</ArticleId><ArticleId IdType="pubmed">20034594</ArticleId></ArticleIdList></Reference><Reference><Citation>ERGO: a template-based expression language for encoding eligibility criteria. http://rctbank.ucsf.edu/home/ergo. Accessed April 7, 2018.</Citation></Reference><Reference><Citation>Tu SW, Peleg M, Carini S, et al. A practical method for transforming free-text eligibility criteria into computable criteria. J Biomed Inform 2011; 44 (2): 239&#x2013;50.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3129371</ArticleId><ArticleId IdType="pubmed">20851207</ArticleId></ArticleIdList></Reference><Reference><Citation>Bhattacharya S, Cantor MN.. Analysis of eligibility criteria representation in industry-standard clinical trial protocols. J Biomed Inform 2013; 46 (5): 805&#x2013;13.</Citation><ArticleIdList><ArticleId IdType="pubmed">23770150</ArticleId></ArticleIdList></Reference><Reference><Citation>Weng C, Wu X, Luo Z, et al. EliXR: an approach to eligibility criteria extraction and representation. J Am Med Inform Assoc 2011; 18 (Suppl 1): i116&#x2013;24.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3241167</ArticleId><ArticleId IdType="pubmed">21807647</ArticleId></ArticleIdList></Reference><Reference><Citation>Boland MR, Tu SW, Carini S, et al. EliXR-TIME: a temporal knowledge representation for clinical research eligibility criteria. AMIA Summits Transl Sci Proc 2012; 2012: 71&#x2013;80.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3392056</ArticleId><ArticleId IdType="pubmed">22779055</ArticleId></ArticleIdList></Reference><Reference><Citation>Hao T, Liu H, Weng C.. Valx: a system for extracting and structuring numeric lab test comparison statements from text. Methods Inf Med 2016; 55 (3): 266&#x2013;75.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5573874</ArticleId><ArticleId IdType="pubmed">26940748</ArticleId></ArticleIdList></Reference><Reference><Citation>Parker CG. Generating medical logic modules for clinical trial eligibility. PhD thesis, Brigham Young University; 2005.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1479939</ArticleId><ArticleId IdType="pubmed">14728468</ArticleId></ArticleIdList></Reference><Reference><Citation>OMOP Common Data Model &#x2013; OHDSI. https://www.ohdsi.org/data-standardization/the-common-data-model/. Accessed March 25, 2018.</Citation></Reference><Reference><Citation>Hripcsak G, Duke JD, Shah NH, et al. Observational Health Data Sciences and Informatics (OHDSI): opportunities for observational researchers. Stud Health Technol Inform 2015; 216: 574&#x2013;8.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4815923</ArticleId><ArticleId IdType="pubmed">26262116</ArticleId></ArticleIdList></Reference><Reference><Citation>ATLAS. http://www.ohdsi.org/web/atlas/#/home. Accessed March 25, 2018.</Citation></Reference><Reference><Citation>
Androutsopoulos I, Ritchie GD, Thanisch P.. 
Natural language interfaces to databases&#x2014;an introduction. Nat Lang Eng 1995; 1 (1): 29&#x2013;81. doi:10.1017/S135132490000005X.</Citation><ArticleIdList><ArticleId IdType="doi">10.1017/S135132490000005X</ArticleId></ArticleIdList></Reference><Reference><Citation>Copestake A, Jones KS.. Natural language interfaces to databases. Knowl Eng Rev 1990; 5 (4): 225&#x2013;49.</Citation></Reference><Reference><Citation>Woods WA. Progress in natural language understanding: an application to lunar geology. In: Proceedings of the June 4-8, 1973, National Computer Conference and Exposition. New York, NY: ACM; 1973:441&#x2013;50.</Citation></Reference><Reference><Citation>
Epstein MN, Walker DE.. 
Natural language access to a melanoma data base. Proc Annu Symp Comput Appl Med Care 1978; 1978: 320&#x2013;5. doi:10.1109/SCAMC.1978.679936.</Citation><ArticleIdList><ArticleId IdType="doi">10.1109/SCAMC.1978.679936</ArticleId></ArticleIdList></Reference><Reference><Citation>Chandra Y, Mihalcea R.. Natural language interfaces to databases. Master of Science thesis, University of North Texas, 2006.</Citation></Reference><Reference><Citation>Pazos RRA, Gonz&#xe1;lez BJJ, Aguirre LMA, et al. Natural language interfaces to databases: an analysis of the state of the art In: Castillo O, Melin P, Kacprzyk J, eds. Recent Advances in Hybrid Intelligence Systems. New York: Springer; 2013; 463&#x2013;80.</Citation></Reference><Reference><Citation>Woodyard M, Hamel B.. A natural language interface to a clinical data base management system. Comput Biomed Res 1981; 14 (1): 41&#x2013;62.</Citation><ArticleIdList><ArticleId IdType="pubmed">7237996</ArticleId></ArticleIdList></Reference><Reference><Citation>Roberts K, Demner-Fushman D.. Toward a natural language interface for EHR questions. AMIA Summits Transl Sci Proc 2015; 2015: 157&#x2013;61.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4525248</ArticleId><ArticleId IdType="pubmed">26306260</ArticleId></ArticleIdList></Reference><Reference><Citation>Loose coupling. Wikipedia. 2018. 
https://en.wikipedia.org/w/index.php?title=Loose_coupling&amp;oldid=840712645. Accessed May 14, 2018.</Citation></Reference><Reference><Citation>
Manning C, Surdeanu M, Bauer J,
et al. The Stanford CoreNLP natural language processing toolkit. In: Proceedings of 52nd Annual Meeting of the Association for Computational Linguistics: System Demonstrations. Baltimore, MD: Association for Computational Linguistics; 2014:55&#x2013;60. http://www.aclweb.org/anthology/P14-5010. Accessed July 18, 2018.</Citation></Reference><Reference><Citation>Chapman WW, Bridewell W, Hanbury P, et al. A simple algorithm for identifying negated findings and diseases in discharge summaries. J Biomed Inform 2001; 34 (5): 301&#x2013;10.</Citation><ArticleIdList><ArticleId IdType="pubmed">12123149</ArticleId></ArticleIdList></Reference><Reference><Citation>
Schuster S, Manning CD. Enhanced English universal dependencies: an improved representation for natural language understanding tasks.  https://nlp.stanford.edu/pubs/schuster2016enhanced.pdf. Accessed March 26, 2018.</Citation></Reference><Reference><Citation>Dijkstra&#x2019;s algorithm. Wikipedia. 2018. 
https://en.wikipedia.org/w/index.php?title=Dijkstra%27s_algorithm&amp;oldid=832284506. Accessed March 26, 2018.</Citation></Reference><Reference><Citation>Bodenreider O. The Unified Medical Language System (UMLS): integrating biomedical terminology. Nucleic Acids Res 2004; 32 (90001): 267D&#x2013;70.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC308795</ArticleId><ArticleId IdType="pubmed">14681409</ArticleId></ArticleIdList></Reference><Reference><Citation>Usagi. https://github.com/OHDSI/Usagi. Accessed April 7, 2018.</Citation></Reference><Reference><Citation>OHDSI WebAPI. http://webapidoc.ohdsi.org/job/WebAPI/WebAPI_Miredot_Documentation/index.html. Accessed April 7, 2018.</Citation></Reference><Reference><Citation>
Chang AX, Manning CD.. 
Sutime: a library for recognizing and normalizing time expressions In: Proceedings of the Eighth International Conference on Language Resources and Evaluation (LREC-2012). Istanbul, Turkey:
ELRA; 2012:3735&#x2013;740. https://pdfs.semanticscholar.org/fe80/746646f6ee819205ca9a8476292ea6b83e66.pdf. Accessed July 5, 2017.</Citation></Reference><Reference><Citation>Dogan RI, Lu Z. An inference method for disease name normalization. Paper presented at: AAAI Fall Symposium: Information Retrieval and Knowledge Discovery in Biomedical Text; November 2&#x2013;4, 2012; Arlington, VA.</Citation></Reference><Reference><Citation>Zhou L, Plasek JM, Mahoney LM, et al. Mapping partners master drug dictionary to RxNorm using an NLP-based approach. J Biomed Inform 2012; 45 (4): 626&#x2013;33.</Citation><ArticleIdList><ArticleId IdType="pubmed">22142948</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">30762164</PMID><DateCompleted><Year>2020</Year><Month>01</Month><Day>17</Day></DateCompleted><DateRevised><Year>2020</Year><Month>03</Month><Day>09</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1179-1942</ISSN><JournalIssue CitedMedium="Internet"><Volume>42</Volume><Issue>6</Issue><PubDate><Year>2019</Year><Month>Jun</Month></PubDate></JournalIssue><Title>Drug safety</Title><ISOAbbreviation>Drug Saf</ISOAbbreviation></Journal><ArticleTitle>A Comparison Study of Algorithms to Detect Drug-Adverse Event Associations: Frequentist, Bayesian, and Machine-Learning Approaches.</ArticleTitle><Pagination><StartPage>743</StartPage><EndPage>750</EndPage><MedlinePgn>743-750</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1007/s40264-018-00792-0</ELocationID><Abstract><AbstractText Label="INTRODUCTION">It is important to monitor the safety profile of drugs, and mining for strong associations between drugs and adverse events is an effective and inexpensive method of post-marketing safety surveillance.</AbstractText><AbstractText Label="OBJECTIVE">The objective of our work was to compare the accuracy of both common and innovative methods of data mining for pharmacovigilance purposes.</AbstractText><AbstractText Label="METHODS">We used the reference standard provided by the Observational Medical Outcomes Partnership, which contains 398 drug-adverse event pairs (165 positive controls, 233 negative controls). Ten methods and algorithms were applied to the US FDA Adverse Event Reporting System data to investigate the 398 pairs. The ten methods include popular methods in the pharmacovigilance literature, newly developed pharmacovigilance methods as at 2018, and popular methods in the genome-wide association study literature. We compared their performance using the receiver operating characteristic (ROC) plot, area under the curve (AUC), and Youden's index.</AbstractText><AbstractText Label="RESULTS">The Bayesian confidence propagation neural network had the highest AUC overall. Monte Carlo expectation maximization, a method developed in 2018, had the second highest AUC and the highest Youden's index, and performed very well in terms of high specificity. The regression-adjusted gamma Poisson shrinkage model performed best under high-sensitivity requirements.</AbstractText><AbstractText Label="CONCLUSION">Our results will be useful to help choose a method for a given desired level of specificity. Methods popular in the genome-wide association study literature did not perform well because of the sparsity of data and will need modification before their properties can be used in the drug-adverse event association problem.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Pham</LastName><ForeName>Minh</ForeName><Initials>M</Initials><Identifier Source="ORCID">0000-0003-3981-0951</Identifier><AffiliationInfo><Affiliation>Department of Mathematics and Statistics, University of South Florida, 4202 East Fowler Ave, CMC342, Tampa, FL, 33620, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cheng</LastName><ForeName>Feng</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Department of Pharmaceutical Sciences, College of Pharmacy, University of South Florida, 12901 Bruce B. Downs Blvd, MDC 30, Tampa, FL, 33612, USA. fcheng1@health.usf.edu.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ramachandran</LastName><ForeName>Kandethody</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Department of Mathematics and Statistics, University of South Florida, 4202 East Fowler Ave, CMC342, Tampa, FL, 33620, USA. ram@usf.edu.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D003160">Comparative Study</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>New Zealand</Country><MedlineTA>Drug Saf</MedlineTA><NlmUniqueID>9002928</NlmUniqueID><ISSNLinking>0114-5916</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D016907" MajorTopicYN="N">Adverse Drug Reaction Reporting Systems</DescriptorName><QualifierName UI="Q000706" MajorTopicYN="Y">statistics &amp; numerical data</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000465" MajorTopicYN="N">Algorithms</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D019540" MajorTopicYN="N">Area Under Curve</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001499" MajorTopicYN="N">Bayes Theorem</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D057225" MajorTopicYN="N">Data Mining</DescriptorName><QualifierName UI="Q000706" MajorTopicYN="N">statistics &amp; numerical data</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016208" MajorTopicYN="N">Databases, Factual</DescriptorName><QualifierName UI="Q000706" MajorTopicYN="N">statistics &amp; numerical data</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D064420" MajorTopicYN="N">Drug-Related Side Effects and Adverse Reactions</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName><QualifierName UI="Q000517" MajorTopicYN="Y">prevention &amp; control</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D055106" MajorTopicYN="N">Genome-Wide Association Study</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000069550" MajorTopicYN="N">Machine Learning</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D060735" MajorTopicYN="N">Pharmacovigilance</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012372" MajorTopicYN="N">ROC Curve</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014481" MajorTopicYN="N" Type="Geographic">United States</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014486" MajorTopicYN="N">United States Food and Drug Administration</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>2019</Year><Month>2</Month><Day>15</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2020</Year><Month>1</Month><Day>18</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2019</Year><Month>2</Month><Day>15</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">30762164</ArticleId><ArticleId IdType="doi">10.1007/s40264-018-00792-0</ArticleId><ArticleId IdType="pii">10.1007/s40264-018-00792-0</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Clin Pharmacol Ther. 2013 Jun;93(6):539-46</Citation><ArticleIdList><ArticleId IdType="pubmed">23571771</ArticleId></ArticleIdList></Reference><Reference><Citation>Pharmacoepidemiol Drug Saf. 2004 Aug;13(8):519-23</Citation><ArticleIdList><ArticleId IdType="pubmed">15317031</ArticleId></ArticleIdList></Reference><Reference><Citation>Sci Rep. 2018 Jan 29;8(1):1806</Citation><ArticleIdList><ArticleId IdType="pubmed">29379048</ArticleId></ArticleIdList></Reference><Reference><Citation>Genet Epidemiol. 2005 Feb;28(2):157-70</Citation><ArticleIdList><ArticleId IdType="pubmed">15532037</ArticleId></ArticleIdList></Reference><Reference><Citation>Eur J Clin Pharmacol. 1998 Jun;54(4):315-21</Citation><ArticleIdList><ArticleId IdType="pubmed">9696956</ArticleId></ArticleIdList></Reference><Reference><Citation>Genomics. 2012 Jun;99(6):323-9</Citation><ArticleIdList><ArticleId IdType="pubmed">22546560</ArticleId></ArticleIdList></Reference><Reference><Citation>Genet Epidemiol. 2001;21 Suppl 1:S600-1</Citation><ArticleIdList><ArticleId IdType="pubmed">11793745</ArticleId></ArticleIdList></Reference><Reference><Citation>Pharmacoepidemiol Drug Saf. 2004 Aug;13(8):525-6; discussion 527-8</Citation><ArticleIdList><ArticleId IdType="pubmed">15317032</ArticleId></ArticleIdList></Reference><Reference><Citation>Pac Symp Biocomput. 2005;:531-42</Citation><ArticleIdList><ArticleId IdType="pubmed">15759657</ArticleId></ArticleIdList></Reference><Reference><Citation>Pharmacoepidemiol Drug Saf. 2001 Oct-Nov;10(6):483-6</Citation><ArticleIdList><ArticleId IdType="pubmed">11828828</ArticleId></ArticleIdList></Reference><Reference><Citation>Br J Clin Pharmacol. 1997 Aug;44(2):109-10</Citation><ArticleIdList><ArticleId IdType="pubmed">9278192</ArticleId></ArticleIdList></Reference><Reference><Citation>Drug Saf. 2013 Oct;36 Suppl 1:S33-47</Citation><ArticleIdList><ArticleId IdType="pubmed">24166222</ArticleId></ArticleIdList></Reference><Reference><Citation>BioData Min. 2016 Apr 06;9:14</Citation><ArticleIdList><ArticleId IdType="pubmed">27053949</ArticleId></ArticleIdList></Reference><Reference><Citation>Ann Clin Psychiatry. 2008 Jan-Mar;20(1):21-31</Citation><ArticleIdList><ArticleId IdType="pubmed">18297583</ArticleId></ArticleIdList></Reference><Reference><Citation>Drug Saf. 2002;25(6):381-92</Citation><ArticleIdList><ArticleId IdType="pubmed">12071774</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">30771218</PMID><DateCompleted><Year>2019</Year><Month>07</Month><Day>12</Day></DateCompleted><DateRevised><Year>2020</Year><Month>02</Month><Day>25</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1826-6983</ISSN><JournalIssue CitedMedium="Internet"><Volume>124</Volume><Issue>7</Issue><PubDate><Year>2019</Year><Month>Jul</Month></PubDate></JournalIssue><Title>La Radiologia medica</Title><ISOAbbreviation>Radiol Med</ISOAbbreviation></Journal><ArticleTitle>Concomitant radiotherapy and TKI in metastatic EGFR- or ALK-mutated non-small cell lung cancer: a multicentric analysis on behalf of AIRO lung cancer study group.</ArticleTitle><Pagination><StartPage>662</StartPage><EndPage>670</EndPage><MedlinePgn>662-670</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1007/s11547-019-00999-w</ELocationID><Abstract><AbstractText Label="PURPOSE" NlmCategory="OBJECTIVE">To investigate the role of radiotherapy (RT) in the management of EGFR- or ALK-mutated metastatic non-small cell lung cancer (NSCLC) treated with TKI.</AbstractText><AbstractText Label="MATERIALS AND METHODS" NlmCategory="METHODS">Clinical data of 106 patients (pts) from five Institutions treated with RT concomitant to TKI were retrospectively revised. Overall survival (OS) and toxicities were analyzed as endpoints of the study.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">Median age of pts was 65&#xa0;years. TKIs were given for EGFR (81%)- or ALK (19%)-mutated metastatic NSCLC. Stereotactic RT (SRT) was delivered to 49 pts (46%). Patients with four or less metastasis were defined as oligometastatic/oligoprogressive (OM/OP); sites of RT were brain, bone, lung or others in 46%, 27%, 14% and 13%, respectively. Median OS was 23&#xa0;months. At univariate analysis SRT, ECOG PS 0-1, OM/OP disease, lung sites and a TKI duration longer than median favorably affected OS (all p&#x2009;&lt;&#x2009;0.001). Multivariate analysis confirmed SRT (HR 0.355, CI 95% 0.212-0.595; p&#x2009;&lt;&#x2009;0.001) and median duration of TKI&#x2009;&gt;&#x2009;14&#xa0;months (HR 0.17, 95% CI 0.10-0.30; p&#x2009;&lt;&#x2009;0.001) as independent factors related to better OS. Toxicities were rare.</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">SRT seems to positively affect OS with limited toxicity in selected patients.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Borghetti</LastName><ForeName>Paolo</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Department of Radiation Oncology, Istituto del Radio O. Alberti, Spedali Civili Hospital and Brescia University, Brescia, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bon&#xf9;</LastName><ForeName>Marco Lorenzo</ForeName><Initials>ML</Initials><AffiliationInfo><Affiliation>Department of Radiation Oncology, Istituto del Radio O. Alberti, Spedali Civili Hospital and Brescia University, Brescia, Italy. marcolorenzo89.mlb@gmail.com.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Giubbolini</LastName><ForeName>Rachele</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Radiotherapy Unit, Oncology and Hematology Department, University Hospital of Modena, Modena, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Levra</LastName><ForeName>Niccolo' Giaj</ForeName><Initials>NG</Initials><AffiliationInfo><Affiliation>Department of Radiation Oncology, Sacro Cuore Hospital, Negrar, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mazzola</LastName><ForeName>Rosario</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Department of Radiation Oncology, Sacro Cuore Hospital, Negrar, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Perna</LastName><ForeName>Marco</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Oncology Radiation Therapy Unit, Careggi University Hospital, Florence, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Visani</LastName><ForeName>Luca</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Department of Oncology Radiation Therapy Unit, Careggi University Hospital, Florence, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Meacci</LastName><ForeName>Fiammetta</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Department of Oncology Radiation Therapy Unit, Careggi University Hospital, Florence, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Taraborrelli</LastName><ForeName>Maria</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Radiotherapy Unit, SS Annunziata Hospital - G. D'annunzio University, Chieti, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Triggiani</LastName><ForeName>Luca</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Department of Radiation Oncology, Istituto del Radio O. Alberti, Spedali Civili Hospital and Brescia University, Brescia, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Franceschini</LastName><ForeName>Davide</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Department of Radiotherapy and Radiosurgery, Humanitas Research Hospital and Cancer Center, Milan, Rozzano, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Greco</LastName><ForeName>Carlo</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Departement of Radiation Oncology, Campus Bio-Medico University, Rome, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bruni</LastName><ForeName>Alessio</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Radiotherapy Unit, Oncology and Hematology Department, University Hospital of Modena, Modena, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Magrini</LastName><ForeName>Stefano Maria</ForeName><Initials>SM</Initials><AffiliationInfo><Affiliation>Department of Radiation Oncology, Istituto del Radio O. Alberti, Spedali Civili Hospital and Brescia University, Brescia, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Scotti</LastName><ForeName>Vieri</ForeName><Initials>V</Initials><AffiliationInfo><Affiliation>Department of Oncology Radiation Therapy Unit, Careggi University Hospital, Florence, Italy.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016448">Multicenter Study</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2019</Year><Month>02</Month><Day>15</Day></ArticleDate></Article><MedlineJournalInfo><Country>Italy</Country><MedlineTA>Radiol Med</MedlineTA><NlmUniqueID>0177625</NlmUniqueID><ISSNLinking>0033-8362</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D047428">Protein Kinase Inhibitors</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 2.7.10.1</RegistryNumber><NameOfSubstance UI="C000626173">ALK protein, human</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 2.7.10.1</RegistryNumber><NameOfSubstance UI="D000077548">Anaplastic Lymphoma Kinase</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 2.7.10.1</RegistryNumber><NameOfSubstance UI="C512478">EGFR protein, human</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 2.7.10.1</RegistryNumber><NameOfSubstance UI="D066246">ErbB Receptors</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000369" MajorTopicYN="N">Aged, 80 and over</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000077548" MajorTopicYN="N">Anaplastic Lymphoma Kinase</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D002289" MajorTopicYN="N">Carcinoma, Non-Small-Cell Lung</DescriptorName><QualifierName UI="Q000188" MajorTopicYN="Y">drug therapy</QualifierName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName><QualifierName UI="Q000532" MajorTopicYN="Y">radiotherapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D003131" MajorTopicYN="N">Combined Modality Therapy</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004252" MajorTopicYN="N">DNA Mutational Analysis</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D066246" MajorTopicYN="N">ErbB Receptors</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007558" MajorTopicYN="N" Type="Geographic">Italy</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008175" MajorTopicYN="N">Lung Neoplasms</DescriptorName><QualifierName UI="Q000188" MajorTopicYN="Y">drug therapy</QualifierName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName><QualifierName UI="Q000532" MajorTopicYN="Y">radiotherapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009154" MajorTopicYN="N">Mutation</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009362" MajorTopicYN="N">Neoplasm Metastasis</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D047428" MajorTopicYN="N">Protein Kinase Inhibitors</DescriptorName><QualifierName UI="Q000627" MajorTopicYN="Y">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012189" MajorTopicYN="N">Retrospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012955" MajorTopicYN="N">Societies, Medical</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015996" MajorTopicYN="N">Survival Rate</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016896" MajorTopicYN="N">Treatment Outcome</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">ALK mutated</Keyword><Keyword MajorTopicYN="N">EGFR mutated</Keyword><Keyword MajorTopicYN="N">Oligometastatic</Keyword><Keyword MajorTopicYN="N">Oligoprogressive</Keyword><Keyword MajorTopicYN="N">Radiotherapy</Keyword><Keyword MajorTopicYN="N">Stage IV NSCLC</Keyword><Keyword MajorTopicYN="N">Stereotactic radiotherapy</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2018</Year><Month>7</Month><Day>25</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2019</Year><Month>1</Month><Day>29</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2019</Year><Month>2</Month><Day>17</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2019</Year><Month>7</Month><Day>13</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2019</Year><Month>2</Month><Day>17</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">30771218</ArticleId><ArticleId IdType="doi">10.1007/s11547-019-00999-w</ArticleId><ArticleId IdType="pii">10.1007/s11547-019-00999-w</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Int J Oncol. 2004 Dec;25(6):1677-83</Citation><ArticleIdList><ArticleId IdType="pubmed">15547705</ArticleId></ArticleIdList></Reference><Reference><Citation>Cancer Res. 2005 Apr 15;65(8):3328-35</Citation><ArticleIdList><ArticleId IdType="pubmed">15833866</ArticleId></ArticleIdList></Reference><Reference><Citation>Acta Oncol. 2009;48(4):578-83</Citation><ArticleIdList><ArticleId IdType="pubmed">19373699</ArticleId></ArticleIdList></Reference><Reference><Citation>Jpn J Clin Oncol. 2010 Feb;40(2):107-11</Citation><ArticleIdList><ArticleId IdType="pubmed">20047860</ArticleId></ArticleIdList></Reference><Reference><Citation>Radiat Oncol. 2011 Jun 30;6:80</Citation><ArticleIdList><ArticleId IdType="pubmed">21718501</ArticleId></ArticleIdList></Reference><Reference><Citation>Lancet Oncol. 2012 Mar;13(3):239-46</Citation><ArticleIdList><ArticleId IdType="pubmed">22285168</ArticleId></ArticleIdList></Reference><Reference><Citation>J Thorac Oncol. 2012 Oct;7(10):1547-55</Citation><ArticleIdList><ArticleId IdType="pubmed">22982655</ArticleId></ArticleIdList></Reference><Reference><Citation>J Natl Cancer Inst. 2013 May 1;105(9):595-605</Citation><ArticleIdList><ArticleId IdType="pubmed">23594426</ArticleId></ArticleIdList></Reference><Reference><Citation>Int J Cancer. 2013 Nov 15;133(10):2277-83</Citation><ArticleIdList><ArticleId IdType="pubmed">23720067</ArticleId></ArticleIdList></Reference><Reference><Citation>Lung Cancer. 2013 Oct;82(1):95-102</Citation><ArticleIdList><ArticleId IdType="pubmed">23973202</ArticleId></ArticleIdList></Reference><Reference><Citation>Lung Cancer. 2013 Dec;82(3):431-5</Citation><ArticleIdList><ArticleId IdType="pubmed">24113550</ArticleId></ArticleIdList></Reference><Reference><Citation>Int J Radiat Oncol Biol Phys. 2014 Mar 15;88(4):892-8</Citation><ArticleIdList><ArticleId IdType="pubmed">24462383</ArticleId></ArticleIdList></Reference><Reference><Citation>Int J Radiat Oncol Biol Phys. 2014 Jul 15;89(4):880-7</Citation><ArticleIdList><ArticleId IdType="pubmed">24867533</ArticleId></ArticleIdList></Reference><Reference><Citation>Oncologist. 2015 Apr;20(4):400-10</Citation><ArticleIdList><ArticleId IdType="pubmed">25795635</ArticleId></ArticleIdList></Reference><Reference><Citation>J Clin Oncol. 2015 Oct 20;33(30):3488-515</Citation><ArticleIdList><ArticleId IdType="pubmed">26324367</ArticleId></ArticleIdList></Reference><Reference><Citation>Ann Oncol. 2016 Sep;27(suppl 5):v1-v27</Citation><ArticleIdList><ArticleId IdType="pubmed">27664245</ArticleId></ArticleIdList></Reference><Reference><Citation>Lancet Oncol. 2016 Dec;17(12):1672-1682</Citation><ArticleIdList><ArticleId IdType="pubmed">27789196</ArticleId></ArticleIdList></Reference><Reference><Citation>Cancer Treat Rev. 2017 Feb;53:25-37</Citation><ArticleIdList><ArticleId IdType="pubmed">28056412</ArticleId></ArticleIdList></Reference><Reference><Citation>Ann Oncol. 2017 Feb 1;28(2):270-277</Citation><ArticleIdList><ArticleId IdType="pubmed">28426106</ArticleId></ArticleIdList></Reference><Reference><Citation>Lancet. 2017 Jul 1;390(10089):29-39</Citation><ArticleIdList><ArticleId IdType="pubmed">28501140</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">30779778</PMID><DateCompleted><Year>2019</Year><Month>11</Month><Day>22</Day></DateCompleted><DateRevised><Year>2024</Year><Month>04</Month><Day>10</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Electronic">1932-6203</ISSN><JournalIssue CitedMedium="Internet"><Volume>14</Volume><Issue>2</Issue><PubDate><Year>2019</Year></PubDate></JournalIssue><Title>PloS one</Title><ISOAbbreviation>PLoS One</ISOAbbreviation></Journal><ArticleTitle>Data model harmonization for the All Of Us Research Program: Transforming i2b2 data into the OMOP common data model.</ArticleTitle><Pagination><StartPage>e0212463</StartPage><MedlinePgn>e0212463</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">e0212463</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1371/journal.pone.0212463</ELocationID><Abstract><AbstractText Label="BACKGROUND">The All Of Us Research Program (AOU) is building a nationwide cohort of one million patients' EHR and genomic data. Data interoperability is paramount to the program's success. AOU is standardizing its EHR data around the Observational Medical Outcomes Partnership (OMOP) data model. OMOP is one of several standard data models presently used in national-scale initiatives. Each model is unique enough to make interoperability difficult. The i2b2 data warehousing and analytics platform is used at over 200 sites worldwide, which uses a flexible ontology-driven approach for data storage. We previously demonstrated this ontology system can drive data reconfiguration, to transform data into new formats without site-specific programming. We previously implemented this on our 12-site Accessible Research Commons for Health (ARCH) network to transform i2b2 into the Patient Centered Outcomes Research Network model.</AbstractText><AbstractText Label="METHODS AND RESULTS">Here, we leverage our investment in i2b2 high-performance transformations to support the AOU OMOP data pipeline. Because the ARCH ontology has gained widespread national interest (through the Accrual to Clinical Trials network, other PCORnet networks, and the Nebraska Lexicon), we leveraged sites' existing investments into this standard ontology. We developed an i2b2-to-OMOP transformation, driven by the ARCH-OMOP ontology and the OMOP concept mapping dictionary. We demonstrated and validated our approach in the AOU New England HPO (NEHPO). First, we transformed into OMOP a fake patient dataset in i2b2 and verified through AOU tools that the data was structurally compliant with OMOP. We then transformed a subset of data in the Partners Healthcare data warehouse into OMOP. We developed a checklist of assessments to ensure the transformed data had self-integrity (e.g., the distributions have an expected shape and required fields are populated), using OMOP's visual Achilles data quality tool. This i2b2-to-OMOP transformation is being used to send NEHPO production data to AOU. It is open-source and ready for use by other research projects.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Klann</LastName><ForeName>Jeffrey G</ForeName><Initials>JG</Initials><Identifier Source="ORCID">0000-0003-2043-1601</Identifier><AffiliationInfo><Affiliation>Research Information Science and Computing, Partners Healthcare, Boston, Massachusetts, United States of America.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Harvard Medical School, Boston, Massachusetts, United States of America.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Laboratory of Computer Science, Department of Medicine, Massachusetts General Hospital, Boston, Massachusetts, United States of America.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Joss</LastName><ForeName>Matthew A H</ForeName><Initials>MAH</Initials><AffiliationInfo><Affiliation>Research Information Science and Computing, Partners Healthcare, Boston, Massachusetts, United States of America.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Embree</LastName><ForeName>Kevin</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Personalized Medicine, Partners Healthcare, Boston, Massachusetts, United States of America.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Murphy</LastName><ForeName>Shawn N</ForeName><Initials>SN</Initials><AffiliationInfo><Affiliation>Research Information Science and Computing, Partners Healthcare, Boston, Massachusetts, United States of America.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Harvard Medical School, Boston, Massachusetts, United States of America.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Laboratory of Computer Science, Department of Medicine, Massachusetts General Hospital, Boston, Massachusetts, United States of America.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>OT2 OD026553</GrantID><Acronym>OD</Acronym><Agency>NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R01 HG009174</GrantID><Acronym>HG</Acronym><Agency>NHGRI NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>U01 HG008685</GrantID><Acronym>HG</Acronym><Agency>NHGRI NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D052061">Research Support, N.I.H., Extramural</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2019</Year><Month>02</Month><Day>19</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>PLoS One</MedlineTA><NlmUniqueID>101285081</NlmUniqueID><ISSNLinking>1932-6203</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D035843" MajorTopicYN="N">Biomedical Research</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015331" MajorTopicYN="N">Cohort Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016208" MajorTopicYN="N">Databases, Factual</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003695" MajorTopicYN="N">Delivery of Health Care</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D057286" MajorTopicYN="N">Electronic Health Records</DescriptorName><QualifierName UI="Q000639" MajorTopicYN="Y">trends</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016247" MajorTopicYN="N">Information Storage and Retrieval</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="Y">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D014481" MajorTopicYN="N" Type="Geographic">United States</DescriptorName></MeshHeading></MeshHeadingList><CoiStatement>The authors have declared that no competing interests exist.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2018</Year><Month>12</Month><Day>4</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2019</Year><Month>2</Month><Day>2</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2019</Year><Month>2</Month><Day>20</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2019</Year><Month>2</Month><Day>20</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2019</Year><Month>11</Month><Day>23</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2019</Year><Month>2</Month><Day>19</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">30779778</ArticleId><ArticleId IdType="pmc">PMC6380544</ArticleId><ArticleId IdType="doi">10.1371/journal.pone.0212463</ArticleId><ArticleId IdType="pii">PONE-D-18-34751</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Sankar PL, Parker LS. The Precision Medicine Initiative&#x2019;s All of Us Research Program: an agenda for research on its ethical, legal, and social issues. Genet Med Off J Am Coll Med Genet. 2017;19: 743&#x2013;750. 10.1038/gim.2016.183</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/gim.2016.183</ArticleId><ArticleId IdType="pubmed">27929525</ArticleId></ArticleIdList></Reference><Reference><Citation>All of Us Research Program. In: National Institutes of Health (NIH) [Internet]. [cited 6 Mar 2017]. Available: https://allofus.nih.gov/</Citation></Reference><Reference><Citation>Health Care Provider Organizations | All of Us [Internet]. [cited 3 Feb 2018]. Available: https://allofus.nih.gov/about/program-components/health-care-provider-organizations</Citation></Reference><Reference><Citation>Verily Life Sciences: Precision Medicine Initiative [Internet]. [cited 3 Feb 2018]. Available: https://verily.com/projects/precision-medicine/precision-medicine-initiative/</Citation></Reference><Reference><Citation>PCORnet Common Data Model (CDM). In: PCORnet [Internet]. [cited 6 Mar 2017]. Available: http://www.pcornet.org/pcornet-common-data-model/</Citation></Reference><Reference><Citation>Murphy SN, Weber G, Mendis M, Gainer V, Chueh HC, Churchill S, et al. Serving the enterprise and beyond with informatics for integrating biology and the bedside (i2b2). J Am Med Inf Assoc. 2010;17: 124&#x2013;130. 10.1136/jamia.2009.000893</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/jamia.2009.000893</ArticleId><ArticleId IdType="pmc">PMC3000779</ArticleId><ArticleId IdType="pubmed">20190053</ArticleId></ArticleIdList></Reference><Reference><Citation>Visweswaran S, Becich MJ, D&#x2019;Itri VS, Sendro ER, MacFadden D, Anderson NR, et al. Accrual to Clinical Trials (ACT): A Clinical and Translational Science Award Consortium Network. JAMIA Open. 10.1093/jamiaopen/ooy033</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/jamiaopen/ooy033</ArticleId><ArticleId IdType="pmc">PMC6241502</ArticleId><ArticleId IdType="pubmed">30474072</ArticleId></ArticleIdList></Reference><Reference><Citation>Kimball R, Ross M. The data warehouse toolkit: the complete guide to dimensional modeling [Internet]. John Wiley &amp; Sons; 2011.  Available: https://books.google.com/books?hl=en&amp;lr=&amp;id=XoS2oy1IcB4C&amp;oi=fnd&amp;pg=PA1&amp;dq=data+warehousing+kimball&amp;ots=1BJgqCeKaA&amp;sig=M6BhBzXKYwHZuXYFaq6NrepNnBY</Citation></Reference><Reference><Citation>Hripcsak G, Duke JD, Shah NH, Reich CG, Huser V, Schuemie MJ, et al. Observational Health Data Sciences and Informatics (OHDSI): Opportunities for Observational Researchers. Stud Health Technol Inform. 2015;216: 574&#x2013;578.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4815923</ArticleId><ArticleId IdType="pubmed">26262116</ArticleId></ArticleIdList></Reference><Reference><Citation>Klann JG, Abend A, Raghavan VA, Mandl KD, Murphy SN. Data interchange using i2b2. J Am Med Inform Assoc. 2016;23: 909&#x2013;915. 10.1093/jamia/ocv188</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/jamia/ocv188</ArticleId><ArticleId IdType="pmc">PMC4997035</ArticleId><ArticleId IdType="pubmed">26911824</ArticleId></ArticleIdList></Reference><Reference><Citation>McMurry AJ, Murphy SN, MacFadden D, Weber G, Simons WW, Orechia J, et al. SHRINE: Enabling Nationally Scalable Multi-Site Disease Studies. PLoS ONE. 2013;8: e55811 10.1371/journal.pone.0055811</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0055811</ArticleId><ArticleId IdType="pmc">PMC3591385</ArticleId><ArticleId IdType="pubmed">23533569</ArticleId></ArticleIdList></Reference><Reference><Citation>Campbell W. Deploying ONC national Standards in Support of Metadata for Big Data Research Warehouse Management of Repurposed Laboratory, Pathology &amp; Patient Findings Data From the EHR. Available: http://grantome.com/grant/NIH/U01-HG009455-02</Citation></Reference><Reference><Citation>UNMC Terminology Development Center | Pathology and Microbiology | University of Nebraska Medical Center [Internet]. [cited 18 Oct 2018]. Available: https://www.unmc.edu/pathology/informatics/tdc.html</Citation></Reference><Reference><Citation>Natarajan K, Velez M. pmi_sprint_reporter: Data Sprints for the All of Us Research Program [Internet]. Department of Biomedical Informatics; 2017. Available: https://github.com/cumc-dbmi/pmi_sprint_reporter</Citation></Reference><Reference><Citation>Phillips L. NCBO Extraction Tool version 2.0. In: NCBO Ontology Tools for i2b2 [Internet]. [cited 4 Dec 2014]. Available: https://community.i2b2.org/wiki/display/NCBO/NCBO+Extraction+Tool+version+2.0</Citation></Reference><Reference><Citation>Observational Health Data Sciences and Informatics: Standardized Vocabulary Principles [Internet]. [cited 2 Feb 2018]. Available: http://www.ohdsi.org/web/wiki/doku.php?id=documentation:vocabulary:principles</Citation></Reference><Reference><Citation>Precision Medicine Initiative Data Sprints [Internet]. [cited 3 Feb 2018]. Available: https://cumc-dbmi.github.io/pmi_sprint_reporter/</Citation></Reference><Reference><Citation>Klann JG, Joss M, Abend A, Embree K. i2o-transform: PCORnet Ontology to OMOP (beta version) [Internet]. Accessible Research Commons for Health; 2018. Available: https://github.com/i2b2-omop/i2o-transform</Citation></Reference><Reference><Citation>Klann JG, Phillips LC, Joss M. arch-ontology: ARCH i2b2 PCORnet Ontology [Internet]. Accessible Research Commons for Health; 2018. Available: https://github.com/ARCH-commons/arch-ontology</Citation></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">30857412</PMID><DateCompleted><Year>2020</Year><Month>05</Month><Day>04</Day></DateCompleted><DateRevised><Year>2024</Year><Month>09</Month><Day>22</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1941-7705</ISSN><JournalIssue CitedMedium="Internet"><Volume>12</Volume><Issue>3</Issue><PubDate><Year>2019</Year><Month>Mar</Month></PubDate></JournalIssue><Title>Circulation. Cardiovascular quality and outcomes</Title><ISOAbbreviation>Circ Cardiovasc Qual Outcomes</ISOAbbreviation></Journal><ArticleTitle>Predicting Future Cardiovascular Events in Patients With Peripheral Artery Disease Using Electronic Health Record Data.</ArticleTitle><Pagination><StartPage>e004741</StartPage><MedlinePgn>e004741</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1161/CIRCOUTCOMES.118.004741</ELocationID><Abstract><AbstractText Label="BACKGROUND">Patients with peripheral artery disease (PAD) are at risk of major adverse cardiac and cerebrovascular events. There are no readily available risk scores that can accurately identify which patients are most likely to sustain an event, making it difficult to identify those who might benefit from more aggressive intervention. Thus, we aimed to develop a novel predictive model-using machine learning methods on electronic health record data-to identify which PAD patients are most likely to develop major adverse cardiac and cerebrovascular events.</AbstractText><AbstractText Label="METHODS AND RESULTS">Data were derived from patients diagnosed with PAD at 2 tertiary care institutions. Predictive models were built using a common data model that allowed for utilization of both structured (coded) and unstructured (text) data. Only data from time of entry into the health system up to PAD diagnosis were used for modeling. Models were developed and tested using nested cross-validation. A total of 7686 patients were included in learning our predictive models. Utilizing almost 1000 variables, our best predictive model accurately determined which PAD patients would go on to develop major adverse cardiac and cerebrovascular events with an area under the curve of 0.81 (95% CI, 0.80-0.83).</AbstractText><AbstractText Label="CONCLUSIONS">Machine learning algorithms applied to data in the electronic health record can learn models that accurately identify PAD patients at risk of future major adverse cardiac and cerebrovascular events, highlighting the great potential of electronic health records to provide automated risk stratification for cardiovascular diseases. Common data models that can enable cross-institution research and technology development could potentially be an important aspect of widespread adoption of newer risk-stratification models.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Ross</LastName><ForeName>Elsie Gyang</ForeName><Initials>EG</Initials><AffiliationInfo><Affiliation>Division of Vascular Surgery (E.G.R., N.J.L.), Stanford University School of Medicine, Stanford, CA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Center for Biomedical Informatics Research (K.J., N.H.S., E.G.R), Stanford University School of Medicine, Stanford, CA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jung</LastName><ForeName>Kenneth</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Center for Biomedical Informatics Research (K.J., N.H.S., E.G.R), Stanford University School of Medicine, Stanford, CA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Dudley</LastName><ForeName>Joel T</ForeName><Initials>JT</Initials><AffiliationInfo><Affiliation>Icahn School of Medicine at Mount Sinai, New York, NY (J.T.D., L.L.).</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Li</LastName><ForeName>Li</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Icahn School of Medicine at Mount Sinai, New York, NY (J.T.D., L.L.).</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Sema4, a Mount Sinai Venture, Stamford, CT (L.L.).</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Leeper</LastName><ForeName>Nicholas J</ForeName><Initials>NJ</Initials><AffiliationInfo><Affiliation>Division of Vascular Surgery (E.G.R., N.J.L.), Stanford University School of Medicine, Stanford, CA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Shah</LastName><ForeName>Nigam H</ForeName><Initials>NH</Initials><AffiliationInfo><Affiliation>Center for Biomedical Informatics Research (K.J., N.H.S., E.G.R), Stanford University School of Medicine, Stanford, CA.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>R01 LM011369</GrantID><Acronym>LM</Acronym><Agency>NLM NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>T32 HL098049</GrantID><Acronym>HL</Acronym><Agency>NHLBI NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016448">Multicenter Study</PublicationType><PublicationType UI="D052061">Research Support, N.I.H., Extramural</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Circ Cardiovasc Qual Outcomes</MedlineTA><NlmUniqueID>101489148</NlmUniqueID><ISSNLinking>1941-7713</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000369" MajorTopicYN="N">Aged, 80 and over</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002561" MajorTopicYN="N">Cerebrovascular Disorders</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName><QualifierName UI="Q000453" MajorTopicYN="Y">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D057225" MajorTopicYN="Y">Data Mining</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D057286" MajorTopicYN="Y">Electronic Health Records</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006331" MajorTopicYN="N">Heart Diseases</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName><QualifierName UI="Q000453" MajorTopicYN="Y">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000069550" MajorTopicYN="Y">Machine Learning</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D058729" MajorTopicYN="N">Peripheral Arterial Disease</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName><QualifierName UI="Q000453" MajorTopicYN="Y">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011379" MajorTopicYN="N">Prognosis</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018570" MajorTopicYN="N">Risk Assessment</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012307" MajorTopicYN="N">Risk Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D062606" MajorTopicYN="N">Tertiary Care Centers</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D013997" MajorTopicYN="N">Time Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014481" MajorTopicYN="N" Type="Geographic">United States</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">electronic health records</Keyword><Keyword MajorTopicYN="N">machine learning</Keyword><Keyword MajorTopicYN="N">mortality</Keyword><Keyword MajorTopicYN="N">peripheral arterial disease</Keyword><Keyword MajorTopicYN="N">risk</Keyword></KeywordList><CoiStatement>Disclosures. The authors have no conflicts of interest to disclose.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2019</Year><Month>3</Month><Day>13</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2019</Year><Month>3</Month><Day>13</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2020</Year><Month>5</Month><Day>6</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2020</Year><Month>3</Month><Day>1</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">30857412</ArticleId><ArticleId IdType="mid">NIHMS1519646</ArticleId><ArticleId IdType="pmc">PMC6415677</ArticleId><ArticleId IdType="doi">10.1161/CIRCOUTCOMES.118.004741</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Henry J, Pylypchuk Y, Searcy T &amp; Patel V (May 2016). Adoption of Electronic Health Record Systems among U.S. Non-Federal Acute Care Hospitals: 2008-2015 ONC Data Brief, no.35. Office of the National Coordinator for Health Information Technology: Washington DC.</Citation></Reference><Reference><Citation>Zhao J, Henriksson A, Asker L and Bostrom H. Predictive modeling of structured electronic health records for adverse drug event detection. BMC medical informatics and decision making. 2015;15 Suppl 4:S1.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4660129</ArticleId><ArticleId IdType="pubmed">26606038</ArticleId></ArticleIdList></Reference><Reference><Citation>Tabak YP, Sun X, Nunez CM and Johannes RS. Using electronic health record data to develop inpatient mortality predictive model: Acute Laboratory Risk of Mortality Score (ALaRMS). Journal of the American Medical Informatics Association : JAMIA. 2014;21:455&#x2013;63.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3994855</ArticleId><ArticleId IdType="pubmed">24097807</ArticleId></ArticleIdList></Reference><Reference><Citation>Jung K, Covington S, Sen CK, Januszyk M, Kirsner RS, Gurtner GC and Shah NH. Rapid identification of slow healing wounds. Wound repair and regeneration : official publication of the Wound Healing Society [and] the European Tissue Repair Society. 2016;24:181&#x2013;8.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4820011</ArticleId><ArticleId IdType="pubmed">26606167</ArticleId></ArticleIdList></Reference><Reference><Citation>Eapen ZJ, Liang L, Fonarow GC, Heidenreich PA, Curtis LH, Peterson ED and Hernandez AF. Validated, electronic health record deployable prediction models for assessing patient risk of 30-day rehospitalization and mortality in older heart failure patients. JACC Heart failure. 2013;1:245&#x2013;51.</Citation><ArticleIdList><ArticleId IdType="pubmed">24621877</ArticleId></ArticleIdList></Reference><Reference><Citation>Goldstein BA, Navar AM, Pencina MJ and Ioannidis JP. Opportunities and challenges in developing risk prediction models with electronic health records data: a systematic review. Journal of the American Medical Informatics Association : JAMIA. 2017;24:198&#x2013;208.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5201180</ArticleId><ArticleId IdType="pubmed">27189013</ArticleId></ArticleIdList></Reference><Reference><Citation>Antman EM, Cohen M, Bernink PJ, McCabe CH, Horacek T, Papuchis G, Mautner B, Corbalan R, Radley D and Braunwald E. The TIMI risk score for unstable angina/non-ST elevation MI: A method for prognostication and therapeutic decision making. Jama. 2000;284:835&#x2013;42.</Citation><ArticleIdList><ArticleId IdType="pubmed">10938172</ArticleId></ArticleIdList></Reference><Reference><Citation>D&#x2019;Agostino RB Sr, Grundy S Sullivan LM, Wilson P and for the CHDRPG. Validation of the framingham coronary heart disease prediction scores: Results of a multiple ethnic groups investigation. Jama. 2001;286:180&#x2013;187.</Citation><ArticleIdList><ArticleId IdType="pubmed">11448281</ArticleId></ArticleIdList></Reference><Reference><Citation>Ntaios G, Lip GY, Makaritsis K, Papavasileiou V, Vemmou A, Koroboki E, Savvari P, Manios E, Milionis H and Vemmos K. CHADS(2), CHA(2)S(2)DS(2)-VASc, and long-term stroke outcome in patients without atrial fibrillation. Neurology. 2013;80:1009&#x2013;17.</Citation><ArticleIdList><ArticleId IdType="pubmed">23408865</ArticleId></ArticleIdList></Reference><Reference><Citation>Knaus WA, Wagner DP, Draper EA, Zimmerman JE, Bergner M, Bastos PG, Sirio CA, Murphy DJ, Lotring T, Damiano A and Harrell F Jr. The APACHE III prognostic system. Risk prediction of hospital mortality for critically ill hospitalized adults. Chest. 1991;100:1619&#x2013;36.</Citation><ArticleIdList><ArticleId IdType="pubmed">1959406</ArticleId></ArticleIdList></Reference><Reference><Citation>Ross EG, Shah NH, Dalman RL, Nead KT, Cooke JP and Leeper NJ. The use of machine learning for the identification of peripheral artery disease and future mortality risk. J Vasc Surg. 2016;64:1515&#x2013;1522.e3.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5079774</ArticleId><ArticleId IdType="pubmed">27266594</ArticleId></ArticleIdList></Reference><Reference><Citation>Banda JM, Halpern Y, Sontag D and Shah NH. Electronic phenotyping with APHRODITE and the Observational Health Sciences and Informatics (OHDSI) data network. AMIA Joint Summits on Translational Science proceedings AMIA Joint Summits on Translational Science. 2017;2017:48&#x2013;57.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5543379</ArticleId><ArticleId IdType="pubmed">28815104</ArticleId></ArticleIdList></Reference><Reference><Citation>Shah NH. Mining the ultimate phenome repository. Nature biotechnology. 2013;31:1095&#x2013;7.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4036679</ArticleId><ArticleId IdType="pubmed">24316646</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen JH and Asch SM. Machine Learning and Prediction in Medicine &#x2014; Beyond the Peak of Inflated Expectations. New England Journal of Medicine. 2017;376:2507&#x2013;2509.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5953825</ArticleId><ArticleId IdType="pubmed">28657867</ArticleId></ArticleIdList></Reference><Reference><Citation>LePendu P, Iyer SV, Bauer-Mehren A, Harpaz R, Mortensen JM, Podchiyska T, Ferris TA and Shah NH. Pharmacovigilance using clinical notes. Clinical pharmacology and therapeutics. 2013;93:547&#x2013;55.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3846296</ArticleId><ArticleId IdType="pubmed">23571773</ArticleId></ArticleIdList></Reference><Reference><Citation>Banda JM. APHRODITE (Automated PHenotype Routine for Observational Definition Identification Training and Evaluation) (2015). [computer program] Available at: https://github.com/OHDSI/Aphrodite. [Accessed 1 October 2016]</Citation></Reference><Reference><Citation>R: A language and environment for statistical computing. [computer program]. Vienna, Austria: R Foundation for Statistical Computing; 2017.</Citation></Reference><Reference><Citation>Makadia R and Ryan PB. Transforming the Premier Perspective Hospital Database into the Observational Medical Outcomes Partnership (OMOP) Common Data Model. EGEMS (Washington, DC). 2014;2:1110.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4371500</ArticleId><ArticleId IdType="pubmed">25848597</ArticleId></ArticleIdList></Reference><Reference><Citation>Lependu P, Iyer SV, Fairon C and Shah NH. Annotation Analysis for Testing Drug Safety Signals using Unstructured Clinical Notes. Journal of biomedical semantics. 2012;3 Suppl 1:S5.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3337270</ArticleId><ArticleId IdType="pubmed">22541596</ArticleId></ArticleIdList></Reference><Reference><Citation>Ross EG, Shah N and Leeper N. Statin Intensity or Achieved LDL? Practice-based Evidence for the Evaluation of New Cholesterol Treatment Guidelines. PloS one. 2016;11:e0154952.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4881915</ArticleId><ArticleId IdType="pubmed">27227451</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu ST, Liu H, Li D, Tao C, Musen MA, Chute CG and Shah NH. Unified Medical Language System term occurrences in clinical notes: a large-scale corpus analysis. Journal of the American Medical Informatics Association : JAMIA. 2012;19:e149&#x2013;56.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3392861</ArticleId><ArticleId IdType="pubmed">22493050</ArticleId></ArticleIdList></Reference><Reference><Citation>Parai GK, Jonquet C, Xu R, Musen MA and Shah NH. The Lexicon Builder Web service: Building Custom Lexicons from two hundred Biomedical Ontologies. AMIA Annual Symposium proceedings / AMIA Symposium AMIA Symposium. 2010;2010:587&#x2013;91.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3041331</ArticleId><ArticleId IdType="pubmed">21347046</ArticleId></ArticleIdList></Reference><Reference><Citation>Leeper NJ, Bauer-Mehren A, Iyer SV, Lependu P, Olson C and Shah NH. Practice-based evidence: profiling the safety of cilostazol by text-mining of clinical notes. PloS one. 2013;8:e63499.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3662653</ArticleId><ArticleId IdType="pubmed">23717437</ArticleId></ArticleIdList></Reference><Reference><Citation>Agarwal V, Podchiyska T, Banda JM, Goel V, Leung TI, Minty EP, Sweeney TE, Gyang E and Shah NH. Learning statistical models of phenotypes using noisy labeled training data. Journal of the American Medical Informatics Association : JAMIA. 2016;23:1166&#x2013;1173.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5070523</ArticleId><ArticleId IdType="pubmed">27174893</ArticleId></ArticleIdList></Reference><Reference><Citation>Beaulieu-Jones BK, Lavage DR, Snyder JW, Moore JH, Pendergrass SA and Bauer CR. Characterizing and Managing Missing Structured Data in Electronic Health Records: Data Analysis. JMIR medical informatics. 2018;6:e11.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5845101</ArticleId><ArticleId IdType="pubmed">29475824</ArticleId></ArticleIdList></Reference><Reference><Citation>Gerds TA, Cai T and Schumacher M. The performance of risk prediction models. Biometrical journal Biometrische Zeitschrift. 2008;50:457&#x2013;79.</Citation><ArticleIdList><ArticleId IdType="pubmed">18663757</ArticleId></ArticleIdList></Reference><Reference><Citation>Steyerberg EW, Vickers AJ, Cook NR, Gerds T, Gonen M, Obuchowski N, Pencina MJ and Kattan MW. Assessing the performance of prediction models: a framework for some traditional and novel measures. Epidemiology (Cambridge, Mass). 2010;21:128&#x2013;138.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3575184</ArticleId><ArticleId IdType="pubmed">20010215</ArticleId></ArticleIdList></Reference><Reference><Citation>Hirsch AT, Criqui MH, Treat-Jacobson D, Regensteiner JG, Creager MA, Olin JW, Krook SH, Hunninghake DB, Comerota AJ, Walsh ME, McDermott MM and Hiatt WR. Peripheral arterial disease detection, awareness, and treatment in primary care. Jama. 2001;286:1317&#x2013;24.</Citation><ArticleIdList><ArticleId IdType="pubmed">11560536</ArticleId></ArticleIdList></Reference><Reference><Citation>Lacroix P, Aboyans V, Voronin D, Le Guyader A, Cautres M and Laskar M. High prevalence of undiagnosed patients with peripheral arterial disease in patients hospitalised for non-vascular disorders. International journal of clinical practice. 2008;62:59&#x2013;64.</Citation><ArticleIdList><ArticleId IdType="pubmed">18028389</ArticleId></ArticleIdList></Reference><Reference><Citation>Hussain MA, Al-Omran M, Mamdani M, Eisenberg N, Premji A, Saldanha L, Wang X, Verma S and Lindsay TF. Efficacy of a Guideline-Recommended Risk-Reduction Program to Improve Cardiovascular and Limb Outcomes in Patients With Peripheral Arterial Disease. JAMA surgery. 2016;151:742&#x2013;50.</Citation><ArticleIdList><ArticleId IdType="pubmed">27050566</ArticleId></ArticleIdList></Reference><Reference><Citation>McDermott MM, Kerwin DR, Liu K, Martin GJ, O&#x2019;Brien E, Kaplan H and Greenland P. Prevalence and significance of unrecognized lower extremity peripheral arterial disease in general medicine practice*. Journal of general internal medicine. 2001;16:384&#x2013;90.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1495229</ArticleId><ArticleId IdType="pubmed">11422635</ArticleId></ArticleIdList></Reference><Reference><Citation>Olin JW and Sealove BA. Peripheral artery disease: current insight into the disease and its diagnosis and management. Mayo Clinic proceedings. 2010;85:678&#x2013;92.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2894725</ArticleId><ArticleId IdType="pubmed">20592174</ArticleId></ArticleIdList></Reference><Reference><Citation>Gonzalez-Clemente JM, Pinies JA, Calle-Pascual A, Saavedra A, Sanchez C, Bellido D, Martin-Folgueras T, Moraga I, Recasens A, Girbes J, Sanchez-Zamorano MA and Mauricio D. Cardiovascular risk factor management is poorer in diabetic patients with undiagnosed peripheral arterial disease than in those with known coronary heart disease or cerebrovascular disease. Results of a nationwide study in tertiary diabetes centres. Diabetic medicine : a journal of the British Diabetic Association. 2008;25:427&#x2013;34.</Citation><ArticleIdList><ArticleId IdType="pubmed">18341592</ArticleId></ArticleIdList></Reference><Reference><Citation>Pande RL, Perlstein TS, Beckman JA and Creager MA. Secondary prevention and mortality in peripheral artery disease: National Health and Nutrition Examination Study, 1999 to 2004. Circulation. 2011;124:17&#x2013;23.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3139992</ArticleId><ArticleId IdType="pubmed">21690489</ArticleId></ArticleIdList></Reference><Reference><Citation>Anand SS, Bosch J, Eikelboom JW, et al. The Lancet. 2018;391:219&#x2013;229.</Citation><ArticleIdList><ArticleId IdType="pubmed">29132880</ArticleId></ArticleIdList></Reference><Reference><Citation>Hemann BA, Bimson WF and Taylor AJ. The Framingham Risk Score: an appraisal of its benefits and limitations. The American heart hospital journal. 2007;5:91&#x2013;6.</Citation><ArticleIdList><ArticleId IdType="pubmed">17478974</ArticleId></ArticleIdList></Reference><Reference><Citation>Arruda&#x2010;Olson Adelaide M, Afzal N, Priya Mallipeddi V, Said A, Moussa Pacha H, Moon S, Chaudhry Alisha P, Scott Christopher G, Bailey Kent R, Rooke Thom W, Wennberg Paul W, Kaggal Vinod C, Oderich Gustavo S, Kullo Iftikhar J, Nishimura Rick A, Chaudhry R and Liu H. Leveraging the Electronic Health Record to Create an Automated Real&#x2010;Time Prognostic Tool for Peripheral Arterial Disease. Journal of the American Heart Association. 2018;7:e009680.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6405562</ArticleId><ArticleId IdType="pubmed">30571601</ArticleId></ArticleIdList></Reference><Reference><Citation>Hripcsak G, Duke JD, Shah NH, Reich CG, Huser V, Schuemie MJ, Suchard MA, Park RW, Wong ICK, Rijnbeek PR, van der Lei J, Pratt N, Nor&#xe9;n GN, Li YC, Stang PE, Madigan D and Ryan PB. Observational Health Data Sciences and Informatics (OHDSI): Opportunities for Observational Researchers. Studies in health technology and informatics. 2015;216:574&#x2013;8.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4815923</ArticleId><ArticleId IdType="pubmed">26262116</ArticleId></ArticleIdList></Reference><Reference><Citation>PCORnet. (2018). National Patient-Centered Clinical Research Network Common Data Model (CDM). Available at: http://www.pcornet.org/pcornet-common-data-model/ [Accessed 20 Nov 2017].</Citation></Reference><Reference><Citation>Ross TR, Ng D, Brown JS, Pardee R, Hornbrook MC, Hart G and Steiner JF. The HMO Research Network Virtual Data Warehouse: A Public Data Model to Support Collaboration. EGEMS (Washington, DC). 2014;2:1049.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4371424</ArticleId><ArticleId IdType="pubmed">25848584</ArticleId></ArticleIdList></Reference><Reference><Citation>Sentinelinitiative.org. (2018). Distributed Database and Common Data Model &#x2223; Sentinel Initiative. Available at: https://www.sentinelinitiative.org/sentinel/data/distributed-database-common-data-model [Accessed 20 Nov. 2017].</Citation></Reference><Reference><Citation>Clinical Data Interchange Standards Consortium. (2018) CDISC Standards in the Clinical Research Process. Available at: https://www.cdisc.org/standards [Accessed 20 Nov 2017].</Citation></Reference><Reference><Citation>Garza M, Del Fiol G, Tenenbaum J, Walden A and Zozus MN. Evaluating common data models for use with a longitudinal community registry. Journal of biomedical informatics. 2016;64:333&#x2013;341.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6810649</ArticleId><ArticleId IdType="pubmed">27989817</ArticleId></ArticleIdList></Reference><Reference><Citation>Xu Y, Zhou X, Suehs BT, Hartzema AG, Kahn MG, Moride Y, Sauer BC, Liu Q, Moll K, Pasquale MK, Nair VP and Bate A. A Comparative Assessment of Observational Medical Outcomes Partnership and Mini-Sentinel Common Data Models and Analytics: Implications for Active Drug Safety Surveillance. Drug safety. 2015;38:749&#x2013;65.</Citation><ArticleIdList><ArticleId IdType="pubmed">26055920</ArticleId></ArticleIdList></Reference><Reference><Citation>Reisinger SJ, Ryan PB, O&#x2019;Hara DJ, Powell GE, Painter JL, Pattishall EN and Morris JA. Development and evaluation of a common data model enabling active drug safety surveillance using disparate healthcare databases. Journal of the American Medical Informatics Association : JAMIA. 2010;17:652&#x2013;62.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3000752</ArticleId><ArticleId IdType="pubmed">20962127</ArticleId></ArticleIdList></Reference><Reference><Citation>FitzHenry F, Resnic F, Robbins S, Denton J, Nookala L, Meeker D, Ohno-Machado L and Matheny M. Creating a Common Data Model for Comparative Effectiveness with the Observational Medical Outcomes Partnership. Applied Clinical Informatics. 2015;6:536&#x2013;47.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4586341</ArticleId><ArticleId IdType="pubmed">26448797</ArticleId></ArticleIdList></Reference><Reference><Citation>Zozus MN, Richesson RL, Walden A, Tenenbaum JD and Hammond W. Research Reproducibility in Longitudinal Multi-Center Studies Using Data from Electronic Health Records. AMIA Summits on Translational Science Proceedings. 2016;2016:279&#x2013;85.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5001777</ArticleId><ArticleId IdType="pubmed">27570682</ArticleId></ArticleIdList></Reference><Reference><Citation>Matcho A, Ryan P, Fife D and Reich C. Fidelity Assessment of a Clinical Practice Research Datalink Conversion to the OMOP Common Data Model. Drug safety. 2014;37:945&#x2013;59.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4206771</ArticleId><ArticleId IdType="pubmed">25187016</ArticleId></ArticleIdList></Reference><Reference><Citation>Celi LA, Tang RJ, Villarroel MC, Davidzon GA, Lester WT and Chueh HC. A Clinical Database-Driven Approach to Decision Support: Predicting Mortality Among Patients with Acute Kidney Injury. Journal of healthcare engineering. 2011;2:97&#x2013;110.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3404157</ArticleId><ArticleId IdType="pubmed">22844575</ArticleId></ArticleIdList></Reference><Reference><Citation>Yadlowsky S, Hayward RA, Sussman JB, McClelland RL, Min YI and Basu S. Clinical Implications of Revised Pooled Cohort Equations for Estimating Atherosclerotic Cardiovascular Disease Risk. Annals of internal medicine. 2018;169:20&#x2013;29.</Citation><ArticleIdList><ArticleId IdType="pubmed">29868850</ArticleId></ArticleIdList></Reference><Reference><Citation>Leek JT and Peng RD. Statistics. What is the question? Science (New York, NY). 2015;347:1314&#x2013;5.</Citation><ArticleIdList><ArticleId IdType="pubmed">25721505</ArticleId></ArticleIdList></Reference><Reference><Citation>Breiman L Statistical Modeling: The Two Cultures (with comments and a rejoinder by the author). 2001:199&#x2013;231.</Citation></Reference><Reference><Citation>Bzdok D, Altman N and Krzywinski M. Statistics versus machine learning. Nature Methods. 2018;15:233.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6082636</ArticleId><ArticleId IdType="pubmed">30100822</ArticleId></ArticleIdList></Reference><Reference><Citation>Verghese A, Shah NH and Harrington RA. What This Computer Needs Is a Physician: Humanism and Artificial Intelligence. Jama. 2018;319:19&#x2013;20.</Citation><ArticleIdList><ArticleId IdType="pubmed">29261830</ArticleId></ArticleIdList></Reference><Reference><Citation>Samad MD, Ulloa A, Wehner GJ, Jing L, Hartzel D, Good CW, Williams BA, Haggerty CM and Fornwalt BK. Predicting Survival From Large Echocardiography and Electronic Health Record Datasets: Optimization With Machine Learning. JACC: Cardiovascular Imaging. 2018. [Epub ahead of print], PMC6286869, DOI: 10.1016/j.jcmg.2018.04.026</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jcmg.2018.04.026</ArticleId><ArticleId IdType="pmc">PMC6286869</ArticleId><ArticleId IdType="pubmed">29909114</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">30912749</PMID><DateCompleted><Year>2020</Year><Month>02</Month><Day>07</Day></DateCompleted><DateRevised><Year>2023</Year><Month>05</Month><Day>02</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1438-8871</ISSN><JournalIssue CitedMedium="Internet"><Volume>21</Volume><Issue>3</Issue><PubDate><Year>2019</Year><Month>Mar</Month><Day>26</Day></PubDate></JournalIssue><Title>Journal of medical Internet research</Title><ISOAbbreviation>J Med Internet Res</ISOAbbreviation></Journal><ArticleTitle>Genomic Common Data Model for Seamless Interoperation of Biomedical Data in Clinical Practice: Retrospective Study.</ArticleTitle><Pagination><StartPage>e13249</StartPage><MedlinePgn>e13249</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">e13249</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.2196/13249</ELocationID><Abstract><AbstractText Label="BACKGROUND">Clinical sequencing data should be shared in order to achieve the sufficient scale and diversity required to provide strong evidence for improving patient care. A distributed research network allows researchers to share this evidence rather than the patient-level data across centers, thereby avoiding privacy issues. The Observational Medical Outcomes Partnership (OMOP) common data model (CDM) used in distributed research networks has low coverage of sequencing data and does not reflect the latest trends of precision medicine.</AbstractText><AbstractText Label="OBJECTIVE">The aim of this study was to develop and evaluate the feasibility of a genomic CDM (G-CDM), as an extension of the OMOP-CDM, for application of genomic data in clinical practice.</AbstractText><AbstractText Label="METHODS">Existing genomic data models and sequencing reports were reviewed to extend the OMOP-CDM to cover genomic data. The Human Genome Organisation Gene Nomenclature Committee and Human Genome Variation Society nomenclature were adopted to standardize the terminology in the model. Sequencing data of 114 and 1060 patients with lung cancer were obtained from the Ajou University School of Medicine database of Ajou University Hospital and The Cancer Genome Atlas, respectively, which were transformed to a format appropriate for the G-CDM. The data were compared with respect to gene name, variant type, and actionable mutations.</AbstractText><AbstractText Label="RESULTS">The G-CDM was extended into four tables linked to tables of the OMOP-CDM. Upon comparison with The Cancer Genome Atlas data, a clinically actionable mutation, p.Leu858Arg, in the EGFR gene was 6.64 times more frequent in the Ajou University School of Medicine database, while the p.Gly12Xaa mutation in the KRAS gene was 2.02 times more frequent in The Cancer Genome Atlas dataset. The data-exploring tool GeneProfiler was further developed to conduct descriptive analyses automatically using the G-CDM, which provides the proportions of genes, variant types, and actionable mutations. GeneProfiler also allows for querying the specific gene name and Human Genome Variation Society nomenclature to calculate the proportion of patients with a given mutation.</AbstractText><AbstractText Label="CONCLUSIONS">We developed the G-CDM for effective integration of genomic data with standardized clinical data, allowing for data sharing across institutes. The feasibility of the G-CDM was validated by assessing the differences in data characteristics between two different genomic databases through the proposed data-exploring tool GeneProfiler. The G-CDM may facilitate analyses of interoperating clinical and genomic datasets across multiple institutions, minimizing privacy issues and enabling researchers to better understand the characteristics of patients and promote personalized medicine in clinical practice.</AbstractText><CopyrightInformation>&#xa9;Seo Jeong Shin, Seng Chan You, Yu Rang Park, Jin Roh, Jang-Hee Kim, Seokjin Haam, Christian G Reich, Clair Blacketer, Dae-Soon Son, Seungbin Oh, Rae Woong Park. Originally published in the Journal of Medical Internet Research (http://www.jmir.org), 26.03.2019.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y" EqualContrib="Y"><LastName>Shin</LastName><ForeName>Seo Jeong</ForeName><Initials>SJ</Initials><Identifier Source="ORCID">0000-0003-0861-3576</Identifier><AffiliationInfo><Affiliation>Department of Biomedical Sciences, Ajou University Graduate School of Medicine, Suwon, Republic of Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y" EqualContrib="Y"><LastName>You</LastName><ForeName>Seng Chan</ForeName><Initials>SC</Initials><Identifier Source="ORCID">0000-0002-5052-6399</Identifier><AffiliationInfo><Affiliation>Department of Biomedical Informatics, Ajou University School of Medicine, Suwon, Republic of Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y" EqualContrib="Y"><LastName>Park</LastName><ForeName>Yu Rang</ForeName><Initials>YR</Initials><Identifier Source="ORCID">0000-0002-4210-2094</Identifier><AffiliationInfo><Affiliation>Department of Biomedical Systems Informatics, Yonsei University College of Medicine, Seoul, Republic of Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Roh</LastName><ForeName>Jin</ForeName><Initials>J</Initials><Identifier Source="ORCID">0000-0002-3995-355X</Identifier><AffiliationInfo><Affiliation>Department of Pathology, Ajou University Hospital, Suwon, Republic of Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kim</LastName><ForeName>Jang-Hee</ForeName><Initials>JH</Initials><Identifier Source="ORCID">0000-0001-5825-1361</Identifier><AffiliationInfo><Affiliation>Department of Pathology, Ajou University Hospital, Suwon, Republic of Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Haam</LastName><ForeName>Seokjin</ForeName><Initials>S</Initials><Identifier Source="ORCID">0000-0002-0403-2216</Identifier><AffiliationInfo><Affiliation>Department of Thoracic &amp; Cardiovascular Surgery, Ajou University Hospital, Suwon, Republic of Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Reich</LastName><ForeName>Christian G</ForeName><Initials>CG</Initials><Identifier Source="ORCID">0000-0002-3641-055X</Identifier><AffiliationInfo><Affiliation>IQVIA, Durham, NC, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Blacketer</LastName><ForeName>Clair</ForeName><Initials>C</Initials><Identifier Source="ORCID">0000-0003-2570-2124</Identifier><AffiliationInfo><Affiliation>Department of Epidemiology, Janssen Research and Development, Titusville, NJ, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Son</LastName><ForeName>Dae-Soon</ForeName><Initials>DS</Initials><Identifier Source="ORCID">0000-0002-5164-4274</Identifier><AffiliationInfo><Affiliation>Samsung Genome Institute, Samsung Medical Center, Seoul, Republic of Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Oh</LastName><ForeName>Seungbin</ForeName><Initials>S</Initials><Identifier Source="ORCID">0000-0002-4183-3637</Identifier><AffiliationInfo><Affiliation>Department of Pharmacy, Kangwon University, Chuncheon, Republic of Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Park</LastName><ForeName>Rae Woong</ForeName><Initials>RW</Initials><Identifier Source="ORCID">0000-0003-4989-3287</Identifier><AffiliationInfo><Affiliation>Department of Biomedical Sciences, Ajou University Graduate School of Medicine, Suwon, Republic of Korea.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Biomedical Informatics, Ajou University School of Medicine, Suwon, Republic of Korea.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2019</Year><Month>03</Month><Day>26</Day></ArticleDate></Article><MedlineJournalInfo><Country>Canada</Country><MedlineTA>J Med Internet Res</MedlineTA><NlmUniqueID>100959882</NlmUniqueID><ISSNLinking>1438-8871</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D016208" MajorTopicYN="N">Databases, Factual</DescriptorName><QualifierName UI="Q000592" MajorTopicYN="Y">standards</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D023281" MajorTopicYN="N">Genomics</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="Y">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D057285" MajorTopicYN="N">Precision Medicine</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="Y">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012189" MajorTopicYN="N">Retrospective Studies</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">data visualization</Keyword><Keyword MajorTopicYN="N">databases, genetic</Keyword><Keyword MajorTopicYN="N">high-throughput nucleotide sequencing</Keyword><Keyword MajorTopicYN="N">multicenter study</Keyword><Keyword MajorTopicYN="N">patient privacy</Keyword></KeywordList><CoiStatement>Conflicts of Interest: None declared.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2018</Year><Month>12</Month><Day>31</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2019</Year><Month>2</Month><Day>25</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2019</Year><Month>2</Month><Day>11</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2019</Year><Month>3</Month><Day>27</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2019</Year><Month>3</Month><Day>27</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2020</Year><Month>2</Month><Day>8</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2019</Year><Month>3</Month><Day>26</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">30912749</ArticleId><ArticleId IdType="pmc">PMC6454347</ArticleId><ArticleId IdType="doi">10.2196/13249</ArticleId><ArticleId IdType="pii">v21i3e13249</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Schwaederle M, Parker BA, Schwab RB, Daniels GA, Piccioni DE, Kesari S, Helsten TL, Bazhenova LA, Romero J, Fanta PT, Lippman SM, Kurzrock R. Precision Oncology: The UC San Diego Moores Cancer Center PREDICT Experience. Mol Cancer Ther. 2016 Dec;15(4):743&#x2013;52. doi: 10.1158/1535-7163.MCT-15-0795. 
 
1535-7163.MCT-15-0795</Citation><ArticleIdList><ArticleId IdType="doi">10.1158/1535-7163.MCT-15-0795</ArticleId><ArticleId IdType="pubmed">26873727</ArticleId></ArticleIdList></Reference><Reference><Citation>Kris MG, Johnson BE, Berry LD, Kwiatkowski DJ, Iafrate AJ, Wistuba II, Varella-Garcia M, Franklin WA, Aronson SL, Su P, Shyr Y, Camidge DR, Sequist LV, Glisson BS, Khuri FR, Garon EB, Pao W, Rudin C, Schiller J, Haura EB, Socinski M, Shirai K, Chen H, Giaccone G, Ladanyi M, Kugler K, Minna JD, Bunn PA. Using multiplexed assays of oncogenic drivers in lung cancers to select targeted drugs. JAMA. 2014 May 21;311(19):1998&#x2013;2006. doi: 10.1001/jama.2014.3741. 
 
1872815</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2014.3741</ArticleId><ArticleId IdType="pmc">PMC4163053</ArticleId><ArticleId IdType="pubmed">24846037</ArticleId></ArticleIdList></Reference><Reference><Citation>Stockley TL, Oza AM, Berman HK, Leighl NB, Knox JJ, Shepherd FA, Chen EX, Krzyzanowska MK, Dhani N, Joshua AM, Tsao M, Serra S, Clarke B, Roehrl MH, Zhang T, Sukhai MA, Califaretti N, Trinkaus M, Shaw P, van der Kwast T, Wang L, Virtanen C, Kim RH, Razak ARA, Hansen AR, Yu C, Pugh TJ, Kamel-Reid S, Siu LL, Bedard PL. Molecular profiling of advanced solid tumors and patient outcomes with genotype-matched clinical trials: the Princess Margaret IMPACT/COMPACT trial. Genome Med. 2016 Dec 25;8(1):109. doi: 10.1186/s13073-016-0364-2. 
 
10.1186/s13073-016-0364-2</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13073-016-0364-2</ArticleId><ArticleId IdType="doi">10.1186/s13073-016-0364-2</ArticleId><ArticleId IdType="pmc">PMC5078968</ArticleId><ArticleId IdType="pubmed">27782854</ArticleId></ArticleIdList></Reference><Reference><Citation>AACR Project GENIE Consortium  AACR Project GENIE: Powering Precision Medicine through an International Consortium. Cancer Discov. 2017 Dec;7(8):818&#x2013;831. doi: 10.1158/2159-8290.CD-17-0151. 
 
2159-8290.CD-17-0151</Citation><ArticleIdList><ArticleId IdType="doi">10.1158/2159-8290.CD-17-0151</ArticleId><ArticleId IdType="pmc">PMC5611790</ArticleId><ArticleId IdType="pubmed">28572459</ArticleId></ArticleIdList></Reference><Reference><Citation>Cyranoski D. China embraces precision medicine on a massive scale. Nature. 2016 Jan 07;529(7584):9&#x2013;10. doi: 10.1038/529009a.529009a</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/529009a</ArticleId><ArticleId IdType="pubmed">26738574</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang S, Jiang X, Tang H, Wang X, Bu D, Carey K, Dyke SO, Fox D, Jiang C, Lauter K, Malin B, Sofia H, Telenti A, Wang L, Wang W, Ohno-Machado L. A community effort to protect genomic data sharing, collaboration and outsourcing. NPJ Genom Med. 2017;2:33. doi: 10.1038/s41525-017-0036-1. 
 
36</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41525-017-0036-1</ArticleId><ArticleId IdType="pmc">PMC5677972</ArticleId><ArticleId IdType="pubmed">29263842</ArticleId></ArticleIdList></Reference><Reference><Citation>Scollen S, Page A, Wilson J. From the data on many, precision medicine for &#x201c;one&#x201d;: The case for widespread genomic data sharing. Biomed Hub. 2017 Nov 21;2(1):21&#x2013;21. doi: 10.1159/000481682.</Citation><ArticleIdList><ArticleId IdType="doi">10.1159/000481682</ArticleId><ArticleId IdType="pmc">PMC6945905</ArticleId><ArticleId IdType="pubmed">31988941</ArticleId></ArticleIdList></Reference><Reference><Citation>Sudlow C, Gallacher J, Allen N, Beral V, Burton P, Danesh J, Downey P, Elliott P, Green J, Landray M, Liu B, Matthews P, Ong G, Pell J, Silman A, Young A, Sprosen T, Peakman T, Collins R. UK biobank: an open access resource for identifying the causes of a wide range of complex diseases of middle and old age. PLoS Med. 2015 Mar;12(3):e1001779. doi: 10.1371/journal.pmed.1001779. 
 
PMEDICINE-D-12-02351</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pmed.1001779</ArticleId><ArticleId IdType="doi">10.1371/journal.pmed.1001779</ArticleId><ArticleId IdType="pmc">PMC4380465</ArticleId><ArticleId IdType="pubmed">25826379</ArticleId></ArticleIdList></Reference><Reference><Citation>Murray MF. The path to routine genomic screening in health care. Ann Intern Med. 2018 Sep 18;169(6):407&#x2013;408. doi: 10.7326/M18-1722.2695042</Citation><ArticleIdList><ArticleId IdType="doi">10.7326/M18-1722</ArticleId><ArticleId IdType="pubmed">30073309</ArticleId></ArticleIdList></Reference><Reference><Citation>Park YR, Shin S. Status and direction of healthcare data in Korea for artificial intelligence. Hanyang Med Rev. 2017;37(2):86. doi: 10.7599/hmr.2017.37.2.86.</Citation><ArticleIdList><ArticleId IdType="doi">10.7599/hmr.2017.37.2.86</ArticleId></ArticleIdList></Reference><Reference><Citation>Nam DJ, Kwon HW, Lee H, Ahn EK. National healthcare service and its big data analytics. Healthc Inform Res. 2018 Jul;24(3):247&#x2013;249. doi: 10.4258/hir.2018.24.3.247. 
 
jpet.118.250076</Citation><ArticleIdList><ArticleId IdType="doi">10.4258/hir.2018.24.3.247</ArticleId><ArticleId IdType="pmc">PMC6085206</ArticleId><ArticleId IdType="pubmed">30109158</ArticleId></ArticleIdList></Reference><Reference><Citation>Park RW. Sharing clinical big data while protecting confidentiality and security: Observational health data sciences and informatics. Healthc Inform Res. 2017 Jan;23(1):1&#x2013;3. doi: 10.4258/hir.2017.23.1.1. 
 
</Citation><ArticleIdList><ArticleId IdType="doi">10.4258/hir.2017.23.1.1</ArticleId><ArticleId IdType="pmc">PMC5334126</ArticleId><ArticleId IdType="pubmed">28261525</ArticleId></ArticleIdList></Reference><Reference><Citation>Murphy SN, Mendis ME, Berkowitz DA, Kohane I, Chueh HC. Integration of clinical and genetic data in the i2b2 architecture. AMIA Annu Symp Proc; 2006; Washington, DC. 2006. Nov 11, p. 1040.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1839291</ArticleId><ArticleId IdType="pubmed">17238659</ArticleId></ArticleIdList></Reference><Reference><Citation>Klann JG, Abend A, Raghavan VA, Mandl KD, Murphy SN. Data interchange using i2b2. J Am Med Inform Assoc. 2016 Dec;23(5):909&#x2013;15. doi: 10.1093/jamia/ocv188. 
 
ocv188</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/jamia/ocv188</ArticleId><ArticleId IdType="pmc">PMC4997035</ArticleId><ArticleId IdType="pubmed">26911824</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim KK, Browe DK, Logan HC, Holm R, Hack L, Ohno-Machado L. Data governance requirements for distributed clinical research networks: triangulating perspectives of diverse stakeholders. J Am Med Inform Assoc. 2014;21(4):714&#x2013;9. doi: 10.1136/amiajnl-2013-002308. 
 
amiajnl-2013-002308</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/amiajnl-2013-002308</ArticleId><ArticleId IdType="pmc">PMC4078279</ArticleId><ArticleId IdType="pubmed">24302285</ArticleId></ArticleIdList></Reference><Reference><Citation>Hripcsak G, Duke JD, Shah NH, Reich CG, Huser V, Schuemie MJ, Suchard MA, Park RW, Wong ICK, Rijnbeek PR, van der Lei J, Pratt N, Nor&#xe9;n GN, Li Y, Stang PE, Madigan D, Ryan PB. Observational Health Data Sciences and Informatics (OHDSI): Opportunities for Observational Researchers. Stud Health Technol Inform. 2015;216:574&#x2013;8. 
 
</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4815923</ArticleId><ArticleId IdType="pubmed">26262116</ArticleId></ArticleIdList></Reference><Reference><Citation>Green R, Rehm H, Kohane I. In: Clinical genome sequencing. Ginsburg H, Willard H, editors. San Diego: Genomic and personalized medicine; 2013.</Citation></Reference><Reference><Citation>Ibrahim MM, Lacadie SA, Ohler U. JAMM: a peak finder for joint analysis of NGS replicates. Bioinformatics. 2015 Jan 01;31(1):48&#x2013;55. doi: 10.1093/bioinformatics/btu568.btu568</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/bioinformatics/btu568</ArticleId><ArticleId IdType="pubmed">25223640</ArticleId></ArticleIdList></Reference><Reference><Citation>Brazma A, Hingamp P, Quackenbush J, Sherlock G, Spellman P, Stoeckert C, Aach J, Ansorge W, Ball CA, Causton HC, Gaasterland T, Glenisson P, Holstege FC, Kim IF, Markowitz V, Matese JC, Parkinson H, Robinson A, Sarkans U, Schulze-Kremer S, Stewart J, Taylor R, Vilo J, Vingron M. Minimum information about a microarray experiment (MIAME)-toward standards for microarray data. Nat Genet. 2001 Dec;29(4):365&#x2013;71. doi: 10.1038/ng1201-365.ng1201-365</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ng1201-365</ArticleId><ArticleId IdType="pubmed">11726920</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee HW, Park YR, Sim J, Park RW, Kim WH, Kim JH. The tissue microarray object model: a data model for storage, analysis, and exchange of tissue microarray experimental data. Arch Pathol Lab Med. 2006 Jul;130(7):1004&#x2013;13. doi: 10.1043/1543-2165(2006)130[1004:TTMOMA]2.0.CO;2.OA5763</Citation><ArticleIdList><ArticleId IdType="doi">10.1043/1543-2165(2006)130[1004:TTMOMA]2.0.CO;2</ArticleId><ArticleId IdType="pubmed">16831026</ArticleId></ArticleIdList></Reference><Reference><Citation>Garwood K, McLaughlin T, Garwood C, Joens S, Morrison N, Taylor CF, Carroll K, Evans C, Whetton AD, Hart S, Stead D, Yin Z, Brown AJP, Hesketh A, Chater K, Hansson L, Mewissen M, Ghazal P, Howard J, Lilley KS, Gaskell SJ, Brass A, Hubbard SJ, Oliver SG, Paton NW. PEDRo: a database for storing, searching and disseminating experimental proteomics data. BMC Genomics. 2004 Sep 17;5:68. doi: 10.1186/1471-2164-5-68. 
 
1471-2164-5-68</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1471-2164-5-68</ArticleId><ArticleId IdType="doi">10.1186/1471-2164-5-68</ArticleId><ArticleId IdType="pmc">PMC521486</ArticleId><ArticleId IdType="pubmed">15377392</ArticleId></ArticleIdList></Reference><Reference><Citation>Kahl G. The dictionary of genomics, transcriptomics and proteomics. Hoboken, NJ: Wiley-Blackwell; 2015. Minimum information about a high-throughput nucleotide sequencing experiment (MINSEQE)</Citation></Reference><Reference><Citation>Pavlopoulou A, Spandidos DA, Michalopoulos I. Human cancer databases (review) Oncol Rep. 2015 Jan;33(1):3&#x2013;18. doi: 10.3892/or.2014.3579. 
 
</Citation><ArticleIdList><ArticleId IdType="doi">10.3892/or.2014.3579</ArticleId><ArticleId IdType="pmc">PMC4254674</ArticleId><ArticleId IdType="pubmed">25369839</ArticleId></ArticleIdList></Reference><Reference><Citation>Tomczak K, Czerwi&#x144;ska P, Wiznerowicz M. The Cancer Genome Atlas (TCGA): an immeasurable source of knowledge. Contemp Oncol (Pozn) 2015;19(1A):A68&#x2013;77. doi: 10.5114/wo.2014.47136. 
 
24047</Citation><ArticleIdList><ArticleId IdType="doi">10.5114/wo.2014.47136</ArticleId><ArticleId IdType="pmc">PMC4322527</ArticleId><ArticleId IdType="pubmed">25691825</ArticleId></ArticleIdList></Reference><Reference><Citation>Tate JG, Bamford S, Jubb HC, Sondka Z, Beare DM, Bindal N, Boutselakis H, Cole CG, Creatore C, Dawson E, Fish P, Harsha B, Hathaway C, Jupe SC, Kok CY, Noble K, Ponting L, Ramshaw CC, Rye CE, Speedy HE, Stefancsik R, Thompson SL, Wang S, Ward S, Campbell PJ, Forbes SA. COSMIC: the Catalogue Of Somatic Mutations In Cancer. Nucleic Acids Res. 2019 Jan 08;47(D1):D941&#x2013;D947. doi: 10.1093/nar/gky1015. 
 
5146192</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/nar/gky1015</ArticleId><ArticleId IdType="pmc">PMC6323903</ArticleId><ArticleId IdType="pubmed">30371878</ArticleId></ArticleIdList></Reference><Reference><Citation>International Cancer Genome Consortium. Hudson TJ, Anderson W, Artez A, Barker AD, Bell C, Bernab&#xe9; RR, Bhan MK, Calvo F, Eerola I, Gerhard DS, Guttmacher A, Guyer M, Hemsley FM, Jennings JL, Kerr D, Klatt P, Kolar P, Kusada J, Lane DP, Laplace F, Youyong L, Nettekoven G, Ozenberger B, Peterson J, Rao TS, Remacle J, Schafer AJ, Shibata T, Stratton MR, Vockley JG, Watanabe K, Yang H, Yuen MMF, Knoppers BM, Bobrow M, Cambon-Thomsen A, Dressler LG, Dyke SOM, Joly Y, Kato K, Kennedy KL, Nicol&#xe1;s P, Parker MJ, Rial-Sebbag E, Romeo-Casabona CM, Shaw KM, Wallace S, Wiesner GL, Zeps N, Lichter P, Biankin AV, Chabannon C, Chin L, Cl&#xe9;ment B, de Alava E, Degos F, Ferguson ML, Geary P, Hayes DN, Hudson TJ, Johns AL, Kasprzyk A, Nakagawa H, Penny R, Piris MA, Sarin R, Scarpa A, Shibata T, van de Vijver M, Futreal PA, Aburatani H, Bay&#xe9;s M, Botwell DDL, Campbell PJ, Estivill X, Gerhard DS, Grimmond SM, Gut I, Hirst M, L&#xf3;pez-Ot&#xed;n C, Majumder P, Marra M, McPherson JD, Nakagawa H, Ning Z, Puente XS, Ruan Y, Shibata T, Stratton MR, Stunnenberg HG, Swerdlow H, Velculescu VE, Wilson RK, Xue HH, Yang L, Spellman PT, Bader GD, Boutros PC, Campbell PJ, Flicek P, Getz G, Guig&#xf3; R, Guo G, Haussler D, Heath S, Hubbard TJ, Jiang T, Jones SM, Li Q, L&#xf3;pez-Bigas N, Luo R, Muthuswamy L, Ouellette BFF, Pearson JV, Puente XS, Quesada V, Raphael BJ, Sander C, Shibata T, Speed TP, Stein LD, Stuart JM, Teague JW, Totoki Y, Tsunoda T, Valencia A, Wheeler DA, Wu H, Zhao S, Zhou G, Stein LD, Guig&#xf3; R, Hubbard TJ, Joly Y, Jones SM, Kasprzyk A, Lathrop M, L&#xf3;pez-Bigas N, Ouellette BFF, Spellman PT, Teague JW, Thomas G, Valencia A, Yoshida T, Kennedy KL, Axton M, Dyke SOM, Futreal PA, Gerhard DS, Gunter C, Guyer M, Hudson TJ, McPherson JD, Miller LJ, Ozenberger B, Shaw KM, Kasprzyk A, Stein LD, Zhang J, Haider SA, Wang J, Yung CK, Cros A, Cross A, Liang Y, Gnaneshan S, Guberman J, Hsu J, Bobrow M, Chalmers DRC, Hasel KW, Joly Y, Kaan TSH, Kennedy KL, Knoppers BM, Lowrance WW, Masui T, Nicol&#xe1;s P, Rial-Sebbag E, Rodriguez LL, Vergely C, Yoshida T, Grimmond SM, Biankin AV, Bowtell DDL, Cloonan N, deFazio A, Eshleman JR, Etemadmoghadam D, Gardiner BB, Gardiner BA, Kench JG, Scarpa A, Sutherland RL, Tempero MA, Waddell NJ, Wilson PJ, McPherson JD, Gallinger S, Tsao M, Shaw PA, Petersen GM, Mukhopadhyay D, Chin L, DePinho RA, Thayer S, Muthuswamy L, Shazand K, Beck T, Sam M, Timms L, Ballin V, Lu Y, Ji J, Zhang X, Chen F, Hu X, Zhou G, Yang Q, Tian G, Zhang L, Xing X, Li X, Zhu Z, Yu Y, Yu J, Yang H, Lathrop M, Tost J, Brennan P, Holcatova I, Zaridze D, Brazma A, Egevard L, Prokhortchouk E, Banks RE, Uhl&#xe9;n M, Cambon-Thomsen A, Viksna J, Ponten F, Skryabin K, Stratton MR, Futreal PA, Birney E, Borg A, B&#xf8;rresen-Dale A, Caldas C, Foekens JA, Martin S, Reis-Filho JS, Richardson AL, Sotiriou C, Stunnenberg HG, Thoms G, van de Vijver M, van't Veer L, Calvo F, Birnbaum D, Blanche H, Boucher P, Boyault S, Chabannon C, Gut I, Masson-Jacquemier JD, Lathrop M, Pauport&#xe9; I, Pivot X, Vincent-Salomon A, Tabone E, Theillet C, Thomas G, Tost J, Treilleux I, Calvo F, Bioulac-Sage P, Cl&#xe9;ment B, Decaens T, Degos F, Franco D, Gut I, Gut M, Heath S, Lathrop M, Samuel D, Thomas G, Zucman-Rossi J, Lichter P, Eils R, Brors B, Korbel JO, Korshunov A, Landgraf P, Lehrach H, Pfister S, Radlwimmer B, Reifenberger G, Taylor MD, von Kalle C, Majumder PP, Sarin R, Rao TS, Bhan MK, Scarpa A, Pederzoli P, Lawlor RA, Delledonne M, Bardelli A, Biankin AV, Grimmond SM, Gress T, Klimstra D, Zamboni G, Shibata T, Nakamura Y, Nakagawa H, Kusada J, Tsunoda T, Miyano S, Aburatani H, Kato K, Fujimoto A, Yoshida T, Campo E, L&#xf3;pez-Ot&#xed;n C, Estivill X, Guig&#xf3; R, de Sanjos&#xe9; S, Piris MA, Montserrat E, Gonz&#xe1;lez-D&#xed;az M, Puente XS, Jares P, Valencia A, Himmelbauer H, Himmelbaue H, Quesada V, Bea S, Stratton MR, Futreal PA, Campbell PJ, Vincent-Salomon A, Richardson AL, Reis-Filho JS, van de Vijver M, Thomas G, Masson-Jacquemier JD, Aparicio S, Borg A, B&#xf8;rresen-Dale A, Caldas C, Foekens JA, Stunnenberg HG, van't Veer L, Easton DF, Spellman PT, Martin S, Barker AD, Chin L, Collins FS, Compton CC, Ferguson ML, Gerhard DS, Getz G, Gunter C, Guttmacher A, Guyer M, Hayes DN, Lander ES, Ozenberger B, Penny R, Peterson J, Sander C, Shaw KM, Speed TP, Spellman PT, Vockley JG, Wheeler DA, Wilson RK, Hudson TJ, Chin L, Knoppers BM, Lander ES, Lichter P, Stein LD, Stratton MR, Anderson W, Barker AD, Bell C, Bobrow M, Burke W, Collins FS, Compton CC, DePinho RA, Easton DF, Futreal PA, Gerhard DS, Green AR, Guyer M, Hamilton SR, Hubbard TJ, Kallioniemi OP, Kennedy KL, Ley TJ, Liu ET, Lu Y, Majumder P, Marra M, Ozenberger B, Peterson J, Schafer AJ, Spellman PT, Stunnenberg HG, Wainwright BJ, Wilson RK, Yang H. International network of cancer genome projects. Nature. 2010 Apr 15;464(7291):993&#x2013;8. doi: 10.1038/nature08987. 
 
nature08987</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nature08987</ArticleId><ArticleId IdType="pmc">PMC2902243</ArticleId><ArticleId IdType="pubmed">20393554</ArticleId></ArticleIdList></Reference><Reference><Citation>Ewing AD, Houlahan KE, Hu Y, Ellrott K, Caloian C, Yamaguchi TN, Bare JC, P'ng C, Waggott D, Sabelnykova VY, ICGC-TCGA DREAM Somatic Mutation Calling Challenge participants. Kellen MR, Norman TC, Haussler D, Friend SH, Stolovitzky G, Margolin AA, Stuart JM, Boutros PC. Combining tumor genome simulation with crowdsourcing to benchmark somatic single-nucleotide-variant detection. Nat Methods. 2015 Jul;12(7):623&#x2013;30. doi: 10.1038/nmeth.3407. 
 
nmeth.3407</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nmeth.3407</ArticleId><ArticleId IdType="pmc">PMC4856034</ArticleId><ArticleId IdType="pubmed">25984700</ArticleId></ArticleIdList></Reference><Reference><Citation>Olaronke I, Gambo I, Soriyan A, Olaleke J. Interoperability in healthcare: benefits, challenges and resolutions. Int J Innov Appl Stud. 2013;38(1):64&#x2013;73.</Citation></Reference><Reference><Citation>Bicer V, Laleci GB, Dogac A, Kabak Y. Artemis message exchange framework: semantic interoperability of exchanged messages in the healthcare domain. SIGMOD Rec. 2005 Sep 01;34(3):71. doi: 10.1145/1084805.1084819.</Citation><ArticleIdList><ArticleId IdType="doi">10.1145/1084805.1084819</ArticleId></ArticleIdList></Reference><Reference><Citation>Campbell JD, Alexandrov A, Kim J, Wala J, Berger AH, Pedamallu CS, Shukla SA, Guo G, Brooks AN, Murray BA, Imielinski M, Hu X, Ling S, Akbani R, Rosenberg M, Cibulskis C, Ramachandran A, Collisson EA, Kwiatkowski DJ, Lawrence MS, Weinstein JN, Verhaak RGW, Wu CJ, Hammerman PS, Cherniack AD, Getz G, Cancer Genome Atlas Research Network. Artyomov MN, Schreiber R, Govindan R, Meyerson M. Distinct patterns of somatic genome alterations in lung adenocarcinomas and squamous cell carcinomas. Nat Genet. 2016 Dec;48(6):607&#x2013;16. doi: 10.1038/ng.3564.ng.3564</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ng.3564</ArticleId><ArticleId IdType="pmc">PMC4884143</ArticleId><ArticleId IdType="pubmed">27158780</ArticleId></ArticleIdList></Reference><Reference><Citation>Cerami E, Gao J, Dogrusoz U, Gross BE, Sumer SO, Aksoy BA, Jacobsen A, Byrne CJ, Heuer ML, Larsson E, Antipin Y, Reva B, Goldberg AP, Sander C, Schultz N. The cBio cancer genomics portal: an open platform for exploring multidimensional cancer genomics data. Cancer Discov. 2012 May;2(5):401&#x2013;4. doi: 10.1158/2159-8290.CD-12-0095. 
 
2/5/401</Citation><ArticleIdList><ArticleId IdType="doi">10.1158/2159-8290.CD-12-0095</ArticleId><ArticleId IdType="pmc">PMC3956037</ArticleId><ArticleId IdType="pubmed">22588877</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu L, Liu J, Shao D, Deng Q, Tang H, Liu Z, Chen X, Guo F, Lin Y, Mao M, Kristiansen K, Ye M, He J. Comprehensive genomic profiling of lung cancer using a validated panel to explore therapeutic targets in East Asian patients. Cancer Sci. 2017 Dec;108(12):2487&#x2013;2494. doi: 10.1111/cas.13410. doi: 10.1111/cas.13410.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/cas.13410</ArticleId><ArticleId IdType="doi">10.1111/cas.13410</ArticleId><ArticleId IdType="pmc">PMC5715245</ArticleId><ArticleId IdType="pubmed">28949084</ArticleId></ArticleIdList></Reference><Reference><Citation>National Comprehensive Cancer Network. 2019.  [2019-02-08].  NCCN Guidelines
 https://www.nccn.org/professionals/physician_gls/default.aspx
.</Citation></Reference><Reference><Citation>Shin SJ, You SC, Kim JH. GitHub. 2019.  [2019-02-08].  GeneProfiler
 https://github.com/ABMI/GeneProfiler
.</Citation></Reference><Reference><Citation>Skidmore ZL, Wagner AH, Lesurf R, Campbell KM, Kunisaki J, Griffith OL, Griffith M. GenVisR: Genomic visualizations in R. Bioinformatics. 2016 Dec 01;32(19):3012&#x2013;4. doi: 10.1093/bioinformatics/btw325. 
 
btw325</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/bioinformatics/btw325</ArticleId><ArticleId IdType="pmc">PMC5039916</ArticleId><ArticleId IdType="pubmed">27288499</ArticleId></ArticleIdList></Reference><Reference><Citation>Carr TH, McEwen R, Dougherty B, Johnson JH, Dry JR, Lai Z, Ghazoui Z, Laing NM, Hodgson DR, Cruzalegui F, Hollingsworth SJ, Barrett JC. Defining actionable mutations for oncology therapeutic development. Nat Rev Cancer. 2016 Dec 26;16(5):319&#x2013;29. doi: 10.1038/nrc.2016.35.nrc.2016.35</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrc.2016.35</ArticleId><ArticleId IdType="pubmed">27112209</ArticleId></ArticleIdList></Reference><Reference><Citation>Arrieta O, Cardona AF, Mart&#xed;n C, M&#xe1;s-L&#xf3;pez L, Corrales-Rodr&#xed;guez L, Bramuglia G, Castillo-Fernandez O, Meyerson M, Amieva-Rivera E, Campos-Parra AD, Carranza H, G&#xf3;mez de la Torre JC, Powazniak Y, Aldaco-Sarvide F, Vargas C, Trigo M, Magallanes-Maciel M, Otero J, S&#xe1;nchez-Reyes R, Cuello M. Updated frequency of EGFR and KRAS mutations in nonsmall-cell lung cancer in Latin America: The Latin-American consortium for the investigation of lung cancer (CLICaP) J Thorac Oncol. 2015 May;10(5):838&#x2013;43. doi: 10.1097/JTO.0000000000000481. 
 
S1556-0864(15)32398-4</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/JTO.0000000000000481</ArticleId><ArticleId IdType="pubmed">25634006</ArticleId></ArticleIdList></Reference><Reference><Citation>Tang C, Plasek JM, Bates DW. Rethinking data sharing at the dawn of a health data economy: A viewpoint. J Med Internet Res. 2018 Nov 22;20(11):e11519. doi: 10.2196/11519. 
 
v20i11e11519</Citation><ArticleIdList><ArticleId IdType="doi">10.2196/11519</ArticleId><ArticleId IdType="pmc">PMC6284141</ArticleId><ArticleId IdType="pubmed">30467103</ArticleId></ArticleIdList></Reference><Reference><Citation>Schadow G, Mead CN, Walker DM. The HL7 reference information model under scrutiny. Stud Health Technol Inform. 2006;124:151&#x2013;6.</Citation><ArticleIdList><ArticleId IdType="pubmed">17108519</ArticleId></ArticleIdList></Reference><Reference><Citation>Beeler GW. HL7 version 3--an object-oriented methodology for collaborative standards development. Int J Med Inform. 1998 Feb;48(1-3):151&#x2013;61.S1386-5056(97)00121-4</Citation><ArticleIdList><ArticleId IdType="pubmed">9600415</ArticleId></ArticleIdList></Reference><Reference><Citation>Shringarpure SS, Bustamante CD. Privacy risks from genomic data-sharing beacons. Am J Hum Genet. 2015 Nov 05;97(5):631&#x2013;46. doi: 10.1016/j.ajhg.2015.09.010. 
 
S0002-9297(15)00374-2</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ajhg.2015.09.010</ArticleId><ArticleId IdType="pmc">PMC4667107</ArticleId><ArticleId IdType="pubmed">26522470</ArticleId></ArticleIdList></Reference><Reference><Citation>Raisaro JL, Tram&#xe8;r F, Ji Z, Bu D, Zhao Y, Carey K, Lloyd D, Sofia H, Baker D, Flicek P, Shringarpure S, Bustamante C, Wang S, Jiang X, Ohno-Machado L, Tang H, Wang X, Hubaux J. Addressing Beacon re-identification attacks: quantification and mitigation of privacy risks. J Am Med Inform Assoc. 2017 Jul 01;24(4):799&#x2013;805. doi: 10.1093/jamia/ocw167. 
 
3038412</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/jamia/ocw167</ArticleId><ArticleId IdType="pmc">PMC5881894</ArticleId><ArticleId IdType="pubmed">28339683</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">30937326</PMID><DateRevised><Year>2020</Year><Month>09</Month><Day>30</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Print">2327-9214</ISSN><JournalIssue CitedMedium="Print"><Volume>7</Volume><Issue>1</Issue><PubDate><Year>2019</Year><Month>Mar</Month><Day>25</Day></PubDate></JournalIssue><Title>EGEMS (Washington, DC)</Title><ISOAbbreviation>EGEMS (Wash DC)</ISOAbbreviation></Journal><ArticleTitle>Learning to Share Health Care Data: A Brief Timeline of Influential Common Data Models and Distributed Health Data Networks in U.S. Health Care Research.</ArticleTitle><Pagination><StartPage>4</StartPage><MedlinePgn>4</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">4</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.5334/egems.279</ELocationID><Abstract><AbstractText>The last twenty years of health care research has seen a steady stream of common health care data models implemented for multi-organization research. Each model offers a uniform interface on data from the diverse organizations that implement them, enabling the sharing of research tools and data. While the groups designing the models have had various needs and aims, and the data available has changed significantly in this time, there are nevertheless striking similarities between them. This paper traces the evolution of common data models, describing their similarities and points of departure. We believe the history of this work should be understood and preserved. The work has empowered collaborative research across competing organizations and brought together researchers from clinical practice, universities and research institutes around the planet. Understanding the eco-system of data models designed for collaborative research allows readers to evaluate where we have been, where we are going as a field, and to evaluate the utility of different models to their own work.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Weeks</LastName><ForeName>John</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Kaiser Permanente Washington Health Research Institute, US.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pardee</LastName><ForeName>Roy</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Kaiser Permanente Washington Health Research Institute, US.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2019</Year><Month>03</Month><Day>25</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>EGEMS (Wash DC)</MedlineTA><NlmUniqueID>101629606</NlmUniqueID><ISSNLinking>2327-9214</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">CDM</Keyword><Keyword MajorTopicYN="N">HCSRN</Keyword><Keyword MajorTopicYN="N">HMORN</Keyword><Keyword MajorTopicYN="N">OHDSI</Keyword><Keyword MajorTopicYN="N">OMOP</Keyword><Keyword MajorTopicYN="N">PCORI</Keyword><Keyword MajorTopicYN="N">PCORnet</Keyword><Keyword MajorTopicYN="N">SHRINE</Keyword><Keyword MajorTopicYN="N">VDW</Keyword><Keyword MajorTopicYN="N">VSD</Keyword><Keyword MajorTopicYN="N">i2b2</Keyword></KeywordList><CoiStatement>RP has no competing financial interests, but is a long time implementer and user of the HCSRN VDW and has participated in its design process since at least 2009. He also supports KPWHRI&#x2019;s implementations of the PCORnet and Sentinel data models and has been an end user of the PCORnet model and infrastructure. JW has no competing financial interests, but as an employee of KP Washington Health Research Institute has supported their use of CESR, OMOP, VDW, PCORnet, VSD, and Sentinel common data models. JW previously was an employee of CHI Institute of Research and Innovation (CIRI) and implemented the HCSRN VDW and OHDSI OMOP data models for the purpose of engaging in collaborative research with other hospital research institutes.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2019</Year><Month>4</Month><Day>3</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2019</Year><Month>4</Month><Day>3</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2019</Year><Month>4</Month><Day>3</Day><Hour>6</Hour><Minute>1</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2019</Year><Month>3</Month><Day>25</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">30937326</ArticleId><ArticleId IdType="pmc">PMC6437693</ArticleId><ArticleId IdType="doi">10.5334/egems.279</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>PCORNet System. PCORnet Common Data Model. [06//2018]. Available from: https://pcornet.org/pcornet-common-data-model/.</Citation></Reference><Reference><Citation>Distributed Health Data Networks: A Practical and Preferred Approach to Multi-Institutional Evaluations of Comparative Effectiveness, Safety, and Quality of Care. Brown, JS, Holmes, JH, Shah, K, Hall, K, Lazarus, R and Platt, R (eds.), Medical Care; 2010. 
https://journals.lww.com/lww-medicalcare/Fulltext/2010/06001/Distributed_Health_Data_Networks__A_Practical_and.9.aspx.</Citation><ArticleIdList><ArticleId IdType="pubmed">20473204</ArticleId></ArticleIdList></Reference><Reference><Citation>DeStefano, F. The Vaccine Safety Datalink project. Pharmacoepidemiology and drug safety. Aug-Sep
2001; 10(5): 403&#x2013;6. https://www.ncbi.nlm.nih.gov/pubmed/11802585.</Citation><ArticleIdList><ArticleId IdType="pubmed">11802585</ArticleId></ArticleIdList></Reference><Reference><Citation>Federal Coordinating Council for Comparative Effectiveness Research. In: Federal Coordinating Council for Comparative Effectiveness Research. Report to the President and Congress, Services UDoHaH (ed.); 2009. 
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4371424/#b5-egems1049.</Citation></Reference><Reference><Citation>Vaccine Safety Datalink Project: A New Tool for Improving Vaccine Safety Monitoring in the United States. In: Chen, RT, Glasser, JW, Rhodes, PH, Davis, RL, Barlow, WE, Thompson, RS, Mullooly, JP, Black, SB, Shinefield, HR, Vadheim, CM, Michael Marcy, S, Ward, JI, Wise, RP, Wassilak, SG, Hadler, SC and the Vaccine Safety Datalink Team (eds.), Pediatrics. June
1997; 99(6): 765&#x2013;773. https://pediatrics.aappublications.org/content/pediatrics/99/6/765.full.pdf DOI: 10.1542/peds.99.6.765</Citation><ArticleIdList><ArticleId IdType="doi">10.1542/peds.99.6.765</ArticleId><ArticleId IdType="pubmed">9164767</ArticleId></ArticleIdList></Reference><Reference><Citation>Vogt, TM, Lafata, JE, Tolsma, DD and Greene, SM. The Role of Research in Integrated Health Care Systems: The HMO Research Network. The Permanente Journal. 2004; 8(4): 10&#x2013;17. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4690686/.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4690686</ArticleId><ArticleId IdType="pubmed">26705313</ArticleId></ArticleIdList></Reference><Reference><Citation>Cancer Research Network. CRN fact sheet. [June/16/2018]. Available from: https://crn.cancer.gov/about/CRN_fact_sheet.pdf.</Citation></Reference><Reference><Citation>Ross, TR, Ng, D, Brown, JS, Pardee, R, Hornbrook, MC, Hart, G and Steiner, JF. The HMO Research Network Virtual Data Warehouse: A Public Data Model to Support Collaboration. EGEMS. 2014; 2(1): 1049
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4371424/ DOI: 10.13063/2327-9214.1049</Citation><ArticleIdList><ArticleId IdType="doi">10.13063/2327-9214.1049</ArticleId><ArticleId IdType="pmc">PMC4371424</ArticleId><ArticleId IdType="pubmed">25848584</ArticleId></ArticleIdList></Reference><Reference><Citation>Health Care System Research Network. The VDW and How to Use It. [October/19/2018]. Available from: https://www.hcsrn.org/en/Tools%20&amp;%20Materials/VDW/VDWScientists/The+VDW+and+How+to+Use+It.pdf.</Citation></Reference><Reference><Citation>Murphy, S and Wilcox, A. Mission and Sustainability of Informatics for Integrating Biology and the Bedside (i2b2). eGEMs. 2014; 2(2): 1074 DOI: 10.13063/2327-9214.1074</Citation><ArticleIdList><ArticleId IdType="doi">10.13063/2327-9214.1074</ArticleId><ArticleId IdType="pmc">PMC4371505</ArticleId><ArticleId IdType="pubmed">25848608</ArticleId></ArticleIdList></Reference><Reference><Citation>National Center for Biomedical Computing. Informatics for Integrating Biology &amp; the Bedside: Overview. [June/26/2018]. Available from: https://www.i2b2.org/about/index.html.</Citation></Reference><Reference><Citation>Prakash, M, Nadkarni, LM, Roland Chen, ES and Gordon Shepherd, PM. Organization of Heterogeneous Scientific Data Using the EAV/CR Representation. Journal of the American Medical Informatics Association. 1 November 1999; 6(6): 478&#x2013;493. DOI: 10.1136/jamia.1999.0060478</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/jamia.1999.0060478</ArticleId><ArticleId IdType="pmc">PMC61391</ArticleId><ArticleId IdType="pubmed">10579606</ArticleId></ArticleIdList></Reference><Reference><Citation>Weber, GM, Murphy, SN, McMurry, AJ, MacFadden, D, Nigrin, DJ, Churchill, S and Kohane, IS. The Shared Health Research Information Network (SHRINE): A Prototype Federated Query Tool for Clinical Data Repositories. Journal of the American Medical Informatics Association: JAMIA. 2009; 16(5): 624&#x2013;630. DOI: 10.1197/jamia.M3191</Citation><ArticleIdList><ArticleId IdType="doi">10.1197/jamia.M3191</ArticleId><ArticleId IdType="pmc">PMC2744712</ArticleId><ArticleId IdType="pubmed">19567788</ArticleId></ArticleIdList></Reference><Reference><Citation>Hripcsak, G, Duke, JD, Shah, NH, Reich, CG, Huser, V, Schuemie, MJ, Ryan, PB, et al. Observational Health Data Sciences and Informatics (OHDSI): Opportunities for Observational Researchers. Studies in Health Technology and Informatics. 2015; 216: 574&#x2013;578. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4815923/.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4815923</ArticleId><ArticleId IdType="pubmed">26262116</ArticleId></ArticleIdList></Reference><Reference><Citation>Foundation for the National Institutes of Health (FNIH). Observational Medical Outcomes Partnership (OMOP). [October/12/2018]. Available from: https://fnih.org/what-we-do/major-completed-programs/omop.</Citation></Reference><Reference><Citation>Observational Health Data Sciences and Informatics. OMOP Common Data Model. [June/16/2018]. Available from: https://www.ohdsi.org/data-standardization/the-common-data-model/.</Citation></Reference><Reference><Citation>Sentinel. Distributed Database Common Data Model. [June/16/2018]. Available from: https://www.sentinelinitiative.org/sentinel/data/distributed-database-common-data-model.</Citation></Reference><Reference><Citation>Ball, R, Robb, M, Anderson, S and Dal Pan, G. The FDA&#x2019;s sentinel initiative&#x2014;A comprehensive approach to medical product surveillance. Clin. Pharmacol. Ther. 2016; 99: 265&#x2013;268. DOI: 10.1002/cpt.320</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/cpt.320</ArticleId><ArticleId IdType="pubmed">26667601</ArticleId></ArticleIdList></Reference><Reference><Citation>Center for Effectiveness &amp; Safety Research. About Us. [June/16/2018]. Available from: https://cesr.kp.org/about.</Citation></Reference><Reference><Citation>Center for Effectiveness &amp; Safety Research. Externally-Funded Studies Led by the Center for Effectiveness &amp; Safety Research. [June/16/2018]. Available from: https://cesr.kp.org/research/studies.</Citation></Reference><Reference><Citation>PCORNet System. PCORnet Common Data Model. [June/16/2018]. Available from: https://pcornet.org/pcornet-common-data-model/.</Citation></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">30942734</PMID><DateCompleted><Year>2019</Year><Month>08</Month><Day>30</Day></DateCompleted><DateRevised><Year>2019</Year><Month>08</Month><Day>30</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1879-8365</ISSN><JournalIssue CitedMedium="Internet"><Volume>258</Volume><PubDate><Year>2019</Year></PubDate></JournalIssue><Title>Studies in health technology and informatics</Title><ISOAbbreviation>Stud Health Technol Inform</ISOAbbreviation></Journal><ArticleTitle>Standardizing Austrians Claims Data Using the OMOP Common Data Model: A Feasibility Study.</ArticleTitle><Pagination><StartPage>151</StartPage><EndPage>152</EndPage><MedlinePgn>151-152</MedlinePgn></Pagination><Abstract><AbstractText>The suitability of the Observational Medical Outcomes Partnership (OMOP) common data model (CDM) for Austrian pseudonymized claims data from social security institutions and information about hospital stays is evaluated. 1,023 (99.7%) of ATC codes and 3,695 (98.6%) of ICD10 codes coincide with the OMOP vocabulary. Mappings for the local vocabularies like the Austrian pharmaceutical registration numbers, the Socio-Economic Index and professional groups, to the OMOP vocabulary do not exist. A standardization with the OMOP CDM is possible, however an initial, not negligible effort is required to adapt and incorporate the vocabulary.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Haberson</LastName><ForeName>Andrea</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Center for Medical Statistics, Informatics and Intelligent Systems, Medical University of Vienna.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rinner</LastName><ForeName>Christoph</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Center for Medical Statistics, Informatics and Intelligent Systems, Medical University of Vienna.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gall</LastName><ForeName>Walter</ForeName><Initials>W</Initials><AffiliationInfo><Affiliation>Center for Medical Statistics, Informatics and Intelligent Systems, Medical University of Vienna.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>Netherlands</Country><MedlineTA>Stud Health Technol Inform</MedlineTA><NlmUniqueID>9214582</NlmUniqueID><ISSNLinking>0926-9630</ISSNLinking></MedlineJournalInfo><MeshHeadingList><MeshHeading><DescriptorName UI="D001317" MajorTopicYN="N" Type="Geographic">Austria</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000078332" MajorTopicYN="Y">Data Analysis</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016208" MajorTopicYN="N">Databases, Factual</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005240" MajorTopicYN="N">Feasibility Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007345" MajorTopicYN="Y">Insurance Claim Review</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015233" MajorTopicYN="Y">Models, Statistical</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">OMOP</Keyword><Keyword MajorTopicYN="N">claims data</Keyword><Keyword MajorTopicYN="N">common data model</Keyword><Keyword MajorTopicYN="N">drug safety</Keyword><Keyword MajorTopicYN="N">secondary use</Keyword><Keyword MajorTopicYN="N">standardized health data</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2019</Year><Month>4</Month><Day>4</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2019</Year><Month>4</Month><Day>4</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2019</Year><Month>8</Month><Day>31</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">30942734</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">30943974</PMID><DateCompleted><Year>2020</Year><Month>05</Month><Day>14</Day></DateCompleted><DateRevised><Year>2024</Year><Month>09</Month><Day>22</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1472-6947</ISSN><JournalIssue CitedMedium="Internet"><Volume>19</Volume><Issue>Suppl 3</Issue><PubDate><Year>2019</Year><Month>Apr</Month><Day>04</Day></PubDate></JournalIssue><Title>BMC medical informatics and decision making</Title><ISOAbbreviation>BMC Med Inform Decis Mak</ISOAbbreviation></Journal><ArticleTitle>Developing a portable natural language processing based phenotyping system.</ArticleTitle><Pagination><StartPage>78</StartPage><MedlinePgn>78</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">78</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1186/s12911-019-0786-z</ELocationID><Abstract><AbstractText Label="BACKGROUND">This paper presents a portable phenotyping system that is capable of integrating both rule-based and statistical machine learning based approaches.</AbstractText><AbstractText Label="METHODS">Our system utilizes UMLS to extract clinically relevant features from the unstructured text and then facilitates portability across different institutions and data systems by incorporating OHDSI's OMOP Common Data Model (CDM) to standardize necessary data elements. Our system can also store the key components of rule-based systems (e.g., regular expression matches) in the format of OMOP CDM, thus enabling the reuse, adaptation and extension of many existing rule-based clinical NLP systems. We experimented with our system on the corpus from i2b2's Obesity Challenge as a pilot study.</AbstractText><AbstractText Label="RESULTS">Our system facilitates portable phenotyping of obesity and its 15 comorbidities based on the unstructured patient discharge summaries, while achieving a performance that often ranked among the top 10 of the challenge participants.</AbstractText><AbstractText Label="CONCLUSION">Our system of standardization enables a consistent application of numerous rule-based and machine learning based classification techniques downstream across disparate datasets which may originate across different institutions and data systems.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Sharma</LastName><ForeName>Himanshu</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Cyberinfrastructure, University of Illinois at Chicago, Chicago, IL, 60612, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mao</LastName><ForeName>Chengsheng</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Department of Preventive Medicine, Feinberg School of Medicine, Northwestern University, Chicago, IL, 60611, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhang</LastName><ForeName>Yizhen</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Department of Preventive Medicine, Feinberg School of Medicine, Northwestern University, Chicago, IL, 60611, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Vatani</LastName><ForeName>Haleh</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Cyberinfrastructure, University of Illinois at Chicago, Chicago, IL, 60612, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yao</LastName><ForeName>Liang</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Department of Preventive Medicine, Feinberg School of Medicine, Northwestern University, Chicago, IL, 60611, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhong</LastName><ForeName>Yizhen</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Department of Preventive Medicine, Feinberg School of Medicine, Northwestern University, Chicago, IL, 60611, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rasmussen</LastName><ForeName>Luke</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Department of Preventive Medicine, Feinberg School of Medicine, Northwestern University, Chicago, IL, 60611, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jiang</LastName><ForeName>Guoqian</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Biomedical Informatics, Mayo Clinic, Rochester, MN, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pathak</LastName><ForeName>Jyotishman</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Health Informatics, Weill Cornell Medicine, New York, NY, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Luo</LastName><ForeName>Yuan</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Department of Preventive Medicine, Feinberg School of Medicine, Northwestern University, Chicago, IL, 60611, USA. yuan.luo@northwestern.edu.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>R01 GM105688</GrantID><Acronym>GM</Acronym><Agency>NIGMS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R21 LM012618</GrantID><Acronym>LM</Acronym><Agency>NLM NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>U54 LM008748</GrantID><Acronym>LM</Acronym><Agency>NLM NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D052061">Research Support, N.I.H., Extramural</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2019</Year><Month>04</Month><Day>04</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>BMC Med Inform Decis Mak</MedlineTA><NlmUniqueID>101088682</NlmUniqueID><ISSNLinking>1472-6947</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D057286" MajorTopicYN="N">Electronic Health Records</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016247" MajorTopicYN="Y">Information Storage and Retrieval</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000069550" MajorTopicYN="Y">Machine Learning</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009323" MajorTopicYN="Y">Natural Language Processing</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009765" MajorTopicYN="N">Obesity</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D010865" MajorTopicYN="N">Pilot Projects</DescriptorName></MeshHeading></MeshHeadingList><CoiStatement>ETHICS APPROVAL AND CONSENT TO PARTICIPATE: Not Applicable. This work used i2b2 Obesity Shared-Task Challenge Data, which is a de-identified and retrospective dataset shared with researchers. CONSENT FOR PUBLICATION: Not applicable. COMPETING INTERESTS: The authors declare that they have no competing interests. PUBLISHER&#x2019;S NOTE: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2019</Year><Month>4</Month><Day>5</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2019</Year><Month>4</Month><Day>5</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2020</Year><Month>5</Month><Day>15</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2019</Year><Month>4</Month><Day>4</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">30943974</ArticleId><ArticleId IdType="pmc">PMC6448187</ArticleId><ArticleId IdType="doi">10.1186/s12911-019-0786-z</ArticleId><ArticleId IdType="pii">10.1186/s12911-019-0786-z</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Harpaz R, Callahan A, Tamang S, Low Y, Odgers D, Finlayson S, Jung K, LePendu P, Shah NH. Text mining for adverse drug events: the promise, challenges, and state of the art. Drug Saf. 2014;37(10):777&#x2013;790. doi: 10.1007/s40264-014-0218-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s40264-014-0218-z</ArticleId><ArticleId IdType="pmc">PMC4217510</ArticleId><ArticleId IdType="pubmed">25151493</ArticleId></ArticleIdList></Reference><Reference><Citation>Sarmiento RF, Dernoncourt F. Improving patient cohort identification using natural language processing. In: Secondary analysis of electronic health records: Springer; 2016. p. 405&#x2013;17.</Citation><ArticleIdList><ArticleId IdType="pubmed">31314253</ArticleId></ArticleIdList></Reference><Reference><Citation>Luo Y, Thompson W, Herr T, Zeng Z, Berendsen M, Jonnalagadda S, Carson M, Starren J. Natural language processing for EHR-based pharmacovigilance: a structured review. Drug Saf. 2017. 10.1007/s40264-017-0558-6.</Citation><ArticleIdList><ArticleId IdType="pubmed">28643174</ArticleId></ArticleIdList></Reference><Reference><Citation>Shivade C, Raghavan P, Fosler-Lussier E, Embi PJ, Elhadad N, Johnson SB, Lai AM. A review of approaches to identifying patient phenotype cohorts using electronic health records. J Am Med Inform Assn. 2014;21(2):221&#x2013;230. doi: 10.1136/amiajnl-2013-001935.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/amiajnl-2013-001935</ArticleId><ArticleId IdType="pmc">PMC3932460</ArticleId><ArticleId IdType="pubmed">24201027</ArticleId></ArticleIdList></Reference><Reference><Citation>Shickel B, Tighe PJ, Bihorac A, Rashidi P. Deep EHR: a survey of recent advances in deep learning techniques for electronic health record (EHR) analysis. Ieee J Biomed Health. 2018;22(5):1589&#x2013;1604. doi: 10.1109/JBHI.2017.2767063.</Citation><ArticleIdList><ArticleId IdType="doi">10.1109/JBHI.2017.2767063</ArticleId><ArticleId IdType="pmc">PMC6043423</ArticleId><ArticleId IdType="pubmed">29989977</ArticleId></ArticleIdList></Reference><Reference><Citation>Zeng Z, Deng Y, Li X, Naumann T, Luo Y. Natural language processing for EHR-based computational phenotyping. IEEE/ACM Trans Comput Biol Bioinform. 2018; [Epub ahead of print].</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6388621</ArticleId><ArticleId IdType="pubmed">29994486</ArticleId></ArticleIdList></Reference><Reference><Citation>Boland MR, Hripcsak G, Shen YF, Chung WK, Weng CH. Defining a comprehensive verotype using electronic health records for personalized medicine. J Am Med Inform Assn. 2013;20(E2):E232&#x2013;E238. doi: 10.1136/amiajnl-2013-001932.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/amiajnl-2013-001932</ArticleId><ArticleId IdType="pmc">PMC3861934</ArticleId><ArticleId IdType="pubmed">24001516</ArticleId></ArticleIdList></Reference><Reference><Citation>Hersh W, Price S, Donohoe L. Assessing thesaurus-based query expansion using the UMLS metathesaurus. J Am Med Inform Assn. 2000:344&#x2013;8.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2244120</ArticleId><ArticleId IdType="pubmed">11079902</ArticleId></ArticleIdList></Reference><Reference><Citation>Passos A, Wainer J. International workshop on web and text intelligence (WTI-2009): 2009. 2009. Wordnet-based metrics do not seem to help document clustering.</Citation></Reference><Reference><Citation>Ferrajolo C, Coloma PM, Verhamme KM, Schuemie MJ, de Bie S, Gini R, Herings R, Mazzaglia G, Picelli G, Giaquinto C, et al. Signal detection of potentially drug-induced acute liver injury in children using a multi-country healthcare database network. Drug Saf. 2014;37(2):99&#x2013;108. doi: 10.1007/s40264-013-0132-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s40264-013-0132-9</ArticleId><ArticleId IdType="pubmed">24446276</ArticleId></ArticleIdList></Reference><Reference><Citation>Luo Y, Szolovits P. Efficient queries of stand-off annotations for natural language processing on electronic medical records. Biomedical Informatics Insights. 2016;8:29&#x2013;38.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4954589</ArticleId><ArticleId IdType="pubmed">27478379</ArticleId></ArticleIdList></Reference><Reference><Citation>Solt I, Tikk D, Gal V, Kardkovacs ZT. Semantic classification of diseases in discharge summaries using a context-aware rule-based classifier. J Am Med Inform Assn. 2009;16(4):580&#x2013;584. doi: 10.1197/jamia.M3087.</Citation><ArticleIdList><ArticleId IdType="doi">10.1197/jamia.M3087</ArticleId><ArticleId IdType="pmc">PMC2705263</ArticleId><ArticleId IdType="pubmed">19390101</ArticleId></ArticleIdList></Reference><Reference><Citation>Yu HF, Huang FL, Lin CJ. Dual coordinate descent methods for logistic regression and maximum entropy models. Mach Learn. 2011;85(1&#x2013;2):41&#x2013;75. doi: 10.1007/s10994-010-5221-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10994-010-5221-8</ArticleId></ArticleIdList></Reference><Reference><Citation>Fan RE, Chang KW, Hsieh CJ, Wang XR, Lin CJ. LIBLINEAR: a library for large linear classification. J Mach Learn Res. 2008;9:1871&#x2013;1874.</Citation></Reference><Reference><Citation>Breiman L. Classification and regression trees: Routledge; 2017.</Citation></Reference><Reference><Citation>Friedman J, Hastie T, Tibshirani R. The elements of statistical learning, vol. 1. New York, NY: Springer series in statistics; 2001.</Citation></Reference><Reference><Citation>Breiman L. Random forests. Mach Learn. 2001;45(1):5&#x2013;32. doi: 10.1023/A:1010933404324.</Citation><ArticleIdList><ArticleId IdType="doi">10.1023/A:1010933404324</ArticleId></ArticleIdList></Reference><Reference><Citation>Chicco D. Ten quick tips for machine learning in computational biology. BioData mining. 2017;10(1):35. doi: 10.1186/s13040-017-0155-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13040-017-0155-3</ArticleId><ArticleId IdType="pmc">PMC5721660</ArticleId><ArticleId IdType="pubmed">29234465</ArticleId></ArticleIdList></Reference><Reference><Citation>Hsu C-W, Chang C-C, Lin C-J: A practical guide to support vector classification.</Citation></Reference><Reference><Citation>Uzuner O. Recognizing obesity and comorbidities in sparse data. J Am Med Inform Assn. 2009;16(4):561&#x2013;570. doi: 10.1197/jamia.M3115.</Citation><ArticleIdList><ArticleId IdType="doi">10.1197/jamia.M3115</ArticleId><ArticleId IdType="pmc">PMC2705260</ArticleId><ArticleId IdType="pubmed">19390096</ArticleId></ArticleIdList></Reference><Reference><Citation>Weng WH, Wagholikar KB, McCray AT, Szolovits P, Chueh HC. Medical subdomain classification of clinical notes using a machine learning-based natural language processing approach. Bmc Med Inform Decis. 2017;17.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5709846</ArticleId><ArticleId IdType="pubmed">29191207</ArticleId></ArticleIdList></Reference><Reference><Citation>Luo Y, Szolovits P: Implementing a portable clinical NLP system with a common data model &#x2013; a LISP perspective. In: Bioinformatics and Biomedicine (BIBM), 2016 IEEE International Conference on: 2018: IEEE; 2018: 461&#x2013;466.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7769694</ArticleId><ArticleId IdType="pubmed">33376623</ArticleId></ArticleIdList></Reference><Reference><Citation>Gottesman O, Kuivaniemi H, Tromp G, Faucett WA, Li RL, Manolio TA, Sanderson SC, Kannry J, Zinberg R, Basford MA, et al. The electronic medical records and genomics (eMERGE) network: past, present, and future. Genet Med. 2013;15(10):761&#x2013;771. doi: 10.1038/gim.2013.72.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/gim.2013.72</ArticleId><ArticleId IdType="pmc">PMC3795928</ArticleId><ArticleId IdType="pubmed">23743551</ArticleId></ArticleIdList></Reference><Reference><Citation>Rasmussen LV, Kiefer RC, Mo H, Speltz P, Thompson WK, Jiang G, Pacheco JA, Xu J, Zhu Q, Denny JC. A modular architecture for electronic health record-driven phenotyping. AMIA Summits on Translational Science Proceedings. 2015;2015:147.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4525215</ArticleId><ArticleId IdType="pubmed">26306258</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">31054141</PMID><DateCompleted><Year>2020</Year><Month>06</Month><Day>09</Day></DateCompleted><DateRevised><Year>2021</Year><Month>01</Month><Day>09</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1179-1942</ISSN><JournalIssue CitedMedium="Internet"><Volume>42</Volume><Issue>11</Issue><PubDate><Year>2019</Year><Month>Nov</Month></PubDate></JournalIssue><Title>Drug safety</Title><ISOAbbreviation>Drug Saf</ISOAbbreviation></Journal><ArticleTitle>Identifying the DEAD: Development and Validation of a Patient-Level Model to Predict Death Status in Population-Level Claims Data.</ArticleTitle><Pagination><StartPage>1377</StartPage><EndPage>1386</EndPage><MedlinePgn>1377-1386</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1007/s40264-019-00827-0</ELocationID><Abstract><AbstractText Label="INTRODUCTION">US claims data contain medical data on large heterogeneous populations and are excellent sources for medical research. Some claims data do not contain complete death records, limiting their use for mortality or mortality-related studies. A model to predict whether a patient died at the end of the follow-up time (referred to as the end of observation) is needed to enable mortality-related studies.</AbstractText><AbstractText Label="OBJECTIVE">The objective of this study was to develop a patient-level model to predict whether the end of observation was due to death in US claims data.</AbstractText><AbstractText Label="METHODS">We used a claims dataset with full death records, Optum<sup>&#xa9;</sup> De-Identified Clinformatics<sup>&#xae;</sup> Data-Mart-Database-Date of Death mapped to the Observational Medical Outcome Partnership common data model, to develop a model that classifies the end of observations into death or non-death. A regularized logistic regression was trained using 88,514 predictors (recorded within the prior 365 or 30&#xa0;days) and externally validated by applying the model to three US claims datasets.</AbstractText><AbstractText Label="RESULTS">Approximately 25 in 1000 end of observations in Optum are due to death. The Discriminating End of observation into Alive and Dead (DEAD) model obtained an area under the receiver operating characteristic curve of 0.986. When defining death as a predicted risk of&#x2009;&gt;&#x2009;0.5, only 2% of the end of observations were predicted to be due to death and the model obtained a sensitivity of 62% and a positive predictive value of 74.8%. The external validation showed the model was transportable, with area under the receiver operating characteristic curves ranging between 0.951 and 0.995 across the US claims databases.</AbstractText><AbstractText Label="CONCLUSIONS">US claims data often lack complete death records. The DEAD model can be used to impute death at various sensitivity, specificity, or positive predictive values depending on the use of the model. The DEAD model can be readily applied to any observational healthcare database mapped to the Observational Medical Outcome Partnership common data model and is available from https://github.com/OHDSI/StudyProtocolSandbox/tree/master/DeadModel .</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Reps</LastName><ForeName>Jenna M</ForeName><Initials>JM</Initials><Identifier Source="ORCID">0000-0002-2970-0778</Identifier><AffiliationInfo><Affiliation>Janssen Research and Development, 1125 Trenton Harbourton Rd, Titusville, NJ, 08560, USA. jreps@its.jnj.com.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rijnbeek</LastName><ForeName>Peter R</ForeName><Initials>PR</Initials><AffiliationInfo><Affiliation>Erasmus MC, Rotterdam, The Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ryan</LastName><ForeName>Patrick B</ForeName><Initials>PB</Initials><AffiliationInfo><Affiliation>Janssen Research and Development, 1125 Trenton Harbourton Rd, Titusville, NJ, 08560, USA.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>New Zealand</Country><MedlineTA>Drug Saf</MedlineTA><NlmUniqueID>9002928</NlmUniqueID><ISSNLinking>0114-5916</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D035843" MajorTopicYN="N">Biomedical Research</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="Y">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D003627" MajorTopicYN="N">Data Interpretation, Statistical</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016208" MajorTopicYN="N">Databases, Factual</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008954" MajorTopicYN="Y">Models, Biological</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009026" MajorTopicYN="Y">Mortality</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012307" MajorTopicYN="N">Risk Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014481" MajorTopicYN="N" Type="Geographic">United States</DescriptorName></MeshHeading></MeshHeadingList><CoiStatement>Jenna Reps is an employee of Janssen Research &amp; Development and a shareholder of Johnson &amp; Johnson. Patrick Ryan is an employee of Janssen Research &amp; Development and a shareholder of Johnson &amp; Johnson. Peter Rijnbeek works for a research group who received unconditional research grants from Boehringer-Ingelheim, GSK, Janssen Research &amp; Development, Novartis, Pfizer, Yamanouchi, and Servier. None of these grants result in a conflict of interest with the content of this paper.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>2019</Year><Month>5</Month><Day>6</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2020</Year><Month>6</Month><Day>10</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2019</Year><Month>5</Month><Day>5</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2019</Year><Month>5</Month><Day>3</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">31054141</ArticleId><ArticleId IdType="pmc">PMC6834730</ArticleId><ArticleId IdType="doi">10.1007/s40264-019-00827-0</ArticleId><ArticleId IdType="pii">10.1007/s40264-019-00827-0</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Mariani AW, Pego-Fernandes PM. Observational studies: why are they so important? Sao Paulo Med J. 2014;132(1):1&#x2013;2. doi: 10.1590/1516-3180.2014.1321784.</Citation><ArticleIdList><ArticleId IdType="doi">10.1590/1516-3180.2014.1321784</ArticleId><ArticleId IdType="pmc">PMC10889453</ArticleId><ArticleId IdType="pubmed">24474072</ArticleId></ArticleIdList></Reference><Reference><Citation>Black N. Why we need observational studies to evaluate the effectiveness of health care. BMJ. 1996;312(7040):1215&#x2013;1218. doi: 10.1136/bmj.312.7040.1215.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.312.7040.1215</ArticleId><ArticleId IdType="pmc">PMC2350940</ArticleId><ArticleId IdType="pubmed">8634569</ArticleId></ArticleIdList></Reference><Reference><Citation>Concato J, Shah N, Horwitz RI. Randomized, controlled trials, observational studies, and the hierarchy of research designs. N Engl J Med. 2000;342(25):1887&#x2013;1892. doi: 10.1056/NEJM200006223422507.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJM200006223422507</ArticleId><ArticleId IdType="pmc">PMC1557642</ArticleId><ArticleId IdType="pubmed">10861325</ArticleId></ArticleIdList></Reference><Reference><Citation>Charlson ME, Pompei P, Ales KA, MacKenzie CR. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis. 1987;40:373&#x2013;383. doi: 10.1016/0021-9681(87)90171-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/0021-9681(87)90171-8</ArticleId><ArticleId IdType="pubmed">3558716</ArticleId></ArticleIdList></Reference><Reference><Citation>Elixhauser A, Steiner C, Harris R, Coffey R. Comorbidity measures for use with administrative data. Med Care. 1998;36:8&#x2013;27. doi: 10.1097/00005650-199801000-00004.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/00005650-199801000-00004</ArticleId><ArticleId IdType="pubmed">9431328</ArticleId></ArticleIdList></Reference><Reference><Citation>Sharabiani M, Aylin P, Bottle A. Systematic review of comorbidity indices for administrative data. Med Care. 2012;50:1109&#x2013;1118. doi: 10.1097/MLR.0b013e31825f64d0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/MLR.0b013e31825f64d0</ArticleId><ArticleId IdType="pubmed">22929993</ArticleId></ArticleIdList></Reference><Reference><Citation>Gutacker N, Bloor K, Cookson R. Comparing the performance of the Charlson/Deyo and Elixhauser comorbidity measures across five European countries and three conditions. Eur J Public Health. 2015;25:15&#x2013;20. doi: 10.1093/eurpub/cku221.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/eurpub/cku221</ArticleId><ArticleId IdType="pubmed">25690125</ArticleId></ArticleIdList></Reference><Reference><Citation>Reps JM, Schuemie MJ, Suchard MA, Ryan PB, Rijnbeek PR. Design and implementation of a standardized framework to generate and evaluate patient-level prediction models using observational healthcare data. J Am Med Inf Assoc. 2018;25(8):969&#x2013;975. doi: 10.1093/jamia/ocy032.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/jamia/ocy032</ArticleId><ArticleId IdType="pmc">PMC6077830</ArticleId><ArticleId IdType="pubmed">29718407</ArticleId></ArticleIdList></Reference><Reference><Citation>Overhage JM, Ryan PB, Reich CG, et al. Validation of a common data model for active safety surveillance research. J Am Med Inform Assoc. 2012;19(1):54&#x2013;60. doi: 10.1136/amiajnl-2011-000376.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/amiajnl-2011-000376</ArticleId><ArticleId IdType="pmc">PMC3240764</ArticleId><ArticleId IdType="pubmed">22037893</ArticleId></ArticleIdList></Reference><Reference><Citation>Suchard MA, Simpson SE, Zorych I, Ryan P, Madigan D. Massive parallelization of serial inference algorithms for a complex generalized linear model. ACM Trans Model Comput Simul. 2013 doi: 10.1145/2414416.2414791.</Citation><ArticleIdList><ArticleId IdType="doi">10.1145/2414416.2414791</ArticleId><ArticleId IdType="pmc">PMC4201181</ArticleId><ArticleId IdType="pubmed">25328363</ArticleId></ArticleIdList></Reference><Reference><Citation>Rubbo B, Fitzpatrick NK, Denaxas S, Daskalopoulou M, Yu N, Patel RS, et al. Use of electronic health records to ascertain, validate and phenotype acute myocardial infarction: a systematic review and recommendations. Int J Cardiol. 2015;187:705&#x2013;711. doi: 10.1016/j.ijcard.2015.03.075.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ijcard.2015.03.075</ArticleId><ArticleId IdType="pubmed">25966015</ArticleId></ArticleIdList></Reference><Reference><Citation>Kumamaru H, Judd SE, Curtis JR, Ramachandran R, Hardy NC, Rhodes JD, et al. Validity of claims-based stroke algorithms in contemporary Medicare data: reasons for geographic and racial differences in stroke (REGARDS) study linked with Medicare claims. Circ Cardiovasc Qual Outcomes. 2014;7:611&#x2013;619. doi: 10.1161/CIRCOUTCOMES.113.000743.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/CIRCOUTCOMES.113.000743</ArticleId><ArticleId IdType="pmc">PMC4109622</ArticleId><ArticleId IdType="pubmed">24963021</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">31065558</PMID><DateRevised><Year>2022</Year><Month>04</Month><Day>08</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Print">2327-9214</ISSN><JournalIssue CitedMedium="Print"><Volume>7</Volume><Issue>1</Issue><PubDate><Year>2019</Year><Month>Apr</Month><Day>23</Day></PubDate></JournalIssue><Title>EGEMS (Washington, DC)</Title><ISOAbbreviation>EGEMS (Wash DC)</ISOAbbreviation></Journal><ArticleTitle>A Data Element-Function Conceptual Model for Data Quality Checks.</ArticleTitle><Pagination><StartPage>17</StartPage><MedlinePgn>17</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">17</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.5334/egems.289</ELocationID><Abstract><AbstractText Label="INTRODUCTION" NlmCategory="BACKGROUND">In aggregate, existing data quality (DQ) checks are currently represented in heterogeneous formats, making it difficult to compare, categorize, and index checks. This study contributes a data element-function conceptual model to facilitate the categorization and indexing of DQ checks and explores the feasibility of leveraging natural language processing (NLP) for scalable acquisition of knowledge of common data elements and functions from DQ checks narratives.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">The model defines a "data element", the primary focus of the check, and a "function", the qualitative or quantitative measure over a data element. We applied NLP techniques to extract both from 172 checks for Observational Health Data Sciences and Informatics (OHDSI) and 3,434 checks for Kaiser Permanente's Center for Effectiveness and Safety Research (CESR).</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">The model was able to classify all checks. A total of 751 unique data elements and 24 unique functions were extracted. The top five frequent data element-function pairings for OHDSI were Person-Count (55 checks), Insurance-Distribution (17), Medication-Count (16), Condition-Count (14), and Observations-Count (13); for CESR, they were Medication-Variable Type (175), Medication-Missing (172), Medication-Existence (152), Medication-Count (127), and Socioeconomic Factors-Variable Type (114).</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">This study shows the efficacy of the data element-function conceptual model for classifying DQ checks, demonstrates early promise of NLP-assisted knowledge acquisition, and reveals the great heterogeneity in the focus in DQ checks, confirming variation in intrinsic checks and use-case specific "fitness-for-use" checks.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Rogers</LastName><ForeName>James R</ForeName><Initials>JR</Initials><Identifier Source="ORCID">0000-0001-7329-3535</Identifier><AffiliationInfo><Affiliation>Department of Biomedical Informatics, Columbia University, US.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Callahan</LastName><ForeName>Tiffany J</ForeName><Initials>TJ</Initials><AffiliationInfo><Affiliation>University of Colorado Denver Anschutz Medical Campus, US.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kang</LastName><ForeName>Tian</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Department of Biomedical Informatics, Columbia University, US.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bauck</LastName><ForeName>Alan</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Kaiser Permanente Northwest Center for Health Research, US.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Khare</LastName><ForeName>Ritu</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Children's Hospital of Philadelphia, US.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Brown</LastName><ForeName>Jeffrey S</ForeName><Initials>JS</Initials><AffiliationInfo><Affiliation>Department of Population Medicine, Harvard Medical School and Harvard Pilgrim Health Care Institute, US.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kahn</LastName><ForeName>Michael G</ForeName><Initials>MG</Initials><AffiliationInfo><Affiliation>University of Colorado Denver Anschutz Medical Campus, US.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Weng</LastName><ForeName>Chunhua</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Department of Biomedical Informatics, Columbia University, US.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>R01 LM009886</GrantID><Acronym>LM</Acronym><Agency>NLM NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>T15 LM007079</GrantID><Acronym>LM</Acronym><Agency>NLM NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>T15 LM009451</GrantID><Acronym>LM</Acronym><Agency>NLM NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2019</Year><Month>04</Month><Day>23</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>EGEMS (Wash DC)</MedlineTA><NlmUniqueID>101629606</NlmUniqueID><ISSNLinking>2327-9214</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">clinical data research networks</Keyword><Keyword MajorTopicYN="N">data quality</Keyword><Keyword MajorTopicYN="N">electronic healthcare records</Keyword><Keyword MajorTopicYN="N">knowledge acquisition</Keyword><Keyword MajorTopicYN="N">natural language processing</Keyword></KeywordList><CoiStatement>The authors have no competing interests to declare.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2019</Year><Month>5</Month><Day>9</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2019</Year><Month>5</Month><Day>9</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2019</Year><Month>5</Month><Day>9</Day><Hour>6</Hour><Minute>1</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2019</Year><Month>4</Month><Day>23</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">31065558</ArticleId><ArticleId IdType="pmc">PMC6484368</ArticleId><ArticleId IdType="doi">10.5334/egems.289</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Raghupathi, W and Raghupathi, V. Big data analytics in healthcare: promise and potential. Health Inf Sci Syst. 2014; 2 DOI: 10.1186/2047-2501-2-3</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/2047-2501-2-3</ArticleId><ArticleId IdType="pmc">PMC4341817</ArticleId><ArticleId IdType="pubmed">25825667</ArticleId></ArticleIdList></Reference><Reference><Citation>Schneeweiss, S. Learning from Big Health Care Data. N Engl J Med. 2014; 370: 2161&#x2013;2163. DOI: 10.1056/NEJMp1401111</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMp1401111</ArticleId><ArticleId IdType="pubmed">24897079</ArticleId></ArticleIdList></Reference><Reference><Citation>Sun, M and Lipsitz, SR. Comparative effectiveness research methodology using secondary data: A starting user&#x2019;s guide. Urol Oncol Semin Orig Investig; 2017. DOI: 10.1016/j.urolonc.2017.10.011</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.urolonc.2017.10.011</ArticleId><ArticleId IdType="pubmed">29146037</ArticleId></ArticleIdList></Reference><Reference><Citation>Mentz, RJ, Hernandez, AF, Berdan, LG, et al. Good Clinical Practice Guidance and Pragmatic Clinical Trials: Balancing the Best of Both Worlds. Circulation. 2016; 133: 872&#x2013;880. DOI: 10.1161/CIRCULATIONAHA.115.019902</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/CIRCULATIONAHA.115.019902</ArticleId><ArticleId IdType="pmc">PMC4777975</ArticleId><ArticleId IdType="pubmed">26927005</ArticleId></ArticleIdList></Reference><Reference><Citation>Schneeweiss, S, Eichler, H-G, Garcia-Altes, A, et al. Real World Data in Adaptive Biomedical Innovation: A Framework for Generating Evidence Fit for Decision-Making. Clin Pharmacol Ther. 2016; 100: 633&#x2013;646. DOI: 10.1002/cpt.512</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/cpt.512</ArticleId><ArticleId IdType="pubmed">27627027</ArticleId></ArticleIdList></Reference><Reference><Citation>Hazlehurst, BL, Kurtz, SE, Masica, A, et al. CER Hub: An informatics platform for conducting comparative effectiveness research using multi-institutional, heterogeneous, electronic clinical data. Int J Med Inf. 2015; 84: 763&#x2013;773. DOI: 10.1016/j.ijmedinf.2015.06.002</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ijmedinf.2015.06.002</ArticleId><ArticleId IdType="pubmed">26138036</ArticleId></ArticleIdList></Reference><Reference><Citation>van Staa, T-P, Dyson, L, McCann, G, et al. The opportunities and challenges of pragmatic point-of-care randomised trials using routinely collected electronic records: evaluations of two exemplar trials. Health Technol Assess Winch Engl. 2014; 18: 1&#x2013;146. DOI: 10.3310/hta18430</Citation><ArticleIdList><ArticleId IdType="doi">10.3310/hta18430</ArticleId><ArticleId IdType="pmc">PMC4781625</ArticleId><ArticleId IdType="pubmed">25011568</ArticleId></ArticleIdList></Reference><Reference><Citation>Mosis, G, Vlug, AE, Mosseveld, M, et al. A Technical Infrastructure to Conduct Randomized Database Studies Facilitated by a General Practice Research Database. J Am Med Inform Assoc JAMIA. 2005; 12: 602&#x2013;607. DOI: 10.1197/jamia.M1803</Citation><ArticleIdList><ArticleId IdType="doi">10.1197/jamia.M1803</ArticleId><ArticleId IdType="pmc">PMC1294030</ArticleId><ArticleId IdType="pubmed">16049228</ArticleId></ArticleIdList></Reference><Reference><Citation>Holmes, JH, Elliott, TE, Brown, JS, et al. Clinical research data warehouse governance for distributed research networks in the USA: a systematic review of the literature. J Am Med Inform Assoc JAMIA. 2014; 21: 730&#x2013;736. DOI: 10.1136/amiajnl-2013-002370</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/amiajnl-2013-002370</ArticleId><ArticleId IdType="pmc">PMC4078282</ArticleId><ArticleId IdType="pubmed">24682495</ArticleId></ArticleIdList></Reference><Reference><Citation>Maro, JC, Platt, R, Holmes, JH, et al. Design of a national distributed health data network. Ann Intern Med. 2009; 151: 341&#x2013;344. DOI: 10.7326/0003-4819-151-5-200909010-00139</Citation><ArticleIdList><ArticleId IdType="doi">10.7326/0003-4819-151-5-200909010-00139</ArticleId><ArticleId IdType="pubmed">19638403</ArticleId></ArticleIdList></Reference><Reference><Citation>Center for Effectiveness &amp; Safety Research &#x2013; Center for Effectiveness &amp; Safety Research. Available at: https://cesr.kp.org/. Accessed October 30, 2017.</Citation></Reference><Reference><Citation>McGlynn, EA, Lieu, TA, Durham, ML, et al. Developing a data infrastructure for a learning health system: the PORTAL network. J Am Med Inform Assoc JAMIA. 2014; 21: 596&#x2013;601. DOI: 10.1136/amiajnl-2014-002746</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/amiajnl-2014-002746</ArticleId><ArticleId IdType="pmc">PMC4078291</ArticleId><ArticleId IdType="pubmed">24821738</ArticleId></ArticleIdList></Reference><Reference><Citation>Forrest, CB, Margolis, PA, Bailey, LC, et al. PEDSnet: a National Pediatric Learning Health System. J Am Med Inform Assoc JAMIA. 2014; 21: 602&#x2013;606. DOI: 10.1136/amiajnl-2014-002743</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/amiajnl-2014-002743</ArticleId><ArticleId IdType="pmc">PMC4078288</ArticleId><ArticleId IdType="pubmed">24821737</ArticleId></ArticleIdList></Reference><Reference><Citation>Forrow, S, Campion, DM, Herrinton, LJ, et al. The organizational structure and governing principles of the Food and Drug Administration&#x2019;s Mini-Sentinel pilot program. Pharmacoepidemiol Drug Saf. 2012; 21: 12&#x2013;17. DOI: 10.1002/pds.2242</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/pds.2242</ArticleId><ArticleId IdType="pubmed">22262588</ArticleId></ArticleIdList></Reference><Reference><Citation>Behrman, RE, Benner, JS, Brown, JS, McClellan, M, Woodcock, J and Platt, R. Developing the Sentinel System &#x2014; A National Resource for Evidence Development. N Engl J Med. 2011; 364: 498&#x2013;499. DOI: 10.1056/NEJMp1014427</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMp1014427</ArticleId><ArticleId IdType="pubmed">21226658</ArticleId></ArticleIdList></Reference><Reference><Citation>Fleurence, RL, Curtis, LH, Califf, RM, Platt, R, Selby, JV and Brown, JS. Launching PCORnet, a national patient-centered clinical research network. J Am Med Inform Assoc JAMIA. 2014; 21: 578&#x2013;582. DOI: 10.1136/amiajnl-2014-002747</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/amiajnl-2014-002747</ArticleId><ArticleId IdType="pmc">PMC4078292</ArticleId><ArticleId IdType="pubmed">24821743</ArticleId></ArticleIdList></Reference><Reference><Citation>Qualls, LG, Phillips, TA, Hammill, BG, et al. Evaluating Foundational Data Quality in the National Patient-Centered Clinical Research Network (PCORnet&#xae;). eGEMs. 2018; 6 DOI: 10.5334/egems.199</Citation><ArticleIdList><ArticleId IdType="doi">10.5334/egems.199</ArticleId><ArticleId IdType="pmc">PMC5983028</ArticleId><ArticleId IdType="pubmed">29881761</ArticleId></ArticleIdList></Reference><Reference><Citation>Hripcsak, G, Duke, JD, Shah, NH, et al. Observational Health Data Sciences and Informatics (OHDSI): Opportunities for Observational Researchers. Stud Health Technol Inform. 2015; 216: 574&#x2013;578.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4815923</ArticleId><ArticleId IdType="pubmed">26262116</ArticleId></ArticleIdList></Reference><Reference><Citation>Bayley, KB, Belnap, T, Savitz, L, Masica, AL, Shah, N and Fleming, NS. Challenges in Using Electronic Health Record Data for CER: Experience of 4 Learning Organizations and Solutions Applied. Med Care. 2013; 51: S80 DOI: 10.1097/MLR.0b013e31829b1d48</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/MLR.0b013e31829b1d48</ArticleId><ArticleId IdType="pubmed">23774512</ArticleId></ArticleIdList></Reference><Reference><Citation>Hersh, WR, Weiner, MG, Embi, PJ, et al. Caveats for the Use of Operational Electronic Health Record Data in Comparative Effectiveness Research. Med Care. 2013; 51: S30&#x2013;S37. DOI: 10.1097/MLR.0b013e31829b1dbd</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/MLR.0b013e31829b1dbd</ArticleId><ArticleId IdType="pmc">PMC3748381</ArticleId><ArticleId IdType="pubmed">23774517</ArticleId></ArticleIdList></Reference><Reference><Citation>Ladha, KS and Eikermann, M. Codifying healthcare &#x2013; big data and the issue of misclassification. BMC Anesthesiol. 2015; 15 DOI: 10.1186/s12871-015-0165-y</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12871-015-0165-y</ArticleId><ArticleId IdType="pmc">PMC4678724</ArticleId><ArticleId IdType="pubmed">26667619</ArticleId></ArticleIdList></Reference><Reference><Citation>Weiskopf, NG, Bakken, S, Hripcsak, G and Weng, C. A Data Quality Assessment Guideline for Electronic Health Record Data Reuse. EGEMs Gener Evid Methods Improve Patient Outcomes. 2017; 5 DOI: 10.13063/egems.1280</Citation><ArticleIdList><ArticleId IdType="doi">10.13063/egems.1280</ArticleId><ArticleId IdType="pmc">PMC5983018</ArticleId><ArticleId IdType="pubmed">29881734</ArticleId></ArticleIdList></Reference><Reference><Citation>Kahn, MG, Callahan, TJ, Barnard, J, et al. A Harmonized Data Quality Assessment Terminology and Framework for the Secondary Use of Electronic Health Record Data. eGEMs. 2016; 4 DOI: 10.13063/2327-9214.1244</Citation><ArticleIdList><ArticleId IdType="doi">10.13063/2327-9214.1244</ArticleId><ArticleId IdType="pmc">PMC5051581</ArticleId><ArticleId IdType="pubmed">27713905</ArticleId></ArticleIdList></Reference><Reference><Citation>Kahn, MG, Brown, JS, Chun, AT, et al. Transparent Reporting of Data Quality in Distributed Data Networks. eGEMs. 2015; 3 DOI: 10.13063/2327-9214.1052</Citation><ArticleIdList><ArticleId IdType="doi">10.13063/2327-9214.1052</ArticleId><ArticleId IdType="pmc">PMC4434997</ArticleId><ArticleId IdType="pubmed">25992385</ArticleId></ArticleIdList></Reference><Reference><Citation>Weiskopf, NG and Weng, C. Methods and dimensions of electronic health record data quality assessment: enabling reuse for clinical research. J Am Med Inform Assoc JAMIA. 2013; 20: 144&#x2013;151. DOI: 10.1136/amiajnl-2011-000681</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/amiajnl-2011-000681</ArticleId><ArticleId IdType="pmc">PMC3555312</ArticleId><ArticleId IdType="pubmed">22733976</ArticleId></ArticleIdList></Reference><Reference><Citation>Brown, J, Kahn, M and Toh, S. Data quality assessment for comparative effectiveness research in distributed data networks. Med Care. 2013; 51: S22&#x2013;S29. DOI: 10.1097/MLR.0b013e31829b1e2c</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/MLR.0b013e31829b1e2c</ArticleId><ArticleId IdType="pmc">PMC4306391</ArticleId><ArticleId IdType="pubmed">23793049</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang, RY and Strong, DM. Beyond Accuracy: What Data Quality Means to Data Consumers. J Manag Inf Syst. 1996; 12: 5&#x2013;33. DOI: 10.1080/07421222.1996.11518099</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/07421222.1996.11518099</ArticleId></ArticleIdList></Reference><Reference><Citation>Estiri, H, Stephens, KA, Klann, JG and Murphy, SN. Exploring completeness in clinical data research networks with DQe-c. J Am Med Inform Assoc. 2018; 25: 17&#x2013;24. DOI: 10.1093/jamia/ocx109</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/jamia/ocx109</ArticleId><ArticleId IdType="pmc">PMC6481389</ArticleId><ArticleId IdType="pubmed">29069394</ArticleId></ArticleIdList></Reference><Reference><Citation>Callahan, TJ, Bauck, AE, Bertoch, D, et al. A Comparison of Data Quality Assessment Checks in Six Data Sharing Networks. EGEMs Gener Evid Methods Improve Patient Outcomes. 2017; 5 DOI: 10.13063/egems.1287</Citation><ArticleIdList><ArticleId IdType="doi">10.13063/egems.1287</ArticleId><ArticleId IdType="pmc">PMC5982846</ArticleId><ArticleId IdType="pubmed">29881733</ArticleId></ArticleIdList></Reference><Reference><Citation>Khare, R, Utidjian, L, Ruth, BJ, et al. A longitudinal analysis of data quality in a large pediatric data research network. J Am Med Inform Assoc JAMIA. 2017; 24: 1072&#x2013;1079. DOI: 10.1093/jamia/ocx033</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/jamia/ocx033</ArticleId><ArticleId IdType="pmc">PMC6259665</ArticleId><ArticleId IdType="pubmed">28398525</ArticleId></ArticleIdList></Reference><Reference><Citation>Huser, V, DeFalco, FJ, Schuemie, M, et al. Multisite Evaluation of a Data Quality Tool for Patient-Level Clinical Data Sets. eGEMs. 2016; 4 DOI: 10.13063/2327-9214.1239</Citation><ArticleIdList><ArticleId IdType="doi">10.13063/2327-9214.1239</ArticleId><ArticleId IdType="pmc">PMC5226382</ArticleId><ArticleId IdType="pubmed">28154833</ArticleId></ArticleIdList></Reference><Reference><Citation>Raebel, MA, Haynes, K, Woodworth, TS, et al. Electronic clinical laboratory test results data tables: lessons from Mini-Sentinel. Pharmacoepidemiol Drug Saf. 2014; 23: 609&#x2013;618. DOI: 10.1002/pds.3580</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/pds.3580</ArticleId><ArticleId IdType="pubmed">24677577</ArticleId></ArticleIdList></Reference><Reference><Citation>Quasthoff, U and Wolff, C. Text-based Knowledge Acquisition for Ontology Engineering. In: Proceedings of Konvens &#x2013; 6 2002; 147&#x2013;154. Saarbr&#xfc;cken, Germany.</Citation></Reference><Reference><Citation>Achilles: Automated Characterization of Health Information at Large-scale Longitudinal Evidence Systems (ACHILLES) &#x2013; descriptive statistics about a OMOP CDM database. Observational Health Data Sciences and Informatics; 2018.  Available at: https://github.com/OHDSI/Achilles. Accessed December 8, 2017.</Citation></Reference><Reference><Citation>Nadkarni, PM, Marenco, L, Chen, R, Skoufos, E, Shepherd, G and Miller, P. Organization of Heterogeneous Scientific Data Using the EAV/CR Representation. J Am Med Inform Assoc. 1999; 6: 478&#x2013;493. DOI: 10.1136/jamia.1999.0060478</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/jamia.1999.0060478</ArticleId><ArticleId IdType="pmc">PMC61391</ArticleId><ArticleId IdType="pubmed">10579606</ArticleId></ArticleIdList></Reference><Reference><Citation>Kang, T, Zhang, S, Tang, Y, et al. EliIE: An open-source information extraction system for clinical trial eligibility criteria. J Am Med Inform Assoc. 2017; 24: 1062&#x2013;1071. DOI: 10.1093/jamia/ocx019</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/jamia/ocx019</ArticleId><ArticleId IdType="pmc">PMC6259668</ArticleId><ArticleId IdType="pubmed">28379377</ArticleId></ArticleIdList></Reference><Reference><Citation>Voss, EA, Makadia, R, Matcho, A, et al. Feasibility and utility of applications of the common data model to multiple, disparate observational health databases. J Am Med Inform Assoc. 2015; 22: 553&#x2013;564. DOI: 10.1093/jamia/ocu023</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/jamia/ocu023</ArticleId><ArticleId IdType="pmc">PMC4457111</ArticleId><ArticleId IdType="pubmed">25670757</ArticleId></ArticleIdList></Reference><Reference><Citation>Domain. Available at: https://github.com/OHDSI/CommonDataModel/wiki/DOMAIN. Accessed January 5, 2018.</Citation></Reference><Reference><Citation>Kahn, MG, Raebel, MA, Glanz, JM, Riedlinger, K and Steiner, JF. A Pragmatic Framework for Single-site and Multisite Data Quality Assessment in Electronic Health Record-based Clinical Research. Med Care. 2012; 50 DOI: 10.1097/MLR.0b013e318257dd67</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/MLR.0b013e318257dd67</ArticleId><ArticleId IdType="pmc">PMC3833692</ArticleId><ArticleId IdType="pubmed">22692254</ArticleId></ArticleIdList></Reference><Reference><Citation>CommonDataModel: Definition and DDLs for the OMOP Common Data Model (CDM). Observational Health Data Sciences and Informatics, 2018.  Available at: https://github.com/OHDSI/CommonDataModel. Accessed January 5, 2018.</Citation></Reference><Reference><Citation>QDM|eCQI Resource Center. Available at: https://ecqi.healthit.gov/qdm. Accessed February 20, 2018.</Citation></Reference><Reference><Citation>HL7 Standards Product Brief &#x2013; HL7 Cross-Paradigm Specification: Clinical Quality Language, Release 1. Health Level Seven Int
2018.  Available at: http://www.hl7.org/implement/standards/product_brief.cfm?product_id=400. Accessed February 20, 2018.</Citation></Reference><Reference><Citation>SNOMED CT Starter Guide. Available at: https://confluence.ihtsdotools.org/display/DOCSTART/SNOMED+CT+Starter+Guide. Accessed February 19, 2018.</Citation></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">31066478</PMID><DateCompleted><Year>2019</Year><Month>12</Month><Day>17</Day></DateCompleted><DateRevised><Year>2020</Year><Month>12</Month><Day>07</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1099-1557</ISSN><JournalIssue CitedMedium="Internet"><Volume>28</Volume><Issue>7</Issue><PubDate><Year>2019</Year><Month>Jul</Month></PubDate></JournalIssue><Title>Pharmacoepidemiology and drug safety</Title><ISOAbbreviation>Pharmacoepidemiol Drug Saf</ISOAbbreviation></Journal><ArticleTitle>Comment on "How pharmacoepidemiology networks can manage distributed analyses to improve replicability and transparency and minimize bias".</ArticleTitle><Pagination><StartPage>1032</StartPage><EndPage>1033</EndPage><MedlinePgn>1032-1033</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1002/pds.4798</ELocationID><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Schuemie</LastName><ForeName>Martijn J</ForeName><Initials>MJ</Initials><Identifier Source="ORCID">0000-0002-0817-5361</Identifier><AffiliationInfo><Affiliation>Observational Health Data Sciences and Informatics, New York, NY.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Epidemiology Analytics, Janssen Research and Development, Titusville, NJ.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Biostatistics, University of California, Los Angeles, CA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Madigan</LastName><ForeName>David</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Observational Health Data Sciences and Informatics, New York, NY.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Statistics, Columbia University, New York, NY.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ryan</LastName><ForeName>Patrick B</ForeName><Initials>PB</Initials><AffiliationInfo><Affiliation>Observational Health Data Sciences and Informatics, New York, NY.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Epidemiology Analytics, Janssen Research and Development, Titusville, NJ.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Biomedical Informatics, Columbia University Medical Center, New York, NY.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Reich</LastName><ForeName>Christian</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Observational Health Data Sciences and Informatics, New York, NY.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Real World Analytics Solutions, IQVIA, Cambridge, MA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Suchard</LastName><ForeName>Marc A</ForeName><Initials>MA</Initials><AffiliationInfo><Affiliation>Observational Health Data Sciences and Informatics, New York, NY.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Biostatistics, University of California, Los Angeles, CA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Biomathematics, University of California, Los Angeles, CA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Human Genetics, University of California, Los Angeles, CA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Berlin</LastName><ForeName>Jesse A</ForeName><Initials>JA</Initials><AffiliationInfo><Affiliation>Observational Health Data Sciences and Informatics, New York, NY.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Epidemiology Analytics, Janssen Research and Development, Titusville, NJ.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hripcsak</LastName><ForeName>George</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Observational Health Data Sciences and Informatics, New York, NY.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Biomedical Informatics, Columbia University Medical Center, New York, NY.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Medical Informatics Services, New York-Presbyterian Hospital, New York, NY.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>R01 LM006910</GrantID><Acronym>LM</Acronym><Agency>NLM NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016422">Letter</PublicationType><PublicationType UI="D016420">Comment</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2019</Year><Month>05</Month><Day>08</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Pharmacoepidemiol Drug Saf</MedlineTA><NlmUniqueID>9208369</NlmUniqueID><ISSNLinking>1053-8569</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><CommentsCorrectionsList><CommentsCorrections RefType="CommentOn"><RefSource>Pharmacoepidemiol Drug Saf. 2019 Jan 15. doi: 10.1002/pds.4722.</RefSource><PMID Version="1">30648307</PMID></CommentsCorrections></CommentsCorrectionsList><MeshHeadingList><MeshHeading><DescriptorName UI="D015982" MajorTopicYN="N">Bias</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017891" MajorTopicYN="Y">Pharmacoepidemiology</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2019</Year><Month>2</Month><Day>1</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2019</Year><Month>4</Month><Day>17</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2019</Year><Month>5</Month><Day>9</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2019</Year><Month>12</Month><Day>18</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2019</Year><Month>5</Month><Day>9</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">31066478</ArticleId><ArticleId IdType="doi">10.1002/pds.4798</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">31104738</PMID><DateCompleted><Year>2019</Year><Month>07</Month><Day>10</Day></DateCompleted><DateRevised><Year>2019</Year><Month>07</Month><Day>10</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1524-4733</ISSN><JournalIssue CitedMedium="Internet"><Volume>22</Volume><Issue>5</Issue><PubDate><Year>2019</Year><Month>May</Month></PubDate></JournalIssue><Title>Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research</Title><ISOAbbreviation>Value Health</ISOAbbreviation></Journal><ArticleTitle>Using Machine Learning Applied to Real-World Healthcare Data for Predictive Analytics: An Applied Example in Bariatric Surgery.</ArticleTitle><Pagination><StartPage>580</StartPage><EndPage>586</EndPage><MedlinePgn>580-586</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.jval.2019.01.011</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S1098-3015(19)30073-7</ELocationID><Abstract><AbstractText Label="OBJECTIVES">Laparoscopic metabolic surgery (MxS) can lead to remission of type 2 diabetes (T2D); however, treatment response to MxS can be heterogeneous. Here, we demonstrate an open-source predictive analytics platform that applies machine-learning techniques to a common data model; we develop and validate a predictive model of antihyperglycemic medication cessation (validated proxy for A1c control) in patients with treated T2D who underwent MxS.</AbstractText><AbstractText Label="METHODS">We selected patients meeting the following criteria in 2 large US healthcare claims databases (Truven Health MarketScan Commercial [CCAE]; Optum Clinformatics [Optum]): underwent MxS between January 1, 2007, to October 1, 2013 (first&#xa0;= index); aged &#x2265;18 years; continuous enrollment 180 days pre-index (baseline) to 730 days postindex; baseline T2D diagnosis and treatment. The outcome was no antihyperglycemic medication treatment from 365 to 730 days after MxS. A regularized logistic regression model was trained using the following candidate predictor categories measured at baseline: demographics, conditions, medications, measurements, and procedures. A 75% to 25% split of the CCAE group was used for model training and testing; the Optum group was used for external validation.</AbstractText><AbstractText Label="RESULTS">13&#x2009;050 (CCAE) and 3477 (Optum) patients met the study inclusion criteria. Antihyperglycemic medication cessation rates were 72.9% (CCAE) and 70.8% (Optum). The model possessed good internal discriminative accuracy (area under the curve [AUC]&#xa0;= 0.778 [95% CI&#xa0;= 0.761-0.795] in CCAE test set N&#xa0;= 3527) and transportability (external AUC&#xa0;= 0.759 [95% CI&#xa0;= 0.741-0.777] in Optum N&#xa0;= 3477).</AbstractText><AbstractText Label="CONCLUSION">The application of machine learning techniques to real-world healthcare data can yield useful predictive models to assist patient selection. In future practice, establishment of prerequisite technological infrastructure will be needed to implement such models for real-world decision support.</AbstractText><CopyrightInformation>Copyright &#xa9; 2019 ISPOR&#x2013;The Professional Society for Health Economics and Outcomes Research. Published by Elsevier Inc. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Johnston</LastName><ForeName>Stephen S</ForeName><Initials>SS</Initials><AffiliationInfo><Affiliation>Epidemiology, Medical Devices, Johnson &amp; Johnson, New Brunswick, NJ, USA. Electronic address: sjohn147@its.jnj.com.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Morton</LastName><ForeName>John M</ForeName><Initials>JM</Initials><AffiliationInfo><Affiliation>Department of Surgery, Stanford University, Stanford, CA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kalsekar</LastName><ForeName>Iftekhar</ForeName><Initials>I</Initials><AffiliationInfo><Affiliation>Epidemiology, Medical Devices, Johnson &amp; Johnson, New Brunswick, NJ, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ammann</LastName><ForeName>Eric M</ForeName><Initials>EM</Initials><AffiliationInfo><Affiliation>Epidemiology, Medical Devices, Johnson &amp; Johnson, New Brunswick, NJ, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hsiao</LastName><ForeName>Chia-Wen</ForeName><Initials>CW</Initials><AffiliationInfo><Affiliation>Ethicon, Johnson &amp; Johnson, Somerville, NJ, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Reps</LastName><ForeName>Jenna</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Epidemiology, Johnson &amp; Johnson, Titusville, NJ, USA.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Value Health</MedlineTA><NlmUniqueID>100883818</NlmUniqueID><ISSNLinking>1098-3015</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D007004">Hypoglycemic Agents</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D050110" MajorTopicYN="Y">Bariatric Surgery</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016208" MajorTopicYN="N">Databases, Factual</DescriptorName><QualifierName UI="Q000706" MajorTopicYN="N">statistics &amp; numerical data</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D003924" MajorTopicYN="N">Diabetes Mellitus, Type 2</DescriptorName><QualifierName UI="Q000188" MajorTopicYN="N">drug therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007004" MajorTopicYN="N">Hypoglycemic Agents</DescriptorName><QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D007345" MajorTopicYN="N">Insurance Claim Review</DescriptorName><QualifierName UI="Q000706" MajorTopicYN="Y">statistics &amp; numerical data</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000069550" MajorTopicYN="Y">Machine Learning</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">antihyperglycemic medication</Keyword><Keyword MajorTopicYN="N">machine learning</Keyword><Keyword MajorTopicYN="N">metabolic surgery</Keyword><Keyword MajorTopicYN="N">prediction</Keyword><Keyword MajorTopicYN="N">type 2 diabetes</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2018</Year><Month>8</Month><Day>27</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2018</Year><Month>12</Month><Day>5</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2019</Year><Month>1</Month><Day>28</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2019</Year><Month>5</Month><Day>21</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2019</Year><Month>5</Month><Day>21</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2019</Year><Month>7</Month><Day>11</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">31104738</ArticleId><ArticleId IdType="doi">10.1016/j.jval.2019.01.011</ArticleId><ArticleId IdType="pii">S1098-3015(19)30073-7</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">31214700</PMID><DateCompleted><Year>2020</Year><Month>07</Month><Day>01</Day></DateCompleted><DateRevised><Year>2025</Year><Month>01</Month><Day>08</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1367-4811</ISSN><JournalIssue CitedMedium="Internet"><Volume>35</Volume><Issue>21</Issue><PubDate><Year>2019</Year><Month>Nov</Month><Day>01</Day></PubDate></JournalIssue><Title>Bioinformatics (Oxford, England)</Title><ISOAbbreviation>Bioinformatics</ISOAbbreviation></Journal><ArticleTitle>PatientExploreR: an extensible application for dynamic visualization of patient clinical history from electronic health records in the OMOP common data model.</ArticleTitle><Pagination><StartPage>4515</StartPage><EndPage>4518</EndPage><MedlinePgn>4515-4518</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1093/bioinformatics/btz409</ELocationID><Abstract><AbstractText Label="MOTIVATION">Electronic health records (EHRs) are quickly becoming omnipresent in healthcare, but interoperability issues and technical demands limit their use for biomedical and clinical research. Interactive and flexible software that interfaces directly with EHR data structured around a common data model (CDM) could accelerate more EHR-based research by making the data more accessible to researchers who lack computational expertise and/or domain knowledge.</AbstractText><AbstractText Label="RESULTS">We present PatientExploreR, an extensible application built on the R/Shiny framework that interfaces with a relational database of EHR data in the Observational Medical Outcomes Partnership CDM format. PatientExploreR produces patient-level interactive and dynamic reports and facilitates visualization of clinical data without any programming required. It allows researchers to easily construct and export patient cohorts from the EHR for analysis with other software. This application could enable easier exploration of patient-level data for physicians and researchers. PatientExploreR can incorporate EHR data from any institution that employs the CDM for users with approved access. The software code is free and open source under the MIT license, enabling institutions to install and users to expand and modify the application for their own purposes.</AbstractText><AbstractText Label="AVAILABILITY AND IMPLEMENTATION">PatientExploreR can be freely obtained from GitHub: https://github.com/BenGlicksberg/PatientExploreR. We provide instructions for how researchers with approved access to their institutional EHR can use this package. We also release an open sandbox server of synthesized patient data for users without EHR access to explore: http://patientexplorer.ucsf.edu.</AbstractText><AbstractText Label="SUPPLEMENTARY INFORMATION">Supplementary data are available at Bioinformatics online.</AbstractText><CopyrightInformation>&#xa9; The Author(s) 2019. Published by Oxford University Press.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Glicksberg</LastName><ForeName>Benjamin S</ForeName><Initials>BS</Initials><AffiliationInfo><Affiliation>Bakar Computational Health Sciences Institute, University of California, San Francisco, San Francisco, CA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Oskotsky</LastName><ForeName>Boris</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Bakar Computational Health Sciences Institute, University of California, San Francisco, San Francisco, CA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Thangaraj</LastName><ForeName>Phyllis M</ForeName><Initials>PM</Initials><AffiliationInfo><Affiliation>Department of Biomedical Informatics, Columbia University, New York, NY, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Systems Biology, Columbia University, New York, NY, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Medicine, Columbia University, New York, NY, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Giangreco</LastName><ForeName>Nicholas</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Department of Biomedical Informatics, Columbia University, New York, NY, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Systems Biology, Columbia University, New York, NY, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Medicine, Columbia University, New York, NY, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Badgeley</LastName><ForeName>Marcus A</ForeName><Initials>MA</Initials><AffiliationInfo><Affiliation>Departments of Genomics and Data Science, Icahn Institute for Genomic Sciences and Multiscale Biology, Icahn School of Medicine at Mount Sinai, Institute of Next Generation Healthcare, New York, NY, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Johnson</LastName><ForeName>Kipp W</ForeName><Initials>KW</Initials><AffiliationInfo><Affiliation>Departments of Genomics and Data Science, Icahn Institute for Genomic Sciences and Multiscale Biology, Icahn School of Medicine at Mount Sinai, Institute of Next Generation Healthcare, New York, NY, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Datta</LastName><ForeName>Debajyoti</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Bakar Computational Health Sciences Institute, University of California, San Francisco, San Francisco, CA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rudrapatna</LastName><ForeName>Vivek A</ForeName><Initials>VA</Initials><AffiliationInfo><Affiliation>Bakar Computational Health Sciences Institute, University of California, San Francisco, San Francisco, CA, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Division of Gastroenterology, Department of Medicine, University of California, San Francisco, CA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rappoport</LastName><ForeName>Nadav</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Bakar Computational Health Sciences Institute, University of California, San Francisco, San Francisco, CA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Shervey</LastName><ForeName>Mark M</ForeName><Initials>MM</Initials><AffiliationInfo><Affiliation>Departments of Genomics and Data Science, Icahn Institute for Genomic Sciences and Multiscale Biology, Icahn School of Medicine at Mount Sinai, Institute of Next Generation Healthcare, New York, NY, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Miotto</LastName><ForeName>Riccardo</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Departments of Genomics and Data Science, Icahn Institute for Genomic Sciences and Multiscale Biology, Icahn School of Medicine at Mount Sinai, Institute of Next Generation Healthcare, New York, NY, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Goldstein</LastName><ForeName>Theodore C</ForeName><Initials>TC</Initials><AffiliationInfo><Affiliation>Bakar Computational Health Sciences Institute, University of California, San Francisco, San Francisco, CA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rutenberg</LastName><ForeName>Eugenia</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Bakar Computational Health Sciences Institute, University of California, San Francisco, San Francisco, CA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Frazier</LastName><ForeName>Remi</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Enterprise Information and Analytics, University of California, San Francisco, San Francisco, CA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lee</LastName><ForeName>Nelson</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Enterprise Information and Analytics, University of California, San Francisco, San Francisco, CA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Israni</LastName><ForeName>Sharat</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Bakar Computational Health Sciences Institute, University of California, San Francisco, San Francisco, CA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Larsen</LastName><ForeName>Rick</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Enterprise Information and Analytics, University of California, San Francisco, San Francisco, CA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Percha</LastName><ForeName>Bethany</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Departments of Genomics and Data Science, Icahn Institute for Genomic Sciences and Multiscale Biology, Icahn School of Medicine at Mount Sinai, Institute of Next Generation Healthcare, New York, NY, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Li</LastName><ForeName>Li</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Departments of Genomics and Data Science, Icahn Institute for Genomic Sciences and Multiscale Biology, Icahn School of Medicine at Mount Sinai, Institute of Next Generation Healthcare, New York, NY, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Dudley</LastName><ForeName>Joel T</ForeName><Initials>JT</Initials><AffiliationInfo><Affiliation>Departments of Genomics and Data Science, Icahn Institute for Genomic Sciences and Multiscale Biology, Icahn School of Medicine at Mount Sinai, Institute of Next Generation Healthcare, New York, NY, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tatonetti</LastName><ForeName>Nicholas P</ForeName><Initials>NP</Initials><AffiliationInfo><Affiliation>Department of Biomedical Informatics, Columbia University, New York, NY, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Systems Biology, Columbia University, New York, NY, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Medicine, Columbia University, New York, NY, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Butte</LastName><ForeName>Atul J</ForeName><Initials>AJ</Initials><AffiliationInfo><Affiliation>Bakar Computational Health Sciences Institute, University of California, San Francisco, San Francisco, CA, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Center for Data-Driven Insights and Innovation, University of California Health, Oakland, CA, USA.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>UL1 TR001872</GrantID><Acronym>TR</Acronym><Agency>NCATS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>T32 DK007007</GrantID><Acronym>DK</Acronym><Agency>NIDDK NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R35 GM131905</GrantID><Acronym>GM</Acronym><Agency>NIGMS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>T32 CA108462</GrantID><Acronym>CA</Acronym><Agency>NCI NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>F30 HL140946</GrantID><Acronym>HL</Acronym><Agency>NHLBI NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D052061">Research Support, N.I.H., Extramural</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Bioinformatics</MedlineTA><NlmUniqueID>9808944</NlmUniqueID><ISSNLinking>1367-4803</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D003201" MajorTopicYN="N">Computers</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016208" MajorTopicYN="N">Databases, Factual</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D057286" MajorTopicYN="Y">Electronic Health Records</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D064887" MajorTopicYN="N">Observational Studies as Topic</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012984" MajorTopicYN="Y">Software</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2018</Year><Month>10</Month><Day>16</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2019</Year><Month>3</Month><Day>20</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2019</Year><Month>6</Month><Day>13</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2019</Year><Month>6</Month><Day>20</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2020</Year><Month>7</Month><Day>2</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2019</Year><Month>6</Month><Day>20</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2019</Year><Month>6</Month><Day>19</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">31214700</ArticleId><ArticleId IdType="pmc">PMC6821222</ArticleId><ArticleId IdType="doi">10.1093/bioinformatics/btz409</ArticleId><ArticleId IdType="pii">5520433</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Attali D., Almende B.V. (2016) timevis: create interactive timeline visualizations in R. R package version 0.4.</Citation></Reference><Reference><Citation>Badgeley M.A. et al. (2016) EHDViz: clinical dashboard development using open-source technologies. BMJ Open, 6, e010579.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4809078</ArticleId><ArticleId IdType="pubmed">27013597</ArticleId></ArticleIdList></Reference><Reference><Citation>Chang W. et al. (2015) Shiny: web application framework for R. R Package Version 0.11, 1, 106.</Citation></Reference><Reference><Citation>Duke J.D. et al. (2017) Risk of angioedema associated with levetiracetam compared with phenytoin: findings of the observational health data sciences and informatics research network. Epilepsia, 58, e101&#x2013;e106.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6632067</ArticleId><ArticleId IdType="pubmed">28681416</ArticleId></ArticleIdList></Reference><Reference><Citation>Estiri H., Stephens K. (2017) DQe-v: a database-agnostic framework for exploring variability in electronic health record data across time and site location. EGEMS, 5, 3.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5994933</ArticleId><ArticleId IdType="pubmed">29930954</ArticleId></ArticleIdList></Reference><Reference><Citation>Frankovich J. et al. (2011) Evidence-based medicine in the EMR era. N. Engl. J. Med., 365, 1758&#x2013;1759.</Citation><ArticleIdList><ArticleId IdType="pubmed">22047518</ArticleId></ArticleIdList></Reference><Reference><Citation>Glicksberg B.S. et al. (2019) ROMOP: a light-weight R package for interfacing with OMOP-formatted electronic health record data. JAMIA Open. 2, 10&#x2013;4.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6800657</ArticleId><ArticleId IdType="pubmed">31633087</ArticleId></ArticleIdList></Reference><Reference><Citation>Hirsch J.S. et al. (2015) HARVEST, a longitudinal patient record summarizer. J. Am. Med. Inform. Assoc., 22, 263&#x2013;274.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4394965</ArticleId><ArticleId IdType="pubmed">25352564</ArticleId></ArticleIdList></Reference><Reference><Citation>Hripcsak G. et al. (2015) Observational health data sciences and informatics (OHDSI): opportunities for observational researchers. Stud. Health Technol. Inform., 216, 574&#x2013;578.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4815923</ArticleId><ArticleId IdType="pubmed">26262116</ArticleId></ArticleIdList></Reference><Reference><Citation>Hripcsak G. et al. (2016) Characterizing treatment pathways at scale using the OHDSI network. Proc. Natl. Acad. Sci. USA, 113, 7329&#x2013;7336.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4941483</ArticleId><ArticleId IdType="pubmed">27274072</ArticleId></ArticleIdList></Reference><Reference><Citation>Huser V. et al. (2016) Multisite evaluation of a data quality tool for patient-level clinical data sets. EGEMS, 4, 1239.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5226382</ArticleId><ArticleId IdType="pubmed">28154833</ArticleId></ArticleIdList></Reference><Reference><Citation>Jensen P.B. et al. (2012) Mining electronic health records: towards better research applications and clinical care. Nat. Rev. Genet., 13, 395&#x2013;405.</Citation><ArticleIdList><ArticleId IdType="pubmed">22549152</ArticleId></ArticleIdList></Reference><Reference><Citation>Krause J. et al. (2016) Supporting iterative Cohort construction with visual temporal queries. IEEE Trans. Vis Comput. Graph, 22, 91&#x2013;100.</Citation><ArticleIdList><ArticleId IdType="pubmed">26529690</ArticleId></ArticleIdList></Reference><Reference><Citation>Levine M.E. et al. (2018) Methodological variations in lagged regression for detecting physiologic drug effects in EHR data. J. Biomed. Inform., 86, 149&#x2013;159.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6207533</ArticleId><ArticleId IdType="pubmed">30172760</ArticleId></ArticleIdList></Reference><Reference><Citation>Malik S. et al. (2015) Cohort comparison of event sequences with balanced integration of visual analytics and statistics In: Proceedings of the 20th International Conference on Intelligent User Interfaces, Atlanta, Georgia, USA, March 29 &#x2013; April 1, 2015. ACM, pp. 38&#x2013;49.</Citation></Reference><Reference><Citation>Mandel J.C. et al. (2016) SMART on FHIR: a standards-based, interoperable apps platform for electronic health records. J. Am. Med. Inform. Assoc., 23, 899&#x2013;908.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4997036</ArticleId><ArticleId IdType="pubmed">26911829</ArticleId></ArticleIdList></Reference><Reference><Citation>Perer A. et al. (2015) Mining and exploring care pathways from electronic medical records with visual analytics. J. Biomed. Inform., 56, 369&#x2013;378.</Citation><ArticleIdList><ArticleId IdType="pubmed">26146159</ArticleId></ArticleIdList></Reference><Reference><Citation>Pivovarov R., Elhadad N. (2015) Automated methods for the summarization of electronic health records. J. Am. Med. Inform. Assoc., 22, 938&#x2013;947.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4986665</ArticleId><ArticleId IdType="pubmed">25882031</ArticleId></ArticleIdList></Reference><Reference><Citation>Rajkomar A. et al. (2018) Scalable and accurate deep learning with electronic health records. Npj Digital Med., 1, 18.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6550175</ArticleId><ArticleId IdType="pubmed">31304302</ArticleId></ArticleIdList></Reference><Reference><Citation>Rind A. et al. (2013) Interactive information visualization to explore and query electronic health records. Found. Trends Hum. Comput. Interact., 5, 207&#x2013;298.</Citation></Reference><Reference><Citation>Schuemie M.J. et al. (2018) Improving reproducibility by using high-throughput observational studies with empirical calibration. Philos Trans. A Math. Phys. Eng. Sci., 376, 1&#x2013;17.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6107542</ArticleId><ArticleId IdType="pubmed">30082302</ArticleId></ArticleIdList></Reference><Reference><Citation>Shaddox T.R. et al. (2016) Hierarchical models for multiple, rare outcomes using massive observational healthcare databases. Stat. Anal. Data Min., 9, 260&#x2013;268.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5423675</ArticleId><ArticleId IdType="pubmed">28503249</ArticleId></ArticleIdList></Reference><Reference><Citation>Sievert C. et al. (2017) plotly: create interactive web graphics via &#x2018;plotly. js&#x2019;. R package version 4.7. 1.</Citation></Reference><Reference><Citation>Soulakis N.D. et al. (2015) Visualizing collaborative electronic health record usage for hospitalized patients with heart failure. J. Am. Med. Inform. Assoc., 22, 299&#x2013;311.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4394967</ArticleId><ArticleId IdType="pubmed">25710558</ArticleId></ArticleIdList></Reference><Reference><Citation>Vashisht R. et al. (2018) Association of hemoglobin A1c levels with use of sulfonylureas, dipeptidyl peptidase 4 inhibitors, and thiazolidinediones in patients with type 2 diabetes treated with metformin: analysis from the observational health data sciences and informatics initiative. JAMA Network Open, 1, e181755.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6324274</ArticleId><ArticleId IdType="pubmed">30646124</ArticleId></ArticleIdList></Reference><Reference><Citation>West V.L. et al. (2015) Innovative information visualization of electronic health record data: a systematic review. J. Am. Med. Inform. Assoc., 22, 330&#x2013;339.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4394966</ArticleId><ArticleId IdType="pubmed">25336597</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang Y. et al. (2015) Paving the COWpath: learning and visualizing clinical pathways from electronic health record data. J. Biomed. Inform., 58, 186&#x2013;197.</Citation><ArticleIdList><ArticleId IdType="pubmed">26419864</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">31238109</PMID><DateCompleted><Year>2020</Year><Month>09</Month><Day>29</Day></DateCompleted><DateRevised><Year>2020</Year><Month>09</Month><Day>29</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1532-0480</ISSN><JournalIssue CitedMedium="Internet"><Volume>96</Volume><PubDate><Year>2019</Year><Month>Aug</Month></PubDate></JournalIssue><Title>Journal of biomedical informatics</Title><ISOAbbreviation>J Biomed Inform</ISOAbbreviation></Journal><ArticleTitle>HemOnc: A new standard vocabulary for chemotherapy regimen representation in the OMOP common data model.</ArticleTitle><Pagination><StartPage>103239</StartPage><MedlinePgn>103239</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.jbi.2019.103239</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S1532-0464(19)30158-3</ELocationID><Abstract><AbstractText>Systematic application of observational data to the understanding of impacts of cancer treatments requires detailed information models allowing meaningful comparisons between treatment regimens. Unfortunately, details of systemic therapies are scarce in registries and data warehouses, primarily due to the complex nature of the protocols and a lack of standardization. Since 2011, we have been creating a curated and semi-structured website of chemotherapy regimens, HemOnc.org. In coordination with the Observational Health Data Sciences and Informatics (OHDSI) Oncology Subgroup, we have transformed a substantial subset of this content into the OMOP common data model, with bindings to multiple external vocabularies, e.g., RxNorm and the National Cancer Institute Thesaurus. Currently, there are &gt;73,000 concepts and &gt;177,000 relationships in the full vocabulary. Content related to the definition and composition of chemotherapy regimens has been released within the ATHENA tool (athena.ohdsi.org) for widespread utilization by the OHDSI membership. Here, we describe the rationale, data model, and initial contents of the HemOnc vocabulary along with several use cases for which it may be valuable.</AbstractText><CopyrightInformation>Copyright &#xa9; 2019 Elsevier Inc. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Warner</LastName><ForeName>Jeremy L</ForeName><Initials>JL</Initials><AffiliationInfo><Affiliation>Vanderbilt University Medical Center, Nashville, TN, United States; HemOnc.org, LLC, Lexington, MA, United States. Electronic address: jeremy.warner@vumc.org.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Dymshyts</LastName><ForeName>Dmitry</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Odysseus Data Services, Inc., Cambridge, MA, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Reich</LastName><ForeName>Christian G</ForeName><Initials>CG</Initials><AffiliationInfo><Affiliation>IQVIA, Cambridge, MA, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gurley</LastName><ForeName>Michael J</ForeName><Initials>MJ</Initials><AffiliationInfo><Affiliation>Northwestern University, Chicago, IL, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hochheiser</LastName><ForeName>Harry</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>University of Pittsburgh, Pittsburgh, PA, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Moldwin</LastName><ForeName>Zachary H</ForeName><Initials>ZH</Initials><AffiliationInfo><Affiliation>University of Illinois at Chicago College of Pharmacy, Chicago, IL, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Belenkaya</LastName><ForeName>Rimma</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Memorial Sloan Kettering Cancer Center, New York, NY, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Williams</LastName><ForeName>Andrew E</ForeName><Initials>AE</Initials><AffiliationInfo><Affiliation>Tufts University, Medford, MA, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yang</LastName><ForeName>Peter C</ForeName><Initials>PC</Initials><AffiliationInfo><Affiliation>HemOnc.org, LLC, Lexington, MA, United States; Massachusetts General Hospital, Harvard Medical School, Boston, MA, United States.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>P30 CA008748</GrantID><Acronym>CA</Acronym><Agency>NCI NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>U01 CA231840</GrantID><Acronym>CA</Acronym><Agency>NCI NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>U24 CA184407</GrantID><Acronym>CA</Acronym><Agency>NCI NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>U24 CA194215</GrantID><Acronym>CA</Acronym><Agency>NCI NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D052061">Research Support, N.I.H., Extramural</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2019</Year><Month>06</Month><Day>22</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>J Biomed Inform</MedlineTA><NlmUniqueID>100970413</NlmUniqueID><ISSNLinking>1532-0464</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000970">Antineoplastic Agents</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000465" MajorTopicYN="N">Algorithms</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000970" MajorTopicYN="N">Antineoplastic Agents</DescriptorName><QualifierName UI="Q000494" MajorTopicYN="Y">pharmacology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016208" MajorTopicYN="N">Databases, Factual</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006405" MajorTopicYN="N">Hematology</DescriptorName><QualifierName UI="Q000592" MajorTopicYN="Y">standards</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D020407" MajorTopicYN="N">Internet</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008490" MajorTopicYN="N">Medical Informatics</DescriptorName><QualifierName UI="Q000592" MajorTopicYN="Y">standards</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008495" MajorTopicYN="N">Medical Oncology</DescriptorName><QualifierName UI="Q000592" MajorTopicYN="Y">standards</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D054547" MajorTopicYN="N">National Cancer Institute (U.S.)</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009369" MajorTopicYN="N">Neoplasms</DescriptorName><QualifierName UI="Q000188" MajorTopicYN="Y">drug therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012955" MajorTopicYN="N">Societies, Medical</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012984" MajorTopicYN="N">Software</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009626" MajorTopicYN="N">Terminology as Topic</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014481" MajorTopicYN="N" Type="Geographic">United States</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014825" MajorTopicYN="N">Vocabulary</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Knowledge engineering</Keyword><Keyword MajorTopicYN="N">Neoplasms</Keyword><Keyword MajorTopicYN="N">Ontologies</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2019</Year><Month>3</Month><Day>29</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2019</Year><Month>6</Month><Day>20</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2019</Year><Month>6</Month><Day>21</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2019</Year><Month>6</Month><Day>27</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2020</Year><Month>9</Month><Day>30</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2019</Year><Month>6</Month><Day>26</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2020</Year><Month>8</Month><Day>1</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">31238109</ArticleId><ArticleId IdType="mid">NIHMS1534326</ArticleId><ArticleId IdType="pmc">PMC6697579</ArticleId><ArticleId IdType="doi">10.1016/j.jbi.2019.103239</ArticleId><ArticleId IdType="pii">S1532-0464(19)30158-3</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Siegel RL, Miller KD, Jemal A, Cancer statistics, 2019, CA Cancer J Clin. 69 (2019) 7&#x2013;34. doi:10.3322/caac.21551.</Citation><ArticleIdList><ArticleId IdType="doi">10.3322/caac.21551</ArticleId><ArticleId IdType="pubmed">30620402</ArticleId></ArticleIdList></Reference><Reference><Citation>Kehl KL, Arora NK, Schrag D, Ayanian JZ, Clauser SB, Klabunde CN, Kahn KL, Fletcher RH, Keating NL, Discussions about clinical trials among patients with newly diagnosed lung and colorectal cancer, J Natl Cancer Inst. 106 (2014). doi:10.1093/jnci/dju216.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/jnci/dju216</ArticleId><ArticleId IdType="pmc">PMC4168309</ArticleId><ArticleId IdType="pubmed">25217775</ArticleId></ArticleIdList></Reference><Reference><Citation>Khozin S, Blumenthal GM, Pazdur R, Real-world Data for Clinical Evidence Generation in Oncology, J Natl Cancer Inst. 109 (2017). doi:10.1093/jnci/djx187.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/jnci/djx187</ArticleId><ArticleId IdType="pubmed">29059439</ArticleId></ArticleIdList></Reference><Reference><Citation>Rosenbloom ST, Carroll RJ, Warner JL, Matheny ME, Denny JC, Representing Knowledge Consistently Across Health Systems, Yearb Med Inform. 26 (2017) 139&#x2013;147. doi:10.15265/IY-2017-018.</Citation><ArticleIdList><ArticleId IdType="doi">10.15265/IY-2017-018</ArticleId><ArticleId IdType="pmc">PMC6239235</ArticleId><ArticleId IdType="pubmed">29063555</ArticleId></ArticleIdList></Reference><Reference><Citation>Warner JL, Cowan AJ, Hall AC, Yang PC, HemOnc.org: A Collaborative Online Knowledge Platform for Oncology Professionals, J Oncol Pract. 11 (2015) e336&#x2013;50. doi:10.1200/JOP.2014.001511.</Citation><ArticleIdList><ArticleId IdType="doi">10.1200/JOP.2014.001511</ArticleId><ArticleId IdType="pmc">PMC5706141</ArticleId><ArticleId IdType="pubmed">25736385</ArticleId></ArticleIdList></Reference><Reference><Citation>Malty AM, Jain SK, Yang PC, Harvey K, Warner JL, Computerized Approach to Creating a Systematic Ontology of Hematology/Oncology Regimens, JCO Clinical Cancer Informatics. (2018) 1&#x2013;11. doi:10.1200/CCI.17.00142.</Citation><ArticleIdList><ArticleId IdType="doi">10.1200/CCI.17.00142</ArticleId><ArticleId IdType="pmc">PMC6141041</ArticleId><ArticleId IdType="pubmed">30238070</ArticleId></ArticleIdList></Reference><Reference><Citation>Hripcsak G, Duke JD, Shah NH, Reich CG, Huser V, Schuemie MJ, Suchard MA, Park RW, Wong ICK, Rijnbeek PR, van der Lei J, Pratt N, Nor&#xe9;n GN, Li Y-C, Stang PE, Madigan D, Ryan PB, Observational Health Data Sciences and Informatics (OHDSI): Opportunities for Observational Researchers, Stud Health Technol Inform. 216 (2015) 574&#x2013;578.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4815923</ArticleId><ArticleId IdType="pubmed">26262116</ArticleId></ArticleIdList></Reference><Reference><Citation>Voss J, Collaborative thesaurus tagging the Wikipedia way, ArXiv:Cs/0604036. (2006). http://arxiv.org/abs/cs/0604036 (accessed
March 17, 2019).</Citation></Reference><Reference><Citation>R: The R Project for Statistical Computing, (n.d.). https://www.r-project.org/ (accessed
February 25, 2019).</Citation></Reference><Reference><Citation>APIs, (n.d.). https://rxnav.nlm.nih.gov/APIsOverview.html (accessed
February 25, 2019).</Citation></Reference><Reference><Citation>Sch&#xf6;fl G, reutils: Talk to the NCBI EUtils, 2016. 
https://CRAN.R-project.org/package=reutils (accessed
February 25, 2019).</Citation></Reference><Reference><Citation>Porschen R, Arkenau H-T, Kubicka S, Greil R, Seufferlein T, Freier W, Kretzschmar A, Graeven U, Grothey A, Hinke A, Schmiegel W, Schmoll H-J, AIO Colorectal Study Group, Phase III study of capecitabine plus oxaliplatin compared with fluorouracil and leucovorin plus oxaliplatin in metastatic colorectal cancer: a final report of the AIO Colorectal Study Group, J. Clin. Oncol 25 (2007) 4217&#x2013;4223. doi:10.1200/JCO.2006.09.2684.</Citation><ArticleIdList><ArticleId IdType="doi">10.1200/JCO.2006.09.2684</ArticleId><ArticleId IdType="pubmed">17548840</ArticleId></ArticleIdList></Reference><Reference><Citation>Savova GK, Tseytlin E, Finan S, Castine M, Miller T, Medvedeva O, Harris D, Hochheiser H, Lin C, Chavan G, Jacobson RS, DeepPhe: A Natural Language Processing System for Extracting Cancer Phenotypes from Clinical Records, Cancer Res. 77 (2017) e115&#x2013;e118. doi:10.1158/0008-5472.CAN-17-0615.</Citation><ArticleIdList><ArticleId IdType="doi">10.1158/0008-5472.CAN-17-0615</ArticleId><ArticleId IdType="pmc">PMC5690492</ArticleId><ArticleId IdType="pubmed">29092954</ArticleId></ArticleIdList></Reference><Reference><Citation>Carroll NM, Burniece KM, Holzman J, McQuillan DB, Plata A, Ritzwoller DP, Algorithm to Identify Systemic Cancer Therapy Treatment Using Structured Electronic Data, JCO Clin Cancer Inform. 1 (2017) 1&#x2013;9. doi:10.1200/CCI.17.00002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1200/CCI.17.00002</ArticleId><ArticleId IdType="pmc">PMC7006900</ArticleId><ArticleId IdType="pubmed">30657379</ArticleId></ArticleIdList></Reference><Reference><Citation>Styler WF, Bethard S, Finan S, Palmer M, Pradhan S, de Groen PC, Erickson B, Miller T, Lin C, Savova G, Pustejovsky J, Temporal Annotation in the Clinical Domain, Transactions of the Association for Computational Linguistics. 2 (2014) 143&#x2013;154. doi:10.1162/tacl_a_00172.</Citation><ArticleIdList><ArticleId IdType="doi">10.1162/tacl_a_00172</ArticleId><ArticleId IdType="pmc">PMC5657277</ArticleId><ArticleId IdType="pubmed">29082229</ArticleId></ArticleIdList></Reference><Reference><Citation>Ontology | HemOnc.org - A Hematology Oncology Wiki, (n.d.). https://hemonc.org/wiki/Ontology (accessed
May 22, 2019).</Citation></Reference><Reference><Citation>Abrams TA, Brightly R, Mao J, Kirkner G, Meyerhardt JA, Schrag D, Fuchs CS, Patterns of adjuvant chemotherapy use in a population-based cohort of patients with resected stage II or III colon cancer, J Clin Oncol. 29 (2011) 3255&#x2013;62. doi:10.1200/JCO.2011.35.0058.</Citation><ArticleIdList><ArticleId IdType="doi">10.1200/JCO.2011.35.0058</ArticleId><ArticleId IdType="pubmed">21768462</ArticleId></ArticleIdList></Reference><Reference><Citation>Defining N-ary Relations on the Semantic Web, (n.d.). https://www.w3.org/TR/swbp-naryRelations/ (accessed
February 23, 2019).</Citation></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">31304370</PMID><DateRevised><Year>2023</Year><Month>10</Month><Day>12</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Electronic">2398-6352</ISSN><JournalIssue CitedMedium="Internet"><Volume>2</Volume><PubDate><Year>2019</Year></PubDate></JournalIssue><Title>NPJ digital medicine</Title><ISOAbbreviation>NPJ Digit Med</ISOAbbreviation></Journal><ArticleTitle>Finding missed cases of familial hypercholesterolemia in health systems using machine learning.</ArticleTitle><Pagination><StartPage>23</StartPage><MedlinePgn>23</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">23</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1038/s41746-019-0101-5</ELocationID><Abstract><AbstractText>Familial hypercholesterolemia (FH) is an underdiagnosed dominant genetic condition affecting approximately 0.4% of the population and has up to a 20-fold increased risk of coronary artery disease if untreated. Simple screening strategies have false positive rates greater than 95%. As part of the FH Foundation's FIND FH initiative, we developed a classifier to identify potential FH patients using electronic health record (EHR) data at Stanford Health Care. We trained a random forest classifier using data from known patients (<i>n</i>&#x2009;=&#x2009;197) and matched non-cases (<i>n</i>&#x2009;=&#x2009;6590). Our classifier obtained a positive predictive value (PPV) of 0.88 and sensitivity of 0.75 on a held-out test-set. We evaluated the accuracy of the classifier's predictions by chart review of 100 patients at risk of FH not included in the original dataset. The classifier correctly flagged 84% of patients at the highest probability threshold, with decreasing performance as the threshold lowers. In external validation on 466 FH patients (236 with genetically proven FH) and 5000 matched non-cases from the Geisinger Healthcare System our FH classifier achieved a PPV of 0.85. Our EHR-derived FH classifier is effective in finding candidate patients for further FH screening. Such machine learning guided strategies can lead to effective identification of the highest risk patients for enhanced management strategies.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Banda</LastName><ForeName>Juan M</ForeName><Initials>JM</Initials><Identifier Source="ORCID">0000-0001-8499-824X</Identifier><AffiliationInfo><Affiliation>1Center for Biomedical Informatics Research, Stanford University, Stanford, CA USA.</Affiliation><Identifier Source="ISNI">0000000419368956</Identifier><Identifier Source="GRID">grid.168010.e</Identifier></AffiliationInfo><AffiliationInfo><Affiliation>2Department of Computer Science, Georgia State University, Atlanta, GA USA.</Affiliation><Identifier Source="ISNI">0000 0004 1936 7400</Identifier><Identifier Source="GRID">grid.256304.6</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sarraju</LastName><ForeName>Ashish</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>3Cardiovascular Medicine and Cardiovascular Institute, Stanford University, Stanford, CA USA.</Affiliation><Identifier Source="ISNI">0000000419368956</Identifier><Identifier Source="GRID">grid.168010.e</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Abbasi</LastName><ForeName>Fahim</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>3Cardiovascular Medicine and Cardiovascular Institute, Stanford University, Stanford, CA USA.</Affiliation><Identifier Source="ISNI">0000000419368956</Identifier><Identifier Source="GRID">grid.168010.e</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Parizo</LastName><ForeName>Justin</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>3Cardiovascular Medicine and Cardiovascular Institute, Stanford University, Stanford, CA USA.</Affiliation><Identifier Source="ISNI">0000000419368956</Identifier><Identifier Source="GRID">grid.168010.e</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pariani</LastName><ForeName>Mitchel</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>3Cardiovascular Medicine and Cardiovascular Institute, Stanford University, Stanford, CA USA.</Affiliation><Identifier Source="ISNI">0000000419368956</Identifier><Identifier Source="GRID">grid.168010.e</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ison</LastName><ForeName>Hannah</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>3Cardiovascular Medicine and Cardiovascular Institute, Stanford University, Stanford, CA USA.</Affiliation><Identifier Source="ISNI">0000000419368956</Identifier><Identifier Source="GRID">grid.168010.e</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Briskin</LastName><ForeName>Elinor</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>3Cardiovascular Medicine and Cardiovascular Institute, Stanford University, Stanford, CA USA.</Affiliation><Identifier Source="ISNI">0000000419368956</Identifier><Identifier Source="GRID">grid.168010.e</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wand</LastName><ForeName>Hannah</ForeName><Initials>H</Initials><Identifier Source="ORCID">0000-0001-8662-3353</Identifier><AffiliationInfo><Affiliation>3Cardiovascular Medicine and Cardiovascular Institute, Stanford University, Stanford, CA USA.</Affiliation><Identifier Source="ISNI">0000000419368956</Identifier><Identifier Source="GRID">grid.168010.e</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Dubois</LastName><ForeName>Sebastien</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>1Center for Biomedical Informatics Research, Stanford University, Stanford, CA USA.</Affiliation><Identifier Source="ISNI">0000000419368956</Identifier><Identifier Source="GRID">grid.168010.e</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jung</LastName><ForeName>Kenneth</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>1Center for Biomedical Informatics Research, Stanford University, Stanford, CA USA.</Affiliation><Identifier Source="ISNI">0000000419368956</Identifier><Identifier Source="GRID">grid.168010.e</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Myers</LastName><ForeName>Seth A</ForeName><Initials>SA</Initials><AffiliationInfo><Affiliation>Atomo, Inc, Austin, TX USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rader</LastName><ForeName>Daniel J</ForeName><Initials>DJ</Initials><AffiliationInfo><Affiliation>5Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA USA.</Affiliation><Identifier Source="ISNI">0000 0004 1936 8972</Identifier><Identifier Source="GRID">grid.25879.31</Identifier></AffiliationInfo><AffiliationInfo><Affiliation>6The FH Foundation, Pasadena, CA USA.</Affiliation><Identifier Source="GRID">grid.490743.d</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Leader</LastName><ForeName>Joseph B</ForeName><Initials>JB</Initials><AffiliationInfo><Affiliation>7Geisinger Health System, Genomic Medicine Institute, Forty Fort, PA USA.</Affiliation><Identifier Source="GRID">grid.280776.c</Identifier><Identifier Source="ISNI">0000 0004 0394 1447</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Murray</LastName><ForeName>Michael F</ForeName><Initials>MF</Initials><AffiliationInfo><Affiliation>8Center for Genomic Health, Yale University, New Haven, CT USA.</Affiliation><Identifier Source="ISNI">0000000419368710</Identifier><Identifier Source="GRID">grid.47100.32</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Myers</LastName><ForeName>Kelly D</ForeName><Initials>KD</Initials><AffiliationInfo><Affiliation>Atomo, Inc, Austin, TX USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>6The FH Foundation, Pasadena, CA USA.</Affiliation><Identifier Source="GRID">grid.490743.d</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wilemon</LastName><ForeName>Katherine</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>6The FH Foundation, Pasadena, CA USA.</Affiliation><Identifier Source="GRID">grid.490743.d</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Shah</LastName><ForeName>Nigam H</ForeName><Initials>NH</Initials><AffiliationInfo><Affiliation>1Center for Biomedical Informatics Research, Stanford University, Stanford, CA USA.</Affiliation><Identifier Source="ISNI">0000000419368956</Identifier><Identifier Source="GRID">grid.168010.e</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Knowles</LastName><ForeName>Joshua W</ForeName><Initials>JW</Initials><AffiliationInfo><Affiliation>3Cardiovascular Medicine and Cardiovascular Institute, Stanford University, Stanford, CA USA.</Affiliation><Identifier Source="ISNI">0000000419368956</Identifier><Identifier Source="GRID">grid.168010.e</Identifier></AffiliationInfo><AffiliationInfo><Affiliation>6The FH Foundation, Pasadena, CA USA.</Affiliation><Identifier Source="GRID">grid.490743.d</Identifier></AffiliationInfo><AffiliationInfo><Affiliation>Stanford Diabetes Research Center, Stanford, CA USA.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>P30 DK116074</GrantID><Acronym>DK</Acronym><Agency>NIDDK NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R01 LM011369</GrantID><Acronym>LM</Acronym><Agency>NLM NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2019</Year><Month>04</Month><Day>11</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>NPJ Digit Med</MedlineTA><NlmUniqueID>101731738</NlmUniqueID><ISSNLinking>2398-6352</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Health care</Keyword><Keyword MajorTopicYN="N">Translational research</Keyword></KeywordList><CoiStatement>Competing interestsS.M. is an employee of Atomo LLC. M.M. has received personal fees from InVitae and Merck, and grant funding from Regeneron, outside the submitted work. K.M. is the founder of Atomo LLC. The remaining authors declare no competing interests. The FH Foundation (EIN 45-4597425) is a 501(c)3 public charity and research advocacy organization receiving funding from a diverse set of program sponsors including Amgen, Inc.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2018</Year><Month>12</Month><Day>3</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2019</Year><Month>3</Month><Day>13</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2019</Year><Month>7</Month><Day>16</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2019</Year><Month>7</Month><Day>16</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2019</Year><Month>7</Month><Day>16</Day><Hour>6</Hour><Minute>1</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2019</Year><Month>4</Month><Day>11</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">31304370</ArticleId><ArticleId IdType="pmc">PMC6550268</ArticleId><ArticleId IdType="doi">10.1038/s41746-019-0101-5</ArticleId><ArticleId IdType="pii">101</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Gidding SS, et al. The agenda for familial hypercholesterolemia: a scientific statement from the american heart association. Circulation. 2015;132:2167&#x2013;2192. doi: 10.1161/CIR.0000000000000297.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/CIR.0000000000000297</ArticleId><ArticleId IdType="pubmed">26510694</ArticleId></ArticleIdList></Reference><Reference><Citation>Abul-Husn NS, et al. Genetic identification of familial hypercholesterolemia within a single U.S. health care system. Science. 2016;354:aaf7000. doi: 10.1126/science.aaf7000.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.aaf7000</ArticleId><ArticleId IdType="pubmed">28008010</ArticleId></ArticleIdList></Reference><Reference><Citation>Khera AV, et al. Diagnostic yield and clinical utility of sequencing familial hypercholesterolemia genes in patients with severe hypercholesterolemia. J. Am. Coll. Cardiol. 2016;67:2578&#x2013;2589. doi: 10.1016/j.jacc.2016.03.520.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jacc.2016.03.520</ArticleId><ArticleId IdType="pmc">PMC5405769</ArticleId><ArticleId IdType="pubmed">27050191</ArticleId></ArticleIdList></Reference><Reference><Citation>Besseling J, et al. Selection of individuals for genetic testing for familial hypercholesterolaemia: development and external validation of a prediction model for the presence of a mutation causing familial hypercholesterolaemia. Eur. Heart J. 2017;38:565&#x2013;573.</Citation><ArticleIdList><ArticleId IdType="pubmed">27044878</ArticleId></ArticleIdList></Reference><Reference><Citation>Nordestgaard BG, et al. Familial hypercholesterolaemia is underdiagnosed and undertreated in the general population: guidance for clinicians to prevent coronary heart disease: consensus statement of the European Atherosclerosis Society. Eur. Heart J. 2013;34:3478&#x2013;90a. doi: 10.1093/eurheartj/eht273.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/eurheartj/eht273</ArticleId><ArticleId IdType="pmc">PMC3844152</ArticleId><ArticleId IdType="pubmed">23956253</ArticleId></ArticleIdList></Reference><Reference><Citation>National Collaborating Centre for Primary Care (UK). Clinical guidelines and evidence review for familial hypercholesterolaemia: the identification and management of adults and children with familial hypercholesterolaemia. (Royal College of General Practitioners (UK), 2011).</Citation></Reference><Reference><Citation>Knowles JW, Rader DJ, Khoury MJ. Cascade screening for familial hypercholesterolemia and the use of genetic testing. JAMA. 2017;318:381&#x2013;382. doi: 10.1001/jama.2017.8543.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2017.8543</ArticleId><ArticleId IdType="pmc">PMC6166431</ArticleId><ArticleId IdType="pubmed">28742895</ArticleId></ArticleIdList></Reference><Reference><Citation>Public Health Genomics. Centers for Disease Control and Prevention (2014). Available at: https://www.cdc.gov/genomics/implementation/toolkit/fh_1.htm. (Accessed: 9th December 2017).</Citation></Reference><Reference><Citation>Obermeyer Z, Emanuel EJ. Predicting the future - big data, machine learning, and clinical medicine. N. Engl. J. Med. 2016;375:1216&#x2013;1219. doi: 10.1056/NEJMp1606181.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMp1606181</ArticleId><ArticleId IdType="pmc">PMC5070532</ArticleId><ArticleId IdType="pubmed">27682033</ArticleId></ArticleIdList></Reference><Reference><Citation>Jordan MI, Mitchell TM. Machine learning: Trends, perspectives, and prospects. Science. 2015;349:255&#x2013;260. doi: 10.1126/science.aaa8415.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.aaa8415</ArticleId><ArticleId IdType="pubmed">26185243</ArticleId></ArticleIdList></Reference><Reference><Citation>Ross EG, et al. The use of machine learning for the identification of peripheral artery disease and future mortality risk. J. Vasc. Surg. 2016;64:1515&#x2013;1522.e3. doi: 10.1016/j.jvs.2016.04.026.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jvs.2016.04.026</ArticleId><ArticleId IdType="pmc">PMC5079774</ArticleId><ArticleId IdType="pubmed">27266594</ArticleId></ArticleIdList></Reference><Reference><Citation>Deo RC. Machine learning in medicine. Circulation. 2015;132:1920&#x2013;1930. doi: 10.1161/CIRCULATIONAHA.115.001593.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/CIRCULATIONAHA.115.001593</ArticleId><ArticleId IdType="pmc">PMC5831252</ArticleId><ArticleId IdType="pubmed">26572668</ArticleId></ArticleIdList></Reference><Reference><Citation>Breiman L. Random Forests. Mach. Learn. 2001;45:5&#x2013;32. doi: 10.1023/A:1010933404324.</Citation><ArticleIdList><ArticleId IdType="doi">10.1023/A:1010933404324</ArticleId></ArticleIdList></Reference><Reference><Citation>Altman DG, Martin Bland J. Statistics notes: diagnostic tests 2: predictive values. BMJ. 1994;309:102. doi: 10.1136/bmj.309.6947.102.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.309.6947.102</ArticleId><ArticleId IdType="pmc">PMC2540558</ArticleId><ArticleId IdType="pubmed">8038641</ArticleId></ArticleIdList></Reference><Reference><Citation>Cook NR. Use and misuse of the receiver operating characteristic curve in risk prediction. Circulation. 2007;115:928&#x2013;935. doi: 10.1161/CIRCULATIONAHA.106.672402.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/CIRCULATIONAHA.106.672402</ArticleId><ArticleId IdType="pubmed">17309939</ArticleId></ArticleIdList></Reference><Reference><Citation>Stone NJ, et al. 2013 ACC/AHA guideline on the treatment of blood cholesterol to reduce atherosclerotic cardiovascular risk in adults: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. J. Am. Coll. Cardiol. 2014;63:2889&#x2013;2934. doi: 10.1016/j.jacc.2013.11.002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jacc.2013.11.002</ArticleId><ArticleId IdType="pubmed">24239923</ArticleId></ArticleIdList></Reference><Reference><Citation>Rajkomar A, et al. Scalable and accurate deep learning with electronic health records. npj Digital. Medicine. 2018;1:18.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6550175</ArticleId><ArticleId IdType="pubmed">31304302</ArticleId></ArticleIdList></Reference><Reference><Citation>deGoma EM, et al. Treatment gaps in adults with heterozygous familial hypercholesterolemia in the United States: data from the CASCADE-FH registry. Circ. Cardiovasc. Genet. 2016;9:240&#x2013;249. doi: 10.1161/CIRCGENETICS.116.001381.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/CIRCGENETICS.116.001381</ArticleId><ArticleId IdType="pmc">PMC5315030</ArticleId><ArticleId IdType="pubmed">27013694</ArticleId></ArticleIdList></Reference><Reference><Citation>Kindt I, Mata P, Knowles JW. The role of registries and genetic databases in familial hypercholesterolemia. Curr. Opin. Lipidol. 2017;28:152&#x2013;160. doi: 10.1097/MOL.0000000000000398.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/MOL.0000000000000398</ArticleId><ArticleId IdType="pubmed">28169870</ArticleId></ArticleIdList></Reference><Reference><Citation>Mata N, et al. Clinical characteristics and evaluation of LDL-cholesterol treatment of the Spanish Familial Hypercholesterolemia Longitudinal Cohort Study (SAFEHEART) Lipids Health Dis. 2011;10:94. doi: 10.1186/1476-511X-10-94.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1476-511X-10-94</ArticleId><ArticleId IdType="pmc">PMC3141550</ArticleId><ArticleId IdType="pubmed">21663647</ArticleId></ArticleIdList></Reference><Reference><Citation>P&#xe9;rez de Isla L, et al. Coronary heart disease, peripheral arterial disease, and stroke in familial hypercholesterolaemia: insights from the SAFEHEART registry (Spanish Familial Hypercholesterolaemia Cohort Study) Arterioscler. Thromb. Vasc. Biol. 2016;36:2004&#x2013;2010. doi: 10.1161/ATVBAHA.116.307514.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/ATVBAHA.116.307514</ArticleId><ArticleId IdType="pubmed">27444203</ArticleId></ArticleIdList></Reference><Reference><Citation>Sturm AC, et al. Clinical Genetic Testing for Familial Hypercholesterolemia: JACC Scientific Expert Panel. J. Am. Coll. Cardiol. 2018;72:662&#x2013;680. doi: 10.1016/j.jacc.2018.05.044.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jacc.2018.05.044</ArticleId><ArticleId IdType="pubmed">30071997</ArticleId></ArticleIdList></Reference><Reference><Citation>Safarova MS, Liu H, Kullo IJ. Rapid identification of familial hypercholesterolemia from electronic health records: The SEARCH study. J. Clin. Lipidol. 2016;10:1230&#x2013;1239. doi: 10.1016/j.jacl.2016.08.001.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jacl.2016.08.001</ArticleId><ArticleId IdType="pmc">PMC9229555</ArticleId><ArticleId IdType="pubmed">27678441</ArticleId></ArticleIdList></Reference><Reference><Citation>Bastarache L, et al. Phenotype risk scores identify patients with unrecognized Mendelian disease patterns. Science. 2018;359:1233&#x2013;1239. doi: 10.1126/science.aal4043.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.aal4043</ArticleId><ArticleId IdType="pmc">PMC5959723</ArticleId><ArticleId IdType="pubmed">29590070</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang, F., Casalino, L. P. &amp; Khullar, D. Deep Learning in Medicine&#x2014;Promise, Progress, and Challenges. JAMA Intern. Med. (2018). 10.1001/jamainternmed.2018.7117.</Citation><ArticleIdList><ArticleId IdType="pubmed">30556825</ArticleId></ArticleIdList></Reference><Reference><Citation>Hastie T, Tibshirani R, Friedman J. The Elements of Statistical Learning: Data Mining, Inference, and Prediction. Second Edition. New York: Springer-Verlag; 2009.</Citation></Reference><Reference><Citation>Wagstaff, K. Machine Learning that Matters. arXiv [cs.LG] (2012).</Citation></Reference><Reference><Citation>Hripcsak G, et al. ObseRvational Health Data Sciences and Informatics (OHDSI): opportunities for observational researchers. Stud. Health Technol. Inform. 2015;216:574&#x2013;578.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4815923</ArticleId><ArticleId IdType="pubmed">26262116</ArticleId></ArticleIdList></Reference><Reference><Citation>Stang PE, et al. Advancing the science for active surveillance: rationale and design for the Observational Medical Outcomes Partnership. Ann. Intern. Med. 2010;153:600&#x2013;606. doi: 10.7326/0003-4819-153-9-201011020-00010.</Citation><ArticleIdList><ArticleId IdType="doi">10.7326/0003-4819-153-9-201011020-00010</ArticleId><ArticleId IdType="pubmed">21041580</ArticleId></ArticleIdList></Reference><Reference><Citation>Banda JM, Halpern Y, Sontag D, Shah NH. Electronic phenotyping with APHRODITE and the Observational Health Sciences and Informatics (OHDSI) data network. AMIA Jt Summits Transl. Sci. Proc. 2017;2017:48&#x2013;57.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5543379</ArticleId><ArticleId IdType="pubmed">28815104</ArticleId></ArticleIdList></Reference><Reference><Citation>Chapman WW, Bridewell W, Hanbury P, Cooper GF, Buchanan BG. A simple algorithm for identifying negated findings and diseases in discharge summaries. J. Biomed. Inform. 2001;34:301&#x2013;310. doi: 10.1006/jbin.2001.1029.</Citation><ArticleIdList><ArticleId IdType="doi">10.1006/jbin.2001.1029</ArticleId><ArticleId IdType="pubmed">12123149</ArticleId></ArticleIdList></Reference><Reference><Citation>Jung K, et al. Functional evaluation of out-of-the-box text-mining tools for data-mining tasks. J. Am. Med. Inform. Assoc. 2015;22:121&#x2013;131.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4433377</ArticleId><ArticleId IdType="pubmed">25336595</ArticleId></ArticleIdList></Reference><Reference><Citation>Haase A, Goldberg AC. Identification of people with heterozygous familial hypercholesterolemia. Curr. Opin. Lipidol. 2012;23:282&#x2013;289. doi: 10.1097/MOL.0b013e3283556c33.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/MOL.0b013e3283556c33</ArticleId><ArticleId IdType="pubmed">22801386</ArticleId></ArticleIdList></Reference><Reference><Citation>Civeira F, International Panel on Management of Familial Hypercholesterolemia. Guidelines for the diagnosis and management of heterozygous familial hypercholesterolemia. Atherosclerosis. 2004;173:55&#x2013;68. doi: 10.1016/j.atherosclerosis.2003.11.010.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.atherosclerosis.2003.11.010</ArticleId><ArticleId IdType="pubmed">15177124</ArticleId></ArticleIdList></Reference><Reference><Citation>Austin MA, Hutter CM, Zimmern RL, Humphries SE. Genetic causes of monogenic heterozygous familial hypercholesterolemia: a HuGE prevalence review. Am. J. Epidemiol. 2004;160:407&#x2013;420. doi: 10.1093/aje/kwh236.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/aje/kwh236</ArticleId><ArticleId IdType="pubmed">15321837</ArticleId></ArticleIdList></Reference><Reference><Citation>Williams RR, et al. Diagnosing heterozygous familial hypercholesterolemia using new practical criteria validated by molecular genetics. Am. J. Cardiol. 1993;72:171&#x2013;176. doi: 10.1016/0002-9149(93)90155-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/0002-9149(93)90155-6</ArticleId><ArticleId IdType="pubmed">8328379</ArticleId></ArticleIdList></Reference><Reference><Citation>Nor&#xe9;n GN, Caster O, Juhlin K, Lindquist M. Zoo or savannah? Choice of training ground for evidence-based pharmacovigilance. Drug Saf. 2014;37:655&#x2013;659. doi: 10.1007/s40264-014-0198-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s40264-014-0198-z</ArticleId><ArticleId IdType="pubmed">25005708</ArticleId></ArticleIdList></Reference><Reference><Citation>Harpaz R, DuMouchel W, Shah NH. Comment on: &#x2018;Zoo or savannah? Choice of training ground for evidence-based pharmacovigilance&#x2032;. Drug Saf. 2015;38:113&#x2013;114. doi: 10.1007/s40264-014-0245-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s40264-014-0245-9</ArticleId><ArticleId IdType="pmc">PMC4706737</ArticleId><ArticleId IdType="pubmed">25432779</ArticleId></ArticleIdList></Reference><Reference><Citation>Witten, I. H., Frank, E., Hall, M. A. &amp; Pal, C. J. Data Mining: Practical Machine Learning Tools and Techniques. (Morgan Kaufmann, 2016).</Citation></Reference><Reference><Citation>Niehaus, K. E., Banda, J. M., Knowles, J. W. &amp; Shah, N. H. FIND FH&#x2014;A phenotype model to identify patients with familial hypercholesterolemia. in Proceedings of Data Mining for Medical Informatics Workshop 2015 (2015).</Citation></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">31307128</PMID><DateRevised><Year>2020</Year><Month>10</Month><Day>01</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Print">1598-866X</ISSN><JournalIssue CitedMedium="Print"><Volume>17</Volume><Issue>2</Issue><PubDate><Year>2019</Year><Month>Jun</Month></PubDate></JournalIssue><Title>Genomics &amp; informatics</Title><ISOAbbreviation>Genomics Inform</ISOAbbreviation></Journal><ArticleTitle>Fully connecting the Observational Health Data Science and Informatics (OHDSI) initiative with the world of linked open data.</ArticleTitle><Pagination><StartPage>e13</StartPage><MedlinePgn>e13</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">e13</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.5808/GI.2019.17.2.e13</ELocationID><Abstract><AbstractText>The usage of controlled biomedical vocabularies is the cornerstone that enables seamless interoperability when using a common data model across multiple data sites. The Observational Health Data Science and Informatics (OHDSI) initiative combines over 100 controlled vocabularies into its own. However, the OHDSI vocabulary is limited in the sense that it combines multiple terminologies and does not provide a direct way to link them outside of their own self-contained scope. This issue makes the tasks of enriching feature sets by using external resources extremely difficult. In order to address these shortcomings, we have created a linked data version of the OHDSI vocabulary, connecting it with already established linked resources like bioportal, bio2rdf, etc. with the ultimate purpose of enabling the interoperability of resources previously foreign to the OHDSI universe.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Banda</LastName><ForeName>Juan M</ForeName><Initials>JM</Initials><AffiliationInfo><Affiliation>Panacea Laboratory, Department of Computer Science, Georgia State University, Atlanta, GA 30303, USA.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2019</Year><Month>06</Month><Day>11</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Genomics Inform</MedlineTA><NlmUniqueID>101223836</NlmUniqueID><ISSNLinking>1598-866X</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">RDF</Keyword><Keyword MajorTopicYN="N">clinical informatics</Keyword><Keyword MajorTopicYN="N">common data model</Keyword><Keyword MajorTopicYN="N">controlled vocabularies</Keyword><Keyword MajorTopicYN="N">linked open data</Keyword><Keyword MajorTopicYN="N">semantic web</Keyword></KeywordList><CoiStatement><b>Conflicts of Interest</b>. No potential conflict of interest relevant to this article was reported.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2018</Year><Month>12</Month><Day>13</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2019</Year><Month>5</Month><Day>20</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2019</Year><Month>7</Month><Day>16</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2019</Year><Month>7</Month><Day>16</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2019</Year><Month>7</Month><Day>16</Day><Hour>6</Hour><Minute>1</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2019</Year><Month>6</Month><Day>1</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">31307128</ArticleId><ArticleId IdType="pmc">PMC6808628</ArticleId><ArticleId IdType="doi">10.5808/GI.2019.17.2.e13</ArticleId><ArticleId IdType="pii">GI.2019.17.2.e13</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>San Franciso: GitHub; 2019. Atlas. Accessed 2019 Apr 2. Available from:  https://github.com/OHDSI/Atlas.</Citation></Reference><Reference><Citation>Reps JM, Schuemie MJ, Suchard MA, Ryan PB, Rijnbeek PR. Design and implementation of a standardized framework to generate and evaluate patient-level prediction models using observational healthcare data. J Am Med Inform Assoc. 2018;25:969&#x2013;975.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6077830</ArticleId><ArticleId IdType="pubmed">29718407</ArticleId></ArticleIdList></Reference><Reference><Citation>Banda JM, Halpern Y, Sontag D, Shah NH. Electronic phenotyping with APHRODITE and the Observational Health Sciences and Informatics (OHDSI) data network. AMIA Jt Summits Transl Sci Proc. 2017;2017:48&#x2013;57.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5543379</ArticleId><ArticleId IdType="pubmed">28815104</ArticleId></ArticleIdList></Reference><Reference><Citation>Hripcsak G, Ryan PB, Duke JD, Shah NH, Park RW, Huser V, et al. Characterizing treatment pathways at scale using the OHDSI network. Proc Natl Acad Sci U S A. 2016;113:7329&#x2013;7336.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4941483</ArticleId><ArticleId IdType="pubmed">27274072</ArticleId></ArticleIdList></Reference><Reference><Citation>Duke JD, Ryan PB, Suchard MA, Hripcsak G, Jin P, Reich C, et al. Risk of angioedema associated with levetiracetam compared with phenytoin: findings of the observational health data sciences and informatics research network. Epilepsia. 2017;58:e101&#x2013;e106.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6632067</ArticleId><ArticleId IdType="pubmed">28681416</ArticleId></ArticleIdList></Reference><Reference><Citation>Vashisht R, Jung K, Schuler A, Banda JM, Park RW, Jin S, et al. Association of hemoglobin A1c levels with use of sulfonylureas, dipeptidyl peptidase 4 inhibitors, and thiazolidinediones in patients with type 2 diabetes treated with metformin: analysis from the observational health data sciences and informatics initiative. JAMA Netw Open. 2018;1:e181755.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6324274</ArticleId><ArticleId IdType="pubmed">30646124</ArticleId></ArticleIdList></Reference><Reference><Citation>Bodenreider O. The Unified Medical Language System (UMLS): integrating biomedical terminology. Nucleic Acids Res. 2004;32:D267&#x2013;D270.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC308795</ArticleId><ArticleId IdType="pubmed">14681409</ArticleId></ArticleIdList></Reference><Reference><Citation>Callahan A, Cruz-Toledo J, Ansell P, Dumontier M. Bio2RDF release 2: improved coverage, interoperability and provenance of life science linked data. In: Cimiano P, Corcho O, Presutti V, Hollink L, Rodolph S, editors. The Semantic Web: Semantics and Big Data; 2013 May 26-30; Montpellier, France. Berlin. 2013. pp. 200&#x2013;212.</Citation></Reference><Reference><Citation>Salvadores M, Alexander PR, Musen MA, Noy NF. BioPortal as a Dataset of Linked Biomedical Ontologies and Terminologies in RDF. Semant Web. 2013;4:277&#x2013;284.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4159173</ArticleId><ArticleId IdType="pubmed">25214827</ArticleId></ArticleIdList></Reference><Reference><Citation>San Franciso: GitHub; 2019. OHDSIananke. Accessed 2019 Apr 2. Available from:  https://github.com/thepanacealab/OHDSIananke.</Citation></Reference><Reference><Citation>Leroux H, Lefort L. Semantic enrichment of longitudinal clinical study data using the CDISC standards and the semantic statistics vocabularies. J Biomed Semantics. 2015;6:16.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4429421</ArticleId><ArticleId IdType="pubmed">25973166</ArticleId></ArticleIdList></Reference><Reference><Citation>Blair DR, Wang K, Nestorov S, Evans JA, Rzhetsky A. Quantifying the impact and extent of undocumented biomedical synonymy. PLoS Comput Biol. 2014;10:e1003799.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4177665</ArticleId><ArticleId IdType="pubmed">25255227</ArticleId></ArticleIdList></Reference><Reference><Citation>Robinson PN, K&#xf6;hler S, Bauer S, Seelow D, Horn D, Mundlos S. The Human Phenotype Ontology: a tool for annotating and analyzing human hereditary disease. Am J Hum Genet. 2008;83:610&#x2013;615.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2668030</ArticleId><ArticleId IdType="pubmed">18950739</ArticleId></ArticleIdList></Reference><Reference><Citation>Henderson J, Bridges R, Ho JC, Wallace BC, Ghosh J. PheKnow-Cloud: A Tool for Evaluating High-Throughput Phenotype Candidates using Online Medical Literature. AMIA Jt Summits Transl Sci Proc. 2017;2017:149&#x2013;157.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5543339</ArticleId><ArticleId IdType="pubmed">28815124</ArticleId></ArticleIdList></Reference><Reference><Citation>Ling Y, An Y, Liu M, Hasan SA, Fan Y, Hu X. Integrating extra knowledge into word embedding models for biomedical NLP tasks. 2017 International Joint Conference on Neural Networks (IJCNN); 2017 May 14-19; Anchorage, AK, USA. Hoffman Estates. 2017. pp. 968&#x2013;975.</Citation></Reference><Reference><Citation>Dubois S, Romano N, Kale DC, Shah N, Jung K.  Ithaca: arXiv, Cornell University; 2017. Effective representations of clinical notes. Accessed 2019 Apr 2. Available from:  http://arxiv.org/abs/1705.07025.</Citation></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">31325501</PMID><DateCompleted><Year>2020</Year><Month>09</Month><Day>29</Day></DateCompleted><DateRevised><Year>2021</Year><Month>02</Month><Day>27</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1532-0480</ISSN><JournalIssue CitedMedium="Internet"><Volume>96</Volume><PubDate><Year>2019</Year><Month>Aug</Month></PubDate></JournalIssue><Title>Journal of biomedical informatics</Title><ISOAbbreviation>J Biomed Inform</ISOAbbreviation></Journal><ArticleTitle>Facilitating phenotype transfer using a common data model.</ArticleTitle><Pagination><StartPage>103253</StartPage><MedlinePgn>103253</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.jbi.2019.103253</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S1532-0464(19)30172-8</ELocationID><Abstract><AbstractText Label="BACKGROUND">Implementing clinical phenotypes across a network is labor intensive and potentially error prone. Use of a common data model may facilitate the process.</AbstractText><AbstractText Label="METHODS">Electronic Medical Records and Genomics (eMERGE) sites implemented the Observational Health Data Sciences and Informatics (OHDSI) Observational Medical Outcomes Partnership (OMOP) Common Data Model across their electronic health record (EHR)-linked DNA biobanks. Two previously implemented eMERGE phenotypes were converted to OMOP and implemented across the network.</AbstractText><AbstractText Label="RESULTS">It was feasible to implement the common data model across sites, with laboratory data producing the greatest challenge due to local encoding. Sites were then able to execute the OMOP phenotype in less than one day, as opposed to weeks of effort to manually implement an eMERGE phenotype in their bespoke research EHR databases. Of the sites that could compare the current OMOP phenotype implementation with the original eMERGE phenotype implementation, specific agreement ranged from 100% to 43%, with disagreements due to the original phenotype, the OMOP phenotype, changes in data, and issues in the databases. Using the OMOP query as a standard comparison revealed differences in the original implementations despite starting from the same definitions, code lists, flowcharts, and pseudocode.</AbstractText><AbstractText Label="CONCLUSION">Using a common data model can dramatically speed phenotype implementation at the cost of having to populate that data model, though this will produce a net benefit as the number of phenotype implementations increases. Inconsistencies among the implementations of the original queries point to a potential benefit of using a common data model so that actual phenotype code and logic can be shared, mitigating human error in reinterpretation of a narrative phenotype definition.</AbstractText><CopyrightInformation>Copyright &#xa9; 2019 Elsevier Inc. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Hripcsak</LastName><ForeName>George</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Department of Biomedical Informatics, Columbia University, New York, NY, United States; Medical Informatics Services, NewYork-Presbyterian Hospital, New York, NY, United States. Electronic address: hripcsak@columbia.edu.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Shang</LastName><ForeName>Ning</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Department of Biomedical Informatics, Columbia University, New York, NY, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Peissig</LastName><ForeName>Peggy L</ForeName><Initials>PL</Initials><AffiliationInfo><Affiliation>Center for Precision Medicine Research, Marshfield Clinic Research Institute, Marshfield, WI, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rasmussen</LastName><ForeName>Luke V</ForeName><Initials>LV</Initials><AffiliationInfo><Affiliation>Northwestern University Feinberg School of Medicine, Chicago, IL, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Liu</LastName><ForeName>Cong</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Department of Biomedical Informatics, Columbia University, New York, NY, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Benoit</LastName><ForeName>Barbara</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Research Information Science and Computing, Partners Healthcare, Boston, MA, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Carroll</LastName><ForeName>Robert J</ForeName><Initials>RJ</Initials><AffiliationInfo><Affiliation>Department of Biomedical Informatics, Vanderbilt University Medical Center, Nashville, TN, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Carrell</LastName><ForeName>David S</ForeName><Initials>DS</Initials><AffiliationInfo><Affiliation>Kaiser Permanente Washington Health Research Institute, Seattle, WA, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Denny</LastName><ForeName>Joshua C</ForeName><Initials>JC</Initials><AffiliationInfo><Affiliation>Department of Biomedical Informatics, Vanderbilt University Medical Center, Nashville, TN, United States; Department of Medicine, Vanderbilt University Medical Center, Nashville, TN, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Dikilitas</LastName><ForeName>Ozan</ForeName><Initials>O</Initials><AffiliationInfo><Affiliation>Department of Cardiovascular Medicine, Mayo Clinic, Rochester, MN, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gainer</LastName><ForeName>Vivian S</ForeName><Initials>VS</Initials><AffiliationInfo><Affiliation>Research Information Science and Computing, Partners Healthcare, Boston, MA, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Howell</LastName><ForeName>Kayla Marie</ForeName><Initials>KM</Initials><AffiliationInfo><Affiliation>Vanderbilt Institute for Clinical and Translational Research, Vanderbilt University Medical Center, Nashville, TN, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Klann</LastName><ForeName>Jeffrey G</ForeName><Initials>JG</Initials><AffiliationInfo><Affiliation>Research Information Science and Computing, Partners Healthcare, Boston, MA, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kullo</LastName><ForeName>Iftikhar J</ForeName><Initials>IJ</Initials><AffiliationInfo><Affiliation>Department of Cardiovascular Medicine, Mayo Clinic, Rochester, MN, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lingren</LastName><ForeName>Todd</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Cincinnati Children's Hospital Medical Center, Cincinnati, OH, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mentch</LastName><ForeName>Frank D</ForeName><Initials>FD</Initials><AffiliationInfo><Affiliation>Center for Applied Genomics, Children's Hospital of Philadelphia, Philadelphia, PA, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Murphy</LastName><ForeName>Shawn N</ForeName><Initials>SN</Initials><AffiliationInfo><Affiliation>Research Information Science and Computing, Partners Healthcare, Boston, MA, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Natarajan</LastName><ForeName>Karthik</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Department of Biomedical Informatics, Columbia University, New York, NY, United States; Medical Informatics Services, NewYork-Presbyterian Hospital, New York, NY, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pacheco</LastName><ForeName>Jennifer A</ForeName><Initials>JA</Initials><AffiliationInfo><Affiliation>Northwestern University Feinberg School of Medicine, Chicago, IL, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wei</LastName><ForeName>Wei-Qi</ForeName><Initials>WQ</Initials><AffiliationInfo><Affiliation>Department of Biomedical Informatics, Vanderbilt University Medical Center, Nashville, TN, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wiley</LastName><ForeName>Ken</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>National Human Genome Research Institute, NIH, Bethesda, MD, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Weng</LastName><ForeName>Chunhua</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Department of Biomedical Informatics, Columbia University, New York, NY, United States.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>S10 RR025141</GrantID><Acronym>RR</Acronym><Agency>NCRR NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>U01 HG008672</GrantID><Acronym>HG</Acronym><Agency>NHGRI NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>U01 HG008684</GrantID><Acronym>HG</Acronym><Agency>NHGRI NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>U01 HG008679</GrantID><Acronym>HG</Acronym><Agency>NHGRI NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>OT2 OD026553</GrantID><Acronym>OD</Acronym><Agency>NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>U54 MD007593</GrantID><Acronym>MD</Acronym><Agency>NIMHD NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>U01 HG008680</GrantID><Acronym>HG</Acronym><Agency>NHGRI NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>U01 HG006379</GrantID><Acronym>HG</Acronym><Agency>NHGRI NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>U01 HG008664</GrantID><Acronym>HG</Acronym><Agency>NHGRI NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>U01 HG008701</GrantID><Acronym>HG</Acronym><Agency>NHGRI NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>U01 HG008676</GrantID><Acronym>HG</Acronym><Agency>NHGRI NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>UL1 TR000445</GrantID><Acronym>TR</Acronym><Agency>NCATS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R01 LM006910</GrantID><Acronym>LM</Acronym><Agency>NLM NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R01 HG009174</GrantID><Acronym>HG</Acronym><Agency>NHGRI NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>U01 HG008657</GrantID><Acronym>HG</Acronym><Agency>NHGRI NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>U01 HG008666</GrantID><Acronym>HG</Acronym><Agency>NHGRI NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R01 HL133786</GrantID><Acronym>HL</Acronym><Agency>NHLBI NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>UL1 RR024975</GrantID><Acronym>RR</Acronym><Agency>NCRR NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>U01 HG008673</GrantID><Acronym>HG</Acronym><Agency>NHGRI NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>UL1 TR002243</GrantID><Acronym>TR</Acronym><Agency>NCATS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>U01 HG008685</GrantID><Acronym>HG</Acronym><Agency>NHGRI NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D052061">Research Support, N.I.H., Extramural</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2019</Year><Month>07</Month><Day>17</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>J Biomed Inform</MedlineTA><NlmUniqueID>100970413</NlmUniqueID><ISSNLinking>1532-0464</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D001289" MajorTopicYN="N">Attention Deficit Disorder with Hyperactivity</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="Y">diagnosis</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D003625" MajorTopicYN="N">Data Collection</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016208" MajorTopicYN="Y">Databases, Factual</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003924" MajorTopicYN="N">Diabetes Mellitus, Type 2</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="Y">diagnosis</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D057286" MajorTopicYN="Y">Electronic Health Records</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008490" MajorTopicYN="N">Medical Informatics</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D054560" MajorTopicYN="N">National Human Genome Research Institute (U.S.)</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D064887" MajorTopicYN="N">Observational Studies as Topic</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017063" MajorTopicYN="N">Outcome Assessment, Health Care</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D010641" MajorTopicYN="N">Phenotype</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012107" MajorTopicYN="N">Research Design</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012984" MajorTopicYN="N">Software</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014481" MajorTopicYN="N" Type="Geographic">United States</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Common data model</Keyword><Keyword MajorTopicYN="N">Electronic health records</Keyword><Keyword MajorTopicYN="N">Phenotyping</Keyword></KeywordList><CoiStatement>Conflicts of interest: None reported.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2019</Year><Month>3</Month><Day>26</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2019</Year><Month>7</Month><Day>11</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2019</Year><Month>7</Month><Day>16</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2019</Year><Month>7</Month><Day>22</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2020</Year><Month>9</Month><Day>30</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2019</Year><Month>7</Month><Day>21</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2020</Year><Month>8</Month><Day>1</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">31325501</ArticleId><ArticleId IdType="mid">NIHMS1535478</ArticleId><ArticleId IdType="pmc">PMC6697565</ArticleId><ArticleId IdType="doi">10.1016/j.jbi.2019.103253</ArticleId><ArticleId IdType="pii">S1532-0464(19)30172-8</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Newton KM, Peissig PL, Kho AN, Bielinski SJ, Berg RL, Choudhary V, Basford M, Chute CG, Kullo IJ, Li R, Pacheco JA, Rasmussen LV, Spangler L, Denny JC. J Am Med Inform Assoc. 2013 Jun;20(e1):e147&#x2013;54. Validation of electronic medical record&#x2013;based phenotyping algorithms: results and lessons learned from the eMERGE network. J Am Med Inform Assoc 2013;20(e1):e147&#x2013;54.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3715338</ArticleId><ArticleId IdType="pubmed">23531748</ArticleId></ArticleIdList></Reference><Reference><Citation>Mo H, Thompson WK, Rasmussen LV, Pacheco JA, Jiang G, Kiefer R, Zhu Q, Xu J, Montague E, Carrell DS, Lingren T, Mentch FD, Ni Y, Wehbe FH, Peissig PL, Tromp G, Larson EB, Chute CG, Pathak J, Denny JC, Speltz P, Kho AN, Jarvik GP, Bejan CA, Williams MS, Borthwick K, Kitchner TE, Roden DM, Harris PA. Desiderata for computable representations of electronic health records-driven phenotype algorithms. J Am Med Inform Assoc. 2015. November;22(6):1220&#x2013;30. doi: 10.1093/jamia/ocv112.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/jamia/ocv112</ArticleId><ArticleId IdType="pmc">PMC4639716</ArticleId><ArticleId IdType="pubmed">26342218</ArticleId></ArticleIdList></Reference><Reference><Citation>Conway M, Berg RL, Carrell D, Denny JC, Kho AN, Kullo IJ, Linneman JG, Pacheco JA, Peissig P, Rasmussen L, Weston N, Chute CG, Pathak J. Analyzing the heterogeneity and complexity of Electronic Health Record oriented phenotyping algorithms. AMIA Annu Symp Proc. 2011;2011:274&#x2013;83.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3243189</ArticleId><ArticleId IdType="pubmed">22195079</ArticleId></ArticleIdList></Reference><Reference><Citation>Hripcsak G, Albers DJ. High-fidelity phenotyping: richness and freedom from bias. J Am Med Inform Assoc 2017. doi: 10.1093/jamia/ocx110.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/jamia/ocx110</ArticleId><ArticleId IdType="pmc">PMC7282504</ArticleId><ArticleId IdType="pubmed">29040596</ArticleId></ArticleIdList></Reference><Reference><Citation>Hripcsak G, Albers DJ. Next-generation phenotyping of electronic health records. J Am Med Inform Assoc 2013;20:117&#x2013;21. doi:10.1136/amiajnl-2012-001145.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/amiajnl-2012-001145</ArticleId><ArticleId IdType="pmc">PMC3555337</ArticleId><ArticleId IdType="pubmed">22955496</ArticleId></ArticleIdList></Reference><Reference><Citation>McCarty CA, Chisholm RL, Chute CG, Kullo IJ, Jarvik GP, Larson EB, Li R, Masys DR, Ritchie MD, Roden DM, Struewing JP, Wolf WA; eMERGE Team. The eMERGE Network: a consortium of biorepositories linked to electronic medical records data for conducting genomic studies. BMC Med Genomics. 2011. January 26;4:13.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3038887</ArticleId><ArticleId IdType="pubmed">21269473</ArticleId></ArticleIdList></Reference><Reference><Citation>Gottesman O, Kuivaniemi H, Tromp G, Faucett WA, Li R, Manolio TA, Sanderson SC, Kannry J, Zinberg R, Basford MA, Brilliant M, Carey DJ, Chisholm RL, Chute CG, Connolly JJ, Crosslin D, Denny JC, Gallego CJ, Haines JL, Hakonarson H, Harley J, Jarvik GP, Kohane I, Kullo IJ, Larson EB, McCarty C, Ritchie MD, Roden DM, Smith ME, B&#xf6;ttinger EP, Williams MS; eMERGE Network. The Electronic Medical Records and Genomics (eMERGE) Network: past, present, and future. Genet Med. 2013. October;15(10):761&#x2013;71.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3795928</ArticleId><ArticleId IdType="pubmed">23743551</ArticleId></ArticleIdList></Reference><Reference><Citation>Pathak J, Wang J, Kashyap S, Basford M, Li R, Masys DR, Chute CG. Mapping clinical phenotype data elements to standardized metadata repositories and controlled terminologies: the eMERGE Network experience. J Am Med Inform Assoc. 2011. Jul-Aug;18(4):376&#x2013;86.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3128396</ArticleId><ArticleId IdType="pubmed">21597104</ArticleId></ArticleIdList></Reference><Reference><Citation>Hripcsak G, Levine ME, Shang N, Ryan PB. Effect of vocabulary mapping for conditions on phenotype cohorts. J Am Med Inform Assoc. 2018. December 1;25(12):1618&#x2013;1625.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6289550</ArticleId><ArticleId IdType="pubmed">30395248</ArticleId></ArticleIdList></Reference><Reference><Citation>Pathak J, Pan H, Wang J, Kashyap S, Schad PA, Hamilton CM, Masys DR, Chute CG. Evaluating Phenotypic Data Elements for Genetics and Epidemiological Research: Experiences from the eMERGE and PhenX Network Projects. AMIA Jt Summits Transl Sci Proc. 2011;2011:41&#x2013;5.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3248754</ArticleId><ArticleId IdType="pubmed">22211178</ArticleId></ArticleIdList></Reference><Reference><Citation>Rasmussen LV, Thompson WK, Pacheco JA, Kho AN, Carrell DS, Pathak J, Peissig PL, Tromp G, Denny JC, Starren JB. Design patterns for the development of electronic health record-driven phenotype extraction algorithms. J Biomed Inform. 2014. October;51:280&#x2013;6</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4194216</ArticleId><ArticleId IdType="pubmed">24960203</ArticleId></ArticleIdList></Reference><Reference><Citation>Thompson WK, Rasmussen LV, Pacheco JA, Peissig PL, Denny JC, Kho AN, Miller A, Pathak J. An evaluation of the NQF Quality Data Model for representing Electronic Health Record driven phenotyping algorithms. AMIA Annu Symp Proc. 2012;2012:911&#x2013;20.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3540514</ArticleId><ArticleId IdType="pubmed">23304366</ArticleId></ArticleIdList></Reference><Reference><Citation>Peissig PL, Rasmussen LV, Berg RL, Linneman JG, McCarty CA, Waudby C, Chen L, Denny JC, Wilke RA, Pathak J, Carrell D, Kho AN, Starren JB. Importance of multimodal approaches to effectively identify cataract cases from electronic health records. J Am Med Inform Assoc. 2012. Mar-Apr;19(2):225&#x2013;34.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3277618</ArticleId><ArticleId IdType="pubmed">22319176</ArticleId></ArticleIdList></Reference><Reference><Citation>Castro VM, Dligach D, Finan S, Yu S, Can A, Abd-El-Barr M, Gainer V, Shadick NA, Murphy S, Cai T, Savova G, Weiss ST, Du R. Large-scale identification of patients with cerebral aneurysms using natural language processing. Neurology 2017. January 10; 88(2):164&#x2013;168.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5224711</ArticleId><ArticleId IdType="pubmed">27927935</ArticleId></ArticleIdList></Reference><Reference><Citation>Liao KP, Ananthakrishnan AN, Kumar V, Xia Z, Cagan A, Gainer VS, Goryachev S, Chen P, Savova GK, Agniel D, Churchill S, Lee J, Murphy SN, Plenge RM, Szolovits P, Kohane I, Shaw SY, Karlson EW, Cai T. Methods to Develop an Electronic Medical Record Phenotype Algorithm to Compare the Risk of Coronary Artery Disease across 3 Chronic Disease Cohorts. PLoS One 2015; 10(8):e0136651.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4547801</ArticleId><ArticleId IdType="pubmed">26301417</ArticleId></ArticleIdList></Reference><Reference><Citation>Yu S, Ma Y, Gronsbell J, Cai T, Ananthakrishnan AN, Gainer VS, Churchill SE, Szolovits P, Murphy SN, Kohane IS, Liao KP, Cai T. Enabling phenotypic big data with PheNorm. J Am Med Inform Assoc 2018. 01 01; 25(1):54&#x2013;60.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6251688</ArticleId><ArticleId IdType="pubmed">29126253</ArticleId></ArticleIdList></Reference><Reference><Citation>Pacheco JA, Rasmussen LV, Kiefer RC, Campion TR, Speltz P, Carroll RJ, Stallings SC, Mo H, Ahuja M, Jiang G, LaRose ER, Peissig PL, Shang N, Benoit B, Gainer VS, Borthwick K, Jackson KL, Sharma A, Wu AY, Kho AN, Roden DM, Pathak J, Denny JC, Thompson WK. A case study evaluating the portability of an executable computable phenotype algorithm across multiple institutions and electronic health record environments. J Am Med Inform Assoc. 2018. November 1;25(11):1540&#x2013;1546.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6213083</ArticleId><ArticleId IdType="pubmed">30124903</ArticleId></ArticleIdList></Reference><Reference><Citation>Hripcsak G, Ryan PB, Duke JD, Shah NH, Park RW, Huser V, Suchard MA, Schuemie MJ, DeFalco FJ, Perotte A, Banda JM, Reich CG, Schilling LM, Matheny ME, Meeker D, Pratt N, Madigan D. Characterizing treatment pathways at scale using the OHDSI network. Proc Natl Acad Sci U S A 2016;113:7329&#x2013;36.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4941483</ArticleId><ArticleId IdType="pubmed">27274072</ArticleId></ArticleIdList></Reference><Reference><Citation>Overhage JM, Ryan PB, Reich CG, Hartzema AG, Stang PE. Validation of a common data model for active safety surveillance research. J Am Med Inform Assoc. 2012. Jan-Feb;19(1):54&#x2013;60.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3240764</ArticleId><ArticleId IdType="pubmed">22037893</ArticleId></ArticleIdList></Reference><Reference><Citation>SNOMED CT. http://www.snomed.org/snomed-ct (accessed 2019 March 14).</Citation></Reference><Reference><Citation>U.S. National Library of Medicine. Unified Medical Language System (UMLS) RxNorm. https://www.nlm.nih.gov/research/umls/rxnorm/ (accessed 2019 March 14).</Citation></Reference><Reference><Citation>Regenstrief Institute. LOINC. https://loinc.org/ (accessed 2019 March 14).</Citation></Reference><Reference><Citation>Wagner EH, Greene SM, Hart G, et al. Building a research consortium of large health systems: the Cancer Research Network. J Natl Cancer Inst Monogr. 2005(35):3&#x2013;11.</Citation><ArticleIdList><ArticleId IdType="pubmed">16287880</ArticleId></ArticleIdList></Reference><Reference><Citation>Fleurence RL, Curtis LH, Califf RM, Platt R, Selby JV, Brown JS. Launching PCORnet, a national patient-centered clinical research network. J Am Med Inform Assoc. 2014;21(4):578&#x2013;582.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4078292</ArticleId><ArticleId IdType="pubmed">24821743</ArticleId></ArticleIdList></Reference><Reference><Citation>United States Food and Drug Administration. Sentinel Distributed Database and Common Data Model. 2017; https://www.sentinelinitiative.org/sentinel/data/distributed-database-commondata-model.
Accessed 2017 Jul 21.</Citation></Reference><Reference><Citation>Kirby JC, Speltz P, Rasmussen LV, Basford M, Gottesman O, Peissig PL, Pacheco JA, Tromp G, Pathak J, Carrell DS, Ellis SB, Lingren T, Thompson WK, Savova G, Haines J, Roden DM, Harris PA, Denny JC. PheKB: a catalog and workflow for creating electronic phenotype algorithms for transportability. J Am Med Inform Assoc 2016;23:1046&#x2013;1052.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5070514</ArticleId><ArticleId IdType="pubmed">27026615</ArticleId></ArticleIdList></Reference><Reference><Citation>International Classification of Diseases, Ninth Revision, Clinical Modification (ICD-9-CM), National Center for Health Statistics; 
http://www.cdc.gov/nchs/icd/icd9cm.htm (accessed 2019 March 14).</Citation></Reference><Reference><Citation>International Classification of Diseases, Tenth Revision, Clinical Modification (ICD-10-CM), National Center for Health Statistics; 
http://www.cdc.gov/nchs/icd/icd10cm.htm (accessed 2019 March 14).</Citation></Reference><Reference><Citation>ODHSI. ATLAS. https://github.com/OHDSI/Atlas (assessed 2019 March 14).</Citation></Reference><Reference><Citation>PheKB. Type 2 Diabetes Mellitus. https://phekb.org/phenotype/type-2-diabetes-mellitus (accessed 2019 March 7).</Citation></Reference><Reference><Citation>PheKB. ADHD phenotype algorithm. https://phekb.org/phenotype/adhd-phenotype-algorithm (accessed 2019 March 7).</Citation></Reference><Reference><Citation>Hripcsak G, Rothschild AS. Agreement, the F-measure, and reliability in information retrieval. J Am Med Inform Assoc 2005;12:296&#x2013;8.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1090460</ArticleId><ArticleId IdType="pubmed">15684123</ArticleId></ArticleIdList></Reference><Reference><Citation>Pryor TA, Hripcsak G. Sharing MLM&#x2019;s: an experiment between Columbia-Presbyterian and LDS Hospital. Proc Annu Symp Comput Appl Med Care 1993:399&#x2013;403.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2248539</ArticleId><ArticleId IdType="pubmed">8130503</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">31365089</PMID><DateCompleted><Year>2021</Year><Month>01</Month><Day>13</Day></DateCompleted><DateRevised><Year>2024</Year><Month>01</Month><Day>04</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1527-974X</ISSN><JournalIssue CitedMedium="Internet"><Volume>26</Volume><Issue>8-9</Issue><PubDate><Year>2019</Year><Month>Aug</Month><Day>01</Day></PubDate></JournalIssue><Title>Journal of the American Medical Informatics Association : JAMIA</Title><ISOAbbreviation>J Am Med Inform Assoc</ISOAbbreviation></Journal><ArticleTitle>Challenges with quality of race and ethnicity data in observational databases.</ArticleTitle><Pagination><StartPage>730</StartPage><EndPage>736</EndPage><MedlinePgn>730-736</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1093/jamia/ocz113</ELocationID><Abstract><AbstractText Label="OBJECTIVE">We sought to assess the quality of race and ethnicity information in observational health databases, including electronic health records (EHRs), and to propose patient self-recording as an improvement strategy.</AbstractText><AbstractText Label="MATERIALS AND METHODS">We assessed completeness of race and ethnicity information in large observational health databases in the United States (Healthcare Cost and Utilization Project and Optum Labs), and at a single healthcare system in New York City serving a racially and ethnically diverse population. We compared race and ethnicity data collected via administrative processes with data recorded directly by respondents via paper surveys (National Health and Nutrition Examination Survey and Hospital Consumer Assessment of Healthcare Providers and Systems). Respondent-recorded data were considered the gold standard for the collection of race and ethnicity information.</AbstractText><AbstractText Label="RESULTS">Among the 160 million patients from the Healthcare Cost and Utilization Project and Optum Labs datasets, race or ethnicity was unknown for 25%. Among the 2.4 million patients in the single New York City healthcare system's EHR, race or ethnicity was unknown for 57%. However, when patients directly recorded their race and ethnicity, 86% provided clinically meaningful information, and 66% of patients reported information that was discrepant with the EHR.</AbstractText><AbstractText Label="DISCUSSION">Race and ethnicity data are critical to support precision medicine initiatives and to determine healthcare disparities; however, the quality of this information in observational databases is concerning. Patient self-recording through the use of patient-facing tools can substantially increase the quality of the information while engaging patients in their health.</AbstractText><AbstractText Label="CONCLUSIONS">Patient self-recording may improve the completeness of race and ethnicity information.</AbstractText><CopyrightInformation>&#xa9; The Author(s) 2019. Published by Oxford University Press on behalf of the American Medical Informatics Association. All rights reserved. For permissions, please email: journals.permissions@oup.com.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Polubriaginof</LastName><ForeName>Fernanda C G</ForeName><Initials>FCG</Initials><AffiliationInfo><Affiliation>Value Institute, NewYork-Presbyterian Hospital, New York, New York, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Steele Institute for Health Innovation, Geisinger, Danville, Pennsylvania and Department of Biomedical Informatics, Columbia University, New York, New York.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ryan</LastName><ForeName>Patrick</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Steele Institute for Health Innovation, Geisinger, Danville, Pennsylvania and Department of Biomedical Informatics, Columbia University, New York, New York.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Epidemiology Analytics, Janssen Research &amp; Development, LLC, Titusville, New Jersey, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Salmasian</LastName><ForeName>Hojjat</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Division of General Internal Medicine, Harvard Medical School, Boston, Massachusetts, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Quality and Safety, Brigham and Women's Hospital Boston, Massachusetts, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Shapiro</LastName><ForeName>Andrea Wells</ForeName><Initials>AW</Initials><AffiliationInfo><Affiliation>Value Institute, NewYork-Presbyterian Hospital, New York, New York, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Perotte</LastName><ForeName>Adler</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Steele Institute for Health Innovation, Geisinger, Danville, Pennsylvania and Department of Biomedical Informatics, Columbia University, New York, New York.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Safford</LastName><ForeName>Monika M</ForeName><Initials>MM</Initials><AffiliationInfo><Affiliation>Division of General Internal Medicine, Department of Medicine, Weill Cornell Medical College, New York, New York, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hripcsak</LastName><ForeName>George</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Steele Institute for Health Innovation, Geisinger, Danville, Pennsylvania and Department of Biomedical Informatics, Columbia University, New York, New York.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Medical Informatics Services, Human Resources, NewYork-Presbyterian Hospital, New York, New York, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Smith</LastName><ForeName>Shaun</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>NewYork-Presbyterian Hospital, New York, New York, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tatonetti</LastName><ForeName>Nicholas P</ForeName><Initials>NP</Initials><AffiliationInfo><Affiliation>Steele Institute for Health Innovation, Geisinger, Danville, Pennsylvania and Department of Biomedical Informatics, Columbia University, New York, New York.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Vawdrey</LastName><ForeName>David K</ForeName><Initials>DK</Initials><AffiliationInfo><Affiliation>Value Institute, NewYork-Presbyterian Hospital, New York, New York, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Steele Institute for Health Innovation, Geisinger, Danville, Pennsylvania and Department of Biomedical Informatics, Columbia University, New York, New York.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>R01 LM006910</GrantID><Acronym>LM</Acronym><Agency>NLM NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R01 HS021816</GrantID><Acronym>HS</Acronym><Agency>AHRQ HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R01 HS024713</GrantID><Acronym>HS</Acronym><Agency>AHRQ HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R01 GM107145</GrantID><Acronym>GM</Acronym><Agency>NIGMS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R35 GM131905</GrantID><Acronym>GM</Acronym><Agency>NIGMS NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D052061">Research Support, N.I.H., Extramural</PublicationType><PublicationType UI="D013487">Research Support, U.S. Gov't, P.H.S.</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>J Am Med Inform Assoc</MedlineTA><NlmUniqueID>9430800</NlmUniqueID><ISSNLinking>1067-5027</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D016208" MajorTopicYN="Y">Databases, Factual</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D066264" MajorTopicYN="N">Datasets as Topic</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D057286" MajorTopicYN="N">Electronic Health Records</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005006" MajorTopicYN="Y">Ethnicity</DescriptorName><QualifierName UI="Q000706" MajorTopicYN="N">statistics &amp; numerical data</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D019538" MajorTopicYN="N">Health Care Surveys</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D054625" MajorTopicYN="N">Healthcare Disparities</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006751" MajorTopicYN="N">Hospital Information Systems</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009519" MajorTopicYN="N" Type="Geographic">New York City</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009749" MajorTopicYN="N">Nutrition Surveys</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D044469" MajorTopicYN="Y">Racial Groups</DescriptorName><QualifierName UI="Q000706" MajorTopicYN="N">statistics &amp; numerical data</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012189" MajorTopicYN="N">Retrospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D057566" MajorTopicYN="N">Self Report</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014481" MajorTopicYN="N" Type="Geographic">United States</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">data quality</Keyword><Keyword MajorTopicYN="N">electronic health records</Keyword><Keyword MajorTopicYN="N">ethnic groups</Keyword><Keyword MajorTopicYN="N">patient-facing tools</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2019</Year><Month>1</Month><Day>3</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2019</Year><Month>5</Month><Day>14</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2019</Year><Month>6</Month><Day>14</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2019</Year><Month>8</Month><Day>1</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2021</Year><Month>1</Month><Day>14</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2019</Year><Month>8</Month><Day>1</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2020</Year><Month>7</Month><Day>31</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">31365089</ArticleId><ArticleId IdType="pmc">PMC6696496</ArticleId><ArticleId IdType="doi">10.1093/jamia/ocz113</ArticleId><ArticleId IdType="pii">5542028</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Adler NE, Stead WW.. Patients in context&#x2013;EHR capture of social and behavioral determinants of health. N Engl J Med 2015; 372 (8): 698&#x2013;701.</Citation><ArticleIdList><ArticleId IdType="pubmed">25693009</ArticleId></ArticleIdList></Reference><Reference><Citation>Hasnain-Wynia R, Pierce D, Pittman MA.. Who, What, When, Where: The Current State of Data of Collection on Race and Ethnicity in Hospitals. New York: Commonwealth Fund; 2004.</Citation></Reference><Reference><Citation>Gail MH, Brinton LA, Byar DP, et al. Projecting individualized probabilities of developing breast cancer for white females who are being examined annually. J Natl Cancer Inst 1989; 81 (24): 1879&#x2013;86.</Citation><ArticleIdList><ArticleId IdType="pubmed">2593165</ArticleId></ArticleIdList></Reference><Reference><Citation>Levey AS, Stevens LA, Schmid CH, et al. A new equation to estimate glomerular filtration rate. Ann Intern Med 2009; 150 (9): 604&#x2013;12.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2763564</ArticleId><ArticleId IdType="pubmed">19414839</ArticleId></ArticleIdList></Reference><Reference><Citation>Stevens LA, Coresh J, Greene T, Levey AS.. Assessing kidney function&#x2013;measured and estimated glomerular filtration rate. N Engl J Med 2006; 354 (23): 2473&#x2013;83.</Citation><ArticleIdList><ArticleId IdType="pubmed">16760447</ArticleId></ArticleIdList></Reference><Reference><Citation>Dorsey R, Graham G, Glied S, Meyers D, Clancy C, Koh H.. Implementing health reform: improved data collection and the monitoring of health disparities. Annu Rev Public Health 2014; 35 (1): 123&#x2013;38.</Citation><ArticleIdList><ArticleId IdType="pubmed">24365094</ArticleId></ArticleIdList></Reference><Reference><Citation>Douglas MD, Dawes DE, Holden KB, Mack D.. Missed policy opportunities to advance health equity by recording demographic data in electronic health records. Am J Public Health 2015; 105 suppl 3: S380&#x2013;8.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4455508</ArticleId><ArticleId IdType="pubmed">25905840</ArticleId></ArticleIdList></Reference><Reference><Citation>Kressin NR. Race/Ethnicity identification: vital for disparities research, quality improvement, and much more than &#x201c;meets the eye&#x201d;. Medical Care 2015; 53 (8): 663&#x2013;5.</Citation><ArticleIdList><ArticleId IdType="pubmed">26172936</ArticleId></ArticleIdList></Reference><Reference><Citation>LaVeist TA, Gaskin D, Richard P.. Estimating the economic burden of racial health inequalities in the United States. Int J Health Serv 2011; 41 (2): 231&#x2013;8.</Citation><ArticleIdList><ArticleId IdType="pubmed">21563622</ArticleId></ArticleIdList></Reference><Reference><Citation>Buntin MB, Ayanian JZ.. Social risk factors and equity in medicare payment. N Engl J Med 2017; 376 (6): 507&#x2013;10.</Citation><ArticleIdList><ArticleId IdType="pubmed">28177864</ArticleId></ArticleIdList></Reference><Reference><Citation>Blustein J. The reliability of racial classifications in hospital discharge abstract data. Am J Public Health 1994; 84 (6): 1018&#x2013;21.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1614947</ArticleId><ArticleId IdType="pubmed">8203669</ArticleId></ArticleIdList></Reference><Reference><Citation>Chakkalakal RJ, Green JC, Krumholz HM, Nallamothu BK.. Standardized data collection practices and the racial/ethnic distribution of hospitalized patients. Med Care 2015; 53 (8): 666&#x2013;72.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4503513</ArticleId><ArticleId IdType="pubmed">26147864</ArticleId></ArticleIdList></Reference><Reference><Citation>Gomez SL, Glaser SL.. Misclassification of race/ethnicity in a Population-based Cancer Registry (United States). Cancer Causes Control 2006; 17 (6): 771&#x2013;81.</Citation><ArticleIdList><ArticleId IdType="pubmed">16783605</ArticleId></ArticleIdList></Reference><Reference><Citation>Hamilton NS, Edelman D, Weinberger M, Jackson GL.. Concordance between self-reported race/ethnicity and that recorded in a Veteran Affairs electronic medical record. N C Med J 2009; 70 (4): 296&#x2013;300.</Citation><ArticleIdList><ArticleId IdType="pubmed">19835243</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee SJC, Grobe JE, Tiro JA.. Assessing race and ethnicity data quality across cancer registries and EMRs in two hospitals. J Am Med Inform Assoc 2016; 23 (3): 627&#x2013;34.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6095103</ArticleId><ArticleId IdType="pubmed">26661718</ArticleId></ArticleIdList></Reference><Reference><Citation>Moscou S, Anderson MR, Kaplan JB, Valencia L.. Validity of racial/ethnic classifications in medical records data: an exploratory study. Am J Public Health 2003; 93 (7): 1084&#x2013;6.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1447913</ArticleId><ArticleId IdType="pubmed">12835189</ArticleId></ArticleIdList></Reference><Reference><Citation>Baker DW, Hasnain-Wynia R, Kandula NR, Thompson JA, Brown ER.. Attitudes toward health care providers, collecting information about patients' race, ethnicity, and language. Med Care 2007; 45 (11): 1034&#x2013;42.</Citation><ArticleIdList><ArticleId IdType="pubmed">18049343</ArticleId></ArticleIdList></Reference><Reference><Citation>Berry C, Kaplan SA, Mijanovich T, Mayer A.. Moving to patient reported collection of race and ethnicity data. International J Health Care QA 2014; 27 (4): 271&#x2013;83.</Citation><ArticleIdList><ArticleId IdType="pubmed">25076602</ArticleId></ArticleIdList></Reference><Reference><Citation>Nelson NC, Evans RS, Samore MH, Gardner RM.. Detection and prevention of medication errors using real-time bedside nurse charting. J Am Med Inform Assoc 2005; 12 (4): 390&#x2013;7.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1174883</ArticleId><ArticleId IdType="pubmed">15802486</ArticleId></ArticleIdList></Reference><Reference><Citation>Office of Management and Budget. Standards for Maintaining, Collecting, and Presenting Federal Data on Race and Ethnicity Statistical Policy Directive No 15. October 1997. Washington, DC: Government Printing Office; 1997.</Citation></Reference><Reference><Citation>
Healthcare Cost and Utilization Project (HCUP). Healthcare Cost and Utilization Project. https://www.hcup-us.ahrq.gov. Accessed August 21, 2017.</Citation></Reference><Reference><Citation>Wallace PJ, Shah ND, Dennen T, Bleicher PA, Bleicher PD, Crown WH.. Optum Labs: building a novel node in the learning health care system. Health Aff (Millwood) 2014; 33 (7): 1187&#x2013;94.</Citation><ArticleIdList><ArticleId IdType="pubmed">25006145</ArticleId></ArticleIdList></Reference><Reference><Citation>
Optum. Optum Data Assets. https://www.optum.com/content/dam/optum/resources/productSheets/5302_Data_Assets_Chart_Sheet_ISPOR.pdf. Accessed January 10, 2018.</Citation></Reference><Reference><Citation>Centers for Disease Control and Prevention. National Health and Nutrition Examination Survey (NHANES). Vol. 2007. Hyattsville, MD: National Center for Health Statistics; 2007.</Citation></Reference><Reference><Citation>Ng PC, Zhao Q, Levy S, Strausberg RL, Venter JC.. Individual genomes instead of race for personalized medicine. Clin Pharmacol Ther 2008; 84 (3): 306&#x2013;9.</Citation><ArticleIdList><ArticleId IdType="pubmed">18714319</ArticleId></ArticleIdList></Reference><Reference><Citation>Yudell M, Roberts D, DeSalle R, Tishkoff S.. SCIENCE AND SOCIETY. Taking race out of human genetics. Science 2016; 351 (6273): 564&#x2013;5.</Citation><ArticleIdList><ArticleId IdType="pubmed">26912690</ArticleId></ArticleIdList></Reference><Reference><Citation>Markus HR. Pride, prejudice, and ambivalence: toward a unified theory of race and ethnicity. Am Psychol 2008; 63 (8): 651&#x2013;70.</Citation><ArticleIdList><ArticleId IdType="pubmed">19014214</ArticleId></ArticleIdList></Reference><Reference><Citation>Robbin A. The problematic status of US statistics on race and ethnicity: An &#x201c;imperfect representation of reality. J Gov Inf 1999; 26 (5): 467&#x2013;83.</Citation></Reference><Reference><Citation>Bhalla R, Yongue BG, Currie BP.. Standardizing race, ethnicity, and preferred language data collection in hospital information systems: results and implications for healthcare delivery and policy. J Healthc Qual 2012; 34 (2): 44&#x2013;52.</Citation><ArticleIdList><ArticleId IdType="pubmed">23552201</ArticleId></ArticleIdList></Reference><Reference><Citation>Sholle ET, Pinheiro LC, Adekkanattu P, et al. Underserved populations with missing race ethnicity data differ significantly from those with structured race/ethnicity documentation. J Am Med Inform Assoc 2019; 94 (8): 666&#x2013;8.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6696506</ArticleId><ArticleId IdType="pubmed">31329882</ArticleId></ArticleIdList></Reference><Reference><Citation>
Polubriaginof F, Salmasian H, Shapiro AW,
et al. Patient-provided data improves race and ethnicity data quality in electronic health records. 2016. 
https://knowledge.amia.org/amia-63300-1.3360278/t001-1.3365273/f001-1.3365274/2498793-1.3365423/2498793-1.3365424.</Citation></Reference><Reference><Citation>Antonio MG, Petrovskaya O, Lau F.. Is research on patient portals attuned to health equity? A scoping review. J Am Med Inform Assoc 2019; 27 (9650): 167&#x2013;13.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7647227</ArticleId><ArticleId IdType="pubmed">31066893</ArticleId></ArticleIdList></Reference><Reference><Citation>Ancker JS, Hafeez B, Kaushal R.. Socioeconomic disparities in adoption of personal health records over time. Am J Manag Care 2016; 22 (8): 539&#x2013;40.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5474311</ArticleId><ArticleId IdType="pubmed">27541700</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">31368080</PMID><DateCompleted><Year>2020</Year><Month>06</Month><Day>09</Day></DateCompleted><DateRevised><Year>2021</Year><Month>01</Month><Day>10</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1179-1942</ISSN><JournalIssue CitedMedium="Internet"><Volume>42</Volume><Issue>11</Issue><PubDate><Year>2019</Year><Month>Nov</Month></PubDate></JournalIssue><Title>Drug safety</Title><ISOAbbreviation>Drug Saf</ISOAbbreviation></Journal><ArticleTitle>A Novel Approach to Visualize Risk Minimization Effectiveness: Peeping at the 2012 UK Proton Pump Inhibitor Label Change Using a Rapid Cycle Analysis Tool.</ArticleTitle><Pagination><StartPage>1365</StartPage><EndPage>1376</EndPage><MedlinePgn>1365-1376</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1007/s40264-019-00853-y</ELocationID><Abstract><AbstractText Label="INTRODUCTION">Evaluation of risk minimization (RM) actions is an emerging area of regulatory science, often without tools to rapidly and systematically assess their effectiveness.</AbstractText><AbstractText Label="PURPOSE">The aim of this study was to evaluate whether chronographs, typically used for rapid signal detection in observational longitudinal databases, could be used to visualize RM effectiveness. We evaluated the UK Medicines and Healthcare products Regulatory Agency (MHRA) 2012 proton-pump inhibitors (PPIs) class-wide label change that warned of increased risk of bone fracture, advocated to limit duration of use, and recommended to treat those at risk for osteoporosis according to clinical guidelines.</AbstractText><AbstractText Label="METHODS">The cohort consisted of adults aged 18&#xa0;years and above prescribed one of the five PPIs available in the UK The Health Improvement Network (THIN) database through September 2015. Four chronographs were compared using drug episodes that started before (PRE) and after (POST) the 20 April 2012 MHRA warning; fracture and osteoporosis were evaluated separately. Chronographs show a measure of observed/expected events, the Information Component (IC) and 95% credibility interval (CI), calculated at monthly time intervals relative to the start date of a prescription, and summed to estimate IC over a 3-year period; IC&#x2009;&gt;&#x2009;0 indicates observed&#x2009;&gt;&#x2009;expected events. We hypothesized that chronographs may assess RM effectiveness if stratified by PRE/POST an RM intervention such as a label change.</AbstractText><AbstractText Label="RESULTS">There were 1,588,973 and 664,601 PPI users in the PRE and POST periods, respectively. We observed a 4.6% reduction in the proportion of long-term PPI episodes and a 4.1% reduction in the overall proportion of the THIN population using PPIs. Compared with the PRE chronographs, when both visually comparing and when examining the summed ICs for fracture in the POST period, a significant reduction was observed overall (IC&#x2009;=&#x2009;0.024 [95% CI 0.015 to 0.33] PRE vs -&#x2009;0.141 [95% CI -&#x2009;0.162 to -&#x2009;0.120] POST), suggesting less observed events than expected, and prior to PPI start, suggestive of strong channeling (IC&#x2009;=&#x2009;-&#x2009;0.027 [95% CI -&#x2009;0.037 to -&#x2009;0.017] PRE vs -&#x2009;0.291 [95% CI -&#x2009;0.308 to -&#x2009;0.274] POST). Results were qualitatively similar for osteoporosis.</AbstractText><AbstractText Label="CONCLUSIONS">This pilot demonstrated a novel application of a visual, rapid analysis technique to assess RM effectiveness, and supported a hypothesis that prescribers altered some behaviors after the MHRA label change, such as channeling patients at risk of fracture or osteoporosis away from PPI use and potentially reducing fracture outcomes. Limitations include lack of confounding control and outcomes defined only by diagnosis code. Results demonstrate the potential to use large healthcare databases with chronographs to rapidly assess RM effectiveness, similar to signal detection in pharmacovigilance, and may help design more comprehensive RM evaluation studies.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Sobel</LastName><ForeName>Rachel E</ForeName><Initials>RE</Initials><Identifier Source="ORCID">0000-0002-4492-9562</Identifier><AffiliationInfo><Affiliation>Epidemiology/Worldwide Research and Development, Pfizer Inc, 235 East 42nd St. MS# 219-9-1, New York, NY, 10017, USA. RachelSobel17@gmail.com.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Blackwell</LastName><ForeName>William</ForeName><Initials>W</Initials><AffiliationInfo><Affiliation>Commonwealth Informatics Inc, a Genpact Company, Waltham, MA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Fram</LastName><ForeName>David M</ForeName><Initials>DM</Initials><AffiliationInfo><Affiliation>Commonwealth Informatics Inc, a Genpact Company, Waltham, MA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bate</LastName><ForeName>Andrew</ForeName><Initials>A</Initials><Identifier Source="ORCID">0000-0003-3151-3653</Identifier><AffiliationInfo><Affiliation>Epidemiology/Worldwide Research and Development, Pfizer Inc, 235 East 42nd St. MS# 219-9-1, New York, NY, 10017, USA.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>New Zealand</Country><MedlineTA>Drug Saf</MedlineTA><NlmUniqueID>9002928</NlmUniqueID><ISSNLinking>0114-5916</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D054328">Proton Pump Inhibitors</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000293" MajorTopicYN="N">Adolescent</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000369" MajorTopicYN="N">Aged, 80 and over</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002648" MajorTopicYN="N">Child</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002675" MajorTopicYN="N">Child, Preschool</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003626" MajorTopicYN="Y">Data Display</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004348" MajorTopicYN="Y">Drug Labeling</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007223" MajorTopicYN="N">Infant</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011358" MajorTopicYN="Y">Product Surveillance, Postmarketing</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D054328" MajorTopicYN="N">Proton Pump Inhibitors</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="Y">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012189" MajorTopicYN="N">Retrospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012308" MajorTopicYN="N">Risk Management</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006113" MajorTopicYN="N" Type="Geographic">United Kingdom</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D055815" MajorTopicYN="N">Young Adult</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>2019</Year><Month>8</Month><Day>2</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2020</Year><Month>6</Month><Day>10</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2019</Year><Month>8</Month><Day>2</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">31368080</ArticleId><ArticleId IdType="doi">10.1007/s40264-019-00853-y</ArticleId><ArticleId IdType="pii">10.1007/s40264-019-00853-y</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Clin Pharmacol Ther. 2016 Mar;99(3):265-8</Citation><ArticleIdList><ArticleId IdType="pubmed">26667601</ArticleId></ArticleIdList></Reference><Reference><Citation>J Allergy Clin Immunol. 2016 Mar;137(3):710-7</Citation><ArticleIdList><ArticleId IdType="pubmed">26725997</ArticleId></ArticleIdList></Reference><Reference><Citation>Pharmacoepidemiol Drug Saf. 2016 Sep;25(9):1079-87</Citation><ArticleIdList><ArticleId IdType="pubmed">27255671</ArticleId></ArticleIdList></Reference><Reference><Citation>Pharmacoepidemiol Drug Saf. 2017 Jan;26(1):9-16</Citation><ArticleIdList><ArticleId IdType="pubmed">27859947</ArticleId></ArticleIdList></Reference><Reference><Citation>Drug Saf. 2014 Jan;37(1):33-42</Citation><ArticleIdList><ArticleId IdType="pubmed">24357107</ArticleId></ArticleIdList></Reference><Reference><Citation>Pharmacoepidemiol Drug Saf. 2018 Jul;27(7):695-706</Citation><ArticleIdList><ArticleId IdType="pubmed">29663572</ArticleId></ArticleIdList></Reference><Reference><Citation>Pharmacoepidemiol Drug Saf. 2013 Oct;22(10):1119-29</Citation><ArticleIdList><ArticleId IdType="pubmed">23832706</ArticleId></ArticleIdList></Reference><Reference><Citation>Pharmacoepidemiol Drug Saf. 2017 Jun;26(6):607-614</Citation><ArticleIdList><ArticleId IdType="pubmed">28397317</ArticleId></ArticleIdList></Reference><Reference><Citation>Drug Saf. 2013 Oct;36 Suppl 1:S107-21</Citation><ArticleIdList><ArticleId IdType="pubmed">24166228</ArticleId></ArticleIdList></Reference><Reference><Citation>Drug Saf. 2015 Jan;38(1):87-100</Citation><ArticleIdList><ArticleId IdType="pubmed">25539877</ArticleId></ArticleIdList></Reference><Reference><Citation>Pharmacoepidemiol Drug Saf. 2016 Apr;25(4):392-8</Citation><ArticleIdList><ArticleId IdType="pubmed">26660710</ArticleId></ArticleIdList></Reference><Reference><Citation>Pharmacoepidemiol Drug Saf. 2009 Jun;18(6):427-36</Citation><ArticleIdList><ArticleId IdType="pubmed">19358225</ArticleId></ArticleIdList></Reference><Reference><Citation>Drug Saf. 2018 Sep;41(9):899-910</Citation><ArticleIdList><ArticleId IdType="pubmed">29725942</ArticleId></ArticleIdList></Reference><Reference><Citation>Drug Saf. 2015 Jun;38(6):565-75</Citation><ArticleIdList><ArticleId IdType="pubmed">25968811</ArticleId></ArticleIdList></Reference><Reference><Citation>Inform Prim Care. 2011;19(4):251-5</Citation><ArticleIdList><ArticleId IdType="pubmed">22828580</ArticleId></ArticleIdList></Reference><Reference><Citation>Pharmacoepidemiol Drug Saf. 2018 Mar;27(3):332-339</Citation><ArticleIdList><ArticleId IdType="pubmed">29392851</ArticleId></ArticleIdList></Reference><Reference><Citation>Pharmacotherapy. 2008 Aug;28(8):951-9</Citation><ArticleIdList><ArticleId IdType="pubmed">18657011</ArticleId></ArticleIdList></Reference><Reference><Citation>Am J Med. 2011 Jun;124(6):519-26</Citation><ArticleIdList><ArticleId IdType="pubmed">21605729</ArticleId></ArticleIdList></Reference><Reference><Citation>Drug Saf. 2016 Jun;39(6):469-90</Citation><ArticleIdList><ArticleId IdType="pubmed">26951233</ArticleId></ArticleIdList></Reference><Reference><Citation>Eur J Clin Pharmacol. 1998 Jun;54(4):315-21</Citation><ArticleIdList><ArticleId IdType="pubmed">9696956</ArticleId></ArticleIdList></Reference><Reference><Citation>JAMA. 2006 Dec 27;296(24):2947-53</Citation><ArticleIdList><ArticleId IdType="pubmed">17190895</ArticleId></ArticleIdList></Reference><Reference><Citation>PLoS One. 2018 Nov 30;13(11):e0208461</Citation><ArticleIdList><ArticleId IdType="pubmed">30500865</ArticleId></ArticleIdList></Reference><Reference><Citation>Pharmacoepidemiol Drug Saf. 2014 Sep;23(9):918-22</Citation><ArticleIdList><ArticleId IdType="pubmed">25044030</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">31369862</PMID><DateCompleted><Year>2020</Year><Month>08</Month><Day>14</Day></DateCompleted><DateRevised><Year>2020</Year><Month>12</Month><Day>16</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1532-0480</ISSN><JournalIssue CitedMedium="Internet"><Volume>97</Volume><PubDate><Year>2019</Year><Month>Sep</Month></PubDate></JournalIssue><Title>Journal of biomedical informatics</Title><ISOAbbreviation>J Biomed Inform</ISOAbbreviation></Journal><ArticleTitle>PheValuator: Development and evaluation of a phenotype algorithm evaluator.</ArticleTitle><Pagination><StartPage>103258</StartPage><MedlinePgn>103258</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.jbi.2019.103258</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S1532-0464(19)30177-7</ELocationID><Abstract><AbstractText Label="BACKGROUND">The primary approach for defining disease in observational healthcare databases is to construct phenotype algorithms (PAs), rule-based heuristics predicated on the presence, absence, and temporal logic of clinical observations. However, a complete evaluation of PAs, i.e., determining sensitivity, specificity, and positive predictive value (PPV), is rarely performed. In this study, we propose a tool (PheValuator) to efficiently estimate a complete PA evaluation.</AbstractText><AbstractText Label="METHODS">We used 4 administrative claims datasets: OptumInsight's de-identified Clinformatics&#x2122; Datamart (Eden Prairie,MN); IBM MarketScan Multi-State Medicaid); IBM MarketScan Medicare Supplemental Beneficiaries; and IBM MarketScan Commercial Claims and Encounters from 2000 to 2017. Using PheValuator involves (1) creating a diagnostic predictive model for the phenotype, (2) applying the model to a large set of randomly selected subjects, and (3) comparing each subject's predicted probability for the phenotype to inclusion/exclusion in PAs. We used the predictions as a 'probabilistic gold standard' measure to classify positive/negative cases. We examined 4 phenotypes: myocardial infarction, cerebral infarction, chronic kidney disease, and atrial fibrillation. We examined several PAs for each phenotype including 1-time (1X) occurrence of the diagnosis code in the subject's record and 1-time occurrence of the diagnosis in an inpatient setting with the diagnosis code as the primary reason for admission (1X-IP-1stPos).</AbstractText><AbstractText Label="RESULTS">Across phenotypes, the 1X PA showed the highest sensitivity/lowest PPV among all PAs. 1X-IP-1stPos yielded the highest PPV/lowest sensitivity. Specificity was very high across algorithms. We found similar results between algorithms across datasets.</AbstractText><AbstractText Label="CONCLUSION">PheValuator appears to show promise as a tool to estimate PA performance characteristics.</AbstractText><CopyrightInformation>Copyright &#xa9; 2019 Elsevier Inc. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Swerdel</LastName><ForeName>Joel N</ForeName><Initials>JN</Initials><AffiliationInfo><Affiliation>Janssen Research &amp; Development, 920 Route 202, Raritan, NJ 08869, USA; OHDSI Collaborators, Observational Health Data Sciences and Informatics (OHDSI), 622 West 168th Street, PH-20, New York, NY 10032, USA. Electronic address: jswerdel@its.jns.com.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hripcsak</LastName><ForeName>George</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>OHDSI Collaborators, Observational Health Data Sciences and Informatics (OHDSI), 622 West 168th Street, PH-20, New York, NY 10032, USA; Columbia University, 622 West 168th Street, PH20, New York, NY 10032, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ryan</LastName><ForeName>Patrick B</ForeName><Initials>PB</Initials><AffiliationInfo><Affiliation>Janssen Research &amp; Development, 920 Route 202, Raritan, NJ 08869, USA; OHDSI Collaborators, Observational Health Data Sciences and Informatics (OHDSI), 622 West 168th Street, PH-20, New York, NY 10032, USA; Columbia University, 622 West 168th Street, PH20, New York, NY 10032, USA.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>R01 LM006910</GrantID><Acronym>LM</Acronym><Agency>NLM NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D023362">Evaluation Study</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D052061">Research Support, N.I.H., Extramural</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2019</Year><Month>07</Month><Day>29</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>J Biomed Inform</MedlineTA><NlmUniqueID>100970413</NlmUniqueID><ISSNLinking>1532-0464</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000465" MajorTopicYN="Y">Algorithms</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001281" MajorTopicYN="N">Atrial Fibrillation</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D002544" MajorTopicYN="N">Cerebral Infarction</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D019295" MajorTopicYN="N">Computational Biology</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D039702" MajorTopicYN="N">Current Procedural Terminology</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016208" MajorTopicYN="N">Databases, Factual</DescriptorName><QualifierName UI="Q000706" MajorTopicYN="N">statistics &amp; numerical data</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D003936" MajorTopicYN="Y">Diagnosis, Computer-Assisted</DescriptorName><QualifierName UI="Q000706" MajorTopicYN="N">statistics &amp; numerical data</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D003951" MajorTopicYN="N">Diagnostic Errors</DescriptorName><QualifierName UI="Q000706" MajorTopicYN="N">statistics &amp; numerical data</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015233" MajorTopicYN="N">Models, Statistical</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009203" MajorTopicYN="N">Myocardial Infarction</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D010641" MajorTopicYN="Y">Phenotype</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011237" MajorTopicYN="N">Predictive Value of Tests</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011336" MajorTopicYN="N">Probability</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D051436" MajorTopicYN="N">Renal Insufficiency, Chronic</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012680" MajorTopicYN="N">Sensitivity and Specificity</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Diagnostic predictive modeling</Keyword><Keyword MajorTopicYN="N">Phenotype algorithms</Keyword><Keyword MajorTopicYN="N">Validation</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2019</Year><Month>4</Month><Day>1</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2019</Year><Month>7</Month><Day>9</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2019</Year><Month>7</Month><Day>28</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2019</Year><Month>8</Month><Day>2</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2020</Year><Month>8</Month><Day>15</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2019</Year><Month>8</Month><Day>2</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2020</Year><Month>12</Month><Day>15</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">31369862</ArticleId><ArticleId IdType="mid">NIHMS1651855</ArticleId><ArticleId IdType="pmc">PMC7736922</ArticleId><ArticleId IdType="doi">10.1016/j.jbi.2019.103258</ArticleId><ArticleId IdType="pii">S1532-0464(19)30177-7</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Rubbo B, Fitzpatrick NK, Denaxas S, Daskalopoulou M, Yu N, Patel RS and Hemingway H. Use of electronic health records to ascertain, validate and phenotype acute myocardial infarction: A systematic review and recommendations. Int J Cardiol. 2015;187:705&#x2013;11.</Citation><ArticleIdList><ArticleId IdType="pubmed">25966015</ArticleId></ArticleIdList></Reference><Reference><Citation>McCormick N, Bhole V, Lacaille D and Avina-Zubieta JA. Validity of Diagnostic Codes for Acute Stroke in Administrative Databases: A Systematic Review. PLoS One. 2015;10:e0135834.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4546158</ArticleId><ArticleId IdType="pubmed">26292280</ArticleId></ArticleIdList></Reference><Reference><Citation>McCormick N, Lacaille D, Bhole V and Avina-Zubieta JA. Validity of Myocardial Infarction Diagnoses in Administrative Databases: A Systematic Review. PLoS One. 2014;9:e92286.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3969323</ArticleId><ArticleId IdType="pubmed">24682186</ArticleId></ArticleIdList></Reference><Reference><Citation>Widdifield J, Labrecque J, Lix L, Paterson JM, Bernatsky S, Tu K, Ivers N and Bombardier C. Systematic review and critical appraisal of validation studies to identify rheumatic diseases in health administrative databases. Arthritis Care Res (Hoboken). 2013;65:1490&#x2013;503.</Citation><ArticleIdList><ArticleId IdType="pubmed">23436765</ArticleId></ArticleIdList></Reference><Reference><Citation>Jensen PN, Johnson K, Floyd J, Heckbert SR, Carnahan R and Dublin S. Identifying atrial fibrillation from electronic medical data: a systematic review. Pharmacoepidemiol Drug Saf. 2012;21:141&#x2013;147.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3674852</ArticleId><ArticleId IdType="pubmed">22262600</ArticleId></ArticleIdList></Reference><Reference><Citation>Pepe MS. The Statistical Evaluation of Medical Tests for Classification and Prediction: Oxford University Press; 2003.</Citation></Reference><Reference><Citation>Terris DD, Litaker DG and Koroukian SM. Health state information derived from secondary databases is affected by multiple sources of bias. J Clin Epidemiol. 2007;60:734&#x2013;741.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1952240</ArticleId><ArticleId IdType="pubmed">17573990</ArticleId></ArticleIdList></Reference><Reference><Citation>Madigan D, Ryan PB, Schuemie M, Stang PE, Overhage JM, Hartzema AG, Suchard MA, DuMouchel W and Berlin JA. Evaluating the Impact of Database Heterogeneity on Observational Study Results. Am J Epidemiol. 2013.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3736754</ArticleId><ArticleId IdType="pubmed">23648805</ArticleId></ArticleIdList></Reference><Reference><Citation>Kho ME, Duffett M, Willison DJ, Cook DJ and Brouwers MC. Written informed consent and selection bias in observational studies using medical records: systematic review. BMJ. 2009;338:b866.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2769263</ArticleId><ArticleId IdType="pubmed">19282440</ArticleId></ArticleIdList></Reference><Reference><Citation>Collins GS, Reitsma JB, Altman DG and Moons KM. Transparent reporting of a multivariable prediction model for individual prognosis or diagnosis (tripod): The tripod statement. Ann Intern Med. 2015;162:55&#x2013;63.</Citation><ArticleIdList><ArticleId IdType="pubmed">25560714</ArticleId></ArticleIdList></Reference><Reference><Citation>Dementia Carlson C.. PheKB: a catalog and workflow for creating electronic phenotype algorithms for transportability. 2012.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5070514</ArticleId><ArticleId IdType="pubmed">27026615</ArticleId></ArticleIdList></Reference><Reference><Citation>Reps JM, Schuemie MJ, Suchard MA, Ryan PB and Rijnbeek PR. Design and implementation of a standardized framework to generate and evaluate patient-level prediction models using observational healthcare data. J Am Med Inform Assoc. 2018;25:969&#x2013;975.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6077830</ArticleId><ArticleId IdType="pubmed">29718407</ArticleId></ArticleIdList></Reference><Reference><Citation>Tibshirani R Regression shrinkage and selection via the lasso. Journal of the Royal Statistical Society Series B (Methodological). 1996;58:267&#x2013;288.</Citation></Reference><Reference><Citation>Agarwal V, Podchiyska T, Banda JM, Goel V, Leung TI, Minty EP, Sweeney TE, Gyang E and Shah NH. Learning statistical models of phenotypes using noisy labeled training data. J Am Med Inform Assoc. 2016.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5070523</ArticleId><ArticleId IdType="pubmed">27174893</ArticleId></ArticleIdList></Reference><Reference><Citation>Suchard MA, Simpson SE, Zorych I, Ryan P and Madigan D. Massive parallelization of serial inference algorithms for a complex generalized linear model. ACM Trans Model Comput Simul. 2013;23.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4201181</ArticleId><ArticleId IdType="pubmed">25328363</ArticleId></ArticleIdList></Reference><Reference><Citation>Kern EFO, Maney M, Miller DR, Tseng C-L, Tiwari A, Rajan M, Aron D and Pogach L. Failure of ICD-9-CM codes to identify patients with comorbid chronic kidney disease in diabetes. Health Serv Res. 2006;41:564&#x2013;580.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1702507</ArticleId><ArticleId IdType="pubmed">16584465</ArticleId></ArticleIdList></Reference><Reference><Citation>Wahl PM, Rodgers K, Schneeweiss S, Gage BF, Butler J, Wilmer C, Nash M, Esper G, Gitlin N, Osborn N, Short LJ and Bohn RL. Validation of claims-based diagnostic and procedure codes for cardiovascular and gastrointestinal serious adverse events in a commercially-insured population. Pharmacoepidemiol Drug Saf. 2010;19:596&#x2013;603.</Citation><ArticleIdList><ArticleId IdType="pubmed">20140892</ArticleId></ArticleIdList></Reference><Reference><Citation>Choma NN, Griffin MR, Huang RL, Mitchel EF Jr., Kaltenbach LA, Gideon P, Stratton SM and Roumie CL. An algorithm to identify incident myocardial infarction using Medicaid data. Pharmacoepidemiol Drug Saf. 2009;18:1064&#x2013;71.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10401667</ArticleId><ArticleId IdType="pubmed">19718697</ArticleId></ArticleIdList></Reference><Reference><Citation>Cutrona SL, Toh S, Iyer A, Foy S, Daniel GW, Nair VP, Ng D, Butler MG, Boudreau D, Forrow S, Goldberg R, Gore J, McManus D, Racoosin JA and Gurwitz JH. Validation of Acute Myocardial Infarction in the Food and Drug Administration&#x2019;s Mini-Sentinel program. Pharmacoepidemiol Drug Saf. 2013;22:40&#x2013;54.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3601831</ArticleId><ArticleId IdType="pubmed">22745038</ArticleId></ArticleIdList></Reference><Reference><Citation>Nadkarni GN, Gottesman O, Linneman JG, Chase H, Berg RL, Farouk S, Nadukuru R, Lotay V, Ellis S, Hripcsak G, Peissig P, Weng C and Bottinger EP. Development and validation of an electronic phenotyping algorithm for chronic kidney disease. AMIA Annual Symposium proceedings AMIA Symposium. 2014;2014:907&#x2013;916.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4419875</ArticleId><ArticleId IdType="pubmed">25954398</ArticleId></ArticleIdList></Reference><Reference><Citation>Gianfrancesco MA, Tamang S, Yazdany J and Schmajuk G. Potential Biases in Machine Learning Algorithms Using Electronic Health Record Data. JAMA Intern Med. 2018;178:1544&#x2013;1547.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6347576</ArticleId><ArticleId IdType="pubmed">30128552</ArticleId></ArticleIdList></Reference><Reference><Citation>Tuot DS and Grubbs V. Chronic kidney disease care in the US safety net. Adv Chronic Kidney Dis. 2015;22:66&#x2013;73.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4291537</ArticleId><ArticleId IdType="pubmed">25573515</ArticleId></ArticleIdList></Reference><Reference><Citation>Peabody JW, Luck J, Jain S, Bertenthal D and Glassman P. Assessing the accuracy of administrative data in health information systems. Med Care. 2004;42:1066&#x2013;72.</Citation><ArticleIdList><ArticleId IdType="pubmed">15586833</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">31386904</PMID><DateCompleted><Year>2020</Year><Month>08</Month><Day>14</Day></DateCompleted><DateRevised><Year>2020</Year><Month>08</Month><Day>14</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1532-0480</ISSN><JournalIssue CitedMedium="Internet"><Volume>97</Volume><PubDate><Year>2019</Year><Month>Sep</Month></PubDate></JournalIssue><Title>Journal of biomedical informatics</Title><ISOAbbreviation>J Biomed Inform</ISOAbbreviation></Journal><ArticleTitle>Supplementing claims data analysis using self-reported data to develop a probabilistic phenotype model for current smoking status.</ArticleTitle><Pagination><StartPage>103264</StartPage><MedlinePgn>103264</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.jbi.2019.103264</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S1532-0464(19)30183-2</ELocationID><Abstract><AbstractText Label="OBJECTIVES">Smoking status is poorly record in US claims data. IBM MarketScan Commercial is a claims database that can be linked to an additional health risk assessment with self-reported smoking status for a subset of 1,966,174 patients. We investigate whether this subset could be used to learn a smoking status phenotype model generalizable to all US claims data that calculates the probability of being a current smoker.</AbstractText><AbstractText Label="METHODS">251,643 (12.8%) had self-reported their smoking status as 'current smoker'. A regularized logistic regression model, the Current Risk of Smoking Status (CROSS), was trained using the subset of patients with self-reported smoking status. CROSS considered 53,027 candidate covariates including demographics and conditions/drugs/measurements/procedures/observations recorded in the prior 365&#x202f;days, The CROSS phenotype model was validated across multiple other claims data.</AbstractText><AbstractText Label="RESULTS">The internal validation showed the CROSS model achieved an area under the receiver operating characteristic curve (AUC) of 0.76 and the calibration plots indicated it was well calibrated. The external validation across three US claims databases obtained AUCs ranging between 0.82 and 0.87 showing the model appears to be transportable across Claims data.</AbstractText><AbstractText Label="CONCLUSION">CROSS predicts current smoking status based on the claims records in the prior year. CROSS can be readily implemented to any US insurance claims mapped to the OMOP common data model and will be a useful way to impute smoking status when conducting epidemiology studies where smoking is a known confounder but smoking status is not recorded. CROSS is available from https://github.com/OHDSI/StudyProtocolSandbox/tree/master/SmokingModel.</AbstractText><CopyrightInformation>Copyright &#xa9; 2019 Elsevier Inc. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Reps</LastName><ForeName>Jenna M</ForeName><Initials>JM</Initials><AffiliationInfo><Affiliation>Janssen Research and Development, Titusville, NJ, USA. Electronic address: jreps@its.jnj.com.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rijnbeek</LastName><ForeName>Peter R</ForeName><Initials>PR</Initials><AffiliationInfo><Affiliation>Erasmus MC, Rotterdam, the Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ryan</LastName><ForeName>Patrick B</ForeName><Initials>PB</Initials><AffiliationInfo><Affiliation>Janssen Research and Development, Titusville, NJ, USA.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2019</Year><Month>08</Month><Day>03</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>J Biomed Inform</MedlineTA><NlmUniqueID>100970413</NlmUniqueID><ISSNLinking>1532-0464</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000073865" MajorTopicYN="N">Cigarette Smoking</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="Y">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D019295" MajorTopicYN="N">Computational Biology</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003627" MajorTopicYN="N">Data Interpretation, Statistical</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016208" MajorTopicYN="N">Databases, Factual</DescriptorName><QualifierName UI="Q000706" MajorTopicYN="N">statistics &amp; numerical data</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007345" MajorTopicYN="N">Insurance Claim Review</DescriptorName><QualifierName UI="Q000706" MajorTopicYN="Y">statistics &amp; numerical data</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015233" MajorTopicYN="Y">Models, Statistical</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D010641" MajorTopicYN="N">Phenotype</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018570" MajorTopicYN="N">Risk Assessment</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D057566" MajorTopicYN="N">Self Report</DescriptorName><QualifierName UI="Q000706" MajorTopicYN="N">statistics &amp; numerical data</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D014481" MajorTopicYN="N" Type="Geographic">United States</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Claims data</Keyword><Keyword MajorTopicYN="N">Imputation</Keyword><Keyword MajorTopicYN="N">Patient-level prediction</Keyword><Keyword MajorTopicYN="N">Probabilistic phenotype</Keyword><Keyword MajorTopicYN="N">Risk</Keyword><Keyword MajorTopicYN="N">Smoking</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2019</Year><Month>2</Month><Day>22</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2019</Year><Month>7</Month><Day>23</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2019</Year><Month>7</Month><Day>31</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2019</Year><Month>8</Month><Day>7</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2020</Year><Month>8</Month><Day>15</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2019</Year><Month>8</Month><Day>7</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">31386904</ArticleId><ArticleId IdType="doi">10.1016/j.jbi.2019.103264</ArticleId><ArticleId IdType="pii">S1532-0464(19)30183-2</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">31436848</PMID><DateCompleted><Year>2021</Year><Month>01</Month><Day>15</Day></DateCompleted><DateRevised><Year>2021</Year><Month>01</Month><Day>15</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1097-0258</ISSN><JournalIssue CitedMedium="Internet"><Volume>38</Volume><Issue>22</Issue><PubDate><Year>2019</Year><Month>Sep</Month><Day>30</Day></PubDate></JournalIssue><Title>Statistics in medicine</Title><ISOAbbreviation>Stat Med</ISOAbbreviation></Journal><ArticleTitle>A plea to stop using the case-control design in retrospective database studies.</ArticleTitle><Pagination><StartPage>4199</StartPage><EndPage>4208</EndPage><MedlinePgn>4199-4208</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1002/sim.8215</ELocationID><Abstract><AbstractText>The case-control design is widely used in retrospective database studies, often leading to spectacular findings. However, results of these studies often cannot be replicated, and the advantage of this design over others is questionable. To demonstrate the shortcomings of applications of this design, we replicate two published case-control studies. The first investigates isotretinoin and ulcerative colitis using a simple case-control design. The second focuses on dipeptidyl peptidase-4 inhibitors and acute pancreatitis, using a nested case-control design. We include large sets of negative control exposures (where the true odds ratio is believed to be 1) in both studies. Both replication studies produce effect size estimates consistent with the original studies, but also generate estimates for the negative control exposures showing substantial residual bias. In contrast, applying a self-controlled design to answer the same questions using the same data reveals far less bias. Although the case-control design in general is not at fault, its application in retrospective database studies, where all exposure and covariate data for the entire cohort are available, is unnecessary, as other alternatives such as cohort and self-controlled designs are available. Moreover, by focusing on cases and controls it opens the door to inappropriate comparisons between exposure groups, leading to confounding for which the design has few options to adjust for. We argue that this design should no longer be used in these types of data. At the very least, negative control exposures should be used to prove that the concerns raised here do not apply.</AbstractText><CopyrightInformation>&#xa9; 2019 The Authors. Statistics&#xa0;in&#xa0;Medicine Published by John Wiley &amp; Sons Ltd.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Schuemie</LastName><ForeName>Martijn J</ForeName><Initials>MJ</Initials><Identifier Source="ORCID">0000-0002-0817-5361</Identifier><AffiliationInfo><Affiliation>Observational Health Data Sciences and Informatics, New York, New York.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Epidemiology Analytics, Janssen Research and Development, Titusville, New Jersey.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Biostatistics, University of California, Los Angeles, California.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ryan</LastName><ForeName>Patrick B</ForeName><Initials>PB</Initials><AffiliationInfo><Affiliation>Observational Health Data Sciences and Informatics, New York, New York.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Epidemiology Analytics, Janssen Research and Development, Titusville, New Jersey.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Biomedical Informatics, Columbia University Medical Center, New York, New York.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Man</LastName><ForeName>Kenneth K C</ForeName><Initials>KKC</Initials><AffiliationInfo><Affiliation>Centre for Safe Medication Practice and Research, Department of Pharmacology and Pharmacy, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Pokfulam, Hong Kong.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Research Department of Practice and Policy, UCL School of Pharmacy, London, UK.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Medical Informatics, Erasmus University Medical Center, Rotterdam, The Netherlands.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Social Work and Social Administration, Faculty of Social Science, The University of Hong Kong, Pokfulam, Hong Kong.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wong</LastName><ForeName>Ian C K</ForeName><Initials>ICK</Initials><AffiliationInfo><Affiliation>Centre for Safe Medication Practice and Research, Department of Pharmacology and Pharmacy, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Pokfulam, Hong Kong.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Research Department of Practice and Policy, UCL School of Pharmacy, London, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Suchard</LastName><ForeName>Marc A</ForeName><Initials>MA</Initials><AffiliationInfo><Affiliation>Observational Health Data Sciences and Informatics, New York, New York.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Biostatistics, University of California, Los Angeles, California.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Biomathematics, University of California, Los Angeles, California.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Human Genetics, University of California, Los Angeles, California.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hripcsak</LastName><ForeName>George</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Observational Health Data Sciences and Informatics, New York, New York.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Biomedical Informatics, Columbia University Medical Center, New York, New York.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Medical Informatics Services, NewYork-Presbyterian Hospital, New York, New York.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>R01 LM006910</GrantID><Acronym>LM</Acronym><Agency>NLM NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R01 LM06910</GrantID><Acronym>NH</Acronym><Agency>NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>U01 HG008680</GrantID><Acronym>NH</Acronym><Agency>NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D052061">Research Support, N.I.H., Extramural</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType><PublicationType UI="D013486">Research Support, U.S. Gov't, Non-P.H.S.</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2019</Year><Month>08</Month><Day>22</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Stat Med</MedlineTA><NlmUniqueID>8215016</NlmUniqueID><ISSNLinking>0277-6715</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><CommentsCorrectionsList><CommentsCorrections RefType="CommentIn"><RefSource>Stat Med. 2019 Sep 30;38(22):4216-4217. doi: 10.1002/sim.8312.</RefSource><PMID Version="1">31489682</PMID></CommentsCorrections><CommentsCorrections RefType="CommentIn"><RefSource>Stat Med. 2019 Sep 30;38(22):4209-4212. doi: 10.1002/sim.8320.</RefSource><PMID Version="1">31489683</PMID></CommentsCorrections><CommentsCorrections RefType="CommentIn"><RefSource>Stat Med. 2019 Sep 30;38(22):4213-4215. doi: 10.1002/sim.8324.</RefSource><PMID Version="1">31489684</PMID></CommentsCorrections></CommentsCorrectionsList><MeshHeadingList><MeshHeading><DescriptorName UI="D015982" MajorTopicYN="N">Bias</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016022" MajorTopicYN="Y">Case-Control Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003198" MajorTopicYN="N">Computer Simulation</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003627" MajorTopicYN="N">Data Interpretation, Statistical</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016208" MajorTopicYN="Y">Databases, Factual</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015203" MajorTopicYN="Y">Reproducibility of Results</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012189" MajorTopicYN="N">Retrospective Studies</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">case control</Keyword><Keyword MajorTopicYN="N">database studies</Keyword><Keyword MajorTopicYN="N">methods</Keyword><Keyword MajorTopicYN="N">retrospective studies</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2018</Year><Month>8</Month><Day>2</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2019</Year><Month>4</Month><Day>29</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2019</Year><Month>5</Month><Day>5</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2019</Year><Month>8</Month><Day>23</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2021</Year><Month>1</Month><Day>16</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2019</Year><Month>8</Month><Day>23</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2019</Year><Month>10</Month><Day>1</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">31436848</ArticleId><ArticleId IdType="pmc">PMC6771795</ArticleId><ArticleId IdType="doi">10.1002/sim.8215</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Vandenbroucke JP, Pearce N. Case&#x2010;control studies: basic concepts. Int J Epidemiol. 2012;41(5):1480&#x2010;1489.</Citation><ArticleIdList><ArticleId IdType="pubmed">23045208</ArticleId></ArticleIdList></Reference><Reference><Citation>Doll R, Hill AB. Smoking and carcinoma of the lung; preliminary report. Br Med J. 1950;2(4682):739&#x2010;748.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2038856</ArticleId><ArticleId IdType="pubmed">14772469</ArticleId></ArticleIdList></Reference><Reference><Citation>Richardson K, Fox C, Maidment I, et al. Anticholinergic drugs and risk of dementia: case&#x2010;control study. BMJ. 2018;361:k1315.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5915701</ArticleId><ArticleId IdType="pubmed">29695481</ArticleId></ArticleIdList></Reference><Reference><Citation>Racette BA, Gross A, Vouri SM, Camacho&#x2010;Soto A, Willis AW, Nielsen SS. Immunosuppressants and risk of Parkinson disease. Ann Clin Transl Neurol. 2018;5:870&#x2010;875.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6043771</ArticleId><ArticleId IdType="pubmed">30009205</ArticleId></ArticleIdList></Reference><Reference><Citation>Rothman KJ, Greenland S, Lash TL. Modern Epidemiology. 3rd ed. Philadelphia, PA: Wolters Kluwer Health/Lippincott Williams and Wilkins; 2008.</Citation></Reference><Reference><Citation>Schneeweiss S. A basic study design for expedited safety signal evaluation based on electronic healthcare data. Pharmacoepidemiol Drug Saf. 2010;19(8):858&#x2010;868.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2917262</ArticleId><ArticleId IdType="pubmed">20681003</ArticleId></ArticleIdList></Reference><Reference><Citation>Madigan D, Schuemie MJ, Ryan PB. Empirical performance of the case&#x2010;control method: lessons for developing a risk identification and analysis system. Drug Safety. 2013;36(Suppl 1):73&#x2010;82.</Citation><ArticleIdList><ArticleId IdType="pubmed">24166225</ArticleId></ArticleIdList></Reference><Reference><Citation>Mayes LC, Horwitz RI, Feinstein AR. A collection of 56 topics with contradictory results in case&#x2010;control research. Int J Epidemiol. 1988;17(3):680&#x2010;685.</Citation><ArticleIdList><ArticleId IdType="pubmed">3272133</ArticleId></ArticleIdList></Reference><Reference><Citation>Crockett SD, Porter CQ, Martin CF, Sandler RS, Kappelman MD. Isotretinoin use and the risk of inflammatory bowel disease: a case&#x2010;control study. Am J Gastroenterol. 2010;105(9):1986&#x2010;1993.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3073620</ArticleId><ArticleId IdType="pubmed">20354506</ArticleId></ArticleIdList></Reference><Reference><Citation>Chou HC, Chen WW, Hsiao FY. Acute pancreatitis in patients with type 2 diabetes mellitus treated with dipeptidyl peptidase&#x2010;4 inhibitors: a population&#x2010;based nested case&#x2010;control study. Drug Safety. 2014;37(7):521&#x2010;528.</Citation><ArticleIdList><ArticleId IdType="pubmed">24859164</ArticleId></ArticleIdList></Reference><Reference><Citation>Schuemie MJ, Hripcsak G, Ryan PB, Madigan D, Suchard MA. Empirical confidence interval calibration for population&#x2010;level effect estimation studies in observational healthcare data. Proc Natl Acad Sci USA. 2018;115(11):2571&#x2010;2577.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5856503</ArticleId><ArticleId IdType="pubmed">29531023</ArticleId></ArticleIdList></Reference><Reference><Citation>Schuemie MJ, Ryan PB, DuMouchel W, Suchard MA, Madigan D. Interpreting observational studies: why empirical calibration is needed to correct p&#x2010;values. Statist Med. 2014;33(2):209&#x2010;218.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4285234</ArticleId><ArticleId IdType="pubmed">23900808</ArticleId></ArticleIdList></Reference><Reference><Citation>Voss EA, Boyce RD, Ryan PB, van der Lei J, Rijnbeek PR, Schuemie MJ. Accuracy of an automated knowledge base for identifying drug adverse reactions. J Biomed Inform. 2017;66:72&#x2010;81.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5316295</ArticleId><ArticleId IdType="pubmed">27993747</ArticleId></ArticleIdList></Reference><Reference><Citation>Avillach P, Dufour JC, Diallo G, et al. Design and validation of an automated method to detect known adverse drug reactions in MEDLINE: a contribution from the EU&#x2010;ADR project. J Am Med Inform Assoc. 2013;20(3):446&#x2010;452.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3628051</ArticleId><ArticleId IdType="pubmed">23195749</ArticleId></ArticleIdList></Reference><Reference><Citation>Kilicoglu H, Rosemblat G, Fiszman M, Rindflesch TC. Constructing a semantic predication gold standard from the biomedical literature. BMC Bioinformatics. 2011;12:486.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3281188</ArticleId><ArticleId IdType="pubmed">22185221</ArticleId></ArticleIdList></Reference><Reference><Citation>
Administration UFaD
. FDA adverse event reporting system (FAERS). 2016. 
http://www.fda.gov/Drugs/GuidanceComplianceRegulatoryInformation/Surveillance/AdverseDrugEffects/
</Citation></Reference><Reference><Citation>Duke J, Friedlin J, Li X. Consistency in the safety labeling of bioequivalent medications. Pharmacoepidemiol Drug Saf. 2013;22(3):294&#x2010;301.</Citation><ArticleIdList><ArticleId IdType="pubmed">23042584</ArticleId></ArticleIdList></Reference><Reference><Citation>Wisniewski AF, Bate A, Bousquet C, et al. Good signal detection practices: evidence from IMI PROTECT. Drug Safety. 2016;39(6):469&#x2010;490.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4871909</ArticleId><ArticleId IdType="pubmed">26951233</ArticleId></ArticleIdList></Reference><Reference><Citation>Whitaker HJ, Farrington CP, Spiessens B, Musonda P. Tutorial in biostatistics: the self&#x2010;controlled case series method. Statist Med. 2006;25(10):1768&#x2010;1797.</Citation><ArticleIdList><ArticleId IdType="pubmed">16220518</ArticleId></ArticleIdList></Reference><Reference><Citation>Bernstein CN, Nugent Z, Longobardi T, Blanchard JF. Isotretinoin is not associated with inflammatory bowel disease: a population&#x2010;based case&#x2010;control study. Am J Gastroenterol. 2009;104(11):2774&#x2010;2778.</Citation><ArticleIdList><ArticleId IdType="pubmed">19623167</ArticleId></ArticleIdList></Reference><Reference><Citation>Singh S, Chang HY, Richards TM, Weiner JP, Clark JM, Segal JB. Glucagonlike peptide 1&#x2010;based therapies and risk of hospitalization for acute pancreatitis in type 2 diabetes mellitus: a population&#x2010;based matched case&#x2010;control study. JAMA Intern Med. 2013;173(7):534&#x2010;539.</Citation><ArticleIdList><ArticleId IdType="pubmed">23440284</ArticleId></ArticleIdList></Reference><Reference><Citation>Gault N, Casta&#xf1;eda&#x2010;Sanabria J, De Rycke Y, Guillo S, Foulon S, Tubach F. Self&#x2010;controlled designs in pharmacoepidemiology involving electronic healthcare databases: a systematic review. BMC Med Res Methodol. 2017;17(1):25.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5299667</ArticleId><ArticleId IdType="pubmed">28178924</ArticleId></ArticleIdList></Reference><Reference><Citation>Walsh MC, Trentham&#x2010;Dietz A, Newcomb PA, Gangnon R, Palta M. Using propensity scores to reduce case&#x2010;control selection bias. Epidemiology. 2012;23(5):772&#x2010;773.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3433168</ArticleId><ArticleId IdType="pubmed">22872122</ArticleId></ArticleIdList></Reference><Reference><Citation>Arbogast PG, Ray WA. Use of disease risk scores in pharmacoepidemiologic studies. Stat Methods Med Res. 2009;18(1):67&#x2010;80.</Citation><ArticleIdList><ArticleId IdType="pubmed">18562398</ArticleId></ArticleIdList></Reference><Reference><Citation>M&#xe5;nsson R, Joffe MM, Sun W, Hennessy S. On the estimation and use of propensity scores in case&#x2010;control and case&#x2010;cohort studies. Am J Epidemiol. 2007;166(3):332&#x2010;339.</Citation><ArticleIdList><ArticleId IdType="pubmed">17504780</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">31437920</PMID><DateCompleted><Year>2019</Year><Month>09</Month><Day>10</Day></DateCompleted><DateRevised><Year>2019</Year><Month>09</Month><Day>10</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1879-8365</ISSN><JournalIssue CitedMedium="Internet"><Volume>264</Volume><PubDate><Year>2019</Year><Month>Aug</Month><Day>21</Day></PubDate></JournalIssue><Title>Studies in health technology and informatics</Title><ISOAbbreviation>Stud Health Technol Inform</ISOAbbreviation></Journal><ArticleTitle>Transforming Two Decades of ePR Data to OMOP CDM for Clinical Research.</ArticleTitle><Pagination><StartPage>233</StartPage><EndPage>237</EndPage><MedlinePgn>233-237</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.3233/SHTI190218</ELocationID><Abstract><AbstractText>This paper presents the extract-transform-and-load (ETL) process from the Electronic Patient Records (ePR) at the Heart Institute (InCor) to the OMOP Common Data Model (CDM) format. We describe the initial database characterization, relational source mappings, selection filters, data transformations and patient de-identification using the open-source OHDSI tools and SQL scripts. We evaluate the resulting InCor-CDM database by recreating the same patient cohort from a previous reference study (over the original data source) and comparing the cohorts' descriptive statistics and inclusion reports. The results exhibit that up to 91% of the reference patients were retrieved by our method from the ePR through InCor-CDM, with AUC=0.938. The results indicate that the method that we employed was able to produce a new database that was both consistent with the original data and in accordance to the OMOP CDM standard.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Lima</LastName><ForeName>Daniel M</ForeName><Initials>DM</Initials><AffiliationInfo><Affiliation>Institute of Mathematical and Computer Sciences (ICMC), University of S&#xe3;o Paulo, S&#xe3;o Carlos, S&#xe3;o Paulo, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rodrigues-Jr</LastName><ForeName>Jose F</ForeName><Initials>JF</Initials><AffiliationInfo><Affiliation>Institute of Mathematical and Computer Sciences (ICMC), University of S&#xe3;o Paulo, S&#xe3;o Carlos, S&#xe3;o Paulo, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Traina</LastName><ForeName>Agma J M</ForeName><Initials>AJM</Initials><AffiliationInfo><Affiliation>Institute of Mathematical and Computer Sciences (ICMC), University of S&#xe3;o Paulo, S&#xe3;o Carlos, S&#xe3;o Paulo, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pires</LastName><ForeName>Fabio A</ForeName><Initials>FA</Initials><AffiliationInfo><Affiliation>Institute of Mathematical and Computer Sciences (ICMC), University of S&#xe3;o Paulo, S&#xe3;o Carlos, S&#xe3;o Paulo, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gutierrez</LastName><ForeName>Marco A</ForeName><Initials>MA</Initials><AffiliationInfo><Affiliation>Heart Institute (InCor), Clinics Hospital, Faculty of Medicine, University of S&#xe3;o Paulo, S&#xe3;o Paulo, S&#xe3;o Paulo, Brazil.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>Netherlands</Country><MedlineTA>Stud Health Technol Inform</MedlineTA><NlmUniqueID>9214582</NlmUniqueID><ISSNLinking>0926-9630</ISSNLinking></MedlineJournalInfo><MeshHeadingList><MeshHeading><DescriptorName UI="D015331" MajorTopicYN="N">Cohort Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016208" MajorTopicYN="N">Databases, Factual</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003695" MajorTopicYN="N">Delivery of Health Care</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D057286" MajorTopicYN="Y">Electronic Health Records</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016247" MajorTopicYN="Y">Information Storage and Retrieval</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Data Curation</Keyword><Keyword MajorTopicYN="N">Health Information Exchange</Keyword><Keyword MajorTopicYN="N">Medical Informatics</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2019</Year><Month>8</Month><Day>24</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2019</Year><Month>8</Month><Day>24</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2019</Year><Month>9</Month><Day>11</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">31437920</ArticleId><ArticleId IdType="doi">10.3233/SHTI190218</ArticleId><ArticleId IdType="pii">SHTI190218</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">31437950</PMID><DateCompleted><Year>2019</Year><Month>09</Month><Day>11</Day></DateCompleted><DateRevised><Year>2019</Year><Month>11</Month><Day>17</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1879-8365</ISSN><JournalIssue CitedMedium="Internet"><Volume>264</Volume><PubDate><Year>2019</Year><Month>Aug</Month><Day>21</Day></PubDate></JournalIssue><Title>Studies in health technology and informatics</Title><ISOAbbreviation>Stud Health Technol Inform</ISOAbbreviation></Journal><ArticleTitle>Detecting Systemic Data Quality Issues in Electronic Health Records.</ArticleTitle><Pagination><StartPage>383</StartPage><EndPage>387</EndPage><MedlinePgn>383-387</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.3233/SHTI190248</ELocationID><Abstract><AbstractText>Secondary analysis of electronic health records for clinical research faces significant challenges due to known data quality issues in health data observationally collected for clinical care and the data biases caused by standard healthcare processes. In this manuscript, we contribute methodology for data quality assessment by plotting domain-level (conditions (diagnoses), drugs, and procedures) aggregate statistics and concept-level temporal frequencies (i.e., annual prevalence rates of clinical concepts). We detect common temporal patterns in concept frequencies by normalizing and clustering annual concept frequencies using K-means clustering. We apply these methods to the Columbia University Irving Medical Center Observational Medical Outcomes Partnership database. The resulting domain-aggregate and cluster plots show a variety of patterns. We review the patterns found in the condition domain and investigate the processes that shape them. We find that these patterns suggest data quality issues influenced by system-wide factors that affect individual concept frequencies.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Ta</LastName><ForeName>Casey N</ForeName><Initials>CN</Initials><AffiliationInfo><Affiliation>Department of Biomedical Informatics, Columbia University Irving Medical Center, New York, NY, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Weng</LastName><ForeName>Chunhua</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Department of Biomedical Informatics, Columbia University Irving Medical Center, New York, NY, USA.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>R01 LM009886</GrantID><Acronym>LM</Acronym><Agency>NLM NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>U01 HG008680</GrantID><Acronym>HG</Acronym><Agency>NHGRI NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>OT3 TR002027</GrantID><Acronym>TR</Acronym><Agency>NCATS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R01 LM012895</GrantID><Acronym>LM</Acronym><Agency>NLM NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>UL1 TR001873</GrantID><Acronym>TR</Acronym><Agency>NCATS NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>Netherlands</Country><MedlineTA>Stud Health Technol Inform</MedlineTA><NlmUniqueID>9214582</NlmUniqueID><ISSNLinking>0926-9630</ISSNLinking></MedlineJournalInfo><MeshHeadingList><MeshHeading><DescriptorName UI="D016000" MajorTopicYN="N">Cluster Analysis</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000068598" MajorTopicYN="Y">Data Accuracy</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016208" MajorTopicYN="N">Databases, Factual</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003695" MajorTopicYN="N">Delivery of Health Care</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D057286" MajorTopicYN="Y">Electronic Health Records</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Cluster Analysis</Keyword><Keyword MajorTopicYN="N">Data Accuracy</Keyword><Keyword MajorTopicYN="N">Electronic Health Records</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2019</Year><Month>8</Month><Day>24</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2019</Year><Month>8</Month><Day>24</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2019</Year><Month>9</Month><Day>12</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2019</Year><Month>11</Month><Day>15</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">31437950</ArticleId><ArticleId IdType="mid">NIHMS1058602</ArticleId><ArticleId IdType="pmc">PMC6857180</ArticleId><ArticleId IdType="doi">10.3233/SHTI190248</ArticleId><ArticleId IdType="pii">SHTI190248</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Hripcsak G, and Albers DJ, Next-generation pheno-typing of electronic health records, J Am Med Inform Assoc 20 (2013), 117&#x2013;121.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3555337</ArticleId><ArticleId IdType="pubmed">22955496</ArticleId></ArticleIdList></Reference><Reference><Citation>Platt R, and Lieu T, Data enclaves for sharing information derived from clinical and administrative data, JAMA (2018), E1&#x2013;E2.</Citation><ArticleIdList><ArticleId IdType="pubmed">30083726</ArticleId></ArticleIdList></Reference><Reference><Citation>Botsis T, Hartvigsen G, Chen F, and Weng C, Secondary use of EHR: data quality issues and informatics opportunities, Summit on Translat Bioinforma 2010 (2010), 1&#x2013;5.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3041534</ArticleId><ArticleId IdType="pubmed">21347133</ArticleId></ArticleIdList></Reference><Reference><Citation>Kharrazi H, Wang C, and Scharfstein D, Prospective EHR-based clinical trials: the challenge of missing data, J Gen Intern Med 29 (2014), 976&#x2013;978.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4061350</ArticleId><ArticleId IdType="pubmed">24839057</ArticleId></ArticleIdList></Reference><Reference><Citation>Kharrazi H et al., Comparing population-based risk-stratification model performance using demographic, diagnosis and medication data extracted from outpatient electronic health records versus administrative claims, Med Care 55 (2017), 789&#x2013;796.</Citation><ArticleIdList><ArticleId IdType="pubmed">28598890</ArticleId></ArticleIdList></Reference><Reference><Citation>Hripcsak G et al., Observational Health Data Sciences and Informatics (OHDSI): opportunities for observational researchers, Stud Health Technol Inform 216 (2015), 574&#x2013;578.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4815923</ArticleId><ArticleId IdType="pubmed">26262116</ArticleId></ArticleIdList></Reference><Reference><Citation>Kahn MG et al., A harmonized data quality assessment terminology and framework for the secondary use of electronic health record data, EGEMS (Wash DC) 4 (2016), 1244.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5051581</ArticleId><ArticleId IdType="pubmed">27713905</ArticleId></ArticleIdList></Reference><Reference><Citation>Hall GC et al., Guidelines for good database selection and use in pharmacoepidemiology research, Pharmacoepidemiology and Drug Safety 21 (2012), 1&#x2013;10.</Citation><ArticleIdList><ArticleId IdType="pubmed">22069180</ArticleId></ArticleIdList></Reference><Reference><Citation>Brown J, Kahn M, and Toh S, Data quality assessment for comparative effectiveness research in distributed data networks, Med Care 51 (2013), S22&#x2013;S29.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4306391</ArticleId><ArticleId IdType="pubmed">23793049</ArticleId></ArticleIdList></Reference><Reference><Citation>Kharrazi H et al., A proposed national research and development agenda for population health informatics: summary recommendations from a national expert workshop, J Am Med Inform Assoc 24 (2017), 2&#x2013;12.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5201177</ArticleId><ArticleId IdType="pubmed">27018264</ArticleId></ArticleIdList></Reference><Reference><Citation>van Oostrom SH et al., Time trends in prevalence of chronic diseases and multimorbidity not only due to aging: data from general practices and health surveys, PLoS One 11 (2016), e0160264.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4970764</ArticleId><ArticleId IdType="pubmed">27482903</ArticleId></ArticleIdList></Reference><Reference><Citation>Hartigan JA, and Wong MA, Algorithm AS 136: a K-means clustering algorithm, Journal of the Royal Statistical Society. Series C (Applied Statistics) 28 (1979), 100&#x2013;108.</Citation></Reference><Reference><Citation>Johnson SG, Speedie S, Simon G, Kumar V, and Westra BL, Application of an Ontology for Characterizing Data Quality for a Secondary Use of EHR Data, Appl Clin Inform 07 (2016), 69&#x2013;88.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4817336</ArticleId><ArticleId IdType="pubmed">27081408</ArticleId></ArticleIdList></Reference><Reference><Citation>Tibshirani R, Walther G, and Hastie T, Estimating the number of clusters in a data set via the gap statistic, Journal of the Royal Statistical Society: Series B (Statistical Methodology) 63 (2001), 411&#x2013;423.</Citation></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">31438202</PMID><DateCompleted><Year>2019</Year><Month>09</Month><Day>04</Day></DateCompleted><DateRevised><Year>2019</Year><Month>09</Month><Day>04</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1879-8365</ISSN><JournalIssue CitedMedium="Internet"><Volume>264</Volume><PubDate><Year>2019</Year><Month>Aug</Month><Day>21</Day></PubDate></JournalIssue><Title>Studies in health technology and informatics</Title><ISOAbbreviation>Stud Health Technol Inform</ISOAbbreviation></Journal><ArticleTitle>Augmenting Medical Device Evaluation Using a Reusable Unique Device Identifier Interoperability Solution Based on the OHDSI Common Data Model.</ArticleTitle><Pagination><StartPage>1502</StartPage><EndPage>1503</EndPage><MedlinePgn>1502-1503</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.3233/SHTI190505</ELocationID><Abstract><AbstractText>The objective of the study is to augment safety and effectiveness evaluation of medical devices through building a reusable unique device identifier (UDI) interoperability solution. We propose a framework for building a UDI research database for medical device evaluation using the OHDSI common data model (CDM). As a pilot study, we design, develop and evaluate a UDI vocabulary, which would enable tackling challenges of data islands and standardization for medical device evaluation.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Jiang</LastName><ForeName>Guoqian</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Department of Health Sciences Research, Mayo Clinic, Rochester, MN, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yu</LastName><ForeName>Yue</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Department of Health Sciences Research, Mayo Clinic, Rochester, MN, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kingsbury</LastName><ForeName>Paul R</ForeName><Initials>PR</Initials><AffiliationInfo><Affiliation>Department of Health Sciences Research, Mayo Clinic, Rochester, MN, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Shah</LastName><ForeName>Nilay</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Department of Health Sciences Research, Mayo Clinic, Rochester, MN, USA.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>Netherlands</Country><MedlineTA>Stud Health Technol Inform</MedlineTA><NlmUniqueID>9214582</NlmUniqueID><ISSNLinking>0926-9630</ISSNLinking></MedlineJournalInfo><MeshHeadingList><MeshHeading><DescriptorName UI="D016208" MajorTopicYN="Y">Databases, Factual</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D010865" MajorTopicYN="N">Pilot Projects</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Controlled Vocabulary</Keyword><Keyword MajorTopicYN="N">Electronic Health Records</Keyword><Keyword MajorTopicYN="N">Equipment Safety</Keyword><Keyword MajorTopicYN="N">Reference Standards</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2019</Year><Month>8</Month><Day>24</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2019</Year><Month>8</Month><Day>24</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2019</Year><Month>9</Month><Day>5</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">31438202</ArticleId><ArticleId IdType="doi">10.3233/SHTI190505</ArticleId><ArticleId IdType="pii">SHTI190505</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">31438258</PMID><DateCompleted><Year>2019</Year><Month>09</Month><Day>12</Day></DateCompleted><DateRevised><Year>2019</Year><Month>09</Month><Day>12</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1879-8365</ISSN><JournalIssue CitedMedium="Internet"><Volume>264</Volume><PubDate><Year>2019</Year><Month>Aug</Month><Day>21</Day></PubDate></JournalIssue><Title>Studies in health technology and informatics</Title><ISOAbbreviation>Stud Health Technol Inform</ISOAbbreviation></Journal><ArticleTitle>Characterizing VA Users with the OMOP Common Data Model.</ArticleTitle><Pagination><StartPage>1614</StartPage><EndPage>1615</EndPage><MedlinePgn>1614-1615</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.3233/SHTI190561</ELocationID><Abstract><AbstractText>In 2015, the VA Informatics and Computing Infrastructure, a resource center of the Department of Veterans Affairs, began to transform parts of its Corporate Data Warehouse (CDW) into the Observational Medical Outcomes Partnership) Common Data Model for use by its research and operations communities. Using the hierarchical relationships within the clinical vocabularies in OMOP we found differences in visits, disease prevalence, and medications prescribed between male and female veterans seen between VA fiscal years 2000-17.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Viernes</LastName><ForeName>Benjamin</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>VA Informatics and Computing Infrastructure, Department of Veterans Affairs, Salt Lake City, UT, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Internal Medicine, Division of Epidemiology, University of Utah, Salt Lake City, UT, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lynch</LastName><ForeName>Kristine E</ForeName><Initials>KE</Initials><AffiliationInfo><Affiliation>VA Informatics and Computing Infrastructure, Department of Veterans Affairs, Salt Lake City, UT, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Internal Medicine, Division of Epidemiology, University of Utah, Salt Lake City, UT, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>South</LastName><ForeName>Brett</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>VA Informatics and Computing Infrastructure, Department of Veterans Affairs, Salt Lake City, UT, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Internal Medicine, Division of Epidemiology, University of Utah, Salt Lake City, UT, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Coronado</LastName><ForeName>Gregorio</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>VA Informatics and Computing Infrastructure, Department of Veterans Affairs, Salt Lake City, UT, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Internal Medicine, Division of Epidemiology, University of Utah, Salt Lake City, UT, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>DuVall</LastName><ForeName>Scott L</ForeName><Initials>SL</Initials><AffiliationInfo><Affiliation>VA Informatics and Computing Infrastructure, Department of Veterans Affairs, Salt Lake City, UT, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Internal Medicine, Division of Epidemiology, University of Utah, Salt Lake City, UT, USA.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>Netherlands</Country><MedlineTA>Stud Health Technol Inform</MedlineTA><NlmUniqueID>9214582</NlmUniqueID><ISSNLinking>0926-9630</ISSNLinking></MedlineJournalInfo><MeshHeadingList><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008490" MajorTopicYN="N">Medical Informatics</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014481" MajorTopicYN="N" Type="Geographic">United States</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014493" MajorTopicYN="Y">United States Department of Veterans Affairs</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014728" MajorTopicYN="Y">Veterans</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Electronic health ecords</Keyword><Keyword MajorTopicYN="N">systematized nomenclature of medicine</Keyword><Keyword MajorTopicYN="N">veterans</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2019</Year><Month>8</Month><Day>24</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2019</Year><Month>8</Month><Day>24</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2019</Year><Month>9</Month><Day>13</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">31438258</ArticleId><ArticleId IdType="doi">10.3233/SHTI190561</ArticleId><ArticleId IdType="pii">SHTI190561</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">31438365</PMID><DateCompleted><Year>2019</Year><Month>09</Month><Day>04</Day></DateCompleted><DateRevised><Year>2019</Year><Month>09</Month><Day>04</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1879-8365</ISSN><JournalIssue CitedMedium="Internet"><Volume>264</Volume><PubDate><Year>2019</Year><Month>Aug</Month><Day>21</Day></PubDate></JournalIssue><Title>Studies in health technology and informatics</Title><ISOAbbreviation>Stud Health Technol Inform</ISOAbbreviation></Journal><ArticleTitle>Standardized Observational Cancer Research Using the OMOP CDM Oncology Module.</ArticleTitle><Pagination><StartPage>1831</StartPage><EndPage>1832</EndPage><MedlinePgn>1831-1832</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.3233/SHTI190670</ELocationID><Abstract><AbstractText>Observational research in cancer requires substantially more detail than most other therapeutic areas. Cancer conditions are defined through histology, affected anatomical structures, staging and grading, and biomarkers, and are treated with complex therapies. Here, we show a new cancer module as part of the OMOP CDM, allowing manual and automated abstraction and standardized analytics. We tested the model in EHR and registry data against a number of typical use cases.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Belenkaya</LastName><ForeName>Rimma</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>OHDSI Oncology Workgroup, Memorial Sloan Kettering Cancer Center, New York City, NY, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gurley</LastName><ForeName>Michael</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Clinical and Translational Sciences Institute, Northwestern University, Chicago, IL, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Dymshyts</LastName><ForeName>Dmitry</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Odysseus Data Science Inc, Cambridge, MA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Araujo</LastName><ForeName>Sonia</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Real World Analytics Solution, IQVIA, London, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Williams</LastName><ForeName>Andrew</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Maine Medical Center Research Institute, Center for Outcomes Research and Evaluation, Portland, ME, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chen</LastName><ForeName>RuiJun</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Biomedical Informatics Department, Columbia University Medical Center, New York City, NY, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Reich</LastName><ForeName>Christian</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Real World Analytics Solution, IQVIA, Cambridge, MA, USA.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>Netherlands</Country><MedlineTA>Stud Health Technol Inform</MedlineTA><NlmUniqueID>9214582</NlmUniqueID><ISSNLinking>0926-9630</ISSNLinking></MedlineJournalInfo><MeshHeadingList><MeshHeading><DescriptorName UI="D016208" MajorTopicYN="N">Databases, Factual</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D057286" MajorTopicYN="Y">Electronic Health Records</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008962" MajorTopicYN="Y">Models, Theoretical</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009369" MajorTopicYN="Y">Neoplasms</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012042" MajorTopicYN="N">Registries</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012106" MajorTopicYN="Y">Research</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Oncology</Keyword><Keyword MajorTopicYN="N">Research</Keyword><Keyword MajorTopicYN="N">Standardized</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2019</Year><Month>8</Month><Day>24</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2019</Year><Month>8</Month><Day>24</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2019</Year><Month>9</Month><Day>5</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">31438365</ArticleId><ArticleId IdType="doi">10.3233/SHTI190670</ArticleId><ArticleId IdType="pii">SHTI190670</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">31438371</PMID><DateCompleted><Year>2019</Year><Month>09</Month><Day>04</Day></DateCompleted><DateRevised><Year>2019</Year><Month>09</Month><Day>04</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1879-8365</ISSN><JournalIssue CitedMedium="Internet"><Volume>264</Volume><PubDate><Year>2019</Year><Month>Aug</Month><Day>21</Day></PubDate></JournalIssue><Title>Studies in health technology and informatics</Title><ISOAbbreviation>Stud Health Technol Inform</ISOAbbreviation></Journal><ArticleTitle>Genomic Common Data Model for Biomedical Data in Clinical Practice.</ArticleTitle><Pagination><StartPage>1843</StartPage><EndPage>1844</EndPage><MedlinePgn>1843-1844</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.3233/SHTI190676</ELocationID><Abstract><AbstractText>A common data model for clinical NGS panel data that is used in a distributed research network to achieve large scale to make evidence for improving patient care should be developed. This study developed OMOP-CDM extension for NGS panel data and confirmed the feasibility of the model by finding the differences between a database generated by research-purpose and clinical practice. We believe this data model can be used in distributed research model and will facilitate the usage of the clinical NGS data in patient care.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Shin</LastName><ForeName>Seo Jeong</ForeName><Initials>SJ</Initials><AffiliationInfo><Affiliation>Department of Biomedical Sciences, Ajou University Graduate School of Medicine, Suwon, South Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>You</LastName><ForeName>Seng Chan</ForeName><Initials>SC</Initials><AffiliationInfo><Affiliation>Department of Biomedical Informatics, Ajou University School of Medicine, Suwon, South Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Roh</LastName><ForeName>Jin</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Pathology, Ajou University Hospital, Suwon, South Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Park</LastName><ForeName>Yu Rang</ForeName><Initials>YR</Initials><AffiliationInfo><Affiliation>Department of Biomedical Systems Informatics, Yonsei University College of Medicine, Seoul, South Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Park</LastName><ForeName>Rae Woong</ForeName><Initials>RW</Initials><AffiliationInfo><Affiliation>Department of Biomedical Sciences, Ajou University Graduate School of Medicine, Suwon, South Korea.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Biomedical Informatics, Ajou University School of Medicine, Suwon, South Korea.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>Netherlands</Country><MedlineTA>Stud Health Technol Inform</MedlineTA><NlmUniqueID>9214582</NlmUniqueID><ISSNLinking>0926-9630</ISSNLinking></MedlineJournalInfo><MeshHeadingList><MeshHeading><DescriptorName UI="D016208" MajorTopicYN="Y">Databases, Factual</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D023281" MajorTopicYN="Y">Genomics</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008962" MajorTopicYN="Y">Models, Theoretical</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Data Analysis</Keyword><Keyword MajorTopicYN="N">High-Throughput Nucleotide Sequencing</Keyword><Keyword MajorTopicYN="N">Observational Study</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2019</Year><Month>8</Month><Day>24</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2019</Year><Month>8</Month><Day>24</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2019</Year><Month>9</Month><Day>5</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">31438371</ArticleId><ArticleId IdType="doi">10.3233/SHTI190676</ArticleId><ArticleId IdType="pii">SHTI190676</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">31445247</PMID><DateCompleted><Year>2019</Year><Month>12</Month><Day>02</Day></DateCompleted><DateRevised><Year>2022</Year><Month>09</Month><Day>14</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1872-8243</ISSN><JournalIssue CitedMedium="Internet"><Volume>129</Volume><PubDate><Year>2019</Year><Month>Sep</Month></PubDate></JournalIssue><Title>International journal of medical informatics</Title><ISOAbbreviation>Int J Med Inform</ISOAbbreviation></Journal><ArticleTitle>Automatic trial eligibility surveillance based on unstructured clinical data.</ArticleTitle><Pagination><StartPage>13</StartPage><EndPage>19</EndPage><MedlinePgn>13-19</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.ijmedinf.2019.05.018</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S1386-5056(18)31052-9</ELocationID><Abstract><AbstractText Label="INTRODUCTION">Insufficient patient enrollment in clinical trials remains a serious and costly problem and is often considered the most critical issue to solve for the clinical trials community. In this project, we assessed the feasibility of automatically detecting a patient's eligibility for a sample of breast cancer clinical trials by mapping coded clinical trial eligibility criteria to the corresponding clinical information automatically extracted from text in the EHR.</AbstractText><AbstractText Label="METHODS">Three open breast cancer clinical trials were selected by oncologists. Their eligibility criteria were manually abstracted from trial descriptions using the OHDSI ATLAS web application. Patients enrolled or screened for these trials were selected as 'positive' or 'possible' cases. Other patients diagnosed with breast cancer were selected as 'negative' cases. A selection of the clinical data and all clinical notes of these 229 selected patients was extracted from the MUSC clinical data warehouse and stored in a database implementing the OMOP common data model. Eligibility criteria were extracted from clinical notes using either manually crafted pattern matching (regular expressions) or a new natural language processing (NLP) application. These extracted criteria were then compared with reference criteria from trial descriptions. This comparison was realized with three different versions of a new application: rule-based, cosine similarity-based, and machine learning-based.</AbstractText><AbstractText Label="RESULTS">For eligibility criteria extraction from clinical notes, the machine learning-based NLP application allowed for the highest accuracy with a micro-averaged recall of 90.9% and precision of 89.7%. For trial eligibility determination, the highest accuracy was reached by the machine learning-based approach with a per-trial AUC between 75.5% and 89.8%.</AbstractText><AbstractText Label="CONCLUSION">NLP can be used to extract eligibility criteria from EHR clinical notes and automatically discover patients possibly eligible for a clinical trial with good accuracy, which could be leveraged to reduce the workload of humans screening patients for trials.</AbstractText><CopyrightInformation>Copyright &#xa9; 2019 Elsevier B.V. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Meystre</LastName><ForeName>St&#xe9;phane M</ForeName><Initials>SM</Initials><AffiliationInfo><Affiliation>Biomedical Informatics Center, Medical University of South Carolina, Charleston, SC, United States; Division of Hematology/Oncology, Medical University of South Carolina, Charleston, SC, United States. Electronic address: meystre@musc.edu.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Heider</LastName><ForeName>Paul M</ForeName><Initials>PM</Initials><AffiliationInfo><Affiliation>Biomedical Informatics Center, Medical University of South Carolina, Charleston, SC, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kim</LastName><ForeName>Youngjun</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Biomedical Informatics Center, Medical University of South Carolina, Charleston, SC, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Aruch</LastName><ForeName>Daniel B</ForeName><Initials>DB</Initials><AffiliationInfo><Affiliation>Division of Hematology/Oncology, Medical University of South Carolina, Charleston, SC, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Britten</LastName><ForeName>Carolyn D</ForeName><Initials>CD</Initials><AffiliationInfo><Affiliation>Division of Hematology/Oncology, Medical University of South Carolina, Charleston, SC, United States.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>U54 CA210962</GrantID><Acronym>CA</Acronym><Agency>NCI NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>UG1 CA189848</GrantID><Acronym>CA</Acronym><Agency>NCI NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>U54 CA210963</GrantID><Acronym>CA</Acronym><Agency>NCI NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>P30 CA138313</GrantID><Acronym>CA</Acronym><Agency>NCI NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>UL1 TR001450</GrantID><Acronym>TR</Acronym><Agency>NCATS NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D052061">Research Support, N.I.H., Extramural</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2019</Year><Month>05</Month><Day>23</Day></ArticleDate></Article><MedlineJournalInfo><Country>Ireland</Country><MedlineTA>Int J Med Inform</MedlineTA><NlmUniqueID>9711057</NlmUniqueID><ISSNLinking>1386-5056</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D001331" MajorTopicYN="N">Automation</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001943" MajorTopicYN="N">Breast Neoplasms</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000073458" MajorTopicYN="N">Data Warehousing</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016208" MajorTopicYN="N">Databases, Factual</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004608" MajorTopicYN="Y">Eligibility Determination</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000069550" MajorTopicYN="N">Machine Learning</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009323" MajorTopicYN="N">Natural Language Processing</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018579" MajorTopicYN="N">Patient Selection</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016526" MajorTopicYN="N">Workload</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Clinical trial</Keyword><Keyword MajorTopicYN="N">Eligibility criteria</Keyword><Keyword MajorTopicYN="N">Machine learning</Keyword><Keyword MajorTopicYN="N">Natural language processing</Keyword></KeywordList><CoiStatement>COMPETING INTERESTS STATEMENT. The authors have no competing interests to declare.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2018</Year><Month>9</Month><Day>15</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2018</Year><Month>12</Month><Day>6</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2019</Year><Month>5</Month><Day>21</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2019</Year><Month>8</Month><Day>25</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2019</Year><Month>12</Month><Day>4</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2019</Year><Month>8</Month><Day>25</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2020</Year><Month>9</Month><Day>1</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">31445247</ArticleId><ArticleId IdType="mid">NIHMS1530600</ArticleId><ArticleId IdType="pmc">PMC6717538</ArticleId><ArticleId IdType="doi">10.1016/j.ijmedinf.2019.05.018</ArticleId><ArticleId IdType="pii">S1386-5056(18)31052-9</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Sung NS, Crowley WF, Genel M, Salber P, Sandy L, Sherwood LM, et al. Central challenges facing the national clinical research enterprise. JAMA. 2003. March 12;289(10):1278&#x2013;1287.</Citation><ArticleIdList><ArticleId IdType="pubmed">12633190</ArticleId></ArticleIdList></Reference><Reference><Citation>Lara PN, Higdon R, Lim N, Kwan K, Tanaka M, Lau DH, et al. Prospective evaluation of cancer clinical trial accrual patterns: identifying potential barriers to enrollment. J Clin Oncol 2001. March 15;19(6):1728&#x2013;1733.</Citation><ArticleIdList><ArticleId IdType="pubmed">11251003</ArticleId></ArticleIdList></Reference><Reference><Citation>Somkin CP, Ackerson L, Husson G, Gomez V, Kolevska T, Goldstein D, et al. Effect of medical oncologists&#x2019; attitudes on accrual to clinical trials in a community setting. J Oncol Pract 2013. November;9(6):e275&#x2013;83.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5706122</ArticleId><ArticleId IdType="pubmed">24151327</ArticleId></ArticleIdList></Reference><Reference><Citation>Penberthy L, Brown R, Puma F, Dahman B. Automated matching software for clinical trials eligibility: measuring efficiency and flexibility. Contemp Clin Trials 2010. May;31(3):207&#x2013;217.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4387843</ArticleId><ArticleId IdType="pubmed">20230913</ArticleId></ArticleIdList></Reference><Reference><Citation>Thadani SR, Weng C, Bigger JT, Ennever JF, Wajngurt D. Electronic screening improves efficiency in clinical trial recruitment. Journal of the American Medical Informatics Association Oxford University Press; 2009. November;16(6):869&#x2013;873.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3002129</ArticleId><ArticleId IdType="pubmed">19717797</ArticleId></ArticleIdList></Reference><Reference><Citation>Embi PJ, Jain A, Clark J, Harris CM. Development of an electronic health record-based Clinical Trial Alert system to enhance recruitment at the point of care. AMIA Annu Symp Proc 2005;:231&#x2013;235.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1560758</ArticleId><ArticleId IdType="pubmed">16779036</ArticleId></ArticleIdList></Reference><Reference><Citation>Heinemann S, Th&#xfc;ring S, Wedeken S, Sch&#xe4;fer T, Scheidt-Nave C, Ketterer M, et al. A clinical trial alert tool to recruit large patient samples and assess selection bias in general practice research. BMC Med Res Methodol BioMed Central; 2011. February 15;11(1):16.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3047292</ArticleId><ArticleId IdType="pubmed">21320358</ArticleId></ArticleIdList></Reference><Reference><Citation>Meystre SM, Savova GK, Kipper-Schuler KC, Hurdle JF. Extracting information from textual documents in the electronic health record: a review of recent research. Yearb Med Inform 2008:128&#x2013;144.</Citation><ArticleIdList><ArticleId IdType="pubmed">18660887</ArticleId></ArticleIdList></Reference><Reference><Citation>Demner-Fushman D, Elhadad N. Aspiring to Unintended Consequences of Natural Language Processing: A Review of Recent Developments in Clinical and Consumer-Generated Text Processing. Yearb Med Inform 2016:224&#x2013;233.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5171557</ArticleId><ArticleId IdType="pubmed">27830255</ArticleId></ArticleIdList></Reference><Reference><Citation>Richesson RL, Sun J, Pathak J, Kho A. A survey of clinical phenotyping in selected national networks: demonstrating the need for high-throughput, portable, and computational methods. Artificial Intelligence in Medicine 2016;71:57&#x2013;61.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5480212</ArticleId><ArticleId IdType="pubmed">27506131</ArticleId></ArticleIdList></Reference><Reference><Citation>Savova GK, Tseytlin E, Finan S, Castine M, Miller T, Medvedeva O, et al. DeepPhe: A Natural Language Processing System for Extracting Cancer Phenotypes from Clinical Records. Cancer Res. 2017. November 1;77(21):e115&#x2013;e118.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5690492</ArticleId><ArticleId IdType="pubmed">29092954</ArticleId></ArticleIdList></Reference><Reference><Citation>Halpern Y, Horng S, Choi Y, Sontag D. Electronic medical record phenotyping using the anchor and learn framework. J Am Med Inform Assoc 2016; 23(4):731&#x2013;40.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4926745</ArticleId><ArticleId IdType="pubmed">27107443</ArticleId></ArticleIdList></Reference><Reference><Citation>Weng C, Wu X, Luo Z, Boland MR, Theodoratos D, Johnson SB. EliXR: an approach to eligibility criteria extraction and representation. J Am Med Inform Assoc 2011;18 Suppl 1(Supplement 1):i116&#x2013;24.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3241167</ArticleId><ArticleId IdType="pubmed">21807647</ArticleId></ArticleIdList></Reference><Reference><Citation>Boland MR, Tu SW, Carini S, Sim I, Weng C. EliXR-TIME: A Temporal Knowledge Representation for Clinical Research Eligibility Criteria. AMIA Summits Transl Sci Proc 2012;2012:71&#x2013;80.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3392056</ArticleId><ArticleId IdType="pubmed">22779055</ArticleId></ArticleIdList></Reference><Reference><Citation>Duryea R, Danese MD. Human Readable Expression of Structured Algorithms for Describing and Storing Clinical Study Criteria and for Generating and Visualizing Queries. AMIA Summits Transl Sci Proc 2015:1&#x2013;5.</Citation></Reference><Reference><Citation>Levy-fix G, Yaman A, Weng C. Structuring Clinical Trial Eligibility Criteria with the Common Data Model. AMIA Summits Transl Sci Proc 2015.</Citation></Reference><Reference><Citation>Ni Y, Wright J, Perentesis J, Lingren T, Deleger L, Kaiser M, et al. Increasing the efficiency of trial-patient matching: automated clinical trial eligibility Pre-screening for pediatric oncology patients. BMC Med Inform Decis Mak; 2015;15(1):28.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4407835</ArticleId><ArticleId IdType="pubmed">25881112</ArticleId></ArticleIdList></Reference><Reference><Citation>Shivade C, Hebert C, Lopetegui M, de Marneffe M-C, Fosler-Lussier E, Lai AM. Textual inference for eligibility criteria resolution in clinical trials. J Biomed Inform 2015. December;58 Suppl:S211&#x2013;8.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4978353</ArticleId><ArticleId IdType="pubmed">26376462</ArticleId></ArticleIdList></Reference><Reference><Citation>NLM. Standard or Comprehensive Radiation Therapy in Treating Patients With Early-Stage Breast Cancer Previously Treated With Chemotherapy and Surgery. 2013. 
Available from: https://clinicaltrials.gov/ct2/show/NCT01872975</Citation></Reference><Reference><Citation>NLM. Comparison of Axillary Lymph Node Dissection With Axillary Radiation for Patients With Node-Positive Breast Cancer Treated With Chemotherapy. 2013. 
Available from: https://clinicaltrials.gov/ct2/show/NCT01901094</Citation></Reference><Reference><Citation>NLM. Fulvestrant and/or Anastrozole in Treating Postmenopausal Patients With Stage II-III Breast Cancer Undergoing Surgery. 2013. 
Available from: https://clinicaltrials.gov/ct2/show/NCT01953588</Citation></Reference><Reference><Citation>de Castilho RE, Mujdricza-Maydt E. A web-based tool for the integrated annotation of semantic and syntactic structures. Proceedings of the Workshop on Language Technology Resources and Tools for Digital Humanities; Osaka, Japan; 2016:76&#x2013;84.</Citation></Reference><Reference><Citation>Si Y, Weng C. An OMOP CDM-Based Relational Database of Clinical Research Eligibility Criteria. Stud Health Technol Inform 2017;245:950&#x2013;954.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5893219</ArticleId><ArticleId IdType="pubmed">29295240</ArticleId></ArticleIdList></Reference><Reference><Citation>Hripcsak G, Duke JD, Shah NH, Reich CG, Huser V, Schuemie MJ, et al. Observational Health Data Sciences and Informatics (OHDSI) - Opportunities for Observational Researchers. Stud Health Technol Inform 2015;216:574&#x2013;578.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4815923</ArticleId><ArticleId IdType="pubmed">26262116</ArticleId></ArticleIdList></Reference><Reference><Citation>ClinicalTrials.gov. Available from: https://clinicaltrials.gov</Citation></Reference><Reference><Citation>Regenstrief Institute. Logical observation identifier names and codes (LOINC). Available from: http://loinc.org/</Citation></Reference><Reference><Citation>NLM. SNOMED Clinical Terms&#xae; (SNOMED-CT&#xae;). Available from: http://www.nlm.nih.gov/research/umls/Snomed/snomed_main.html</Citation></Reference><Reference><Citation>Apache. UIMA (Unstructured Information Management Architecture). Available from: http://uima.apache.org/</Citation></Reference><Reference><Citation>Kim Y, Riloff E, Hurdle JF. A Study of Concept Extraction Across Different Types of Clinical Notes. AMIA Annu Symp Proc 2015:737&#x2013;746.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4765588</ArticleId><ArticleId IdType="pubmed">26958209</ArticleId></ArticleIdList></Reference><Reference><Citation>Lafferty JD, McCallum A, Pereira F. Conditional random fields: Probabilistic models for segmenting and labeling sequence data. Proc. 18th International Conf. on Machine Learning 2001;:282&#x2013;289.</Citation></Reference><Reference><Citation>Fan R-E, Chang K-W, Hsieh C-J, Wang X-R, Lin C-J. LIBLINEAR: A Library for Large Linear Classification. JMLR 2008;9(Aug):1871&#x2013;1874.</Citation></Reference><Reference><Citation>van Rijsbergen CJ. Information Retrieval. Butterworth; 1979.</Citation></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">31456304</PMID><DateCompleted><Year>2020</Year><Month>07</Month><Day>27</Day></DateCompleted><DateRevised><Year>2021</Year><Month>01</Month><Day>10</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1099-1557</ISSN><JournalIssue CitedMedium="Internet"><Volume>28</Volume><Issue>12</Issue><PubDate><Year>2019</Year><Month>Dec</Month></PubDate></JournalIssue><Title>Pharmacoepidemiology and drug safety</Title><ISOAbbreviation>Pharmacoepidemiol Drug Saf</ISOAbbreviation></Journal><ArticleTitle>Diabetic ketoacidosis in patients with type 2 diabetes treated with sodium glucose co-transporter 2 inhibitors versus other antihyperglycemic agents: An observational study of four US administrative claims databases.</ArticleTitle><Pagination><StartPage>1620</StartPage><EndPage>1628</EndPage><MedlinePgn>1620-1628</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1002/pds.4887</ELocationID><Abstract><AbstractText Label="PURPOSE">To compare the incidence of diabetic ketoacidosis (DKA) among patients with type 2 diabetes mellitus (T2DM) who were new users of sodium glucose co-transporter 2 inhibitors (SGLT2i) versus other classes of antihyperglycemic agents (AHAs).</AbstractText><AbstractText Label="METHODS">Patients were identified from four large US claims databases using broad (all T2DM patients) and narrow (intended to exclude patients with type 1 diabetes or secondary diabetes misclassified as T2DM) definitions of T2DM. New users of SGLT2i and seven groups of comparator AHAs were matched (1:1) on exposure propensity scores to adjust for imbalances in baseline covariates. Cox proportional hazards regression models, conditioned on propensity score-matched pairs, were used to estimate hazard ratios (HRs) of DKA for new users of SGLT2i versus other AHAs. When I<sup>2</sup> &lt;40%, a combined HR across the four databases was estimated.</AbstractText><AbstractText Label="RESULTS">Using the broad definition of T2DM, new users of SGLT2i had an increased risk of DKA versus sulfonylureas (HR [95% CI]: 1.53 [1.31-1.79]), DPP-4i (1.28 [1.11-1.47]), GLP-1 receptor agonists (1.34 [1.12-1.60]), metformin (1.31 [1.11-1.54]), and insulinotropic AHAs (1.38 [1.15-1.66]). Using the narrow definition of T2DM, new users of SGLT2i had an increased risk of DKA versus sulfonylureas (1.43 [1.01-2.01]). New users of SGLT2i had a lower risk of DKA versus insulin and a similar risk as thiazolidinediones, regardless of T2DM definition.</AbstractText><AbstractText Label="CONCLUSIONS">Increased risk of DKA was observed for new users of SGLT2i versus several non-SGLT2i AHAs when T2DM was defined broadly. When T2DM was defined narrowly to exclude possible misclassified patients, an increased risk of DKA with SGLT2i was observed compared with sulfonylureas.</AbstractText><CopyrightInformation>&#xa9; 2019 The Authors. Pharmacoepidemiology &amp; Drug Safety Published by John Wiley &amp; Sons Ltd.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Wang</LastName><ForeName>Lu</ForeName><Initials>L</Initials><Identifier Source="ORCID">0000-0001-7225-9407</Identifier><AffiliationInfo><Affiliation>Janssen Research &amp; Development, LLC, Titusville, New Jersey.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Voss</LastName><ForeName>Erica A</ForeName><Initials>EA</Initials><AffiliationInfo><Affiliation>Janssen Research &amp; Development, LLC, Raritan, New Jersey.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Weaver</LastName><ForeName>James</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Janssen Research &amp; Development, LLC, Titusville, New Jersey.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hester</LastName><ForeName>Laura</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Janssen Research &amp; Development, LLC, Titusville, New Jersey.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yuan</LastName><ForeName>Zhong</ForeName><Initials>Z</Initials><Identifier Source="ORCID">0000-0002-5824-2040</Identifier><AffiliationInfo><Affiliation>Janssen Research &amp; Development, LLC, Titusville, New Jersey.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>DeFalco</LastName><ForeName>Frank</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Janssen Research &amp; Development, LLC, Raritan, New Jersey.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Schuemie</LastName><ForeName>Martijn J</ForeName><Initials>MJ</Initials><AffiliationInfo><Affiliation>Janssen Research &amp; Development, LLC, Titusville, New Jersey.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ryan</LastName><ForeName>Patrick B</ForeName><Initials>PB</Initials><AffiliationInfo><Affiliation>Janssen Research &amp; Development, LLC, Titusville, New Jersey.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sun</LastName><ForeName>Don</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Janssen Research &amp; Development, LLC, Titusville, New Jersey.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Freedman</LastName><ForeName>Amy</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Janssen Research &amp; Development, LLC, Titusville, New Jersey.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Alba</LastName><ForeName>Maria</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Janssen Research &amp; Development, LLC, Raritan, New Jersey.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lind</LastName><ForeName>Joan</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Janssen Research &amp; Development, LLC, Raritan, New Jersey.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Meininger</LastName><ForeName>Gary</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Janssen Research &amp; Development, LLC, Raritan, New Jersey.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Berlin</LastName><ForeName>Jesse A</ForeName><Initials>JA</Initials><AffiliationInfo><Affiliation>Johnson &amp; Johnson, Titusville, New Jersey.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rosenthal</LastName><ForeName>Norman</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Janssen Research &amp; Development, LLC, Raritan, New Jersey.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D003160">Comparative Study</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D064888">Observational Study</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2019</Year><Month>08</Month><Day>27</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Pharmacoepidemiol Drug Saf</MedlineTA><NlmUniqueID>9208369</NlmUniqueID><ISSNLinking>1053-8569</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D001786">Blood Glucose</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000067757">Glucagon-Like Peptide-1 Receptor</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D007328">Insulin</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000077203">Sodium-Glucose Transporter 2 Inhibitors</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D013453">Sulfonylurea Compounds</NameOfSubstance></Chemical><Chemical><RegistryNumber>9100L32L2N</RegistryNumber><NameOfSubstance UI="D008687">Metformin</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000067575" MajorTopicYN="N">Administrative Claims, Healthcare</DescriptorName><QualifierName UI="Q000706" MajorTopicYN="N">statistics &amp; numerical data</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001786" MajorTopicYN="N">Blood Glucose</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016208" MajorTopicYN="N">Databases, Factual</DescriptorName><QualifierName UI="Q000706" MajorTopicYN="N">statistics &amp; numerical data</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D003924" MajorTopicYN="N">Diabetes Mellitus, Type 2</DescriptorName><QualifierName UI="Q000188" MajorTopicYN="Y">drug therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016883" MajorTopicYN="N">Diabetic Ketoacidosis</DescriptorName><QualifierName UI="Q000139" MajorTopicYN="N">chemically induced</QualifierName><QualifierName UI="Q000453" MajorTopicYN="Y">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000067757" MajorTopicYN="N">Glucagon-Like Peptide-1 Receptor</DescriptorName><QualifierName UI="Q000037" MajorTopicYN="N">antagonists &amp; inhibitors</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015994" MajorTopicYN="N">Incidence</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007328" MajorTopicYN="N">Insulin</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008687" MajorTopicYN="N">Metformin</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012307" MajorTopicYN="N">Risk Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000077203" MajorTopicYN="N">Sodium-Glucose Transporter 2 Inhibitors</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="Y">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D013453" MajorTopicYN="N">Sulfonylurea Compounds</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D014481" MajorTopicYN="N" Type="Geographic">United States</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">SGLT2 inhibitor</Keyword><Keyword MajorTopicYN="N">diabetic ketoacidosis</Keyword><Keyword MajorTopicYN="N">type 2 diabetes</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2019</Year><Month>3</Month><Day>26</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2019</Year><Month>7</Month><Day>1</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2019</Year><Month>7</Month><Day>25</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2019</Year><Month>8</Month><Day>29</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2020</Year><Month>7</Month><Day>28</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2019</Year><Month>8</Month><Day>29</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2019</Year><Month>12</Month><Day>17</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">31456304</ArticleId><ArticleId IdType="pmc">PMC6916409</ArticleId><ArticleId IdType="doi">10.1002/pds.4887</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Gosmanov AR, Gosmanova EO, Dillard&#x2010;Cannon E. Management of adult diabetic ketoacidosis. Diabetes Metab Syndr Obes. 2014;7:255&#x2010;264.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4085289</ArticleId><ArticleId IdType="pubmed">25061324</ArticleId></ArticleIdList></Reference><Reference><Citation>Kitabchi AE, Umpierrez GE, Miles JM, Fisher JN. Hyperglycemic crises in adult patients with diabetes. Diabetes Care. 2009;32(7):1335&#x2010;1343.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2699725</ArticleId><ArticleId IdType="pubmed">19564476</ArticleId></ArticleIdList></Reference><Reference><Citation>International Diabetes Federation . IDF Diabetes Atlas. 8th ed. Brussels, Belgium: International Diabetes Federation; 2017.</Citation></Reference><Reference><Citation>Fazeli Farsani S, Brodovicz K, Soleymanlou N, Marquard J, Wissinger E, Maiese BA. Incidence and prevalence of diabetic ketoacidosis (DKA) among adults with type 1 diabetes mellitus (T1D): a systematic literature review. BMJ Open. 2017;7(7):e016587.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5642652</ArticleId><ArticleId IdType="pubmed">28765134</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang ZH, Kihl&#x2010;Selstam E, Eriksson JW. Ketoacidosis occurs in both Type 1 and Type 2 diabetes&#x2014;a population&#x2010;based study from Northern Sweden. Diabet Med. 2008;25(7):867&#x2010;870.</Citation><ArticleIdList><ArticleId IdType="pubmed">18644074</ArticleId></ArticleIdList></Reference><Reference><Citation>Jensen ML, Persson F, Andersen GS, et al. Incidence of ketoacidosis in the Danish type 2 diabetes population before and after introduction of sodium&#x2010;glucose cotransporter 2 inhibitors&#x2014;a nationwide, retrospective cohort study, 1995&#x2010;2014. Diabetes Care. 2017;40(5):e57&#x2010;e58.</Citation><ArticleIdList><ArticleId IdType="pubmed">28283564</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim YG, Jeon JY, Han SJ, Kim DJ, Lee KW, Kim HJ. Sodium&#x2010;glucose co&#x2010;transporter&#x2010;2 inhibitors and the risk of ketoacidosis in patients with type 2 diabetes mellitus: a nationwide population&#x2010;based cohort study. Diabetes Obes Metab. 2018;20(8):1852&#x2010;1858.</Citation><ArticleIdList><ArticleId IdType="pubmed">29569427</ArticleId></ArticleIdList></Reference><Reference><Citation>Lam KS, Chow CC, Tan KC, et al. Practical considerations for the use of sodium&#x2010;glucose co&#x2010;transporter type 2 inhibitors in treating hyperglycemia in type 2 diabetes. Curr Med Res Opin. 2016;32(6):1097&#x2010;1108.</Citation><ArticleIdList><ArticleId IdType="pubmed">26933918</ArticleId></ArticleIdList></Reference><Reference><Citation>INVOKANA&#xae; (canagliflozin) tablets, for oral use [package insert]. Titusville, NJ: Janssen Pharmaceuticals; 2018.</Citation></Reference><Reference><Citation>Invokana (canagliflozin hemihydrate) [package insert]. Italy: Janssen&#x2010;Cilag SpA; n.d.</Citation></Reference><Reference><Citation>FARXIGA&#xae; (dapagliflozin) [package insert]. Wilmington, DE AstraZeneca Pharmaceuticals; October 2017.</Citation></Reference><Reference><Citation>Forxiga (dapagliflozin) [package insert]. Germany: AstraZeneca GmbH; n.d.</Citation></Reference><Reference><Citation>JARDIANCE&#xae; (empagliflozin) [package insert]. Ridgefield, CT; Boehringer Ingelheim Pharmaceuticals; December 2017.</Citation></Reference><Reference><Citation>Jardiance (empagliflozin) [package insert]. Germany: Boehringer Ingelheim Pharma GmbH &amp; Co. KG; n.d.</Citation></Reference><Reference><Citation>STEGLATRO&#x2122; (ertugliflozin) [package insert]. Whitehouse Station, NJ: Merck Sharp &amp; Dohme Corp; December 2017.</Citation></Reference><Reference><Citation>Steglatro (ertugliflozin) [packet insert]. Belgium: Schering&#x2010;Plough Labo NV; n.d.</Citation></Reference><Reference><Citation>
Food and Drug Administration
. FDA drug safety communication: FDA warns that SGLT2 inhibitors for diabetes may result in a serious condition of too much acid in the blood. Available at: http://www.fda.gov/downloads/Drugs/DrugSafety/UCM446954.pdf. Accessed March 22, 2018.</Citation></Reference><Reference><Citation>
European Medicines Agency
. EMA confirms recommendations to minimise ketoacidosis risk with SGLT2 inhibitors for diabetes. Healthcare professionals should be aware of possible atypical cases. Available at: http://www.ema.europa.eu/docs/en_GB/document_library/Referrals_document/SGLT2_inhibitors__20/European_Commission_final_decision/WC500202393.pdf. Accessed June 19, 2017.</Citation></Reference><Reference><Citation>Erondu N, Desai M, Ways K, Meininger G. Diabetic ketoacidosis and related events in the canagliflozin type 2 diabetes clinical program. Diabetes Care. 2015;38(9):1680&#x2010;1686.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4542268</ArticleId><ArticleId IdType="pubmed">26203064</ArticleId></ArticleIdList></Reference><Reference><Citation>Neal B, Perkovic V, Mahaffey KW, et al. Canagliflozin and cardiovascular and renal events in type 2 diabetes. N Engl J Med. 2017;377(7):644&#x2010;657.</Citation><ArticleIdList><ArticleId IdType="pubmed">28605608</ArticleId></ArticleIdList></Reference><Reference><Citation>Jabbour S, Seufert J, Scheen A, Bailey CJ, Karup C, Langkilde AM. Dapagliflozin in patients with type 2 diabetes mellitus: a pooled analysis of safety data from Phase 2b/3 clinical trials. Diabetes Obes Metab. 2017;20(3):620&#x2010;628.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5836959</ArticleId><ArticleId IdType="pubmed">28950419</ArticleId></ArticleIdList></Reference><Reference><Citation>Wiviott SD, Raz I, Bonaca MP, et al. Dapagliflozin and cardiovascular outcomes in type 2 diabetes. N Engl J Med. 2018;380(4):347&#x2010;357.</Citation><ArticleIdList><ArticleId IdType="pubmed">30415602</ArticleId></ArticleIdList></Reference><Reference><Citation>Kohler S, Zeller C, Iliev H, Kaspers S. Safety and tolerability of empagliflozin in patients with type 2 diabetes: pooled analysis of phase I&#x2010;III clinical trials. Adv Ther. 2017;34(7):1707&#x2010;1726.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5504200</ArticleId><ArticleId IdType="pubmed">28631216</ArticleId></ArticleIdList></Reference><Reference><Citation>Zinman B, Wanner C, Lachin JM, et al. Empagliflozin, cardiovascular outcomes, and mortality in type 2 diabetes. N Engl J Med. 2015;373(22):2117&#x2010;2128.</Citation><ArticleIdList><ArticleId IdType="pubmed">26378978</ArticleId></ArticleIdList></Reference><Reference><Citation>Monami M, Nreu B, Zannoni S, Lualdi C, Mannucci E. Effects of SGLT&#x2010;2 inhibitors on diabetic ketoacidosis: a meta&#x2010;analysis of randomised controlled trials. Diabetes Res Clin Pract. 2017;130:53&#x2010;60.</Citation><ArticleIdList><ArticleId IdType="pubmed">28570924</ArticleId></ArticleIdList></Reference><Reference><Citation>Tang H, Li D, Wang T, Zhai S, Song Y. Effect of sodium&#x2010;glucose cotransporter 2 inhibitors on diabetic ketoacidosis among patients with type 2 diabetes: a meta&#x2010;analysis of randomized controlled trials. Diabetes Care. 2016;39(8):e123&#x2010;e124.</Citation><ArticleIdList><ArticleId IdType="pubmed">27311492</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang Y, Desai M, Ryan PB, et al. Incidence of diabetic ketoacidosis among patients with type 2 diabetes mellitus treated with SGLT2 inhibitors and other antihyperglycemic agents. Diabetes Res Clin Pract. 2017;128:83&#x2010;90.</Citation><ArticleIdList><ArticleId IdType="pubmed">28448895</ArticleId></ArticleIdList></Reference><Reference><Citation>Fralick M, Schneeweiss S, Patorno E. Risk of diabetic ketoacidosis after initiation of an SGLT2 inhibitor. N Engl J Med. 2017;376(23):2300&#x2010;2302.</Citation><ArticleIdList><ArticleId IdType="pubmed">28591538</ArticleId></ArticleIdList></Reference><Reference><Citation>Voss EA, Makadia R, Matcho A, et al. Feasibility and utility of applications of the common data model to multiple, disparate observational health databases. J Am Med Inform Assoc. 2015;22(3):553&#x2010;564.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4457111</ArticleId><ArticleId IdType="pubmed">25670757</ArticleId></ArticleIdList></Reference><Reference><Citation>
R Core Team
. R: a language and environment for statistical computing. R Foundation for Statistical Computing, Vienna, Austria. Available at: https://www.R-project.org/.</Citation></Reference><Reference><Citation>Genkin A, Lewis DD, Madigan D. Large&#x2010;scale bayesian logistic regression for text categorization. Technometrics. 2007;49(3):291&#x2010;304.</Citation></Reference><Reference><Citation>Tibshirani R. Regression shrinkage and selection via the lasso. J Royal Statistical Soc, Series B (Methodological). 1996;58(1):267&#x2010;228.</Citation></Reference><Reference><Citation>Suchard MA, Simpson SE, Zorych I, Ryan P, Madigan D. Massive parallelization of serial inference algorithms for a complex generalized linear model. ACM Trans Model Comput Simul. 2013;23(1):1&#x2010;17.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4201181</ArticleId><ArticleId IdType="pubmed">25328363</ArticleId></ArticleIdList></Reference><Reference><Citation>Rassen JA, Shelat AA, Myers J, Glynn RJ, Rothman KJ, Schneeweiss S. One&#x2010;to&#x2010;many propensity score matching in cohort studies. Pharmacoepidemiol Drug Saf. 2012;21(Suppl 2):69&#x2010;80.</Citation><ArticleIdList><ArticleId IdType="pubmed">22552982</ArticleId></ArticleIdList></Reference><Reference><Citation>Austin PC. Optimal caliper widths for propensity&#x2010;score matching when estimating differences in means and differences in proportions in observational studies. Pharm Stat. 2011;10(2):150&#x2010;161.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3120982</ArticleId><ArticleId IdType="pubmed">20925139</ArticleId></ArticleIdList></Reference><Reference><Citation>Schuemie MJ, Ryan PB, DuMouchel W, Suchard MA, Madigan D. Interpreting observational studies: why empirical calibration is needed to correct p&#x2010;values. Stat Med. 2014;33(2):209&#x2010;218.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4285234</ArticleId><ArticleId IdType="pubmed">23900808</ArticleId></ArticleIdList></Reference><Reference><Citation>DerSimonian R, Laird N. Meta&#x2010;analysis in clinical trials. Control Clin Trials. 1986;7(3):177&#x2010;188.</Citation><ArticleIdList><ArticleId IdType="pubmed">3802833</ArticleId></ArticleIdList></Reference><Reference><Citation>Hine J, Paterson H, Abrol E, Russell&#x2010;Jones D, Herring R. SGLT inhibition and euglycaemic diabetic ketoacidosis. Lancet Diabetes Endocrinol. 2015;3(7):503&#x2010;504.</Citation><ArticleIdList><ArticleId IdType="pubmed">26025388</ArticleId></ArticleIdList></Reference><Reference><Citation>Ahmed M, McKenna MJ, Crowley RK. Diabetic ketoacidosis in patients with type 2 diabetes recently commenced on Sglt&#x2010;2 inhibitors: an ongoing concern. Endocr Pract. 2017;23(4):506&#x2010;508.</Citation><ArticleIdList><ArticleId IdType="pubmed">28437153</ArticleId></ArticleIdList></Reference><Reference><Citation>Bell DSH. Re: diabetic ketoacidosis in patients with type 2 diabetes on Sglt&#x2010;2 inhibitors: an ongoing concern. Endocr Pract. 2018;24(1):126.</Citation><ArticleIdList><ArticleId IdType="pubmed">29368970</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">31483279</PMID><DateCompleted><Year>2019</Year><Month>09</Month><Day>13</Day></DateCompleted><DateRevised><Year>2019</Year><Month>09</Month><Day>13</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1879-8365</ISSN><JournalIssue CitedMedium="Internet"><Volume>267</Volume><PubDate><Year>2019</Year><Month>Sep</Month><Day>03</Day></PubDate></JournalIssue><Title>Studies in health technology and informatics</Title><ISOAbbreviation>Stud Health Technol Inform</ISOAbbreviation></Journal><ArticleTitle>Moving Towards an EHR Data Quality Framework: The MIRACUM Approach.</ArticleTitle><Pagination><StartPage>247</StartPage><EndPage>253</EndPage><MedlinePgn>247-253</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.3233/SHTI190834</ELocationID><Abstract><AbstractText Label="INTRODUCTION" NlmCategory="BACKGROUND">Data quality (DQ) is an important prerequisite for secondary use of electronic health record (EHR) data in clinical research, particularly with regards to progressing towards a learning health system, one of the MIRACUM consortium's goals. Following the successful integration of the i2b2 research data repository in MIRACUM, we present a standardized and generic DQ framework.</AbstractText><AbstractText Label="STATE OF THE ART" NlmCategory="BACKGROUND">Already established DQ evaluation methods do not cover all of MIRACUM's requirements.</AbstractText><AbstractText Label="CONCEPT" NlmCategory="METHODS">A data quality analysis plan was developed to assess common data quality dimensions for demographic-, condition-, procedure- and department-related variables of MIRACUM's research data repository.</AbstractText><AbstractText Label="IMPLEMENTATION" NlmCategory="METHODS">A data quality analysis (DQA) tool was developed using R scripts packaged in a Docker image with all the necessary dependencies and R libraries for easy distribution. It integrates with the i2b2 data repository at each MIRACUM site, executes an analysis on the data and generates a DQ report.</AbstractText><AbstractText Label="LESSONS LEARNED" NlmCategory="CONCLUSIONS">Our DQA tool brings the analysis to the data and thus meets the MIRACUM data protection requirements. It evaluates established DQ dimensions of data repositories in a standardized and easily distributable way. This analysis allowed us to reveal and revise inconsistencies in earlier versions of the ETL jobs. The framework is portable, easy to deploy across different sites and even further adaptable to other database schemes.</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">The presented framework provides the first step towards a unified, standardized and harmonized EHR DQ assessment in MIRACUM. DQ issues can now be systematically identified by individual hospitals to subsequently implement site- or consortium-wide feedback loops to increase data quality.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Kapsner</LastName><ForeName>Lorenz A</ForeName><Initials>LA</Initials><AffiliationInfo><Affiliation>Center of Medical Information and Communication Technology, University Hospital Erlangen, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kampf</LastName><ForeName>Marvin O</ForeName><Initials>MO</Initials><AffiliationInfo><Affiliation>Center of Medical Information and Communication Technology, University Hospital Erlangen, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Seuchter</LastName><ForeName>Susanne A</ForeName><Initials>SA</Initials><AffiliationInfo><Affiliation>Center of Medical Information and Communication Technology, University Hospital Erlangen, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kamdje-Wabo</LastName><ForeName>Gaetan</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Department of Biomedical Informatics of the Heinrich-Lanz-Center, Mannheim University Medicine, Ruprecht-Karls-University Heidelberg, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gradinger</LastName><ForeName>Tobias</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Department of Biomedical Informatics of the Heinrich-Lanz-Center, Mannheim University Medicine, Ruprecht-Karls-University Heidelberg, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ganslandt</LastName><ForeName>Thomas</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Department of Biomedical Informatics of the Heinrich-Lanz-Center, Mannheim University Medicine, Ruprecht-Karls-University Heidelberg, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mate</LastName><ForeName>Sebastian</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Center of Medical Information and Communication Technology, University Hospital Erlangen, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gruendner</LastName><ForeName>Julian</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Friedrich-Alexander University Erlangen-N&#xfc;rnberg, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kraska</LastName><ForeName>Detlef</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Center of Medical Information and Communication Technology, University Hospital Erlangen, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Prokosch</LastName><ForeName>Hans-Ulrich</ForeName><Initials>HU</Initials><AffiliationInfo><Affiliation>Center of Medical Information and Communication Technology, University Hospital Erlangen, Germany.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Friedrich-Alexander University Erlangen-N&#xfc;rnberg, Germany.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>Netherlands</Country><MedlineTA>Stud Health Technol Inform</MedlineTA><NlmUniqueID>9214582</NlmUniqueID><ISSNLinking>0926-9630</ISSNLinking></MedlineJournalInfo><MeshHeadingList><MeshHeading><DescriptorName UI="D000068598" MajorTopicYN="Y">Data Accuracy</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016208" MajorTopicYN="N">Databases, Factual</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D057286" MajorTopicYN="Y">Electronic Health Records</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Data analysis</Keyword><Keyword MajorTopicYN="N">clinical research</Keyword><Keyword MajorTopicYN="N">data quality</Keyword><Keyword MajorTopicYN="N">electronic health record</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2019</Year><Month>9</Month><Day>5</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2019</Year><Month>9</Month><Day>5</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2019</Year><Month>9</Month><Day>14</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">31483279</ArticleId><ArticleId IdType="doi">10.3233/SHTI190834</ArticleId><ArticleId IdType="pii">SHTI190834</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">31494719</PMID><DateCompleted><Year>2020</Year><Month>02</Month><Day>18</Day></DateCompleted><DateRevised><Year>2020</Year><Month>02</Month><Day>25</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1573-689X</ISSN><JournalIssue CitedMedium="Internet"><Volume>43</Volume><Issue>10</Issue><PubDate><Year>2019</Year><Month>Sep</Month><Day>07</Day></PubDate></JournalIssue><Title>Journal of medical systems</Title><ISOAbbreviation>J Med Syst</ISOAbbreviation></Journal><ArticleTitle>Feasibility of Mapping Austrian Health Claims Data to the OMOP Common Data Model.</ArticleTitle><Pagination><StartPage>314</StartPage><MedlinePgn>314</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">314</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1007/s10916-019-1436-9</ELocationID><Abstract><AbstractText>The Main Association of Austrian Social Security Institutions collects pseudonymized claims data from Austrian social security institutions and information about hospital stays in a database for research purposes. For new studies the same data are repeatedly reprocessed and it is difficult to compare different study results even though the data is already preprocessed and prepared in a proprietary data model. Based on a study on adverse drug events in relation to inappropriate medication in geriatric patients the suitability of the Observational Medical Outcomes Partnership (OMOP) common data model (CDM) is analyzed and data is transformed into the OMOP CDM. 1,023 (99.7%) of drug codes and 3,812 (99.2%) of diagnoses codes coincide with the OMOP vocabularies. The biggest obstacles are missing mappings for the Local Vocabularies like the Austrian pharmaceutical registration numbers and the Socio-Economic Index to the OMOP vocabularies. OMOP CDM is a promising approach for the standardization of Austrian claims data. In the long run, the benefits of standardization and reproducibility of research should outweigh this initial drawback.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Haberson</LastName><ForeName>Andrea</ForeName><Initials>A</Initials><Identifier Source="ORCID">0000-0003-2138-9732</Identifier><AffiliationInfo><Affiliation>Center for Medical Statistics, Informatics and Intelligent Systems, Medical University of Vienna, Spitalgasse 23, 1090, Vienna, Austria. a.haberson@gmail.com.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rinner</LastName><ForeName>Christoph</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Center for Medical Statistics, Informatics and Intelligent Systems, Medical University of Vienna, Spitalgasse 23, 1090, Vienna, Austria.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sch&#xf6;berl</LastName><ForeName>Alexander</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Center for Medical Statistics, Informatics and Intelligent Systems, Medical University of Vienna, Spitalgasse 23, 1090, Vienna, Austria.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gall</LastName><ForeName>Walter</ForeName><Initials>W</Initials><AffiliationInfo><Affiliation>Center for Medical Statistics, Informatics and Intelligent Systems, Medical University of Vienna, Spitalgasse 23, 1090, Vienna, Austria.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2019</Year><Month>09</Month><Day>07</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>J Med Syst</MedlineTA><NlmUniqueID>7806056</NlmUniqueID><ISSNLinking>0148-5598</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000369" MajorTopicYN="N">Aged, 80 and over</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001317" MajorTopicYN="N" Type="Geographic">Austria</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016208" MajorTopicYN="N">Databases, Factual</DescriptorName><QualifierName UI="Q000592" MajorTopicYN="Y">standards</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D064420" MajorTopicYN="N">Drug-Related Side Effects and Adverse Reactions</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005240" MajorTopicYN="N">Feasibility Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005853" MajorTopicYN="N">Geriatrics</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007345" MajorTopicYN="N">Insurance Claim Review</DescriptorName><QualifierName UI="Q000458" MajorTopicYN="Y">organization &amp; administration</QualifierName><QualifierName UI="Q000592" MajorTopicYN="N">standards</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D063487" MajorTopicYN="N">Prescription Drug Misuse</DescriptorName><QualifierName UI="Q000706" MajorTopicYN="N">statistics &amp; numerical data</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015203" MajorTopicYN="N">Reproducibility of Results</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012959" MajorTopicYN="N">Socioeconomic Factors</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Claims data</Keyword><Keyword MajorTopicYN="N">Common data model</Keyword><Keyword MajorTopicYN="N">Drug safety</Keyword><Keyword MajorTopicYN="N">OMOP</Keyword><Keyword MajorTopicYN="N">Secondary use</Keyword><Keyword MajorTopicYN="N">Standardized health data</Keyword></KeywordList><CoiStatement>The authors declare that they have no conflicts of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2019</Year><Month>3</Month><Day>15</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2019</Year><Month>8</Month><Day>20</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2019</Year><Month>9</Month><Day>9</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2019</Year><Month>9</Month><Day>9</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2020</Year><Month>2</Month><Day>19</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2019</Year><Month>9</Month><Day>7</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">31494719</ArticleId><ArticleId IdType="pmc">PMC6732152</ArticleId><ArticleId IdType="doi">10.1007/s10916-019-1436-9</ArticleId><ArticleId IdType="pii">10.1007/s10916-019-1436-9</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Ohlmeier C, Leverkus F, Kloss S, Basic E, Ble&#xdf; H-H. Estimating the incidence of venous thromboembolism (VTE) using various types of routine data of the German healthcare system. Z f Evidenz, Fortbild. und Qualitat Im Gesundheitswesen. 2018;139:46&#x2013;52. doi: 10.1016/j.zefq.2018.11.005.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.zefq.2018.11.005</ArticleId><ArticleId IdType="pubmed">30477975</ArticleId></ArticleIdList></Reference><Reference><Citation>Safran C, Bloomrosen M, Hammond WE, Labkoff S, Markel-Fox S, Tang PC, Detmer DE, Expert P. Toward a national framework for the secondary use of health data: An American medical informatics association white paper. J. Am. Med. Inform. Assoc. 2007;14:1):1&#x2013;1):9. doi: 10.1197/jamia.M2273.</Citation><ArticleIdList><ArticleId IdType="doi">10.1197/jamia.M2273</ArticleId><ArticleId IdType="pmc">PMC2329823</ArticleId><ArticleId IdType="pubmed">17077452</ArticleId></ArticleIdList></Reference><Reference><Citation>Reisinger SJ, Ryan PB, O'Hara DJ, Powell GE, Painter JL, Pattishall EN, Morris JA. Development and evaluation of a common data model enabling active drug safety surveillance using disparate healthcare databases. J. Am. Med. Inform. Assoc. 2010;17(6):652&#x2013;662. doi: 10.1136/jamia.2009.002477.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/jamia.2009.002477</ArticleId><ArticleId IdType="pmc">PMC3000752</ArticleId><ArticleId IdType="pubmed">20962127</ArticleId></ArticleIdList></Reference><Reference><Citation>Xu Y, Zhou X, Suehs BT, Hartzema AG, Kahn MG, Moride Y, Sauer BC, Liu Q, Moll K, Pasquale MK, Nair VP, Bate A. A comparative assessment of observational medical outcomes partnership and mini-sentinel common data models and analytics: Implications for active drug safety surveillance. Drug Saf. 2015;38(8):749&#x2013;765. doi: 10.1007/s40264-015-0297-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s40264-015-0297-5</ArticleId><ArticleId IdType="pubmed">26055920</ArticleId></ArticleIdList></Reference><Reference><Citation>Rinner C, Gezgin D, Wendl C, Gall W. A clinical data warehouse based on OMOP and i2b2 for Austrian health claims data. Stud. Health Technol. Inform. 2018;248:94&#x2013;99.</Citation><ArticleIdList><ArticleId IdType="pubmed">29726424</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim H, Choi J, Jang I, Quach J, Ohno-Machado L. Feasibility of representing data from published nursing research using the OMOP common data model. AMIA Annu. Symp. Proc. 2016;2016:715&#x2013;723.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5333244</ArticleId><ArticleId IdType="pubmed">28269868</ArticleId></ArticleIdList></Reference><Reference><Citation>Maier C, Lang L, Storf H, Vormstein P, Bieber R, Bernarding J, Herrmann T, Haverkamp C, Horki P, Laufer J, Berger F, Honing G, Fritsch HW, Schuttler J, Ganslandt T, Prokosch HU, Sedlmayr M. Towards implementation of OMOP in a German University hospital consortium. Appl. Clin. Inform. 2018;9(1):54&#x2013;61. doi: 10.1055/s-0037-1617452.</Citation><ArticleIdList><ArticleId IdType="doi">10.1055/s-0037-1617452</ArticleId><ArticleId IdType="pmc">PMC5801887</ArticleId><ArticleId IdType="pubmed">29365340</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">31542521</PMID><DateCompleted><Year>2020</Year><Month>10</Month><Day>05</Day></DateCompleted><DateRevised><Year>2020</Year><Month>11</Month><Day>01</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1532-0480</ISSN><JournalIssue CitedMedium="Internet"><Volume>99</Volume><PubDate><Year>2019</Year><Month>Nov</Month></PubDate></JournalIssue><Title>Journal of biomedical informatics</Title><ISOAbbreviation>J Biomed Inform</ISOAbbreviation></Journal><ArticleTitle>Making work visible for electronic phenotype implementation: Lessons learned from the eMERGE network.</ArticleTitle><Pagination><StartPage>103293</StartPage><MedlinePgn>103293</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.jbi.2019.103293</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S1532-0464(19)30212-6</ELocationID><Abstract><AbstractText Label="BACKGROUND">Implementation of phenotype algorithms requires phenotype engineers to interpret human-readable algorithms and translate the description (text and flowcharts) into computable phenotypes - a process that can be labor intensive and error prone. To address the critical need for reducing the implementation efforts, it is important to develop portable algorithms.</AbstractText><AbstractText Label="METHODS">We conducted a retrospective analysis of phenotype algorithms developed in the Electronic Medical Records and Genomics (eMERGE) network and identified common customization tasks required for implementation. A novel scoring system was developed to quantify portability from three aspects: Knowledge conversion, clause Interpretation, and Programming (KIP). Tasks were grouped into twenty representative categories. Experienced phenotype engineers were asked to estimate the average time spent on each category and evaluate time saving enabled by a common data model (CDM), specifically the Observational Medical Outcomes Partnership (OMOP) model, for each category.</AbstractText><AbstractText Label="RESULTS">A total of 485 distinct clauses (phenotype criteria) were identified from 55 phenotype algorithms, corresponding to 1153 customization tasks. In addition to 25 non-phenotype-specific tasks, 46 tasks are related to interpretation, 613 tasks are related to knowledge conversion, and 469 tasks are related to programming. A score between 0 and 2 (0 for easy, 1 for moderate, and 2 for difficult portability) is assigned for each aspect, yielding a total KIP score range of 0 to 6. The average clause-wise KIP score to reflect portability is 1.37&#x202f;&#xb1;&#x202f;1.38. Specifically, the average knowledge (K) score is 0.64&#x202f;&#xb1;&#x202f;0.66, interpretation (I) score is 0.33&#x202f;&#xb1;&#x202f;0.55, and programming (P) score is 0.40&#x202f;&#xb1;&#x202f;0.64. 5% of the categories can be completed within one hour (median). 70% of the categories take from days to months to complete. The OMOP model can assist with vocabulary mapping tasks.</AbstractText><AbstractText Label="CONCLUSION">This study presents firsthand knowledge of the substantial implementation efforts in phenotyping and introduces a novel metric (KIP) to measure portability of phenotype algorithms for quantifying such efforts across the eMERGE Network. Phenotype developers are encouraged to analyze and optimize the portability in regards to knowledge, interpretation and programming. CDMs can be used to improve the portability for some 'knowledge-oriented' tasks.</AbstractText><CopyrightInformation>Copyright &#xa9; 2019 Elsevier Inc. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Shang</LastName><ForeName>Ning</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Department of Biomedical Informatics, Columbia University, New York, NY, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Liu</LastName><ForeName>Cong</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Department of Biomedical Informatics, Columbia University, New York, NY, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rasmussen</LastName><ForeName>Luke V</ForeName><Initials>LV</Initials><AffiliationInfo><Affiliation>Northwestern University Feinberg School of Medicine, Chicago, IL, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ta</LastName><ForeName>Casey N</ForeName><Initials>CN</Initials><AffiliationInfo><Affiliation>Department of Biomedical Informatics, Columbia University, New York, NY, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Caroll</LastName><ForeName>Robert J</ForeName><Initials>RJ</Initials><AffiliationInfo><Affiliation>Department of Biomedical Informatics, Vanderbilt University Medical Center, Nashville, TN, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Benoit</LastName><ForeName>Barbara</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Research Information Science and Computing, Partners Healthcare, Boston, MA, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lingren</LastName><ForeName>Todd</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Department of Biomedical Informatics, Cincinnati Children's Hospital Medical Center, Cincinnati, OH, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Dikilitas</LastName><ForeName>Ozan</ForeName><Initials>O</Initials><AffiliationInfo><Affiliation>Department of Cardiovascular Medicine, Mayo Clinic, Rochester, MN, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mentch</LastName><ForeName>Frank D</ForeName><Initials>FD</Initials><AffiliationInfo><Affiliation>Center for Applied Genomics, Children's Hospital of Philadelphia, Philadelphia, PA, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Carrell</LastName><ForeName>David S</ForeName><Initials>DS</Initials><AffiliationInfo><Affiliation>Kaiser Permanente Washington Health Research Institute, Seattle, WA, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wei</LastName><ForeName>Wei-Qi</ForeName><Initials>WQ</Initials><AffiliationInfo><Affiliation>Department of Biomedical Informatics, Vanderbilt University Medical Center, Nashville, TN, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Luo</LastName><ForeName>Yuan</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Northwestern University Feinberg School of Medicine, Chicago, IL, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gainer</LastName><ForeName>Vivian S</ForeName><Initials>VS</Initials><AffiliationInfo><Affiliation>Research Information Science and Computing, Partners Healthcare, Boston, MA, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kullo</LastName><ForeName>Iftikhar J</ForeName><Initials>IJ</Initials><AffiliationInfo><Affiliation>Department of Cardiovascular Medicine, Mayo Clinic, Rochester, MN, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pacheco</LastName><ForeName>Jennifer A</ForeName><Initials>JA</Initials><AffiliationInfo><Affiliation>Northwestern University Feinberg School of Medicine, Chicago, IL, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hakonarson</LastName><ForeName>Hakon</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Center for Applied Genomics, Children's Hospital of Philadelphia, Philadelphia, PA, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Walunas</LastName><ForeName>Theresa L</ForeName><Initials>TL</Initials><AffiliationInfo><Affiliation>Northwestern University Feinberg School of Medicine, Chicago, IL, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Denny</LastName><ForeName>Joshua C</ForeName><Initials>JC</Initials><AffiliationInfo><Affiliation>Department of Biomedical Informatics, Vanderbilt University Medical Center, Nashville, TN, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wiley</LastName><ForeName>Ken</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>National Human Genome Research Institute, NIH, Bethesda, MD, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Murphy</LastName><ForeName>Shawn N</ForeName><Initials>SN</Initials><AffiliationInfo><Affiliation>Research Information Science and Computing, Partners Healthcare, Boston, MA, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hripcsak</LastName><ForeName>George</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Department of Biomedical Informatics, Columbia University, New York, NY, United States; Medical Informatics Services, NewYork-Presbyterian Hospital, New York, NY, United States. Electronic address: hripcsak@columbia.edu.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Weng</LastName><ForeName>Chunhua</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Department of Biomedical Informatics, Columbia University, New York, NY, United States. Electronic address: chunhua@columbia.edu.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>U01 HG008676</GrantID><Acronym>HG</Acronym><Agency>NHGRI NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>U01 HG008657</GrantID><Acronym>HG</Acronym><Agency>NHGRI NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R01 LM009886</GrantID><Acronym>LM</Acronym><Agency>NLM NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>U01 HG008672</GrantID><Acronym>HG</Acronym><Agency>NHGRI NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>U01 HG008684</GrantID><Acronym>HG</Acronym><Agency>NHGRI NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>U01 HG008673</GrantID><Acronym>HG</Acronym><Agency>NHGRI NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>U01 HG008701</GrantID><Acronym>HG</Acronym><Agency>NHGRI NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>U01 HG008666</GrantID><Acronym>HG</Acronym><Agency>NHGRI NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R01 HL133786</GrantID><Acronym>HL</Acronym><Agency>NHLBI NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>U01 HG006388</GrantID><Acronym>HG</Acronym><Agency>NHGRI NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>U01 HG008680</GrantID><Acronym>HG</Acronym><Agency>NHGRI NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>U01 HG006379</GrantID><Acronym>HG</Acronym><Agency>NHGRI NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>UL1 TR001873</GrantID><Acronym>TR</Acronym><Agency>NCATS NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2019</Year><Month>09</Month><Day>19</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>J Biomed Inform</MedlineTA><NlmUniqueID>100970413</NlmUniqueID><ISSNLinking>1532-0464</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000465" MajorTopicYN="N">Algorithms</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D057286" MajorTopicYN="N">Electronic Health Records</DescriptorName><QualifierName UI="Q000145" MajorTopicYN="Y">classification</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D023281" MajorTopicYN="N">Genomics</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008490" MajorTopicYN="N">Medical Informatics</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="Y">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D010641" MajorTopicYN="N">Phenotype</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012189" MajorTopicYN="N">Retrospective Studies</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Electronic health records</Keyword><Keyword MajorTopicYN="N">Phenotyping</Keyword><Keyword MajorTopicYN="N">Portability</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2019</Year><Month>6</Month><Day>14</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2019</Year><Month>8</Month><Day>26</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2019</Year><Month>9</Month><Day>19</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2019</Year><Month>9</Month><Day>23</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2020</Year><Month>10</Month><Day>6</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2019</Year><Month>9</Month><Day>23</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2020</Year><Month>11</Month><Day>1</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">31542521</ArticleId><ArticleId IdType="mid">NIHMS1544840</ArticleId><ArticleId IdType="pmc">PMC6894517</ArticleId><ArticleId IdType="doi">10.1016/j.jbi.2019.103293</ArticleId><ArticleId IdType="pii">S1532-0464(19)30212-6</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Liao KP, Cai T, Savova GK, et al. Development of phenotype algorithms using electronic medical records and incorporating natural language processing. BMJ 2015;350:h1885. doi:10.1136/bmj.h1885</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.h1885</ArticleId><ArticleId IdType="pmc">PMC4707569</ArticleId><ArticleId IdType="pubmed">25911572</ArticleId></ArticleIdList></Reference><Reference><Citation>McCarty CA, Chisholm RL, Chute CG, et al. The eMERGE Network: A consortium of biorepositories linked to electronic medical records data for conducting genomic studies. BMC Med Genomics 2011;4:13. doi:10.1186/1755-8794-4-13</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1755-8794-4-13</ArticleId><ArticleId IdType="pmc">PMC3038887</ArticleId><ArticleId IdType="pubmed">21269473</ArticleId></ArticleIdList></Reference><Reference><Citation>Conway M, Berg RL, Carrell D, et al. Analyzing the Heterogeneity and Complexity of Electronic Health Record Oriented Phenotyping Algorithms. AMIA Annu Symp Proc 2011;2011:274&#x2013;83.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3243189</ArticleId><ArticleId IdType="pubmed">22195079</ArticleId></ArticleIdList></Reference><Reference><Citation>Newton KM, Peissig PL, Kho AN, et al. Validation of electronic medical record-based phenotyping algorithms: results and lessons learned from the eMERGE network. J Am Med Inform Assoc 2013;20:e147&#x2013;54. doi:10.1136/amiajnl-2012-000896</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/amiajnl-2012-000896</ArticleId><ArticleId IdType="pmc">PMC3715338</ArticleId><ArticleId IdType="pubmed">23531748</ArticleId></ArticleIdList></Reference><Reference><Citation>Wei W-Q, Denny JC. Extracting research-quality phenotypes from electronic health records to support precision medicine. Genome Med 2015;7:41. doi:10.1186/s13073-015-0166-y</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13073-015-0166-y</ArticleId><ArticleId IdType="pmc">PMC4416392</ArticleId><ArticleId IdType="pubmed">25937834</ArticleId></ArticleIdList></Reference><Reference><Citation>Banda JM, Seneviratne M, Hernandez-Boussard T, et al. Advances in Electronic Phenotyping: From Rule-Based Definitions to Machine Learning Models. Annu Rev Biomed Data Sci 2018;1:53&#x2013;68. doi:10.1146/annurev-biodatasci-080917-013315</Citation><ArticleIdList><ArticleId IdType="doi">10.1146/annurev-biodatasci-080917-013315</ArticleId><ArticleId IdType="pmc">PMC6583807</ArticleId><ArticleId IdType="pubmed">31218278</ArticleId></ArticleIdList></Reference><Reference><Citation>Kho AN, Hayes MG, Rasmussen-Torvik L, et al. Use of diverse electronic medical record systems to identify genetic risk for type 2 diabetes within a genome-wide association study. J Am Med Inform Assoc 2012;19:212&#x2013;8. doi:10.1136/amiajnl-2011-000439</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/amiajnl-2011-000439</ArticleId><ArticleId IdType="pmc">PMC3277617</ArticleId><ArticleId IdType="pubmed">22101970</ArticleId></ArticleIdList></Reference><Reference><Citation>Shim U, Kim H-N, Sung Y-A, et al. Pathway Analysis of Metabolic Syndrome Using a Genome-Wide Association Study of Korea Associated Resource (KARE) Cohorts. Genomics Inform 2014;12:195&#x2013;202. doi:10.5808/GI.2014.12.4.195</Citation><ArticleIdList><ArticleId IdType="doi">10.5808/GI.2014.12.4.195</ArticleId><ArticleId IdType="pmc">PMC4330254</ArticleId><ArticleId IdType="pubmed">25705158</ArticleId></ArticleIdList></Reference><Reference><Citation>Kullo IJ, Ding K, Jouni H, et al. A genome-wide association study of red blood cell traits using the electronic medical record. PloS One 2010;5. doi:10.1371/journal.pone.0013011</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0013011</ArticleId><ArticleId IdType="pmc">PMC2946914</ArticleId><ArticleId IdType="pubmed">20927387</ArticleId></ArticleIdList></Reference><Reference><Citation>Crawford DC, Crosslin DR, Tromp G, et al. eMERGEing progress in genomics&#x2014;the first seven years. Front Genet 2014;5. doi:10.3389/fgene.2014.00184</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fgene.2014.00184</ArticleId><ArticleId IdType="pmc">PMC4060012</ArticleId><ArticleId IdType="pubmed">24987407</ArticleId></ArticleIdList></Reference><Reference><Citation>Kirby JC, Speltz P, Rasmussen LV, et al. PheKB: a catalog and workflow for creating electronic phenotype algorithms for transportability. J Am Med Inform Assoc 2016;23:1046&#x2013;52. doi:10.1093/jamia/ocv202</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/jamia/ocv202</ArticleId><ArticleId IdType="pmc">PMC5070514</ArticleId><ArticleId IdType="pubmed">27026615</ArticleId></ArticleIdList></Reference><Reference><Citation>Patterson O, Hurdle JF. Document Clustering of Clinical Narratives: a Systematic Study of Clinical Sublanguages. AMIA Annu Symp Proc 2011;2011:1099&#x2013;107.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3243234</ArticleId><ArticleId IdType="pubmed">22195171</ArticleId></ArticleIdList></Reference><Reference><Citation>Studer R, Benjamins VR, Fensel D. Knowledge engineering: Principles and methods. Data Knowl Eng 1998;25:161&#x2013;97. doi:10.1016/S0169-023X(97)00056-6</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0169-023X(97)00056-6</ArticleId></ArticleIdList></Reference><Reference><Citation>Aylett RS, Doniat C. Supporting the Domain expert in planning domain construction. In: Proceedings of the AIPS&#x2019;02 Workshop on Knowledge Engineering Tools and Techniques for AI Planning. Citeseer 2002.</Citation></Reference><Reference><Citation>Alonso F, Mat&#xe9; JL, Pazos J. Knowledge engineering versus software engineering. Data Knowl Eng 1990;5:79&#x2013;91. doi:10.1016/0169-023X(90)90005-X</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/0169-023X(90)90005-X</ArticleId></ArticleIdList></Reference><Reference><Citation>Hripcsak G, Albers DJ. High-fidelity phenotyping: richness and freedom from bias. J Am Med Inform Assoc doi:10.1093/jamia/ocx110</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/jamia/ocx110</ArticleId><ArticleId IdType="pmc">PMC7282504</ArticleId><ArticleId IdType="pubmed">29040596</ArticleId></ArticleIdList></Reference><Reference><Citation>Richesson RL, Sun J, Pathak J, et al. Clinical phenotyping in selected national networks: demonstrating the need for high-throughput, portable, and computational methods. Artif Intell Med 2016;71:57&#x2013;61. doi:10.1016/j.artmed.2016.05.005</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.artmed.2016.05.005</ArticleId><ArticleId IdType="pmc">PMC5480212</ArticleId><ArticleId IdType="pubmed">27506131</ArticleId></ArticleIdList></Reference><Reference><Citation>Carroll RJ, Thompson WK, Eyler AE, et al. Portability of an algorithm to identify rheumatoid arthritis in electronic health records. J Am Med Inform Assoc 2012;19:e162&#x2013;9. doi:10.1136/amiajnl-2011-000583</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/amiajnl-2011-000583</ArticleId><ArticleId IdType="pmc">PMC3392871</ArticleId><ArticleId IdType="pubmed">22374935</ArticleId></ArticleIdList></Reference><Reference><Citation>Denny JC, Crawford DC, Ritchie MD, et al. Variants Near FOXE1 Are Associated with Hypothyroidism and Other Thyroid Conditions: Using Electronic Medical Records for Genome- and Phenome-wide Studies. Am J Hum Genet 2011;89:529&#x2013;42. doi:10.1016/j.ajhg.2011.09.008</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ajhg.2011.09.008</ArticleId><ArticleId IdType="pmc">PMC3188836</ArticleId><ArticleId IdType="pubmed">21981779</ArticleId></ArticleIdList></Reference><Reference><Citation>Thompson WK, Rasmussen LV, Pacheco JA, et al.
An evaluation of the NQF Quality Data Model for representing Electronic Health Record driven phenotyping algorithms. In: AMIA. Citeseer
2012. 
http://citeseerx.ist.psu.edu/viewdoc/download?doi=10.1.1.453.993&amp;rep=rep1&amp;type=pdf (accessed 1 Mar 2016).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3540514</ArticleId><ArticleId IdType="pubmed">23304366</ArticleId></ArticleIdList></Reference><Reference><Citation>Mo H, Thompson WK, Rasmussen LV, et al. Desiderata for computable representations of electronic health records-driven phenotype algorithms. J Am Med Inform Assoc 2015;22:1220&#x2013;30. doi:10.1093/jamia/ocv112</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/jamia/ocv112</ArticleId><ArticleId IdType="pmc">PMC4639716</ArticleId><ArticleId IdType="pubmed">26342218</ArticleId></ArticleIdList></Reference><Reference><Citation>Pacheco JA, Rasmussen LV, Kiefer RC, et al. A case study evaluating the portability of an executable computable phenotype algorithm across multiple institutions and electronic health record environments. J Am Med Inform Assoc 2018;25:1540&#x2013;6. doi:10.1093/jamia/ocy101</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/jamia/ocy101</ArticleId><ArticleId IdType="pmc">PMC6213083</ArticleId><ArticleId IdType="pubmed">30124903</ArticleId></ArticleIdList></Reference><Reference><Citation>Rasmussen LV, Thompson WK, Pacheco JA, et al. Design patterns for the development of electronic health record-driven phenotype extraction algorithms. J Biomed Inform 2014;51:280&#x2013;6. doi:10.1016/j.jbi.2014.06.007</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jbi.2014.06.007</ArticleId><ArticleId IdType="pmc">PMC4194216</ArticleId><ArticleId IdType="pubmed">24960203</ArticleId></ArticleIdList></Reference><Reference><Citation>Hripcsak G, Shang N, Peissig PL, et al. Facilitating phenotype transfer using a common data model. J Biomed Inform Accepted.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6697565</ArticleId><ArticleId IdType="pubmed">31325501</ArticleId></ArticleIdList></Reference><Reference><Citation>Shang N, Weng C, Hripcsak G. A Method for Enhancing the Portability of Electronic Phenotyping Algorithms: An eMERGE Pilot Study. 2016.</Citation></Reference><Reference><Citation>Hripcsak G, Ludemann P, Pryor TA, et al. Rationale for the Arden Syntax. Comput Biomed Res 1994;27:291&#x2013;324. doi:10.1006/cbmr.1994.1023</Citation><ArticleIdList><ArticleId IdType="doi">10.1006/cbmr.1994.1023</ArticleId><ArticleId IdType="pubmed">7956129</ArticleId></ArticleIdList></Reference><Reference><Citation>Hripcsak G Writing Arden Syntax medical logic modules. Comput Biol Med 1994;24:331&#x2013;63. doi:10.1016/0010-4825(94)90002-7</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/0010-4825(94)90002-7</ArticleId><ArticleId IdType="pubmed">7705066</ArticleId></ArticleIdList></Reference><Reference><Citation>Samwald M, Fehre K, de Bruin J, et al. The Arden Syntax standard for clinical decision support: Experiences and directions. J Biomed Inform 2012;45:711&#x2013;8. doi:10.1016/j.jbi.2012.02.001</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jbi.2012.02.001</ArticleId><ArticleId IdType="pubmed">22342733</ArticleId></ArticleIdList></Reference><Reference><Citation>OHDSI. ATLAS. http://www.ohdsi.org/web/atlas (accessed 28 May 2019).</Citation></Reference><Reference><Citation>Yuan C, Ryan PB, Ta C, et al. Criteria2Query: a natural language interface to clinical databases for cohort definition. J Am Med Inform Assoc 2019;26:294&#x2013;305. doi:10.1093/jamia/ocy178</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/jamia/ocy178</ArticleId><ArticleId IdType="pmc">PMC6402359</ArticleId><ArticleId IdType="pubmed">30753493</ArticleId></ArticleIdList></Reference><Reference><Citation>Denny JC, Spickard A, Johnson KB, et al. Evaluation of a method to identify and categorize section headers in clinical documents. J Am Med Inform Assoc JAMIA 2009;16:806&#x2013;15. doi:10.1197/jamia.M3037</Citation><ArticleIdList><ArticleId IdType="doi">10.1197/jamia.M3037</ArticleId><ArticleId IdType="pmc">PMC3002123</ArticleId><ArticleId IdType="pubmed">19717800</ArticleId></ArticleIdList></Reference><Reference><Citation>Xu H, Stenner SP, Doan S, et al. MedEx: a medication information extraction system for clinical narratives. J Am Med Inform Assoc 2010;17:19&#x2013;24. doi:10.1197/jamia.M3378</Citation><ArticleIdList><ArticleId IdType="doi">10.1197/jamia.M3378</ArticleId><ArticleId IdType="pmc">PMC2995636</ArticleId><ArticleId IdType="pubmed">20064797</ArticleId></ArticleIdList></Reference><Reference><Citation>Denny JC, Smithers JD, Miller RA, et al. &#x201c;Understanding&#x201d; medical school curriculum content using KnowledgeMap. J Am Med Inform Assoc JAMIA 2003;10:351&#x2013;62. doi:10.1197/jamia.M1176</Citation><ArticleIdList><ArticleId IdType="doi">10.1197/jamia.M1176</ArticleId><ArticleId IdType="pmc">PMC181986</ArticleId><ArticleId IdType="pubmed">12668688</ArticleId></ArticleIdList></Reference><Reference><Citation>Ferrucci D, Lally A. UIMA: an architectural approach to unstructured information processing in the corporate research environment. Nat Lang Eng 2004;10:327&#x2013;48. doi:10.1017/S1351324904003523</Citation><ArticleIdList><ArticleId IdType="doi">10.1017/S1351324904003523</ArticleId></ArticleIdList></Reference><Reference><Citation>Savova GK, Masanz JJ, Ogren PV, et al. Mayo clinical Text Analysis and Knowledge Extraction System (cTAKES): architecture, component evaluation and applications. J Am Med Inform Assoc 2010;17:507&#x2013;13. doi:10.1136/jamia.2009.001560</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/jamia.2009.001560</ArticleId><ArticleId IdType="pmc">PMC2995668</ArticleId><ArticleId IdType="pubmed">20819853</ArticleId></ArticleIdList></Reference><Reference><Citation>Kullo IJ, Fan J, Pathak J, et al. Leveraging informatics for genetic studies: use of the electronic medical record to enable a genome-wide association study of peripheral arterial disease. J Am Med Inform Assoc 2010;17:568&#x2013;74.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2995686</ArticleId><ArticleId IdType="pubmed">20819866</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu H, Bielinski SJ, Sohn S, et al. An Information Extraction Framework for Cohort Identification Using Electronic Health Records. AMIA Summits Transl Sci Proc 2013;2013:149&#x2013;53.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3845757</ArticleId><ArticleId IdType="pubmed">24303255</ArticleId></ArticleIdList></Reference><Reference><Citation>Mo H, Pacheco JA, Rasmussen LV, et al. A Prototype for Executable and Portable Electronic Clinical Quality Measures Using the KNIME Analytics Platform. AMIA Summits Transl Sci Proc 2015;2015:127&#x2013;31.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4525225</ArticleId><ArticleId IdType="pubmed">26306254</ArticleId></ArticleIdList></Reference><Reference><Citation>Friedman C, Alderson PO, Austin JH, et al. A general natural-language text processor for clinical radiology. J Am Med Inform Assoc JAMIA 1994;1:161&#x2013;74.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC116194</ArticleId><ArticleId IdType="pubmed">7719797</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">31545380</PMID><DateCompleted><Year>2021</Year><Month>01</Month><Day>29</Day></DateCompleted><DateRevised><Year>2024</Year><Month>03</Month><Day>30</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1527-974X</ISSN><JournalIssue CitedMedium="Internet"><Volume>26</Volume><Issue>11</Issue><PubDate><Year>2019</Year><Month>Nov</Month><Day>01</Day></PubDate></JournalIssue><Title>Journal of the American Medical Informatics Association : JAMIA</Title><ISOAbbreviation>J Am Med Inform Assoc</ISOAbbreviation></Journal><ArticleTitle>Comparison of the cohort selection performance of Australian Medicines Terminology to Anatomical Therapeutic Chemical mappings.</ArticleTitle><Pagination><StartPage>1237</StartPage><EndPage>1246</EndPage><MedlinePgn>1237-1246</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1093/jamia/ocz143</ELocationID><Abstract><AbstractText Label="OBJECTIVE">Electronic health records are increasingly utilized for observational and clinical research. Identification of cohorts using electronic health records is an important step in this process. Previous studies largely focused on the methods of cohort selection, but there is little evidence on the impact of underlying vocabularies and mappings between vocabularies used for cohort selection. We aim to compare the cohort selection performance using Australian Medicines Terminology to Anatomical Therapeutic Chemical (ATC) mappings from 2 different sources. These mappings were taken from the Observational Medical Outcomes Partnership Common Data Model (OMOP-CDM) and the Pharmaceutical Benefits Scheme (PBS) schedule.</AbstractText><AbstractText Label="MATERIALS AND METHODS">We retrieved patients from the electronic Practice Based Research Network data repository using 3 ATC classification groups (A10, N02A, N06A). The retrieved patients were further verified manually and pooled to form a reference standard which was used to assess the accuracy of mappings using precision, recall, and F measure metrics.</AbstractText><AbstractText Label="RESULTS">The OMOP-CDM mappings identified 2.6%, 15.2%, and 24.4% more drugs than the PBS mappings in the A10, N02A and N06A groups respectively. Despite this, the PBS mappings generally performed the same in cohort selection as OMOP-CDM mappings except for the N02A Opioids group, where a significantly greater number of patients were retrieved. Both mappings exhibited variable recall, but perfect precision, with all drugs found to be correctly identified.</AbstractText><AbstractText Label="CONCLUSION">We found that 1 of the 3 ATC groups had a significant difference and this affected cohort selection performance. Our findings highlighted that underlying terminology mappings can greatly impact cohort selection accuracy. Clinical researchers should carefully evaluate vocabulary mapping sources including methodologies used to develop those mappings.</AbstractText><CopyrightInformation>&#xa9; The Author(s) 2019. Published by Oxford University Press on behalf of the American Medical Informatics Association. All rights reserved. For permissions, please email: journals.permissions@oup.com.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Guo</LastName><ForeName>Guan N</ForeName><Initials>GN</Initials><AffiliationInfo><Affiliation>School of Public Health and Community Medicine, University of New South Wales, Sydney, Australia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>WHO Collaborating Centre for eHealth, University of New South Wales, Sydney, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jonnagaddala</LastName><ForeName>Jitendra</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>School of Public Health and Community Medicine, University of New South Wales, Sydney, Australia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>WHO Collaborating Centre for eHealth, University of New South Wales, Sydney, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Farshid</LastName><ForeName>Sanjay</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>School of Public Health and Community Medicine, University of New South Wales, Sydney, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Huser</LastName><ForeName>Vojtech</ForeName><Initials>V</Initials><AffiliationInfo><Affiliation>Lister Hill National Centre for Biomedical Communications, National Library of Medicine National Institutes of Health, Bethesda, Maryland, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Reich</LastName><ForeName>Christian</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>IQVIA, Cambridge, Massachusetts, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Liaw</LastName><ForeName>Siaw-Teng</ForeName><Initials>ST</Initials><AffiliationInfo><Affiliation>School of Public Health and Community Medicine, University of New South Wales, Sydney, Australia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>WHO Collaborating Centre for eHealth, University of New South Wales, Sydney, Australia.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D003160">Comparative Study</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D052061">Research Support, N.I.H., Extramural</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>J Am Med Inform Assoc</MedlineTA><NlmUniqueID>9430800</NlmUniqueID><ISSNLinking>1067-5027</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D004364">Pharmaceutical Preparations</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D001315" MajorTopicYN="N" Type="Geographic">Australia</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D057286" MajorTopicYN="Y">Electronic Health Records</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016247" MajorTopicYN="N">Information Storage and Retrieval</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D018579" MajorTopicYN="Y">Patient Selection</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004364" MajorTopicYN="N">Pharmaceutical Preparations</DescriptorName><QualifierName UI="Q000145" MajorTopicYN="Y">classification</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D039061" MajorTopicYN="N">Systematized Nomenclature of Medicine</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009626" MajorTopicYN="Y">Terminology as Topic</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018875" MajorTopicYN="Y">Vocabulary, Controlled</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Australian Medicines Terminology</Keyword><Keyword MajorTopicYN="N">anatomical therapeutic chemical classification</Keyword><Keyword MajorTopicYN="N">clinical trials</Keyword><Keyword MajorTopicYN="N">cohort selection</Keyword><Keyword MajorTopicYN="N">electronic health records</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2019</Year><Month>1</Month><Day>11</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2019</Year><Month>6</Month><Day>10</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2019</Year><Month>7</Month><Day>22</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2019</Year><Month>9</Month><Day>24</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2021</Year><Month>1</Month><Day>30</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2019</Year><Month>9</Month><Day>24</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2020</Year><Month>9</Month><Day>23</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">31545380</ArticleId><ArticleId IdType="pmc">PMC7647230</ArticleId><ArticleId IdType="doi">10.1093/jamia/ocz143</ArticleId><ArticleId IdType="pii">5572827</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Charles D, Gabriel M, Furukawa MF.. Adoption of electronic health record systems among US non-federal acute care hospitals: 2008&#x2013;2012. ONC Data Brief 2013; 9: 1&#x2013;9.</Citation></Reference><Reference><Citation>Safran C. Using routinely collected data for clinical research. Stat Med 1991; 104: 559&#x2013;64.</Citation><ArticleIdList><ArticleId IdType="pubmed">1905417</ArticleId></ArticleIdList></Reference><Reference><Citation>de Lusignan S, van Weel C.. The use of routinely collected computer data for research in primary care: opportunities and challenges. Fam Pract 2006; 232: 253&#x2013;63.</Citation><ArticleIdList><ArticleId IdType="pubmed">16368704</ArticleId></ArticleIdList></Reference><Reference><Citation>Concato J, Shah N, Horwitz RI.. Randomized, controlled trials, observational studies, and the hierarchy of research designs. N Engl J Med 2000; 34225: 1887&#x2013;92.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1557642</ArticleId><ArticleId IdType="pubmed">10861325</ArticleId></ArticleIdList></Reference><Reference><Citation>Sherman RE, Anderson SA, Dal Pan GJ, et al. Real-world evidence&#x2014;what is it and what can it tell us. N Engl J Med 2016; 37523: 2293&#x2013;7.</Citation><ArticleIdList><ArticleId IdType="pubmed">27959688</ArticleId></ArticleIdList></Reference><Reference><Citation>Gottesman O, Kuivaniemi H, Tromp G, et al. The electronic medical records and genomics (eMERGE) network: past, present, and future. Genet Med 2013; 1510: 761..</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3795928</ArticleId><ArticleId IdType="pubmed">23743551</ArticleId></ArticleIdList></Reference><Reference><Citation>Banda JM, Halpern Y, Sontag D, et al. Electronic phenotyping with APHRODITE and the Observational Health Sciences and Informatics (OHDSI) data network. AMIA Joint Summits on Translational Science proceedings. AMIA Jt Summits Transl Sci 2017; 2017: 48&#x2013;57.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5543379</ArticleId><ArticleId IdType="pubmed">28815104</ArticleId></ArticleIdList></Reference><Reference><Citation>Mo H, Thompson WK, Rasmussen LV, et al. Desiderata for computable representations of electronic health records-driven phenotype algorithms. J Am Med Inform Assoc 2015; 226: 1220&#x2013;30.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4639716</ArticleId><ArticleId IdType="pubmed">26342218</ArticleId></ArticleIdList></Reference><Reference><Citation>Wei W-Q, Teixeira PL, Mo H, et al. Combining billing codes, clinical notes, and medications from electronic health records provides superior phenotyping performance. J Am Med Inform Assoc 2016; 23 (e1): e20&#x2013;7.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4954637</ArticleId><ArticleId IdType="pubmed">26338219</ArticleId></ArticleIdList></Reference><Reference><Citation>Jensen PB, Jensen LJ, Brunak S.. Mining electronic health records: towards better research applications and clinical care. Nat Rev Genet 2012; 136: 395..</Citation><ArticleIdList><ArticleId IdType="pubmed">22549152</ArticleId></ArticleIdList></Reference><Reference><Citation>Shivade C, Raghavan P, Fosler-Lussier E, et al. A review of approaches to identifying patient phenotype cohorts using electronic health records. J Am Med Inform Assoc 2014; 212: 221&#x2013;30.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3932460</ArticleId><ArticleId IdType="pubmed">24201027</ArticleId></ArticleIdList></Reference><Reference><Citation>Liao KP, Cai T, Gainer V, et al. Electronic medical records for discovery research in rheumatoid arthritis. Arthritis Care Res 2010; 628: 1120&#x2013;7.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3121049</ArticleId><ArticleId IdType="pubmed">20235204</ArticleId></ArticleIdList></Reference><Reference><Citation>Hripcsak G, Levine ME, Shang N, et al. Effect of vocabulary mapping for conditions on phenotype cohorts. J Am Med Inform Assoc 2018; 25 (12): 1618&#x2013;25.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6289550</ArticleId><ArticleId IdType="pubmed">30395248</ArticleId></ArticleIdList></Reference><Reference><Citation>Reich C, Ryan PB, Stang PE, et al. Evaluation of alternative standardized terminologies for medical conditions within a network of observational healthcare databases. J Biomed Inform 2012; 454: 689&#x2013;96.</Citation><ArticleIdList><ArticleId IdType="pubmed">22683994</ArticleId></ArticleIdList></Reference><Reference><Citation>Jonnagaddala J, Dai H-J, Ray P, et al. Mining electronic health records to guide and support clinical decision support systems In: Siaw-Teng Liaw, Andrew Nunn, Tony Sahama, eds. Improving Health Management through Clinical Decision Support Systems. Pennsylvania, USA: IGI Global; 2016: 252&#x2013;69.</Citation></Reference><Reference><Citation>WHO Collaborating Centre for Drug Statistics Methodology. Guidelines for ATC Classification and DDD Assignment. Oslo: WHO; 2005.</Citation></Reference><Reference><Citation>Natsch S, Hekster YA, Jong R, et al. Application of the ATC/DDD methodology to monitor antibiotic drug use. Eur J Clin Microbiol Infect Dis 1998; 171: 20&#x2013;4.</Citation><ArticleIdList><ArticleId IdType="pubmed">9512177</ArticleId></ArticleIdList></Reference><Reference><Citation>Basger BJ, Chen TF, Moles RJ.. Application of a prescribing indicators tool to assist in identifying drug-related problems in a cohort of older Australians. Int J Pharm Pract 2012; 203: 172&#x2013;82.</Citation><ArticleIdList><ArticleId IdType="pubmed">22554160</ArticleId></ArticleIdList></Reference><Reference><Citation>Barrows RC Jr, Cimino JJ, Clayton PD. Mapping clinically useful terminology to a controlled medical vocabulary. In: Proceedings of the Annual Symposium on Computer Application in Medical Care. November 5&#x2013;9, 1994; Washington, DC. Pennsylvania: Hanley &amp; Belfus, Inc.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2247832</ArticleId><ArticleId IdType="pubmed">7949922</ArticleId></ArticleIdList></Reference><Reference><Citation>Humphreys BL, Lindberg D.. The UMLS project: making the conceptual connection between users and the information they need. Bull Med Libr Assoc 1993; 812: 170..</Citation><ArticleIdList><ArticleId IdType="pmc">PMC225759</ArticleId><ArticleId IdType="pubmed">8472002</ArticleId></ArticleIdList></Reference><Reference><Citation>Caughey GE, Roughead EE, Vitry AI, et al. Comorbidity in the elderly with diabetes: Identification of areas of potential treatment conflicts. Diabetes Res Clin Pract 2010; 873: 385&#x2013;93.</Citation><ArticleIdList><ArticleId IdType="pubmed">19923032</ArticleId></ArticleIdList></Reference><Reference><Citation>Inacio MC, Hansen C, Pratt NL, et al. Risk factors for persistent and new chronic opioid use in patients undergoing total hip arthroplasty: a retrospective cohort study. BMJ Open 2016; 64: e010664.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4853994</ArticleId><ArticleId IdType="pubmed">27130165</ArticleId></ArticleIdList></Reference><Reference><Citation>Vitry AI, Roughead EE, Preiss AK, et al. Influence of comorbidities on therapeutic progression of diabetes treatment in Australian veterans: a cohort study. PLoS One 2010; 511: e14024..</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2984440</ArticleId><ArticleId IdType="pubmed">21103337</ArticleId></ArticleIdList></Reference><Reference><Citation>Pahor M, Chrischilles E, Guralnik J, et al. Drug data coding and analysis in epidemiologic studies. Eur J Epidemiol 1994; 104: 405&#x2013;11.</Citation><ArticleIdList><ArticleId IdType="pubmed">7843344</ArticleId></ArticleIdList></Reference><Reference><Citation>Huber CA, Szucs TD, Rapold R, et al. Identifying patients with chronic conditions using pharmacy data in Switzerland: an updated mapping approach to the classification of medications. BMC Public Health 2013; 131: 1030.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3840632</ArticleId><ArticleId IdType="pubmed">24172142</ArticleId></ArticleIdList></Reference><Reference><Citation>Peissig PL, Costa VS, Caldwell MD, et al. Relational machine learning for electronic health record-driven phenotyping. J Biomed Inform 2014; 52: 260&#x2013;70.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4261015</ArticleId><ArticleId IdType="pubmed">25048351</ArticleId></ArticleIdList></Reference><Reference><Citation>Yu S, Ma Y, Gronsbell J, et al. Enabling phenotypic big data with PheNorm. J Am Med Inform Assoc 2018; 251: 54&#x2013;60.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6251688</ArticleId><ArticleId IdType="pubmed">29126253</ArticleId></ArticleIdList></Reference><Reference><Citation>Saitwal H, Qing D, Jones S, et al. Cross-terminology mapping challenges: a demonstration using medication terminological systems. J Biomed Inform 2012; 454: 613&#x2013;25.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4398308</ArticleId><ArticleId IdType="pubmed">22750536</ArticleId></ArticleIdList></Reference><Reference><Citation>Defalco FJ, Ryan PB, Soledad Cepeda M.. Applying standardized drug terminologies to observational healthcare databases: a case study on opioid exposure. Health Serv Outcomes Res Method 2013; 131: 58&#x2013;67.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3566397</ArticleId><ArticleId IdType="pubmed">23396660</ArticleId></ArticleIdList></Reference><Reference><Citation>Choi Y, Jung C, Chae Y, et al. Comparison of validity of mapping between drug indications and ICD-10. Methods Inf Med 2014; 533: 195&#x2013;201.</Citation><ArticleIdList><ArticleId IdType="pubmed">24727865</ArticleId></ArticleIdList></Reference><Reference><Citation>Park H-T, Lu D.-F, Konicek D, et al. Nursing interventions classification in systematized nomenclature of medicine clinical terms: a cross-mapping validation. Comput Inform Nurs 2007; 254: 198&#x2013;208.</Citation><ArticleIdList><ArticleId IdType="pubmed">17625400</ArticleId></ArticleIdList></Reference><Reference><Citation>Fung KW, Bodenreider O, Aronson AR, et al. Combining lexical and semantic methods of inter-terminology mapping using the UMLS. Stud Health Technol Inform 2007; 129 (Pt 1): 605..</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2430093</ArticleId><ArticleId IdType="pubmed">17911788</ArticleId></ArticleIdList></Reference><Reference><Citation>Steinberg DM, Fine J, Chappell R.. Sample size for positive and negative predictive value in diagnostic research using case-control designs. Biostatistics 2008; 101: 94&#x2013;105.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3668447</ArticleId><ArticleId IdType="pubmed">18556677</ArticleId></ArticleIdList></Reference><Reference><Citation>Burt T, Button KS, Thom HHZ, et al. The burden of the &#x201c;false-negatives&#x201d; in clinical development: analyses of current and alternative scenarios and corrective measures. Clin Transl Sci 2017; 106: 470&#x2013;9.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6402187</ArticleId><ArticleId IdType="pubmed">28675646</ArticleId></ArticleIdList></Reference><Reference><Citation>Schulz S, Rodrigues JM, Rector A, et al. Interface terminologies, reference terminologies and aggregation terminologies: a strategy for better integration. Stud Health Technol Inform 2017; 245: 940&#x2013;4.</Citation><ArticleIdList><ArticleId IdType="pubmed">29295238</ArticleId></ArticleIdList></Reference><Reference><Citation>Chute CG. Clinical classification and terminology: some history and current observations. J Am Med Inform Assoc 2000; 73: 298&#x2013;303.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC61433</ArticleId><ArticleId IdType="pubmed">10833167</ArticleId></ArticleIdList></Reference><Reference><Citation>Bowman SE. Coordination of SNOMED-CT and ICD-10: Getting the Most Out of Electronic Health Record Systems. J AHIMA 2005; 767: 60&#x2013;1.</Citation><ArticleIdList><ArticleId IdType="pubmed">16097126</ArticleId></ArticleIdList></Reference><Reference><Citation>Chiang MF, Hwang JC, Alexander CY, et al. Reliability of SNOMED-CT coding by three physicians using two terminology browsers. AMIA Annu Symp Proc 2006; 2006: 131&#x2013;5; Washington, DC.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1839418</ArticleId><ArticleId IdType="pubmed">17238317</ArticleId></ArticleIdList></Reference><Reference><Citation>
World Health Organization. Classification of diseases (ICD). 2018. 
https://www.who.int/classifications/icd/en/. Accessed December 23, 2018.</Citation></Reference><Reference><Citation>Jonnagaddala J, Hu F. Automatic coding of death certificates to ICD-10 terminology. In: Linda Cappellato, Nicola Ferro, Lorraine Goeuriot, Thomas Mandl, eds. CLEF (Working Notes) Dublin, Ireland: Sun SITE Central Europe; 2017.</Citation></Reference><Reference><Citation>
National Clinical Terminology Service. Australian medicines terminology fact sheet. 2016. 
https://www.digitalhealth.gov.au/using-the-my-health-record-system/digital-health-training-resources/guides/australian-medicines-terminology-amt-fact-sheet. Accessed November 14, 2018.</Citation></Reference><Reference><Citation>
International Health Terminology Standards Development Organisation. SNOMED CT July 2018 International Edition&#x2014;SNOMED International Release notes. 2018. 
https://confluence.ihtsdotools.org/display/RMT/SNOMED+CT+July+2018+International+Edition+-+SNOMED+International+Release+notes. Accessed December 11, 2018.</Citation></Reference><Reference><Citation>Bodenreider O, Rodriguez LM.. Analyzing U.S. prescription lists with RxNorm and the ATC/DDD Index. AMIA Annu Symp Proc 2014; 2014: 297&#x2013;306.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4419961</ArticleId><ArticleId IdType="pubmed">25954332</ArticleId></ArticleIdList></Reference><Reference><Citation>Hripcsak G, Wilcox A.. Reference standards, judges, and comparison subjects: roles for experts in evaluating system performance. J Am Med Inform Assoc 2002; 91: 1&#x2013;15.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC349383</ArticleId><ArticleId IdType="pubmed">11751799</ArticleId></ArticleIdList></Reference><Reference><Citation>Hripcsak G, Friedman C, Alderson PO, et al. Unlocking clinical data from narrative reports: a study of natural language processing. Ann Intern Med 1995; 1229: 681&#x2013;8.</Citation><ArticleIdList><ArticleId IdType="pubmed">7702231</ArticleId></ArticleIdList></Reference><Reference><Citation>
ePBRN
. ePBRN/AMT-Study-JAMIA. 2019. 
https://github.com/ePBRN/AMT-Study-JAMIA. Accessed June 5, 2019.</Citation></Reference><Reference><Citation>
Pharmaceutical Benefits Scheme. PBS publications archive. 2018. 
http://www.pbs.gov.au/info/publication/schedule/archive. Accessed December 11, 2018.</Citation></Reference><Reference><Citation>Hripcsak G, Duke JD, Shah NH, et al. Observational Health Data Sciences and Informatics (OHDSI): opportunities for observational researchers. Stud Health Technol Inform 2015; 216: 574.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4815923</ArticleId><ArticleId IdType="pubmed">26262116</ArticleId></ArticleIdList></Reference><Reference><Citation>
US National Library of Medicine. RxNorm release notes. 2013. 
https://www.nlm.nih.gov/research/umls/rxnorm/docs/2013/rxnorm_releasenotes_full_08052013.html. Accessed December 11, 2018.</Citation></Reference><Reference><Citation>
Observational Health Data Sciences and Informatics. Release notes 2017-09-06. 2017. 
https://github.com/OHDSI/OMOP-Standardized-Vocabularies/blob/master/Release%20Notes%202017-09-06.txt. Accessed November 10, 2018.</Citation></Reference><Reference><Citation>
Observational Health Data Sciences and Informatics. Athena&#x2014;OHDSI Vocabularies Repository. 2015. 
http://athena.ohdsi.org/search-terms/terms/43351380. Accessed December 10, 2018.</Citation></Reference><Reference><Citation>Taggart J, Liaw ST, Yu H.. Structured data quality reports to improve EHR data quality. Int J Med Inform 2015; 8412: 1094&#x2013;8.</Citation><ArticleIdList><ArticleId IdType="pubmed">26480872</ArticleId></ArticleIdList></Reference><Reference><Citation>Boyle D, Rafael N.. BioGrid Australia and GRHANITE&#x2122;: privacy-protecting subject matching. Stud Health Technol Inform 2011; 168: 24&#x2013;34.</Citation><ArticleIdList><ArticleId IdType="pubmed">21893908</ArticleId></ArticleIdList></Reference><Reference><Citation>Liaw S-T, Boyle D. Secure data linkage and information sharing with GRHANITE. In: Heather Grain, ed. HISA Health Informatics Conference (HIC) 2008. Melbourne: Health Informatics Society of Australia; August 31&#x2013;September 2 2008, pp. 159&#x2013;165.</Citation></Reference><Reference><Citation>
Farshid S, Jonnagaddala J, Guo GN, Wu M, Liaw, S.-T. Harmonising primary care data using international standard vocabularies for observational research; 2018. https://zenodo.org/record/1401691#.XUF9n-gzaUn. Accessed December 10, 2018.</Citation></Reference><Reference><Citation>Kohler F, Liaw S-T, Pennock R, et al. Integrated health care&#x2014;a population health approach in South Western Sydney. Int J Integr Care 2014; 149.</Citation></Reference><Reference><Citation>Royal Australian College of General Practitioners. RACGP Standards for General Practices 5th ed. East Melbourne, Australia: RACGP. 2017.</Citation></Reference><Reference><Citation>Meystre S, Haug PJ.. Natural language processing to extract medical problems from electronic clinical documents: performance evaluation. J Biomed Inform 2006; 396: 589&#x2013;99.</Citation><ArticleIdList><ArticleId IdType="pubmed">16359928</ArticleId></ArticleIdList></Reference><Reference><Citation>Hripcsak G, Rothschild AS.. Agreement, the F-measure, and reliability in information retrieval. J Am Med Inform Assoc 2005; 123: 296&#x2013;8.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1090460</ArticleId><ArticleId IdType="pubmed">15684123</ArticleId></ArticleIdList></Reference><Reference><Citation>Kohavi R. A study of cross-validation and bootstrap for accuracy estimation and model selection. In: International Joint Conference on Artificial Intelligence, 1995.</Citation></Reference><Reference><Citation>Tilson L, Bennett K, Barry M.. Prescribing trends for nicotine replacement therapy in primary care. Irish Med J 2004; 979: 270&#x2013;73.</Citation><ArticleIdList><ArticleId IdType="pubmed">15568584</ArticleId></ArticleIdList></Reference><Reference><Citation>Smith MV, Costello D, Yonkers KA.. Clinical correlates of prescription opioid analgesic use in pregnancy. Matern Child Health J 2015; 193: 548&#x2013;56.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4272915</ArticleId><ArticleId IdType="pubmed">24951127</ArticleId></ArticleIdList></Reference><Reference><Citation>Handal M, Engeland A, R&#xf8;nning M, et al. Use of prescribed opioid analgesics and co-medication with benzodiazepines in women before, during, and after pregnancy: a population-based cohort study. Eur J Clin Pharmacol 2011; 679: 953..</Citation><ArticleIdList><ArticleId IdType="pubmed">21484468</ArticleId></ArticleIdList></Reference><Reference><Citation>Dale O, Borchgrevink PC, Fredheim OMS, et al. Prevalence of use of non-prescription analgesics in the Norwegian HUNT3 population: impact of gender, age, exercise and prescription of opioids. BMC Public Health 2015; 151: 461..</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4428499</ArticleId><ArticleId IdType="pubmed">25934132</ArticleId></ArticleIdList></Reference><Reference><Citation>Hasselstr&#xf6;m J, Liu-Palmgren J, Rasj&#xf6;-Wr&#xe5;&#xe5;k G.. Prevalence of pain in general practice. Eur J Pain 2002; 65: 375&#x2013;85.</Citation><ArticleIdList><ArticleId IdType="pubmed">12160512</ArticleId></ArticleIdList></Reference><Reference><Citation>Australian Bureau of Statistics. 4364.0.55.001&#x2014;National Health Survey: First Results, 2014&#x2013;15 2015. Canberra, Australia: Australian Bureau of Statistics.</Citation></Reference><Reference><Citation>Dhombres F, Charlet J.. As ontologies reach maturity, artificial intelligence starts being fully efficient: findings from the section on knowledge representation and management for the yearbook 2018. Yearb Med Inform 2018; 2701: 140&#x2013;5.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6115232</ArticleId><ArticleId IdType="pubmed">30157517</ArticleId></ArticleIdList></Reference><Reference><Citation>Hamunen K, Laitinen-Parkkonen P, Paakkari P, et al. What do different databases tell about the use of opioids in seven European countries in 2002? Eur J Pain 2008; 126: 705&#x2013;15.</Citation><ArticleIdList><ArticleId IdType="pubmed">18162422</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">31553307</PMID><DateRevised><Year>2025</Year><Month>05</Month><Day>30</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Print">2291-9694</ISSN><JournalIssue CitedMedium="Print"><Volume>7</Volume><Issue>4</Issue><PubDate><Year>2019</Year><Month>Nov</Month><Day>29</Day></PubDate></JournalIssue><Title>JMIR medical informatics</Title><ISOAbbreviation>JMIR Med Inform</ISOAbbreviation></Journal><ArticleTitle>Mapping ICD-10 and ICD-10-CM Codes to Phecodes: Workflow Development and Initial Evaluation.</ArticleTitle><Pagination><StartPage>e14325</StartPage><MedlinePgn>e14325</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">e14325</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.2196/14325</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">The phecode system was built upon the International Classification of Diseases, Ninth Revision, Clinical Modification (ICD-9-CM) for phenome-wide association studies (PheWAS) using the electronic health record (EHR).</AbstractText><AbstractText Label="OBJECTIVE" NlmCategory="OBJECTIVE">The goal of this paper was to develop and perform an initial evaluation of maps from the International Classification of Diseases, 10th Revision (ICD-10) and the International Classification of Diseases, 10th Revision, Clinical Modification (ICD-10-CM) codes to phecodes.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">We mapped ICD-10 and ICD-10-CM codes to phecodes using a number of methods and resources, such as concept relationships and explicit mappings from the Centers for Medicare &amp; Medicaid Services, the Unified Medical Language System, Observational Health Data Sciences and Informatics, Systematized Nomenclature of Medicine-Clinical Terms, and the National Library of Medicine. We assessed the coverage of the maps in two databases: Vanderbilt University Medical Center (VUMC) using ICD-10-CM and the UK Biobank (UKBB) using ICD-10. We assessed the fidelity of the ICD-10-CM map in comparison to the gold-standard ICD-9-CM phecode map by investigating phenotype reproducibility and conducting a PheWAS.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">We mapped &gt;75% of ICD-10 and ICD-10-CM codes to phecodes. Of the unique codes observed in the UKBB (ICD-10) and VUMC (ICD-10-CM) cohorts, &gt;90% were mapped to phecodes. We observed 70-75% reproducibility for chronic diseases and &lt;10% for an acute disease for phenotypes sourced from the ICD-10-CM phecode map. Using the ICD-9-CM and ICD-10-CM maps, we conducted a PheWAS with a Lipoprotein(a) genetic variant, rs10455872, which replicated two known genotype-phenotype associations with similar effect sizes: coronary atherosclerosis (ICD-9-CM: P&lt;.001; odds ratio (OR) 1.60 [95% CI 1.43-1.80] vs ICD-10-CM: P&lt;.001; OR 1.60 [95% CI 1.43-1.80]) and chronic ischemic heart disease (ICD-9-CM: P&lt;.001; OR 1.56 [95% CI 1.35-1.79] vs ICD-10-CM: P&lt;.001; OR 1.47 [95% CI 1.22-1.77]).</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">This study introduces the beta versions of ICD-10 and ICD-10-CM to phecode maps that enable researchers to leverage accumulated ICD-10 and ICD-10-CM data for PheWAS in the EHR.</AbstractText><CopyrightInformation>&#xa9;Patrick Wu, Aliya Gifford, Xiangrui Meng, Xue Li, Harry Campbell, Tim Varley, Juan Zhao, Robert Carroll, Lisa Bastarache, Joshua C Denny, Evropi Theodoratou, Wei-Qi Wei. Originally published in JMIR Medical Informatics (http://medinform.jmir.org), 29.11.2019.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y" EqualContrib="Y"><LastName>Wu</LastName><ForeName>Patrick</ForeName><Initials>P</Initials><Identifier Source="ORCID">0000-0002-1437-6688</Identifier><AffiliationInfo><Affiliation>Department of Biomedical Informatics, Vanderbilt University Medical Center, Nashville, TN, United States.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Medical Scientist Training Program, Vanderbilt University School of Medicine, Nashville, TN, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y" EqualContrib="Y"><LastName>Gifford</LastName><ForeName>Aliya</ForeName><Initials>A</Initials><Identifier Source="ORCID">0000-0001-8931-8362</Identifier><AffiliationInfo><Affiliation>Department of Biomedical Informatics, Vanderbilt University Medical Center, Nashville, TN, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y" EqualContrib="Y"><LastName>Meng</LastName><ForeName>Xiangrui</ForeName><Initials>X</Initials><Identifier Source="ORCID">0000-0003-4889-4640</Identifier><AffiliationInfo><Affiliation>Centre for Global Health Research, Usher Institute of Population Health Sciences and Informatics, The University of Edinburgh, Edinburgh, United Kingdom.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Li</LastName><ForeName>Xue</ForeName><Initials>X</Initials><Identifier Source="ORCID">0000-0001-6880-2577</Identifier><AffiliationInfo><Affiliation>Centre for Global Health Research, Usher Institute of Population Health Sciences and Informatics, The University of Edinburgh, Edinburgh, United Kingdom.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Campbell</LastName><ForeName>Harry</ForeName><Initials>H</Initials><Identifier Source="ORCID">0000-0002-6169-6262</Identifier><AffiliationInfo><Affiliation>Centre for Global Health Research, Usher Institute of Population Health Sciences and Informatics, The University of Edinburgh, Edinburgh, United Kingdom.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Varley</LastName><ForeName>Tim</ForeName><Initials>T</Initials><Identifier Source="ORCID">0000-0002-6106-568X</Identifier><AffiliationInfo><Affiliation>Public Health and Intelligence Strategic Business Unit, National Services Scotland, Edinburgh, United Kingdom.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhao</LastName><ForeName>Juan</ForeName><Initials>J</Initials><Identifier Source="ORCID">0000-0003-1429-0662</Identifier><AffiliationInfo><Affiliation>Department of Biomedical Informatics, Vanderbilt University Medical Center, Nashville, TN, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Carroll</LastName><ForeName>Robert</ForeName><Initials>R</Initials><Identifier Source="ORCID">0000-0003-3802-8183</Identifier><AffiliationInfo><Affiliation>Department of Biomedical Informatics, Vanderbilt University Medical Center, Nashville, TN, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bastarache</LastName><ForeName>Lisa</ForeName><Initials>L</Initials><Identifier Source="ORCID">0000-0003-3020-447X</Identifier><AffiliationInfo><Affiliation>Department of Biomedical Informatics, Vanderbilt University Medical Center, Nashville, TN, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Denny</LastName><ForeName>Joshua C</ForeName><Initials>JC</Initials><Identifier Source="ORCID">0000-0002-3049-7332</Identifier><AffiliationInfo><Affiliation>Department of Biomedical Informatics, Vanderbilt University Medical Center, Nashville, TN, United States.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Medicine, Vanderbilt University Medical Center, Nashville, TN, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Theodoratou</LastName><ForeName>Evropi</ForeName><Initials>E</Initials><Identifier Source="ORCID">0000-0001-5887-9132</Identifier><AffiliationInfo><Affiliation>Centre for Global Health Research, Usher Institute of Population Health Sciences and Informatics, The University of Edinburgh, Edinburgh, United Kingdom.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Edinburgh Cancer Research Centre, Institute of Genetics and Molecular Medicine, University of Edinburgh, Edinburgh, United Kingdom.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wei</LastName><ForeName>Wei-Qi</ForeName><Initials>WQ</Initials><Identifier Source="ORCID">0000-0003-4985-056X</Identifier><AffiliationInfo><Affiliation>Department of Biomedical Informatics, Vanderbilt University Medical Center, Nashville, TN, United States.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>22804</GrantID><Acronym>CRUK_</Acronym><Agency>Cancer Research UK</Agency><Country>United Kingdom</Country></Grant><Grant><GrantID>T15 LM007450</GrantID><Acronym>LM</Acronym><Agency>NLM NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R01 LM010685</GrantID><Acronym>LM</Acronym><Agency>NLM NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R01 HL133786</GrantID><Acronym>HL</Acronym><Agency>NHLBI NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>T32 GM007347</GrantID><Acronym>GM</Acronym><Agency>NIGMS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>P50 GM115305</GrantID><Acronym>GM</Acronym><Agency>NIGMS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>T32 GM152284</GrantID><Acronym>GM</Acronym><Agency>NIGMS NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2019</Year><Month>11</Month><Day>29</Day></ArticleDate></Article><MedlineJournalInfo><Country>Canada</Country><MedlineTA>JMIR Med Inform</MedlineTA><NlmUniqueID>101645109</NlmUniqueID><ISSNLinking>2291-9694</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">data science</Keyword><Keyword MajorTopicYN="N">electronic health record</Keyword><Keyword MajorTopicYN="N">genome-wide association study</Keyword><Keyword MajorTopicYN="N">medical informatics applications</Keyword><Keyword MajorTopicYN="N">phenome-wide association study</Keyword><Keyword MajorTopicYN="N">phenotyping</Keyword></KeywordList><CoiStatement>Conflicts of Interest: None declared.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2019</Year><Month>4</Month><Day>9</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2019</Year><Month>9</Month><Day>24</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2019</Year><Month>8</Month><Day>3</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2019</Year><Month>9</Month><Day>26</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2019</Year><Month>9</Month><Day>26</Day><Hour>6</Hour><Minute>1</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2019</Year><Month>9</Month><Day>26</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2019</Year><Month>11</Month><Day>29</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">31553307</ArticleId><ArticleId IdType="pmc">PMC6911227</ArticleId><ArticleId IdType="doi">10.2196/14325</ArticleId><ArticleId IdType="pii">v7i4e14325</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Kirby JC, Speltz P, Rasmussen LV, Basford M, Gottesman O, Peissig PL, Pacheco JA, Tromp G, Pathak J, Carrell DS, Ellis SB, Lingren T, Thompson WK, Savova G, Haines J, Roden DM, Harris PA, Denny JC. PheKB: a catalog and workflow for creating electronic phenotype algorithms for transportability. J Am Med Inform Assoc. 2016 Nov;23(6):1046&#x2013;1052. doi: 10.1093/jamia/ocv202.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/jamia/ocv202</ArticleId><ArticleId IdType="pmc">PMC5070514</ArticleId><ArticleId IdType="pubmed">27026615</ArticleId></ArticleIdList></Reference><Reference><Citation>Gamazon ER, Segr&#xe8; Ayellet V, van de Bunt M, Wen X, Xi HS, Hormozdiari F, Ongen H, Konkashbaev A, Derks EM, Aguet F, Quan J, GTEx Consortium. Nicolae DL, Eskin E, Kellis M, Getz G, McCarthy MI, Dermitzakis ET, Cox NJ, Ardlie KG. Using an atlas of gene regulation across 44 human tissues to inform complex disease- and trait-associated variation. Nat Genet. 2018 Jul;50(7):956&#x2013;967. doi: 10.1038/s41588-018-0154-4.  </Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41588-018-0154-4</ArticleId><ArticleId IdType="pmc">PMC6248311</ArticleId><ArticleId IdType="pubmed">29955180</ArticleId></ArticleIdList></Reference><Reference><Citation>Nielsen JB, Thorolfsdottir RB, Fritsche LG, Zhou W, Skov MW, Graham SE, Herron TJ, McCarthy S, Schmidt EM, Sveinbjornsson G, Surakka I, Mathis MR, Yamazaki M, Crawford RD, Gabrielsen ME, Skogholt AH, Holmen OL, Lin M, Wolford BN, Dey R, Dalen H, Sulem P, Chung JH, Backman JD, Arnar DO, Thorsteinsdottir U, Baras A, O'Dushlaine C, Holst AG, Wen X, Hornsby W, Dewey FE, Boehnke M, Kheterpal S, Mukherjee B, Lee S, Kang HM, Holm H, Kitzman J, Shavit JA, Jalife J, Brummett CM, Teslovich TM, Carey DJ, Gudbjartsson DF, Stefansson K, Abecasis GR, Hveem K, Willer CJ. Biobank-driven genomic discovery yields new insight into atrial fibrillation biology. Nat Genet. 2018 Sep;50(9):1234&#x2013;1239. doi: 10.1038/s41588-018-0171-3.  </Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41588-018-0171-3</ArticleId><ArticleId IdType="pmc">PMC6530775</ArticleId><ArticleId IdType="pubmed">30061737</ArticleId></ArticleIdList></Reference><Reference><Citation>Simonti CN, Vernot B, Bastarache L, Bottinger E, Carrell DS, Chisholm RL, Crosslin DR, Hebbring SJ, Jarvik GP, Kullo IJ, Li R, Pathak J, Ritchie MD, Roden DM, Verma SS, Tromp G, Prato JD, Bush WS, Akey JM, Denny JC, Capra JA. The phenotypic legacy of admixture between modern humans and Neandertals. Science. 2016 Feb 12;351(6274):737&#x2013;41. doi: 10.1126/science.aad2149.  </Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.aad2149</ArticleId><ArticleId IdType="pmc">PMC4849557</ArticleId><ArticleId IdType="pubmed">26912863</ArticleId></ArticleIdList></Reference><Reference><Citation>Diogo D, Bastarache L, Liao KP, Graham RR, Fulton RS, Greenberg JD, Eyre S, Bowes J, Cui J, Lee A, Pappas DA, Kremer JM, Barton A, Coenen MJH, Franke B, Kiemeney LA, Mariette X, Richard-Miceli C, Canh&#xe3;o Helena, Fonseca JE, de Vries N, Tak PP, Crusius JBA, Nurmohamed MT, Kurreeman F, Mikuls TR, Okada Y, Stahl EA, Larson DE, Deluca TL, O'Laughlin M, Fronick CC, Fulton LL, Kosoy R, Ransom M, Bhangale TR, Ortmann W, Cagan A, Gainer V, Karlson EW, Kohane I, Murphy SN, Martin J, Zhernakova A, Klareskog L, Padyukov L, Worthington J, Mardis ER, Seldin MF, Gregersen PK, Behrens T, Raychaudhuri S, Denny JC, Plenge RM. TYK2 protein-coding variants protect against rheumatoid arthritis and autoimmunity, with no evidence of major pleiotropic effects on non-autoimmune complex traits. PLoS One. 2015;10(4):e0122271. doi: 10.1371/journal.pone.0122271.  </Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0122271</ArticleId><ArticleId IdType="doi">10.1371/journal.pone.0122271</ArticleId><ArticleId IdType="pmc">PMC4388675</ArticleId><ArticleId IdType="pubmed">25849893</ArticleId></ArticleIdList></Reference><Reference><Citation>Rastegar-Mojarad M, Ye Z, Kolesar JM, Hebbring SJ, Lin SM. Opportunities for drug repositioning from phenome-wide association studies. Nat Biotechnol. 2015 Apr;33(4):342&#x2013;5. doi: 10.1038/nbt.3183.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nbt.3183</ArticleId><ArticleId IdType="pubmed">25850054</ArticleId></ArticleIdList></Reference><Reference><Citation>Millard LAC, Davies NM, Timpson NJ, Tilling K, Flach PA, Davey Smith G. MR-PheWAS: hypothesis prioritization among potential causal effects of body mass index on many outcomes, using Mendelian randomization. Sci Rep. 2015 Nov 16;5:16645. doi: 10.1038/srep16645. doi: 10.1038/srep16645.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/srep16645</ArticleId><ArticleId IdType="doi">10.1038/srep16645</ArticleId><ArticleId IdType="pmc">PMC4644974</ArticleId><ArticleId IdType="pubmed">26568383</ArticleId></ArticleIdList></Reference><Reference><Citation>Ehm MG, Aponte JL, Chiano MN, Yerges-Armstrong LM, Johnson T, Barker JN, Cook SF, Gupta A, Hinds DA, Li L, Nelson MR, Simpson MA, Tian C, McCarthy LC, Rajpal DK, Waterworth DM. Phenome-wide association study using research participants' self-reported data provides insight into the Th17 and IL-17 pathway. PLoS One. 2017;12(11):e0186405. doi: 10.1371/journal.pone.0186405.  </Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0186405</ArticleId><ArticleId IdType="doi">10.1371/journal.pone.0186405</ArticleId><ArticleId IdType="pmc">PMC5665418</ArticleId><ArticleId IdType="pubmed">29091937</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu J, Ye Z, Mayer JG, Hoch BA, Green C, Rolak L, Cold C, Khor S, Zheng X, Miyagawa T, Tokunaga K, Brilliant MH, Hebbring SJ. Phenome-wide association study maps new diseases to the human major histocompatibility complex region. J Med Genet. 2016 Oct;53(10):681&#x2013;9. doi: 10.1136/jmedgenet-2016-103867.  </Citation><ArticleIdList><ArticleId IdType="doi">10.1136/jmedgenet-2016-103867</ArticleId><ArticleId IdType="pmc">PMC5035188</ArticleId><ArticleId IdType="pubmed">27287392</ArticleId></ArticleIdList></Reference><Reference><Citation>Neuraz A, Chouchana L, Malamut G, Le Beller C, Roche D, Beaune P, Degoulet P, Burgun A, Loriot M, Avillach P. Phenome-wide association studies on a quantitative trait: application to TPMT enzyme activity and thiopurine therapy in pharmacogenomics. PLoS Comput Biol. 2013;9(12):e1003405. doi: 10.1371/journal.pcbi.1003405.  </Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pcbi.1003405</ArticleId><ArticleId IdType="doi">10.1371/journal.pcbi.1003405</ArticleId><ArticleId IdType="pmc">PMC3873228</ArticleId><ArticleId IdType="pubmed">24385893</ArticleId></ArticleIdList></Reference><Reference><Citation>Doshi-Velez F, Ge Y, Kohane I. Comorbidity clusters in autism spectrum disorders: an electronic health record time-series analysis. Pediatrics. 2014 Jan;133(1):e54&#x2013;63. doi: 10.1542/peds.2013-0819.  </Citation><ArticleIdList><ArticleId IdType="doi">10.1542/peds.2013-0819</ArticleId><ArticleId IdType="pmc">PMC3876178</ArticleId><ArticleId IdType="pubmed">24323995</ArticleId></ArticleIdList></Reference><Reference><Citation>Li X, Meng X, Spiliopoulou A, Timofeeva M, Wei W, Gifford A, Shen X, He Y, Varley T, McKeigue P, Tzoulaki I, Wright AF, Joshi P, Denny JC, Campbell H, Theodoratou E. MR-PheWAS: exploring the causal effect of SUA level on multiple disease outcomes by using genetic instruments in UK Biobank. Ann Rheum Dis. 2018 Jul;77(7):1039&#x2013;1047. doi: 10.1136/annrheumdis-2017-212534.  </Citation><ArticleIdList><ArticleId IdType="doi">10.1136/annrheumdis-2017-212534</ArticleId><ArticleId IdType="pmc">PMC6029646</ArticleId><ArticleId IdType="pubmed">29437585</ArticleId></ArticleIdList></Reference><Reference><Citation>Carroll RJ, Bastarache L, Denny JC. R PheWAS: data analysis and plotting tools for phenome-wide association studies in the R environment. Bioinformatics. 2014 Aug 15;30(16):2375&#x2013;6. doi: 10.1093/bioinformatics/btu197.  </Citation><ArticleIdList><ArticleId IdType="doi">10.1093/bioinformatics/btu197</ArticleId><ArticleId IdType="pmc">PMC4133579</ArticleId><ArticleId IdType="pubmed">24733291</ArticleId></ArticleIdList></Reference><Reference><Citation>PheWAS Catalog.  [2019-07-14].  Phecode Map 1.2 with ICD-9 Codes.  https://phewascatalog.org/phecodes.</Citation></Reference><Reference><Citation>Steindel SJ. International classification of diseases, 10th edition, clinical modification and procedure coding system: descriptive overview of the next generation HIPAA code sets. J Am Med Inform Assoc. 2010;17(3):274&#x2013;82. doi: 10.1136/jamia.2009.001230.  </Citation><ArticleIdList><ArticleId IdType="doi">10.1136/jamia.2009.001230</ArticleId><ArticleId IdType="pmc">PMC2995704</ArticleId><ArticleId IdType="pubmed">20442144</ArticleId></ArticleIdList></Reference><Reference><Citation>Topaz M, Shafran-Topaz L, Bowles KH. ICD-9 to ICD-10: evolution, revolution, and current debates in the United States. Perspect Health Inf Manag. 2013;10:1d.  </Citation><ArticleIdList><ArticleId IdType="pmc">PMC3692324</ArticleId><ArticleId IdType="pubmed">23805064</ArticleId></ArticleIdList></Reference><Reference><Citation>Fung KW, Richesson R, Smerek M, Pereira KC, Green BB, Patkar A, Clowse M, Bauck A, Bodenreider O. Preparing for the ICD-10-CM Transition: Automated Methods for Translating ICD Codes in Clinical Phenotype Definitions. EGEMS (Wash DC) 2016;4(1):1211. doi: 10.13063/2327-9214.1211.  </Citation><ArticleIdList><ArticleId IdType="doi">10.13063/2327-9214.1211</ArticleId><ArticleId IdType="pmc">PMC4862764</ArticleId><ArticleId IdType="pubmed">27195309</ArticleId></ArticleIdList></Reference><Reference><Citation>Wilder V.  NLM Technical Bulletin. US National Library of Medicine; 2018. May,  [2019-07-16].  UMLS 2018AA Release Available.  https://www.nlm.nih.gov/pubs/techbull/mj18/mj18_umls_2018aa_release.html.</Citation></Reference><Reference><Citation>Denny JC, Bastarache L, Ritchie MD, Carroll RJ, Zink R, Mosley JD, Field JR, Pulley JM, Ramirez AH, Bowton E, Basford MA, Carrell DS, Peissig PL, Kho AN, Pacheco JA, Rasmussen LV, Crosslin DR, Crane PK, Pathak J, Bielinski SJ, Pendergrass SA, Xu H, Hindorff LA, Li R, Manolio TA, Chute CG, Chisholm RL, Larson EB, Jarvik GP, Brilliant MH, McCarty CA, Kullo IJ, Haines JL, Crawford DC, Masys DR, Roden DM. Systematic comparison of phenome-wide association study of electronic medical record data and genome-wide association study data. Nat Biotechnol. 2013 Dec;31(12):1102&#x2013;10. doi: 10.1038/nbt.2749.  </Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nbt.2749</ArticleId><ArticleId IdType="pmc">PMC3969265</ArticleId><ArticleId IdType="pubmed">24270849</ArticleId></ArticleIdList></Reference><Reference><Citation>Wei W, Bastarache LA, Carroll RJ, Marlo JE, Osterman TJ, Gamazon ER, Cox NJ, Roden DM, Denny JC. Evaluating phecodes, clinical classification software, and ICD-9-CM codes for phenome-wide association studies in the electronic health record. PLoS One. 2017;12(7):e0175508. doi: 10.1371/journal.pone.0175508.  </Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0175508</ArticleId><ArticleId IdType="doi">10.1371/journal.pone.0175508</ArticleId><ArticleId IdType="pmc">PMC5501393</ArticleId><ArticleId IdType="pubmed">28686612</ArticleId></ArticleIdList></Reference><Reference><Citation>Sudlow C, Gallacher J, Allen N, Beral V, Burton P, Danesh J, Downey P, Elliott P, Green J, Landray M, Liu B, Matthews P, Ong G, Pell J, Silman A, Young A, Sprosen T, Peakman T, Collins R. UK biobank: an open access resource for identifying the causes of a wide range of complex diseases of middle and old age. PLoS Med. 2015 Mar;12(3):e1001779. doi: 10.1371/journal.pmed.1001779.  </Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pmed.1001779</ArticleId><ArticleId IdType="doi">10.1371/journal.pmed.1001779</ArticleId><ArticleId IdType="pmc">PMC4380465</ArticleId><ArticleId IdType="pubmed">25826379</ArticleId></ArticleIdList></Reference><Reference><Citation>Centers for Medicare &amp; Medicaid Services  CMS.gov. 2017. Aug 11,  [2019-07-05].  2018 ICD-10-CM and GEMs.  https://www.cms.gov/Medicare/Coding/ICD10/2018-ICD-10-CM-and-GEMs.html.</Citation><ArticleIdList><ArticleId IdType="pubmed">26110197</ArticleId></ArticleIdList></Reference><Reference><Citation>US National Library of Medicine. 2018. Jan 26,  [2019-04-06].  SNOMED CT to ICD-9-CM Rule Based Mapping to Support Reimbursement.  https://www.nlm.nih.gov/research/umls/mapping_projects/snomedct_to_icd9cm_reimburse.html.</Citation></Reference><Reference><Citation>Fung KW, Bodenreider O. Utilizing the UMLS for semantic mapping between terminologies. AMIA Annu Symp Proc. 2005:266&#x2013;70.  </Citation><ArticleIdList><ArticleId IdType="pmc">PMC1560893</ArticleId><ArticleId IdType="pubmed">16779043</ArticleId></ArticleIdList></Reference><Reference><Citation>Observational Health Data Sciences and Informatics. 2016. Jun 04,  [2019-07-17].  ICD9CM.  https://www.ohdsi.org/web/wiki/doku.php?id=documentation:vocabulary:icd9cm.</Citation></Reference><Reference><Citation>Hripcsak G, Duke JD, Shah NH, Reich CG, Huser V, Schuemie MJ, Suchard MA, Park RW, Wong ICK, Rijnbeek PR, van der Lei Johan, Pratt N, Nor&#xe9;n G Niklas, Li Y, Stang PE, Madigan D, Ryan PB. Observational Health Data Sciences and Informatics (OHDSI): Opportunities for Observational Researchers. Stud Health Technol Inform. 2015;216:574&#x2013;8.  </Citation><ArticleIdList><ArticleId IdType="pmc">PMC4815923</ArticleId><ArticleId IdType="pubmed">26262116</ArticleId></ArticleIdList></Reference><Reference><Citation>Giuse DA. Supporting communication in an integrated patient record system. AMIA Annu Symp Proc. 2003:1065.  </Citation><ArticleIdList><ArticleId IdType="pmc">PMC1480157</ArticleId><ArticleId IdType="pubmed">14728568</ArticleId></ArticleIdList></Reference><Reference><Citation>Nordestgaard BG, Chapman MJ, Ray K, Bor&#xe9;n Jan, Andreotti F, Watts GF, Ginsberg H, Amarenco P, Catapano A, Descamps OS, Fisher E, Kovanen PT, Kuivenhoven JA, Lesnik P, Masana L, Reiner Z, Taskinen M, Tokg&#xf6;zoglu Lale, Tybj&#xe6;rg-Hansen Anne, European Atherosclerosis Society Consensus Panel  Lipoprotein(a) as a cardiovascular risk factor: current status. Eur Heart J. 2010 Dec;31(23):2844&#x2013;53. doi: 10.1093/eurheartj/ehq386.  </Citation><ArticleIdList><ArticleId IdType="doi">10.1093/eurheartj/ehq386</ArticleId><ArticleId IdType="pmc">PMC3295201</ArticleId><ArticleId IdType="pubmed">20965889</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhao J, Feng Q, Wu P, Warner JL, Denny JC, Wei W. Using topic modeling via non-negative matrix factorization to identify relationships between genetic variants and disease phenotypes: A case study of Lipoprotein(a) (LPA) PLoS One. 2019;14(2):e0212112. doi: 10.1371/journal.pone.0212112.  </Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0212112</ArticleId><ArticleId IdType="doi">10.1371/journal.pone.0212112</ArticleId><ArticleId IdType="pmc">PMC6374022</ArticleId><ArticleId IdType="pubmed">30759150</ArticleId></ArticleIdList></Reference><Reference><Citation>Wei W, Li X, Feng Q, Kubo M, Kullo IJ, Peissig PL, Karlson EW, Jarvik GP, Lee MTM, Shang N, Larson EA, Edwards T, Shaffer CM, Mosley JD, Maeda S, Horikoshi M, Ritchie M, Williams MS, Larson EB, Crosslin DR, Bland ST, Pacheco JA, Rasmussen-Torvik LJ, Cronkite D, Hripcsak G, Cox NJ, Wilke RA, Stein CM, Rotter JI, Momozawa Y, Roden DM, Krauss RM, Denny JC. LPA Variants Are Associated With Residual Cardiovascular Risk in Patients Receiving Statins. Circulation. 2018 Oct 23;138(17):1839&#x2013;1849. doi: 10.1161/CIRCULATIONAHA.117.031356.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/CIRCULATIONAHA.117.031356</ArticleId><ArticleId IdType="pmc">PMC6202211</ArticleId><ArticleId IdType="pubmed">29703846</ArticleId></ArticleIdList></Reference><Reference><Citation>Roden DM, Pulley JM, Basford MA, Bernard GR, Clayton EW, Balser JR, Masys DR. Development of a large-scale de-identified DNA biobank to enable personalized medicine. Clin Pharmacol Ther. 2008 Sep;84(3):362&#x2013;9. doi: 10.1038/clpt.2008.89.  </Citation><ArticleIdList><ArticleId IdType="doi">10.1038/clpt.2008.89</ArticleId><ArticleId IdType="pmc">PMC3763939</ArticleId><ArticleId IdType="pubmed">18500243</ArticleId></ArticleIdList></Reference><Reference><Citation>PheWAS  GitHub.  [2019-10-04].  PheWAS R Package.  https://github.com/PheWAS/PheWAS.</Citation></Reference><Reference><Citation>Zhou W, Nielsen JB, Fritsche LG, Dey R, Gabrielsen ME, Wolford BN, LeFaive J, VandeHaar P, Gagliano SA, Gifford A, Bastarache LA, Wei W, Denny JC, Lin M, Hveem K, Kang HM, Abecasis GR, Willer CJ, Lee S. Efficiently controlling for case-control imbalance and sample relatedness in large-scale genetic association studies. Nat Genet. 2018 Sep;50(9):1335&#x2013;1341. doi: 10.1038/s41588-018-0184-y.  </Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41588-018-0184-y</ArticleId><ArticleId IdType="pmc">PMC6119127</ArticleId><ArticleId IdType="pubmed">30104761</ArticleId></ArticleIdList></Reference><Reference><Citation>Chaganti S, Mawn LA, Kang H, Egan J, Resnick SM, Beason-Held LL, Landman BA, Lasko T. Electronic Medical Record Context Signatures Improve Diagnostic Classification Using Medical Image Computing. IEEE J Biomed Health Inform. 2019 Sep;23(5):2052&#x2013;2062. doi: 10.1109/JBHI.2018.2890084.</Citation><ArticleIdList><ArticleId IdType="doi">10.1109/JBHI.2018.2890084</ArticleId><ArticleId IdType="pmc">PMC6844192</ArticleId><ArticleId IdType="pubmed">30602428</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhao J, Feng Q, Wu P, Lupu RA, Wilke RA, Wells QS, Denny JC, Wei W. Learning from Longitudinal Data in Electronic Health Record and Genetic Data to Improve Cardiovascular Event Prediction. Sci Rep. 2019 Jan 24;9(1):717. doi: 10.1038/s41598-018-36745-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-018-36745-x</ArticleId><ArticleId IdType="pmc">PMC6345960</ArticleId><ArticleId IdType="pubmed">30679510</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang M, ElTayeby O, Zolnoori M, Yao L. Public Opinions Toward Diseases: Infodemiological Study on News Media Data. J Med Internet Res. 2018 May 08;20(5):e10047. doi: 10.2196/10047.  </Citation><ArticleIdList><ArticleId IdType="doi">10.2196/10047</ArticleId><ArticleId IdType="pmc">PMC5964307</ArticleId><ArticleId IdType="pubmed">29739741</ArticleId></ArticleIdList></Reference><Reference><Citation>Shi X, Li X, Cai T. Spherical Regression under Mismatch Corruption with Application to Automated Knowledge Translation. arXiv preprint. 2019 Sep 04;  </Citation></Reference><Reference><Citation>Bastarache L, Hughey JJ, Hebbring S, Marlo J, Zhao W, Ho WT, Van Driest SL, McGregor TL, Mosley JD, Wells QS, Temple M, Ramirez AH, Carroll R, Osterman T, Edwards T, Ruderfer D, Velez Edwards DR, Hamid R, Cogan J, Glazer A, Wei W, Feng Q, Brilliant M, Zhao ZJ, Cox NJ, Roden DM, Denny JC. Phenotype risk scores identify patients with unrecognized Mendelian disease patterns. Science. 2018 Mar 16;359(6381):1233&#x2013;1239. doi: 10.1126/science.aal4043.  </Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.aal4043</ArticleId><ArticleId IdType="pmc">PMC5959723</ArticleId><ArticleId IdType="pubmed">29590070</ArticleId></ArticleIdList></Reference><Reference><Citation>Agency for Healthcare Research and Quality  Healthcare Cost and Utilization Project (HCUP) 2012. Jan,  [2019-07-15].  HCUP CCS Fact Sheet.  https://www.hcup-us.ahrq.gov/toolssoftware/ccs/ccsfactsheet.jsp.</Citation><ArticleIdList><ArticleId IdType="pubmed">21413206</ArticleId></ArticleIdList></Reference><Reference><Citation>Sabbatini AK, Kocher KE, Basu A, Hsia RY. In-Hospital Outcomes and Costs Among Patients Hospitalized During a Return Visit to the Emergency Department. JAMA. 2016 Feb 16;315(7):663&#x2013;71. doi: 10.1001/jama.2016.0649.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2016.0649</ArticleId><ArticleId IdType="pmc">PMC8366576</ArticleId><ArticleId IdType="pubmed">26881369</ArticleId></ArticleIdList></Reference><Reference><Citation>Hu Z, Hao S, Jin B, Shin AY, Zhu C, Huang M, Wang Y, Zheng L, Dai D, Culver DS, Alfreds ST, Rogow T, Stearns F, Sylvester KG, Widen E, Ling X. Online Prediction of Health Care Utilization in the Next Six Months Based on Electronic Health Record Information: A Cohort and Validation Study. J Med Internet Res. 2015 Sep 22;17(9):e219. doi: 10.2196/jmir.4976.  </Citation><ArticleIdList><ArticleId IdType="doi">10.2196/jmir.4976</ArticleId><ArticleId IdType="pmc">PMC4642374</ArticleId><ArticleId IdType="pubmed">26395541</ArticleId></ArticleIdList></Reference><Reference><Citation>Agency for Healthcare Research and Quality  Healthcare Cost and Utilization Project (HCUP) 2019. Sep,  [2019-07-05].  Clinical Classifications Software (CCS) for ICD-10-PCS (beta version).  https://www.hcup-us.ahrq.gov/toolssoftware/ccs10/ccs10.jsp.</Citation><ArticleIdList><ArticleId IdType="pubmed">21413206</ArticleId></ArticleIdList></Reference><Reference><Citation>Hripcsak G, Levine ME, Shang N, Ryan PB. Effect of vocabulary mapping for conditions on phenotype cohorts. J Am Med Inform Assoc. 2018 Dec 01;25(12):1618&#x2013;1625. doi: 10.1093/jamia/ocy124.  </Citation><ArticleIdList><ArticleId IdType="doi">10.1093/jamia/ocy124</ArticleId><ArticleId IdType="pmc">PMC6289550</ArticleId><ArticleId IdType="pubmed">30395248</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">31581246</PMID><DateCompleted><Year>2020</Year><Month>03</Month><Day>11</Day></DateCompleted><DateRevised><Year>2020</Year><Month>03</Month><Day>11</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Electronic">1932-6203</ISSN><JournalIssue CitedMedium="Internet"><Volume>14</Volume><Issue>10</Issue><PubDate><Year>2019</Year></PubDate></JournalIssue><Title>PloS one</Title><ISOAbbreviation>PLoS One</ISOAbbreviation></Journal><ArticleTitle>KETOS: Clinical decision support and machine learning as a service - A training and deployment platform based on Docker, OMOP-CDM, and FHIR Web Services.</ArticleTitle><Pagination><StartPage>e0223010</StartPage><MedlinePgn>e0223010</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">e0223010</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1371/journal.pone.0223010</ELocationID><Abstract><AbstractText Label="BACKGROUND AND OBJECTIVE">To take full advantage of decision support, machine learning, and patient-level prediction models, it is important that models are not only created, but also deployed in a clinical setting. The KETOS platform demonstrated in this work implements a tool for researchers allowing them to perform statistical analyses and deploy resulting models in a secure environment.</AbstractText><AbstractText Label="METHODS">The proposed system uses Docker virtualization to provide researchers with reproducible data analysis and development environments, accessible via Jupyter Notebook, to perform statistical analysis and develop, train and deploy models based on standardized input data. The platform is built in a modular fashion and interfaces with web services using the Health Level 7 (HL7) Fast Healthcare Interoperability Resources (FHIR) standard to access patient data. In our prototypical implementation we use an OMOP common data model (OMOP-CDM) database. The architecture supports the entire research lifecycle from creating a data analysis environment, retrieving data, and training to final deployment in a hospital setting.</AbstractText><AbstractText Label="RESULTS">We evaluated the platform by establishing and deploying an analysis and end user application for hemoglobin reference intervals within the University Hospital Erlangen. To demonstrate the potential of the system to deploy arbitrary models, we loaded a colorectal cancer dataset into an OMOP database and built machine learning models to predict patient outcomes and made them available via a web service. We demonstrated both the integration with FHIR as well as an example end user application. Finally, we integrated the platform with the open source DataSHIELD architecture to allow for distributed privacy preserving data analysis and training across networks of hospitals.</AbstractText><AbstractText Label="CONCLUSION">The KETOS platform takes a novel approach to data analysis, training and deploying decision support models in a hospital or healthcare setting. It does so in a secure and privacy-preserving manner, combining the flexibility of Docker virtualization with the advantages of standardized vocabularies, a widely applied database schema (OMOP-CDM), and a standardized way to exchange medical data (FHIR).</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Gruendner</LastName><ForeName>Julian</ForeName><Initials>J</Initials><Identifier Source="ORCID">0000-0001-7204-5329</Identifier><AffiliationInfo><Affiliation>Chair of Medical Informatics, Friedrich-Alexander-University Erlangen-N&#xfc;rnberg (FAU), Erlangen, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Schwachhofer</LastName><ForeName>Thorsten</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Chair of Medical Informatics, Friedrich-Alexander-University Erlangen-N&#xfc;rnberg (FAU), Erlangen, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sippl</LastName><ForeName>Phillip</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Chair of Medical Informatics, Friedrich-Alexander-University Erlangen-N&#xfc;rnberg (FAU), Erlangen, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wolf</LastName><ForeName>Nicolas</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Chair of Medical Informatics, Friedrich-Alexander-University Erlangen-N&#xfc;rnberg (FAU), Erlangen, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Erpenbeck</LastName><ForeName>Marcel</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Chair of Medical Informatics, Friedrich-Alexander-University Erlangen-N&#xfc;rnberg (FAU), Erlangen, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gulden</LastName><ForeName>Christian</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Chair of Medical Informatics, Friedrich-Alexander-University Erlangen-N&#xfc;rnberg (FAU), Erlangen, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kapsner</LastName><ForeName>Lorenz A</ForeName><Initials>LA</Initials><Identifier Source="ORCID">0000-0003-1866-860X</Identifier><AffiliationInfo><Affiliation>Medical Centre for Information and Communication Technology, Universit&#xe4;tsklinikum Erlangen, Erlangen, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zierk</LastName><ForeName>Jakob</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Medical Centre for Information and Communication Technology, Universit&#xe4;tsklinikum Erlangen, Erlangen, Germany.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Pediatrics and Adolescent Medicine, Universit&#xe4;tsklinikumErlangen, Erlangen, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mate</LastName><ForeName>Sebastian</ForeName><Initials>S</Initials><Identifier Source="ORCID">0000-0002-1389-3384</Identifier><AffiliationInfo><Affiliation>Medical Centre for Information and Communication Technology, Universit&#xe4;tsklinikum Erlangen, Erlangen, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>St&#xfc;rzl</LastName><ForeName>Michael</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Surgery, Division of Molecular and Experimental Surgery, Friedrich-Alexander-University Erlangen-N&#xfc;rnberg (FAU), Erlangen, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Croner</LastName><ForeName>Roland</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Department of General, Visceral, Vascular and Graft Surgery, University Hospital, Magdeburg, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Prokosch</LastName><ForeName>Hans-Ulrich</ForeName><Initials>HU</Initials><AffiliationInfo><Affiliation>Chair of Medical Informatics, Friedrich-Alexander-University Erlangen-N&#xfc;rnberg (FAU), Erlangen, Germany.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Medical Centre for Information and Communication Technology, Universit&#xe4;tsklinikum Erlangen, Erlangen, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Toddenroth</LastName><ForeName>Dennis</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Chair of Medical Informatics, Friedrich-Alexander-University Erlangen-N&#xfc;rnberg (FAU), Erlangen, Germany.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2019</Year><Month>10</Month><Day>03</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>PLoS One</MedlineTA><NlmUniqueID>101285081</NlmUniqueID><ISSNLinking>1932-6203</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D006454">Hemoglobins</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><CommentsCorrectionsList><CommentsCorrections RefType="ErratumIn"><RefSource>PLoS One. 2019 Nov 13;14(11):e0225442. doi: 10.1371/journal.pone.0225442.</RefSource><PMID Version="1">31721815</PMID></CommentsCorrections></CommentsCorrectionsList><MeshHeadingList><MeshHeading><DescriptorName UI="D015179" MajorTopicYN="N">Colorectal Neoplasms</DescriptorName><QualifierName UI="Q000628" MajorTopicYN="N">therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D020000" MajorTopicYN="Y">Decision Support Systems, Clinical</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000073892" MajorTopicYN="Y">Health Information Interoperability</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006454" MajorTopicYN="N">Hemoglobins</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D020407" MajorTopicYN="Y">Internet</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000069550" MajorTopicYN="Y">Machine Learning</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008962" MajorTopicYN="Y">Models, Theoretical</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018907" MajorTopicYN="N">Privacy</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012016" MajorTopicYN="N">Reference Values</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016896" MajorTopicYN="N">Treatment Outcome</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014584" MajorTopicYN="N">User-Computer Interface</DescriptorName></MeshHeading></MeshHeadingList><CoiStatement>The authors have declared that no competing interests exist.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2019</Year><Month>5</Month><Day>3</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2019</Year><Month>9</Month><Day>11</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2019</Year><Month>10</Month><Day>4</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2019</Year><Month>10</Month><Day>4</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2020</Year><Month>3</Month><Day>12</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2019</Year><Month>10</Month><Day>3</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">31581246</ArticleId><ArticleId IdType="pmc">PMC6776354</ArticleId><ArticleId IdType="doi">10.1371/journal.pone.0223010</ArticleId><ArticleId IdType="pii">PONE-D-19-12555</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Wehling M. Translational medicine: science or wishful thinking? J Transl Med. 2008;6:31 Epub 2008/06/19. 10.1186/1479-5876-6-31</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1479-5876-6-31</ArticleId><ArticleId IdType="pmc">PMC2442586</ArticleId><ArticleId IdType="pubmed">18559092</ArticleId></ArticleIdList></Reference><Reference><Citation>Glasgow RE, Emmons KM. How can we increase translation of research into practice? Types of evidence needed. Annu Rev Public Health. 2007;28:413&#x2013;33. Epub 2006/12/08. 10.1146/annurev.publhealth.28.021406.144145 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1146/annurev.publhealth.28.021406.144145</ArticleId><ArticleId IdType="pubmed">17150029</ArticleId></ArticleIdList></Reference><Reference><Citation>Horig H, Marincola E, Marincola FM. Obstacles and opportunities in translational research. Nat Med. 2005;11(7):705&#x2013;8. Epub 2005/07/15. 10.1038/nm0705-705 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nm0705-705</ArticleId><ArticleId IdType="pubmed">16015353</ArticleId></ArticleIdList></Reference><Reference><Citation>Soto GES J. A. EPOCH and ePRISM: A web-based translational framework for bridging outcomes research and clinical practice. Computers in Cardiology. 2007; 10.1109/CIC.2007.4745457:4</Citation><ArticleIdList><ArticleId IdType="doi">10.1109/CIC.2007.4745457:4</ArticleId></ArticleIdList></Reference><Reference><Citation>Velickovski F, Ceccaroni L, Roca J, Burgos F, Galdiz JB, Marina N, et al. Clinical Decision Support Systems (CDSS) for preventive management of COPD patients. J Transl Med. 2014;12 Suppl 2:S9 Epub 2014/12/05. 10.1186/1479-5876-12-S2-S9</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1479-5876-12-S2-S9</ArticleId><ArticleId IdType="pmc">PMC4255917</ArticleId><ArticleId IdType="pubmed">25471545</ArticleId></ArticleIdList></Reference><Reference><Citation>Baldow C, Salentin S, Schroeder M, Roeder I, Glauche I. MAGPIE: Simplifying access and execution of computational models in the life sciences. PLoS Comput Biol. 2017;13(12):e1005898 Epub 2017/12/16. 10.1371/journal.pcbi.1005898</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pcbi.1005898</ArticleId><ArticleId IdType="pmc">PMC5747461</ArticleId><ArticleId IdType="pubmed">29244826</ArticleId></ArticleIdList></Reference><Reference><Citation>Gibson E, Li W, Sudre C, Fidon L, Shakir DI, Wang G, et al. NiftyNet: a deep-learning platform for medical imaging. Comput Methods Programs Biomed. 2018;158:113&#x2013;22. Epub 2018/03/17. 10.1016/j.cmpb.2018.01.025</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cmpb.2018.01.025</ArticleId><ArticleId IdType="pmc">PMC5869052</ArticleId><ArticleId IdType="pubmed">29544777</ArticleId></ArticleIdList></Reference><Reference><Citation>Khalilia M, Choi M, Henderson A, Iyengar S, Braunstein M, Sun J. Clinical Predictive Modeling Development and Deployment through FHIR Web Services. AMIA Annu Symp Proc. 2015;2015:717&#x2013;26. Epub 2015/01/01.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4765683</ArticleId><ArticleId IdType="pubmed">26958207</ArticleId></ArticleIdList></Reference><Reference><Citation>GT-FHIR: OMOP on FHIR Project [Internet]. 2018 [cited 2019 Sep 3]. Available from: https://github.com/gt-health/GT-FHIR.</Citation></Reference><Reference><Citation>HL7.org. HL7 FHIR [Internet]. [cited 2019 Sep 3]. Available from: https://www.hl7.org/fhir/.</Citation></Reference><Reference><Citation>Definition and DDLs for the OMOP Common Data Model (CDM) [Internet]. [cited 2019 Sep 3]. Available from: https://github.com/OHDSI/CommonDataModel.</Citation></Reference><Reference><Citation>Semler SC, Wissing F, Heyder R. German Medical Informatics Initiative. Methods Inf Med. 2018;57(S 01):e50&#x2013;e6. Epub 2018/07/18. 10.3414/ME18-03-0003</Citation><ArticleIdList><ArticleId IdType="doi">10.3414/ME18-03-0003</ArticleId><ArticleId IdType="pmc">PMC6178199</ArticleId><ArticleId IdType="pubmed">30016818</ArticleId></ArticleIdList></Reference><Reference><Citation>Winter A, Staubert S, Ammon D, Aiche S, Beyan O, Bischoff V, et al. Smart Medical Information Technology for Healthcare (SMITH). Methods Inf Med. 2018;57(S 01):e92&#x2013;e105. Epub 2018/07/18. 10.3414/ME18-02-0004</Citation><ArticleIdList><ArticleId IdType="doi">10.3414/ME18-02-0004</ArticleId><ArticleId IdType="pmc">PMC6193398</ArticleId><ArticleId IdType="pubmed">30016815</ArticleId></ArticleIdList></Reference><Reference><Citation>Haarbrandt B, Schreiweis B, Rey S, Sax U, Scheithauer S, Rienhoff O, et al. HiGHmed&#x2014;An Open Platform Approach to Enhance Care and Research across Institutional Boundaries. Methods Inf Med. 2018;57(S 01):e66&#x2013;e81. Epub 2018/07/18. 10.3414/ME18-02-0002</Citation><ArticleIdList><ArticleId IdType="doi">10.3414/ME18-02-0002</ArticleId><ArticleId IdType="pmc">PMC6193407</ArticleId><ArticleId IdType="pubmed">30016813</ArticleId></ArticleIdList></Reference><Reference><Citation>Prasser F, Kohlbacher O, Mansmann U, Bauer B, Kuhn KA. Data Integration for Future Medicine (DIFUTURE). Methods Inf Med. 2018;57(S 01):e57&#x2013;e65. Epub 2018/07/18. 10.3414/ME17-02-0022</Citation><ArticleIdList><ArticleId IdType="doi">10.3414/ME17-02-0022</ArticleId><ArticleId IdType="pmc">PMC6178202</ArticleId><ArticleId IdType="pubmed">30016812</ArticleId></ArticleIdList></Reference><Reference><Citation>Hripcsak G, Duke JD, Shah NH, Reich CG, Huser V, Schuemie MJ, et al. Observational Health Data Sciences and Informatics (OHDSI): Opportunities for Observational Researchers. Stud Health Technol Inform. 2015;216:574&#x2013;8. Epub 2015/08/12.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4815923</ArticleId><ArticleId IdType="pubmed">26262116</ArticleId></ArticleIdList></Reference><Reference><Citation>Hughes N, Rijnbeek P, Van Speybroeck M. The European Health Data and Evidence Network (EHDEN) [Internet]. Liberating Evidence via Harmonisation of EU Real world data. Rotterdam: European ODHSI Symposium;  [cited 2019 Sep 3]. Available from: http://www.ohdsi-europe.org/images/symposium-2018/posters/24-Nigel-Hughes.pdf.</Citation></Reference><Reference><Citation>Prokosch HU, Acker T, Bernarding J, Binder H, Boeker M, Boerries M, et al. MIRACUM: Medical Informatics in Research and Care in University Medicine. Methods Inf Med. 2018;57(S 01):e82&#x2013;e91. Epub 2018/07/18. 10.3414/ME17-02-0025</Citation><ArticleIdList><ArticleId IdType="doi">10.3414/ME17-02-0025</ArticleId><ArticleId IdType="pmc">PMC6178200</ArticleId><ArticleId IdType="pubmed">30016814</ArticleId></ArticleIdList></Reference><Reference><Citation>Project Jupyter. jupyter [Internet]. 2018 [cited 2019 Sep 3]. Available from: http://jupyter.org/.</Citation></Reference><Reference><Citation>Fortier I, Burton PR, Robson PJ, Ferretti V, Little J, L'Heureux F, et al. Quality, quantity and harmony: the DataSHaPER approach to integrating data across bioclinical studies. Int J Epidemiol. 2010;39(5):1383&#x2013;93. Epub 2010/09/04. 10.1093/ije/dyq139</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/ije/dyq139</ArticleId><ArticleId IdType="pmc">PMC2972444</ArticleId><ArticleId IdType="pubmed">20813861</ArticleId></ArticleIdList></Reference><Reference><Citation>Laursen SO. [SNOMED (Systematized Nomenclature of Medicine)&#x2014;multiaxial data registration]. Ugeskr Laeger. 1981;143(17):1081&#x2013;3. Epub 1981/04/20. .</Citation><ArticleIdList><ArticleId IdType="pubmed">7245387</ArticleId></ArticleIdList></Reference><Reference><Citation>Vreeman DJ, McDonald CJ, Huff SM. LOINC(R)&#x2014;A Universal Catalog of Individual Clinical Observations and Uniform Representation of Enumerated Collections. Int J Funct Inform Personal Med. 2010;3(4):273&#x2013;91. Epub 2010/01/01. 10.1504/IJFIPM.2010.040211</Citation><ArticleIdList><ArticleId IdType="doi">10.1504/IJFIPM.2010.040211</ArticleId><ArticleId IdType="pmc">PMC3418707</ArticleId><ArticleId IdType="pubmed">22899966</ArticleId></ArticleIdList></Reference><Reference><Citation>Rishi Kanth S. Fast Health Interoperability Resources (FHIR): Current Status in the Healthcare System. International Journal of E-Health and Medical Communications (IJEHMC). 2019;10(1):76&#x2013;93. 10.4018/IJEHMC.2019010105</Citation><ArticleIdList><ArticleId IdType="doi">10.4018/IJEHMC.2019010105</ArticleId></ArticleIdList></Reference><Reference><Citation>ATLAS [Internet]. 2018 [cited 2019 Sep 3]. Available from: https://github.com/OHDSI/Atlas.</Citation></Reference><Reference><Citation>Grundner J, Prokosch HU, Sturzl M, Croner R, Christoph J, Toddenroth D. Predicting Clinical Outcomes in Colorectal Cancer Using Machine Learning. Stud Health Technol Inform. 2018;247:101&#x2013;5. Epub 2018/04/22. .</Citation><ArticleIdList><ArticleId IdType="pubmed">29677931</ArticleId></ArticleIdList></Reference><Reference><Citation>Logemann T. General Data Protection Regulation GDPR [Internet]. [cited 2019 14.01.2019]. Available from: https://gdpr-info.eu/.</Citation></Reference><Reference><Citation>Zierk J, Arzideh F, Haeckel R, Rauh M, Metzler M, Ganslandt T, et al. Indirect determination of hematology reference intervals in adult patients on Beckman Coulter UniCell DxH 800 and Abbott CELL-DYN Sapphire devices. Clin Chem Lab Med. 2018. Epub 2018/10/28. 10.1515/cclm-2018-0771 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1515/cclm-2018-0771</ArticleId><ArticleId IdType="pubmed">30367783</ArticleId></ArticleIdList></Reference><Reference><Citation>Arzideh F. Reference Limit Estimator [Internet]. https://www.dgkl.de/fileadmin/Verbandsarbeit/Entscheidungsgrenzen/RLE49.zip2018 [cited 2019 Sep 3]. Available from: https://www.dgkl.de/fileadmin/Verbandsarbeit/Entscheidungsgrenzen/RLE49.zip.</Citation></Reference><Reference><Citation>Povey S, Lovering R, Bruford E, Wright M, Lush M, Wain H. The HUGO Gene Nomenclature Committee (HGNC). Hum Genet. 2001;109(6):678&#x2013;80. Epub 2002/01/26. 10.1007/s00439-001-0615-0 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00439-001-0615-0</ArticleId><ArticleId IdType="pubmed">11810281</ArticleId></ArticleIdList></Reference><Reference><Citation>Jones BBaMLaLKaJSaJRaESaGCaZM. mlr: Machine Learning in R. Journal of Machine Learning Research. 2016;17(170):1&#x2013;5.</Citation></Reference><Reference><Citation>Kuhn M. The caret Package.</Citation></Reference><Reference><Citation>Gruendner J, Prokosch HU, Schindler S, Lenz S, Binder H. A Queue-Poll Extension and DataSHIELD: Standardised, Monitored, Indirect and Secure Access to Sensitive Data. Stud Health Technol Inform. 2019;258:115&#x2013;9. Epub 2019/04/04. .</Citation><ArticleIdList><ArticleId IdType="pubmed">30942726</ArticleId></ArticleIdList></Reference><Reference><Citation>Leisch F, Dimitriadou E. mlbench: Machine Learning Benchmark Problems [Internet]. 2012.  [cited 2019 Aug 27]. Available from: https://cran.r-project.org/web/packages/mlbench/index.html.</Citation></Reference><Reference><Citation>Dua D, Graff C. Machine Learning Repository [Internet]. 2019.  [cited 2019 Aug 27]. Available from: http://archive.ics.uci.edu/ml.</Citation></Reference><Reference><Citation>HL7. HL7 FHIR&#x2014;Version History [Internet]. 2018 [cited 2019 Aug 13]. Available from: http://hl7.org/fhir/history.html.</Citation></Reference><Reference><Citation>Google. Cloud Healthcare API [Internet]. 2019 [cited 2019 Aug 14]. Available from: https://cloud.google.com/healthcare/.</Citation></Reference><Reference><Citation>Microsoft. Azure API for FHIR. [Internet]. 2019. Available from: https://azure.microsoft.com/en-us/services/azure-api-for-fhir/.</Citation></Reference><Reference><Citation>Apple. Accessing Health Records [Internet]. 2019 [cited 2019 Aug 14]. Available from: https://developer.apple.com/documentation/healthkit/samples/accessing_health_records.</Citation></Reference><Reference><Citation>Posnack S, Barker W. Heat Wave: The U.S. is Poised to Catch FHIR in 2019 [Internet]. 2018.  [cited 2019 Sep 3 ]. Available from: https://www.healthit.gov/buzz-blog/interoperability/heat-wave-the-u-s-is-poised-to-catch-fhir-in-2019.</Citation></Reference><Reference><Citation>Medizininformatik-Initiative. Medizininformatik-Initiative beschlie&#xdf;t Verwendung von FHIR. [Internet]. 2019 [cited 2019 Aug 17]. Available from: https://www.medizininformatik-initiative.de/de/medizininformatik-initiative-beschliesst-verwendung-von-fhir.</Citation></Reference><Reference><Citation>Gaye A, Marcon Y, Isaeva J, LaFlamme P, Turner A, Jones EM, et al. DataSHIELD: taking the analysis to the data, not the data to the analysis. Int J Epidemiol. 2014;43(6):1929&#x2013;44. Epub 2014/09/30. 10.1093/ije/dyu188</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/ije/dyu188</ArticleId><ArticleId IdType="pmc">PMC4276062</ArticleId><ArticleId IdType="pubmed">25261970</ArticleId></ArticleIdList></Reference><Reference><Citation>Maier C, Lang L, Storf H, Vormstein P, Bieber R, Bernarding J, et al. Towards Implementation of OMOP in a German University Hospital Consortium. Appl Clin Inform. 2018;9(1):54&#x2013;61. Epub 2018/01/25. 10.1055/s-0037-1617452</Citation><ArticleIdList><ArticleId IdType="doi">10.1055/s-0037-1617452</ArticleId><ArticleId IdType="pmc">PMC5801887</ArticleId><ArticleId IdType="pubmed">29365340</ArticleId></ArticleIdList></Reference><Reference><Citation>Mandel JC, Kreda DA, Mandl KD, Kohane IS, Ramoni RB. SMART on FHIR: a standards-based, interoperable apps platform for electronic health records. J Am Med Inform Assoc. 2016;23(5):899&#x2013;908. Epub 2016/02/26. 10.1093/jamia/ocv189</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/jamia/ocv189</ArticleId><ArticleId IdType="pmc">PMC4997036</ArticleId><ArticleId IdType="pubmed">26911829</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">31596493</PMID><DateCompleted><Year>2020</Year><Month>06</Month><Day>18</Day></DateCompleted><DateRevised><Year>2020</Year><Month>06</Month><Day>18</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">2574-3805</ISSN><JournalIssue CitedMedium="Internet"><Volume>2</Volume><Issue>10</Issue><PubDate><Year>2019</Year><Month>Oct</Month><Day>02</Day></PubDate></JournalIssue><Title>JAMA network open</Title><ISOAbbreviation>JAMA Netw Open</ISOAbbreviation></Journal><ArticleTitle>Feasibility of Using Real-World Data to Replicate Clinical Trial Evidence.</ArticleTitle><Pagination><StartPage>e1912869</StartPage><MedlinePgn>e1912869</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">e1912869</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1001/jamanetworkopen.2019.12869</ELocationID><Abstract><AbstractText Label="IMPORTANCE">Although randomized clinical trials are considered to be the criterion standard for generating clinical evidence, the use of real-world evidence to evaluate the efficacy and safety of medical interventions is gaining interest. Whether observational data can be used to address the same clinical questions being answered by traditional clinical trials is still unclear.</AbstractText><AbstractText Label="OBJECTIVE">To identify the number of clinical trials published in high-impact journals in 2017 that could be feasibly replicated using observational data from insurance claims and/or electronic health records (EHRs).</AbstractText><AbstractText Label="DESIGN, SETTING, AND PARTICIPANTS">In this cross-sectional analysis, PubMed was searched to identify all US-based clinical trials, regardless of randomization, published between January 1, 2017, and December 31, 2017, in the top 7 highest-impact general medical journals of 2017. Trials were excluded if they did not involve human participants, did not use end points that represented clinical outcomes among patients, were not characterized as clinical trials, and had no recruitment sites in the United States.</AbstractText><AbstractText Label="MAIN OUTCOMES AND MEASURES">The primary outcomes were the number and percentage of trials for which the intervention, indication, trial inclusion and exclusion criteria, and primary end points could be ascertained from insurance claims and/or EHR data.</AbstractText><AbstractText Label="RESULTS">Of the 220 US-based trials analyzed, 33 (15.0%) could be replicated using observational data because their intervention, indication, inclusion and exclusion criteria, and primary end points could be routinely ascertained from insurance claims and/or EHR data. Of the 220 trials, 86 (39.1%) had an intervention that could be ascertained from insurance claims and/or EHR data. Among the 86 trials, 62 (72.1%) had an indication that could be ascertained. Forty-five (72.6%) of 62 trials had at least 80% of inclusion and exclusion criteria data that could be ascertained. Of these 45 studies, 33 (73.3%) had at least 1 primary end point that could be ascertained.</AbstractText><AbstractText Label="CONCLUSIONS AND RELEVANCE">This study found that only 15% of the US-based clinical trials published in high-impact journals in 2017 could be feasibly replicated through analysis of administrative claims or EHR data. This finding suggests the potential for real-world evidence to complement clinical trials, both by examining the concordance between randomized experiments and observational studies and by comparing the generalizability of the trial population with the real-world population of interest.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Bartlett</LastName><ForeName>Victoria L</ForeName><Initials>VL</Initials><AffiliationInfo><Affiliation>Yale School of Medicine, New Haven, Connecticut.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Dhruva</LastName><ForeName>Sanket S</ForeName><Initials>SS</Initials><AffiliationInfo><Affiliation>Department of Medicine, University of California, San Francisco School of Medicine, San Francisco.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Section of Cardiology, San Francisco Veterans Affairs Health Care System, San Francisco, California.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Shah</LastName><ForeName>Nilay D</ForeName><Initials>ND</Initials><AffiliationInfo><Affiliation>Division of Health Care Policy &amp; Research, Mayo Clinic, Rochester, Minnesota.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ryan</LastName><ForeName>Patrick</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Epidemiology Analytics, Janssen Research and Development, Titusville, New Jersey.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Observational Health Data Sciences and Informatics (OHDSI), Department of Biomedical Informatics, Columbia University Medical Center, New York, New York.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ross</LastName><ForeName>Joseph S</ForeName><Initials>JS</Initials><AffiliationInfo><Affiliation>Section of General Internal Medicine and the National Clinician Scholars Program, Yale School of Medicine, New Haven, Connecticut.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Health Policy and Management, Yale School of Public Health, New Haven, Connecticut.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Center for Outcomes Research and Evaluation, Yale-New Haven Hospital, New Haven, Connecticut.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>UL1 TR001863</GrantID><Acronym>TR</Acronym><Agency>NCATS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>T35 HL007649</GrantID><Acronym>HL</Acronym><Agency>NHLBI NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D052061">Research Support, N.I.H., Extramural</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2019</Year><Month>10</Month><Day>02</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>JAMA Netw Open</MedlineTA><NlmUniqueID>101729235</NlmUniqueID><ISSNLinking>2574-3805</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D015706" MajorTopicYN="Y">Bibliometrics</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002986" MajorTopicYN="N">Clinical Trials as Topic</DescriptorName><QualifierName UI="Q000706" MajorTopicYN="Y">statistics &amp; numerical data</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D003430" MajorTopicYN="N">Cross-Sectional Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D057286" MajorTopicYN="N">Electronic Health Records</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005240" MajorTopicYN="N">Feasibility Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007348" MajorTopicYN="N">Insurance, Health</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D064887" MajorTopicYN="N">Observational Studies as Topic</DescriptorName><QualifierName UI="Q000706" MajorTopicYN="N">statistics &amp; numerical data</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015203" MajorTopicYN="Y">Reproducibility of Results</DescriptorName></MeshHeading></MeshHeadingList><CoiStatement><b>Conflict of Interest Disclosures:</b> Dr Shah reported receiving grants from the US Food and Drug Administration (FDA), Agency for Healthcare Research and Quality (AHRQ), Center for Medicare and Medicaid Innovation (CMMI), National Heart, Lung and Blood Institute of the National Institutes of Health (NHLBI/NIH), National Science Foundation, and Patient Centered Outcomes Research Institute (PCORI) outside the submitted work and receiving research support through Mayo Clinic from the FDA to establish the Yale-Mayo Clinic Center for Excellence in Regulatory Science and Innovation (CERSI) program. Dr Ryan reported being an employee of Janssen Research and Development and a shareholder of Johnson &amp; Johnson. Dr Ross reported receiving grants from the FDA, the Centers for Medicare &amp; Medicaid Services, Medtronic Inc, Blue Cross Blue Shield Association, AHRQ, NHLBI/NIH, and Laura and John Arnold Foundation outside the submitted work and receiving research support through Yale University from Johnson &amp; Johnson. No other disclosures were reported.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2019</Year><Month>10</Month><Day>10</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2019</Year><Month>10</Month><Day>10</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2020</Year><Month>6</Month><Day>19</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2019</Year><Month>10</Month><Day>9</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">31596493</ArticleId><ArticleId IdType="pmc">PMC6802419</ArticleId><ArticleId IdType="doi">10.1001/jamanetworkopen.2019.12869</ArticleId><ArticleId IdType="pii">2752575</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Sherman RE, Anderson SA, Dal Pan GJ, et al. . Real-world evidence&#x2014;what is it and what can it tell us? N Engl J Med. 2016;375(23):-. doi:10.1056/NEJMsb1609216</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMsb1609216</ArticleId><ArticleId IdType="pubmed">27959688</ArticleId></ArticleIdList></Reference><Reference><Citation>Institute of Medicine Forum on Drug Discovery, Development, and Translation Transforming Clinical Research in the United States: Challenges and Opportunities: Workshop Summary. Washington, DC:National Academies Press; 2010.</Citation><ArticleIdList><ArticleId IdType="pubmed">21210556</ArticleId></ArticleIdList></Reference><Reference><Citation>Dhruva SS, Ross JS, Desai NR. Real-world evidence: promise and peril for medical product evaluation. P T. 2018;43(8):464-472.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6065494</ArticleId><ArticleId IdType="pubmed">30100687</ArticleId></ArticleIdList></Reference><Reference><Citation>US Food and Drug Administration  Use of real-world evidence to support regulatory decision-making for medical devices: guidance for industry and Food and Drug Administration staff. https://www.fda.gov/downloads/medicaldevices/deviceregulationandguidance/guidancedocuments/ucm513027.pdf. Published August 2017. Accessed August 31, 2019.</Citation></Reference><Reference><Citation>National Academies of Sciences, Engineering, and Medicine; Health and Medicine Division; Board on Health Sciences Policy; Forum on Drug Discovery, Development, and Translation. Real-World Evidence Generation and Evaluation of Therapeutics: Proceedings of a Workshop Washington, DC: National Academies Press; 2017.</Citation><ArticleIdList><ArticleId IdType="pubmed">28211655</ArticleId></ArticleIdList></Reference><Reference><Citation>Hannan EL. Randomized clinical trials and observational studies: guidelines for assessing respective strengths and limitations. JACC Cardiovasc Interv. 2008;1(3):211-217. doi:10.1016/j.jcin.2008.01.008</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jcin.2008.01.008</ArticleId><ArticleId IdType="pubmed">19463302</ArticleId></ArticleIdList></Reference><Reference><Citation>Fleurence RL, Curtis LH, Califf RM, Platt R, Selby JV, Brown JS. Launching PCORnet, a national patient-centered clinical research network. J Am Med Inform Assoc. 2014;21(4):578-582. doi:10.1136/amiajnl-2014-002747</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/amiajnl-2014-002747</ArticleId><ArticleId IdType="pmc">PMC4078292</ArticleId><ArticleId IdType="pubmed">24821743</ArticleId></ArticleIdList></Reference><Reference><Citation>Cowie MR, Blomster JI, Curtis LH, et al. . Electronic health records to facilitate clinical research. Clin Res Cardiol. 2017;106(1):1-9. doi:10.1007/s00392-016-1025-6</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00392-016-1025-6</ArticleId><ArticleId IdType="pmc">PMC5226988</ArticleId><ArticleId IdType="pubmed">27557678</ArticleId></ArticleIdList></Reference><Reference><Citation>Kesselheim AS, Avorn J. New &#x201c;21st Century Cures&#x201d; legislation: speed and ease vs science. JAMA. 2017;317(6):581-582. doi:10.1001/jama.2016.20640</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2016.20640</ArticleId><ArticleId IdType="pubmed">28056124</ArticleId></ArticleIdList></Reference><Reference><Citation>US Food and Drug Administration  Federal Food, Drug, and Cosmetic Act. https://www.fda.gov/regulatory-information/laws-enforced-fda/federal-food-drug-and-cosmetic-act-fdc-act. Accessed August 31, 2019.</Citation></Reference><Reference><Citation>Thomson Reuters. InCites Journal Citation Reports. https://jcr.clarivate.com. Accessed June 30, 2018.</Citation></Reference><Reference><Citation>Dhruva SS, Ross JS, Schulz WL, Krumholz HM. Fulfilling the promise of unique device identifiers. Ann Intern Med. 2018;169(3):183-185. doi:10.7326/M18-0526</Citation><ArticleIdList><ArticleId IdType="doi">10.7326/M18-0526</ArticleId><ArticleId IdType="pubmed">29868760</ArticleId></ArticleIdList></Reference><Reference><Citation>US National Library of Medicine 
https://clinicaltrials.gov. Accessed October 8, 2018.</Citation></Reference><Reference><Citation>Resnic FS, Majithia A, Marinac-Dabic D, et al. . Registry-based prospective, active surveillance of medical-device safety. N Engl J Med. 2017;376(6):526-535. doi:10.1056/NEJMoa1516333</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa1516333</ArticleId><ArticleId IdType="pmc">PMC6145132</ArticleId><ArticleId IdType="pubmed">28121489</ArticleId></ArticleIdList></Reference><Reference><Citation>Luo Y, Thompson WK, Herr TM, et al. . Natural language processing for EHR-based pharmacovigilance: a structured review. Drug Saf. 2017;40(11):1075-1089. doi:10.1007/s40264-017-0558-6</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s40264-017-0558-6</ArticleId><ArticleId IdType="pubmed">28643174</ArticleId></ArticleIdList></Reference><Reference><Citation>Moses H III, Matheson DH, Cairns-Smith S, George BP, Palisch C, Dorsey ER. The anatomy of medical research: US and international comparisons. JAMA. 2015;313(2):174-189. doi:10.1001/jama.2014.15939</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2014.15939</ArticleId><ArticleId IdType="pubmed">25585329</ArticleId></ArticleIdList></Reference><Reference><Citation>DiMasi JA, Grabowski HG, Hansen RW. Innovation in the pharmaceutical industry: new estimates of R&amp;D costs. J Health Econ. 2016;47:20-33. doi:10.1016/j.jhealeco.2016.01.012</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jhealeco.2016.01.012</ArticleId><ArticleId IdType="pubmed">26928437</ArticleId></ArticleIdList></Reference><Reference><Citation>Pease AM, Krumholz HM, Downing NS, Aminawung JA, Shah ND, Ross JS. Postapproval studies of drugs initially approved by the FDA on the basis of limited evidence: systematic review. BMJ. 2017;357:j1680. doi:10.1136/bmj.j1680</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.j1680</ArticleId><ArticleId IdType="pmc">PMC5421452</ArticleId><ArticleId IdType="pubmed">28468750</ArticleId></ArticleIdList></Reference><Reference><Citation>Downing NS, Shah ND, Aminawung JA, et al. . Postmarket safety events among novel therapeutics approved by the US Food and Drug Administration between 2001 and 2010. JAMA. 2017;317(18):1854-1863. doi:10.1001/jama.2017.5150</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2017.5150</ArticleId><ArticleId IdType="pmc">PMC5815036</ArticleId><ArticleId IdType="pubmed">28492899</ArticleId></ArticleIdList></Reference><Reference><Citation>Darrow JJ, Avorn J, Kesselheim AS. New FDA breakthrough-drug category&#x2013;implications for patients. N Engl J Med. 2014;370(13):1252-1258. doi:10.1056/NEJMhle1311493</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMhle1311493</ArticleId><ArticleId IdType="pubmed">24670173</ArticleId></ArticleIdList></Reference><Reference><Citation>Mess&#xe9; SR, Kent DM. Still no closure on the question of PFO closure. N Engl J Med. 2013;368(12):1152-1153. doi:10.1056/NEJMe1301680</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMe1301680</ArticleId><ArticleId IdType="pmc">PMC4420155</ArticleId><ArticleId IdType="pubmed">23514293</ArticleId></ArticleIdList></Reference><Reference><Citation>Gottlieb S. FDA budget matters: a cross-cutting data enterprise for real world evidence. FDA Voices.https://www.fda.gov/NewsEvents/Newsroom/FDAVoices/ucm614669.htm. Published June 10, 2018. Accessed November 11, 2018.</Citation></Reference><Reference><Citation>US Food and Drug Administration  Framework for FDA&#x2019;s real-world evidence program. https://www.fda.gov/media/120060/download. Published December 2018. Accessed August 31, 2019.</Citation></Reference><Reference><Citation>Guimar&#xe3;es PO, Krishnamoorthy A, Kaltenbach LA, et al. . Accuracy of medical claims for identifying cardiovascular and bleeding events after myocardial infarction: a secondary analysis of the TRANSLATE-ACS study. JAMA Cardiol. 2017;2(7):750-757. doi:10.1001/jamacardio.2017.1460</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamacardio.2017.1460</ArticleId><ArticleId IdType="pmc">PMC5710613</ArticleId><ArticleId IdType="pubmed">28538984</ArticleId></ArticleIdList></Reference><Reference><Citation>Kiyota Y, Schneeweiss S, Glynn RJ, Cannuscio CC, Avorn J, Solomon DH. Accuracy of Medicare claims-based diagnosis of acute myocardial infarction: estimating positive predictive value on the basis of review of hospital records. Am Heart J. 2004;148(1):99-104. doi:10.1016/j.ahj.2004.02.013</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ahj.2004.02.013</ArticleId><ArticleId IdType="pubmed">15215798</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">31633087</PMID><DateRevised><Year>2025</Year><Month>01</Month><Day>08</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">2574-2531</ISSN><JournalIssue CitedMedium="Internet"><Volume>2</Volume><Issue>1</Issue><PubDate><Year>2019</Year><Month>Apr</Month></PubDate></JournalIssue><Title>JAMIA open</Title><ISOAbbreviation>JAMIA Open</ISOAbbreviation></Journal><ArticleTitle>ROMOP: a light-weight R package for interfacing with OMOP-formatted electronic health record data.</ArticleTitle><Pagination><StartPage>10</StartPage><EndPage>14</EndPage><MedlinePgn>10-14</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1093/jamiaopen/ooy059</ELocationID><Abstract><AbstractText Label="OBJECTIVES" NlmCategory="OBJECTIVE">Electronic health record (EHR) data are increasingly used for biomedical discoveries. The nature of the data, however, requires expertise in both data science and EHR structure. The Observational Medical Out-comes Partnership (OMOP) common data model (CDM) standardizes the language and structure of EHR data to promote interoperability of EHR data for research. While the OMOP CDM is valuable and more attuned to research purposes, it still requires extensive domain knowledge to utilize effectively, potentially limiting more widespread adoption of EHR data for research and quality improvement.</AbstractText><AbstractText Label="MATERIALS AND METHODS" NlmCategory="METHODS">We have created ROMOP: an R package for direct interfacing with EHR data in the OMOP CDM format.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">ROMOP streamlines typical EHR-related data processes. Its functions include exploration of data types, extraction and summarization of patient clinical and demographic data, and patient searches using any CDM vocabulary concept.</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">ROMOP is freely available under the Massachusetts Institute of Technology (MIT) license and can be obtained from GitHub (http://github.com/BenGlicksberg/ROMOP). We detail instructions for setup and use in the Supplementary Materials. Additionally, we provide a public sandbox server containing synthesized clinical data for users to explore OMOP data and ROMOP (http://romop.ucsf.edu).</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Glicksberg</LastName><ForeName>Benjamin S</ForeName><Initials>BS</Initials><AffiliationInfo><Affiliation>Department of Pediatrics Bakar Computational Health Sciences Institute, University of California San Francisco, San Francisco, California, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Oskotsky</LastName><ForeName>Boris</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Department of Pediatrics Bakar Computational Health Sciences Institute, University of California San Francisco, San Francisco, California, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Giangreco</LastName><ForeName>Nicholas</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Departments of Biomedical Informatics, Systems Biology, and Medicine, Columbia University, New York, New York, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Thangaraj</LastName><ForeName>Phyllis M</ForeName><Initials>PM</Initials><AffiliationInfo><Affiliation>Departments of Biomedical Informatics, Systems Biology, and Medicine, Columbia University, New York, New York, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rudrapatna</LastName><ForeName>Vivek</ForeName><Initials>V</Initials><AffiliationInfo><Affiliation>Department of Pediatrics Bakar Computational Health Sciences Institute, University of California San Francisco, San Francisco, California, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Datta</LastName><ForeName>Debajyoti</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Department of Pediatrics Bakar Computational Health Sciences Institute, University of California San Francisco, San Francisco, California, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Frazier</LastName><ForeName>Remi</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Academic Research Systems, Department of Enterprise Data Warehouse University of California San Francisco, San Francisco, California, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lee</LastName><ForeName>Nelson</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Academic Research Systems, Department of Enterprise Data Warehouse University of California San Francisco, San Francisco, California, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Larsen</LastName><ForeName>Rick</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Academic Research Systems, Department of Enterprise Data Warehouse University of California San Francisco, San Francisco, California, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tatonetti</LastName><ForeName>Nicholas P</ForeName><Initials>NP</Initials><AffiliationInfo><Affiliation>Departments of Biomedical Informatics, Systems Biology, and Medicine, Columbia University, New York, New York, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Butte</LastName><ForeName>Atul J</ForeName><Initials>AJ</Initials><AffiliationInfo><Affiliation>Department of Pediatrics Bakar Computational Health Sciences Institute, University of California San Francisco, San Francisco, California, USA.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>F30 HL140946</GrantID><Acronym>HL</Acronym><Agency>NHLBI NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R35 GM131905</GrantID><Acronym>GM</Acronym><Agency>NIGMS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>T32 CA108462</GrantID><Acronym>CA</Acronym><Agency>NCI NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>UL1 TR001872</GrantID><Acronym>TR</Acronym><Agency>NCATS NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2019</Year><Month>01</Month><Day>04</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>JAMIA Open</MedlineTA><NlmUniqueID>101730643</NlmUniqueID><ISSNLinking>2574-2531</ISSNLinking></MedlineJournalInfo><CoiStatement>Conflict of interest statement. None declared.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2019</Year><Month>10</Month><Day>22</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2019</Year><Month>10</Month><Day>22</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2019</Year><Month>10</Month><Day>22</Day><Hour>6</Hour><Minute>1</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2019</Year><Month>1</Month><Day>4</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">31633087</ArticleId><ArticleId IdType="mid">NIHMS1052565</ArticleId><ArticleId IdType="pmc">PMC6800657</ArticleId><ArticleId IdType="doi">10.1093/jamiaopen/ooy059</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Blumenthal D, Tavenner M.. The &#x201c;meaningful use&#x201d; regulation for electronic health records. N Engl J Med 2010; 3636: 501&#x2013;4.</Citation><ArticleIdList><ArticleId IdType="pubmed">20647183</ArticleId></ArticleIdList></Reference><Reference><Citation>Jensen PB, Jensen LJ, Brunak S.. Mining electronic health records: towards better research applications and clinical care. Nat Rev Genet 2012; 136: 395&#x2013;405.</Citation><ArticleIdList><ArticleId IdType="pubmed">22549152</ArticleId></ArticleIdList></Reference><Reference><Citation>Bodenreider O. The Unified Medical Language System (UMLS): integrating biomedical terminology. Nucleic Acids Res 2004; 32: D267&#x2013;70.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC308795</ArticleId><ArticleId IdType="pubmed">14681409</ArticleId></ArticleIdList></Reference><Reference><Citation>Huser V, DeFalco FJ, Schuemie M, et al. Multisite evaluation of a data quality tool for patient-level clinical data sets. EGEMS (Wash DC) 2016; 41: 1239.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5226382</ArticleId><ArticleId IdType="pubmed">28154833</ArticleId></ArticleIdList></Reference><Reference><Citation>Shaddox TR, Ryan PB, Schuemie MJ, Madigan D, Suchard MA.. Hierarchical models for multiple, rare outcomes using massive observational healthcare databases. Stat Anal Data Min 2016; 94: 260&#x2013;8.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5423675</ArticleId><ArticleId IdType="pubmed">28503249</ArticleId></ArticleIdList></Reference><Reference><Citation>Duke JD, Ryan PB, Suchard MA, et al. Risk of angioedema associated with levetiracetam compared with phenytoin: findings of the observational health data sciences and informatics research network. Epilepsia 2017; 588: e101&#x2013;6.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6632067</ArticleId><ArticleId IdType="pubmed">28681416</ArticleId></ArticleIdList></Reference><Reference><Citation>Garza M, Del Fiol G, Tenenbaum J, Walden A, Zozus MN.. Evaluating common data models for use with a longitudinal community registry. J Biomed Inform 2016; 64: 333&#x2013;41.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6810649</ArticleId><ArticleId IdType="pubmed">27989817</ArticleId></ArticleIdList></Reference><Reference><Citation>Rajkomar A, Oren E, Chen K, et al. Scalable and accurate deep learning with electronic health records. NPJ Digit Med 2018; 11: 18.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6550175</ArticleId><ArticleId IdType="pubmed">31304302</ArticleId></ArticleIdList></Reference><Reference><Citation>Vashisht R, Jung K, Shah N.. Learning effective treatment pathways for type-2 diabetes from a clinical data warehouse. AMIA Annu Symp Proc 2016; 2016: 2036&#x2013;42.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5333256</ArticleId><ArticleId IdType="pubmed">28269963</ArticleId></ArticleIdList></Reference><Reference><Citation>
Wickham H, Danenberg P, Eugster M.. 
roxygen2: in-source documentation for R
https://cran.r-project.org/package=roxygen2 (version 6.0.1)2013; 3(0).</Citation></Reference><Reference><Citation>
Dowle M, Srinivasan A, Gorecki J,
et al.
Package &#x2018;data.table&#x2019;
2018. 
https://cran.r-project.org/web/packages/data.table/data.table.pdf (version 1.11.8)</Citation></Reference><Reference><Citation>
James D.
DBI: R database interface (2009); 2012. 
https://cran.r-project.org/web/packages/DBI/index.html (version 1.0.0).</Citation></Reference><Reference><Citation>
Wickham H, Francois R, Henry L, M&#xfc;ller K.. 
dplyr: A Grammar of Data Manipulation. R package version 0.5.0. Vienna: R Core Development Team; 2016. 
https://cran.r-project.org/web/packages/dplyr/dplyr.pdf (version 0.7.8)</Citation></Reference><Reference><Citation>
Hester J, Wickham H. odbc: connect to ODBC compatible databases (using the DBI interface). CRAN; 2018. 
https://cran.r-project.org/web/packages/odbc/odbc.pdf (version 1.1.5)</Citation></Reference><Reference><Citation>
Ooms J, James D, DebRoy S, Wickham H, Horner J.. 
RMySQL: Database Interface and MySQL Driver for R.
https://cran.r-project.org/web/packages/RMySQL/index.html (version 0.10.15); 3.</Citation></Reference><Reference><Citation>
Scheumie M, Suchard M.. 
DatabaseConnector: Connecting to Various Database Platforms
https://cran.r-project.org/web/packages/DatabaseConnector/index.html (version 2.2.0). 2018.</Citation></Reference><Reference><Citation>
Scheumie M, Suchard M.. 
DatabaseConnectorJars: JAR Dependencies for the &#x2018;DatabaseConnector&#x2019; Package
https://cran.r-project.org/web/packages/DatabaseConnectorJars/index.html (version 1.0.0). 2018.</Citation></Reference><Reference><Citation>
Scheumie M, Suchard M.. 
SqlRender: Rendering Parameterized SQL and Translation to Dialects
https://cran.r-project.org/web/packages/SqlRender/index.html (version 1.5.2). 2018.</Citation></Reference><Reference><Citation>
Wickham H, Chang W.. 
devtools: Tools to Make Developing R Packages Easier
https://cran.r-project.org/web/packages/devtools/index.html (version 1.13.6). 2016.</Citation></Reference><Reference><Citation>
Chang W, Cheng J, Allaire JJ, Xie Y, McPherson J.. 
Shiny: Web Application Framework for R.
https://cran.r-project.org/web/packages/shiny/index.html (version 1.1.0); 1 (4): 106.</Citation></Reference><Reference><Citation>
Schloerke B, Allaire J, Borges B.. 
learnr: Interactive Tutorials for R.
https://cran.rstudio.com/web/packages/learnr/index.html (version 0.9.2.1)
2018.</Citation></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">31645076</PMID><DateCompleted><Year>2020</Year><Month>07</Month><Day>02</Day></DateCompleted><DateRevised><Year>2020</Year><Month>10</Month><Day>01</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1869-0327</ISSN><JournalIssue CitedMedium="Internet"><Volume>10</Volume><Issue>5</Issue><PubDate><Year>2019</Year><Month>Oct</Month></PubDate></JournalIssue><Title>Applied clinical informatics</Title><ISOAbbreviation>Appl Clin Inform</ISOAbbreviation></Journal><ArticleTitle>Incrementally Transforming Electronic Medical Records into the Observational Medical Outcomes Partnership Common Data Model: A Multidimensional Quality Assurance Approach.</ArticleTitle><Pagination><StartPage>794</StartPage><EndPage>803</EndPage><MedlinePgn>794-803</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1055/s-0039-1697598</ELocationID><Abstract><AbstractText Label="BACKGROUND">The development and adoption of health care common data models (CDMs) has addressed some of the logistical challenges of performing research on data generated from disparate health care systems by standardizing data representations and leveraging standardized terminology to express clinical information consistently. However, transforming a data system into a CDM is not a trivial task, and maintaining an operational, enterprise capable CDM that is incrementally updated within a data warehouse is challenging.</AbstractText><AbstractText Label="OBJECTIVES">To develop a quality assurance (QA) process and code base to accompany our incremental transformation of the Department of Veterans Affairs Corporate Data Warehouse health care database into the Observational Medical Outcomes Partnership (OMOP) CDM to prevent incremental load errors.</AbstractText><AbstractText Label="METHODS">We designed and implemented a multistage QA) approach centered on completeness, value conformance, and relational conformance data-quality elements. For each element we describe key incremental load challenges, our extract, transform, and load (ETL) solution of data to overcome those challenges, and potential impacts of incremental load failure.</AbstractText><AbstractText Label="RESULTS">Completeness and value conformance data-quality elements are most affected by incremental changes to the CDW, while updates to source identifiers impact relational conformance. ETL failures surrounding these elements lead to incomplete and inaccurate capture of clinical concepts as well as data fragmentation across patients, providers, and locations.</AbstractText><AbstractText Label="CONCLUSION">Development of robust QA processes supporting accurate transformation of OMOP and other CDMs from source data is still in evolution, and opportunities exist to extend the existing QA framework and tools used for incremental ETL QA processes.</AbstractText><CopyrightInformation>Georg Thieme Verlag KG Stuttgart &#xb7; New York.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Lynch</LastName><ForeName>Kristine E</ForeName><Initials>KE</Initials><AffiliationInfo><Affiliation>VA Salt Lake City Health Care System, Salt Lake City, Utah, United States.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Internal Medicine, Division of Epidemiology, University of Utah, Salt Lake City, Utah, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Deppen</LastName><ForeName>Stephen A</ForeName><Initials>SA</Initials><AffiliationInfo><Affiliation>Vanderbilt University Medical Center, Nashville, Tennessee, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>DuVall</LastName><ForeName>Scott L</ForeName><Initials>SL</Initials><AffiliationInfo><Affiliation>VA Salt Lake City Health Care System, Salt Lake City, Utah, United States.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Internal Medicine, Division of Epidemiology, University of Utah, Salt Lake City, Utah, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Viernes</LastName><ForeName>Benjamin</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>VA Salt Lake City Health Care System, Salt Lake City, Utah, United States.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Internal Medicine, Division of Epidemiology, University of Utah, Salt Lake City, Utah, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cao</LastName><ForeName>Aize</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Vanderbilt University Medical Center, Nashville, Tennessee, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Park</LastName><ForeName>Daniel</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Tennessee Valley Healthcare System, Nashville, Tennessee, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hanchrow</LastName><ForeName>Elizabeth</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Vanderbilt University Medical Center, Nashville, Tennessee, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hewa</LastName><ForeName>Kushan</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Vanderbilt University Medical Center, Nashville, Tennessee, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Greaves</LastName><ForeName>Peter</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Vanderbilt University Medical Center, Nashville, Tennessee, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Matheny</LastName><ForeName>Michael E</ForeName><Initials>ME</Initials><AffiliationInfo><Affiliation>Vanderbilt University Medical Center, Nashville, Tennessee, United States.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Tennessee Valley Healthcare System, Nashville, Tennessee, United States.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013486">Research Support, U.S. Gov't, Non-P.H.S.</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2019</Year><Month>10</Month><Day>23</Day></ArticleDate></Article><MedlineJournalInfo><Country>Germany</Country><MedlineTA>Appl Clin Inform</MedlineTA><NlmUniqueID>101537732</NlmUniqueID><ISSNLinking>1869-0327</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D003695" MajorTopicYN="N">Delivery of Health Care</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D057286" MajorTopicYN="N">Electronic Health Records</DescriptorName><QualifierName UI="Q000706" MajorTopicYN="Y">statistics &amp; numerical data</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015233" MajorTopicYN="Y">Models, Statistical</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011785" MajorTopicYN="Y">Quality Assurance, Health Care</DescriptorName></MeshHeading></MeshHeadingList><CoiStatement>None declared.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2019</Year><Month>10</Month><Day>24</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2019</Year><Month>10</Month><Day>24</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2020</Year><Month>7</Month><Day>3</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2020</Year><Month>10</Month><Day>1</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">31645076</ArticleId><ArticleId IdType="pmc">PMC6811349</ArticleId><ArticleId IdType="doi">10.1055/s-0039-1697598</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Voss E A, Makadia R, Matcho A et al.Feasibility and utility of applications of the common data model to multiple, disparate observational health databases. J Am Med Inform Assoc. 2015;22(03):553&#x2013;564.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4457111</ArticleId><ArticleId IdType="pubmed">25670757</ArticleId></ArticleIdList></Reference><Reference><Citation>J&#xf6;rg T, DeBloch S.Towards generating ETL processes for incremental loadingIn: ACM International Conference Proceeding Series; September 10&#x2013;12, 2008; Coimbra, Portugal. pp. 101&#x2013;110</Citation></Reference><Reference><Citation>Post A R, Ai M, Kalsanka Pai A, Overcash M, Stephens D S. Architecting the data loading process for an i2b2 research data warehouse: full reload versus incremental updating. AMIA Annu Symp Proc. 2018;2017:1411&#x2013;1420.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5977612</ArticleId><ArticleId IdType="pubmed">29854210</ArticleId></ArticleIdList></Reference><Reference><Citation>Kahn M G, Brown J S, Chun A T et al.Transparent reporting of data quality in distributed data networks. EGEMS (Wash DC) 2015;3(01):1052.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4434997</ArticleId><ArticleId IdType="pubmed">25992385</ArticleId></ArticleIdList></Reference><Reference><Citation>Kahn M G, Callahan T J, Barnard J et al.A harmonized data quality assessment terminology and framework for the secondary use of electronic health record data. EGEMS (Wash DC) 2016;4(01):1244.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5051581</ArticleId><ArticleId IdType="pubmed">27713905</ArticleId></ArticleIdList></Reference><Reference><Citation>Hersh W R, Cimino J, Payne P R et al.Recommendations for the use of operational electronic health record data in comparative effectiveness research. EGEMS (Wash DC) 2013;1(01):1018.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4371471</ArticleId><ArticleId IdType="pubmed">25848563</ArticleId></ArticleIdList></Reference><Reference><Citation>Qualls L G, Phillips T A, Hammill B G et al.Evaluating foundational data quality in the National Patient-Centered Clinical Research Network (PCORnet&#xae;) EGEMS (Wash DC) 2018;6(01):3.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5983028</ArticleId><ArticleId IdType="pubmed">29881761</ArticleId></ArticleIdList></Reference><Reference><Citation>Hripcsak G, Duke J D, Shah N H et al.Observational Health Data Sciences and Informatics (OHDSI): opportunities for observational researchers. Stud Health Technol Inform. 2015;216:574&#x2013;578.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4815923</ArticleId><ArticleId IdType="pubmed">26262116</ArticleId></ArticleIdList></Reference><Reference><Citation>OHDSI. Available at:https://www.ohdsi.org. Accessed August 30, 2019</Citation></Reference><Reference><Citation>Makadia R, Ryan P B. Transforming the premier perspective hospital database into the Observational Medical Outcomes Partnership (OMOP) common data model. EGEMS (Wash DC) 2014;2(01):1110.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4371500</ArticleId><ArticleId IdType="pubmed">25848597</ArticleId></ArticleIdList></Reference><Reference><Citation>Matcho A, Ryan P, Fife D, Reich C. Fidelity assessment of a clinical practice research datalink conversion to the OMOP common data model. Drug Saf. 2014;37(11):945&#x2013;959.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4206771</ArticleId><ArticleId IdType="pubmed">25187016</ArticleId></ArticleIdList></Reference><Reference><Citation>Schwalm M, Raoul T, Chu D et al.PRM59 - Conversion of a French electronic medical record (EMR) database into the Observational Medical Outcomes Partnership common data model. Value Health. 2017;20(09):A741.</Citation></Reference><Reference><Citation>Maier C, Lang L, Storf H et al.Towards implementation of OMOP in a German university hospital consortium. Appl Clin Inform. 2018;9(01):54&#x2013;61.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5801887</ArticleId><ArticleId IdType="pubmed">29365340</ArticleId></ArticleIdList></Reference><Reference><Citation>Klann J G, Joss M AH, Embree K, Murphy S N. Data model harmonization for the All Of Us Research Program: transforming i2b2 data into the OMOP common data model. PLoS One. 2019;14(02):e0212463.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6380544</ArticleId><ArticleId IdType="pubmed">30779778</ArticleId></ArticleIdList></Reference><Reference><Citation>Yoon D, Ahn E K, Park M Y et al.Conversion and data quality assessment of electronic health record data at a Korean tertiary teaching hospital to a common data model for distributed network research. Healthc Inform Res. 2016;22(01):54&#x2013;58.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4756059</ArticleId><ArticleId IdType="pubmed">26893951</ArticleId></ArticleIdList></Reference><Reference><Citation>You S C, Lee S, Cho S Y et al.Conversion of national health insurance service-national sample cohort (NHIS-NSC) database into Observational Medical Outcomes Partnership-common data model (OMOP-CDM) Stud Health Technol Inform. 2017;245:467&#x2013;470.</Citation><ArticleIdList><ArticleId IdType="pubmed">29295138</ArticleId></ArticleIdList></Reference><Reference><Citation>FitzHenry F, Resnic F S, Robbins S L et al.Creating a common data model for comparative effectiveness with the Observational Medical Outcomes Partnership. Appl Clin Inform. 2015;6(03):536&#x2013;547.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4586341</ArticleId><ArticleId IdType="pubmed">26448797</ArticleId></ArticleIdList></Reference><Reference><Citation>U.S. Department of Veterans Affairs. National center for veterans analysis and statistics [11/13/2017]. Available at:https://www.va.gov/vetdata/Utilization.asp. Accessed August 30, 2019</Citation></Reference><Reference><Citation>Fihn S D, Francis J, Clancy C et al.Insights from advanced analytics at the Veterans Health Administration. Health Aff (Millwood) 2014;33(07):1203&#x2013;1211.</Citation><ArticleIdList><ArticleId IdType="pubmed">25006147</ArticleId></ArticleIdList></Reference><Reference><Citation>Singh R, Singh S. A description of classification of causes of data quality problems in data warehousing. International Journal of Computer Science Issues. 2010;7(03):41&#x2013;49.</Citation></Reference><Reference><Citation>Rupali G, Singh J. A review of contemporary data quality issues in data warehouse ETL environment. Journal on Today's Ideas &#x2013; Tomorrow's Technologies. 2014;2(02):153&#x2013;160.</Citation></Reference><Reference><Citation>Weiskopf N G, Bakken S, Hripcsak G, Weng C. A data quality assessment guideline for electronic health record data reuse. EGEMS (Wash DC) 2017;5(01):14.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5983018</ArticleId><ArticleId IdType="pubmed">29881734</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>